% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-08-17}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 4959.

\begin{enumerate}[leftmargin=*]
\item Pérez Rosal Sergio R., Faber Sonya C. (2026). \textit{Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement}. Psychedelics. [published; Crossref]. \href{https://doi.org/10.1016/j.psyche.2026.100029}{doi:10.1016/j.psyche.2026.100029}.
\item Albertyn Christopher P., Richard Jérémie, Shore Ron, Carlson Linda E. (2026). \textit{Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model}. Psychedelics. [published; Crossref]. \href{https://doi.org/10.1016/j.psyche.2026.100032}{doi:10.1016/j.psyche.2026.100032}.
\item Seyfourian P, Marks LC, Claar LD, Nahas Y, Keating M, Koch C, Rembado I (2026). \textit{Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.}. Journal of neuroscience methods. [published; PubMed]. \href{https://doi.org/10.1016/j.jneumeth.2026.110848}{doi:10.1016/j.jneumeth.2026.110848}.
\item Kelly Carlton M., Fradet Mathieu, Bostian Catherine M., Donnelly Anna, Ellis Sara, Ostacher Michael, Aaronson Scott, Suppes Trisha (2026). \textit{Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression}. Journal of Affective Disorders. [published; Crossref]. \href{https://doi.org/10.1016/j.jad.2026.122063}{doi:10.1016/j.jad.2026.122063}.
\item Ladislavová Lucie, Kútná Viera, Mazochová Kristýna, Šíchová Klára, Danda Hynek, Lhotková Eva, Uttl Libor, Brejtr Vojtěch, Syrová Kateřina, Mazoch Vladimír, Horsley Rachel, Páleníček Tomáš (2026). \textit{Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats}. Pharmacology Biochemistry and Behavior. [published; Crossref]. \href{https://doi.org/10.1016/j.pbb.2026.174231}{doi:10.1016/j.pbb.2026.174231}.
\item Yang Kevin H., Satybaldiyeva Nora, Kepner Wayne, Friedman Joseph, Ping Siyuan, Leas Eric C. (2026). \textit{Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults}. American Journal of Preventive Medicine. [published; Crossref]. \href{https://doi.org/10.1016/j.amepre.2026.108381}{doi:10.1016/j.amepre.2026.108381}.
\item Emmett Sonya K., Cameron Lee, Hestermann Mark, Holland Darren, Kessler Simon, McFarlane Luke, Chooi Yit-Heng, Moggach Stephen A. (2026). \textit{Single-crystal structure determination of psilocybin after dehydration}. Acta Crystallographica Section C Structural Chemistry. [published; Crossref]. \href{https://doi.org/10.1107/s2053229626007692}{doi:10.1107/s2053229626007692}.
\item Husein A, Traylor M, Vest MF, Wood BJ, Brogan M, Thomas A, McNeil S, Bhuiyan MAN, Hendricks P, Kelly JR, Gribben A, Al-Qahtani MM, Keys K, Edinoff AN, Patterson JC, Murnane KS (2026). \textit{Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251381806}{doi:10.1177/28314425251381806}.
\item Rich R, Laird K, Siddarth P, Youssef B, Schwartz GM, Ramos A, Sergi K, Linton M, Schwartzberg L, Kelly DF, Heinzerling KG (2026). \textit{A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251387655}{doi:10.1177/28314425251387655}.
\item Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL (2026). \textit{Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251404460}{doi:10.1177/28314425251404460}.
\item Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki (2026). \textit{Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress}. Neuropsychopharmacology Reports. [published; Crossref]. \href{https://doi.org/10.1002/npr2.70152}{doi:10.1002/npr2.70152}.
\item Cheung Katherine, Propes Caleigh, Yaden David B. (2026). \textit{Balancing safety and access in Oregon’s psilocybin services}. International Journal of Drug Policy. [published; Crossref]. \href{https://doi.org/10.1016/j.drugpo.2026.105384}{doi:10.1016/j.drugpo.2026.105384}.
\item Abrahms Zachary N., Majdi Mohammad, Madsen Siena M., Morton Chloe J., Sen Abhishek K., Fried Niya B., Sawyer Lily E., Cegielski Evelyn R., Spezzano Sean J., Jones J. Andrew (2026). \textit{Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases}. Metabolic Engineering. [published; Crossref]. \href{https://doi.org/10.1016/j.ymben.2026.102490}{doi:10.1016/j.ymben.2026.102490}.
\item Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC (2026). \textit{Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.}. Journal of clinical psychology. [published; PubMed]. \href{https://doi.org/10.1002/jclp.70167}{doi:10.1002/jclp.70167}.
\item Kelly C, Cooley BJ, Zeng L, Hurzeler T, Manning V, McNally GP, Watt J, Haber PS, Morley KC (2026). \textit{Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2026.106911}{doi:10.1016/j.neubiorev.2026.106911}.
\item Region Skane (2026). \textit{The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07169747}{source link}.
\item Johns Hopkins University (2026). \textit{Safety for Home Administration of Microdose Psilocybin Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06450210}{source link}.
\item Johns Hopkins University (2026). \textit{Psilocybin Administration With 5-HT1a Blockade}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07565493}{source link}.
\item VA Office of Research and Development (2026). \textit{A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07226232}{source link}.
\item Brian Ross (2026). \textit{Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00517}{doi:10.1556/2054.2026.00517}.
\item Meshkat S, Leung M, Meshkat S, Lin Q, Wijendran D, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Monson CM, Vermetten E, Jetly R, Lou W, Zeifman RJ, Bhat V. (2026). \textit{Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.}. CNS drugs. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-026-01325-5}{doi:10.1007/s40263-026-01325-5}.
\item University of Wisconsin, Madison (2026). \textit{Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06692192}{source link}.
\item Rachel Yehuda (2026). \textit{Processing Intergenerational Trauma With Psilocybin-Assisted Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899165}{source link}.
\item Sharmin Ghaznavi (2026). \textit{The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06247839}{source link}.
\item Nathan Brashares Sackett (2026). \textit{PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06853912}{source link}.
\item Brigham and Women's Hospital (2026). \textit{Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296094}{source link}.
\item Anthony L. Back, Robert Bosnak (2026). \textit{Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2026.1895181}{doi:10.3389/fpsyt.2026.1895181}.
\item Anderson D, Maillot N, Thomas CW, Golden CT, Gilmour G, Robinson ES. (2026). \textit{Investigating the Effects of Psilocybin on Cognitive Flexibility in Touchscreen and Naturalistic Variations of the Probabilistic Reversal Learning Task}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.08.06.743309}{doi:10.64898/2026.08.06.743309}.
\item Thompson S, Effinger D, Novick A, Bates S, Conley A, Tobin-Cambell C, Epperson N, Skievaski N. (2026). \textit{Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and Colorado}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.08.11.26360133}{doi:10.64898/2026.08.11.26360133}.
\item Salgaço Mateus Kawata, Farias David de Paulo, Souza Mariela Zucolo de, Sartoratto Adilson, Bottino Flavia, Barud Hernane da Silva, Oliveira Fellipe Lopes de, Medeiros Alexandra Ivo de, Raimundo Breno Vilas Boas, Nascimento Victor Hugo, Galdino Taynah P., Silva Suédina M. L., Fook Marcus V. L., Sivieri Katia (2026). \textit{Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety}. Drugs and Drug Candidates. [published; Crossref]. \href{https://doi.org/10.3390/ddc5030046}{doi:10.3390/ddc5030046}.
\item Anghel Teodora, Cojocaru Adriana, Hogea Lavinia, Costea Iuliana, Marinca Amalia, Dumache Raluca, Nussbaum Laura, Trăilă Iuliana-Anamaria (2026). \textit{Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)}. Journal of Clinical Medicine. [published; Crossref]. \href{https://doi.org/10.3390/jcm15166228}{doi:10.3390/jcm15166228}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06200155}{source link}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06801041}{source link}.
\item NYU Langone Health (2026). \textit{Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06349083}{source link}.
\item The University of Texas Health Science Center, Houston (2026). \textit{Acceptability \& Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06706232}{source link}.
\item Roswell Park Cancer Institute (2026). \textit{Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06827054}{source link}.
\item M.D. Anderson Cancer Center (2026). \textit{NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07227909}{source link}.
\item Claudio N Soares (2026). \textit{A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06969170}{source link}.
\item Saanvi Gutta (2026). \textit{Psychedelic Therapy for Depression}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21893916}{doi:10.5281/zenodo.21893916}.
\item Kaadt E, Søkilde RF, Garling HD, Raval NR, Lundgaard L, Just J, Knudsen GM, Elfving B. (2026). \textit{Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.}. European journal of pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ejphar.2026.179222}{doi:10.1016/j.ejphar.2026.179222}.
\item Todesco S, Allan Z, Liu MYM, Schütz C. (2026). \textit{Effects of naturalistic psychedelic use on executive functioning: An online survey of lifetime history and recent use in university students.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111888}{doi:10.1016/j.pnpbp.2026.111888}.
\item Ke X, Du X, Wang X. (2026). \textit{Psychedelics and astrocytes: a hypothesis-driven perspective on neuro-glial integration, network plasticity, and neuroimmune reprogramming.}. Molecular psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03816-9}{doi:10.1038/s41380-026-03816-9}.
\item Nicky Mehtani, MD, MPH (2026). \textit{Psilocybin Recovery Intervention for Stopping Methamphetamine Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07756736}{source link}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06656702}{source link}.
\item Ijaz Durrani (2026). \textit{Could Psilocybin Be the Key to Treating Anorexia? -Breaking the Mind's Most Stubborn Loop}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.13140/rg.2.2.11011.26400}{doi:10.13140/rg.2.2.11011.26400}.
\item O’Shea A, Mason NL, Briede JJ, Schreiber R, Verheijen MC, Krauskopf J, Ramaekers JG. (2026). \textit{Circulating MicroRNAs and Their Associations with Neurotrophic, Inflammatory and Glutamate Markers in Healthy Volunteers}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.08.04.742737}{doi:10.64898/2026.08.04.742737}.
\item O’Shea A, Mason N, Schreiber R, Verheijen MC, Ramaekers JG, Briedé JJ, Krauskopf J. (2026). \textit{Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in healthy young adults}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.08.04.742716}{doi:10.64898/2026.08.04.742716}.
\item Mason N, Mallaroni P, Kuypers K, De La Torre Fornell R, Reckweg J, Preller K, Ramaekers J. (2026). \textit{Psilocybin acutely dissociates cognitive and affective empathy, with empathic concern predicting persisting positive psychological effects}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.08.04.742704}{doi:10.64898/2026.08.04.742704}.
\item Kothiwala FM, Murphy RJ, Alshakhouri M, Douglass HM, Evans WJ, Paterson T, Muthukumaraswamy S, Sumner RL. (2026). \textit{An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.}. Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1159/pha/aejag002}{doi:10.1159/pha/aejag002}.
\item Charles Raison (2026). \textit{An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512194}{source link}.
\item COMPASS Pathways (2026). \textit{A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05711940}{source link}.
\item James J. Peters Veterans Affairs Medical Center (2026). \textit{Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07251491}{source link}.
\item COMPASS Pathways (2026). \textit{A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05624268}{source link}.
\item University of Colorado, Denver (2026). \textit{A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07516405}{source link}.
\item University Health Network, Toronto (2026). \textit{Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06506019}{source link}.
\item Ham R, Gardner J, Carter A, Liknaitzky P. (2026). \textit{'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.}. Psychology and psychotherapy. [published; Europe PMC]. \href{https://doi.org/10.1111/papt.70098}{doi:10.1111/papt.70098}.
\item Gary Enos (2026). \textit{Advanced research eyes potential of psychedelics for complex cases}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.34966}{doi:10.1002/mhw.34966}.
\item Petranker R, Syed OA, Sobolenko V, Giacobbe P, Kruger DJ, Aday JS, Lake S, Lucas P. (2026). \textit{Microdosing psychedelics: What, why, when, and how often? Insights from an international survey of people who use psychedelics.}. The International journal on drug policy. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2026.105459}{doi:10.1016/j.drugpo.2026.105459}.
\item Dean JG, Hurwitz E, Furnish T, Castellanos J, McKinty A, Farrell B, Barrows D, Peck SK, Trim J, Samadhi E, Renwick G, Mudge R, Vieten C, Cuccurazzu B, Coleman P, Lin A, Geyer MA, Zeidan F, Halberstadt AL. (2026). \textit{Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.}. The journal of pain. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpain.2026.106404}{doi:10.1016/j.jpain.2026.106404}.
\item Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA. (2026). \textit{Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.}. CNS drugs. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-026-01326-4}{doi:10.1007/s40263-026-01326-4}.
\item National Institute on Aging (NIA) (2026). \textit{Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07721467}{source link}.
\item Joshua Woolley, MD, PhD (2026). \textit{The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06455293}{source link}.
\item Johns Hopkins University (2026). \textit{Open Label Psilocybin Brain Stimulation and Imaging Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06835699}{source link}.
\item Giovenzana M, Nicosia N, Spinosa S, Musazzi L, Mingardi J. (2026). \textit{Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.}. Pharmacological research. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2026.108366}{doi:10.1016/j.phrs.2026.108366}.
\item Hörnqvist N. (2026). \textit{Correspondence: "Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy".}. Journal of affective disorders. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2026.122315}{doi:10.1016/j.jad.2026.122315}.
\item Rucker JJ, Mantingh T, Kerr-Gaffney J, Bird C, Chu P, Modlin NL, Campbell-Coker K, Hambleton S, Seath P, Hignett R, Fennema D, Hampsey E, Tsapekos D, Thomas RJ, Cattell J, Jafari H, Day C, Borissova A, Lloyd M, Boardman-Pretty T, Seynaeve M, Askari F, Creed M, Baxter L, Rifkin-Zybutz R, Butler M, Jelen LA, Carter B, Young AH. (2026). \textit{Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.}. Nature medicine. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-026-04541-0}{doi:10.1038/s41591-026-04541-0}.
\item Trent Emerick (2026). \textit{Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07406828}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06731621}{source link}.
\item University of Southern California (2026). \textit{An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06233344}{source link}.
\item Chiu YT, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD, Llorach P, Bowyer KR, Liu B, Sciaky N, Hua K, Chen C, Mott SE, Niehaus J, DiBerto JF, English J, Walsh JJ, Scherrer G, Herman MA, Wu Z, Wetsel WC, Roth BL. (2026). \textit{A suite of engineered mice for interrogating psychedelic drug actions.}. Nature neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1038/s41593-026-02375-0}{doi:10.1038/s41593-026-02375-0}.
\item Li, Z.; Weber, C.; Sellitti, F.; Simmler, L. D. (2026). \textit{Mapping excitatory synaptic plasticity evoked by single-dose psilocybin in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.31.741703}{doi:10.64898/2026.07.31.741703}.
\item Ippolito A, Tiranti A, Hurley S, Gilmour G, Churchill G, Sharp T (2026). \textit{Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00138}{doi:10.1021/acschemneuro.6c00138}.
\item Yvan Beaussant, MD, MSci (2026). \textit{Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06001749}{source link}.
\item Thomas JE, Dellarole A, Caballero J (2026). \textit{Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review.}. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists. [published; PubMed]. \href{https://doi.org/10.1093/ajhp/zxag062}{doi:10.1093/ajhp/zxag062}.
\item University of New Mexico (2026). \textit{Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07745569}{source link}.
\item Kuypers KPC, Mason NL, Carlier A, Totomanova I, Haijen-Bongers ECHM. (2026). \textit{Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.}. Molecular psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03801-2}{doi:10.1038/s41380-026-03801-2}.
\item Martin, H. M.; Cofre, R.; Destexhe, A. (2026). \textit{Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.20.683366}{doi:10.1101/2025.10.20.683366}.
\item Frederik Gudmundsen, Julia Czurylo, Daniel Ryskamp Rijsketic, Camilla Trang Vo, Janika Ruuska, Naja S. Jessen, Sophie Woodruff, Christina Baun, Matthias M. Herth, Vladimir Shalgunov, Boris D. Heifets, Patrick M. Fisher, Mikael Palner (2026). \textit{Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networks}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-026-75890-0}{doi:10.1038/s41467-026-75890-0}.
\item Gómez-Cañón JS, Leininger C, Mayall D, Dougherty RF, Bowling DL. (2026). \textit{Music for Psilocybin Therapy and the Temporal Arc of Psychedelic Experience}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-10403919/v1}{doi:10.21203/rs.3.rs-10403919/v1}.
\item Schaefer DA, Agrawal M, Mazzola E, Leff MK, Leeks C, Kematick BS, Beaussant Y. (2026). \textit{Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.}. Journal of pain and symptom management. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpainsymman.2026.07.030}{doi:10.1016/j.jpainsymman.2026.07.030}.
\item Werle I, Probst MEC, Bertoglio LJ. (2026). \textit{Where is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models.}. Journal of psychopharmacology (Oxford, England). [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261464979}{doi:10.1177/02698811261464979}.
\item Yale University (2026). \textit{Psilocybin as a Treatment for Chronic Pain in Smokers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07118332}{source link}.
\item Oregon Health and Science University (2026). \textit{Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06988319}{source link}.
\item Sinclair Rachel (2026). \textit{Evaluating psilocybin for the management of depression: a literature review}. British Journal of Mental Health Nursing. [published; Crossref]. \href{https://doi.org/10.12968/bjmh.2025.0020}{doi:10.12968/bjmh.2025.0020}.
\item Cho Matthew, Rosenbaum Daniel, Hapke Emma, Hales Sarah (2026). \textit{Psilocybin for Fear of Cancer Recurrence}. Supportive Care in Cancer. [published; Crossref]. \href{https://doi.org/10.1007/s00520-026-11065-3}{doi:10.1007/s00520-026-11065-3}.
\item Karel Richard B. (2026). \textit{One Dose of Psilocybin May Alter Brain Structure}. Psychiatric News. [published; Crossref]. \href{https://doi.org/10.1176/appi.pn.2026.08.8.12}{doi:10.1176/appi.pn.2026.08.8.12}.
\item Szarpak Lukasz, Pruc Michal, Swieczkowski Damian, Rybczynski Bernard, Pieta Aleksandra, Cubała Wiesław Jerzy (2026). \textit{Cardiovascular safety of psilocybin in psychiatric practice: a narrative review}. European Journal of Clinical Pharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00228-026-04151-2}{doi:10.1007/s00228-026-04151-2}.
\item Martiadis V (2026). \textit{From trial to clinic: psilocybin's efficacy in routine treatment-resistant depression.}. The Lancet regional health. Europe. [published; PubMed]. \href{https://doi.org/10.1016/j.lanepe.2026.101780}{doi:10.1016/j.lanepe.2026.101780}.
\item Chwyl Christina, Bazinet Alissa, Wilson-Poe Adrianne R., Hoffman Kim, Pertl Kellie, Wolf R. Cameron, Korthuis P. Todd, Luoma Jason B. (2026). \textit{Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study}. Neuroethics. [published; Crossref]. \href{https://doi.org/10.1007/s12152-026-09645-5}{doi:10.1007/s12152-026-09645-5}.
\item Kase M, Kaup KK, Aru J (2026). \textit{Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251412012}{doi:10.1177/02698811251412012}.
\item Jurowski Kamil, Kobylarz Damian, Noga Maciej (2026). \textit{In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin}. Archives of Toxicology. [published; Crossref]. \href{https://doi.org/10.1007/s00204-026-04365-4}{doi:10.1007/s00204-026-04365-4}.
\item Akbar Razeen J., Stringer Amy D., Wiah Sonita, Dachepalli Meghana, Daws Stephanie E., Inan Saadet, Rawls Scott M. (2026). \textit{Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/fbp.0000000000000879}{doi:10.1097/fbp.0000000000000879}.
\item Hampsey E, Martin K, Kalfas M, Benson L, Wihlborg S, Jelen L, Young AH, Rucker J (2026). \textit{A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261453938}{doi:10.1177/02698811261453938}.
\item Vicentini AB, de Paula CC, Silva Reis JA, Bouso JC, Hallak JEC, Dos Santos RG (2026). \textit{Classic psychedelics and personality: An updated systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261449386}{doi:10.1177/02698811261449386}.
\item Boehnke KF, Pouyan N, Aday JS (2026). \textit{Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-026-02339-5}{doi:10.1007/s40265-026-02339-5}.
\item Lu S, Zhang Z, Xue X, Jiang Y, Zhang C, Liu P, He D, Shen W, Yang S, Wang F (2026). \textit{Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.}. Hearing research. [published; PubMed]. \href{https://doi.org/10.1016/j.heares.2026.109701}{doi:10.1016/j.heares.2026.109701}.
\item Mingardi J., Molteni R., Bifari F. (2026). \textit{Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression}. Pharmacological Research. [published; Crossref]. \href{https://doi.org/10.1016/j.phrs.2026.108290}{doi:10.1016/j.phrs.2026.108290}.
\item Guimarães AL, Beserra FR, Cruz L, Bienemmann B, Freind JMK, Guinle V, Rodrigues RS, Regalado JA, Mograbi DC (2026). \textit{Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders.}. Clinical therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.clinthera.2026.05.012}{doi:10.1016/j.clinthera.2026.05.012}.
\item Potoczna M, Kasica N, Chmielewska-Krzesińska M, Dybalska-Szczepanek J, Wąsowicz K, Sokołowska E, Podlasz P (2026). \textit{Anxiety-related platform in zebrafish (Danio rerio) larvae: An integrated analysis of behavioural and molecular assay in drug screening research.}. Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie. [published; PubMed]. \href{https://doi.org/10.1016/j.biopha.2026.119680}{doi:10.1016/j.biopha.2026.119680}.
\item Kishi Taro, Sakuma Kenji, Hatano Masakazu, Uchida Hiroyuki, Iwata Nakao (2026). \textit{Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis}. Journal of Affective Disorders. [published; Crossref]. \href{https://doi.org/10.1016/j.jad.2026.121675}{doi:10.1016/j.jad.2026.121675}.
\item Goodwin Guy M., Aaronson Scott T., Alvarez Oscar, Carhart-Harris Robin, Croal Megan, Feifel David, Hellerstein David J., Husain Muhammad I., Kelly John R., Kirlic Namik, Licht Rasmus W., Marwood Lindsey, Nowakowska Ania, Páleníček Tomáš, Repantis Dimitris, Schoevers Robert A., Simmons Hollie, Soares Jair C., Somers Metten, Tsai Joyce, Wahba Mourad, Williams Ella, Young Allan H., Young Matthew B., Zisook Sidney, Malievskaia Ekaterina (2026). \textit{The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis}. Journal of Affective Disorders. [published; Crossref]. \href{https://doi.org/10.1016/j.jad.2026.121662}{doi:10.1016/j.jad.2026.121662}.
\item Feldman R, Audette M, Leacock PR, Theobald J (2026). \textit{A25-year analysis of Armillaria (honey mushroom) poisoning in Wisconsin.}. The American journal of emergency medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.ajem.2026.04.033}{doi:10.1016/j.ajem.2026.04.033}.
\item Berg CJ, LoParco CR, Rossheim ME, McCready DM, Langan L, Platt E, Romm KF, Johnson M, Speer MB, Burris S, Cavazos-Rehg PA (2026). \textit{Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2026.113218}{doi:10.1016/j.drugalcdep.2026.113218}.
\item Graham M, Ge Y, Pacula RL, Pessar SC, Wilkins C, Hall W, Hammond D (2026). \textit{A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2026.105348}{doi:10.1016/j.drugpo.2026.105348}.
\item Eric P. Rubenstein (2026). \textit{The Experience-Trajectory Framework: Substance-Specific Risk Stratification for Psychedelic Preparation and Aftercare Beyond Set and Setting}. International Journal For Multidisciplinary Research. [published; OpenAlex]. \href{https://doi.org/10.36948/ijfmr.2026.v08i04.84804}{doi:10.36948/ijfmr.2026.v08i04.84804}.
\item University of Washington (2026). \textit{A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07336238}{source link}.
\item Sergio R Pérez Rosal, Sonya Faber, M. Myriah MacIntyre, Monnica Williams (2026). \textit{Retreat from racism: A psychedelic group experience for racial stress and trauma}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2026.100031}{doi:10.1016/j.psyche.2026.100031}.
\item Lasham S, P B, W E, C P, A S, R P. (2026). \textit{Beyond psilocybin: Do magic mushroom preparations contain other compounds with pharmacological effects?}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/authorea.15006829/v1}{doi:10.22541/authorea.15006829/v1}.
\item Titus Scheid (2026). \textit{Shrooming Ahead: How the U.S. is Marching Toward Psilocybin Legalization and What Other Countries May Learn}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://scholarship.law.ufl.edu/fjil/vol36/iss1/6}{source link}.
\item Lorraine Li, Paige Seath, Nadav Liam Modlin, James Rucker (2026). \textit{Childhood trauma and psychological outcomes following psychedelic use: a scoping review}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-026-00233-2}{doi:10.1038/s44184-026-00233-2}.
\item Joshua Rosenblat (2026). \textit{Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07737990}{source link}.
\item Tel-Aviv Sourasky Medical Center (2026). \textit{Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07737054}{source link}.
\item Armstrong Stacey B., Levin Adam W., Sepeda Nathan D., Shaub Hillary, Hunter Taweh, Douglas Angela, Lancelotta Rafaelle, Davis Alan K. (2026). \textit{Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial}. Communications Medicine. [published; Crossref]. \href{https://doi.org/10.1038/s43856-026-01767-4}{doi:10.1038/s43856-026-01767-4}.
\item Centre for Addiction and Mental Health (2026). \textit{Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512220}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06518720}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07211438}{source link}.
\item Sams Caitlyn Hanna, Davis Jasmine, Ramdas Anuradha, Delgoda Rupika, Vidot Denise, Reid Marvin, De La Haye Winston (2026). \textit{Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica}. Frontiers in Psychiatry. [published; Crossref]. \href{https://doi.org/10.3389/fpsyt.2026.1876189}{doi:10.3389/fpsyt.2026.1876189}.
\item Scottsdale Research Institute (2026). \textit{An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07275970}{source link}.
\item University of Wisconsin, Madison (2026). \textit{Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05866471}{source link}.
\item Kareem Soliman (2026). \textit{Is BOLD Measurement-Invariant Across Pharmacological State? A Pre-Registered Test of Haemodynamic Response Function Drug-Invariance Using Simultaneous EEG-fMRI (PsiConnect)}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/hba3y}{doi:10.17605/osf.io/hba3y}.
\item Jones GH, Gilbert JR, Johnston JN, Akula N, Schulmann A, Arakelian M, Peng S, Yuan P, Winful EA, Yavi M, Quintanilla B, Elkahloun A, Moaddel R, Henter ID, Greenstein D, Machado-Vieira R, Bartley CM, Kadriu B, Amit M, Rezvani K, Kvarta MD, McMahon FJ, Zarate CA (2026). \textit{Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03777-z}{doi:10.1038/s41380-026-03777-z}.
\item Pontifícia Universidade Católica do Rio de Janeiro (2026). \textit{Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07732166}{source link}.
\item Fleury S, Chang LJ, Nautiyal KM. (2026). \textit{Identifying factors that contribute to the behavioral effects of psilocybin in preclinical mouse models}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.24.740586}{doi:10.64898/2026.07.24.740586}.
\item Wawrzczak-Bargieła Agnieszka, Jelonek-Kozioł Małgorzata, Kumorek Weronika, Bilecki Wiktor, Maćkowiak Marzena (2026). \textit{Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex}. Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00213-026-07132-6}{doi:10.1007/s00213-026-07132-6}.
\item Wilkowska A, Nizgorska-Ohler J, Cubała WJ (2026). \textit{Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.}. Molecular neurobiology. [published; PubMed]. \href{https://doi.org/10.1007/s12035-026-06086-2}{doi:10.1007/s12035-026-06086-2}.
\item Centre for Addiction and Mental Health (2026). \textit{Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06299319}{source link}.
\item Danial Beniameen, Armya Beniameen (2026). \textit{A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in Depression}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.1027}{doi:10.26685/urncst.1027}.
\item Torres Mc Cook, A. R.; Mimura, C. B.; Alvarez, L. D.; Liberman, A. C. (2026). \textit{Network Pharmacology-Guided Discovery of Fungal Autophagy Modulators for Tauopathies: Structural and Proteomic Evidence}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.24.740367}{doi:10.64898/2026.07.24.740367}.
\item Pereira de Oliveira AB, Hein M (2026). \textit{[Illicit use of classic psychedelics and suicidality: A systematic literature review].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2026.04.004}{doi:10.1016/j.encep.2026.04.004}.
\item Nicholas Vucak, Raimondo Bruno, Julio Quealy, James G. Casimaty, Susan L. Rossell, D Castle, Nicola Acevedo (2026). \textit{Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2026.100030}{doi:10.1016/j.psyche.2026.100030}.
\item O'Callaghan C, Kallianis V, Ross M (2026). \textit{Participants' Music Experiences Associated With Psychedelic-Assisted Psychotherapy for Life-Threatening Illness: Interpretivist Research.}. Journal of music therapy. [published; PubMed]. \href{https://doi.org/10.1093/jmt/thag015}{doi:10.1093/jmt/thag015}.
\item Charles Raison (2026). \textit{An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07719088}{source link}.
\item Johns Hopkins University (2026). \textit{Psilocybin and Affective Function in Chronic Lower Back Pain Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06355414}{source link}.
\item Parr BA, Young WB, Silberstein SD (2026). \textit{Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2026.2706794}{doi:10.1080/14737175.2026.2706794}.
\item Tyler WJ, Sellers E, McDonnell MB. (2026). \textit{Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure-Response Model}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.19.739440}{doi:10.64898/2026.07.19.739440}.
\item Bailey Neil Wayne, Webb Samantha Lee, Fitzgibbon Bernadette Mary, Denning Nigel Christopher, Dowie Traill, Schweickle Monica Margaret, Modak Anish, Chan Grace, Knight Jackie, Waldron Molly, Gainsford Kirsten, Hawkes Hannah, Zammit Sonia, Sutanto Novi Christina, Godfrey Kate, Fitzgerald Paul Bernard (2026). \textit{No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study}. Journal of Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1177/02698811261464991}{doi:10.1177/02698811261464991}.
\item Francisco A Moreno (2026). \textit{A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07347405}{source link}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05301608}{source link}.
\item King's College London (2026). \textit{Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05723276}{source link}.
\item Usona Institute (2026). \textit{A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06308653}{source link}.
\item Ohio State University (2026). \textit{A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06820723}{source link}.
\item Kunik AR, Christopher MW, Lemmond B, Dentinger BTM, Slot J, Garrett TJ, Smith ME (2026). \textit{The "dark magic mushroom" co-produces amatoxins and psilocybin.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.07.17.739257}{doi:10.64898/2026.07.17.739257}.
\item Pallavicini Carla, Llobenes Lorena, Cavanna Federico, de la Fuente Laura Alethia, Muller Stephanie, Costa María, Gumiy Natali, Bruno Nicolás, D'Amelio Tomás, Basran Jaskaran, Plowright Ptarmigan, Zamberlan Federico, Pasqualetti Guillermo, Stolkiner Ain, Namías Mauro, Gilbert Paul, Tagliazucchi Enzo (2026). \textit{Longitudinal neural and psychological changes following psilocybin under compassion imagery priming}. Frontiers in Human Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnhum.2026.1874178}{doi:10.3389/fnhum.2026.1874178}.
\item Cervera-Sanchez Miguel Benjamin, San-Juan Daniel, Díaz-Peregrino Roberto, Camacho-Castillo Evelin Zulema, Bringas-Ortiz Sthefany Anahi, Padilla-Cabezutd Christian (2026). \textit{Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations}. British Journal of Clinical Pharmacology. [published; Crossref]. \href{https://doi.org/10.1002/bcp.70690}{doi:10.1002/bcp.70690}.
\item Jacobs D, Pacheco AT, Olson R, Langdon AJ, Moghaddam B (2026). \textit{Psilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertainty.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.07.16.733837}{doi:10.64898/2026.07.16.733837}.
\item Johns Hopkins University (2026). \textit{PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610135}{source link}.
\item University of California, San Diego (2026). \textit{Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06814522}{source link}.
\item Yale University (2026). \textit{The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610369}{source link}.
\item Savalia NK, Shao LX, Knox CA, Gilbert AD, Jiang Q, Kwan AC (2026). \textit{Psychedelic drug action at dendrites is gated by behavioral state and serotonin receptors.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.07.16.738983}{doi:10.64898/2026.07.16.738983}.
\item Tsang Vivian WL, Kryskow Pamela, Watler Crosbie, Allard Pearl, Dames Shannon (2026). \textit{Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis}. Frontiers in Public Health. [published; Crossref]. \href{https://doi.org/10.3389/fpubh.2026.1767215}{doi:10.3389/fpubh.2026.1767215}.
\item Levy-Cooperman N, Sellers E, Glue P, Szeto I, Brown D, Jarecki-Smith J, Tyler WJ, McDonnell MB. (2026). \textit{A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.07.16.26358273}{doi:10.64898/2026.07.16.26358273}.
\item Gattuso James J., Kamal Ahmed, Payet Jennyfer M., Havaux Kato, Hendey Jenna, Bezcioglu Bilgenur, Phelan Zoe J., Orchard Maddy, Bhanot Divyesh, Hale Matthew W., Hannan Anthony J., Renoir Thibault (2026). \textit{Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-026-02501-3}{doi:10.1038/s41386-026-02501-3}.
\item Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra Blicharz, Wojciech Kozdraś, Lidia Kozaczko, Gabriela Szewczyk, Elżbieta Bukowczan, Alicja Zając, Damian Broda, Alicja Benecka (2026). \textit{Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21406174}{doi:10.5281/zenodo.21406174}.
\item Diamond Therapeutics Inc. (2026). \textit{A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07710027}{source link}.
\item Çağrı Özkurt (2026). \textit{Publication bias in randomized trials of psilocybin for depression: a Robust Bayesian Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6gy8v\_v1}{doi:10.31234/osf.io/6gy8v\_v1}.
\item Johns Hopkins University (2026). \textit{Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06067737}{source link}.
\item Jakub Bajer, Aleksandra Włodarczyk, Hubert Kulawinek, Julia Obersztyn, Krzysztof Kasparek, Marta Czech, Grzegorz Kasparek, Adrianna Szczecińska, Wiktoria Glanert, Aleksandra Mliczek, Piotr Mrozek (2026). \textit{Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2026.94.73071}{doi:10.12775/jehs.2026.94.73071}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Hidalgo Jiménez J, Martín-Guerrero SM, González-Maeso J, López-Giménez JF (2026). \textit{Integrated 5-HT-TrkB and G protein signaling in serotonergic psychedelic responses.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03746-6}{doi:10.1038/s41380-026-03746-6}.
\item Novicky F, Jajcay N, Hlinka J. (2026). \textit{Uncovering the spatiotemporal structure of neural avalanches through optimal transport and dynamic time warping}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.10.737743}{doi:10.64898/2026.07.10.737743}.
\item Dougherty Robert F., Modlin Nadav Liam, McGowan Niall M., Staples Patrick, Williams Ella, Clarke Patrick, Shafiei Mario, Leininger Carly, Alti Merve, Croal Megan, Marwood Lindsey, Kirlić Namik, Ryslik Gregory A., Goodwin Guy M. (2026). \textit{Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder}. Journal of Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1177/02698811261464988}{doi:10.1177/02698811261464988}.
\item Yale University (2026). \textit{Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07306364}{source link}.
\item Ron Shore (2026). \textit{The ANCHOR Framework for Psychedelic Accompaniment}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6jdaw\_v1}{doi:10.31234/osf.io/6jdaw\_v1}.
\item Johansen A, Plavén-Sigray P, Madsen MK, Søndergaard A, Messel C, Geisler M, Nasser A, McCulloch DE, Beliveau V, Vassilieva A, Lund A, Lehel S, Ozenne B, Stenbæk DS, Fisher PM, Svarer C, Knudsen GM (2026). \textit{Psilocybin's effect on human brain synaptic plasticity.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-026-04285-y}{doi:10.1038/s41398-026-04285-y}.
\item Shumake, Robert S. (Ajarn Shaman Shu | Oluwo Jolaoso Osainbola, PhD | Shri Suryanarayana Swamikal) (2026). \textit{Shurooms: The First Ethnomycological Study from Within the African Initiatory Tradition - Ewe, Soma, and the Ceremonial Architecture of Psilocybin Healing (N = 300+)}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21349907}{doi:10.5281/zenodo.21349907}.
\item Khyber Medical University Peshawar (2026). \textit{Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07703722}{source link}.
\item Zarrabi AJ, Mletzko T, Grant G, Peacock C, Palitsky R, McPherson T, Shub I, Eisenacher S, Maples-Keller JL, Kaplan D, Rothbaum BO, Rab F, Dalal N, Curseen KA, Raison C, Dunlop BW (2026). \textit{Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.}. medRxiv: the preprint server for health sciences. [published; PubMed]. \href{https://doi.org/10.64898/2026.07.11.26357570}{doi:10.64898/2026.07.11.26357570}.
\item Mason NL, Haijen-Bongers EC, Kuypers KP, Frick A, Toennes SW, Mallaroni P, Ramaekers JG. (2026). \textit{Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.08.737179}{doi:10.64898/2026.07.08.737179}.
\item Hörnqvist Nils (2026). \textit{Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00505}{doi:10.1556/2054.2026.00505}.
\item Yale University (2026). \textit{Mechanistic Studies of Psilocybin in Headache Disorders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06464367}{source link}.
\item Brinzei OV. (2026). \textit{MDMA and Psilocybin-Assisted Therapy in Australia: Early Real-World Prescribing, Safety Monitoring and Regulatory Developments}. ScienceOpen Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.14293/pr2199.004090.v1}{doi:10.14293/pr2199.004090.v1}.
\item Dong Albert M., Han Yi, Xu Zheng, Schlüter Oliver M., Huang Xiaojie (2026). \textit{Psilocybin-induced behavioral and cellular effects}. Journal of Neurogenetics. [published; Crossref]. \href{https://doi.org/10.1080/01677063.2026.2695462}{doi:10.1080/01677063.2026.2695462}.
\item Gary Enos (2026). \textit{National bill seeks to jump-start psychedelic treatment for veterans}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.34973}{doi:10.1002/adaw.34973}.
\item Nele Böhm, Frank Euteneuer (2026). \textit{Psilocybin bei Depression: Systematisches Review und Meta-Analyse zur antidepressiven Wirksamkeit}. OSF. [preprint; OpenAlex]. \href{https://doi.org/10.17605/osf.io/axgjw}{doi:10.17605/osf.io/axgjw}.
\item Lin C, Wang X (2026). \textit{Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03744-8}{doi:10.1038/s41380-026-03744-8}.
\item Thomas CW, LaMalfa KS, Whelan TP, Blackmore T, Golden CT, Pizzagalli DA, Bergman J, Gilmour G, Kangas BD (2026). \textit{Psychedelics produce enduring enhancement of reward responsiveness in male rats.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02475-2}{doi:10.1038/s41386-026-02475-2}.
\item Bruyère Health Research Institute. (2026). \textit{PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07063862}{source link}.
\item Ottawa Hospital Research Institute (2026). \textit{PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04754061}{source link}.
\item University of California, Berkeley (2026). \textit{Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05265546}{source link}.
\item Liu C, Ho EM, Enos AS, Baublyte UB, Luna IM, Kosche AR, Sohal VS (2026). \textit{Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.07.05.736652}{doi:10.64898/2026.07.05.736652}.
\item Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo (2026). \textit{Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/guqxr}{doi:10.17605/osf.io/guqxr}.
\item Yale University (2026). \textit{The Effects of Psilocybin on Social Connectedness}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07693153}{source link}.
\item Rukhsar S, Yousaf N, Sadaf, Fazal M, Hanif M, Muhammad M, Egamberdieva D, Li WJ (2026). \textit{First molecular record of Panaeolus subbalteatus (Psathyrellaceae, Agaricales) from Pakistan.}. Antonie van Leeuwenhoek. [published; PubMed]. \href{https://doi.org/10.1007/s10482-026-02361-3}{doi:10.1007/s10482-026-02361-3}.
\item Gagnon F, Philibert A, Carignan B, Labonté E, Dufresne Y (2026). \textit{Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2026.105427}{doi:10.1016/j.drugpo.2026.105427}.
\item University Health Network, Toronto (2026). \textit{Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06341426}{source link}.
\item Yale University (2026). \textit{Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06624137}{source link}.
\item University of Pennsylvania (2026). \textit{Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06810310}{source link}.
\item Baker JJ, Kogan E, Ma S, Lu J, Zuo Y (2026). \textit{Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.04.06.716778}{doi:10.64898/2026.04.06.716778}.
\item Schüller Thomas (2026). \textit{Entourage-Psilocybin-Ganzpilz}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21253711}{doi:10.5281/zenodo.21253711}.
\item Schüller Thomas (2026). \textit{Entourage-Psilocybin-Ganzpilz}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.21253712}{doi:10.5281/zenodo.21253712}.
\item Douglass Hannah M., Spriggs Meg J., Godfrey Kate, Danby Jennifer L., de Magalhaes Frederico J. C., Macdonald Lauren, Alderton Kirsty L., Archer Stephanie, Ahmad Kirran, Martell Jonny, Frias Jennifer T., Sawicka Gabriela, Read Tim, Blemings Allan, Lafrance Adele, Nicholls Dasha, Erritzoe David, Park Rebecca J., Nutt David J., Carhart-Harris Robin L. (2026). \textit{Psilocybin therapy for adult females with anorexia nervosa: pilot study}. The British Journal of Psychiatry. [published; Crossref]. \href{https://doi.org/10.1192/bjp.2026.10687}{doi:10.1192/bjp.2026.10687}.
\item Bray E, Glatfelter GC, Maitland AD, Gonzalez NR, Walther D, Yacoub J, Baumann MH, von Salm JL (2026). \textit{Synthesis and Biological Evaluation of 4-Bromo-dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.}. ACS omega. [published; PubMed]. \href{https://doi.org/10.1021/acsomega.6c02996}{doi:10.1021/acsomega.6c02996}.
\item Rosado Axel F., Yu Abigail L., Yang Jen-Hau, Rondeau Jocelyne, Floris Gabriele, Basu Aakash, Staszko Stephanie, Dibbs Mark, Feng Jiesi, Li Yulong, Warner-Schmidt Jennifer, Kelmendi Benjamin, Krystal John H., Pittenger Christopher, Kwan Alex C., Kaye Alfred P. (2026). \textit{α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice}. Molecular Psychiatry. [published; Crossref]. \href{https://doi.org/10.1038/s41380-026-03713-1}{doi:10.1038/s41380-026-03713-1}.
\item Paslawski Wojciech, Doyon Daniel, Ekman Carl Johan, Yngwe Hampus, Mamula Dejan, Zareba-Paslawska Justyna, Beckman Maria, Xu Zhi-Qing David, Hökfelt Tomas, Tiger Mikael, Lundberg Johan, Svenningsson Per (2026). \textit{CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-026-02490-3}{doi:10.1038/s41386-026-02490-3}.
\item Tahamtan Golnush, Chernoloz Olga (2026). \textit{Caution in interpreting value-related change after psilocybin: Comment on Kerr-Gaffney et al. (2026)}. Journal of Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1177/02698811261466617}{doi:10.1177/02698811261466617}.
\item University of Wisconsin, Madison (2026). \textit{Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04161066}{source link}.
\item Yale University (2026). \textit{Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06160284}{source link}.
\item Adler Hannah, Filipic Rebecca, Gonzalez Maria, Kwon Ki, Lacey Judith, McDonald Geraldine, Sarris Jerome, Chmiel Katarzyna, Low Mitchell, Sinclair Justin, Grant Suzanne (2026). \textit{The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer}. BMC Medicine. [published; Crossref]. \href{https://doi.org/10.1186/s12916-026-05024-2}{doi:10.1186/s12916-026-05024-2}.
\item Omar Azuara-Antonio, Erika Rubí De La Cruz-Elizaldeb, José Eduardo Carmona-Rodriguez, Lesly Idaliht Hernandez-Martinez (2026). \textit{Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review}. Mexican Journal of Medical Research ICSA. [published; OpenAlex]. \href{https://doi.org/10.29057/mjmr.v14i28.16493}{doi:10.29057/mjmr.v14i28.16493}.
\item Enriquez-Geppert Stefanie, Bevers Lisa, Rosander Arvid, Fodran Peter, Polito Vince (2026). \textit{Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development}. Biomolecules. [published; Crossref]. \href{https://doi.org/10.3390/biom16070983}{doi:10.3390/biom16070983}.
\item Whitfield Henry J., Schepers Jan, Mason Natasha L., Luca Maria, Kuypers Kim P. C. (2026). \textit{Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00530}{doi:10.1556/2054.2026.00530}.
\item Sharchaton A, Parsha S, Azerrad SP, Dekel Y, Rabah N, Páleníček T, Kurzbaum E (2026). \textit{Surprising Variability in Tryptamine Profiles of Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled Conditions.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof12070486}{doi:10.3390/jof12070486}.
\item Matthew A. Boehm, Oriana Mayorga (2026). \textit{Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?}. Journal of Science Policy \& Governance. [published; OpenAlex]. \href{https://doi.org/10.38126/jspg280103}{doi:10.38126/jspg280103}.
\item Koning Elena, Richard Jérémie, Keshen Aaron (2026). \textit{Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions}. International Journal of Eating Disorders. [published; Crossref]. \href{https://doi.org/10.1002/eat.70164}{doi:10.1002/eat.70164}.
\item Seale M. (2026). \textit{Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-10208910/v1}{doi:10.21203/rs.3.rs-10208910/v1}.
\item University of Wisconsin, Madison (2026). \textit{Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07360301}{source link}.
\item Bhavaraju Krishna Prasad, Mason Natasha L., Mallaroni Pablo, Heinke Dietmar, Toennes Stefan W., Ramaekers Johannes G., Amico Enrico (2026). \textit{Unmixing the psychedelic connectome: Brain network traits of psilocybin}. Network Neuroscience. [published; Crossref]. \href{https://doi.org/10.1162/netn.a.594}{doi:10.1162/netn.a.594}.
\item Meyer Thomas D, Vale Lauren N, Ibrahim Maya, Olmos Carolina, Quevedo João, Soares Jair C (2026). \textit{Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study}. BMJ Open. [published; Crossref]. \href{https://doi.org/10.1136/bmjopen-2026-118471}{doi:10.1136/bmjopen-2026-118471}.
\item Busby Mattha (2026). \textit{Psilocybin helps woman with Alzheimer's}. New Scientist. [published; Crossref]. \href{https://doi.org/10.1016/s0262-4079(26)01034-1}{doi:10.1016/s0262-4079(26)01034-1}.
\item Askari M, Surapaneni V. (2026). \textit{Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?}. EcoEvoRxiv. [preprint; Europe PMC]. \href{https://doi.org/10.32942/x2fd49}{doi:10.32942/x2fd49}.
\item Hummel Haley M., Obrochta Alexia N., Kerr David C. R., Cservenka Anita (2026). \textit{Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms}. Journal of Drug Issues. [published; Crossref]. \href{https://doi.org/10.1177/00220426261466154}{doi:10.1177/00220426261466154}.
\item Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y (2026). \textit{Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-026-07110-y}{doi:10.1007/s00213-026-07110-y}.
\item Centre Hospitalier Universitaire de Nīmes (2026). \textit{Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07638553}{source link}.
\item Sunstone Medical (2026). \textit{A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06902974}{source link}.
\item Pasquini Lorenzo, Vohryzek Jakub, Escrichs Anira, Perl Yonatan Sanz, Ponce-Alvarez Adrian, Idesis Sebastian, Girn Manesh, Roseman Leor, Mitchell Jennifer M., Gazzaley Adam, Kringelbach Morten, Nutt David J., Lyons Taylor, Carhart-Harris Robin L., Deco Gustavo (2026). \textit{Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits}. Human Brain Mapping. [published; Crossref]. \href{https://doi.org/10.1002/hbm.70596}{doi:10.1002/hbm.70596}.
\item Sun Mingyu, Zhao Xiaoyu, Kong Fandi, Wang Jinsong, Lu Yunchang, Tong Liang (2026). \textit{Raman Activity Investigation and Utilization of Psilocybin}. Journal of Raman Spectroscopy. [published; Crossref]. \href{https://doi.org/10.1002/jrs.70133}{doi:10.1002/jrs.70133}.
\item Sabani Astrit, Khatak Adnan (2026). \textit{Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence}. Annals of Medicine \& Surgery. [published; Crossref]. \href{https://doi.org/10.1097/ms9.0000000000005244}{doi:10.1097/ms9.0000000000005244}.
\item Jalalian-Javadpour Marzieh, Yekta Batool Ghorbani, Reyhani Niloufar, Hajizamani Shadi, Azizi Ali, Azad Najma Khoshrooz, Mohammadi Hamidreza, Vaseghi Salar (2026). \textit{Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review}. Journal of Affective Disorders Reports. [published; Crossref]. \href{https://doi.org/10.1016/j.jadr.2026.101098}{doi:10.1016/j.jadr.2026.101098}.
\item St Pierre M, Argento E, Cates J, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Paschall SA, Kuypers KPC, Rootman J, Walsh Z (2026). \textit{Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06913-9}{doi:10.1007/s00213-025-06913-9}.
\item Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ (2026). \textit{Provider perspectives on challenges in treatment during psychedelic therapy.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06907-7}{doi:10.1007/s00213-025-06907-7}.
\item Grant Jon E., Boutouis Sophia, O’Brien Margaret, Avila Laurie, Neelapu Megha, Ehsan Dustin (2026). \textit{An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder}. Clinical Neuropharmacology. [published; Crossref]. \href{https://doi.org/10.1097/wnf.0000000000000683}{doi:10.1097/wnf.0000000000000683}.
\item Orsini DK, Wong S, Di Luch S, Chan B, Vasudeva S, Lovell GFM, Le GH, Jones BDM, Chisamore N, Mollica A, Johnson DE, Kaczmarek ES, Goel A, Burke MJ, Mansur R, McIntyre RS, Husain MI, Rosenblat JD (2026). \textit{Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0255}{doi:10.1001/jamapsychiatry.2026.0255}.
\item Plourde Louis, Chang Sue-Ling, Nguyen Olivia, Garel Nicolas, Farzin Houman, Stephan Jean-François, Fallu Jean-Sébastien, Dorval Michel (2026). \textit{Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders}. Palliative Medicine. [published; Crossref]. \href{https://doi.org/10.1177/02692163261446141}{doi:10.1177/02692163261446141}.
\item Junior WSC, Bezerra KS, Matias EGC, Oliveira JIN, Fulco UL (2026). \textit{MFCC-DFT mapping of ligand recognition at the 5-HT receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.}. Physical chemistry chemical physics: PCCP. [published; PubMed]. \href{https://doi.org/10.1039/d6cp00943c}{doi:10.1039/d6cp00943c}.
\item Allen Josh, Jupp Bianca, Baker Tamara L., Haskali Mohammad B., Brkljača Robert, Plummer Zoe, Sun Mujun, Brand Justin, Christie Brian R., Debert Chantel T., McDonald Stuart J., O’Brien Terence J., Casillas-Espinosa Pablo M., Shultz Sandy R. (2026). \textit{Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats}. Cell Reports Medicine. [published; Crossref]. \href{https://doi.org/10.1016/j.xcrm.2026.102867}{doi:10.1016/j.xcrm.2026.102867}.
\item Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK (2026). \textit{The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456191}{doi:10.1177/02698811261456191}.
\item Giaffone de Paiva Ferreira F, Fernandes JAB, Filev R, da Silveira DX, Fidalgo TM (2026). \textit{The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261453850}{doi:10.1177/02698811261453850}.
\item Özaydın Y, Canlan Özaydın B (2026). \textit{Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456196}{doi:10.1177/02698811261456196}.
\item Gumpper RH, Nichols DE (2026). \textit{Chemistry/structural biology of psychedelic drugs and their receptor(s).}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17361}{doi:10.1111/bph.17361}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Nutt DJ, Hunt P, Schlag AK, Fitzgerald P (2026). \textit{The Australia story: Current status and future challenges for the clinical applications of psychedelics.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17398}{doi:10.1111/bph.17398}.
\item Sharp T, Ippolito A (2026). \textit{Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70050}{doi:10.1111/bph.70050}.
\item Hoyer D (2026). \textit{Psychedelics, entactogens and psychoplastogens for depression and related disorders.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70088}{doi:10.1111/bph.70088}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T (2026). \textit{Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70109}{doi:10.1111/bph.70109}.
\item Qureshi O, Cowley J, Pegg A, Cooper AJ, Gordon J, Brady CA, Belli A, Butterworth S, Upthegrove R, Andrews N, Barnes NM (2026). \textit{Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70138}{doi:10.1111/bph.70138}.
\item Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D (2026). \textit{Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70181}{doi:10.1111/bph.70181}.
\item Fleury S, Nautiyal KM (2026). \textit{Correction: The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03488-5}{doi:10.1038/s41380-026-03488-5}.
\item Ascone F, Buzzelli V, Mottarlini F, Di Trapano M, Miglioranza P, Rava A, Feo A, Spano F, Hausman M, Sugaya K, Caffino L, Fumagalli F, Trezza V (2026). \textit{Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02361-x}{doi:10.1038/s41386-026-02361-x}.
\item Hondebrink L, Faber K, Kader A, Jagpal PS, Arif T, Hermanns-Clausen M (2026). \textit{Recreational drug poisonings reported to six European poison centres from 2021 to 2024.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2628073}{doi:10.1080/15563650.2026.2628073}.
\item Silvester A, Hampton S, May TW, Holmes GD, Leang YH (2026). \textit{Three cases of wood-lover paralysis: clinical insights from Victoria, Australia.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2640196}{doi:10.1080/15563650.2026.2640196}.
\item Artna E, Sandhu G, Chisamore N, Lipsitz O, Kaczmarek ES, Johnson DE, Rosenblat JD, Sediqzadah S (2026). \textit{Psychedelics as a potential treatment for borderline personality disorder: A narrative review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2026.117152}{doi:10.1016/j.psychres.2026.117152}.
\item Arikci Denis, Borgulya Joran, Straumann Isabelle, Vizeli Patrick, Luethi Dino, Thomann Jan, Rudin Deborah, Vukalovic Ina, Eckert Anne, Liechti Matthias E., Holze Friederike (2026). \textit{Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-026-02428-9}{doi:10.1038/s41386-026-02428-9}.
\item Giri Y, Furst P, Loo CK, Clark SR, Tibrewal P (2026). \textit{Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674261450390}{doi:10.1177/00048674261450390}.
\item Escobar-Cornejo Guillermo, Corredor-Gamba Julián, Rodriguez-Rojas Yoly, Cárdenas F. P. (2026). \textit{The relevance of the 5HT2A-mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin}. Revista de Neuro-Psiquiatría. [published; Crossref]. \href{https://doi.org/10.20453/rnp.v89i2.7539}{doi:10.20453/rnp.v89i2.7539}.
\item Sjöström David, Schau Rybäck Olea, Claesdotter Knutsson Emma, Kajonius Petri, Jensen Sondén Oskar, Carlbring Per, Björkstrand Johannes, Movahed Rad Pouya (2026). \textit{Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”}. PLOS One. [published; Crossref]. \href{https://doi.org/10.1371/journal.pone.0352246}{doi:10.1371/journal.pone.0352246}.
\item Wang Y, Wang H, Lin C, Wang X (2026). \textit{Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.2535785123}{doi:10.1073/pnas.2535785123}.
\item Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT (2026). \textit{Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.}. Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. [published; PubMed]. \href{https://doi.org/10.1007/s40211-026-00584-4}{doi:10.1007/s40211-026-00584-4}.
\item Stefanie Enriquez Geppert, Lisa Bevers, Arvid Rosander, Peter Fodran, Vince Polito (2026). \textit{Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development}. University of Groningen research database (University of Groningen / Centre for Information Technology). [published; OpenAlex]. \href{https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b}{source link}.
\item Johns Hopkins University (2026). \textit{5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05452772}{source link}.
\item Du Yingjie, Zhao Xiangting, Yao Yishan, Li Yunfeng, Wang Guyan, Zhang Liming (2026). \textit{Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex}. Journal of Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1177/02698811261453819}{doi:10.1177/02698811261453819}.
\item Unity Health Toronto (2026). \textit{Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06386003}{source link}.
\item Dagnino PC, Acero-Pousa I, Carhart-Harris RL, Erritzoe D, Nutt DJ, Kringelbach ML, Perl YS, Deco G. (2026). \textit{Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitalopram}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.22.733731}{doi:10.64898/2026.06.22.733731}.
\item Petit B, Michrafy I, Nafie J, Dyer GE, Marshall EM, Riquelme C, Cabrera-Pardo JR, Strother JA, Loesgen S (2026). \textit{Anthracaurisin A─Discovery of a Cytotoxic -Sesquiterpene Dimer from Patagonian.}. Journal of natural products. [published; PubMed]. \href{https://doi.org/10.1021/acs.jnatprod.6c00531}{doi:10.1021/acs.jnatprod.6c00531}.
\item University Hospital, Basel, Switzerland (2026). \textit{Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06884514}{source link}.
\item Anthony P King (2026). \textit{A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07104916}{source link}.
\item Guidetti C, Fava M, Papakostas GI (2026). \textit{Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03722-0}{doi:10.1038/s41380-026-03722-0}.
\item Łoś Aleksandra, Szkodziński Kacper, Jakubczyk Inga, Maternia Jagoda, Majowicz-Czaszyńska Karolina, Pempuś Wiktoria, Król Nikola, Tomaszek Barbara, Blok Aleksandra, Wiater Dominik, Płodzień Gabriela (2026). \textit{PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW}. International Journal of Innovative Technologies in Social Science. [published; Crossref]. \href{https://doi.org/10.31435/ijitss.2(50).2026.5755}{doi:10.31435/ijitss.2(50).2026.5755}.
\item McCulloch DE, Olsen AS, Ozenne B, Larsen K, Stenbæk DS, Armand S, Madsen MK, Knudsen GM, Fisher PM (2026). \textit{Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-026-74215-5}{doi:10.1038/s41467-026-74215-5}.
\item Claudino Dos Santos JC, Bolan SJ, Lodetti G, Viana GL, Rico EP, Gonçalves CL (2026). \textit{Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2026.06.035}{doi:10.1016/j.jpsychires.2026.06.035}.
\item Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti (2026). \textit{Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-04203-2}{doi:10.1038/s41398-026-04203-2}.
\item Yale University (2026). \textit{Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07449351}{source link}.
\item University Health Network, Toronto (2026). \textit{Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07048743}{source link}.
\item University of Virginia (2026). \textit{Psilocybin-Assisted Therapy for Prolonged Grief}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06724289}{source link}.
\item Seillier L, Seillier A, Zvolska MA, Šlamberová R (2026). \textit{Blocking 5-HT2B receptors abolishes psilocybin's efficacy in the rat forced swim test.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261458349}{doi:10.1177/02698811261458349}.
\item van den Busken WJ, Dines AM, Eyer F, Heyerdahl F, Hovda KE, Liechti ME, Miró Ò, Vallersnes OM, Wood DM, Yates C, Dargan PI, (on behalf of the Euro-DEN Plus Research Group), Gresnigt FMJ, Euro-DEN Plus Research Group (2026). \textit{Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2669671}{doi:10.1080/15563650.2026.2669671}.
\item Johns Hopkins University (2026). \textit{Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06407635}{source link}.
\item University Health Network, Toronto (2026). \textit{Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06416085}{source link}.
\item Racca Camille, Cordier Cécilie (2026). \textit{Psychedelics and related compounds in cluster headache and migraine: a systematic review and meta-analysis v1}. protocols.io. [protocol; Crossref]. \href{https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1}{doi:10.17504/protocols.io.j8nlk7ey6g5r/v1}.
\item Low ZXB (2026). \textit{Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2026.111717}{doi:10.1016/j.pnpbp.2026.111717}.
\item Frick A, Blest-Hopley G, Grin M, Erritzoe D, Nutt D, Carhart-Harris R. (2026). \textit{Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9880403/v1}{doi:10.21203/rs.3.rs-9880403/v1}.
\item Berg CJ, McCready DM, LoParco CR, Schubel LC, Romm KF, Thakkar S, Williams J, Cavazos-Rehg PA, Yang YT (2026). \textit{Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2026.2685527}{doi:10.1080/02791072.2026.2685527}.
\item Dong Mengxuan, Zhang Yi, Cao Manzhu, Shi Tong, Li Liqin, Zong Xingxing, Wang Chen (2026). \textit{DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish}. Molecules. [published; Crossref]. \href{https://doi.org/10.3390/molecules31122143}{doi:10.3390/molecules31122143}.
\item Wanke Michał, Matuszewski Paweł, Siuda Piotr (2026). \textit{“I even saw four deer grazing”: online-offline entanglements in the psilocybin pluriverse}. OSF Preprints. [preprint; Crossref]. \href{https://doi.org/10.31235/osf.io/tk4bv\_v1}{doi:10.31235/osf.io/tk4bv\_v1}.
\item Eric P. Rubenstein (2026). \textit{Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use}. Journal of Advances in Developmental Research. [published; OpenAlex]. \href{https://doi.org/10.71097/ijaidr.v17.i1.1997}{doi:10.71097/ijaidr.v17.i1.1997}.
\item Leeman Lawrence, Armstrong Maya, Menashi Dara, Nayo-Washington Hanifa, Marseille Elliot, Herrera Janus, Romero Crystal, Page-Reeves Janet (2026). \textit{Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico}. Frontiers in Public Health. [published; Crossref]. \href{https://doi.org/10.3389/fpubh.2026.1845943}{doi:10.3389/fpubh.2026.1845943}.
\item Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S (2026). \textit{Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00202}{doi:10.1021/acschemneuro.6c00202}.
\item Dagnino PC, Acero-Pousa I, Zamora-López G, Escrichs A, Erritzoe D, Nutt DJ, Carhart-Harris RL, Sanz Perl Y, Kringelbach ML, Deco G. (2026). \textit{Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.12.731811}{doi:10.64898/2026.06.12.731811}.
\item Pines AR, Zhang X, Kochalka J, Vesuna SS, Kauvar IV, Rajasekharan D, Reneau TR, Akiki TJ, Hack LM, Siegel JS, Williams LM (2026). \textit{Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.2522000123}{doi:10.1073/pnas.2522000123}.
\item Manoj Doss (2026). \textit{The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07079852}{source link}.
\item SAIMSARA (2026). \textit{Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA}. SAIMSARA Journal. [published; Crossref]. \href{https://doi.org/10.62487/saimsara7a54f680}{doi:10.62487/saimsara7a54f680}.
\item Labra-Lorenzana Angel, Lima-Sánchez Dania Nimbe, Delaflor-Wagner Christian Alejandro, Martínez-Hernández Diana, Ramos-Jiménez Christian, Toledo-Lozano Christian Gabriel (2026). \textit{Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis}. Psychiatry International. [published; Crossref]. \href{https://doi.org/10.3390/psychiatryint7030137}{doi:10.3390/psychiatryint7030137}.
\item West CL, Imai F, Bastos G, Hornick MA, Rachmany L, Duran A, Nadeem S, Ricci D, Rader Groves AM, Wargo JA, Leeuwen NV, Sershen H, Vinod KY, Peterka DS, Hamm JP (2026). \textit{Psychedelics relax predictive processing in the post-acute period by remodeling cortico-cortical feedback circuits.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.07.03.601959}{doi:10.1101/2024.07.03.601959}.
\item Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj (2026). \textit{THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.2(50).2026.5605}{doi:10.31435/ijitss.2(50).2026.5605}.
\item Edward P. Hackett, Aditi Chaudhri -, Linda Hasman, Rajbala Thakur, Michael Scott, Robert H. Dworkin (2026). \textit{Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review}. CNS Drugs. [published; OpenAlex]. \href{https://doi.org/10.1007/s40263-026-01305-9}{doi:10.1007/s40263-026-01305-9}.
\item Zuzana Postránecká, Matyáš Lucký, Viktor Mravčík, Tomáš Páleníček (2026). \textit{Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00514}{doi:10.1556/2054.2026.00514}.
\item Zane Qarni, Jeremie Richard (2026). \textit{Altered States, Enhanced Potential: Psychedelics and Physical Performance}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/txgq2\_v2}{source link}.
\item Jajcay N, Vejmola Č, Korčák J, Tylš F, Viktorinová M, Viktorin V, Bravermanová A, Androvičová R, Balíková M, Horáček J, Brunovský M, Hlinka J, Páleníček T. (2026). \textit{EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changes}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.09.731183}{doi:10.64898/2026.06.09.731183}.
\item Zhang T, Lin C, Wang X (2026). \textit{Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.6c00146}{doi:10.1021/acsptsci.6c00146}.
\item Theo Tobel, Aidan Cone, Emily M Choquette, McKenna Garland, Micah Johnson, Keller Mink, Caitlin Lynch, Joel Frohlich, Justin Feinstein, Nicco Reggente (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v2}{source link}.
\item Raikkerus H, Bujour A, Kennedy M, Tiihonen J (2026). \textit{The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2026.10088}{doi:10.1017/neu.2026.10088}.
\item Bryson Alexander, Bhagavan Chiranth, Carter Olivia, Nielsen Glenn, Berlowitz David, Issak Sara, Attard Zachary, Eleftheriadis Dina, Oliver Gina, Mayne Deanne, Roebuck Greg, Rucker James, Butler Matthew, Kanaan Richard (2026). \textit{Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)}. Neurology. [published; Crossref]. \href{https://doi.org/10.1212/wnl.0000000000212934}{doi:10.1212/wnl.0000000000212934}.
\item Gillet M, Doudeau N, Vilain F, Sadat K, Morvan Y, Frajerman A (2026). \textit{Alcohol consumption and substance use among French medical students: A nationwide cross-sectional study: Consommation d'alcool et de substances chez les étudiants en médecine de France: une étude transversale nationale.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437261457220}{doi:10.1177/07067437261457220}.
\item Jennifer Mitchell (2026). \textit{A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07386730}{source link}.
\item Robin Carhart-Harris, PhD, MA (2026). \textit{Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-sampling}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05698511}{source link}.
\item Reid Matthew J., Kettner Hannes, Blanken Tessa F., Weiss Brandon, Carhart-Harris Robin (2026). \textit{Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action}. Current Psychiatry Reports. [published; Crossref]. \href{https://doi.org/10.1007/s11920-026-01685-1}{doi:10.1007/s11920-026-01685-1}.
\item Ahmadian-Moghadam Samaneh, Roshan-Milani Shiva, Saboory Ehsan (2026). \textit{Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticity}. Translational Psychiatry. [published; Crossref]. \href{https://doi.org/10.1038/s41398-026-04151-x}{doi:10.1038/s41398-026-04151-x}.
\item Tarbi Elise C., Bhatia Ian, Balach Nabil, Buehler Suzannah, Demeo-Meres Magdalena, Gramling Cailin, Thambi Tej, Hart Julia, Reblin Maija, Rizzo Donna M., Gramling Robert, Agrawal Manish, Manetta Emily (2026). \textit{Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy}. Healthcare. [published; Crossref]. \href{https://doi.org/10.3390/healthcare14111589}{doi:10.3390/healthcare14111589}.
\item Yale University (2026). \textit{Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05370911}{source link}.
\item Robin Carhart-Harris, PhD, MA (2026). \textit{2 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06626139}{source link}.
\item Barajas David A, Carter Heather C Noda, Tomedi Michael R, Lam Hiu Yu, Deloatch Tiffany N, Reynolds Gregory D, Castaneto Marisol S, Ke Pucheng (2026). \textit{Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometry}. Journal of Analytical Toxicology. [published; Crossref]. \href{https://doi.org/10.1093/jat/bkag030}{doi:10.1093/jat/bkag030}.
\item Dorval Michel, Audet-Croteau Virginie, Chang Sue-Ling, Masse-Grenier Marianne, Tremblay Annie, Bénard Elodie, Chapdelaine Alexandra, Garel Nicolas, Guertin Jason Robert (2026). \textit{Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation}. Healthcare. [published; Crossref]. \href{https://doi.org/10.3390/healthcare14111559}{doi:10.3390/healthcare14111559}.
\item University of Calgary (2026). \textit{The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06768944}{source link}.
\item Carter D, Reardon I, Swain J, Vando L. (2026). \textit{Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9839240/v1}{doi:10.21203/rs.3.rs-9839240/v1}.
\item Kelly JR, Sheridan C, Iusan P, Coakley L, Burke L, Brennan C, MacDonald A, Ivers JH, Trepel D, Tormey G, Finnegan M, Young GW, Harkin A (2026). \textit{Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyag028}{doi:10.1093/ijnp/pyag028}.
\item Ona Genís, Llagostera Cristina, Alvarez Oscar, Dueñas Rosa M., González Debora, Soto-Angona Oscar (2026). \textit{Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy}. Natural Product Research. [published; Crossref]. \href{https://doi.org/10.1080/14786419.2026.2683121}{doi:10.1080/14786419.2026.2683121}.
\item Pastre M., Pereira F., Gibert T., Giron A., Goemare B., Olié E., Courtet P., Lopez-Castroman J., Conejero I. (2026). \textit{One dose of Psilocybin modulates Brain Activity among Depressive patients: Preliminary Neuroimaging Results from the PSILODAC Study}. European Psychiatry. [published; Crossref]. \href{https://doi.org/10.1192/j.eurpsy.2026.10729}{doi:10.1192/j.eurpsy.2026.10729}.
\item M. Pastuszak, K. Jakuszkowiak-Wojten, M. Gałuszko-Węgielnik, A. W. Kwaśny, A. Mechlińska, D. Świeczkowski, W. J. Cubała (2026). \textit{A Molecule-Resolved Bibliometric Analysis of PubMed-Indexed Psychedelic Research (2015-2025): Volume, Temporal Trends, and Publication Types}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2026.11510}{doi:10.1192/j.eurpsy.2026.11510}.
\item Gaurav Uppal, Naima Gul, Asha Dhandapani, Sathyan Soundararajan, Khushboo Kansal (2026). \textit{From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern Psychiatry}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2026.11141}{doi:10.1192/bjo.2026.11141}.
\item Udoro AJ, Yukyi Y, Ansari AZ, Gandara HA, Ahmed F, Hunt D (2026). \textit{Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.110791}{doi:10.7759/cureus.110791}.
\item Li EJ, Mosharraf B, Ali H, Noyes M, Doshi P, Wallace C, Petranker R, Adili A, Khan M, Busse JW, MacKillop J, Madden K. (2026). \textit{Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional survey}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.05.29.26354422}{doi:10.64898/2026.05.29.26354422}.
\item Canady Valerie A. (2026). \textit{Psilocybin shows rapid relief for depression symptoms}. Mental Health Weekly. [published; Crossref]. \href{https://doi.org/10.1002/mhw.34890}{doi:10.1002/mhw.34890}.
\item Wongumpornpinit Vorawut, Ingkaninan Kornkanok, Temkitthawon Prapapan, Waranuch Neti, Copetti Pivetta Rhannanda, Zuo Jieyu, Araujo Gabriel Lima Barros de, Bou-Chacra Nádia, Somayaji Vijay, Loebenberg Raimar (2026). \textit{Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase development}. Journal of Drug Delivery Science and Technology. [published; Crossref]. \href{https://doi.org/10.1016/j.jddst.2026.108228}{doi:10.1016/j.jddst.2026.108228}.
\item Sidovar Matthew, O'Connor Shane J., Orsini Lucinda (2026). \textit{EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE}. Value in Health. [published; Crossref]. \href{https://doi.org/10.1016/j.jval.2026.03.422}{doi:10.1016/j.jval.2026.03.422}.
\item Mallard Austin, Harbour Jessica, Pappano Catherine, Mancuso Mary, Kilbourn Kristin, Fischer Stacy M. (2026). \textit{Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network Analysis}. Journal of Pain and Symptom Management. [published; Crossref]. \href{https://doi.org/10.1016/j.jpainsymman.2026.04.025}{doi:10.1016/j.jpainsymman.2026.04.025}.
\item Ziadi Yosr, Park Taehwan (2026). \textit{EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION}. Value in Health. [published; Crossref]. \href{https://doi.org/10.1016/j.jval.2026.03.635}{doi:10.1016/j.jval.2026.03.635}.
\item Patil Shivaputra A., Hunsberger Holly C. (2026). \textit{Psilocybin: Chemical Foundations and Emerging Therapeutic Potential}. Mini-Reviews in Medicinal Chemistry. [published; Crossref]. \href{https://doi.org/10.2174/0113895575429775260119043318}{doi:10.2174/0113895575429775260119043318}.
\item Stanger MK, Soffer HO, Bryan AD, Skrzynski CJ (2026). \textit{Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used Psilocybin.}. Cannabis and cannabinoid research. [published; PubMed]. \href{https://doi.org/10.1089/can.2024.0059}{doi:10.1089/can.2024.0059}.
\item Mallaroni P, Singleton SP, Mason NL, Satterthwaite TD, Ramaekers JG (2026). \textit{Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03447-0}{doi:10.1038/s41380-026-03447-0}.
\item He Z, Wang Y, Chen J, Cheng J, Feng Y, Niu S, Yan J (2026). \textit{Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.}. European archives of psychiatry and clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.1007/s00406-025-02165-y}{doi:10.1007/s00406-025-02165-y}.
\item Sahoo I, Masadi S, Maheswari A, Utama R, Abeer MI, Soltanpour S, Nasseef MT, Chukwuemeka T, Sinhal N, Pandit J, Ortiz RJ, Cavallaro N, Brengel E, Kulkarni PP, Gitcho MA, Ferris CF (2026). \textit{Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02356-8}{doi:10.1038/s41386-026-02356-8}.
\item Ehmann S, Hager NM, Regier PS, Jones G, Allen JJB (2026). \textit{Lifetime psychedelic use and opioid use disorder severity in a National Survey: the roles of psychedelic type and mental health.}. Addictive behaviors. [published; PubMed]. \href{https://doi.org/10.1016/j.addbeh.2026.108652}{doi:10.1016/j.addbeh.2026.108652}.
\item Yonezawa Kengo, Hirata Mayuko, Takano Hiroaki, Kusudo Keisuke, Tomiyama Sota, Harada Lisa, Suzuki Kouta, Nutt David J., Uchida Hiroyuki, Tani Hideaki (2026). \textit{Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations}. Psychiatry and Clinical Neurosciences. [published; Crossref]. \href{https://doi.org/10.1111/pcn.70042}{doi:10.1111/pcn.70042}.
\item Sabé M, Grof P, Sackett NB, Tai S, Kryskow P, Bershad A, Turkington D, Buonarroti M, De Pieri M, Baniotopoulos P, Eskinazi M, Böge K, Leucht S, Seragnoli F, Furtado L, Brakha TA, Curtis L, Kirschner M, Kaiser S, Penzenstadler L, Zullino D, Højlund M, Gallo J, Solmi M, Sapienza J, Bosia M, La Torre J (2026). \textit{Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.}. Schizophrenia research. [published; PubMed]. \href{https://doi.org/10.1016/j.schres.2026.03.003}{doi:10.1016/j.schres.2026.03.003}.
\item Varela YM, de O Tavares VD, Delgado LM, de Faria HAT, Menezes LQ, Almeida RM, Agrícola P, de Carvalho BS, Bienemann B, Falchi-Carvalho M, Cavalcanti-Ribeiro P, Palhano-Fontes F, Fernandes-Osterhold G, de Araujo DB, Galvão-Coelho N (2026). \textit{Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.}. European archives of psychiatry and clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.1007/s00406-025-02188-5}{doi:10.1007/s00406-025-02188-5}.
\item Lappan SN, Davis SD (2026). \textit{Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251404021}{doi:10.1177/28314425251404021}.
\item Egger K, Bozsak R, Aicher HD, Sari H, Poetzsch SN, Rominger A, Martin-Soelch C, Smallridge JW, Dornbierer D, Quednow BB, Scheidegger M, Cumming P (2026). \textit{Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [F]FDG-PET study.}. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. [published; PubMed]. \href{https://doi.org/10.1177/0271678x261454172}{doi:10.1177/0271678x261454172}.
\item Houff Jenna, Williams Andrew, Allen Obie, Gisabella Barbara, Pantazopoulos Harry, Del Arco Alberto (2026). \textit{Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex}. European Journal of Neuroscience. [published; Crossref]. \href{https://doi.org/10.1111/ejn.70574}{doi:10.1111/ejn.70574}.
\item Fotiadis P, Jang H, Dai R, Li D, Cofré R, Timmermann C, Mashour GA, Hudetz AG, Huang Z (2026). \textit{Reorganization of Human Brain Waves Across Diverse States of Consciousness.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.05.27.728182}{doi:10.64898/2026.05.27.728182}.
\item Miller CWT, Kozak Z (2026). \textit{Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens.}. Psychodynamic psychiatry. [published; PubMed]. \href{https://doi.org/10.1521/pdps.2026.54.2.308}{doi:10.1521/pdps.2026.54.2.308}.
\item Poppe C, Lyck L, Bechtold L, Repantis D (2026). \textit{Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment-Resistant Depression: A Qualitative Study.}. Brain and behavior. [published; PubMed]. \href{https://doi.org/10.1002/brb3.71544}{doi:10.1002/brb3.71544}.
\item Rosa WE, Napolitano S, McAndrew N, Jenkins B, Lichtenthal WG, Applebaum AJ, Breitbart W, Agrawal M (2026). \textit{Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251363983}{doi:10.1177/28314425251363983}.
\item Bazzichi L, Di Carlo M, Salaffi F, Farah S, Porta F, Ablin JN, Varrassi G, Galli F, Fornasari D, Carotti M, Alciati A, Pellegrino G, Batticciotto A, Lucini D, Casale R, Di Franco M, Sarzi-Puttini P, Iannuccelli C, Pain Study Group of the Italian Society of Rheumatology (SIR) (2026). \textit{Therapeutic advances in fibromyalgia: one year in review 2026.}. Clinical and experimental rheumatology. [published; PubMed]. \href{https://doi.org/10.55563/clinexprheumatol/xscnij}{doi:10.55563/clinexprheumatol/xscnij}.
\item Rowe T, Hurzeler T, Towers E, Louie E, Morley KC (2026). \textit{Psychedelic Therapy and the Role of Music: A Scoping Review of Quantitative Evidence on Subjective and Objective Outcomes.}. Brain and behavior. [published; PubMed]. \href{https://doi.org/10.1002/brb3.71533}{doi:10.1002/brb3.71533}.
\item Kaczmarek Erica S., Rodrigues Nelson B., Chisamore Noah, Doyle Zoe, Meshkat Shakila, Blainey Marc G., Brudner Ryan, Ali Shaun, Teopiz Kayla M., McIntyre Roger S., Rosenblat Joshua D. (2026). \textit{Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression}. Journal of Affective Disorders. [published; Crossref]. \href{https://doi.org/10.1016/j.jad.2026.121385}{doi:10.1016/j.jad.2026.121385}.
\item Weintraub Marc J., Jeffrey Jessica K., Ichinose Megan C., Bergman R. Lindsey, Shapiro Benjamin, Barnett Gregory, Artin Hewa, Lynn Marc, Salimian Anabel, Grody Shelby, Ramesh Rahul, Eales Lauren, Grob Charles S., Miklowitz David J. (2026). \textit{Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial}. Journal of Affective Disorders. [published; Crossref]. \href{https://doi.org/10.1016/j.jad.2026.121423}{doi:10.1016/j.jad.2026.121423}.
\item Bysiek Agnieszka, Szpręgiel Izabela, Wojtas Adam, Maćkowiak Marzena, Wawrzczak-Bargieła Agnieszka, Leśkiewicz Monika, Trojan Ewa, Kamińska Katarzyna, Kumorek Weronika, Bilecki Wiktor, Gołembiowska Krystyna (2026). \textit{Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.pnpbp.2026.111710}{doi:10.1016/j.pnpbp.2026.111710}.
\item Priest M, Kilmer B, Senator B, Setodji CM (2026). \textit{U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.}. Rand health quarterly. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/42368324/}{source link}.
\item Hood Alex, Elkins Gary (2026). \textit{Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00507}{doi:10.1556/2054.2026.00507}.
\item Brendstrup-Brix Kristoffer, Ozenne Brice, Fisher Patrick M., Stenbæk Dea S., Petersen Anja S., Armand Sophia, McCulloch Drummond E-Wen., Marstrand-Joergensen Maja Rou, Ulv Larsen Sara M., Johansen Annette, Jensen Rigmor H., Knudsen Gitte M., Madsen Martin K. (2026). \textit{Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache}. Journal of Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1177/02698811261449380}{doi:10.1177/02698811261449380}.
\item Pei Gang (2026). \textit{A spatiotemporal gating hypothesis for psilocybin plasticity: reconciling the 5-HT₂A-TrkB mechanistic paradox}. Cell Discovery. [published; Crossref]. \href{https://doi.org/10.1038/s41421-026-00906-4}{doi:10.1038/s41421-026-00906-4}.
\item Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M (2026). \textit{Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-026-03657-6}{doi:10.1038/s41380-026-03657-6}.
\item L Belinger, N M Rieser, E J E Engeli, L Becciolini, M Clamote, M Pribis, F Saissi, G.A. Florineth, N L Hehl, M Herdener, K H Preller (2026). \textit{Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.}. Open Access CRIS of the University of Bern. [published; OpenAlex]. \href{https://doi.org/10.48620/98266}{doi:10.48620/98266}.
\item Lin Wei, Chen Hong, Li Yuanyuan (2026). \textit{Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman Spectroscopy}. Journal of Raman Spectroscopy. [published; Crossref]. \href{https://doi.org/10.1002/jrs.70178}{doi:10.1002/jrs.70178}.
\item Atiq Mazen A., Weisman Eli, Guerra Rodrigo B., Martinez Luis Luna, Yaden David B., Barrett Frederick S., Nayak Sandeep, Sayali Ceyda (2026). \textit{Psilocybin-induced neurocardiogenic syncope: a case report}. Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00213-026-07079-8}{doi:10.1007/s00213-026-07079-8}.
\item LoParco CR, Rossheim ME, Tillett KK, Cui Y, Johnson M, Speer M, Mihelich D, Amdeta H, Ndisebuye D, Berg CJ (2026). \textit{Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions.}. Journal of studies on alcohol and drugs. [published; PubMed]. \href{https://doi.org/10.15288/jsad.26-00013}{doi:10.15288/jsad.26-00013}.
\item Lago Marcos, Cerveira Mariana, Simonet Joe Xavier (2026). \textit{Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report}. Frontiers in Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnins.2026.1813281}{doi:10.3389/fnins.2026.1813281}.
\item NYU Langone Health (2026). \textit{Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07607938}{source link}.
\item Mertens Lea J., Betzler Felix, Brand Manuela, Evens Ricarda, Jungaberle Andrea, Jungaberle Henrik, Kärtner Laura, Majić Tomislav, Schmitz Christian N., Ströhle Andreas, Scharf Dennis, Spangemacher Moritz, Wolff Max, Assadi Zahra, Bahri Scharif, Becher Lilith, Färber Luca V., Harder Henry, Kirchen Niklas, Kulakova Eugenia, Kunz Linda C., Meijer Andy, Rohrmoser Barbara, Wellek Stefan, Berger Moritz M., Koslowski Michael, Gründer Gerhard (2026). \textit{Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial}. Psychotherapy and Psychosomatics. [published; Crossref]. \href{https://doi.org/10.1159/000552272}{doi:10.1159/000552272}.
\item Singh Jasbir, Mruthyunjaya Pranathi (2026). \textit{Catatonia Associated With First-Time Psilocybin Exposure: A Case Report}. Cureus. [published; Crossref]. \href{https://doi.org/10.7759/cureus.c439}{doi:10.7759/cureus.c439}.
\item Emory University (2026). \textit{The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07332143}{source link}.
\item Rahman T. (2026). \textit{Environmental and Internal Gating of Memory: ARCH Multiplicative Threshold Framework for Encoding and Retrieval}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202605.1558.v1}{doi:10.20944/preprints202605.1558.v1}.
\item Urban Marvin M., Zillich Lea, Rieser Nathalie M., Herdener Marcus, Spanagel Rainer, Vollenweider Franz X., Preller Katrin H., Meinhardt Marcus W. (2026). \textit{Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder}. Translational Psychiatry. [published; Crossref]. \href{https://doi.org/10.1038/s41398-026-03961-3}{doi:10.1038/s41398-026-03961-3}.
\item Laursen DRT, Salazar J, Jürgens G, Hróbjartsson A (2026). \textit{Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.}. Journal of clinical epidemiology. [published; PubMed]. \href{https://doi.org/10.1016/j.jclinepi.2026.112345}{doi:10.1016/j.jclinepi.2026.112345}.
\item Naja Bralic, Elena Bragagnolo, Mikael Palner (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gf7bq\_v1}{source link}.
\item Bergh Marianne Skov-Skov, Bogen Inger Lise, Vevelstad Merete, Øiestad Åse Marit Leere (2026). \textit{Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake}. Journal of Analytical Toxicology. [published; Crossref]. \href{https://doi.org/10.1093/jat/bkag015}{doi:10.1093/jat/bkag015}.
\item Dallas T Mason (2026). \textit{Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6}{source link}.
\item Rachel N Clark (2026). \textit{The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694\&context=dmscjournal}{source link}.
\item Caleb Lemus (2026). \textit{Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713\&context=dmscjournal}{source link}.
\item University of Colorado, Denver (2026). \textit{Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06230757}{source link}.
\item University of New Mexico (2026). \textit{Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07506395}{source link}.
\item Novelli Leonardo, Stoliker Devon, Barta Tamrin, Greaves Matthew D., Chopra Sidhant, Jackson James, Kwee Jessica, Pang James C., Williams Martin L., Razi Adeel (2026). \textit{PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under Psilocybin}. Scientific Data. [published; Crossref]. \href{https://doi.org/10.1038/s41597-026-07312-1}{doi:10.1038/s41597-026-07312-1}.
\item Cavallaro N, Rai P, Akins D, Soltanpour S, Nasseef MT, Ortiz RJ, Utama R, Cody CR, Mistry A, Brenhouse HC, Kulkarni PP, Ferris CF (2026). \textit{Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats.}. Neuroscience bulletin. [published; PubMed]. \href{https://doi.org/10.1007/s12264-026-01632-3}{doi:10.1007/s12264-026-01632-3}.
\item Washington University School of Medicine (2026). \textit{A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07582120}{source link}.
\item Millay T, Kodali M, Cottler L. (2026). \textit{265 Self-reported rates of psilocybin use in North Florida, 2012 to present}. Journal of clinical and translational science. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC13172864}{source link}.
\item Huels E, Smith S, Liu T, Pal D. (2026). \textit{361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized pain}. Journal of clinical and translational science. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC13172966}{source link}.
\item University of California, Los Angeles (2026). \textit{Psilocybin-assisted Cognitive Behavioral Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05227612}{source link}.
\item Geoffrey Ready, Ron Cole-Turner (2026). \textit{Ancient Wisdom, Modern Questions: Western and Orthodox Christianity Engage Psychedelic Spirituality}. Religions. [published; OpenAlex]. \href{https://doi.org/10.3390/rel17050604}{doi:10.3390/rel17050604}.
\item University of Alabama at Birmingham (2026). \textit{Psilocybin-facilitated Treatment for Cocaine Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02037126}{source link}.
\item Conn K, Wong N, Sunnetci S, Al Siyabi A, McCoy K, Huang K, Greaves E, Milton LK, Kuhlmann L, Maguire S, Foldi CJ. (2026). \textit{Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine function}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.14.725265}{doi:10.64898/2026.05.14.725265}.
\item Yang KH, Rasmussen M, Bhatt K, Satybaldiyeva N, Kepner W, Moore AA, Bergstrom J (2026). \textit{Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2026.2673845}{doi:10.1080/02791072.2026.2673845}.
\item Yngwe Hampus, Plavén-Sigray Pontus, Ekman Carl Johan, Henje Eva, Berglund Anders, Tiger Mikael, Beckman Maria, Lundberg Johan (2026). \textit{Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression}. JAMA Network Open. [published; Crossref]. \href{https://doi.org/10.1001/jamanetworkopen.2026.12589}{doi:10.1001/jamanetworkopen.2026.12589}.
\item Alan Davis (2026). \textit{Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07216404}{source link}.
\item University of Calgary (2026). \textit{Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06885996}{source link}.
\item Jacob Cohen, Peter Parbo, Per Trads Ørskov, Dirk Wildgruber, Benjamin Kreifelts, ulrich kirk, Oke Gerke, Martin Korsbak Madsen, Mikael Palner (2026). \textit{Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/3b9fx\_v1}{source link}.
\item Kwiatos N, Ossel S, Mutti FG (2026). \textit{Synthesis of Amines for Active Pharmaceutical Ingredients Using the Whole-Cell Factory Saccharomyces Cerevisae.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202500898}{doi:10.1002/cbic.202500898}.
\item Geller Jamarie A., Pacilio Rachel, Downey Amanda E., Ragnhildstveit Anya, Raymond-Flesch Marissa, Knatz-Peck Stephanie, Gukasyan Natalie (2026). \textit{Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care}. Current Psychiatry Reports. [published; Crossref]. \href{https://doi.org/10.1007/s11920-026-01679-z}{doi:10.1007/s11920-026-01679-z}.
\item Vaart Andrew van der, LaPratt Jeffrey, Swartz Kimberly, Shoultz Audrey, Lauterbach Margo, Suppes Trisha, Sackeim Harold A., Aaronson Scott T. (2026). \textit{Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation}. The Journal of Clinical Psychiatry. [published; Crossref]. \href{https://doi.org/10.4088/jcp.26m16338}{doi:10.4088/jcp.26m16338}.
\item Yu Feliciano, Tafur Joe, Moreno Francisco, Dahmer Stephen (2026). \textit{Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization}. Frontiers in Psychiatry. [published; Crossref]. \href{https://doi.org/10.3389/fpsyt.2026.1777387}{doi:10.3389/fpsyt.2026.1777387}.
\item Francisco A Moreno (2026). \textit{Psilocybin for Treatment of Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06992999}{source link}.
\item University of Wisconsin, Madison (2026). \textit{Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05322954}{source link}.
\item COMPASS Pathways (2026). \textit{A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07570654}{source link}.
\item Kosiarski Bartłomiej, Skrzypek Anna, Markowicz Patrycja, Zbrożek Mikołaj, Biłyk Krzysztof, Hutkowski Maciej, Chwostek Zuzanna, Maruchniak Hanna, Marzec Wiktoria, Biedroń Paulina (2026). \textit{Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin}. Journal of Pre-Clinical and Clinical Research. [published; Crossref]. \href{https://doi.org/10.26444/jpccr/221219}{doi:10.26444/jpccr/221219}.
\item Khadija Kamene (2026). \textit{Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care}. Premier Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.70389/pjn.100014}{doi:10.70389/pjn.100014}.
\item Sean M. Viña (2026). \textit{Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for Care}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives5020014}{doi:10.3390/psychoactives5020014}.
\item Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ. (2026). \textit{Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9283280/v1}{doi:10.21203/rs.3.rs-9283280/v1}.
\item Jessie Kim, Liam Lochhead, Cory R. Weissman (2026). \textit{From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70262}{doi:10.1002/prp2.70262}.
\item University Medical Center Groningen (2026). \textit{The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06782724}{source link}.
\item Tarailis P, Griskova-Bulanova I. (2026). \textit{Characterizing Resting-State Brain Dynamics with Frequency-Resolved EEG Microstates: Parallel Analyses of Psilocybin Microdosing and Acute Inhaled DMT}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.05.723034}{doi:10.64898/2026.05.05.723034}.
\item Reid Matthew, Yaffe Abigail, Geithner Ian, Rebman Alison, Aucott John, Garcia-Romeu Albert (2026). \textit{1020 Long-term Impact of Psilocybin Administration on Sleep-Continuity via Wearable Sensor Time-series: Preliminary-results in Post-Treatment Lyme Disease}. SLEEPJ. [published; Crossref]. \href{https://doi.org/10.1093/sleep/zsag091.1019}{doi:10.1093/sleep/zsag091.1019}.
\item Reid Matthew, Weisman Eli, Martinez Luis Luna, Coon William, Barrett Frederick (2026). \textit{1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power}. SLEEPJ. [published; Crossref]. \href{https://doi.org/10.1093/sleep/zsag091.1079}{doi:10.1093/sleep/zsag091.1079}.
\item Vidot Denise, Diggs Bria-Necole, Baral Amrit, Thompson Michelle, Jean-Louis Girardin (2026). \textit{0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart Study}. SLEEPJ. [published; Crossref]. \href{https://doi.org/10.1093/sleep/zsag091.0408}{doi:10.1093/sleep/zsag091.0408}.
\item Pasquini Lorenzo, Girn Manesh, Kettner Hannes, Ostrand Avery, Allison Kate, Valtierra Christian, Lucas Will, McConnell Patrick, Miller Catriona, Griffith Sydney, Weinstein Dawn, Anderson Brian, Rosati Andrea, Mitchell Jennifer, Carhart-Harris Robin (2026). \textit{Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer study}. JoCN Forum. [published; Crossref]. \href{https://doi.org/10.21428/8e6ba8ef.1db8272c}{doi:10.21428/8e6ba8ef.1db8272c}.
\item Vamvakopoulou IA, Nicholls D, Nutt DJ, Di Simplicio M (2026). \textit{Exploring new avenues: Psychedelic-assisted therapy for young people.}. British journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1002/bcp.70579}{doi:10.1002/bcp.70579}.
\item Centre for Addiction and Mental Health (2026). \textit{Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05710237}{source link}.
\item Zachar Kinga, Sito Maksymilian, Jurkowski Filip, Wójcik Łukasz, Gawron Natalia, Bojanowski Hubert Tomasz, Dobracka Aleksandra, Marczak Zuzanna, Jarowicz Monika, Czmyr Jędrzej (2026). \textit{Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review}. Journal of Education, Health and Sport. [published; Crossref]. \href{https://doi.org/10.12775/jehs.2026.91.70672}{doi:10.12775/jehs.2026.91.70672}.
\item Hendricks Peter S., Lappan Sara N., Shelton Richard C., Lahti Adrienne C., Cropsey Karen L., Johnson Matthew W., Bradley Melissa, Simonsson Otto, Davis Lori L., Grossman Daniel H., Ortiz Cynthia E. (2026). \textit{Psilocybin in the Treatment of Cocaine Use Disorder}. JAMA Network Open. [published; Crossref]. \href{https://doi.org/10.1001/jamanetworkopen.2026.11029}{doi:10.1001/jamanetworkopen.2026.11029}.
\item Bonar Erin E. (2026). \textit{Pilot Results for Psilocybin-Assisted Psychotherapy for Cocaine Use Disorder-A Critical Appraisal}. JAMA Network Open. [published; Crossref]. \href{https://doi.org/10.1001/jamanetworkopen.2026.11042}{doi:10.1001/jamanetworkopen.2026.11042}.
\item Forsyth Dayna, Faraone Nicoletta, Lamarre Simon G., Currie Suzanne (2026). \textit{The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus}. Frontiers in Behavioral Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnbeh.2026.1767175}{doi:10.3389/fnbeh.2026.1767175}.
\item Bart A. Ellenbroek, Gernot Riedel (2026). \textit{Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000878}{doi:10.1097/fbp.0000000000000878}.
\item Sunstone Medical (2026). \textit{A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05947383}{source link}.
\item University of North Carolina, Chapel Hill (2026). \textit{Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06303739}{source link}.
\item Stanford University (2026). \textit{A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07479550}{source link}.
\item University of Nebraska (2026). \textit{An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal Cancers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05220046}{source link}.
\item Nuwer R (2026). \textit{Magic mushroom compound shows promise against cocaine addiction.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.aei6155}{doi:10.1126/science.aei6155}.
\item Lyons T., Spriggs M., Kerkelä L., Rosas F. E., Roseman L., Mediano P. A. M., Timmermann C., Oestreich L., Pagni B. A., Zeifman R. J., Hampshire A., Trender W., Douglass H. M., Girn M., Godfrey K., Kettner H., Sharif F., Espasiano L., Gazzaley A., Wall M. B., Erritzoe D., Nutt D. J., Carhart-Harris R. L. (2026). \textit{Human brain changes after first psilocybin use}. Nature Communications. [published; Crossref]. \href{https://doi.org/10.1038/s41467-026-71962-3}{doi:10.1038/s41467-026-71962-3}.
\item Usona Institute (2026). \textit{A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04353921}{source link}.
\item University of Washington (2026). \textit{A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07565909}{source link}.
\item University of California, Los Angeles (2026). \textit{Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07566104}{source link}.
\item Sayali Ceyda, Weisman Eli, Barrett Frederick (2026). \textit{Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use Disorder}. JoCN Forum. [published; Crossref]. \href{https://doi.org/10.21428/8e6ba8ef.31e358f9}{doi:10.21428/8e6ba8ef.31e358f9}.
\item Lakshmi N Yatham (2026). \textit{Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06943573}{source link}.
\item Mauney Erin, Zambrano Juliana, Clukey Jenna, Burton-Murray Helen, Datko Michael, Napadow Vitaly, Kuo Braden, King Franklin (2026). \textit{Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBS}. Gastrointestinal Endoscopy. [published; Crossref]. \href{https://doi.org/10.1016/s0016-5107(26)04363-4}{doi:10.1016/s0016-5107(26)04363-4}.
\item Herman Melissa (2026). \textit{Sex-Specific Effects of Psilocin on Paraventricular Nucleus of the Thalamus (PVT) Circuitry and Threat Responding Behavior in Male and Female Rats}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.055}{doi:10.1016/j.biopsych.2026.03.055}.
\item LaMalfa Kayleigh, Pizzagalli Diego A., Bergman Jack, Thomas Christopher W., Kangas Brian (2026). \textit{Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)}. The Journal of Pharmacology and Experimental Therapeutics. [published; Crossref]. \href{https://doi.org/10.1016/j.jpet.2026.104267}{doi:10.1016/j.jpet.2026.104267}.
\item Holze Friederike, Arikci Denis, Thomann Jan, Rudin Deborah, Luethi Dino, Liechti Matthias E. (2026). \textit{Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy Participants}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.056}{doi:10.1016/j.biopsych.2026.03.056}.
\item Hayduk Sean, Stringer Amy, Zagorski Satoria, Ward Sara Jane (2026). \textit{PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)}. The Journal of Pharmacology and Experimental Therapeutics. [published; Crossref]. \href{https://doi.org/10.1016/j.jpet.2026.104282}{doi:10.1016/j.jpet.2026.104282}.
\item Schuler Heike, Zhou Delong, Savignac Chloé, Cvetkovska Vedrana, Tse Yiu-Chung, Meccia Juliet, Bzdok Danilo, Bagot Rosemary (2026). \textit{Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal Cortexh}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.054}{doi:10.1016/j.biopsych.2026.03.054}.
\item Bradley Ellen, Kelley D Parker, Picard Martin, Szigeti Balazs, Sakai Kimberly, Fernandes Gisele, Ostrem Jill, Tanner Caroline, Finley Patrick, Ludwig Connie, Llerena Katiah, Busby Zach, McKernan Amber, Zuzuarregui Jose Rafael, Bock Meredith, Wang Aliss, Penn Andrew, Woolley Josh, O'Donovan Aoife (2026). \textit{356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s Disease}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.590}{doi:10.1016/j.biopsych.2026.03.590}.
\item Poulin Joshua, Viulet Nic, Liu Ashley, MacIntosh Bradley J., Nestor Sean M. (2026). \textit{483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.717}{doi:10.1016/j.biopsych.2026.03.717}.
\item Andreia Machado Brito-da-Costa, Francisco Sacadura, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias da Silva (2026). \textit{Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in rats}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v8isupii.46826}{doi:10.51126/revsalus.v8isupii.46826}.
\item Hecker L, Kleinhenz J M, Coarfa C, Kato K (2026). \textit{C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung Diseases}. American Journal of Respiratory and Critical Care Medicine. [published; Crossref]. \href{https://doi.org/10.1093/ajrccm/aamag162.144}{doi:10.1093/ajrccm/aamag162.144}.
\item Yockey R. Andrew, Amis Amber, Devier Elise, Apu Aminul, Hoopsick Rachel (2026). \textit{Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA}. AJPM Focus. [published; Crossref]. \href{https://doi.org/10.1016/j.focus.2026.100518}{doi:10.1016/j.focus.2026.100518}.
\item Hennessey Joseph, Mantsch John, McCorvy John (2026). \textit{Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)}. The Journal of Pharmacology and Experimental Therapeutics. [published; Crossref]. \href{https://doi.org/10.1016/j.jpet.2026.104291}{doi:10.1016/j.jpet.2026.104291}.
\item Mariana Silva-Carvalho, Andreia Machado Brito-da-Costa, Ricardo Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias-da-Silva (2026). \textit{Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoforms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v8isupii.46635}{doi:10.51126/revsalus.v8isupii.46635}.
\item Signor Anna, Colognesi Martina, Finzi Giovanna, Gabbia Daniela, Mattarei Andrea, Comai Stefano, Pasut Gianfranco, Folli Franco, Manfredi Paolo, De Martin Sara (2026). \textit{SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models}. Journal of Hepatology. [published; Crossref]. \href{https://doi.org/10.1016/s0168-8278(26)01861-1}{doi:10.1016/s0168-8278(26)01861-1}.
\item Pagni Broc, Ross Stephen, Kim Yuna, Bogenschutz Michael (2026). \textit{6. Open-Label Extension of Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Continued Safety and Short-Term Efficacy Signal for Drinking, Craving, and Self-Efficacy}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.240}{doi:10.1016/j.biopsych.2026.03.240}.
\item Andreia Machado Brito-da-Costa, Mariana Carvalho, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Sérgio F. Sousa, Diana Dias da Silva (2026). \textit{Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening Study}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v8isupii.46839}{doi:10.51126/revsalus.v8isupii.46839}.
\item Gupta Gyandev, Yadav Ravina (2026). \textit{Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted Clinical}. JOURNAL OF ADVANCE AND FUTURE RESEARCH. [published; Crossref]. \href{https://doi.org/10.56975/jaafr.v4i5.509087}{doi:10.56975/jaafr.v4i5.509087}.
\item Greenway KT, Garel N, Dinh-Williams LL, Thibault Lévesque J, Kaelen M, Dagenais-Beaulé V, de la Salle S, Erritzoe D, Looper K, Turecki G, Rej S, Richard-Devantoy S (2026). \textit{The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.}. The British journal of psychiatry: the journal of mental science. [published; PubMed]. \href{https://doi.org/10.1192/bjp.2025.102}{doi:10.1192/bjp.2025.102}.
\item Bruno V, López-Canul M, Richardson B, Camarini R, Marcourakis T, Gobbi G (2026). \textit{High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251368361}{doi:10.1177/02698811251368361}.
\item Uyar A, Forbrich L, Lueken U, Evens R (2026). \textit{Landscape analysis of pre-registered clinical trials involving classical psychedelics.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251371690}{doi:10.1177/02698811251371690}.
\item Viljoen G, Walter H, Bendau A, Koslowski M, Betzler F (2026). \textit{Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251389581}{doi:10.1177/02698811251389581}.
\item Stocker K, Hartmann M, Schmid Y, Vogt SB, Becker AM, Ley L, Straumann I, Arikci D, Klaiber A, Erne L, Vizeli P, Holze F, Liechti ME (2026). \textit{The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251397328}{doi:10.1177/02698811251397328}.
\item Diehl VJ, Calder AE, Hasler G (2026). \textit{The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251397306}{doi:10.1177/02698811251397306}.
\item Scholle P, Wenke Š, Nekovářová T, Zaytseva Y, Tylš F, Brunovský M, Horáček J, Andrashko V, Koudelka V, Viktorinová M, Viktorin V, Hájková K, Kuchař M, Páleníček T (2026). \textit{The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251389552}{doi:10.1177/02698811251389552}.
\item Garcia Garcia M, Belahda D, Graux C, Serrand C, Igounenc N, Sergent F, Mura T, Luquiens A (2026). \textit{Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2026.121215}{doi:10.1016/j.jad.2026.121215}.
\item Mills Laura, Rossell Susan L., Carruthers Sean P. (2026). \textit{Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts}. Journal of Affective Disorders. [published; Crossref]. \href{https://doi.org/10.1016/j.jad.2026.121220}{doi:10.1016/j.jad.2026.121220}.
\item Domi Ana, Lucente Erika, Cadeddu Davide, Bengtsson Niklas, Smedler Erik, Adermark Louise (2026). \textit{Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms}. Neuropharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.neuropharm.2026.110854}{doi:10.1016/j.neuropharm.2026.110854}.
\item Kerr-Gaffney J, Myrtle S, Askari F, Bird C, Modlin NL, Young AH, Rucker J (2026). \textit{Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251408769}{doi:10.1177/02698811251408769}.
\item Lewis BR, Reid MJ, Novick AM, Byrne K, Niciu MJ, Fonzo GA, Meyer TD, Feifel D, El-Mallakh RS, Soares J, Suppes T, Barrett FS (2026). \textit{Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251413490}{doi:10.1177/02698811251413490}.
\item Goldy SP, Sepeda ND, Hilbert SN, Bari BA, Garcia-Romeu A, Gukasyan N, Barrett FS, Yaden DB, Nayak SM (2026). \textit{Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2026.117010}{doi:10.1016/j.psychres.2026.117010}.
\item Courtes Alan C., Myers Blake, Daly Noah, Jones Greg, Soares Jair C., Zarate Carlos A., Machado-Vieira Rodrigo (2026). \textit{Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine}. General Hospital Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.genhosppsych.2026.02.011}{doi:10.1016/j.genhosppsych.2026.02.011}.
\item Montoy JCC, Wang RC, Coker AR, Anderson BT (2026). \textit{Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and Health.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2026.113059}{doi:10.1016/j.drugalcdep.2026.113059}.
\item Moreno Francisco A., Allen Katja E., Wiegand Christopher B., Dunne Rajan, Prickett James I., Bayze Brian, Allen John J. B. (2026). \textit{A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder}. Journal of Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1177/02698811261424214}{doi:10.1177/02698811261424214}.
\item Mertens Lea J., Koslowski Michael, Betzler Felix, Brand Manuela, Evens Ricarda, Kärtner Laura, Jungaberle Andrea, Jungaberle Henrik, Majić Tomislav, Schmitz Christian N., Ströhle Andreas, Scharf Dennis, Spangemacher Moritz, Wolff Max, Assadi Zahra, Bahri Scharif, Becher Lilith, Färber Luca V., Kirchen Niklas, Kulakova Eugenia, Kunz Linda, Meijer Andy, Rohrmoser Barbara, Wellek Stefan, Berger Moritz M., Gründer Gerhard (2026). \textit{Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression}. JAMA Psychiatry. [published; Crossref]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0132}{doi:10.1001/jamapsychiatry.2026.0132}.
\item Hudson James I., Pope Harrison G. (2026). \textit{Enlightenment in a Pill-Testing the Efficacy of Psilocybin}. JAMA Psychiatry. [published; Crossref]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0070}{doi:10.1001/jamapsychiatry.2026.0070}.
\item Brusky B, M'Bailara K, Alla F, Barrault M (2026). \textit{Psychological support in psychedelic-assisted therapy clinical trials: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261424204}{doi:10.1177/02698811261424204}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Gillet A, Geron C, Vitello MM, Lejeune N (2026). \textit{Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-026-01274-z}{doi:10.1007/s40263-026-01274-z}.
\item Simonsson O, Lyons T, Marks J, Kettner H, Roseman L, Haijen E, Kaelen M, Carhart-Harris R (2026). \textit{Effects of psychedelic use on authoritarian attitudes revisited.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261443677}{doi:10.1177/02698811261443677}.
\item Simonsson O, Sun S, Wesseldijk LW, Ullén F, Osika W, Mosing MA (2026). \textit{Associations between psychedelic use and migraine history in Swedish twins.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261449385}{doi:10.1177/02698811261449385}.
\item Silva MH (2026). \textit{New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants.}. Birth defects research. [published; PubMed]. \href{https://doi.org/10.1002/bdr2.70048}{doi:10.1002/bdr2.70048}.
\item Hajivalizadeh S, Farahmand K, Kazemzadeh K, Hajivalizadeh G, Shamabadi A (2026). \textit{Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.}. Cancer reports (Hoboken, N.J.). [published; PubMed]. \href{https://doi.org/10.1002/cnr2.70587}{doi:10.1002/cnr2.70587}.
\item Beidas Zeina, Ragnhildstveit Anya, Blackman Adam, Anderson Thomas, Fewster Emily, Syed Omer A., Sobolenko Valentyne, Kanca Ismail Kaan, Son Tatiana, Farb Norman, Petranker Rotem (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM}. BJPsych Open. [published; Crossref]. \href{https://doi.org/10.1192/bjo.2026.12000}{doi:10.1192/bjo.2026.12000}.
\item Zolali Elmira, McMahon Lance R., Obeng Samuel (2026). \textit{Therapeutic Potential of Psilocybin in Alcohol and Opioid Use Disorders: A Promising Role for Psychedelics}. Pharmaceutical Sciences. [published; Crossref]. \href{https://doi.org/10.34172/ps.026.43663}{doi:10.34172/ps.026.43663}.
\item Nayak SM, Sepeda ND, Dick MN, Tiwari P, Zahid Z, Sayalı C, Weiss BM, Yaden DB, Garcia-Romeu A, Barnett BS, Barrett FS. (2026). \textit{Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety Recommendations}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.04.28.26351625}{doi:10.64898/2026.04.28.26351625}.
\item Kurt Stocker, Matthias Hartmann, Frederick S. Barrett, William A. Richards, Nathan D. Sepeda, Laura Ley, Anna M. Becker, Friederike Holze, Matthias E. Liechti (2026). \textit{Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings}. Repository for Publications and Research Data (ETH Zurich). [published; OpenAlex]. \href{https://doi.org/10.3929/ethz-c-000799490}{doi:10.3929/ethz-c-000799490}.
\item Tyler Girard, Boris Heifets, Robert Sapolsky, X Chen, Stanford University (2026). \textit{Characterizing psilocybin’s effects on nociception and thermoregulation in preclinical pain models}. Stanford Digital Repository. [published; OpenAlex]. \href{https://doi.org/10.25740/yr748bv5776}{doi:10.25740/yr748bv5776}.
\item Briggs Dylan, Sease Thomas B., Menou Ruthie, Perkins David R. (2026). \textit{Does Psychological Flexibility Correlate with Mystical Experiences: A Machine Learning Approach Including State of Surrender, Near-Death Experiences, and Psilocybin Consumption}. Behavioral Sciences. [published; Crossref]. \href{https://doi.org/10.3390/bs16050686}{doi:10.3390/bs16050686}.
\item University Hospital, Basel, Switzerland (2026). \textit{Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05883540}{source link}.
\item Joshua Woolley, MD, PhD (2026). \textit{A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05351541}{source link}.
\item Marini S, De Berardis D. (2026). \textit{The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1998.v1}{doi:10.20944/preprints202604.1998.v1}.
\item Anne-Fiona Griesfeller, Lotte Kooman, Lilian Kloft-Heller, Samuli Kangaslampi, Johannes G Ramaekers, Henry Otgaar (2026). \textit{Evaluating the evidence for repressed memory recovery in psychedelic contexts}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-026-07076-x}{doi:10.1007/s00213-026-07076-x}.
\item Zajaczkowski M, Koutsoftidis S, Sheeraz M, Barsakcioglu DY, Jia T, McGeady CA, Kundu A, Pizzi M, Tatti F, Bashford J, Bhavesh P, Farina D, Drakakis E. (2026). \textit{A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary Experiments}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9266175/v1}{doi:10.21203/rs.3.rs-9266175/v1}.
\item Magnani L, Ghirotto L, Fesce F, Re T, Tanzi S, Amerio A, Costanza A (2026). \textit{Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review.}. BMJ supportive \& palliative care. [published; PubMed]. \href{https://doi.org/10.1136/spcare-2025-005689}{doi:10.1136/spcare-2025-005689}.
\item Schober S, Dorfmann L, Walther K, Blei F, Chadeayne AR, Gressler M, Bartram S, O'Connor SE, Hoffmeister D (2026). \textit{Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.70318}{doi:10.1002/cbic.70318}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Rockhill KM, Bemis EA, Schow N, Olsen HA, Beekman K, Fox EJ, Monte AA, Black JC (2026). \textit{Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.}. Journal of medical Internet research. [published; PubMed]. \href{https://doi.org/10.2196/86059}{doi:10.2196/86059}.
\item Neil K. Savalia, Lingxiao Shao, Cory Knox, A. Gilbert, Quan Jiang, Alex Kwan (2026). \textit{157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium Dynamics}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.391}{doi:10.1016/j.biopsych.2026.03.391}.
\item Barbieri A (2026). \textit{Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders.}. Trends in psychiatry and psychotherapy. [published; PubMed]. \href{https://doi.org/10.47626/2237-6089-2025-1273}{doi:10.47626/2237-6089-2025-1273}.
\item Chaganti Joga, Siefried Krista J, Vyakaranam Veda S, Acheson Liam, Brett Jonathan (2026). \textit{“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use Disorder}. American Journal of Neuroradiology. [published; Crossref]. \href{https://doi.org/10.3174/ajnr.a9364}{doi:10.3174/ajnr.a9364}.
\item Askey Tatum, Allen-Ross Daniel, Luzyanin Daniil, Lasrado Reena, Gilmour Gary, Hunt Stephen P., Tamagnini Francesco, Ahmed Maqsood, Stephens Gary J., Maiarú Maria (2026). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia}. Communications Biology. [published; Crossref]. \href{https://doi.org/10.1038/s42003-026-10065-7}{doi:10.1038/s42003-026-10065-7}.
\item Stark-Elster Eli, Sethathi Mamosebetsi, van der Merwe Breyten, Nayak Sandeep Manel, Yaden David Bryce, Singh Manvir (2026). \textit{Psilocybin use among Basotho healers and non-healers in southern Africa}. OSF Preprints. [preprint; Crossref]. \href{https://doi.org/10.31235/osf.io/429dw\_v1}{doi:10.31235/osf.io/429dw\_v1}.
\item Salinsky LM, Fox JL, Diaz KC, Timmons BC, Ferguson SM (2026). \textit{Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit Adaptations.}. Research square. [published; PubMed]. \href{https://doi.org/10.21203/rs.3.rs-9306429/v1}{doi:10.21203/rs.3.rs-9306429/v1}.
\item Portland VA Research Foundation, Inc (2026). \textit{Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04982796}{source link}.
\item Usona Institute (2026). \textit{A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03866174}{source link}.
\item Kyle Greenway (2026). \textit{Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07373535}{source link}.
\item Hinchcliffe JK, Bartlett J, Thomas CW, Golden CT, Gilmour G, Bortolotto ZA, Robinson ES. (2026). \textit{Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.20.719483}{doi:10.64898/2026.04.20.719483}.
\item Cahuasqui-Mendoza Deivid Antonio (2026). \textit{Psilocybin as an alternative to conventional treatments: A systematic review}. Gaceta Médica de Caracas. [published; Crossref]. \href{https://doi.org/10.47307/gmc.2026.134.s2.32}{doi:10.47307/gmc.2026.134.s2.32}.
\item Yang Kevin H., Eun Avery, Palamar Joseph J. (2026). \textit{Prevalence and Correlates of Past-Year Psilocybin Use in the United States}. American Journal of Psychiatry. [published; Crossref]. \href{https://doi.org/10.1176/appi.ajp.20251343}{doi:10.1176/appi.ajp.20251343}.
\item Baral A, Pan Y, Hlaing WM, Garcia-Romeu A, Pinheiro PS, Vidot DC (2026). \textit{Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.}. Cancer causes \& control: CCC. [published; PubMed]. \href{https://doi.org/10.1007/s10552-026-02172-x}{doi:10.1007/s10552-026-02172-x}.
\item Knox CA, Woodburn SC, Gilbert AD, Schlotzhauer JM, Kwan AC (2026). \textit{Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed mice.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.04.21.720014}{doi:10.64898/2026.04.21.720014}.
\item University of Colorado, Denver (2026). \textit{Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06430541}{source link}.
\item Khosravi Mohsen, De Berardis Domenico, Tusconi Massimo (2026). \textit{The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes}. Mental Wellness. [published; Crossref]. \href{https://doi.org/10.4081/mw.2026.40}{doi:10.4081/mw.2026.40}.
\item Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari (2026). \textit{Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials}. Open Access Indonesian Journal of Medical Reviews. [published; Crossref]. \href{https://doi.org/10.37275/oaijmr.v6i2.883}{doi:10.37275/oaijmr.v6i2.883}.
\item Yacoub J, Bray E, Bayyat J, Glatfelter GC, Leake A, Buitrago EM, Maitland AD, Partilla J, Cavalco NG, Schalk SS, Lammers JC, Baumann MH, McCorvy J, Leahy JW, Gulick D, Witowski CG, von Salm JL (2026). \textit{Serotonergic Polypharmacology of 2-Halogenated Tryptamines.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.04.16.718915}{doi:10.64898/2026.04.16.718915}.
\item Drange Sivert, Cohen Jacob, Johansen Sys Stybe, Dunkley Ben, Palner Mikael (2026). \textit{Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins}. Frontiers in Psychiatry. [published; Crossref]. \href{https://doi.org/10.3389/fpsyt.2026.1819962}{doi:10.3389/fpsyt.2026.1819962}.
\item Bhagavan C, Dandash O, Carter O, Bryson A, Kanaan RA. (2026). \textit{Sustained Effects of Low-to-Moderate Doses of Psilocybin on Brain Connectivity}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.04.17.26351147}{doi:10.64898/2026.04.17.26351147}.
\item Brinzei OV. (2026). \textit{Comparative Medico-Legal Frameworks for Psilocybin Regulation: A March 2026 Update}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1423.v1}{doi:10.20944/preprints202604.1423.v1}.
\item Vipul Janardan, Amit Khanna, Om Prakash, Anadrika Debbarma, SK Mathur (2026). \textit{Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers}. Journal of Mental Health Disorders. [published; OpenAlex]. \href{https://doi.org/10.33696/mentalhealth.6.068}{doi:10.33696/mentalhealth.6.068}.
\item Gondi CS, Gnanamony M, Gondi TP, Nersesyan L, Demirkhanyan L (2026). \textit{Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.}. Current issues in molecular biology. [published; PubMed]. \href{https://doi.org/10.3390/cimb48040417}{doi:10.3390/cimb48040417}.
\item Francisco Sacadura, Cláudia Marques, Andreia Machado Brito-da-Costa, Mariana Carvalho, Helena Carmo, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias da Silva (2026). \textit{Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han rats}. Science Letters. [published; OpenAlex]. \href{https://doi.org/10.48797/sl.2026.492}{doi:10.48797/sl.2026.492}.
\item Diana Dias da Silva, Andreia Machado Brito-da-Costa, Francisco Sacadura, Mariana Carvalho, Helena Carmo, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho (2026). \textit{Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in rats}. Science Letters. [published; OpenAlex]. \href{https://doi.org/10.48797/sl.2026.497}{doi:10.48797/sl.2026.497}.
\item Beatriz P. Senra, Ricardo Jorge Dinis-Oliveira, Carlos J. A. Ribeiro (2026). \textit{Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe Mushrooms}. Science Letters. [published; OpenAlex]. \href{https://doi.org/10.48797/sl.2026.498}{doi:10.48797/sl.2026.498}.
\item Juan Moisés de la Serna de la Serna (2026). \textit{Neural Entropy and Cognitive Flexibility: A Research Agenda for Psilocybin-Assisted Therapy [FUTURE DIRECTIONS v1.0]}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.19620938}{doi:10.5281/zenodo.19620938}.
\item Davoudian PA, Jiang Q, Knox CA, Savalia NK, Shao LX, Wilson J, Weiner AM, Chong CW, Liao C, Nothnagel JD, Sakurai T, Kwan AC (2026). \textit{Psilocybin reshapes cortical inhibition through selective interneuron recruitment.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.04.16.718963}{doi:10.64898/2026.04.16.718963}.
\item Norris JJ (2026). \textit{Substance use predictors of arrest and self-reported criminal behavior in the United States: The role of psychedelics and rarely used drugs.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261436577}{doi:10.1177/02698811261436577}.
\item Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O. (2026). \textit{Psilocybin’s Kinematic Effect on Manual Dexterity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9291780/v1}{doi:10.21203/rs.3.rs-9291780/v1}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item Vélez Rodríguez Jean C., Duquesne-Maldonado Yanice, Hernández Torres Julián M., Da'Luz Sant'Ana Istoni, Nazario Cruz M. (2026). \textit{Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00519}{doi:10.1556/2054.2026.00519}.
\item Black Joshua C., Bau Gabrielle E., Cook Ryan R., Bemis Elizabeth A., Monte Andrew A. (2026). \textit{Psilocybin Trends in States That Decriminalized Use}. JAMA. [published; Crossref]. \href{https://doi.org/10.1001/jama.2026.1952}{doi:10.1001/jama.2026.1952}.
\item Keenan Ryan J., Haque Rifa T., Jin Xiangjun, Mustafa Tomris, Homman-Ludiye Jihane, Elysee Kayla, Wee Zi Shan, Simonds Stephanie E., Foldi Claire J., Cowley Michael A. (2026). \textit{Effects of a single dose of psilocybin on diet-induced weight loss in obese mice}. Translational Psychiatry. [published; Crossref]. \href{https://doi.org/10.1038/s41398-026-03995-7}{doi:10.1038/s41398-026-03995-7}.
\item Back Anthony L., McGregor Bonnie A., Thorn Leslie L., Harvey Kalin, Blom Dianna, Callan George, Guy John, Kumar Sameet, Hershberg Rob, Layer Melissa, Levin Jackie, Myers Susanna, Perez Juliana, Salmonson Kathy, Thompson Peter, Whinney Joseph (2026). \textit{A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience}. Frontiers in Public Health. [published; Crossref]. \href{https://doi.org/10.3389/fpubh.2026.1810904}{doi:10.3389/fpubh.2026.1810904}.
\item Section for Affective Disorders; Northern Stockholm Psychiatry (2026). \textit{CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06319378}{source link}.
\item Olsen AS, Larsen K, McCulloch DE, Ganz M, Madsen MK, Ozenne B, Knudsen GM, Rehman Nu, Fisher PM. (2026). \textit{Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.09.717379}{doi:10.64898/2026.04.09.717379}.
\item Penberthy J. Kim, A. Wise Fatma, Cherup Nicholas, Penberthy J. Morgan, Mitchell Evaline, Burns Madeline, Akinlade Oluwafunmilayo, Chung David, Parmar Harshit, Singer Jonathan (2026). \textit{Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol}. Psychoactives. [published; Crossref]. \href{https://doi.org/10.3390/psychoactives5020012}{doi:10.3390/psychoactives5020012}.
\item Rundquist Eric, Monasterio López Diego Nicolás, Oyarzo Alvarado Juan Jonathan, Carhart-Harris Robin, Pasquini Lorenzo, Vinson Erin, Girn Manesh, Ostrand Avery, Allison Kate, Kettner Hannes, Miller Catriona, Griffith Sydney, Gazzaley Adam, Rosati Andrea, Mitchell Jennifer (2026). \textit{Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybin}. Philosophical Psychology. [published; Crossref]. \href{https://doi.org/10.1080/09515089.2026.2657452}{doi:10.1080/09515089.2026.2657452}.
\item Veysi A, Atanasovski D, Ardalan M, Motamed N, Eriksson E (2026). \textit{Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2026.10075}{doi:10.1017/neu.2026.10075}.
\item Effinger D. P., Hoffman J. L., Quadir S. G., Rollison C. S., Toedt D., Echeveste Sanchez M., High M. W., Hodge C. W., Herman M. A. (2026). \textit{Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration}. Nature Communications. [published; Crossref]. \href{https://doi.org/10.1038/s41467-026-71481-1}{doi:10.1038/s41467-026-71481-1}.
\item Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman (2026). \textit{Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.32048850}{doi:10.6084/m9.figshare.32048850}.
\item Morel Nikita Sanati, Stenbaek Dea Siggaard, Lundberg Johan, Beckman Maria (2026). \textit{Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression}. BMC Medical Education. [published; Crossref]. \href{https://doi.org/10.1186/s12909-026-09124-8}{doi:10.1186/s12909-026-09124-8}.
\item Yap Sin-Yee, Noman Fuad, Loo Junn Yong, Stoliker Devon, Khajehnejad Moein, Phan Raphaël C.-W., Dowe David L., Razi Adeel, Ting Chee-Ming (2026). \textit{Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under Psilocybin}. 2026 IEEE 23rd International Symposium on Biomedical Imaging (ISBI). [published; Crossref]. \href{https://doi.org/10.1109/isbi61048.2026.11515300}{doi:10.1109/isbi61048.2026.11515300}.
\item Rumph JT, Winquist A, Troeschel AN, Pulver S, Schnall AH, Ebersole J, Yeh M, Burt B, Federman SL, Klontz K, Dasenbrock C, Leahy HL, Brady S, Stuteville H, Patel K, Daniel J, Chang A (2026). \textit{Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.}. MMWR. Morbidity and mortality weekly report. [published; PubMed]. \href{https://doi.org/10.15585/mmwr.mm7513a2}{doi:10.15585/mmwr.mm7513a2}.
\item University of California, Los Angeles (2026). \textit{Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06102434}{source link}.
\item Gallardo LM. (2026). \textit{Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.0415.v1}{doi:10.20944/preprints202604.0415.v1}.
\item Singleton S. Parker, Sevchik Brooke L., Lahey Analiese, Cuijpers Pim, Harrer Mathias, Jones Megan T., Nayak Sandeep M., Strain Eric C., Vandekar Simon N., Dworkin Robert H., Scott J. Cobb, Satterthwaite Theodore D. (2026). \textit{A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression}. Nature Mental Health. [published; Crossref]. \href{https://doi.org/10.1038/s44220-026-00630-8}{doi:10.1038/s44220-026-00630-8}.
\item Minauro-Sanmiguel F, Vargas-Perez H (2026). \textit{Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes.}. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroscience.2026.02.028}{doi:10.1016/j.neuroscience.2026.02.028}.
\item Berman P, Höfer J, Mehlman H, Almekias-Siegl E, Khersonsky O, Dong Y, Heinig U, Sulimani L, Hao LK, Cohen S, Peleg Y, Meir S, Rogachev I, Meiri D, Fleishman SJ, Aharoni A (2026). \textit{Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants.}. Science advances. [published; PubMed]. \href{https://doi.org/10.1126/sciadv.aeb3034}{doi:10.1126/sciadv.aeb3034}.
\item Lerer Leonard (2026). \textit{Psilocybin and human longevity}. npj Aging. [published; Crossref]. \href{https://doi.org/10.1038/s41514-026-00380-y}{doi:10.1038/s41514-026-00380-y}.
\item University Hospital, Basel, Switzerland (2026). \textit{Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy Participants}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06180759}{source link}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05546658}{source link}.
\item Stubbe DE (2026). \textit{"I've Done My Research": Psychedelics, PTSD, and the Therapeutic Alliance.}. Focus (American Psychiatric Publishing). [published; PubMed]. \href{https://doi.org/10.1176/appi.focus.20260003}{doi:10.1176/appi.focus.20260003}.
\item Buchanan Christine (2026). \textit{26-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORT}. JACC. [published; Crossref]. \href{https://doi.org/10.1016/j.jacc.2026.02.3249}{doi:10.1016/j.jacc.2026.02.3249}.
\item Richmond Linda M. (2026). \textit{MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!}. Psychiatric News. [published; Crossref]. \href{https://doi.org/10.1176/appi.pn.2026.04.4.3}{doi:10.1176/appi.pn.2026.04.4.3}.
\item Pichler Helena (2026). \textit{Psilocybin: Wirksam, aber kein Wundermittel}. MMW - Fortschritte der Medizin. [published; Crossref]. \href{https://doi.org/10.1007/s15006-026-5871-5}{doi:10.1007/s15006-026-5871-5}.
\item Meshkat Shakila, Jha Manish K., Bhat Venkat (2026). \textit{Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications}. Focus. [published; Crossref]. \href{https://doi.org/10.1176/appi.focus.20250043}{doi:10.1176/appi.focus.20250043}.
\item Allen J, Sun M, Baker TL, Dames S, Kryskow P, Christie BR, McDonald SJ, Shultz SR (2026). \textit{Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03329-x}{doi:10.1038/s41380-025-03329-x}.
\item Teopiz KM, Le GH, Wong S, McIntyre RS (2026). \textit{The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120836}{doi:10.1016/j.jad.2025.120836}.
\item Schindler EAD, Gottschalk CH, Pittman BP, D'Souza DC (2026). \textit{Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.}. Headache. [published; PubMed]. \href{https://doi.org/10.1111/head.70024}{doi:10.1111/head.70024}.
\item Weiser S, Jung S, Bardl B, Kufs JE, Janevska S, Valiante V, Hoffmeister D, Regestein L (2026). \textit{Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions.}. Biotechnology and bioengineering. [published; PubMed]. \href{https://doi.org/10.1002/bit.70137}{doi:10.1002/bit.70137}.
\item Swieczkowski Damian, Kwaśny Aleksander, Sadko Krzysztof, Cubała Wiesław Jerzy (2026). \textit{Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2025.112746}{doi:10.1016/j.euroneuro.2025.112746}.
\item Olejnik P, Kamińska K, Gołembiowska K, Kasarełło K (2026). \textit{Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-026-00824-y}{doi:10.1007/s43440-026-00824-y}.
\item Žuljević Marija Franka, Mijatović Antonija, Orhanović Renata, Goasdoué Glenn, Gujinović Diana (2026). \textit{Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin}. Journal of Clinical Epidemiology. [published; Crossref]. \href{https://doi.org/10.1016/j.jclinepi.2026.112170}{doi:10.1016/j.jclinepi.2026.112170}.
\item Syed Omer A., Tsang Benjamin, Nestor Sean M., Lipsman Nir, Husain Muhammad Ishrat, Alam Fahad, Giacobbe Peter (2026). \textit{Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis}. Neuroscience \& Biobehavioral Reviews. [published; Crossref]. \href{https://doi.org/10.1016/j.neubiorev.2026.106573}{doi:10.1016/j.neubiorev.2026.106573}.
\item Downar J, Lapenskie J, Anderson K, Parsons G, Polskaia N, Lalumiere G, Lawlor P (2026). \textit{PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial.}. Palliative medicine. [published; PubMed]. \href{https://doi.org/10.1177/02692163261416269}{doi:10.1177/02692163261416269}.
\item Nogueira Marcel, García-Hernández Solimary, Roberto Gleicy Sotéro, Rodrigues Daniel Cardoso (2026). \textit{Regulatory ambiguity and governance challenges for psilocybin mushrooms in Brazil}. International Journal of Drug Policy. [published; Crossref]. \href{https://doi.org/10.1016/j.drugpo.2026.105198}{doi:10.1016/j.drugpo.2026.105198}.
\item Griškova-Bulanova Inga, Vejmola Čestmír, Páleníček Tomáš (2026). \textit{Serotonergic modulation of cortical gamma synchronization: right-lateralized psilocin effects on 40 Hz auditory steady-state responses in rats}. Journal of Neurophysiology. [published; Crossref]. \href{https://doi.org/10.1152/jn.00519.2025}{doi:10.1152/jn.00519.2025}.
\item Bhatt KV, Friedman J, Benster L, Narasimhan R, Yang K, Mishra J, Weissman CR, Ramanathan D (2026). \textit{Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.}. Community mental health journal. [published; PubMed]. \href{https://doi.org/10.1007/s10597-026-01620-x}{doi:10.1007/s10597-026-01620-x}.
\item Adams DR, Xu KY, Cabassa LJ (2026). \textit{Psychedelic-Assisted Therapy: Breakthrough for Whom?}. Psychiatric services (Washington, D.C.). [published; PubMed]. \href{https://doi.org/10.1176/appi.ps.26077010}{doi:10.1176/appi.ps.26077010}.
\item Kazdan J, Ladha KS, Husain MI (2026). \textit{Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.}. Pharmacology research \& perspectives. [published; PubMed]. \href{https://doi.org/10.1002/prp2.70238}{doi:10.1002/prp2.70238}.
\item Girn M, Doss MK, Roseman L, Preller KH, Palhano-Fontes F, Pasquini L, Barrett FS, Mallaroni P, Mason NL, Timmermann C, McCulloch DE, Fisher PM, Winston BS, Moujaes F, Muller F, Liechti ME, Vollenweider FX, Ramaekers JG, Kuypers K, Araujo DB, Sporns O, Siegel J, Dosenbach N, Nutt DJ, Carhart-Harris RL, Stamatakis EA, Bzdok D (2026). \textit{An international mega-analysis of psychedelic drug effects on brain circuit function.}. Nature medicine. [published; PubMed]. \href{https://doi.org/10.1038/s41591-026-04287-9}{doi:10.1038/s41591-026-04287-9}.
\item Marazziti D, Gambini M, Gurrieri R, Russomanno G, Sità G, Pescini E, Digiuseppe FR, Mucci F (2026). \textit{Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.}. Expert opinion on pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1080/14656566.2026.2654682}{doi:10.1080/14656566.2026.2654682}.
\item Qiao Yong-xing, Dai Wei, Yao Yi-shan, Wei Qian-qian, Yue Chen-xing, Yin Yong-yu, Li Yun-feng, Zhang Li-ming (2026). \textit{The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse model}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.pnpbp.2026.111698}{doi:10.1016/j.pnpbp.2026.111698}.
\item Kurt Stocker, Matthias Hartmann, Frederick S. Barrett, Willam Richards, Nathan D. Sepeda, Isabelle Straumann, Aaron Klaiber, Severin B. Vogt, Livio Erne, Laura Ley, A. Becker, Patrick Vizeli, Friederike Holze, Matthias E. Liechti (2026). \textit{Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studies}. Religion Brain \& Behavior. [published; OpenAlex]. \href{https://doi.org/10.1080/2153599x.2026.2635353}{doi:10.1080/2153599x.2026.2635353}.
\item Saif S. Ali, Robin L. Carhart-Harris, Karl G. Sieg (2026). \textit{Classic psychedelics in obsessive-compulsive disorder: a circuit-based framework}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-026-00626-4}{doi:10.1038/s44220-026-00626-4}.
\item Maltman JL, González-Maeso J (2026). \textit{Reshaping human neurons.}. eLife. [published; PubMed]. \href{https://doi.org/10.7554/elife.110981}{doi:10.7554/elife.110981}.
\item Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin (2026). \textit{Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders}. Psychiatry and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.65801/pcp.3512}{doi:10.65801/pcp.3512}.
\item Sunnybrook Health Sciences Centre (2026). \textit{Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06072898}{source link}.
\item Indiana University (2026). \textit{Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07499583}{source link}.
\item Max Wolff, Samuli Kangaslampi, Richard J. Zeifman, Moritz Spangemacher (2026). \textit{Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8s7xk\_v1}{source link}.
\item Smith Katharine A., Harcourt Edward, Cipriani Andrea (2026). \textit{Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin}. The British Journal of Psychiatry. [published; Crossref]. \href{https://doi.org/10.1192/bjp.2026.10612}{doi:10.1192/bjp.2026.10612}.
\item Catchlove SJ, Oliver K, Savic M, Arunogiri S (2026). \textit{Unlocking 'stuckness' and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic-assisted therapy for substance use and mental health problems.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.70403}{doi:10.1111/add.70403}.
\item Knibb Graeme, Ward Ruby, Christiansen Paul, Roberts Carl Alexander (2026). \textit{Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-Stigma}. Substance Use \& Misuse. [published; Crossref]. \href{https://doi.org/10.1080/10826084.2026.2643418}{doi:10.1080/10826084.2026.2643418}.
\item Federal University of Latin American Integration (2026). \textit{Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06898606}{source link}.
\item Schmidt Malin, Hoffrichter Anne, Davoudi Mahnaz, Horschitz Sandra, Lau Thorsten, Meinhardt Marcus W, Spanagel Rainer, Ladewig Julia, Köhr Georg, Koch Philipp (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons}. eLife. [published; Crossref]. \href{https://doi.org/10.7554/elife.104006}{doi:10.7554/elife.104006}.
\item Johnson JD, Tian R, Etemadi Y, Li Z (2026). \textit{Psilocybin Attenuates Cortical Representations of Aversion in the Mouse Auditory Cortex.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.03.26.714498}{doi:10.64898/2026.03.26.714498}.
\item Aly Shah Aziz (2026). \textit{Classic psychedelic medicines for adolescent refractory mental health disease}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00452}{doi:10.1556/2054.2026.00452}.
\item Ana Cláudia Mesquita Garcia, Geovanna Maria Isidoro, Cremilson de Paula Silva (2026). \textit{Psychedelic Experiences and Finitude in Serious Illness: A Qualitative Synthesis}. Journal of Pain and Symptom Management. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpainsymman.2026.03.012}{doi:10.1016/j.jpainsymman.2026.03.012}.
\item Broc A Pagni, Stephen Ross, Sarah Mennenga, Snehal R Bhatt, Richard J. Zeifman, Petros Petridis, Brennan Carrithers, Lindsay Worth, Samantha Podrebarac, Lindsey Owens (2026). \textit{Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7xfek\_v1}{source link}.
\item Mäki-Marttunen Verónica (2026). \textit{Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors}. Communications Biology. [published; Crossref]. \href{https://doi.org/10.1038/s42003-026-09912-4}{doi:10.1038/s42003-026-09912-4}.
\item Skalski Piotr, Pękacka-Falkowska Katarzyna, Pluto-Prądzyńska Agnieszka, Owecki Michał K. (2026). \textit{Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)}. Brain Sciences. [published; Crossref]. \href{https://doi.org/10.3390/brainsci16040358}{doi:10.3390/brainsci16040358}.
\item Stanley Everett Sambey (2026). \textit{Psychedelic-Induced Constraint Destabilization and Reconstruction as a Mechanism for Cognitive Reset}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.19221582}{doi:10.5281/zenodo.19221582}.
\item Zirkel RT, Isaacson M, Liao C, Yi M, Yamaguchi K, Rivera D, Kuceyeski A, Nishimura N, Kwan AC, Schaffer CB (2026). \textit{Psilocybin Prolongs the Neurovascular Coupling Response in Mouse Visual Cortex.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.07.25.666803}{doi:10.1101/2025.07.25.666803}.
\item Anders Fink-Jensen, MD, DMSci (2026). \textit{The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05416229}{source link}.
\item Medical University of Vienna (2026). \textit{Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07490353}{source link}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Jiménez JH, Martín-Guerrero SM, González-Maeso J, López-Giménez JF (2026). \textit{Integrated 5-HT -TrkB and G protein signaling in serotonergic psychedelic responses.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.64898/2026.03.19.712961}{doi:10.64898/2026.03.19.712961}.
\item Jordan J. Negrine, Stephen Bright, Monica J. Barratt, Matthew Pennell, Anthony Barnett, James Bennett-Levy, Timothy Piatkowski (2026). \textit{“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice}. Drugs Education Prevention and Policy. [published; OpenAlex]. \href{https://doi.org/10.1080/09687637.2026.2645025}{doi:10.1080/09687637.2026.2645025}.
\item Alexandra Hopkins, Cassandra A. Bailey, Emily Rybak, Mia M. Ricardo (2026). \textit{Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military Personnel}. Journal of Police and Criminal Psychology. [published; OpenAlex]. \href{https://doi.org/10.1007/s11896-026-09807-4}{doi:10.1007/s11896-026-09807-4}.
\item Nößler Denis (2026). \textit{Psilocybin, Lp(a), CAC, Niere und Darmkrebs - Evidenz-Quickies KW12}. EvidenzUpdate. [published; Crossref]. \href{https://doi.org/10.69156/quick/2026.03.00011}{doi:10.69156/quick/2026.03.00011}.
\item J K Aronson (2026). \textit{When I use a word... The psychedelic mind’s eye}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.s548}{doi:10.1136/bmj.s548}.
\item University of New Mexico (2026). \textit{Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07484906}{source link}.
\item Bhagavan C, Carter O, Bryson A, Dandash O, Kanaan R (2026). \textit{Psychedelics in functional disorders: A scoping review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2026.111642}{doi:10.1016/j.pnpbp.2026.111642}.
\item Portes MAM, Bertoglio LJ (2026). \textit{Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2026.2644865}{doi:10.1080/02791072.2026.2644865}.
\item Anchesi I, Raffaele I, Astorino MF, Lui M, Calabrò M, Cipriano GL (2026). \textit{Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms27062811}{doi:10.3390/ijms27062811}.
\item Komarczewska Anna, Kociński Michał, Iglewski Patryk, Pietrasz Michał, Idziński Jakub, Lubomska Anna (2026). \textit{PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS}. International Journal of Innovative Technologies in Social Science. [published; Crossref]. \href{https://doi.org/10.31435/ijitss.1(49).2026.5034}{doi:10.31435/ijitss.1(49).2026.5034}.
\item Farré-Colomés Àlvar, Rublinetska Olga, Soto-Angona Óscar (2026). \textit{Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies}. Discover Mental Health. [published; Crossref]. \href{https://doi.org/10.1007/s44192-026-00384-w}{doi:10.1007/s44192-026-00384-w}.
\item Matsukubo Jenna, Friesen Erik Loewen, MacDonald-Spracklin Rachael, Iseman Rachael, Solmi Marco, Fiedorowicz Jess G., Fischer Benedikt, Myran Daniel T. (2026). \textit{Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution}. Canadian Journal of Public Health. [published; Crossref]. \href{https://doi.org/10.17269/s41997-026-01178-x}{doi:10.17269/s41997-026-01178-x}.
\item Johns Hopkins University (2026). \textit{Pilot Study of Psilocybin-assisted Treatment for Cannabis Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06660381}{source link}.
\item Gustavo Vazquez (2026). \textit{Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06818994}{source link}.
\item Williamson Samuel E., Burkhartzmeyer Elise K., Faley Michael T., Ohana Rachel F., Guzei Ilia A., Valley Mike, Cali James J., Sherwood Alexander M. (2026). \textit{Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs}. ACS Chemical Neuroscience. [published; Crossref]. \href{https://doi.org/10.1021/acschemneuro.5c00879}{doi:10.1021/acschemneuro.5c00879}.
\item Kate Brough, Corinna Lange (2026). \textit{A fungus among us: investigating queensland’s largest magic mushroom growing operation}. Australian Journal of Forensic Sciences. [published; OpenAlex]. \href{https://doi.org/10.1080/00450618.2026.2617320}{doi:10.1080/00450618.2026.2617320}.
\item Georgia Chlebek (2026). \textit{Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted Therapies}. ThinkIR: The University of Louisville's Institutional Repository (University of Louisville). [published; OpenAlex]. \href{https://ir.library.louisville.edu/tce/vol3/iss1/11}{source link}.
\item Johns Hopkins University (2026). \textit{Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04123314}{source link}.
\item Sungheetha Akey, Rajesh Sharma R., Aroba Oluwasegun Julius, Mahapatra Sheila, Mahendhiran P. D. (2026). \textit{Explainable AI framework for psilocybin depression treatment optimization}. Frontiers in Computer Science. [published; Crossref]. \href{https://doi.org/10.3389/fcomp.2025.1652190}{doi:10.3389/fcomp.2025.1652190}.
\item Lyons FE, Rockhill KM, Fox EJ, Bemis EA, Black JC, Monte AA, Dart RC (2026). \textit{Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT).}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2026.2644863}{doi:10.1080/02791072.2026.2644863}.
\item Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino (2026). \textit{Editorial: Psychedelic substances and neurological diseases: from basics to clinical application}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1816812}{doi:10.3389/fphar.2026.1816812}.
\item Johns Hopkins University (2026). \textit{Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04620759}{source link}.
\item Crocq MA, Auby P (2026). \textit{The renaissance of research on psychedelics in child and adolescent psychopharmacology.}. Child and adolescent psychiatry and mental health. [published; PubMed]. \href{https://doi.org/10.1186/s13034-026-01069-6}{doi:10.1186/s13034-026-01069-6}.
\item Wood BJ, Vest MF, Carfagno C, Bartley KR, Sharma P, Halberstadt AL, Blough BE, Murnane KS (2026). \textit{Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00484}{doi:10.1021/acsptsci.5c00484}.
\item McAlpine R, Jaglinska M, Jedlovszky K, Kuc J, Castro A, Piot A, Timmermann C, Skipper JI, Sacchet MD, Kamboj SK (2026). \textit{Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2025-107512}{doi:10.1136/bmjopen-2025-107512}.
\item University of Alabama at Birmingham (2026). \textit{Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05227742}{source link}.
\item University of Alabama at Birmingham (2026). \textit{Psilocybin-facilitated Treatment for Chronic Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05068791}{source link}.
\item Yale University (2026). \textit{Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06442423}{source link}.
\item Jason Luoma, Kim Hoffman, Adie Wilson-Poe, Ximena Levander, Alissa Bazinet, Ryan Cook, Dennis McCarty, Kellie Pertl, Sarann Bielavitz, Devin Gregoire (2026). \textit{Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1080/02791072.2025.2454474.}{doi:10.1080/02791072.2025.2454474.}.
\item Bradshaw AJ, Sharp C, Van Der Merwe B, Tremble KS, Dentinger BTM (2026). \textit{Discovery of the closest free-living relative of the domesticated 'magic mushroom' Psilocybe cubensis in Africa.}. Proceedings. Biological sciences. [published; PubMed]. \href{https://doi.org/10.1098/rspb.2025.2270}{doi:10.1098/rspb.2025.2270}.
\item Chauhan SB, Akhtar N, Jain C, Singh I (2026). \textit{Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.}. CNS \& neurological disorders drug targets. [published; PubMed]. \href{https://doi.org/10.2174/0118715273434237251212095005}{doi:10.2174/0118715273434237251212095005}.
\item Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M. (2026). \textit{Age moderates the relationship between psychedelics use and mental health in naturalistic settings}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9022170/v1}{doi:10.21203/rs.3.rs-9022170/v1}.
\item Floris G, Jefferson SJ, Rondeau J, Yu AL, Menniti FS, Kwan AC, De Aquino JP, Krystal JH, Pittenger C, Kaye AP. (2026). \textit{Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.06.710108}{doi:10.64898/2026.03.06.710108}.
\item Johnson Matthew W., Naudé Gideon P., Hendricks Peter S., Garcia-Romeu Albert (2026). \textit{Psilocybin or Nicotine Patch for Smoking Cessation}. JAMA Network Open. [published; Crossref]. \href{https://doi.org/10.1001/jamanetworkopen.2026.0972}{doi:10.1001/jamanetworkopen.2026.0972}.
\item Shore Ronald, Dobson Kat, Thomson Nina, Barnim Nigel, Bergman Hailey, Rideout Katie, McKeown Sandra, Olmstead Mary C., Goldie Craig, Dumont Eric (2026). \textit{Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2025.00364}{doi:10.1556/2054.2025.00364}.
\item Rebecchi Kevin (2026). \textit{“Diversity makes the richness of humanity”: The emergence and persistence of mental imagery after self-reported psilocybin truffles intake in an autistic woman with “blind imagination” (aphantasia): A33-month retrospective case report}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2025.00320}{doi:10.1556/2054.2025.00320}.
\item Shah S, Morrin H. (2026). \textit{Substance-induced manic psychosis in which delusions were corroborated by a chatbot - case report}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8919841/v1}{doi:10.21203/rs.3.rs-8919841/v1}.
\item Priest Michelle, Kilmer Beau, Ramchand Rajeev, Atshan Samer (2026). \textit{Psilocybin microdosing in the United States: Insights from a nationally representative survey}. Addiction. [published; Crossref]. \href{https://doi.org/10.1111/add.70368}{doi:10.1111/add.70368}.
\item Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R (2026). \textit{The combination of exercise and psychedelics for the treatment of major depressive disorder.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-026-00408-5}{doi:10.1007/s44192-026-00408-5}.
\item NYU Langone Health (2026). \textit{Pilot Proof of Concept Study Evaluating the Potential Psilocybin Assisted Psychotherapy (PAP) as a Therapeutic Tool for Patients Suffering From Severe Irritable Bowel Syndrome.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06760533}{source link}.
\item Ohio State University (2026). \textit{Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05554094}{source link}.
\item Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ. (2026). \textit{Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.02.709133}{doi:10.64898/2026.03.02.709133}.
\item Psyence Australia Pty Ltd (2026). \textit{A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07072728}{source link}.
\item Marissa Raymond-Flesch, MD, MPH (2026). \textit{Study of Psilocybin for Anorexia in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06399263}{source link}.
\item Prusti SP, Salian R, Das AK, Kumbhakar P (2026). \textit{Mushroom-Derived Carbon Nanosheets for Efficient Photothermal De-Icing Applications.}. Langmuir: the ACS journal of surfaces and colloids. [published; PubMed]. \href{https://doi.org/10.1021/acs.langmuir.5c05324}{doi:10.1021/acs.langmuir.5c05324}.
\item Valerie A. Canady (2026). \textit{Public attitudes diverge sharply on legal use of psychedelics}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.34775}{doi:10.1002/mhw.34775}.
\item Rebekah Senānāyaka (2026). \textit{Multidimensional Ego-Dissolution Assessment (MEDA): Scale Development and Substance-Specific Comparisons}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9c6xg\_v1}{source link}.
\item Stanley Kisourin (2026). \textit{Nicotinoyl-Tryptamine Derivatives as Potential Dual-Action Prodrugs for NAD⁺ Enhancement and Neuroprotection}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18825289}{doi:10.5281/zenodo.18825289}.
\item Zeinab Asghari, Gregory Robinson, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Timur Zanikov, Yasaman Rastamian, Olga Kovalchuk, Igor Kovalchuk* (2026). \textit{THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICE}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18796594}{doi:10.5281/zenodo.18796594}.
\item Corder Greg, Rogers Sophie, Oswell Corinna (2026). \textit{Psilocybin Reshapes Anterior Cingulate Network Neuropathic Topology to Reduce Chronic Pain}. The Journal of Pain. [published; Crossref]. \href{https://doi.org/10.1016/j.jpain.2025.105705}{doi:10.1016/j.jpain.2025.105705}.
\item Richmond Linda M. (2026). \textit{MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and More}. Psychiatric News. [published; Crossref]. \href{https://doi.org/10.1176/appi.pn.2026.03.3.5}{doi:10.1176/appi.pn.2026.03.3.5}.
\item Wrathall David J., Gosnell Hannah, Wickson Fern, Spanger Erika, Associates* (2026). \textit{Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways Forward}. Action Research. [published; Crossref]. \href{https://doi.org/10.1177/14767503251404263}{doi:10.1177/14767503251404263}.
\item Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA (2026). \textit{Meaning and Psychedelics in Palliative Care: A Narrative Review.}. Journal of pain and symptom management. [published; PubMed]. \href{https://doi.org/10.1016/j.jpainsymman.2025.10.015}{doi:10.1016/j.jpainsymman.2025.10.015}.
\item Guo Cui, Luu Nguyen N.T., Adwer Maryem M., Hosseinzadeh Hemen, Balan Venkatesh, Yan Yajun, Lin Yuheng (2026). \textit{Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocin}. Metabolic Engineering. [published; Crossref]. \href{https://doi.org/10.1016/j.ymben.2025.11.002}{doi:10.1016/j.ymben.2025.11.002}.
\item Syed OA, Nestor SM, Husain MI, Sinyor M, Alam F, Giacobbe P (2026). \textit{Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase).}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116929}{doi:10.1016/j.psychres.2025.116929}.
\item Jorgenson DM, Santos Leon E, Vakkalanka JP, Krispin S, Radke JB (2026). \textit{Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023-2024.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2025.2599402}{doi:10.1080/15563650.2025.2599402}.
\item Lewis S (2026). \textit{Psilocybin shapes neural plasticity in selective brain networks.}. Nature reviews. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41583-025-01019-9}{doi:10.1038/s41583-025-01019-9}.
\item Rached G, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, Barnett BS (2026). \textit{Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-025-01256-7}{doi:10.1007/s40263-025-01256-7}.
\item Doyle Zoe, Chisamore Noah, Kaczmarek Erica S., Johnson Danica E., Brudner Ryan M., Weiglein Geneva, Blainey Marc G., Bawks Jordan, Riva-Cambrin Jeremy, Sethi Rickinder, McIntyre Roger S., Rosenblat Joshua D. (2026). \textit{Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy}. General Hospital Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.genhosppsych.2026.01.001}{doi:10.1016/j.genhosppsych.2026.01.001}.
\item Xu T, Wong S, Le GH, Dri CE, Teopiz KM, Lu A, Lee S, Rhee TG, Yin L, Bargiota S, Ho R, McIntyre RS (2026). \textit{Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-2794-6487}{doi:10.1055/a-2794-6487}.
\item Shiju S, Tirumala R, Marseille E (2026). \textit{Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence.}. Exploratory research in clinical and social pharmacy. [published; PubMed]. \href{https://doi.org/10.1016/j.rcsop.2026.100709}{doi:10.1016/j.rcsop.2026.100709}.
\item Keshen A, Touyz S, Lacroix E, Hay P, McElroy SL (2026). \textit{Innovative Pharmacological Approaches to Eating Disorder Treatment.}. The Psychiatric clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.psc.2025.08.014}{doi:10.1016/j.psc.2025.08.014}.
\item Shokr MM, Fawzy MN, Abdelaziz AM (2026). \textit{Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.}. Molecular and cellular neurosciences. [published; PubMed]. \href{https://doi.org/10.1016/j.mcn.2026.104076}{doi:10.1016/j.mcn.2026.104076}.
\item Koutrouli Isis Rita Anzel, Brejtr Vojtěch, Schwendt Marek, Witek Kacper, Charalambous Chrysostomos, Aleksič Kristýna, Miniariková Nina, Lhotková Eva, Toman Martin, Nikolič Marek, Jurok Radek, Cihlářová Petra, Mazoch Vladimír, Ryšánek Pavel, Kuchař Martin, Šíchová Klára, Páleníček Tomáš (2026). \textit{Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention}. Addiction Biology. [published; Crossref]. \href{https://doi.org/10.1111/adb.70111}{doi:10.1111/adb.70111}.
\item Girault N, Quiroga L, Jedrecy S, Bertin S, Djonouma N, Fossati P (2026). \textit{[Perspectives opened up by the physiopathological understanding of psychiatric disorders].}. La Revue du praticien. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/41878960/}{source link}.
\item van der Meer PB, Schukking N, Dik M, van Reemst A, Fuentes JJ, Kaptein AA, Schoones JW, Verboeket S, de Waal MM, Goudriaan AE, Kramers C, Schellekens A, Bossong MG, Somers M, Batalla A (2026). \textit{Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251364182}{doi:10.1177/28314425251364182}.
\item Mosurinjohn S, Ascough R (2026). \textit{Psychedelics, Eleusis, and the Invention of Religious Experience.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251361835}{doi:10.1177/28314425251361835}.
\item Khan Faheem Ahmed, Pandupuspitasari Nuruliarizki Shinta, Tencomnao Tewin, Chuchawankul Siriporn (2026). \textit{Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy}. Journal of Affective Disorders. [published; Crossref]. \href{https://doi.org/10.1016/j.jad.2025.120882}{doi:10.1016/j.jad.2025.120882}.
\item Ziadi Yosr, Park Taehwan (2026). \textit{Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression}. Value in Health Regional Issues. [published; Crossref]. \href{https://doi.org/10.1016/j.vhri.2026.101605}{doi:10.1016/j.vhri.2026.101605}.
\item Ip Cheng-Teng, Olbrich Sebastian, de Bardeci Mateo, Monn Anna, Ort Andres, Smallridge John W., Vollenweider Franz (2026). \textit{Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.pnpbp.2026.111626}{doi:10.1016/j.pnpbp.2026.111626}.
\item Jacobsen Celia Faye, Stenbæk Dea Siggaard, Poulsen Stig, Armand Sophia (2026). \textit{The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?}. Psychiatric Research and Clinical Practice. [published; Crossref]. \href{https://doi.org/10.1176/appi.prcp.20250113}{doi:10.1176/appi.prcp.20250113}.
\item Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo (2026). \textit{A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253261433836}{doi:10.1177/20451253261433836}.
\item Zhang J, Lin C, Lv X, Zhao H, Wang X (2026). \textit{Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2026.02.011}{doi:10.1016/j.biopsych.2026.02.011}.
\item C Faria, Diana Dias da Silva, João José Sousa (2026). \textit{Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making}. Instituto Politécnico do Porto. [published; OpenAlex]. \href{https://doi.org/10.26537/prpaeh.v4i3.7173}{doi:10.26537/prpaeh.v4i3.7173}.
\item Beaussant Y, Sager Z, Brennan C, Kristan I, Ljuslin M, Mazzola E, Macdonald D, Murphy ME, Nigam K, Rinaldi AD, Sanders J, Schaefer KG, Sholevar R, Summer L, Waliji-Banglawala A, Yudilevich-Espinoza S, Tulsky JA (2026). \textit{Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.}. BMJ supportive \& palliative care. [published; PubMed]. \href{https://doi.org/10.1136/spcare-2025-005773}{doi:10.1136/spcare-2025-005773}.
\item Gearin A, Docherty J, Sun X, Cheung EH, Tanuseputro P (2026). \textit{Psychedelic therapy and cultural humility.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-026-03913-x}{doi:10.1038/s41398-026-03913-x}.
\item Li Tianjie, Reynolds Erin E., Wang Ziqi, Torrens-Spence Michael P., Weng Jing-Ke, Wang Yi (2026). \textit{Calcium activation mechanism of a noncanonical aromatic L-amino acid decarboxylase from psilocybin mushroom Psilocybe cubensis}. Communications Biology. [published; Crossref]. \href{https://doi.org/10.1038/s42003-026-09756-y}{doi:10.1038/s42003-026-09756-y}.
\item Diana Silva, Andreia Machado Brito-da-Costa, Mariana Carvalho, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Sérgio F. Sousa (2026). \textit{Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico Evidence}. Instituto Politécnico do Porto. [published; OpenAlex]. \href{https://doi.org/10.26537/prpaeh.v4i3.7159}{doi:10.26537/prpaeh.v4i3.7159}.
\item Centre for Addiction and Mental Health (2026). \textit{Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive Impairment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06041152}{source link}.
\item Gabriella Gobbi (2026). \textit{The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07433452}{source link}.
\item Garcia-Romeu Albert, Naudé Gideon P., Rebman Alison W., So Sara, Yaffe Abigail, Geithner Ian, Kozero Erica A., Yang Ting, Soloski Mark J., Aucott John N. (2026). \textit{Pilot study of psilocybin in patients with post-treatment lyme disease}. Scientific Reports. [published; Crossref]. \href{https://doi.org/10.1038/s41598-026-38091-9}{doi:10.1038/s41598-026-38091-9}.
\item Ishii M, Zervas M. (2026). \textit{SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD Treatment}. ScienceOpen Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.14293/pr2199.003034.v1}{doi:10.14293/pr2199.003034.v1}.
\item Johns Hopkins University (2026). \textit{Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06005662}{source link}.
\item Johns Hopkins University (2026). \textit{Investigation of Psychedelic Effects in Psychoactive Substances}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06772753}{source link}.
\item Shultz S, Allen J, O'Regan G, Brand J, Liknaitzky P, O'Brien T, Christie B, McDonald S. (2026). \textit{Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8555503/v1}{doi:10.21203/rs.3.rs-8555503/v1}.
\item Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A. (2026). \textit{Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8319478/v1}{doi:10.21203/rs.3.rs-8319478/v1}.
\item Jacobs E, Zahid Z, Hinkle J, Nayak S, Yaden DB (2026). \textit{Psychedelic medicine: mechanisms, evidence, and translation to practice.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj-2024-081723}{doi:10.1136/bmj-2024-081723}.
\item Anita Lino (2026). \textit{Cogumelos do gênero Psilocybe nas Américas e no Brasil}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.70031}{doi:10.1111/anoc.70031}.
\item Gow A, Shih E, Reid R, Qian JJ, Mellor C, McInnes LA, Carhart-Harris R, Davis JN. (2026). \textit{Prospective real-world evidence of mental health outcomes following supervised psilocybin services within the Oregon state-regulated model}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.02.18.26346580}{doi:10.64898/2026.02.18.26346580}.
\item Christina Chwyl, Alissa Bazinet, Adie Wilson-Poe, Kim Hoffman, Kellie Pertl, Sara McCrimmon, Philip Korthuis, Jason Luoma (2026). \textit{Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/mdz73\_v2}{source link}.
\item Jordan McDowell, Jada Middleton, Alanna Bluett, Alisa Kozachenko, Bayan Attar, Yuvraj Singh Saini, Jennifer Burke, Cayden McPhee, Mutahera Mutahera, Talya Ahmed, Nabila Ibrahim, Gilbert Atukwatsibwe, Sulabha Adhikari, Mohammad Esmaili, Jean-Vital Yambayamba (2026). \textit{Effects of Psilocybin and Select Pharmaceutical Interactions}. MacEwan University Student eJournal. [published; OpenAlex]. \href{https://doi.org/10.31542/bcek6t76}{doi:10.31542/bcek6t76}.
\item Khan Z, Weaver S, Dando RV, Schlag AK, Neill JC, Wainwright V (2026). \textit{Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis.}. Qualitative health research. [published; PubMed]. \href{https://doi.org/10.1177/10497323261419338}{doi:10.1177/10497323261419338}.
\item Yvan Beaussant, MD, MSci (2026). \textit{Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04950608}{source link}.
\item Knatz Peck S, Brewerton TD (2026). \textit{Rebuttal to "Questioning the recovery of dissociated traumatic memories under psilocybin".}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-026-01532-x}{doi:10.1186/s40337-026-01532-x}.
\item Beidas Z, Ragnhildstveit A, Blackman A, Anderson T, Fewster E, Syed OA, Sobolenko V, Kanca IK, Jaglinska M, Son T, Farb N, Petranker R (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2025.10968}{doi:10.1192/bjo.2025.10968}.
\item Abramowitz JS, Abramovitch A, McKay D, Draffin A (2026). \textit{Management of obsessive-compulsive disorder in adults.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj-2024-083443}{doi:10.1136/bmj-2024-083443}.
\item Prochazkova L, Marschall J, van Elk M, Rifkin BD, Schon NR, Fiacchino D, Fejer G, Kuchar M, Hommel B (2026). \textit{Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110732}{doi:10.1016/j.neuropharm.2025.110732}.
\item Murray Z, Lewies A, Wentzel JF, Schutte-Smith M, Erasmus E, Noreljaleel A, Visser H, Wilhelm A, Issahaku AR (2026). \textit{Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-026-39483-7}{doi:10.1038/s41598-026-39483-7}.
\item Dolenec P, Pelčić G, Pilipović K, Mršić-Pelčić J, Hrkać AH (2026). \textit{Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph19020316}{doi:10.3390/ph19020316}.
\item MycoMedica Life Sciences PBC (2026). \textit{A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07050368}{source link}.
\item Johns Hopkins University (2026). \textit{Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07053917}{source link}.
\item Amanda L. Elyse (2026). \textit{Psilocybin and Animal Testing: Charting an End to the Use of Animals in Drug Development Research}. Digital Commons at University of Maryland Carey Law (University of Maryland Francis King Carey School of Law). [published; OpenAlex]. \href{https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002\&context=jhclp\_online\_issue}{source link}.
\item Rafael Lancelotta, Paul Nagib, Stacey B. Armstrong, Adam W. Levin, A. B. Davis (2026). \textit{Development and assessment of a psychedelic-assisted therapy music playlist for clinical trials: Theory, intentionality, and metrics}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00462}{doi:10.1556/2054.2026.00462}.
\item Centre for Addiction and Mental Health (2026). \textit{Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07405606}{source link}.
\item University of California, Los Angeles (2026). \textit{Psilocybin-Assisted Cognitive Behavioral Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07281352}{source link}.
\item Matthew Hicks, Olivia Hicks, Ryan Bradley, Heather Zwickey (2026). \textit{Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00485}{doi:10.1556/2054.2026.00485}.
\item Banzato Marco, Colognesi Martina, Lucatello Lorena, Comai Stefano, Pasut Gianfranco, Capolongo Francesca, Orian Laura, Biasutto Lucia, Signor Anna, Gabbia Daniela, Manfredi Paolo L., De Martin Sara, Mattarei Andrea (2026). \textit{Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure}. Journal of Medicinal Chemistry. [published; Crossref]. \href{https://doi.org/10.1021/acs.jmedchem.5c01797}{doi:10.1021/acs.jmedchem.5c01797}.
\item Renner AC, Kargbo RB (2026). \textit{Chemical Design and Pharmacokinetics Enable Precision Psychedelic Therapeutics.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00780}{doi:10.1021/acsmedchemlett.5c00780}.
\item Johnston J, Jones G, Peng S, Yuan P, Yavi M, Kadriu B, Henter I, Quintanilla B, Elkahloun AG, Moaddel R, Schulmann A, Akula N, Kvarta M, McMahon F, Zarate C (2026). \textit{Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.}. Research square. [published; PubMed]. \href{https://doi.org/10.21203/rs.3.rs-8733841/v1}{doi:10.21203/rs.3.rs-8733841/v1}.
\item Sarah Shnayder, Gabrielle Agin-Liebes, Troy Hubert, Terence Ching, Jamila Hokanson, Christopher Pittenger, Benjamin Kelmendi, Thomas Adams (2026). \textit{Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/d94hb\_v1}{source link}.
\item Blake Beaton (2026). \textit{Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature}. Deviant Behavior. [published; OpenAlex]. \href{https://doi.org/10.1080/01639625.2026.2624690}{doi:10.1080/01639625.2026.2624690}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring: Mechanisms of Psilocybin-Induced Cortical Network Reorganization}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501568}{doi:10.5281/zenodo.18501568}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501514}{doi:10.5281/zenodo.18501514}.
\item Alexa Camarena-Michel, John Michael Rague (2026). \textit{Effects of cannabis and psychedelic use on cognitive, psychomotor, and driving performance: A review of recent literature}. Current Opinion in Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cotox.2026.100574}{doi:10.1016/j.cotox.2026.100574}.
\item Hadassah Medical Organization (2026). \textit{Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07079930}{source link}.
\item TRYP Therapeutics (2026). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06206265}{source link}.
\item Nantes University Hospital (2026). \textit{Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07391332}{source link}.
\item Tom A, Reddy BSC, Sethi MIS, Math SB (2026). \textit{India's Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics.}. Indian journal of psychological medicine. [published; PubMed]. \href{https://doi.org/10.1177/02537176261416347}{doi:10.1177/02537176261416347}.
\item Christopher Michael W., Prentice Boone M., Garrett Timothy J. (2026). \textit{Distinguishing 4- vs 5-Hydroxy- N, N -Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-Exchange}. Journal of the American Society for Mass Spectrometry. [published; Crossref]. \href{https://doi.org/10.1021/jasms.5c00421}{doi:10.1021/jasms.5c00421}.
\item Liu Junhong, Wang Yuanyuan, Xia Ke, Wu Jinfeng, Zheng Danhao, Cai Aoling, Yan Haitao, Su Ruibin (2026). \textit{Acute psilocin increased cortical activity in rat}. Frontiers in Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnins.2026.1593703}{doi:10.3389/fnins.2026.1593703}.
\item Sheida Shadani, Erika Greaves, Zane B. Andrews, Claire J. Foldi (2026). \textit{Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp026a.0003}{doi:10.61373/pp026a.0003}.
\item Anton T. Gregersen, Tobias Whelan, Caroline T. Golden, T. Blackmore, Mikael Palner (2026). \textit{Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot Study}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251386879}{doi:10.1177/28314425251386879}.
\item Bostancıklıoğlu M, Kaplan DS, Bal R, Yiğit E, Ulusal H, Temiz E (2026). \textit{MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2026.01.016}{doi:10.1016/j.biopsych.2026.01.016}.
\item Ben-Zion Z, Simon G, Lazebnik T. (2026). \textit{Can LLMs Get High? A Dual-Metric Framework for Evaluating Psychedelic Simulation and Safety in Large Language Models}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8682370/v1}{doi:10.21203/rs.3.rs-8682370/v1}.
\item Thomas Müller (2026). \textit{Psilocybin wirkt bei therapieresistenter Depression}. DNP - Die Neurologie \& Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15202-025-6636-1}{doi:10.1007/s15202-025-6636-1}.
\item Jorge Encantado, Laura C. Carvalho, Pedro Mota, Catarina Cunha, Albert Garcia-Romeu, Matthew W. Johnson, Pedro J. Teixeira (2026). \textit{Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).}. Professional Psychology Research and Practice. [published; OpenAlex]. \href{https://doi.org/10.1037/pro0000664}{doi:10.1037/pro0000664}.
\item Gründer G, Mertens LJ, Jungaberle A, Jungaberle H, Spangemacher M (2026). \textit{Compassionate use of psilocybin for treatment-resistant depression in Germany.}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(25)00277-9}{doi:10.1016/s2215-0366(25)00277-9}.
\item Vale LN, Ibrahim M, Fávaro-Pereira L, Soares JC, Meyer TD (2026). \textit{Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120437}{doi:10.1016/j.jad.2025.120437}.
\item Prochazkova L, Marschall J, Lippelt DP, Schon NR, Kuchař M, Hommel B (2026). \textit{Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110722}{doi:10.1016/j.neuropharm.2025.110722}.
\item Rakić V (2026). \textit{Love (Drugs), Happiness, and Morality.}. Bioethics. [published; PubMed]. \href{https://doi.org/10.1111/bioe.70043}{doi:10.1111/bioe.70043}.
\item Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN (2026). \textit{Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437251389090}{doi:10.1177/07067437251389090}.
\item Do A, Cloutier L, Hébert-Tremblay L, Thauvin C (2026). \textit{Psilocybin use in bipolar disorder: A comprehensive review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120485}{doi:10.1016/j.jad.2025.120485}.
\item Wolff M, Kangaslampi S (2026). \textit{Pharmacodynamic biomarker - or psychotherapeutic process? Comment on "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression".}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120637}{doi:10.1016/j.jad.2025.120637}.
\item Kramer HM, Hibicke M, Middleton J, Jaster AM, Kristensen JL, Nichols CD (2026). \textit{Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-025-02272-3}{doi:10.1038/s41386-025-02272-3}.
\item Ansari M, Elliott SI, Holmes SE, Sanacora G (2026). \textit{Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.}. Neurologic clinics. [published; PubMed]. \href{https://doi.org/10.1016/j.ncl.2025.08.009}{doi:10.1016/j.ncl.2025.08.009}.
\item Hirsch D, Reed J, Naqvi A, Ngor A, Dugan L, Costa K, Ganasi RS, Truman K, Danovitch I, IsHak WW, Hedrick R (2026). \textit{Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-025-01248-7}{doi:10.1007/s40263-025-01248-7}.
\item Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M (2026). \textit{New treatments for OCD? Evidence for cannabinoids and psychedelics.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2025.11.021}{doi:10.1016/j.jpsychires.2025.11.021}.
\item Reid MR, Song J, Boehnke KF, Buchanan NT, Aday JS (2026). \textit{Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106516}{doi:10.1016/j.neubiorev.2025.106516}.
\item Olofsson M, Osika W, Goldberg SB, Hendricks PS, Petrovic P, White T, Stenfors CUD, Chaturvedi S, Simonsson O (2026). \textit{Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2025.105105}{doi:10.1016/j.drugpo.2025.105105}.
\item Dutton M, Schwenn P, Mitchell J, Hoffmann P, Bailey NW, Fitzgerald PB, Lagopoulos J, Can AT (2026). \textit{Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674251398677}{doi:10.1177/00048674251398677}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M (2026). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Marques MG, Patarroyo-Rodriguez L, Singh B (2026). \textit{Psilocybin and Bipolar Depression: Promise and Prudence.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-025-01255-8}{doi:10.1007/s40263-025-01255-8}.
\item Kościuk Zuzanna, Szpręgiel Izabela, Bysiek Agnieszka, Gołembiowska Krystyna (2026). \textit{The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior}. Pharmacological Reports. [published; Crossref]. \href{https://doi.org/10.1007/s43440-025-00817-3}{doi:10.1007/s43440-025-00817-3}.
\item Haghdoost F, Bahceci D, Delcourt C, Wijeratne T, Jensen RH, Cincinnato C, Tomlinson S, Wold B, Polito V, Carcel C, Ashraf U, Jenkins B, Petersen AS, Ray JC, Schindler EAD, Tsang B, Gianacas C, Rodgers A (2026). \textit{Patient perspectives on research gaps in cluster headache.}. Headache. [published; PubMed]. \href{https://doi.org/10.1111/head.70031}{doi:10.1111/head.70031}.
\item Ham R, Gardner J, Carter A, Liknaitzky P (2026). \textit{Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy.}. Brain and behavior. [published; PubMed]. \href{https://doi.org/10.1002/brb3.71262}{doi:10.1002/brb3.71262}.
\item Halm S (2026). \textit{Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access.}. Brain and behavior. [published; PubMed]. \href{https://doi.org/10.1002/brb3.71265}{doi:10.1002/brb3.71265}.
\item Homon A, Laramie J, Hayward JJ, Trant JF (2026). \textit{We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine.}. ChemMedChem. [published; PubMed]. \href{https://doi.org/10.1002/cmdc.202500525}{doi:10.1002/cmdc.202500525}.
\item Roser P (2026). \textit{[Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches].}. Therapeutische Umschau. Revue therapeutique. [published; PubMed]. \href{https://doi.org/10.23785/tu.2026.01.006}{doi:10.23785/tu.2026.01.006}.
\item Kala K, Bederska-Lojewska D, Lazur J, Gasior K, Maslanka A, Szewczyk A, Sulkowska-Ziaja K, Turek J, Szewczyk B, Pilc A, Muszynska B (2026). \textit{Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.}. Journal of physiology and pharmacology: an official journal of the Polish Physiological Society. [published; PubMed]. \href{https://doi.org/10.26402/jpp.2026.1.07}{doi:10.26402/jpp.2026.1.07}.
\item McNaughton N, Shadli SM, Beaglehole B, Glue P (2026). \textit{Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments.}. Journal of the Royal Society of New Zealand. [published; PubMed]. \href{https://doi.org/10.1002/snz2.70002}{doi:10.1002/snz2.70002}.
\item Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item Kristensen J (2026). \textit{Regarding "The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses".}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-026-03844-7}{doi:10.1038/s41398-026-03844-7}.
\item Aditi Kanwar, Nitin Jeengar, Pramod Kumar Ashaiya (2026). \textit{Protecting patient autonomy in psychedelic-assisted psychotherapy: a nursing ethics perspective}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18425838}{doi:10.5281/zenodo.18425838}.
\item H. Knegtering, Thalia Herder, Nynke Boonstra, S. K. Spoelstra (2026). \textit{Psychedelic research and sexuality: opportunities and pitfalls}. The Journal of Sexual Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/jsxmed/qdag025}{doi:10.1093/jsxmed/qdag025}.
\item Rebensburg P. (2026). \textit{Psilocybin and the Evolutionary Significance of Altered Neural States: Interaction-Based Perspectives Beyond Deterrence Models}. EcoEvoRxiv. [preprint; Europe PMC]. \href{https://doi.org/10.32942/x2v66q}{doi:10.32942/x2v66q}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska (2026). \textit{Psychedelics in psychiatric treatment: a literature review}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.50.68013}{doi:10.12775/qs.2026.50.68013}.
\item Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero (2026). \textit{The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18375715}{doi:10.5281/zenodo.18375715}.
\item Rishika Scott, James Smith (2026). \textit{The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression}. Emerging Minds Journal for Student Research. [published; OpenAlex]. \href{https://doi.org/10.59973/emjsr.317}{doi:10.59973/emjsr.317}.
\item Valerie A. Canady (2026). \textit{RAND: Microdosing surges as millions turned to psychedelics in 2025}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.34732}{doi:10.1002/mhw.34732}.
\item NYU Langone Health (2026). \textit{A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06796062}{source link}.
\item Tripdatabase (2026). \textit{Is psilocybin only effective as part of psychotherapy?}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18339347}{doi:10.5281/zenodo.18339347}.
\item Tripdatabase (2026). \textit{Does psilocybin help with mental health conditions?}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18339283}{doi:10.5281/zenodo.18339283}.
\item Baylor College of Medicine (2026). \textit{The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06888128}{source link}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item Gregory NS, Girard TE, Ram A, Casey AB, Malenka RC, Tawfik VL, Heifets BD (2026). \textit{No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of pain.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-026-68763-z}{doi:10.1038/s41467-026-68763-z}.
\item Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria (2026). \textit{Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.}. Open Access CRIS of the University of Bern. [published; OpenAlex]. \href{https://doi.org/10.48620/94398}{doi:10.48620/94398}.
\item de la Fuente Revenga M, González-Maeso J (2026). \textit{Snapshot IP Detection Following 5-HTA Receptor Stimulation in the Mouse Brain.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00932}{doi:10.1021/acschemneuro.5c00932}.
\item Kandilakis CL, Papatheodoropoulos C (2026). \textit{Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00892}{doi:10.1021/acschemneuro.5c00892}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Miles Sarill, Lucia Centofanti, Andrea Rinaldi, Luciano Cascione, Sara Nunziata, Marco Banzato, Andrea Mattarei, Giovanna Finzi, Sonia Sonda, Diana Pendin, Ilaria Zanotto, Stefano Comai, Gianfranco Pasut, Abdullah Alajati, Miriam Saponaro, Loredana Bucciarelli, Maria Elena Lunati, Andrea Alimonti, et al. (2026). \textit{Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms}. Repository for Publications and Research Data (ETH Zurich). [published; OpenAlex]. \href{https://doi.org/10.3929/ethz-c-000793359}{doi:10.3929/ethz-c-000793359}.
\item Xia K, Gao T (2026). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. [published; PubMed]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item Barovic A, Pittiglio MK, Barrett JM, Aretz CDJ, Tesfatsion TT, Ramirez GA, Cruces W (2026). \textit{Presence of 4-Hydroxy--methyl--ethyltryptamine in Commercially Available Products.}. ACS omega. [published; PubMed]. \href{https://doi.org/10.1021/acsomega.5c10889}{doi:10.1021/acsomega.5c10889}.
\item Anthony L. Back, Bonnie A. McGregor, Leslie Lazar Thorn, Kelsey K. Baker, T. Gooley, Mendel Kaelen, Kalin Harvey, John M. Guy, Susanna Myers, Juliana Pérez, Peter Thompson, Lindsay Billingsley, Cheryl Sesnon (2026). \textit{Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251413856}{doi:10.1177/28314425251413856}.
\item Larsen K, Fisher PM, McCulloch DE, Olsen AS, Mueller F, Liechti M, Borgwardt S, Holze F, Vizeli P, Ley L, Klaiber A, Becker A, Ozenne B, Avram M. (2026). \textit{Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.01.15.26344193}{doi:10.64898/2026.01.15.26344193}.
\item Theo Tobel, Aidan Cone, Emily M Choquette, McKenna Garland, Micah Johnson, Keller Mink, Caitlin Lynch, Joel Frohlich, Justin Feinstein, Nicco Reggente (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v1}{source link}.
\item Hinchcliffe JK, Thomas CW, Gilmour G, Robinson ES. (2026). \textit{Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.01.14.699553}{doi:10.64898/2026.01.14.699553}.
\item Benjamin Kelmendi, Thomas Adams, Terence Ching, Rachael Grazioplene, Stephen Kichuk, Geena Fram, Prerana Patel, Jeff Eilbott, Elizabeth D’Amico, Sarah Shnayder (2026). \textit{Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/atfum\_v1}{source link}.
\item Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS (2026). \textit{Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120335}{doi:10.1016/j.jad.2025.120335}.
\item Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E (2026). \textit{Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.120352}{doi:10.1016/j.jad.2025.120352}.
\item Hà Trần Nguyên, Dung Nguyễn Thùy, Bình Nguyễn Nho, Trường Nguyễn Xuân, Hạnh Bùi Thị Hồng, Linh Nguyễn Thị Thùy, Bình Vũ Ngân (2026). \textit{XÂY DỰNG PHƯƠNG PHÁP ĐỊNH LƯỢNG PSILOCIN VÀ PSILOCYBIN TRONG HUYẾT TƯƠNG NGƯỜI BẰNG LC-MS/MS}. TNU Journal of Science and Technology. [published; Crossref]. \href{https://doi.org/10.34238/tnu-jst.13559}{doi:10.34238/tnu-jst.13559}.
\item Kelsey T. Laird, Prabha Siddarth, Ashley Ramos, Rhianna Rich, Brittany Youssef, Grace M. Schwartz, Karina Sergi, Micah Linton, L. Schwartzberg, Daniel F. Kelly, Keith G. Heinzerling (2026). \textit{Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted Therapy}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251413425}{doi:10.1177/28314425251413425}.
\item University of California, San Diego (2026). \textit{Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05224336}{source link}.
\item Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna; id\_orcid 0000-0002-2717-9739 Neill, Verity; id\_orcid 0000-0002-9876-250X Wainwright (2026). \textit{Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological Analysis}. Research Explorer (The University of Manchester). [published; OpenAlex]. \href{https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3}{source link}.
\item Renner AC, Kargbo RB (2026). \textit{Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine-DMT Formulations.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00714}{doi:10.1021/acsmedchemlett.5c00714}.
\item Koch P, Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt M, Spanagel R, Ladewig J, Köhr G. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4242829/v3}{doi:10.21203/rs.3.rs-4242829/v3}.
\item Mitchell J, Neitzke-Spruill L, Mathai DS, Robinson JO, Kavan Z, Averil LA, McGuire AL (2026). \textit{From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.}. Translational behavioral medicine. [published; PubMed]. \href{https://doi.org/10.1093/tbm/ibag027}{doi:10.1093/tbm/ibag027}.
\item Cornelius T, Barba T (2026). \textit{Associations of Couples' Psychedelic Use with Shared Reality and Relational Well-Being.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2607729}{doi:10.1080/02791072.2025.2607729}.
\item Kucukdereli H, Douglass AM (2026). \textit{Neuroscience: What doesn't kill you makes you stronger.}. Current biology: CB. [published; PubMed]. \href{https://doi.org/10.1016/j.cub.2025.11.056}{doi:10.1016/j.cub.2025.11.056}.
\item Dallery J, Miller JL, Boissoneault J, Harvey L, Ives L, Knerr A, Blaes S, Ransom MN, Munson M, Gilligan JP, Silverman MH, Guzzo PR, Loeser B (2026). \textit{An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-025-01508-3}{doi:10.1186/s40337-025-01508-3}.
\item Slot J, Bradshaw A, Dentinger B, Borovička J, Konkel Z, Rockefeller A, Bollinger I. (2026). \textit{The one that abstained: Psilocybe fuscofulva genome suggests two recent origins of the psilocybin gene cluster in Psilocybe}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.30.697041}{doi:10.64898/2025.12.30.697041}.
\item Sancilio Frederick D., Dariani Maghsoud, Chavda Purvi, Rajagopal Harsha Mysore, Tomlinson Lyl (2026). \textit{Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress}. Journal of Psychoactive Drugs. [published; Crossref]. \href{https://doi.org/10.1080/02791072.2025.2607726}{doi:10.1080/02791072.2025.2607726}.
\item Moshfeghinia R, Mostafavi S, Jazi K, Ghasemi AR, Khosravaninezhad Y, Narayanan S, Ahmadi J, Pasalar M (2026). \textit{The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis.}. BMC psychology. [published; PubMed]. \href{https://doi.org/10.1186/s40359-025-03935-y}{doi:10.1186/s40359-025-03935-y}.
\item McGuire AL, Neitzke-Spruill L, Robinson JO, Beit CS, Singh N, Mathai DS, Averill LA (2026). \textit{Reported Safety Practices of Publicly Advertised Psychedelic Retreats.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2025.52505}{doi:10.1001/jamanetworkopen.2025.52505}.
\item Florineth GA, Klima I, Boeker AL, Catzeflis P, Wopfner A, Denier N, Bracht T, Adorjan K, Pfammatter M, Müller F, Soravia LM (2026). \textit{Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2025.54843}{doi:10.1001/jamanetworkopen.2025.54843}.
\item Federico Durbano, Marco Otto Toscano (2026). \textit{Psychedelic Drugs}. IntechOpen. [published; OpenAlex]. \href{https://www.intechopen.com/books/1004886}{source link}.
\item CA Madsen, M. Navarro, E. Kolesnik, D. Kazani, V. Shalgunov, M. Zabrocki, A. Nasser, D. Luethi, F. Holze, M.E. Liechti, S.S. Johansen, M.K.K. Nielsen, H.D. Hansen, G.M. Knudsen (2026). \textit{Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigs}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106824}{doi:10.1016/j.nsa.2025.106824}.
\item Marecki R, Zaniewska W, Hamed A, Waszkiewicz N, Baker JJ, Łukasiewicz K (2026). \textit{Sex-dependent effects of psychedelics: review of evidence from rodent models.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2026.1824073}{doi:10.3389/fpsyt.2026.1824073}.
\item Rodrigues Paulo Henrique Rodrigues e, Júnior Weliton Rodrigues dos Santos, Araújo Ivan de Sousa, Leony Leonardo Maia, Gomes Fernanda Adélia Almeida Custódio Pires, Junior Tairone Matos de Lima, Moreira Luís Felipe Freitas, Santana Rafael Telles, Santos Manoel Carlos Matos, Silva Roberto de Barros (2026). \textit{COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSIS}. The Study of Phenomena Related to Health. [published; Crossref]. \href{https://doi.org/10.55905/edicon.978-65-83115-47-8\_8}{doi:10.55905/edicon.978-65-83115-47-8\_8}.
\item Ethan Klukas (2026). \textit{Motivation-based subtypes of psilocybin microdosers}. Open Collections. [published; OpenAlex]. \href{https://doi.org/10.14288/1.0452623}{doi:10.14288/1.0452623}.
\item Mahvash Khan, Muhammad Omar Malik, Sara Sajjad, Muhammad Uzair, Inayat Shah, Muhammad Ismail Bhatti (2026). \textit{COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER}. Genetics and Molecular Research. [published; OpenAlex]. \href{https://doi.org/10.4238/e91xh631}{doi:10.4238/e91xh631}.
\item Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate (2026). \textit{Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/yu3n9}{doi:10.17605/osf.io/yu3n9}.
\item E. Lopez, J O Lundberg, F. Hieronymus, M. Beckman, H. Yngwe, C.J. Ekman, M. Tiger, N. Edvall (2026). \textit{Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2026.106904}{doi:10.1016/j.nsa.2026.106904}.
\item I. Totomanova, E.C.H.M. Haijen, P.P.M. Hurks, NL Mason, JG Ramaekers, K.P.C. Kuypers (2026). \textit{Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic study}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2026.106942}{doi:10.1016/j.nsa.2026.106942}.
\item Y. Ge, T.P. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, F.M. Ponteduro, N. Khalil, S. Fenn-Moltu, NA Puts, E. Daly, D.G.M. Murphy, G.M. McAlonan, D. Batalle (2026). \textit{Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adults}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2026.106906}{doi:10.1016/j.nsa.2026.106906}.
\item Yosr Ziadi, Taehwan Park (2026). \textit{Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/nrt59}{doi:10.17605/osf.io/nrt59}.
\item Mateus Araújo da Luz, Taynah Pereira Galdino, Lucas Matheus da S. Oliveira, H. Guedes, Anauara Silva, Victor I. Afonso, Suédina M. L. Silva, Antônio G. B. Lima, Marcus V. L. Fook, Maria C. M. Torres (2026). \textit{Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal Extract}. Journal of the Brazilian Chemical Society. [published; OpenAlex]. \href{https://doi.org/10.21577/0103-5053.20260049}{doi:10.21577/0103-5053.20260049}.
\item Stefan Jerotić, Olga Čolović, Nađa Marić (2026). \textit{Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy"}. Medicinska istrazivanja. [published; OpenAlex]. \href{https://doi.org/10.5937/medi0-62051}{doi:10.5937/medi0-62051}.
\item Belle Buzzi (2026). \textit{Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/etd/8246}{source link}.
\item Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser (2026). \textit{Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.31199186.v1}{doi:10.6084/m9.figshare.31199186.v1}.
\item Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser (2026). \textit{Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.31199189.v1}{doi:10.6084/m9.figshare.31199189.v1}.
\item Hannah Whitmore, Maria Mangini, Heather Leutwyler, Brian Anderson (2026). \textit{Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay Men}. Palliative Medicine Reports. [published; OpenAlex]. \href{https://doi.org/10.1177/26892820251401798}{doi:10.1177/26892820251401798}.
\item Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah (2026). \textit{‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury}. Internal Medicine Journal. [published; OpenAlex]. \href{https://doi.org/10.1111/imj.70313}{doi:10.1111/imj.70313}.
\item B. Richardson, V. Bruno, J. O'Byrne, G. Gobbi (2026). \textit{Electrical brain changes following psilocybin administration in sprague-dawley rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106819}{doi:10.1016/j.nsa.2025.106819}.
\item T. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, N. Khalil, G. Ivin, E. Daly, NA Puts, D.G.M. Murphy, G.M. McAlonan (2026). \textit{Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic people}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105782}{doi:10.1016/j.nsa.2025.105782}.
\item L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer (2026). \textit{Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105779}{doi:10.1016/j.nsa.2025.105779}.
\item L. Marwood, M. Young, J. Chai-Rees, S. Mistry, S. Maxwell, G.M. Goodwin (2026). \textit{The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106572}{doi:10.1016/j.nsa.2025.106572}.
\item I.R.A. Koutrouli, K. Šíchová, W. Kacper, V. Brejtr, K. Aleksič, N. Miniariková, E. Lhotková, M. Nikolič, T. Páleníček (2026). \textit{Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106393}{doi:10.1016/j.nsa.2025.106393}.
\item N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin (2026). \textit{An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106821}{doi:10.1016/j.nsa.2025.106821}.
\item K. Aleksič (2026). \textit{The role of 5-HT2A receptors in sleep architecture and memory consolidation in the animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106729}{doi:10.1016/j.nsa.2025.106729}.
\item L. Puhl, L. Kunz, M. Berger, G. Gründer, L. Mertens, M. Spangemacher (2026). \textit{Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106390}{doi:10.1016/j.nsa.2025.106390}.
\item Jensen, Hailey A (2026). \textit{Psilocybin Treatment for Refractory Depression: A Clinical Review}. Digital Commons - Gardner-Webb University (Gardner-Webb University). [published; OpenAlex]. \href{https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63}{source link}.
\item Sam Lasham, Rhys Ponton (2026). \textit{The impact of drug control on wider research: Psychedelic mushroom exploration}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245251412697}{doi:10.1177/20503245251412697}.
\item LoParco CR, Bone C, Galvin AM, Rossheim ME, Berg CJ (2026). \textit{Oregon's Psilocybin Services: A Summary and Public Health Commentary.}. Health behavior research. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/42428139/}{source link}.
\item Schuman HDM, Mina R, Barkova S, Nguyen T, Deleemans JM, Carlson LE (2026). \textit{Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".}. Global advances in integrative medicine and health. [published; PubMed]. \href{https://doi.org/10.1177/27536130261459354}{doi:10.1177/27536130261459354}.
\item N. Martínez-Álvarez, I. Erkizia-Santamaría, A. Tomás-Alvarado, A.M. Erdozain, J.J. Meana, J.E. Ortega (2026). \textit{Preclinical evaluation of psilocybin as an anti-inflammatory agent}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105853}{doi:10.1016/j.nsa.2025.105853}.
\item M. Benes, D. Gregus, P. Adamek, T. Páleníček, J. Horacek (2026). \textit{Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106823}{doi:10.1016/j.nsa.2025.106823}.
\item O. Ollari, T.P. Whelan, C.L. Ellis, N. Khalil, F. Moruzzi, D.G.M. Murphy, E. Daly, L. Mason, N. Puts, G.M. McAlonan (2026). \textit{Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adults}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2026.106903}{doi:10.1016/j.nsa.2026.106903}.
\item Sellitti F., Weber C., Tamura É., Li Z., Thomann J., Luethi D., Simmler L.D. (2026). \textit{Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in mice}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2025.106574}{doi:10.1016/j.nsa.2025.106574}.
\item I. Totomanova, E.C.H.M. Haijen, Petra P. M. Hurks, NL Mason, K.P.C. Kuypers (2026). \textit{Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybin}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106822}{doi:10.1016/j.nsa.2025.106822}.
\item A. O'shea, JG Ramaekers, R. Schreiber, J.J. Briedé, J. Krauskopf, N. Mason, M.C.T. Verheijen (2026). \textit{Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in humans}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106576}{doi:10.1016/j.nsa.2025.106576}.
\item C. Weber, F. Sellitti, L. Ziming, J. von Arx, L.D. Simmler (2026). \textit{Behavioral and neuronal effects of psilocybin in mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106575}{doi:10.1016/j.nsa.2025.106575}.
\item Espi Forcen F (2026). \textit{A Psilocybin Experience Gone Wrong: The Importance of Psychedelic Assisted Psychotherapy.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2449918}{doi:10.1080/02791072.2025.2449918}.
\item Cuttler C, Stueber A, Simone J, Mayo LM (2026). \textit{Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users' Patterns of Use and Perceived Effects.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2452226}{doi:10.1080/02791072.2025.2452226}.
\item Gushken F, Fidalgo TM, Tardelli VS (2026). \textit{Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases.}. Journal of addiction medicine. [published; PubMed]. \href{https://doi.org/10.1097/adm.0000000000001580}{doi:10.1097/adm.0000000000001580}.
\item Islas-Vargas J, Armenta S, Rivera-Román ÁA, Hernández-León S, Méndez-Hernández JE, Arce-Cervantes O. (2026). \textit{Psilocybin: clinical potential, mechanistic insights, and biotechnological advances for scalable production}. World journal of microbiology \& biotechnology.. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609383879}{source link}.
\item Thomas K (2026). \textit{Toxicology and Pharmacological Interactions of Classic Psychedelics.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_508}{doi:10.1007/7854\_2024\_508}.
\item Holze F, Liechti ME, Müller F (2026). \textit{Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_510}{doi:10.1007/7854\_2024\_510}.
\item Choi C, Johnson DE, Chen-Li D, Rosenblat J (2026). \textit{Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241286771}{doi:10.1177/02698811241286771}.
\item Viljoen G, Betzler F (2026). \textit{Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_534}{doi:10.1007/7854\_2024\_534}.
\item Aghajanian S, Shafiee A, Parvizi Omran S, Rezaei Nejad A, Jafarabady K, Kohandel Gargari O, Rajai S, Mohammadi I, Bahrami Babaheidari T, Bakhtiyari M (2026). \textit{Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241287542}{doi:10.1177/02698811241287542}.
\item Barstowe A, Kajonius PJ (2026). \textit{Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2424272}{doi:10.1080/02791072.2024.2424272}.
\item Syed OA, Petranker R, Fewster EC, Sobolenko V, Beidas Z, Husain MI, Lake S, Lucas P (2026). \textit{Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2424284}{doi:10.1080/02791072.2024.2424284}.
\item Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM (2026). \textit{Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241303594}{doi:10.1177/02698811241303594}.
\item Bradberry MM, Appelbaum PS, Gukasyan N (2026). \textit{Informed Consent in Psychedelic-Assisted Therapy.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_559}{doi:10.1007/7854\_2024\_559}.
\item Windsor C, Kreynes AE, Chilton JS, Chioffi WA, Niebergall C, Dodds K (2026). \textit{Development of Psilocybe Mushroom Species Reference Material-Cultivation Parameters and Chemical Profiles.}. Journal of AOAC International. [published; PubMed]. \href{https://doi.org/10.1093/jaoacint/qsaf007}{doi:10.1093/jaoacint/qsaf007}.
\item Prostko S, Wu A, Maddams S, Szpak V, Rosenblum N, Hilt LM, Suzuki J (2026). \textit{Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.}. Journal of addiction medicine. [published; PubMed]. \href{https://doi.org/10.1097/adm.0000000000001517}{doi:10.1097/adm.0000000000001517}.
\item Foster K, Morrison I, Daniel S, Antoine J, Thankappan B, De La Haye W, Tyler M, Grant C, Delgoda R (2026). \textit{Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi.}. Journal of AOAC International. [published; PubMed]. \href{https://doi.org/10.1093/jaoacint/qsaf072}{doi:10.1093/jaoacint/qsaf072}.
\item Chwyl C, Wilson-Poe AR, Hoffman KA, Bazinet A, Pertl K, Luoma JB, des Jarlais D, Bielavitz S, Korthuis PT (2026). \textit{Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2025.104938}{doi:10.1016/j.drugpo.2025.104938}.
\item Higgins GA, MacMillan C, de Lannoy I, Tyler C, Slassi M (2026). \textit{Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251361453}{doi:10.1177/02698811251361453}.
\item McGowan NM, Rucker JJ, Yehuda R, Agrawal M, Modlin NL, Simmons H, Tofil-Kaluza A, Das S, Goodwin GM (2026). \textit{Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251362390}{doi:10.1177/02698811251362390}.
\item Hirschfeld T, Blei F, Stegemann L, van der Gouwe D, Smit-Rigter L (2026). \textit{Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2025\_606}{doi:10.1007/7854\_2025\_606}.
\item Heal DJ, Gosden J, Smith SL (2026). \textit{Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251382147}{doi:10.1177/02698811251382147}.
\item Marek GJ, Makai-Bölöni S, Umbricht D, Christian EP, Winters J, Dvorak D, Raines S, Hughes ZA, Austin EW, Klein AK, Leong W, Krol FJ, Graaf AJV, Juachon MJ, Otto ME, Borghans LGJM, Jacobs G, Kruegel AC, Sporn J (2026). \textit{A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251378512}{doi:10.1177/02698811251378512}.
\item Hutchison KE, Hooper JF, Karoly HC (2026). \textit{Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2025.3038}{doi:10.1001/jamapsychiatry.2025.3038}.
\item Lewis S (2026). \textit{'Magic' mechanisms underlie psilocybin's effects in chronic pain.}. Nature reviews. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41583-025-00999-y}{doi:10.1038/s41583-025-00999-y}.
\item Pinhas N, Eidlman N, Barnea A, Peled-Avron L (2026). \textit{Effects of psychedelic microdosing on cognitive functions: A systematic review and meta-analysis.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106493}{doi:10.1016/j.neubiorev.2025.106493}.
\item Konstantinou GN, Rosenblat J, Hales S, Husain MI, Blumberger DM (2026). \textit{Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.}. General hospital psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.005}{doi:10.1016/j.genhosppsych.2025.12.005}.
\item Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S (2026). \textit{Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.}. Palliative medicine. [published; PubMed]. \href{https://doi.org/10.1177/02692163251383335}{doi:10.1177/02692163251383335}.
\item Dwyer J, Johnston RB, O'Callaghan C, Ross M (2026). \textit{Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill.}. General hospital psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.002}{doi:10.1016/j.genhosppsych.2025.12.002}.
\item Kamilar-Britt P, Oliva AB, Earleywine M (2026). \textit{Perceptions of Psilocybin-Assisted Psychotherapy and Standard Interventions for Nicotine Cessation.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2607724}{doi:10.1080/02791072.2025.2607724}.
\item Maltby CJ, Klein AK, Paschen E, Pinto J, Dvorak D, Hedde JR, Hanks AN, Bianchi M, Hughes ZA (2026). \textit{An exploration of the relationships between the effects of psilocybin on behavior, 5-HT receptor occupancy, and neuroplastic effects in mice.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251395386}{doi:10.1177/02698811251395386}.
\item Moghadam H, Akbari P, Beirami E, Nabavifard S, Ameli A, Valian N (2026). \textit{The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors.}. Journal of neuroscience research. [published; PubMed]. \href{https://doi.org/10.1002/jnr.70107}{doi:10.1002/jnr.70107}.
\item Rasheed S, Arif R, Raza AA, Samadi A (2026). \textit{Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.}. Annals of medicine and surgery (2012). [published; PubMed]. \href{https://doi.org/10.1097/ms9.0000000000004349}{doi:10.1097/ms9.0000000000004349}.
\item Freitas da Costa B, Hartmann P, Pagnin D (2026). \textit{Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin.}. Human psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1002/hup.70032}{doi:10.1002/hup.70032}.
\item Magar V, Robbins M, Fernández Lobo Blanco ÓML, Ali IL, Anderson B, Grob C, Henningfield JE, Kryskow P, Kuiper H, Loizaga-Velder A, Rush B, Volat M, Iron Rope S (2026). \textit{Indigenous Knowledge Systems \& Psychedelic Science: Towards Ethical and Reciprocal Collaboration.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251387104}{doi:10.1177/02698811251387104}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W (2026). \textit{Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex.}. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.neurot.2026.e00841}{doi:10.1016/j.neurot.2026.e00841}.
\item Rasool M, Hannan TM, Imam M (2026). \textit{Magic mushrooms and mood: Exploring psilocybin as a depression treatment.}. JPMA. The Journal of the Pakistan Medical Association. [published; PubMed]. \href{https://doi.org/10.47391/jpma.30858}{doi:10.47391/jpma.30858}.
\item Bröcker AL, Majić T, Montag C (2026). \textit{Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2026\_613}{doi:10.1007/7854\_2026\_613}.
\item Majić T, Gouzoulis-Mayfrank E, Evens R (2026). \textit{Classifying Psychedelic-Related Complications.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2026\_614}{doi:10.1007/7854\_2026\_614}.
\item Durns T, Iannuzzi G (2026). \textit{Contextualizing Violence Risk Associated With Hallucinogens.}. Focus (American Psychiatric Publishing). [published; PubMed]. \href{https://doi.org/10.1176/appi.focus.20250027}{doi:10.1176/appi.focus.20250027}.
\item Spiti A, Caldirola D, Perna G (2026). \textit{New Antidepressant Development in the Treatment of Depression.}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-95-6872-7\_23}{doi:10.1007/978-981-95-6872-7\_23}.
\item Olivier B, Olivier JDA (2026). \textit{Psychedelics: Future Therapeutics in Major Depression?}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-95-6872-7\_25}{doi:10.1007/978-981-95-6872-7\_25}.
\item Shiner B, DuFort V, Peltzman T, Watts BV (2026). \textit{Rural-Urban Disparities in Access to Interventional Psychiatry Treatments among VA Patients.}. Rural mental health. [published; PubMed]. \href{https://doi.org/10.1037/rmh0000333}{doi:10.1037/rmh0000333}.
\item He MQ, Yang WQ, Phurbu D, Liu F, Li JX, Cao B, Zhao RL (2026). \textit{﻿Systematic study of (, ) sensu lato and psilocybin-producing traits of species from China.}. IMA fungus. [published; PubMed]. \href{https://doi.org/10.3897/imafungus.17.167329}{doi:10.3897/imafungus.17.167329}.
\item Raza M, Kaur J (2026). \textit{A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.102421}{doi:10.7759/cureus.102421}.
\item Siwek L, Nowocien M, Balajewicz B, Samborska A, Szukalska S, Karczewska M, Lichwala K, Wróblewski K, Wróblewska P (2026). \textit{The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.102694}{doi:10.7759/cureus.102694}.
\item Frontiers Editorial Office (2026). \textit{Retraction: Acute psilocybin increased cortical activities in rats.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2026.1787833}{doi:10.3389/fnins.2026.1787833}.
\item Habelt B (2026). \textit{The potential of event-related beta oscillations as biomarkers for neuromodulatory treatment efficacy.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2026.1779055}{doi:10.3389/fpsyg.2026.1779055}.
\item Kirlić N, Atli M, Mistry S, Gold M, Goodwin GM (2026). \textit{The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000002119}{doi:10.1097/jcp.0000000000002119}.
\item Poh C, Head C, Nunez JJ, Lapadat L, Morton E, Collaborative RESearch Team to Study Psychosocial Issues in Bipolar Disorder (CREST.BD), Michalak EE (2026). \textit{5 Years of bipolar disorder conversations on Reddit: Methods, key topics and future directions.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0338622}{doi:10.1371/journal.pone.0338622}.
\item Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR (2026). \textit{Psychedelic therapy and postpartum depression: priorities and prospects.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251408280}{doi:10.1177/20451253251408280}.
\item Evans M, Charrette A (2026). \textit{Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2026.1816932}{doi:10.3389/fnins.2026.1816932}.
\item Albert OM, Arthur A (2026). \textit{Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling.}. Therapeutic advances in drug safety. [published; PubMed]. \href{https://doi.org/10.1177/20420986261436104}{doi:10.1177/20420986261436104}.
\item Geraci J, Viirre E, Qorri B, Pani L (2026). \textit{Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2026.1777613}{doi:10.3389/fphar.2026.1777613}.
\item Ghaffarzadegan R, Karimi M, Hedayatjoo B, Behnoud H, Jasemi E, Mohammadi M, Roustaei S, Razmi A, Vaseghi S (2026). \textit{The Effect of on Spatial Memory and BDNF Expression in Male Rats Exposed to Chronic Unpredictable Mild Stress.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2428241}{doi:10.1080/02791072.2024.2428241}.
\item Syed OA, Petranker R, Fewster EC, Sobolenko V, Beidas Z, Husain MI, Lake S, Lucas P (2026). \textit{Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2446445}{doi:10.1080/02791072.2024.2446445}.
\item Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L (2026). \textit{Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2026.1834094}{doi:10.3389/fpsyt.2026.1834094}.
\item Sheheitli H, Hermosillo R, Grimsrud G, Madison T, Dominguez OM, Nelson S, Fair D, Nahas Z (2026). \textit{Metastability of resting-state bold fMRI as a reliable biomarker of individual brain dynamics: An interrogation of within-subject variability as a function of total acquisition time.}. Network neuroscience (Cambridge, Mass.). [published; PubMed]. \href{https://doi.org/10.1162/netn.a.537}{doi:10.1162/netn.a.537}.
\item Beichmann K, Catzeflis P, Aicher HD, Seragnoli F, Calder A, Amrani A, Hasler G (2026). \textit{Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253261448745}{doi:10.1177/20451253261448745}.
\item Domnauer C, Dentinger BTM (2026). \textit{Phylogenomic systematics of (Boletaceae) reveals cryptic diversity, resolves global evolutionary relationships, and suggests a novel psychoactive lineage.}. Mycologia. [published; PubMed]. \href{https://doi.org/10.1080/00275514.2026.2670968}{doi:10.1080/00275514.2026.2670968}.
\item Apollonio DE, Dennehy CE, Tsourounis C, Wakefield T (2026). \textit{Marketing by online tobacco retailers: An observational cross-sectional study.}. Tobacco induced diseases. [published; PubMed]. \href{https://doi.org/10.18332/tid/220983}{doi:10.18332/tid/220983}.
\item Kervadec E, Bezo A, Serreau R, Strika-Bruneau L, Fauvel B, Amirouche A, Benyamina A, Romeo B (2026). \textit{Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000002197}{doi:10.1097/jcp.0000000000002197}.
\item Kunal Kumar Sharma (2025). \textit{Psychedelics and neuroanesthesia: A narrative review of converging mechanisms}. Journal of Scientific Innovations in Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.65929/jsia.2026.1.2.002}{doi:10.65929/jsia.2026.1.2.002}.
\item Aneta Petrušková (2025). \textit{Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity}. OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg. [published; OpenAlex]. \href{https://doi.org/10.25593/open-fau-2619}{doi:10.25593/open-fau-2619}.
\item Sebastian Ehmann, Nikoloz Mosahvili, Angela White, John Cuzzupe, Brooke Tompkins, Jodi McKibben, John J.B. Allen, Michael Gawrysiak (2025). \textit{Self-Transcendent Perceptual Dynamics and the Effects of Dispositional Mindfulness on Altered States of Consciousness: A Prospective Longitudinal Observational Study of a Naturalistic Psychedelic Retreat}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6jf49\_v1}{source link}.
\item University of Calgary (2025). \textit{A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06615908}{source link}.
\item Rotem Petranker (2025). \textit{Microdosing Psychedelics to Improve Mood}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05259943}{source link}.
\item Cervera-Sanchez MB, San-Juan D, Díaz-Peregrino R, Camacho-Castillo EZ, Bringas-Ortiz SA, Padilla-Cabezutd C. (2025). \textit{Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.176701186.65064859/v1}{doi:10.22541/au.176701186.65064859/v1}.
\item Dominiak M, Gędek A, Modrzejewski S, Permoda-Pachuta A, Antosik AZ (2025). \textit{Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.}. Journal of clinical medicine. [published; PubMed]. \href{https://doi.org/10.3390/jcm15010253}{doi:10.3390/jcm15010253}.
\item Houff J, Williams A, Allen O, Gisabella B, Pantazopoulos H, Del Arco A. (2025). \textit{Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.22.696123}{doi:10.64898/2025.12.22.696123}.
\item Fei Liu, Jiaxin Li, Wen-Qiang Yang, Mao-Qiang He, Bin Cao, Qi Wu, R. Cheewangkoon, Rui-Lin Zhao (2025). \textit{Evolution and horizontal transfer of the psilocybin biosynthetic gene cluster drive the diversification of magic mushrooms}. Mycosphere. [published; OpenAlex]. \href{https://doi.org/10.5943/mycosphere/16/1/28}{doi:10.5943/mycosphere/16/1/28}.
\item Manasicha Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon, Maddison Vail (2025). \textit{A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder}. Current Treatment Options in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1007/s40501-025-00373-w}{doi:10.1007/s40501-025-00373-w}.
\item Sheppard Pratt Health System (2025). \textit{The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05220410}{source link}.
\item University of Chicago (2025). \textit{An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05399498}{source link}.
\item Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA. (2025). \textit{A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2025.12.22.25342874}{doi:10.64898/2025.12.22.25342874}.
\item Dana W. Sawyer (2025). \textit{Allowing Similarities: Using Aldous Huxley’s Views on Mystical Experience to Assess the Import of Profound Unitive Experiences Occasioned by Psychedelic Substances}. Religions. [published; OpenAlex]. \href{https://doi.org/10.3390/rel17010009}{doi:10.3390/rel17010009}.
\item Giuseppe Venturella, Manuela Rollini, Giulia Mirabile, Nicola Favia, Maria Letizia Gargano (2025). \textit{The genus Psilocybe in Italy}. Italian Botanist. [published; OpenAlex]. \href{https://doi.org/10.3897/italianbotanist.20.181001}{doi:10.3897/italianbotanist.20.181001}.
\item NYU Langone Health (2025). \textit{Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296328}{source link}.
\item Shadani S, McCoy K, Ong L, Greaves E, Conn K, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin modulates social behaviour in male and female mice in a time-dependent manner}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.18.695064}{doi:10.64898/2025.12.18.695064}.
\item Pallavicini C, Llobenes L, Cavanna F, de la Fuente LA, Muller S, Costa M, Gumiy N, Bruno N, D’Amelio T, Basran J, Plowright P, Stolkiner A, Namías M, Gilbert P, Tagliazucchi E. (2025). \textit{A Naturalistic Study on the Combined Neural and Psychological Effects of Psilocybin and Compassion Focused Imagery}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694940}{doi:10.64898/2025.12.17.694940}.
\item Brett J, Lea T, Knock E, Albert S, Acheson L, Siefried KJ, Job S (2025). \textit{A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorder.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.70284}{doi:10.1111/add.70284}.
\item Carlson LE, Richardson H, Shore R, Albertyn CP, Balneaves LG, Bates A, Burnell M, Chochinov HM, Clements D, Deleemans J, Horlock H, Mathews J, McKenzie M, Savard C, Soares CN, Tu W, Williams M (2025). \textit{The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.}. Current oncology (Toronto, Ont.). [published; PubMed]. \href{https://doi.org/10.3390/curroncol33010007}{doi:10.3390/curroncol33010007}.
\item Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P (2025). \textit{Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111541}{doi:10.1016/j.pnpbp.2025.111541}.
\item Johnson DE, Meshkat S, Kaczmarek ES, Rabin JS, Brudner RM, Chisamore N, Doyle Z, Bawks J, Riva-Cambrin J, Mansur RB, Lipsitz O, McIntyre RS, Lanctôt KL, Rosenblat JD (2025). \textit{Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111565}{doi:10.1016/j.pnpbp.2025.111565}.
\item Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen (2025). \textit{From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications}. Creative Science. [published; OpenAlex]. \href{https://doi.org/10.55674/cs.v18i1.264689}{doi:10.55674/cs.v18i1.264689}.
\item Mylène Cheng, Tatiana Aboulafia Brakha, Albert Buchard, Raya Anastasova, Léa Girani, Anna Breitenmoser, Sylvie Alaux, Cédric Mabilais, Caroline Amberger, Federico Seragnoli, Leonice Furtado, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler (2025). \textit{Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study}. Psychology International. [published; OpenAlex]. \href{https://doi.org/10.3390/psycholint8010001}{doi:10.3390/psycholint8010001}.
\item Koning E, Gamberg S, Keshen A. (2025). \textit{Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale \& Considerations for Protocol Development}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202512.1705.v1}{doi:10.20944/preprints202512.1705.v1}.
\item Matthews Nicholass K, Flis I, Hanley M, Knight M, Lane S, Littlejohn G, Thom M, Billington R, Boden R, Cummins R, Green B, Griffin C, Jones S, Salmon D, Sleep I, Smirnoff N, Ellis J. (2025). \textit{Wherefore the magic? The evolutionary role of psilocybin in nature}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694186}{doi:10.64898/2025.12.17.694186}.
\item Brar G, Burke T, Gribben AD, Harrington C, Thuery G, Kelly JR (2025). \textit{Psilocybin reporting in media (PRiMe) for the treatment of depression.}. Irish journal of psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/ipm.2025.10142}{doi:10.1017/ipm.2025.10142}.
\item Koning E, Bacchi P, Chaves C, Gomes FA, Brietzke E (2025). \textit{Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?}. Trends in psychiatry and psychotherapy. [published; PubMed]. \href{https://doi.org/10.47626/2237-6089-2025-1197}{doi:10.47626/2237-6089-2025-1197}.
\item Sophie Woodruff, Meghan Hibicke, Charles D. Nichols (2025). \textit{Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251393186}{doi:10.1177/28314425251393186}.
\item M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya (2025). \textit{Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment}. The journal of desk research review and analysis.. [published; OpenAlex]. \href{https://doi.org/10.4038/jdrra.v3i2.87}{doi:10.4038/jdrra.v3i2.87}.
\item Shannon Antoine-Hardy, D’Elia Bonilla (2025). \textit{Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot Study}. Journal of Complementary and Alternative Medical Research. [published; OpenAlex]. \href{https://doi.org/10.9734/jocamr/2025/v26i11723}{doi:10.9734/jocamr/2025/v26i11723}.
\item Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ (2025). \textit{The Role of Touch in Psychedelic Therapy: Perspectives From a Survey of Practitioners in Research Settings.}. American journal of psychotherapy. [published; PubMed]. \href{https://doi.org/10.1176/appi.psychotherapy.20240025}{doi:10.1176/appi.psychotherapy.20240025}.
\item Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI (2025). \textit{Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.119952}{doi:10.1016/j.jad.2025.119952}.
\item Ledwos N, Baer J, Husain MI, Blumberger DM, Patterson R, Hollingdrake E, Cheung E, Hawco C, Zrenner C, Zrenner B, Feusner JD, Rossell SL, Castle DJ, Zai G (2025). \textit{Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2025.10895}{doi:10.1192/bjo.2025.10895}.
\item Carhart-Harris R. (2025). \textit{The entropic brain today}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ubzq3\_v1}{doi:10.31234/osf.io/ubzq3\_v1}.
\item Robin Carhart-Harris (2025). \textit{The entropic brain today}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ubzq3\_v1}{source link}.
\item Samuel Hosford, Heather Austin-Robillard (2025). \textit{Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency}. Contemporary Family Therapy. [published; OpenAlex]. \href{https://doi.org/10.1007/s10591-025-09766-8}{doi:10.1007/s10591-025-09766-8}.
\item Renner AC, Kargbo RB (2025). \textit{Engineering the Next Generation of Psychedelic Therapeutics through Serotonergic Precision and Pharmacokinetic Control.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00661}{doi:10.1021/acsmedchemlett.5c00661}.
\item Jake Hooper, Sarah Williams, Raeghan Mueller, Kent Hutchison (2025). \textit{Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v2}{source link}.
\item Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S. (2025). \textit{Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8079137/v1}{doi:10.21203/rs.3.rs-8079137/v1}.
\item Magee Sarah N., Sereno Allison C., Echeveste-Sanchez Maria, Shannon Elizabeth G., Mohsin Abir, Mott Sarah E., Faccidomo Sara P., Hodge Clyde W., Herman Melissa A. (2025). \textit{The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice}. The Journal of Neuroscience. [published; Crossref]. \href{https://doi.org/10.1523/jneurosci.0652-25.2025}{doi:10.1523/jneurosci.0652-25.2025}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag.2}{doi:10.32388/xcfsag.2}.
\item Mohammad Reza Mirzadeh, Khalid Moinuddin, Vasso Apostolopoulos, Caine Barlow, Jianhua Zhang (2025). \textit{Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challenges}. Mycological Progress. [published; OpenAlex]. \href{https://doi.org/10.1007/s11557-025-02106-y}{doi:10.1007/s11557-025-02106-y}.
\item Wohlfarth, Gale, Hardy, Susan, Ray, Herman (2025). \textit{Are Magic Mushrooms the Magic to Healing?}. DigitalCommons - Kennesaw State University (Kennesaw State University). [published; OpenAlex]. \href{https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134}{source link}.
\item Imperial College London (2025). \textit{Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06798636}{source link}.
\item Taslim Uddin, Suma Akter, Kanak Yadab Ghosh (2025). \textit{Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges}. Advanced Neurology. [published; OpenAlex]. \href{https://doi.org/10.36922/an025410095}{doi:10.36922/an025410095}.
\item University of British Columbia (2025). \textit{Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05585229}{source link}.
\item NYU Langone Health (2025). \textit{A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05398484}{source link}.
\item Avery Ostrand, Matthew Nour, Christopher Timmermann, Andrea Rosati, Lisa Luan, Andrés Gómez-Emilsson, Julia Bornemann, Kyle Greenway, Leor Roseman, Robin Carhart-Harris (2025). \textit{Defining ‘psychedelic’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5ybhk\_v1}{source link}.
\item Kangaslampi S, Wolff M, Doss MK, Kloft-Heller L, Otgaar H (2025). \textit{Questioning the recovery of dissociated traumatic memories under psilocybin: comment on "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa".}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-025-01484-8}{doi:10.1186/s40337-025-01484-8}.
\item Spohn, Kyle (2025). \textit{Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://repository.law.miami.edu/umialr/vol57/iss1/7}{source link}.
\item Amin Reihani, Fatemeh Shaki (2025). \textit{Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case Report}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22038/apjmt.2025.89401.1525}{doi:10.22038/apjmt.2025.89401.1525}.
\item F. Seragnoli (2025). \textit{Psychedelic Assisted Psychotherapy (PAP): the Geneva University Hospital model}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100256}{doi:10.1016/j.etdah.2025.100256}.
\item S. Fereydouni (2025). \textit{Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100215}{doi:10.1016/j.etdah.2025.100215}.
\item Jones, Ariyah (2025). \textit{Taking a Trip into Nature’s Medicine Cabinet: A Country Comparison of Efforts to Reschedule Psilocybin and MDMA for Therapeutic Use}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://digitalcommons.law.uga.edu/gjicl/vol53/iss2/7}{source link}.
\item Wopfner, Alexander, Soravia, Leila M. (2025). \textit{Psilocybin-assistierte Gruppenpsychotherapie bei Abhängigkeitserkrankungen}. Open Access CRIS of the University of Bern. [published; OpenAlex]. \href{https://doi.org/10.48620/92823}{doi:10.48620/92823}.
\item Johannes Klaus, Fritz Schneider, Rena Schaletzky, Daniel Sippel, Anil Batra (2025). \textit{Psychedelics for the Treatment of Substance Use Disorders}. SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice. [published; OpenAlex]. \href{https://doi.org/10.1024/0939-5911/a000953}{doi:10.1024/0939-5911/a000953}.
\item Philip Garrity, Alicia Danforth, Brian Anderson, Jason M. Thompson (2025). \textit{Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care Patients}. Journal of Health Service Psychology. [published; OpenAlex]. \href{https://doi.org/10.1007/s42843-025-00145-3}{doi:10.1007/s42843-025-00145-3}.
\item Dario Jalilzadeh Masah, Derin Marbin, Tomislav Majić (2025). \textit{Three Cases of Depersonalization/Derealization Disorder Related to the Use of Classic Psychedelics}. SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice. [published; OpenAlex]. \href{https://doi.org/10.1024/0939-5911/a000959}{doi:10.1024/0939-5911/a000959}.
\item Bukovsky D, Amaev A, Song J, Torres-Carmona E, Kyte S, Ueno F, Deluca V, Bowie C, Flint A, Husain I, Graff-Guerrero A, Gerretsen P. (2025). \textit{Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging study}. Alzheimer's \& dementia: the journal of the Alzheimer's Association. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12740486}{source link}.
\item Madhu L, Somayaji Y, Kotian S, Attaluri S, Patel J, Panda P, Rao V, Kodali M, Shankar G, Rao S, Weintraub S, Shuai B, Rao X, Shetty A. (2025). \textit{Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal Neurogenesis}. Alzheimer's \& dementia: the journal of the Alzheimer's Association. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12739712}{source link}.
\item Buchard A, Seragnoli F, Sabe M, Eskinazi M, Aboulafia T, Furtado L, Briefer J, Roediger E, Penzenstadler L, Zullino D, Thorens G. (2025). \textit{Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8214817/v1}{doi:10.21203/rs.3.rs-8214817/v1}.
\item Aboulafia-Brakha T, Buchard A, Mabilais C, Alaux S, Amberger C, Furtado L, Seragnoli F, Briefer J, Thorens G, Sabé M, Szczesniak L, Iuga R, Zullino D, Penzenstadler L. (2025). \textit{Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.12.01.25341335}{doi:10.1101/2025.12.01.25341335}.
\item Stirn Judith, Berger Raphael, Hübner Harald, Gmeiner Peter, Klein Christian D. (2025). \textit{Towards "unmakable" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategy}. European Journal of Medicinal Chemistry Reports. [published; Crossref]. \href{https://doi.org/10.1016/j.ejmcr.2025.100278}{doi:10.1016/j.ejmcr.2025.100278}.
\item Dumenil M, Cordova G, El-Hage W (2025). \textit{[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2025.02.007}{doi:10.1016/j.encep.2025.02.007}.
\item Gillespie CM, Bering JM (2025). \textit{Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older Patients.}. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.jagp.2025.07.003}{doi:10.1016/j.jagp.2025.07.003}.
\item Li Y, Li H, Wang H, Wang X (2025). \textit{Exploring the therapeutic potential of psychedelics in treating substance use disorders.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03168-w}{doi:10.1038/s41380-025-03168-w}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC (2025). \textit{Between enhancement and risk: A critical review of psychedelic microdosing.}. Current opinion in psychology. [published; PubMed]. \href{https://doi.org/10.1016/j.copsyc.2025.102129}{doi:10.1016/j.copsyc.2025.102129}.
\item Drewko AJ, Habets RLP, Brunt TM (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Purple RJ, Gupta R, Thomas CW, Golden CT, Palomero-Gallagher N, Carhart-Harris R, Froudist-Walsh S, Jones MW (2025). \textit{Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03182-y}{doi:10.1038/s41380-025-03182-y}.
\item Brownstien M, Lazar M, Botvinnik A, Pogodin I, Lifschytz T, Lerer B (2025). \textit{Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)".}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03173-z}{doi:10.1038/s41380-025-03173-z}.
\item Purple RJ, Gupta R, Thomas CW, Golden CT, Palomero-Gallagher N, Carhart-Harris R, Froudist-Walsh S, Jones MW (2025). \textit{Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03231-6}{doi:10.1038/s41380-025-03231-6}.
\item Gattuso JJ, Kong G, Bezcioglu B, Lu D, Ekwudo MN, Wilson C, Gubert C, Hannan AJ, Renoir T (2025). \textit{Corrigendum to "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder" [Neuropharmacology 279 (2025) 110648].}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110679}{doi:10.1016/j.neuropharm.2025.110679}.
\item Inan S, Morris P, Rawls SM, Daws S (2025). \textit{Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats.}. Behavioural pharmacology. [published; PubMed]. \href{https://doi.org/10.1097/fbp.0000000000000856}{doi:10.1097/fbp.0000000000000856}.
\item Du X, Liu J, Wang X (2025). \textit{The transformational power of psychedelics: catalysts for creativity, consciousness, and mental health.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03291-8}{doi:10.1038/s41380-025-03291-8}.
\item García-Cabrerizo R, Beruete-Fresnillo I, Bergas-Cladera P, García-Fuster MJ (2025). \textit{Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity.}. Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie. [published; PubMed]. \href{https://doi.org/10.1016/j.biopha.2025.118720}{doi:10.1016/j.biopha.2025.118720}.
\item Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M (2025). \textit{Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2025.09.011}{doi:10.1016/j.euroneuro.2025.09.011}.
\item Ferreira J (2025). \textit{Psilocybin reduces comorbid chronic pain and depression in mice.}. Lab animal. [published; PubMed]. \href{https://doi.org/10.1038/s41684-025-01663-9}{doi:10.1038/s41684-025-01663-9}.
\item Downey AE, Tai ML, Bradley ER, Woolley JD (2025). \textit{Sudden Loss of Consciousness Following Psilocybin Ingestion.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20250037}{doi:10.1176/appi.ajp.20250037}.
\item Kleditzsch N, Gattuso JJ, Hannan AJ, Renoir T (2025). \textit{Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin.}. The European journal of neuroscience. [published; PubMed]. \href{https://doi.org/10.1111/ejn.70351}{doi:10.1111/ejn.70351}.
\item Modlin NL, Williamson V, Goodwin GM, Malievskaia E, Atli M, Elek Z, Gaillard A, Koelpin D, Cleare A, Agrawal M, Yehuda R, Kirlic N, Rucker J (2025). \textit{Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.}. EClinicalMedicine. [published; PubMed]. \href{https://doi.org/10.1016/j.eclinm.2025.103692}{doi:10.1016/j.eclinm.2025.103692}.
\item Palitsky R, Grant GH (2025). \textit{Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics, Spirituality, and the Sacred: Commentary on Griffiths et al. (2025).}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251393983}{doi:10.1177/28314425251393983}.
\item Brach T (2025). \textit{Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions: The Great Promise of Psychedelics: Evolving Human Consciousness.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251408081}{doi:10.1177/28314425251408081}.
\item Lorenz J, Hawkins S, McCarthy B (2025). \textit{Griffiths et al.'s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian Perspective.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251406251}{doi:10.1177/28314425251406251}.
\item Griffiths RR, Jesse R, Richards WA, Johnson MW, Sepeda ND, Bossis AP, Ross S (2025). \textit{Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0044}{doi:10.1089/psymed.2023.0044}.
\item de Wit H (2025). \textit{Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions, by Griffiths et al.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251409219}{doi:10.1177/28314425251409219}.
\item Pargament KI (2025). \textit{Psilocybin, Spirituality, and the Potential for Personal Transformation: Commentary on Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions by Griffiths et al.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251406613}{doi:10.1177/28314425251406613}.
\item Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J (2025). \textit{Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.99942}{doi:10.7759/cureus.99942}.
\item Julian Kiverstein, Hüseyin Beyköylü, Michiel van Elk (2025). \textit{A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience}. Philosophical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/09515089.2025.2590741}{doi:10.1080/09515089.2025.2590741}.
\item Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana (2025). \textit{Efficacy of psilocybin on death anxiety in terminal patients: a narrative review}. Progress in Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1080/09699260.2026.2657096}{doi:10.1080/09699260.2026.2657096}.
\item Bjørn Holmøy, Kristoffer Andreas Aamodt Andersen (2025). \textit{Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects}. Tidsskrift for Norsk psykologforening. [published; OpenAlex]. \href{https://doi.org/10.52734/hgsn7664}{doi:10.52734/hgsn7664}.
\item University of Iowa (2025). \textit{Psilocybin vs Ketamine for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06405607}{source link}.
\item University College, London (2025). \textit{Digital Intervention for Psychedelic Preparation (DIPP): A Randomised Controlled Feasibility Trial Comparing Meditation and Music-Based Programs in Healthy Volunteers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06815653}{source link}.
\item University of Texas at Austin (2025). \textit{Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06132178}{source link}.
\item Domżalska M, Kwiatkowska J, Cichoń I, Sokołowska E (2025). \textit{A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-025-29642-7}{doi:10.1038/s41598-025-29642-7}.
\item Charles S. Grob, M.D. (2025). \textit{Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05403086}{source link}.
\item Kruger DJ, Mersereau G, Sullivan A, Barron J, Herberholz M, Pouyan N, Aday JS, Boehnke KF (2025). \textit{Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-025-01337-2}{doi:10.1186/s12954-025-01337-2}.
\item Rodríguez Luisina, Morera Guillermo, Lupo Sandra, Davyt Danilo, Carrera Ignacio, Hernández Dossi Gonzalo (2025). \textit{Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms}. ACS Omega. [published; Crossref]. \href{https://doi.org/10.1021/acsomega.5c07092}{doi:10.1021/acsomega.5c07092}.
\item J Pincombe, M.L. Williams, Sean Carruthers, Susan L. Rossell (2025). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251394012}{doi:10.1177/28314425251394012}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag}{doi:10.32388/xcfsag}.
\item Stacey B. Armstrong, Meghan DellaCrosse, Jaime Fuentes-Balderrama, Rafaelle Lancelotta, Alan K. Davis (2025). \textit{Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2025.100006}{doi:10.1016/j.psyche.2025.100006}.
\item Holly Hepburn, Bart Ellenbroek, Jiun Youn (2025). \textit{Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2025.100005}{doi:10.1016/j.psyche.2025.100005}.
\item Óscar Véliz-García, Marcos Domic-Siede (2025). \textit{Exploring the first use of psychedelic macrodoses in Latin American adults: Sociodemographic profiles, consumption factors, and subjective experiences}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00454}{doi:10.1556/2054.2025.00454}.
\item Jaster AM, Hadlock TM, Buzzi B, Maltman JL, Silva GM, Saha S, Koseli E, Pondelick AM, Thakur N, Zhang X, Li G, Ledesma-Corvi S, Moore KN, Peterson HR, Fujita B, Zylko AL, Lewis MR, Poklis JL, Halquist MS, Wolstenholme JT, Selley DE, Hamilton PJ, Lu C, Damaj MI, González-Maeso J (2025). \textit{Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-64887-w}{doi:10.1038/s41467-025-64887-w}.
\item Natoli S, Cuomo A, Marchesini M, Luongo L, Lo Bianco G, Guardamagna VA, Yamaguchi S (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Medical sciences (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item University of Zurich (2025). \textit{Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06081179}{source link}.
\item Beersheva Mental Health Center (2025). \textit{A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07183748}{source link}.
\item Beersheva Mental Health Center (2025). \textit{Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04882839}{source link}.
\item Brown KA, Ajibola MI, Medeiros GC, Gould TD (2025). \textit{Synaptic priming: A framework for pharmacotherapy in depression.}. Neuron. [published; PubMed]. \href{https://doi.org/10.1016/j.neuron.2025.09.010}{doi:10.1016/j.neuron.2025.09.010}.
\item Agrawal R, Gillie D, Mungenast A, Chytil M, Engel S, Wu MC, Rasmussen K, Salinas E, Olson DE (2025). \textit{Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00667}{doi:10.1021/acschemneuro.5c00667}.
\item Zhang W, Hwang SY, Luther J (2025). \textit{Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.}. Current gastroenterology reports. [published; PubMed]. \href{https://doi.org/10.1007/s11894-025-01026-x}{doi:10.1007/s11894-025-01026-x}.
\item Oblak, Aleš, Hudnik Korošec, Liam, Levačić, Anja, Elersič, Kristian, Pregelj, Peter, Bon, Jurij (2025). \textit{Salience, sensemaking, and setting in psilocybin microdosing}. Repository of the University of Ljubljana (University of Ljubljana). [published; OpenAlex]. \href{https://repozitorij.uni-lj.si/IzpisGradiva.php?id=176012}{source link}.
\item Montgomery Tony, Grant DeMond M. (2025). \textit{Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Restoration}. Advance. [preprint; Crossref]. \href{https://doi.org/10.31124/advance.175630073.36585408/v2}{doi:10.31124/advance.175630073.36585408/v2}.
\item Peggy C Nopoulos (2025). \textit{Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05421065}{source link}.
\item Ioakimidis-MacDougall G, Gardner J, Liknaitzky P. (2025). \textit{Psilocybin Experiential Therapist Training: Insights from a World-First Study}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.11.15.25340324}{doi:10.1101/2025.11.15.25340324}.
\item Rosal SRP, Faber SC. (2025). \textit{Standardization of Psilocybin Dosing in a Natural Product-Based Retreat Setting: A Practical Method for Dose Quantification and Adjustment Across Sessions}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8000629/v1}{doi:10.21203/rs.3.rs-8000629/v1}.
\item Bhavaraju KP, Mason NL, Mallaroni P, Heinke D, Toennes SW, Ramaekers JG, Amico E. (2025). \textit{Unmixing the Psychedelic Connectome: Brain Network Traits of Psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.11.17.688834}{doi:10.1101/2025.11.17.688834}.
\item Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily Fewster, Omer Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son (2025). \textit{Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/hmnsw\_v1}{source link}.
\item Vargas Ibarra, Pablo (2025). \textit{Spiritual dimension and psychedelic experiences: A phenomenological approach}. PhilArchive. [preprint; OpenAlex]. \href{https://philarchive.org/rec/VARSDA}{source link}.
\item Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis (2025). \textit{Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2025.100004}{doi:10.1016/j.psyche.2025.100004}.
\item Ellis S, Bostian C, Donnelly A, Feng W, Eisen K, Lean M, Conlan E, Ostacher M, Aaronson S, Suppes T (2025). \textit{Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2025.119655}{doi:10.1016/j.jad.2025.119655}.
\item Gattuso JJ, Kong G, Bezcioglu B, Lu D, Ekwudo MN, Wilson C, Gubert C, Hannan AJ, Renoir T (2025). \textit{Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110648}{doi:10.1016/j.neuropharm.2025.110648}.
\item William Roseby, Catriona Osborn Moar (2025). \textit{A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040041}{doi:10.3390/psychoactives4040041}.
\item Renner AC, Kargbo RB (2025). \textit{Toward Precision Psychedelic Therapies: Chemical, Computational, and Neuromodulatory Innovations.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00597}{doi:10.1021/acsmedchemlett.5c00597}.
\item Renner AC, Kargbo RB (2025). \textit{Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00595}{doi:10.1021/acsmedchemlett.5c00595}.
\item Sabnis Ram W. (2025). \textit{Novel Psilocin Derivatives as Serotonergic Psychedelic Agents for Treating CNS Disorders}. ACS Medicinal Chemistry Letters. [published; Crossref]. \href{https://doi.org/10.1021/acsmedchemlett.5c00608}{doi:10.1021/acsmedchemlett.5c00608}.
\item Martens MAG, Cunha BG, Erritzoe D, Nutt D, Carhart-Harris R, Harmer CJ (2025). \textit{Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03693-w}{doi:10.1038/s41398-025-03693-w}.
\item Kenneth Shinozuka, Katarina Jerotic, Pedro A. M. Mediano, A ZHAO, Katrin H. Preller, Robin Carhart-Harris, Morten L. Kringelbach (2025). \textit{Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03731-7}{doi:10.1038/s41398-025-03731-7}.
\item Presley Aspen, Presley Pham, Jennifer Mitchell (2025). \textit{Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term Outcomes}. Berkeley Scientific Journal. [published; OpenAlex]. \href{https://doi.org/10.5070/bs329265627}{doi:10.5070/bs329265627}.
\item Luisina Rodríguez (12333694), Guillermo Morera (22593717), Sandra Lupo (22593720), Danilo Davyt (2738347), Ignacio Carrera (1677175), Gonzalo Hernández Dossi (22593723) (2025). \textit{Novel qNMR Methodto Quantify Psilocybin and Psilocinin Psychedelic Mushrooms}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.5c07092.s001}{doi:10.1021/acsomega.5c07092.s001}.
\item Schäfer T, Haun F, Rupp B, Hoffmeister D (2025). \textit{Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms.}. Angewandte Chemie (International ed. in English). [published; PubMed]. \href{https://doi.org/10.1002/anie.202512017}{doi:10.1002/anie.202512017}.
\item Mehtani NJ, Mian MN, Agin-Liebes G, Coker AR, Huebner C, Anderson BT, Mitchell JM (2025). \textit{Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2583960}{doi:10.1080/02791072.2025.2583960}.
\item Zech JM, Richard J, Jones GM (2025). \textit{The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2583967}{doi:10.1080/02791072.2025.2583967}.
\item Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P, Vollenweider FX, Diaconescu AO. (2025). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.11.06.687023}{doi:10.1101/2025.11.06.687023}.
\item Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Larsen IB, Knudsen GM, Klein AB, Clemmensen C (2025). \textit{Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03729-1}{doi:10.1038/s41398-025-03729-1}.
\item Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider, Andreea O. Diaconescu (2025). \textit{Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-292276}{doi:10.5167/uzh-292276}.
\item Yale University (2025). \textit{Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03554174}{source link}.
\item University of Washington (2025). \textit{A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05847686}{source link}.
\item Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J, Harker S, Ford A, Lewis C. (2025). \textit{Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7890051/v1}{doi:10.21203/rs.3.rs-7890051/v1}.
\item Jevotovsky DS, Chopra H, Pak DJ, Durbhakula S, Shustorovich A, Juneja T, Broachwala MY, AlFarra T, Silver C, Kreitzer G, Oreoluwa P, Weissman BB, AlFarra A, Mayrsohn BG, Orhurhu V, Emerick T, Furnish T, Castellanos JP (2025). \textit{Psilocybin and chronic neuropathic pain: a systematic review.}. Regional anesthesia and pain medicine. [published; PubMed]. \href{https://doi.org/10.1136/rapm-2024-105532}{doi:10.1136/rapm-2024-105532}.
\item Aisling McGuigan (2025). \textit{Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required}. Drugs \& Therapy Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1007/s40267-025-01199-5}{doi:10.1007/s40267-025-01199-5}.
\item Bhagavan C, Bryson A, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Eleftheriadis D, Oliver G, Mayne D, Roebuck G, Rucker J, Butler M, Kanaan R (2025). \textit{Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2025.10042}{doi:10.1017/neu.2025.10042}.
\item Srivastava AB, Gold MS (2025). \textit{A Tragedy of Errors: The State of Psychedelic Research in the Treatment of Alcohol Use Disorder.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15111190}{doi:10.3390/brainsci15111190}.
\item Marinis J, Clarke ST, Guerin AA, Guastella AJ, Bedi G (2025). \textit{Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2025.10847}{doi:10.1192/bjo.2025.10847}.
\item Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli (2025). \textit{Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040039}{doi:10.3390/psychoactives4040039}.
\item Tyler D. McGehee, Nicole Lacap, Adeel Iqbal, Alan M. Langlieb (2025). \textit{92. Mushrooms and Mania: Differentiating Psilocybin-Induced Mania From First-Break Bipolar Mania}. Journal of the Academy of Consultation-Liaison Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaclp.2025.10.094}{doi:10.1016/j.jaclp.2025.10.094}.
\item Richard Drexler, Belgin Yalçın, Rebecca Mancusi, Abigail Rogers, Kiarash Shamardani, Pamelyn J. Woo, Alexandre Ravel, Yahaya A Yabo, Carlos Alberto Oliveira de Biagi-Junior, Costanza Lo Cascio, Robert C. Malenka, Boris D. Heifets, Mariella G. Filbin, Dieter Henrik Heiland, Karl Deisseroth, Michelle Monje (2025). \textit{CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS}. Neuro-Oncology. [published; OpenAlex]. \href{https://doi.org/10.1093/neuonc/noaf201.0244}{doi:10.1093/neuonc/noaf201.0244}.
\item Thomas Zandonai, Sofia Venturini, Ornella Corazza (2025). \textit{Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?}. Performance Enhancement \& Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.peh.2025.100386}{doi:10.1016/j.peh.2025.100386}.
\item Hartter N, Däumichen M, Schmidt C, Wolff M, Gründer G, Jungaberle H (2025). \textit{[Acceptance of psilocybin-assisted therapy in German-speaking countries].}. Der Nervenarzt. [published; PubMed]. \href{https://doi.org/10.1007/s00115-024-01792-5}{doi:10.1007/s00115-024-01792-5}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ (2025). \textit{Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis.}. International journal of psychiatry in medicine. [published; PubMed]. \href{https://doi.org/10.1177/00912174251337572}{doi:10.1177/00912174251337572}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Molecular neurobiology. [published; PubMed]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S (2025). \textit{Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.}. Health policy (Amsterdam, Netherlands). [published; PubMed]. \href{https://doi.org/10.1016/j.healthpol.2025.105392}{doi:10.1016/j.healthpol.2025.105392}.
\item Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH (2025). \textit{The emotional architecture of the psychedelic brain.}. Trends in cognitive sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tics.2025.07.006}{doi:10.1016/j.tics.2025.07.006}.
\item Koenig HG (2025). \textit{Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians.}. International journal of psychiatry in medicine. [published; PubMed]. \href{https://doi.org/10.1177/00912174251369880}{doi:10.1177/00912174251369880}.
\item Rahmani S, Crupi R, Riley AL, Davidson T (2025). \textit{The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2025.174087}{doi:10.1016/j.pbb.2025.174087}.
\item Vohryzek J, Luppi AI, Atasoy S, Deco G, Carhart-Harris RL, Timmermann C, Kringelbach ML (2025). \textit{N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-025-02190-4}{doi:10.1038/s41386-025-02190-4}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item Hammo A, Wisser S, Cichon J (2025). \textit{Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain.}. Nature neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41593-025-02068-0}{doi:10.1038/s41593-025-02068-0}.
\item Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS (2025). \textit{Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.}. EClinicalMedicine. [published; PubMed]. \href{https://doi.org/10.1016/j.eclinm.2025.103517}{doi:10.1016/j.eclinm.2025.103517}.
\item Padawer-Curry JA, Krentzman OJ, Kuo CC, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ (2025). \textit{Psychedelic 5-HT receptor agonism alters neurovascular coupling and differentially affects neuronal and hemodynamic measures of brain function.}. Nature neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41593-025-02069-z}{doi:10.1038/s41593-025-02069-z}.
\item Oo AP, Tseu S, Ponnusamy A (2025). \textit{Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine Exposure.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.96718}{doi:10.7759/cureus.96718}.
\item Luo W, Dai Q, van Beek TA, Zuilhof H, Chen B, Chen Z, Salentijn GI. (2025). \textit{Paper spray and direct mushroom spray mass spectrometry methods for the analysis of psycho-neurological disorder toxins}. Food Chemistry. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609225828}{source link}.
\item André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich (2025). \textit{Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications}. Caderno Pedagógico. [published; OpenAlex]. \href{https://doi.org/10.54033/cadpedv22n12-345}{doi:10.54033/cadpedv22n12-345}.
\item Blake Beaton (2025). \textit{“It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics}. Journal of Drug Issues. [published; OpenAlex]. \href{https://doi.org/10.1177/00220426251395178}{doi:10.1177/00220426251395178}.
\item Washington University School of Medicine (2025). \textit{Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04501653}{source link}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item Anna Rose Childress, Ph.D. (2025). \textit{A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06786325}{source link}.
\item Richardson C, Chan C, Macgregor E, Hare C, Hannon B, Black S, Schneider E, Buchman D, Wang S, Rac V, Abrahamyan L, Huszti E, Nissim R, Li M, Zimmermann C, Hapke E, Rosenbaum D, Hales S (2025). \textit{Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.}. Pilot and feasibility studies. [published; PubMed]. \href{https://doi.org/10.1186/s40814-025-01706-5}{doi:10.1186/s40814-025-01706-5}.
\item James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir (2025). \textit{Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025i.0044}{doi:10.61373/pp025i.0044}.
\item Li R, Yan H, Chen Y, Liu Y, Tang L, Yu J, Liu J, Wang H, Wang S, Cheng J (2025). \textit{Structure-Guided Design of Novel 5-HT Partial Agonists as Psychedelic Analogues with Antidepressant Effects.}. Journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1021/acs.jmedchem.5c02045}{doi:10.1021/acs.jmedchem.5c02045}.
\item Farzin H, Koren B, Ferrier H, Sanders JJ, Garel N (2025). \textit{Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s1478951525100941}{doi:10.1017/s1478951525100941}.
\item Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA (2025). \textit{A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.}. Healthcare (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/healthcare13212668}{doi:10.3390/healthcare13212668}.
\item Pu Jiang, Cong Lin, Xiaohui Wang (2025). \textit{Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025p.0041}{doi:10.61373/pp025p.0041}.
\item University of California, Berkeley (2025). \textit{Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06367738}{source link}.
\item special to C EN Mara Johnson-Groh (2025). \textit{Is there more to magic mushrooms than psilocybin?}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10322-feature2}{doi:10.1021/cen-10322-feature2}.
\item Ashvind N. Singh, Glauber Loures de Assis (2025). \textit{The THRIVE Model of Psychedelic Integration: A Holistic Framework Bridging Indigenous Knowledge and Evidence-Based Practice}. Current Treatment Options in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1007/s40501-025-00368-7}{doi:10.1007/s40501-025-00368-7}.
\item Suspene J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202510.1355.v1}{doi:10.20944/preprints202510.1355.v1}.
\item Gabriele M. König, Li-Ming Hsu, Yi-Ting Chiu, Gavin P. Schmitz, Martin MacKinnon, Yen-Yu I. Shih, Bryan L. Roth, Sarah N. Magee, Evi Kostenis, Melissa A. Herman, Mia L. Foglesong (2025). \textit{Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/ce6e-4888}{doi:10.17615/ce6e-4888}.
\item Rongyan Li (11403789), Haohan Yan (22432650), Yujin Chen (1412254), Yangyang Liu (807797), Lingjie Tang (9276407), Jing Yu (81085), Junjun Liu (674159), Huan Wang (109286), Sheng Wang (339979), Jianjun Cheng (646595) (2025). \textit{Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant Effects}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.5c02045.s001}{doi:10.1021/acs.jmedchem.5c02045.s001}.
\item Douglas B. Craig (2025). \textit{Analysis of Serotonin in Caenorhabditis Elegans Subjected to Micro-Dosing with Psilocybin| Iris Publishers}. Insights in Chemistry and Biochemistry. [published; OpenAlex]. \href{https://doi.org/10.33552/icbc.2025.03.000562}{doi:10.33552/icbc.2025.03.000562}.
\item Shadani S, Greaves E, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA)}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.14.682467}{doi:10.1101/2025.10.14.682467}.
\item Sha Jin, H.Y. Wang, Xiaohui Wang (2025). \textit{Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025v.0038}{doi:10.61373/pp025v.0038}.
\item University of Washington (2025). \textit{A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06644170}{source link}.
\item Kolbman N, Huels ER, Nelson A, Summerfield R, Byraju K, Groenhout T, Liu T, Hudetz AG, Vanini G, Pal D (2025). \textit{Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High Gamma Functional Connectivity in Rats.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.10.12.681880}{doi:10.1101/2025.10.12.681880}.
\item Moskovitz M (2025). \textit{The Research Deficit and Expert Disagreement Regarding Music Selection for Psychedelic Assisted Therapy.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00583}{doi:10.1021/acsptsci.5c00583}.
\item Razidlo J, Cataldo N, Wenthur CJ (2025). \textit{Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00462}{doi:10.1021/acsptsci.5c00462}.
\item Vanessa Zavala Cruz, Lynnette A. Averill, David S. Mathai, James J. Crowley, Muñoz, Josselyn S, Carolyn I. Rodríguez, Jill O. Robinson, Eric A. Storch, Kevin M. Wagner, Amy L. McGuire, Jacey L Anderberg, Logan Neitzke-Spruill, Dayan Berrones, Renee M Frederick (2025). \textit{Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/qr51-1n44}{doi:10.17615/qr51-1n44}.
\item Renee Ireland (2025). \textit{Psychedelics in Practice: Science, Safety, and the Future of Healing}. The proceedings of sliit international conference on advancements in science and humanities. [published; OpenAlex]. \href{https://doi.org/10.54389/epsd8792}{doi:10.54389/epsd8792}.
\item Mallaroni P, Mason NL, Preller KH, Razi A, Ereira S, Ramaekers JG. (2025). \textit{Neurocomputational evidence of sustained Self-Other mergence after psychedelics}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.10.07.25337510}{doi:10.1101/2025.10.07.25337510}.
\item Kevin Murnane (2025). \textit{A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899594}{source link}.
\item Centre Hospitalier St Anne (2025). \textit{Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07210112}{source link}.
\item Domzalska M, Kwiatkowska J, Cichon I, Sokolowska E. (2025). \textit{Towards Novel Antidepressant Strategies: A Comparative Study of Ketamine, Psilocybin, and Fluoxetine in a Chronic Stress Model}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7269356/v1}{doi:10.21203/rs.3.rs-7269356/v1}.
\item Mackenzie Hancock, Nicole Getz, Shambhu Prasad Adhikari (2025). \textit{Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/ar2s4}{doi:10.17605/osf.io/ar2s4}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani T, Preller KH, Taylor JP, Waters F, Winston BS, Leptourgos P (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.}. Schizophrenia bulletin. [published; PubMed]. \href{https://doi.org/10.1093/schbul/sbaf068}{doi:10.1093/schbul/sbaf068}.
\item M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali (2025). \textit{Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders}. Journal of Pharma Insights and Research.. [published; OpenAlex]. \href{https://doi.org/10.69613/thv1dn30}{doi:10.69613/thv1dn30}.
\item Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P (2025). \textit{Harm reduction practises for users of psychedelic drugs: a scoping review.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-025-01264-2}{doi:10.1186/s12954-025-01264-2}.
\item Arif Ersegün Kahraman (2025). \textit{Psilocybin as a Treatment for Depression}. University of Debrecen Electronic Archive. [published; OpenAlex]. \href{https://hdl.handle.net/2437/398317}{source link}.
\item Bodhi Norton (2025). \textit{An Evaluation of Therapeutic Harm Reduction and Psilocybin-Assisted Therapy Within Oregon's Measure 109}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/open\_access\_etds/6963}{source link}.
\item Chweikh Mohamad (2025). \textit{Legal and Regulatory Barriers to Medical Psilocybin Use: An International Overview}. OSF Preprints. [preprint; Crossref]. \href{https://doi.org/10.31219/osf.io/dy5cu\_v1}{doi:10.31219/osf.io/dy5cu\_v1}.
\item University Hospital, Geneva (2025). \textit{Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164287}{source link}.
\item Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V (2025). \textit{Psilocybin-assisted psychotherapy in adults with depression - A literature review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111508}{doi:10.1016/j.pnpbp.2025.111508}.
\item Richardson B, Inserra A, Pileggi M, Prud'Homme T, Bruno V, Wan-Yan-Chan D, Shareghi-Ghahreman I, Nasini S, Strand T, Leyton M, Sonenberg N, De Gregorio D, Sprouse J, Bambico FR, Gobbi G (2025). \textit{Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111522}{doi:10.1016/j.pnpbp.2025.111522}.
\item de Oliveira AL, de Oliveira DP, Dos Santos RG, Hallak JEC (2025). \textit{Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111534}{doi:10.1016/j.pnpbp.2025.111534}.
\item Rupika Delgoda, Kimberley Foster, Isaac Morrison, Marshall Tyler, William Irvine, Lavonne Wilson, Babumon M. Thankappan, Shemar Daniel (2025). \textit{Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in Jamaica}. Phytochemistry Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/j.phytol.2025.103139}{doi:10.1016/j.phytol.2025.103139}.
\item Kangaslampi S, Lietz M (2025). \textit{Psychedelics and autobiographical memory - six open questions.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06771-5}{doi:10.1007/s00213-025-06771-5}.
\item Johns Hopkins University (2025). \textit{Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06989957}{source link}.
\item Courtney Y, Anderson JM, Lagares-Linares C, Wenthur CJ, Lehtinen MK. (2025). \textit{Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.30.677638}{doi:10.1101/2025.09.30.677638}.
\item Chisamore N, Kaczmarek ES, Doyle Z, Johnson DE, Weiglein G, Meshkat S, Brudner RM, Blainey MG, Riva-Cambrin J, McIntyre RS, Rosenblat JD (2025). \textit{Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437251328316}{doi:10.1177/07067437251328316}.
\item Afrooghe Arya, Ahmadi Elham, Lesani Ali, Mehranjani Mahya Soleymani, Elahi Mohammad, Babaei Mohammadreza, Shayan Maryam, Shafaroodi Hamed, Jafari Razieh Mohammad, Foroumadi Alireza, Manavi Mohammad Amin, Dehpour Ahmad-Reza (2025). \textit{Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway}. Naunyn-Schmiedeberg's Archives of Pharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00210-025-04152-5}{doi:10.1007/s00210-025-04152-5}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD (2025). \textit{Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06788-w}{doi:10.1007/s00213-025-06788-w}.
\item McGriff SA, Hecker JC, Maitland AD, Partilla JS, Baumann MH, Glatfelter GC (2025). \textit{Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06795-x}{doi:10.1007/s00213-025-06795-x}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD (2025). \textit{Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06818-7}{doi:10.1007/s00213-025-06818-7}.
\item Pellegrini L, Fineberg NA, O'Connor S, De Souza AMFLP, Godfrey K, Reed S, Peill J, Healy M, Rohani-Shukla C, Lee H, Carhart-Harris R, Robbins TW, Nutt D, Erritzoe D (2025). \textit{Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.}. Comprehensive psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.comppsych.2025.152619}{doi:10.1016/j.comppsych.2025.152619}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Larsen JK, Kølbæk P, Østergaard SD (2025). \textit{Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases.}. Nordic journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1080/08039488.2025.2529449}{doi:10.1080/08039488.2025.2529449}.
\item Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, Suomivuori CM, Huang XP, Shub L, DiBerto JF, Kim K, DeLeon C, Krumm BE, Fay JF, Keiser M, Hauser AS, Dror RO, Shoichet B, Gloriam DE, Nichols DE, Roth BL (2025). \textit{The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.}. Neuron. [published; PubMed]. \href{https://doi.org/10.1016/j.neuron.2025.06.012}{doi:10.1016/j.neuron.2025.06.012}.
\item Rosa I, Padula LP, Semeraro F, Marrangone C, Inserra A, De Risio L, Boffa M, Zoratto F, Borgi M, Guidotti R, Lorenzo GD, D'Addario C, Pettorruso M, Martinotti G (2025). \textit{Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116697}{doi:10.1016/j.psychres.2025.116697}.
\item Rajwani K, Jacobs E, Bruce L, Hokanson J, Almonte MT, Feroz F, Waldman E, Cheung K, Levy N, Savulescu J, Singh I, Yaden DB, Earp BD (2025). \textit{Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.}. The Lancet. Child \& adolescent health. [published; PubMed]. \href{https://doi.org/10.1016/s2352-4642(25)00208-1}{doi:10.1016/s2352-4642(25)00208-1}.
\item Montoy JCC, Wang RC, Coker AR, Smollin CG, Anderson BT (2025). \textit{US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022.}. Journal of the American College of Emergency Physicians open. [published; PubMed]. \href{https://doi.org/10.1016/j.acepjo.2025.100231}{doi:10.1016/j.acepjo.2025.100231}.
\item Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA (2025). \textit{Concomitant use of antidepressants and classic psychedelics: A scoping review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251368360}{doi:10.1177/02698811251368360}.
\item Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD (2025). \textit{Serotonin 5-HT Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00647}{doi:10.1021/acschemneuro.5c00647}.
\item He Z, Tang R, Feng M, Li X, Zhang C, Li J (2025). \textit{Dynamic myocardial injury and variable hallucination latency in poisoning: a molecularly confirmed case series from China.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2025.2552438}{doi:10.1080/15563650.2025.2552438}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC (2025). \textit{Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-025-09671-y}{doi:10.1038/s41586-025-09671-y}.
\item Sabé M, Seragnoli F, Penzenstadler L, Thorens G (2025). \textit{[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?].}. La Revue du praticien. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/41575100/}{source link}.
\item Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman (2025). \textit{3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception}. Poster Abstracts. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjno-2025-anzan.170}{doi:10.1136/bmjno-2025-anzan.170}.
\item Stephanie Marco (2025). \textit{B-302 Psychedelics and Dissociative Anesthetics: Concentrations in Suspected Impaired Driving Investigations, 2024}. Clinical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1093/clinchem/hvaf086.689}{doi:10.1093/clinchem/hvaf086.689}.
\item Hatzipantelis CJ, Liu M, Love A, Leventhal SJ, Maera H, Viswanathan S, Avetisyan E, Belinsky L, Rangel MM, Jain NJ, Kelly M, Copeland C, Khatib YA, Fiehn O, Olson DE, Stolzenberg DS (2025). \textit{Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-64371-5}{doi:10.1038/s41467-025-64371-5}.
\item Pereira Galdino Taynah, Bisneto Antônio Braz de Medeiros, Pedro Marcelo da Silva, de Oliveira Lucas Cordeiro, Luz Mateus Araújo, de Lima Antônio Gilson Barbosa, Silva Suédina Maria de Lima, Fook Marcus Vinicius Lia (2025). \textit{Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin Compounds}. ACS Omega. [published; Crossref]. \href{https://doi.org/10.1021/acsomega.5c05606}{doi:10.1021/acsomega.5c05606}.
\item Pinelopi Vlotinou, Konstantinos Christodoulou, Anna Tsiakiri, Foteini Christidi, Aspasia Serdari (2025). \textit{Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review}. Brazilian Journal of Science. [published; OpenAlex]. \href{https://doi.org/10.14295/bjs.v4i10.785}{doi:10.14295/bjs.v4i10.785}.
\item Egger, Klemens, Meling, Daniel, Polat, Firuze, Seifritz, Erich, Avram, Mihai, Scheidegger, Milan (2025). \textit{Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-280470}{doi:10.5167/uzh-280470}.
\item Nicole Torres (2025). \textit{Psychedelics Offer Healing and Ecological Remembrance for Marginalized Individuals Failed by U.S. Health Care}. Ecopsychology. [published; OpenAlex]. \href{https://doi.org/10.1177/19429347251382234}{doi:10.1177/19429347251382234}.
\item Caporuscio C, Poppe C, Gieselmann A, Repantis D (2025). \textit{Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s0033291725101761}{doi:10.1017/s0033291725101761}.
\item Greguš D, Hlinka J, Tylš F, Viktorin V, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Nikolič M, Adámek P, Beneš M, Páleníček T, Horáček J. (2025). \textit{Regional Specificity of the Cingulate Cortex Thickness Association with the Intensity of Psilocybin Experience: A Replication Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7544401/v1}{doi:10.21203/rs.3.rs-7544401/v1}.
\item Stefania Chiappini, Clara Cavallotto, Andrea Miuli, Giacomo d’Andrea, Alessio Mosca, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Antonio d'Attilio, Giovanna Mammarella, Luca Persico, Alessia Santeusanio, Gianfranco Tamagnini, Mauro Pettorruso, Giovanni Martinotti (2025). \textit{Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review}. Clinical Neuropsychopharmacology and Addiction. [published; OpenAlex]. \href{https://doi.org/10.53941/cna.2025.100006}{doi:10.53941/cna.2025.100006}.
\item Healing Advocacy Fund (2025). \textit{Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07189988}{source link}.
\item Matthew Halma, R. Levy, Joseph Varón (2025). \textit{With great power comes great responsibility: Promise and caution in the new psychedelic renaissance}. Brain Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dscb.2025.100286}{doi:10.1016/j.dscb.2025.100286}.
\item Hunt T. (2025). \textit{Electrodynamics of the Psychedelic Experience}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202509.1813.v1}{doi:10.20944/preprints202509.1813.v1}.
\item Tim Schäfer, Fabian Haun, Bernhard Rupp, Dirk Hoffmeister (2025). \textit{Unterschiedliche Reaktionen und Enzyme in der Psilocybin- Biosynthese bei Inocybe- und Psilocybe -Pilzen}. Angewandte Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/ange.202512017}{doi:10.1002/ange.202512017}.
\item Knock E, Siefried KJ, Bedi G, Albert S, Day RO, Ezard N, Ross M, Liknaitzky P, Brett J (2025). \textit{Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.70187}{doi:10.1111/add.70187}.
\item Benjamin R. Lewis (22279166), John Hendrick (22279169), Kevin Byrne (1610821), Madeleine Odette (22279172), Chaorong Wu (8444343), Eric L. Garland (4666660) (2025). \textit{S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pmed.1004519.s001}{doi:10.1371/journal.pmed.1004519.s001}.
\item Delgado-Sallent C, Ahmed SA, Khawaja-Lopez A, Lee BS, Senne R, Scott BB, Ramirez S. (2025). \textit{Psychedelics Relax Priors and Reshape Orbitofrontal Dynamics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.18.677110}{doi:10.1101/2025.09.18.677110}.
\item Beaglehole B, Manuel J (2025). \textit{Reappraisal of the hype and hope offered by psilocybin treatment of depression.}. The New Zealand medical journal. [published; PubMed]. \href{https://doi.org/10.26635/6965.7138}{doi:10.26635/6965.7138}.
\item Calin A, Burlec AF, Mircea C, Macovei I, Hancianu M, Corciova A (2025). \textit{Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US.}. Journal of clinical medicine. [published; PubMed]. \href{https://doi.org/10.3390/jcm14186613}{doi:10.3390/jcm14186613}.
\item Johns Hopkins University (2025). \textit{PRoMiSS: Psilocybin and the Role of Music in Set and Setting}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07180108}{source link}.
\item Lopez, Alissa A, Salloum, Ihsan, Lopez-Alvarenga, Juan C (2025). \textit{Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-Analyses}. ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley). [published; OpenAlex]. \href{https://scholarworks.utrgv.edu/colloquium/2025/talks/1}{source link}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2025). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.15.676273}{doi:10.1101/2025.09.15.676273}.
\item Ophir Netzer, Noa Magal, Yonatan Stern, Tzuk Polinsky, Raz Gross, Roee Admon, Roy Salomon (2025). \textit{Trauma under psychedelics: how psychoactive substances impact trauma processing}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21363}{doi:10.1002/wps.21363}.
\item Maastricht University (2025). \textit{The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06368492}{source link}.
\item Sapienza J, Spangaro M, Comai S, Sabé M, La Torre J, Buonarroti M, Cavallaro R, Bosia M (2025). \textit{Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26188949}{doi:10.3390/ijms26188949}.
\item Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910) (2025). \textit{Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00647.s001}{doi:10.1021/acschemneuro.5c00647.s001}.
\item Masjedi NS, Razi A. (2025). \textit{Effective connectivity of the human claustrum: Triple networks, subcortical circuits, and psychedelic modulation}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.07.674759}{doi:10.1101/2025.09.07.674759}.
\item Chwyl C, Spata A, Lucas W, Luoma JB. (2025). \textit{Mindset Over Molecule: Comparing Self-Transcendent and Mystical Experiences Across Recreational Psilocybin, MDMA, and Cannabis Use}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7266162/v1}{doi:10.21203/rs.3.rs-7266162/v1}.
\item Bélanger A, Chang SL, Stephan JF, Moureaux F, Tapp D, Foxman R, Gagnon P, Hébert J, Farzin H, Dorval M (2025). \textit{Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy.}. Healthcare (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/healthcare13182290}{doi:10.3390/healthcare13182290}.
\item Tereza Dleštíková (2025). \textit{The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030034}{doi:10.3390/psychoactives4030034}.
\item Kargbo RB (2025). \textit{Therapeutic Divergence in 5-HTA Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00475}{doi:10.1021/acsmedchemlett.5c00475}.
\item King's College London (2025). \textit{Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164755}{source link}.
\item Alan K. Davis, Meghan DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Washington Taylor, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan, Stacey B. Armstrong, Frederick S. Barrett (2025). \textit{Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00461}{doi:10.1556/2054.2025.00461}.
\item Aday JS, Carhart-Harris R, Boehnke KF. (2025). \textit{Blunted psychedelic drug effects in older adults}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yz4cd\_v2}{doi:10.31234/osf.io/yz4cd\_v2}.
\item Jacob S. Aday, Robin Carhart-Harris, Kevin F. Boehnke (2025). \textit{Blunted psychedelic drug effects in older adults}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yz4cd\_v2}{source link}.
\item Chiu I, Tate M, Trujillo D, Suprasert B, Marr A, Arayasirikul S, Wilson EC, Raymond HF, McFarland W (2025). \textit{Sample composition and HIV prevention indicator differences using physical vs virtual venue recruitment of men who have sex with men in San Francisco.}. American journal of epidemiology. [published; PubMed]. \href{https://doi.org/10.1093/aje/kwae443}{doi:10.1093/aje/kwae443}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Mesquita Garcia AC, Teixeira F, Maia LO (2025). \textit{Integrating Holistic Communication into Psychedelic-Assisted Therapies in Hospice and Palliative Care: An Approach Based on Peplau's Theory.}. Journal of holistic nursing: official journal of the American Holistic Nurses' Association. [published; PubMed]. \href{https://doi.org/10.1177/08980101251374371}{doi:10.1177/08980101251374371}.
\item Kaylee Reid, Daniel Kot, Argel Aguilar-Valles (2025). \textit{Therapeutic Effects of Psychedelics and their Non-Hallucinogenic Analogs on Depressive-Like Behaviour}. Carleton undergraduate journal of science.. [published; OpenAlex]. \href{https://doi.org/10.22215/cujs.v5i1.5286}{doi:10.22215/cujs.v5i1.5286}.
\item Maham Khurram (2025). \textit{The Psychedelic Reset: How Psychedelics May Reshape the Corticostriatal Circuit in Anorexia Nervosa}. Carleton undergraduate journal of science.. [published; OpenAlex]. \href{https://doi.org/10.22215/cujs.v5i1.5285}{doi:10.22215/cujs.v5i1.5285}.
\item Gregor Hasler (2025). \textit{Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0032}{doi:10.61373/pp025k.0032}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher (2025). \textit{Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030031}{doi:10.3390/psychoactives4030031}.
\item Khyber Medical University Peshawar (2025). \textit{Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06746441}{source link}.
\item van Breemen RB, Simchuk D, Fritzsche B, Huson D, Kuzdzal SA, Ferguson J (2025). \textit{Active Constituents of Psilocybin Mushroom Edibles.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2025.31345}{doi:10.1001/jamanetworkopen.2025.31345}.
\item Chris Simms (2025). \textit{We may know why psilocybin helps treat mental health conditions}. The New Scientist. [published; OpenAlex]. \href{https://doi.org/10.1016/s0262-4079(25)01446-0}{doi:10.1016/s0262-4079(25)01446-0}.
\item M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler (2025). \textit{Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030030}{doi:10.3390/psychoactives4030030}.
\item Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna (2025). \textit{PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.3(47).2025.3650}{doi:10.31435/ijitss.3(47).2025.3650}.
\item Beck SA, Barlow C, Engel L, Barratt MJ (2025). \textit{"Wood-lover paralysis": Describing a toxidrome with symptoms of weakness caused by some lignicolous "wood-loving" Psilocybe mushrooms.}. Toxicon: official journal of the International Society on Toxinology. [published; PubMed]. \href{https://doi.org/10.1016/j.toxicon.2025.108450}{doi:10.1016/j.toxicon.2025.108450}.
\item McCoy K, Reed F, Conn K, Foldi CJ (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa.}. Physiology \& behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.physbeh.2025.114957}{doi:10.1016/j.physbeh.2025.114957}.
\item Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review}. Curr Microbiol. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609227368}{source link}.
\item Palitsky R, Maples-Keller JL, Peacock C, Dunlop BW, Mletzko T, Grant GH, Raison CL, Chao S, Shub I, Mendelbaum-Kweller M, Smolyar L, Kaplan DM, Rothbaum BO, Zarrabi AJ (2025). \textit{A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.}. Psychotherapy (Chicago, Ill.). [published; PubMed]. \href{https://doi.org/10.1037/pst0000551}{doi:10.1037/pst0000551}.
\item Ahuja S, Zaher F, Palaniyappan L (2025). \textit{Quantitative natural language processing markers of psychoactive drug effects: A pre-registered systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251319455}{doi:10.1177/02698811251319455}.
\item Bjurenfalk Z, Cosmo A, Simonsson O, Ran C (2025). \textit{Lifetime classic psychedelic use and headaches: A cross-sectional study.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251324372}{doi:10.1177/02698811251324372}.
\item Keller MR, McKinney MG, Sen AK, Guagliardo FG, Hellwarth EB, Islam KN, Kaplan NA, Gibbons WJ, Kemmerly GE, Meers C, Wang X, Jones JA (2025). \textit{Psilocybin biosynthesis enhancement through gene source optimization.}. Metabolic engineering. [published; PubMed]. \href{https://doi.org/10.1016/j.ymben.2025.04.003}{doi:10.1016/j.ymben.2025.04.003}.
\item Estric C, Duron T, Kabani S, Lopez-Castroman J (2025). \textit{Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251338214}{doi:10.1177/02698811251338214}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa}. Physiology \& behavior. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609297819}{source link}.
\item Vella Y, Syrová K, Petrušková A, Koutrouli I, Kútna V, Pala J, Šíchová K, Nikolič M, Mazoch V, Jurok R, Kuchař M, Bendová Z, Páleníček T (2025). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251338232}{doi:10.1177/02698811251338232}.
\item Andersen KAA, Holmøy B, Kvam TM, Johnson MW (2025). \textit{Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2025.05.062}{doi:10.1016/j.jpsychires.2025.05.062}.
\item Beck SA, Barlow C, Engel L, Barratt MJ. (2025). \textit{“Wood-lover paralysis”: Describing a toxidrome with symptoms of weakness caused by some lignicolous “wood-loving” Psilocybe mushrooms}. Toxicon. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609301091}{source link}.
\item Blanton AM, Parikh P, Zhou S, Mohamed M, Ufret-Vincenty RL, Mancini R (2025). \textit{Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms.}. American journal of ophthalmology case reports. [published; PubMed]. \href{https://doi.org/10.1016/j.ajoc.2025.102359}{doi:10.1016/j.ajoc.2025.102359}.
\item Brudner RM, Kaczmarek E, Blainey MG, Schulz-Quach C, Meshkat S, Doyle Z, Lipsitz O, Offman H, Sethi R, Weiglein G, McIntyre RS, Rosenblat JD (2025). \textit{Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251346697}{doi:10.1177/02698811251346697}.
\item Vejmola Čestmír, Šíchová Klára, Syrová Kateřina, Janečková Lucie, Koudelka Vlastimil, Tesař Michael, Nikolič Marek, Viktorinová Michaela, Tylš Filip, Korčák Jakub, Viktorin Vojtěch, Kelemen Eduard, Nekovářová Tereza, Brunovský Martin, Horáček Jiří, Kuchař Martin, Páleníček Tomáš (2025). \textit{Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats}. Biological Psychiatry Global Open Science. [published; Crossref]. \href{https://doi.org/10.1016/j.bpsgos.2025.100524}{doi:10.1016/j.bpsgos.2025.100524}.
\item Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL (2025). \textit{Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-025-01199-z}{doi:10.1007/s40263-025-01199-z}.
\item Swieczkowski D, Kwaśny A, Ciurkowska P, Pruc M, Szarpak L, Cubała WJ (2025). \textit{Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251353250}{doi:10.1177/02698811251353250}.
\item Glenn DL, Choi SH, Zimmerman RS (2025). \textit{A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251353251}{doi:10.1177/02698811251353251}.
\item Nadeem Z, Parker S, McGovern H, Sebben B, Oestreich LK (2025). \textit{Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674251346679}{doi:10.1177/00048674251346679}.
\item Cherup NP, Finan PH (2025). \textit{Psilocybin as a psychophysical adaptogen in chronic pain rehabilitation.}. The journal of pain. [published; PubMed]. \href{https://doi.org/10.1016/j.jpain.2025.105507}{doi:10.1016/j.jpain.2025.105507}.
\item Holas P, Kamińska J (2025). \textit{Psychedelic use in Poland: prevalence, correlates and social attitudes.}. Postepy psychiatrii neurologii. [published; PubMed]. \href{https://doi.org/10.5114/ppn.2025.153566}{doi:10.5114/ppn.2025.153566}.
\item Kermanshah A, Stapleton M, Mauriello CM, Cobas M, Cordoba Torres IT (2025). \textit{Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.92568}{doi:10.7759/cureus.92568}.
\item Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL (2025). \textit{Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.}. PLoS medicine. [published; PubMed]. \href{https://doi.org/10.1371/journal.pmed.1004519}{doi:10.1371/journal.pmed.1004519}.
\item David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill (2025). \textit{A lexicon for psychedelic research and treatment}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245251380511}{doi:10.1177/20503245251380511}.
\item Müller Thomas (2025). \textit{„Wir haben gezeigt, dass die Psilocybin-unterstützte Psychotherapie wirksam ist“}. InFo Neurologie + Psychiatrie. [published; Crossref]. \href{https://doi.org/10.1007/s15005-025-4445-x}{doi:10.1007/s15005-025-4445-x}.
\item Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR (2025). \textit{Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111448}{doi:10.1016/j.pnpbp.2025.111448}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item Avanceña ALV, Vuong L, Kahn JG, Marseille E (2025). \textit{Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03556-4}{doi:10.1038/s41398-025-03556-4}.
\item Jason K. Day, Michael Th. Grooff (2025). \textit{Freedom of Recreation: A Critique of the Prohibition, Decriminalization, and Legal Regulation of Psychedelics for Recreational Use}. Contemporary Drug Problems. [published; OpenAlex]. \href{https://doi.org/10.1177/00914509251371749}{doi:10.1177/00914509251371749}.
\item Islam S, Salam S, Hasan MN. (2025). \textit{Unsupervised Extractive Summarization of Psychedelic User Experience Reports}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.08.22.25334176}{doi:10.1101/2025.08.22.25334176}.
\item Samir A Nader (2025). \textit{Psychedelic minimalism: the case against music in psychedelic therapy settings}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1652568}{doi:10.3389/fpsyt.2025.1652568}.
\item Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C, Gonzalez-Bolaños R, Brito-Rey R, Marín-Lorenzo C, Arribas-Simon B. (2025). \textit{Psilocybin: Systematic review of its use in the treatment of depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12436869}{source link}.
\item Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Kimberly Roddy, James A. Tulsky, Manish Agrawal, Yvan Beaussant (2025). \textit{“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251370303}{doi:10.1177/28314425251370303}.
\item Greaves MD, Barta T, Novelli L, Stoliker D, Razi A. (2025). \textit{Context-dependent structurally informed effective connectivity under psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.08.18.671000}{doi:10.1101/2025.08.18.671000}.
\item Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V, Ross S, Erritzoe D, Carhart-Harris R (2025). \textit{Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion.}. Research square. [published; PubMed]. \href{https://doi.org/10.21203/rs.3.rs-7420529/v1}{doi:10.21203/rs.3.rs-7420529/v1}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic Seizures}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06647056}{source link}.
\item Bilenker D, Avena NM (2025). \textit{Psychedelics and the Serotonin Hypothesis of Eating Disorders.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15080893}{doi:10.3390/brainsci15080893}.
\item Albert Garcia-Romeu (2025). \textit{Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics?}. NPP-Digital Psychiatry and Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s44277-025-00043-y}{doi:10.1038/s44277-025-00043-y}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06650800}{source link}.
\item Johns Hopkins University (2025). \textit{Effects of Psilocybin in Post-Treatment Lyme Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05305105}{source link}.
\item COMPASS Pathways (2025). \textit{A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05733546}{source link}.
\item Schuman HD, Deleemans JM, Nguyen T, Savard C, Mina R, Carlson LE. (2025). \textit{Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6941009/v1}{doi:10.21203/rs.3.rs-6941009/v1}.
\item Madden MB, Schaefgen C, Vedak B, Kwon J, Pedra KSD, Sheats SH, Puche AC, Wolff SBE, Mathur BN (2025). \textit{Serotonin and psilocybin activate 5-HT receptors to suppress cortical signaling through the claustrum.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-62980-8}{doi:10.1038/s41467-025-62980-8}.
\item Kim A, Morato NM, Saha P, Eyimegwu PN, Niyaz AA, Huang R, Cooks RG, Phelan RM, Lewis JC (2025). \textit{Selective Phosphorylation of Phenols and Benzenediols by the Kinase PsiK and Variants Thereof.}. Angewandte Chemie (International ed. in English). [published; PubMed]. \href{https://doi.org/10.1002/anie.202503538}{doi:10.1002/anie.202503538}.
\item Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD. (2025). \textit{Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.08.13.25333530}{doi:10.1101/2025.08.13.25333530}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Jussi Jylkkä, Aila Mustamo (2025). \textit{Psychedelic researchers’ own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-025-06871-2}{doi:10.1007/s00213-025-06871-2}.
\item Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A (2025). \textit{Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.}. Medical science monitor: international medical journal of experimental and clinical research. [published; PubMed]. \href{https://doi.org/10.12659/msm.948302}{doi:10.12659/msm.948302}.
\item Im JJH, Sandoe CH (2025). \textit{Psychedelics and Headache Disorders: an Update.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-025-01446-2}{doi:10.1007/s11910-025-01446-2}.
\item Harsha S. Krishna (2025). \textit{Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders}. JUNIOR RESEARCHERS. [published; OpenAlex]. \href{https://doi.org/10.52340/jr.2025.03.03.09}{doi:10.52340/jr.2025.03.03.09}.
\item Zhang Miyuan, Zhai Haojiang, Yang Longwei, Li Haohong, Wang Xiaohui (2025). \textit{The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin}. ACS Pharmacology \& Translational Science. [published; Crossref]. \href{https://doi.org/10.1021/acsptsci.5c00324}{doi:10.1021/acsptsci.5c00324}.
\item Fernández-Borkel T, Borkel LF, Rojas-Hernández J, Hernández-Álvarez E, Quintana-Hernández DJ, Ponti LG, Henríquez-Hernández LA (2025). \textit{The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00445}{doi:10.1021/acsptsci.5c00445}.
\item Trevor R. Norman (2025). \textit{The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2025.1006105}{doi:10.37349/en.2025.1006105}.
\item Rebolledo-Pérez L, Hernández-Bello J, Martínez-Ramos A, Castañeda-Arellano R, Fernández-Quezada D, Sandoval-García F, Aguilar-García IG (2025). \textit{Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26157638}{doi:10.3390/ijms26157638}.
\item Jiang Q, Shao L, Yao S, Savalia NK, Gilbert AD, Davoudian PA, Nothnagel JD, Tian G, Hung TS, Lai H, Beier KT, Zeng H, Kwan AC. (2025). \textit{Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.08.06.668927}{doi:10.1101/2025.08.06.668927}.
\item Wang X, Jun F, Lin C, Wang X (2025). \textit{Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00418}{doi:10.1021/acschemneuro.5c00418}.
\item Yang A, Lv X, Wang H, Wang X (2025). \textit{Psychedelics, Spirituality, and Fundamentalism: A Brain Network Approach to Cognitive Flexibility and Rigidity.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00509}{doi:10.1021/acschemneuro.5c00509}.
\item Meacham MC, Mian MN, Wang RC, Coker AR, Anderson BT, Montoy JCC (2025). \textit{Latent Classes of Lifetime Use of Seven Hallucinogens in the United States.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2537040}{doi:10.1080/02791072.2025.2537040}.
\item Miller M, Meyers M, Krainak K, Lewis SP (2025). \textit{Interventions to support spirituality among adults with cancer: a scoping review.}. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. [published; PubMed]. \href{https://doi.org/10.1007/s00520-025-09787-x}{doi:10.1007/s00520-025-09787-x}.
\item Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola (2025). \textit{544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.363}{doi:10.1093/ijnp/pyaf052.363}.
\item Guy M. Goodwin (2025). \textit{670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE?}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.159}{doi:10.1093/ijnp/pyaf052.159}.
\item Mickaël Naassïla (2025). \textit{Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamine}. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroscience.2025.05.064}{doi:10.1016/j.neuroscience.2025.05.064}.
\item N Acevdo, D Castle, S Rossell (2025). \textit{519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359785}{source link}.
\item G Martinotti, C Cavallotto, G D'Andrea, A D'Attilio, G Mammarella, F Zoratto, M Pettorruso (2025). \textit{631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359594}{source link}.
\item V Bruno, B Richardson, M Lopez-Canul, T Marcourakis, R Camarini, G Gobbi (2025). \textit{317. PSILOCYBIN DOES NOT INDUCE CONDITIONED PLACE PREFERENCE, BUT MODIFIES BEHAVIORAL PATTERNS IN SPRAGUE-DAWLEY RATS}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359800}{source link}.
\item C Hatzipantelis, D Olson, D Stolzenberg (2025). \textit{164. PSILOCYBIN DURING THE POSTPARTUM PERIOD INDUCES LONG-LASTING ADVERSE EFFECTS IN BOTH MOTHERS AND OFFSPRING}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359495}{source link}.
\item A Gibbons, P Liknaitzky, S Sundram (2025). \textit{620. IDENTIFICATION OF BLOOD BIOMARKERS OF PSILOCYBIN-ASSISTED THERAPY TREATMENT RESPONSE FOR GENERALISED ANXIETY DISORDER}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359512}{source link}.
\item Y Babii, C-S Barbara, D Bederska-Łojewska, B Szewczyk, A Pałucha-Poniewiera, K Gołembiowska, A Pilc (2025). \textit{426. THE MGLUR2/3 ANTAGONIST ENHANCES THE BEHAVIORAL AND CELLULAR ANTIDEPRESSANT-LIKE EFFECTS OF PSILOCYBIN AND SCOPOLAMINE}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359596}{source link}.
\item N Fabila, N P Manaph, V Rudkowsky, D Sketriene, Y Li, R Anversa, L Walker, A Reichelt, C Foldi, M Menden, R Brown (2025). \textit{694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATING}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359587}{source link}.
\item B Richardson, M Pileggi, T Prud’Homme, D Wan-Yan-Chan, I Shareghi-Ghahreman, S Nasini, V Bruno, T Strand, M Leyton, N Sonenberg, D De Gregorio, J Sprouse, F Bambico, G Gobbi (2025). \textit{363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359530}{source link}.
\item S Meikle, O Carter, P Liknaitzky, L Johansen, R Iyer, N Strauss, M Williams, D Castle, S Rossell (2025). \textit{229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359778}{source link}.
\item B Lerer, T Ben Tal, I Pogodin, A Botvinnik, T Lifschytz, U Heresco-Levy (2025). \textit{205. SYNERGISTIC BEHAVIORAL AND NEUROPLASTIC EFFECTS OF PSILOCYBIN-NMDAR MODULATOR ADMINISTRATION}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359736}{source link}.
\item C Foldi (2025). \textit{564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359394}{source link}.
\item T Renoir, J Gattuso, B Bezcioglu, G Kong, M Ekwudo, C Wilson, N Kleditzsch, A Kamal, J Hendey, C Gubert, A Hannan (2025). \textit{476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERS}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359791}{source link}.
\item S Kasper (2025). \textit{597. ARE SIDE EFFECTS NECESSARY FOR ANTIDEPRESSIVE TREATMENT: THE PSILOCYBIN EXPERIENCE}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359505}{source link}.
\item Hashimoto K (2025). \textit{Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?}. European archives of psychiatry and clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.1007/s00406-024-01770-7}{doi:10.1007/s00406-024-01770-7}.
\item Yasmo Perez JP, Chegwin Angarita C, Saldarriaga Ochoa OD, Urrego Restrepo SA (2025). \textit{Development and validation of a HPLC-DAD method for determining the content of tryptamines in methanolic extracts of fruiting bodies of mushrooms belonging to species of the Psilocybe genus.}. Talanta. [published; PubMed]. \href{https://doi.org/10.1016/j.talanta.2025.127777}{doi:10.1016/j.talanta.2025.127777}.
\item Ley L, Liechti ME, Becker AM, Straumann I, Klaiber A, Holze F, Vogt SB, Arikci D, Schmid Y (2025). \textit{Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06772-4}{doi:10.1007/s00213-025-06772-4}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T (2025). \textit{Letter to the editor: Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024).}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03005-0}{doi:10.1038/s41380-025-03005-0}.
\item Abrahms ZN, Sen AK, Jones JA (2025). \textit{Pathway engineering for the biosynthesis of psychedelics.}. Current opinion in biotechnology. [published; PubMed]. \href{https://doi.org/10.1016/j.copbio.2025.103314}{doi:10.1016/j.copbio.2025.103314}.
\item Paracha N (2025). \textit{Navigating Intentional and Attentional Practices for Healing Across Psychedelic and Biofield Settings: A Comparative Ethnographic Study.}. Journal of integrative and complementary medicine. [published; PubMed]. \href{https://doi.org/10.1089/jicm.2024.0713}{doi:10.1089/jicm.2024.0713}.
\item Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ (2025). \textit{Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116559}{doi:10.1016/j.psychres.2025.116559}.
\item Berkovitch L, Fauvel B, Preller KH, Gaillard R (2025). \textit{Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106239}{doi:10.1016/j.neubiorev.2025.106239}.
\item Vinarcsik L, Smoller C, Grossberg G (2025). \textit{Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.}. Drugs \& aging. [published; PubMed]. \href{https://doi.org/10.1007/s40266-025-01221-5}{doi:10.1007/s40266-025-01221-5}.
\item Bayes A (2025). \textit{Australia's psychedelic experiment: reflections from a psychiatrist clinical researcher.}. Australasian psychiatry: bulletin of Royal Australian and New Zealand College of Psychiatrists. [published; PubMed]. \href{https://doi.org/10.1177/10398562251347890}{doi:10.1177/10398562251347890}.
\item Sulstarova A, Scheuerlein L, Monari S, Seragnoli F, Gabriel T, Preller K, Böge K, Sentissi O, Kaiser S, Solmi M, Kirschner M, Sabé M (2025). \textit{Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2025.104604}{doi:10.1016/j.ajp.2025.104604}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Fundamental \& clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB (2025). \textit{Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders:.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2024.0031}{doi:10.1089/psymed.2024.0031}.
\item Bernard Lerer, Peretz Golding, Michal Brownstien, Adam Kozikowski, Tzuri Lifschytz (2025). \textit{204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDER}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.019}{doi:10.1093/ijnp/pyaf052.019}.
\item Hiroe Tani (2025). \textit{577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.377}{doi:10.1093/ijnp/pyaf052.377}.
\item Bernard Lerer, Michal Brownstien, Mitchell A. Lazar, Peter A. Goldstein, Alexander Botvinnik, Alan P. Kozikowski, Tzuri Lifschytz (2025). \textit{551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.368}{doi:10.1093/ijnp/pyaf052.368}.
\item Cheung K, Brodie M, Chang SL, Deschamps P, Fallu JS, Farzin H, Hébert J, Stephan JF, Dorval M, Joly Y, P3A Study Group (2025). \textit{Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.}. The Journal of law, medicine \& ethics: a journal of the American Society of Law, Medicine \& Ethics. [published; PubMed]. \href{https://doi.org/10.1017/jme.2025.10109}{doi:10.1017/jme.2025.10109}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Folia medica Cracoviensia. [published; PubMed]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Heidi Allen, B. Stott (2025). \textit{Preparing Social Work for Psychedelic-Assisted Therapy}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swaf031}{doi:10.1093/sw/swaf031}.
\item Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus (2025). \textit{Psilocybin-assisted treatment of depression}. Medical Science. [published; OpenAlex]. \href{https://doi.org/10.54905/disssi.v29i161.e110ms3657}{doi:10.54905/disssi.v29i161.e110ms3657}.
\item Egger K, Meling D, Polat F, Seifritz E, Avram M, Scheidegger M. (2025). \textit{Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation Retreat}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.07.30.25332422}{doi:10.1101/2025.07.30.25332422}.
\item Modlin NL, Jessica L MK, Sarang M, Siebenaler L, Maggio C, Pick S, Williamson V, Cleare A, Rucker J (2025). \textit{Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.}. Psychiatry and clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.5152/pcp.2025.24934}{doi:10.5152/pcp.2025.24934}.
\item Sutherland MH, Nicholas CR, Lennertz RC, Wenthur CJ, Krause BM, Sauder CJ, Riedner BA, Smith RF, Hutson PR, Raison CL, Banks MI. (2025). \textit{Electrophysiological effects of psilocybin co-administered with midazolam}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.25.666887}{doi:10.1101/2025.07.25.666887}.
\item Bevione F, Lacidogna MC, Lavalle R, Abbate Daga G, Preti A (2025). \textit{Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.}. Eating and weight disorders: EWD. [published; PubMed]. \href{https://doi.org/10.1007/s40519-025-01771-y}{doi:10.1007/s40519-025-01771-y}.
\item King's College London (2025). \textit{Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05651126}{source link}.
\item Egger K, Bozsak R, Aicher H, Sari H, Poetzsch S, Rominger A, Martin-Soelch C, Dornbierer D, Quednow B, Scheidegger M, Cumming P. (2025). \textit{Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7099164/v1}{doi:10.21203/rs.3.rs-7099164/v1}.
\item Rudy LM, Godlewski MM (2025). \textit{Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26157233}{doi:10.3390/ijms26157233}.
\item Luquiens A, Belahda D, Graux C, Igounenc N, Serrand C, Rochefort P, Mura T, Sergent F (2025). \textit{Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.70152}{doi:10.1111/add.70152}.
\item Rodan SC, Meez N, Lloyd-Hurwitz S, Bedoya-Pérez MA, Suraev A, Sommer N, Greenstien K, Maguire S, McGregor IS (2025). \textit{Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-025-01328-5}{doi:10.1186/s40337-025-01328-5}.
\item Emory University (2025). \textit{The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05506982}{source link}.
\item Pereira Galdino Taynah, Oliveira Lucas C., Luz Mateus A., Costa Barbosa Raquel, Torres Maria C. M., Sivieri Katia, Fernandes Paula A., Santos Márcio L., Lima Antonio G. B., Silva Suédina M. L., Fook Marcus V. L. (2025). \textit{Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms}. ACS Omega. [published; Crossref]. \href{https://doi.org/10.1021/acsomega.5c02751}{doi:10.1021/acsomega.5c02751}.
\item Cioe PA, Stang GS, Azam D, Dugal S (2025). \textit{"I've learned that I'm open-minded to this possibility": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke.}. Addiction science \& clinical practice. [published; PubMed]. \href{https://doi.org/10.1186/s13722-025-00563-0}{doi:10.1186/s13722-025-00563-0}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Vollenweider FX, Spanagel R, Preller KH, Meinhardt MW. (2025). \textit{Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.18.664368}{doi:10.1101/2025.07.18.664368}.
\item Ashutosh Bhave (2025). \textit{Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns}. Journal of Public Policy \& Marketing. [published; OpenAlex]. \href{https://doi.org/10.1177/07439156251360774}{doi:10.1177/07439156251360774}.
\item Michael-Paul Schallmo, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Link Swanson (2025). \textit{Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot study}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/jov.25.9.2091}{doi:10.1167/jov.25.9.2091}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v3}{doi:10.31234/osf.io/7x8q4\_v3}.
\item Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.}. Current microbiology. [published; PubMed]. \href{https://doi.org/10.1007/s00284-025-04379-8}{doi:10.1007/s00284-025-04379-8}.
\item Nathan H. Heller, Frederick Streeter Barrett, Tobias Buchborn, Daniel Collerton, David Dupuis, Adam L. Halberstadt, Renaud Jardri, Tehseen N. Noorani, Katrin H. Preller, John-Paul Taylor (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7x8q4\_v3}{source link}.
\item Danda H, Mazochová K, Šíchová K, Mazoch V, Olejníková-Ladislavová L, Syrová K, Jurásek B, Cihlářová P, Jurok R, Páleníček T, Kuchař M (2025). \textit{Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111439}{doi:10.1016/j.pnpbp.2025.111439}.
\item Zschoche N, Schober S, Walther K, Chadeayne AR, Gressler M, Bartram S, O'Connor SE, Hoffmeister D (2025). \textit{Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202500167}{doi:10.1002/cbic.202500167}.
\item Lacey C (2025). \textit{Equitable access to psilocybin-assisted psychotherapy in New Zealand.}. The New Zealand medical journal. [published; PubMed]. \href{https://doi.org/10.26635/6965.e1618}{doi:10.26635/6965.e1618}.
\item Cohen ZZ, Blest-Hopley G (2025). \textit{Females in Psychedelic Research: A Perspective for Advancing Research and Practice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00255}{doi:10.1021/acsptsci.5c00255}.
\item Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899) (2025). \textit{The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324.s001}{doi:10.1021/acsptsci.5c00324.s001}.
\item Rajwani K, Almonte MT, Feroz F, Hokanson J, Jacobs E, Savulescu J, Singh I, Yaden DB, Earp BD. (2025). \textit{Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.24181.1}{doi:10.12688/wellcomeopenres.24181.1}.
\item Kato K, Kleinhenz JM, Shin YJ, Coarfa C, Zarrabi AJ, Hecker L (2025). \textit{Psilocybin treatment extends cellular lifespan and improves survival of aged mice.}. npj aging. [published; PubMed]. \href{https://doi.org/10.1038/s41514-025-00244-x}{doi:10.1038/s41514-025-00244-x}.
\item Balazs Szigeti (2025). \textit{An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/97cqx\_v1}{source link}.
\item Gregory NS, Girard TE, Ram A, Casey AB, Malenka RC, Tawfik VL, Heifets BD (2025). \textit{Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain models.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.07.06.663398}{doi:10.1101/2025.07.06.663398}.
\item Yutong Song (2025). \textit{Explore the effect of psilocybin on depression and anxiety}. Arts Culture and Language. [published; OpenAlex]. \href{https://doi.org/10.61173/rcg8me57}{doi:10.61173/rcg8me57}.
\item Szigeti B. (2025). \textit{An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/97cqx\_v1}{doi:10.31234/osf.io/97cqx\_v1}.
\item Ahmed KE, Abu Nasrieh D, Banihani HA, Obaidat MF, Mazzawi T, Al-Tarawneh AK, Bani Mustafa R, Al Kayed Z (2025). \textit{Exploring Jordanian Physicians' and Medical Students' Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2526403}{doi:10.1080/02791072.2025.2526403}.
\item Braekow Pauline, Neumann Joachim, Kirchhefer Uwe, Gergs Ulrich (2025). \textit{Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice}. Pharmaceuticals. [published; Crossref]. \href{https://doi.org/10.3390/ph18071009}{doi:10.3390/ph18071009}.
\item Mark Haden, Sarah A. Paschall, Birgitta Woods (2025). \textit{Beyond prohibition: A public health analysis of naturalistic psychedelic use}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00450}{doi:10.1556/2054.2025.00450}.
\item Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM. (2025). \textit{Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.02.662710}{doi:10.1101/2025.07.02.662710}.
\item Priya Chaudhary, Pracheta Janmeda (2025). \textit{Psychedelic and Medicinal Mushrooms: Potent Source of Active Metabolites and Medicines}. Current Bioactive Compounds. [published; OpenAlex]. \href{https://doi.org/10.2174/0115734072383313250602052217}{doi:10.2174/0115734072383313250602052217}.
\item David W. Lawrence, Alex P. Di Battista, Michael G. Hutchison (2025). \textit{Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030022}{doi:10.3390/psychoactives4030022}.
\item Rahbarnia A, Li Z, Fletcher PJ (2025). \textit{Effects of psilocybin, the 5-HT receptor agonist TCB-2, and the 5-HT receptor antagonist M100907 on visual attention in male mice in the continuous performance test.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-023-06474-9}{doi:10.1007/s00213-023-06474-9}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A (2025). \textit{Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06644-3}{doi:10.1007/s00213-024-06644-3}.
\item Croarkin PE, Sutherland I, Ho MF (2025). \textit{Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise.}. Journal of the American Academy of Child and Adolescent Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.jaac.2024.12.003}{doi:10.1016/j.jaac.2024.12.003}.
\item Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ (2025). \textit{Exploring serotonergic psychedelics as a treatment for personality disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110413}{doi:10.1016/j.neuropharm.2025.110413}.
\item Bradley ER, Sakai K, Fernandes-Osterhold G, Szigeti B, Ludwig C, Ostrem JL, Tanner CM, Bock MA, Llerena K, Finley PR, O'Donovan A, Zuzuarregui JRP, Busby Z, McKernan A, Penn AD, Wang ACC, Rosen RC, Woolley JD (2025). \textit{Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-025-02097-0}{doi:10.1038/s41386-025-02097-0}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ (2025). \textit{Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-2529-7029}{doi:10.1055/a-2529-7029}.
\item Rockhill KM, Black JC, Ladka MS, Sumbundu KB, Olsen HA, Jewell JS, Hunt J, Wolf RC, Nerurkar K, Dart RC, Monte AA (2025). \textit{The Rise of Psilocybin Use in the United States: A Multisource Observational Study.}. Annals of internal medicine. [published; PubMed]. \href{https://doi.org/10.7326/annals-24-03145}{doi:10.7326/annals-24-03145}.
\item Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L (2025). \textit{Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03035-8}{doi:10.1038/s41380-025-03035-8}.
\item Syed OA, Petranker R, Tsang B (2025). \textit{The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106204}{doi:10.1016/j.neubiorev.2025.106204}.
\item Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD (2025). \textit{Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116532}{doi:10.1016/j.psychres.2025.116532}.
\item Yang L, Li H, Wang X (2025). \textit{Psilocybin and Obsessive-Compulsive Disorder: Exploring New Therapeutic Horizons.}. Neuroscience bulletin. [published; PubMed]. \href{https://doi.org/10.1007/s12264-025-01415-2}{doi:10.1007/s12264-025-01415-2}.
\item Pego AMF, Schoffner M, Sammeta VR, Naeem M, Manke DR, Chadeayne A, Glatfelter GC, Baumann MH, Concheiro-Guisán M (2025). \textit{Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography-tandem mass spectrometry.}. Journal of analytical toxicology. [published; PubMed]. \href{https://doi.org/10.1093/jat/bkaf045}{doi:10.1093/jat/bkaf045}.
\item Cummins BR, Billac GB, Nichols DE, Nichols CD (2025). \textit{5-HT receptors: Pharmacology and functional selectivity.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmr.2025.100059}{doi:10.1016/j.pharmr.2025.100059}.
\item Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L (2025). \textit{Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-025-03066-1}{doi:10.1038/s41380-025-03066-1}.
\item Wu Y, Ran J, Mo J, Wang J (2025). \textit{4-HIAA Blocks Methamphetamine-Induced Conditioned Place Preference in Mice Through Modulation of the 5-HT Pathway in the Nucleus Accumbens.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.70063}{doi:10.1111/adb.70063}.
\item Calnan M, Blest-Hopley G, Busch C, Adams M, Ruffell SGD, Piper T, Roseman L, Kettner H, Carhart-Harris R (2025). \textit{Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.}. Brain and behavior. [published; PubMed]. \href{https://doi.org/10.1002/brb3.70660}{doi:10.1002/brb3.70660}.
\item Stirn Judith, Klein Christian D. (2025). \textit{Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic-Assisted Therapy}. Archiv der Pharmazie. [published; Crossref]. \href{https://doi.org/10.1002/ardp.70022}{doi:10.1002/ardp.70022}.
\item Sofuoglu M, De Aquino JP, MacLean RR (2025). \textit{Psychedelic drugs for the treatment of substance use disorders.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2541103}{doi:10.1080/17512433.2025.2541103}.
\item Luz MA, Guedes HVS, Bisneto ABM, Jesus RA, Galdino TP, Oliveira LC, Afonso VI, Fook MVL, Lima AGB, Silva SML, Torres MCM (2025). \textit{Chemical Composition and Biological Activities of Mushrooms: Gaps and Perspectives.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18070989}{doi:10.3390/ph18070989}.
\item Hieronymus F, López E, Werin Sjögren H, Lundberg J (2025). \textit{Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2025.24119}{doi:10.1001/jamanetworkopen.2025.24119}.
\item Brown Rodney, Hamilton Niall M., Mallon Connor, Stevenson James, Faley Michael T., Kargbo Robert B., Sherwood Alexander M., Upeandran Balasubramaniam (2025). \textit{Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-Position}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; Crossref]. \href{https://doi.org/10.1002/jlcr.4155}{doi:10.1002/jlcr.4155}.
\item Christen SE, Bekka E, Schmid Y, Benowitz NL, Liakoni E (2025). \textit{Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances.}. Swiss medical weekly. [published; PubMed]. \href{https://doi.org/10.57187/s.4346}{doi:10.57187/s.4346}.
\item Islam S, Liden T, Goff R, Schug KA. (2025). \textit{Untargeted analysis of psilocybin and non-psilocybin mushrooms using liquid chromatography quadrupole time of flight mass spectrometry}. Journal of Chromatography A. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609270047}{source link}.
\item Rodrigo A. Petter, María D. Montero, Cinthia D. Gigliotti (2025). \textit{Prolonged hallucinogenic effects following Psilocybe cubensis ingestion: Case report}. The poison.. [published; OpenAlex]. \href{https://doi.org/10.62129/dmad8764}{doi:10.62129/dmad8764}.
\item H. T. McGovern, Lura Bajo, Gerard Hassed, Rick Hoefnagels, Martin Levey, Nikolas Rose, Alexander De Foe, Brendan Hutchinson (2025). \textit{Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic Experience}. Brain and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1002/brb3.70687}{doi:10.1002/brb3.70687}.
\item Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE (2025). \textit{Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.}. Current oncology (Toronto, Ont.). [published; PubMed]. \href{https://doi.org/10.3390/curroncol32070380}{doi:10.3390/curroncol32070380}.
\item Mathieu Fradet (2025). \textit{Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030021}{doi:10.3390/psychoactives4030021}.
\item Nayiri Barton (2025). \textit{Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease}. Global Journal of Medical Research. [published; OpenAlex]. \href{https://doi.org/10.34257/gjmravol25is1pg1}{doi:10.34257/gjmravol25is1pg1}.
\item Paul Okugo Imoh, Aderonke Ajiboye, Tahir Kolawole Balogun, Amina Catherine Ijiga, Toyosi Motilola Olola, Emmanuel Oluwasayomi Ahmadu (2025). \textit{Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autism}. Magna Scientia Advanced Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.30574/msarr.2025.14.1.0079}{doi:10.30574/msarr.2025.14.1.0079}.
\item Carvalho LC, Encantado J, Kettner H, Timmermann C, Veiga D, Teixeira PJ (2025). \textit{A Scoping Review of Research in Naturalistic Studies with Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2520221}{doi:10.1080/02791072.2025.2520221}.
\item University of Minnesota (2025). \textit{Visual Surround Suppression and Perceptual Expectation Under Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04424225}{source link}.
\item Stoliker D, Bernasconi F, Blanke O, Razi A. (2025). \textit{Psilocybin Modulates TPJ Effective Connectivity during Out-of-Body Experiences}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.24.25330245}{doi:10.1101/2025.06.24.25330245}.
\item Koolen M, Wirsching A, Krediet E, van Elk M (2025). \textit{Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2508156}{doi:10.1080/02791072.2025.2508156}.
\item Daroui D, Mastrostefano A, Davini F, Giuseppe G, Terracina S. (2025). \textit{The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202506.1536.v1}{doi:10.20944/preprints202506.1536.v1}.
\item McCulloch DE, Larsen K, Johansen A, Reveles Jensen KH, Nykjaer CH, Holze F, Falck N, Neufeld VAB, Steenstrup E, Skov-Andersen PM, Spangaard A, Geisler M, Randrup PP, Jensen PS, Shulganov V, Johansen SS, Nielsen MKK, Andersen TL, Stenbaek DS, Svarer C, Fisher PM, Knudsen GM. (2025). \textit{Molecular, haemodynamic and functional effects of LSD in the human brain}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.17.25329677}{doi:10.1101/2025.06.17.25329677}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item Subramanian S, Reneau TR, Perry D, Chacko R, Laumann TO, Flavin K, Horan C, Schweiger J, Metcalf N, Lenze EJ, Snyder AZ, Dosenbach NUF, Nicol G, Siegel JS (2025). \textit{Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.}. Scientific data. [published; PubMed]. \href{https://doi.org/10.1038/s41597-025-05397-8}{doi:10.1038/s41597-025-05397-8}.
\item Zhang Y, Yang L, Zhang Q, Li C, Mao F, Zhuo C (2025). \textit{The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03410-7}{doi:10.1038/s41398-025-03410-7}.
\item Modzelewski S, Stankiewicz A, Waszkiewicz N, Łukasiewicz K (2025). \textit{Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110402}{doi:10.1016/j.neuropharm.2025.110402}.
\item Agrawal M, Roddy K, Jenkins B, Leeks C, Emanuel E (2025). \textit{Long-term benefits of single-dose psilocybin in depressed patients with cancer.}. Cancer. [published; PubMed]. \href{https://doi.org/10.1002/cncr.35889}{doi:10.1002/cncr.35889}.
\item Erkizia-Santamaría I, Horrillo I, Martínez-Álvarez N, Pérez-Martínez D, Rivero G, Erdozain AM, Meana JJ, Ortega JE (2025). \textit{Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03421-4}{doi:10.1038/s41398-025-03421-4}.
\item COMPASS Pathways (2025). \textit{The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05312151}{source link}.
\item Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL (2025). \textit{The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00208}{doi:10.1021/acsptsci.5c00208}.
\item Zhai H, Wang H, Li H, Wang X (2025). \textit{The Intersection of Psychedelics and Sleep: Exploring the Impacts on Sleep Architecture, Dream States, and Therapeutic Implications.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00234}{doi:10.1021/acsptsci.5c00234}.
\item Pepe M, Hesami M, Fleishmann L, Hsiang T, Jones AMP (2025). \textit{Mycelium Growth and Development of spp. Mother Cultures on Agar-Based Media.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof11060450}{doi:10.3390/jof11060450}.
\item Liu Yi-Fei, Lien-Chung Wei (2025). \textit{Advancing the Anthropology of Psychedelics: Integrating Clinical Evidence, Sociocultural Insights, and Ethical Frameworks}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.70004}{doi:10.1111/anoc.70004}.
\item MycoMedica Life Sciences PBC (2025). \textit{A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06643637}{source link}.
\item Stephen Ross (2025). \textit{Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disorders}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0017}{doi:10.61373/pp025k.0017}.
\item Luke Lanham, Alistair R. McTaggart, James R. Falconer (2025). \textit{Is there mush-room to improve the environmental sustainability of psilocybin production?}. Journal of CO2 Utilization. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcou.2025.103137}{doi:10.1016/j.jcou.2025.103137}.
\item Agin-Liebes G, Petridis P, Zeifman R, Link M, Cordova MJ, Bogenschutz M. (2025). \textit{Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f27jm\_v1}{doi:10.31234/osf.io/f27jm\_v1}.
\item University of California, San Francisco (2025). \textit{Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05317689}{source link}.
\item Gabrielle Agin-Liebes, Petros Petridis, Richard Zeifman, Max Link, Matthew J Cordova, Michael Bogenschutz (2025). \textit{Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/f27jm\_v1}{source link}.
\item Fradet M, Kelly CM, Donnelly AJ, Suppes T (2025). \textit{Psilocybin and hallucinogenic mushrooms - ERRATUM.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852925100291}{doi:10.1017/s1092852925100291}.
\item Slot J, Hoffmeister D (2025). \textit{Psychedelic fungi.}. Current biology: CB. [published; PubMed]. \href{https://doi.org/10.1016/j.cub.2025.02.026}{doi:10.1016/j.cub.2025.02.026}.
\item Joshua Woolley, MD, PhD (2025). \textit{Psilocybin With Intracranial Neural Sensing}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06919640}{source link}.
\item Jylkkä J. (2025). \textit{Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ugr69\_v2}{doi:10.31234/osf.io/ugr69\_v2}.
\item Erkizia-Santamaría I, Martínez-Álvarez N, Salinas-Novoa L, Meana JJ, Ortega JE (2025). \textit{Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyaf035}{doi:10.1093/ijnp/pyaf035}.
\item Jussi Jylkkä (2025). \textit{Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ugr69\_v2}{source link}.
\item Matthew Hicks (2025). \textit{Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06372197}{source link}.
\item National University of Natural Medicine (2025). \textit{Optimizing Microdosing and Meditation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06560658}{source link}.
\item Subramanian S, Reneau TR, Perry D, Chacko R, Laumann TO, Flavin K, Horan C, Schweiger J, Metcalf N, Lenze EJ, Snyder AZ, Dosenbach NUF, Nicol G, Siegel JS (2025). \textit{Psilocybin's acute and persistent brain effects: a precision imaging drug trial.}. Scientific data. [published; PubMed]. \href{https://doi.org/10.1038/s41597-025-05189-0}{doi:10.1038/s41597-025-05189-0}.
\item Erin E. Mauney (2025). \textit{Erin Mauney: Psychedelics as modulators of the gut-brain interaction}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0020}{doi:10.61373/pp025k.0020}.
\item Frautschi PC, Singh AP, Stowe NA, Grady SM, Zahid Z, Banks MI, Yu JJ (2025). \textit{Effects of Psilocybin on Mouse Brain Microstructure.}. AJNR. American journal of neuroradiology. [published; PubMed]. \href{https://doi.org/10.3174/ajnr.a8634}{doi:10.3174/ajnr.a8634}.
\item Cali James (2025). \textit{In vitro assessment of psilocin for CYP-dependent drug-drug interaction potential using rapid luminescent assays}. Drug Metabolism and Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1016/j.dmpk.2025.101231}{doi:10.1016/j.dmpk.2025.101231}.
\item Vina SM (2025). \textit{Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians.}. Journal of racial and ethnic health disparities. [published; PubMed]. \href{https://doi.org/10.1007/s40615-024-02023-y}{doi:10.1007/s40615-024-02023-y}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A (2025). \textit{Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06654-1}{doi:10.1007/s00213-024-06654-1}.
\item Jungwirth J, von Rotz R, Dziobek I, Vollenweider FX, Preller KH (2025). \textit{Psilocybin increases emotional empathy in patients with major depression.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02875-0}{doi:10.1038/s41380-024-02875-0}.
\item Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M, Enriquez-Geppert S (2025). \textit{Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06742-2}{doi:10.1007/s00213-024-06742-2}.
\item Glynos NG, Baker A, Aday JS, Kruger D, Boehnke KF, Lake S, Lucas P (2025). \textit{Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.}. British journal of pain. [published; PubMed]. \href{https://doi.org/10.1177/20494637251319497}{doi:10.1177/20494637251319497}.
\item Becker AM, Humbert-Droz M, Mueller L, Jelušić A, Tolev A, Straumann I, Avedisian I, Erne L, Thomann J, Luethi D, Grünblatt E, Meyer Zu Schwabedissen H, Liechti ME (2025). \textit{Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.3618}{doi:10.1002/cpt.3618}.
\item Weleff J, Pulido-Saavedra A, Aghaei AM, Ing K, Arakelian M, Fontenele R, Nero N, Barnett BS, Anand A, Bassir Nia A, Angarita GA (2025). \textit{The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116446}{doi:10.1016/j.psychres.2025.116446}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC (2025). \textit{Psilocybin's lasting action requires pyramidal cell types and 5-HT receptors.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-025-08813-6}{doi:10.1038/s41586-025-08813-6}.
\item Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH (2025). \textit{Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.}. Expert opinion on emerging drugs. [published; PubMed]. \href{https://doi.org/10.1080/14728214.2025.2488786}{doi:10.1080/14728214.2025.2488786}.
\item Meshkat S, Malik G, Zeifman RJ, Swainson J, Balachandra K, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Vermetten E, Mayo LM, Tanguay R, Jetly R, Bhat V (2025). \textit{Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106163}{doi:10.1016/j.neubiorev.2025.106163}.
\item Klim C, VanDreese B, Meyerhoefer T, Breitinger S (2025). \textit{Innovation and inequity in psychedelic research at the Mayo Clinic.}. History of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/0957154x251318489}{doi:10.1177/0957154x251318489}.
\item Morris R, Keeler J, Treasure J, Himmerich H (2025). \textit{The pharmacological treatment of anxiety in people with eating disorders: A systematic review.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2025.107782}{doi:10.1016/j.phrs.2025.107782}.
\item Menge J, Evitt B (2025). \textit{Pharmacologic interventions for alcohol use disorder.}. JAAPA: official journal of the American Academy of Physician Assistants. [published; PubMed]. \href{https://doi.org/10.1097/01.jaa.0000000000000106}{doi:10.1097/01.jaa.0000000000000106}.
\item Fonzo GA, Doss MK, Nemeroff CB (2025). \textit{There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20250247}{doi:10.1176/appi.ajp.20250247}.
\item Viña SM (2025). \textit{Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2024.0021}{doi:10.1089/psymed.2024.0021}.
\item Karthiyayini B, Kalyani NN, Gowdhami B, Muthuselvam M, Dharumadurai D (2025). \textit{Characterization and Identification of an Antimicrobial Compound Psilocybin from Psychedelic Mushroom.}. Indian journal of microbiology. [published; PubMed]. \href{https://doi.org/10.1007/s12088-024-01396-2}{doi:10.1007/s12088-024-01396-2}.
\item Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S (2025). \textit{The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.86659}{doi:10.7759/cureus.86659}.
\item Laabi Salma, LeMmon Claire, Vogel Callie, Chacon Mariana, Jimenez Victor M. (2025). \textit{Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling}. International Immunopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.intimp.2025.114940}{doi:10.1016/j.intimp.2025.114940}.
\item Toby A. Clark (2025). \textit{Mystical States \& Psilocybin. From Dissociation Towards Association: A Conversational Model Discussion}. The Therapeutic Conversation. [published; OpenAlex]. \href{https://doi.org/10.66330/100520252}{doi:10.66330/100520252}.
\item Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P. (2025). \textit{Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.26.655791}{doi:10.1101/2025.05.26.655791}.
\item Fitzgerald PB, Webb SL, Denning NC, Dowie T, Schweickle MM, Modak A, Chan G, Knight J, Waldron M, Gainsford K, Hawkes H, Zammit S, Sutanto NC, Fitzgibbon BM, Bailey NW. (2025). \textit{Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.05.28.25328532}{doi:10.1101/2025.05.28.25328532}.
\item Abboud A, Schiebrel C, Nahhas RW, Durkin S, Hua K, Redding H, Gainer D (2025). \textit{Patients' Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2511752}{doi:10.1080/02791072.2025.2511752}.
\item University Hospital, Basel, Switzerland (2025). \textit{Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06796361}{source link}.
\item Peck SK, Brewerton TD, Fisher H, Trim J, Shao S, Modlin NL, Kim J, Finn DM, Kaye WH (2025). \textit{Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-025-01274-2}{doi:10.1186/s40337-025-01274-2}.
\item Palmer C, Ferber AT, Greenwald BD (2025). \textit{The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15060572}{doi:10.3390/brainsci15060572}.
\item Johns Hopkins University (2025). \textit{Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01943994}{source link}.
\item Han C, Baek H, Lim JY, Kim E, Tran CK, Freeman E, Chen Z, Yoo SH, Burish MJ (2025). \textit{Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.}. The journal of headache and pain. [published; PubMed]. \href{https://doi.org/10.1186/s10194-025-02008-0}{doi:10.1186/s10194-025-02008-0}.
\item Hooper J, Williams S, Mueller R, Hutchison K. (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dczw2\_v1}{doi:10.31234/osf.io/dczw2\_v1}.
\item Jake Hooper, Sarah Williams, Raeghan Mueller, Kent Hutchison (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v1}{source link}.
\item Schäfer T, Sherwood A, Kirkland T, Krüger T, Worbs J, Kniemeyer O, Gressler M, Hoffmeister D (2025). \textit{In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes.}. Chemistry (Weinheim an der Bergstrasse, Germany). [published; PubMed]. \href{https://doi.org/10.1002/chem.202501037}{doi:10.1002/chem.202501037}.
\item Hellman M (2025). \textit{We need to talk about shrooms.}. Nordisk alkohol- \& narkotikatidskrift: NAT. [published; PubMed]. \href{https://doi.org/10.1177/14550725251341722}{doi:10.1177/14550725251341722}.
\item Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C. (2025). \textit{Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6hjkm\_v1}{doi:10.31234/osf.io/6hjkm\_v1}.
\item University of Wisconsin, Madison (2025). \textit{Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05592379}{source link}.
\item Lukas A. Basedow, Lynn Lottes, Irina Falkenberg, Christoph Vogelbacher, Cüneyt Yildiz (2025). \textit{Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6hjkm\_v1}{source link}.
\item Viña SM (2025). \textit{The Relationships Between Healthcare Access, Gender, and Psychedelics and Their Effects on Distress.}. Healthcare (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/healthcare13101158}{doi:10.3390/healthcare13101158}.
\item Sara G. Gloeckler, Julien Thibault Lévesque, Alexandre Lehmann, Houman Farzin, Kyle T. Greenway (2025). \textit{Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silence}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00421}{doi:10.1556/2054.2024.00421}.
\item Icahn School of Medicine at Mount Sinai (2025). \textit{Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06592833}{source link}.
\item Muller S, Cavanna F, de la Fuente LA, Bruno N, D’Amelio TA, Pallavicini C, Tagliazucchi E. (2025). \textit{Psilocybin-induced modulation of visual salience processing}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.10.652897}{doi:10.1101/2025.05.10.652897}.
\item Kargbo RB (2025). \textit{Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory Technologies.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00182}{doi:10.1021/acsmedchemlett.5c00182}.
\item Ong Jennifer A. (2025). \textit{Psychedelic-assisted psychotherapy and its potential to manage demoralization: A brief exploration of an alternative approach to end of life care}. Advances in Complementary and Integrative Medicine. [published; Crossref]. \href{https://doi.org/10.70462/acim.2025.1.001}{doi:10.70462/acim.2025.1.001}.
\item Wang H, Wang X (2025). \textit{Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00247}{doi:10.1021/acschemneuro.5c00247}.
\item Michael A. Wheeler (2025). \textit{Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeed}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0011}{doi:10.61373/pp025k.0011}.
\item Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y. (2025). \textit{Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5493661/v1}{doi:10.21203/rs.3.rs-5493661/v1}.
\item Hannes Kettner (2025). \textit{Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contexts}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.25560/125300}{doi:10.25560/125300}.
\item Ritika Jagdeep Shah, Ashish Sarangi (2025). \textit{Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review}. Alcoholism Treatment Quarterly. [published; OpenAlex]. \href{https://doi.org/10.1080/07347324.2025.2500345}{doi:10.1080/07347324.2025.2500345}.
\item Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther (2025). \textit{Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung}. Nervenheilkunde. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2517-1621}{doi:10.1055/a-2517-1621}.
\item Jonathan A. Leighton, Carmen Lau, Aisha Savdo, L Granata (2025). \textit{Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series}. Cephalalgia Reports. [published; OpenAlex]. \href{https://doi.org/10.1177/25158163251345472}{doi:10.1177/25158163251345472}.
\item de Lannoy Ines, Magomedova Lilia, Izhakova Julia, de Rivera Christina, Lanthier James, Atkinson Jason, Higgins Guy A., Slassi Malik, Araujo Joseph A. (2025). \textit{Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogs}. Journal of Pharmacological and Toxicological Methods. [published; Crossref]. \href{https://doi.org/10.1016/j.vascn.2025.107663}{doi:10.1016/j.vascn.2025.107663}.
\item Gray BA, Bolts OL, Fidler D, Prince M (2025). \textit{Identifying Three Psilocybin Use Patterns by Frequency and Quantity.}. Journal of studies on alcohol and drugs. [published; PubMed]. \href{https://doi.org/10.15288/jsad.23-00312}{doi:10.15288/jsad.23-00312}.
\item Bagdasarian FA, Larsen K, Deng HP, Fisher PM, Mandeville JB, Sander CY, Wey HY, Hansen HD (2025). \textit{Neurochemical characterization of 5-HTR partial agonists with simultaneous PET-MRI.}. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. [published; PubMed]. \href{https://doi.org/10.1177/0271678x241302937}{doi:10.1177/0271678x241302937}.
\item Menon V, Ramamurthy P, Venu S, Andrade C (2025). \textit{Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.}. Acta psychiatrica Scandinavica. [published; PubMed]. \href{https://doi.org/10.1111/acps.13778}{doi:10.1111/acps.13778}.
\item Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, Breevoort S, Bromberg M, Brown A, Carter GT, Chang V, Crayle J, Fullam T, Greene M, Heiman-Patterson T, Jackson C, Jhooty S, Mallon E, Cadavid JM, Mcdermott CJ, Pattee G, Pierce K, Ratner D, Sun Y, Wang O, Wicks P, Wiedau M, Bedlack R (2025). \textit{ALSUntangled \#77: Psilocybin.}. Amyotrophic lateral sclerosis \& frontotemporal degeneration. [published; PubMed]. \href{https://doi.org/10.1080/21678421.2024.2441274}{doi:10.1080/21678421.2024.2441274}.
\item Liebnau J, Betzler F, Kerber A (2025). \textit{Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241312866}{doi:10.1177/02698811241312866}.
\item Noback M, Kenton JA, Klein AK, Hughes ZA, Kruegel AC, Schmid Y, Halberstadt AL, Young JW (2025). \textit{Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110334}{doi:10.1016/j.neuropharm.2025.110334}.
\item Dave M, Shore R, Cupido T, Haley C, Clinkard D (2025). \textit{Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.}. European journal of anaesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/eja.0000000000002138}{doi:10.1097/eja.0000000000002138}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Bezo A, Piolino P, Benyamina A (2025). \textit{The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106086}{doi:10.1016/j.neubiorev.2025.106086}.
\item Al-Imam A, Lora R, Motyka MA, Marletta E, Vezzaro M, Moczko J, Younus M, Michalak M (2025). \textit{Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing Mushrooms.}. Drug safety. [published; PubMed]. \href{https://doi.org/10.1007/s40264-025-01530-z}{doi:10.1007/s40264-025-01530-z}.
\item Koseli E, Buzzi B, Honaker T, Rakholia Y, Lewis M, Gaines-Smith M, Jaster AM, Gonzalez-Maeso J, Damaj MI (2025). \textit{IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT receptors in mouse models of chronic pain.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2025.107699}{doi:10.1016/j.phrs.2025.107699}.
\item Rockhill KM, Black JC, Iwanicki J, Abraham A (2025). \textit{Polysubstance Use Profiles Among the General Adult Population, United States, 2022.}. American journal of public health. [published; PubMed]. \href{https://doi.org/10.2105/ajph.2024.307979}{doi:10.2105/ajph.2024.307979}.
\item Ghaznavi S, Richter SG (2025). \textit{Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-025-02172-2}{doi:10.1007/s40265-025-02172-2}.
\item Cardone P, Núñez P, Alnagger NLN, Martial C, van der Lande GJM, Sandell R, Carhart-Harris R, Gosseries O (2025). \textit{Psilocybin for disorders of consciousness: A case-report study.}. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology. [published; PubMed]. \href{https://doi.org/10.1016/j.clinph.2025.02.264}{doi:10.1016/j.clinph.2025.02.264}.
\item Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D (2025). \textit{Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106132}{doi:10.1016/j.neubiorev.2025.106132}.
\item Pałasz A, Pukowiec M, Bogus K, Suszka-Świtek A, Filipczyk Ł, Mordecka-Chamera K, Worthington JJ, Sygidus M, Wojtas A, Bysiek A, Gołembiowska K (2025). \textit{Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251330783}{doi:10.1177/02698811251330783}.
\item Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D (2025). \textit{Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-025-02091-6}{doi:10.1038/s41386-025-02091-6}.
\item Weintraub MJ, Miklowitz DJ, Jeffrey JK (2025). \textit{Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.}. Journal of psychiatric practice. [published; PubMed]. \href{https://doi.org/10.1097/pra.0000000000000853}{doi:10.1097/pra.0000000000000853}.
\item Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK (2025). \textit{From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2515866}{doi:10.1080/17512433.2025.2515866}.
\item Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR (2025). \textit{Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?}. Neurobiology of stress. [published; PubMed]. \href{https://doi.org/10.1016/j.ynstr.2025.100732}{doi:10.1016/j.ynstr.2025.100732}.
\item Sevander Saara Susan, Rissanen Marja-Liisa Susan (2025). \textit{The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review}. Health, environment and sustainable development: interdisciplinary approach. [published; Crossref]. \href{https://doi.org/10.59476/hesdia.v0i1.700}{doi:10.59476/hesdia.v0i1.700}.
\item Kim Hoffman, Todd P. Korthuis, Kellie Pertl, David Morgan (2025). \textit{Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study}. International Journal of Multiple Research Approaches. [published; OpenAlex]. \href{https://doi.org/10.29034/ijmra.v17n1a1}{doi:10.29034/ijmra.v17n1a1}.
\item Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Ranya Marrakchi El Fellah, Kylee Krivijanski, Albert Garcia-Romeu, Winston De La Haye, Clarence Locklear, Girardin Jean-Louis (2025). \textit{0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart Study}. SLEEP. [published; OpenAlex]. \href{https://doi.org/10.1093/sleep/zsaf090.0391}{doi:10.1093/sleep/zsaf090.0391}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Lucia Centofanti, Stefano La Rosa, Giovanna Finzi, Franco Folli, M. Pappagallo, Paolo L. Manfredi, Sara De Martin (2025). \textit{FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(25)01632-0}{doi:10.1016/s0168-8278(25)01632-0}.
\item Michal Židó, Tomáš Páleníček, Ivana Štětkářová (2025). \textit{Psychedelics in the treatment of cluster headaches}. Klinická farmakologie a farmacie. [published; OpenAlex]. \href{https://doi.org/10.36290/far.2025.021}{doi:10.36290/far.2025.021}.
\item Gale Wohlfarth (2025). \textit{Psilocybin Mushrooms: Identifying the Profile of the Most Likely Users}. DigitalCommons - Kennesaw State University (Kennesaw State University). [published; OpenAlex]. \href{https://digitalcommons.kennesaw.edu/undergradsymposiumksu/spring2025/spring2025/26}{source link}.
\item Wang Y, Li T, Reynolds E, Wang Z, Torrens-Spence M, Weng J. (2025). \textit{Calcium Activation Mechanism of a Noncanonical Aromatic L-Amino Acid Decarboxylase from Psilocybin Mushroom}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6329392/v1}{doi:10.21203/rs.3.rs-6329392/v1}.
\item Shayla Frinton, Jill O. Robinson (2025). \textit{University Students’ Motives for Psilocybin Use: A Mixed-Methods Analysis}. Journal of Drug Issues. [published; OpenAlex]. \href{https://doi.org/10.1177/00220426251338187}{doi:10.1177/00220426251338187}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A (2025). \textit{Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2495937}{doi:10.1080/02791072.2025.2495937}.
\item Jérémie Richard, Jeremy Scott, Sandeep M. Nayak, Nathan D. Sepeda, Matthew X. Lowe, Heather Jackson, Albert Garcia-Romeu (2025). \textit{Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-025-01489-z}{doi:10.1007/s11469-025-01489-z}.
\item McClure, Taylor, Krzywicki, AJ, Nathan, Jude, Kane, Jackson (2025). \textit{Undergraduate Students' Perceptions and Understanding of Psychedelic-Assisted Therapy}. Exhibit - A Showcase of Scholarship, Creativity and Preservation Provided by Xavier University Library (Xavier University). [published; OpenAlex]. \href{https://www.exhibit.xavier.edu/curca/2025/schedule/48}{source link}.
\item Penzenstadler L, Baudois S, Lingenberg A, Catalano Chiuvé S, Tomkova E, Fleury V (2025). \textit{[Treatment with psychedelics: potential benefits in Parkinson's disease].}. Revue medicale suisse. [published; PubMed]. \href{https://doi.org/10.53738/revmed.2025.21.915.47180}{doi:10.53738/revmed.2025.21.915.47180}.
\item Sophie van der Helder, Krista J. Siefried, Liam Acheson, Maureen Steele, Mary Ellen Harrod, Jonathan Brett (2025). \textit{Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00422}{doi:10.1556/2054.2025.00422}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Lusher (2025). \textit{Regulatory Challenges of Integrating Psychedelics into Mental Health Sector}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4020011}{doi:10.3390/psychoactives4020011}.
\item Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD (2025). \textit{Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s147895152500032x}{doi:10.1017/s147895152500032x}.
\item Cohen J, Sulimani L, Procaccia S, Lerenthal Y, Milay L, Taran I, Shapira A, Meiri D (2025). \textit{Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-025-97710-z}{doi:10.1038/s41598-025-97710-z}.
\item Thaoboonruang Nilubon, Lohitnavy Ornrat, Ya Kimheang, Lohitnavy Manupat (2025). \textit{Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans}. Scientific Reports. [published; Crossref]. \href{https://doi.org/10.1038/s41598-025-98202-w}{doi:10.1038/s41598-025-98202-w}.
\item Kevin Boehnke (2025). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05128162}{source link}.
\item Beesley VL, Kennedy TJ, Maccallum F, Ross M, Harvey R, Rossell SL, Sarris J, Perkins D, Neale RE, Bennett-Levy J, Johnson S, Beebe H, Roset N, Strobel J, Parker S (2025). \textit{Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2024-095992}{doi:10.1136/bmjopen-2024-095992}.
\item Felix Mueller (2025). \textit{The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05570708}{source link}.
\item Effinger DP, Schalk SS, King JL, Strong JR, O’Connell CK, Calderon JR, McCorvy JD, Thompson SM. (2025). \textit{Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.08.647757}{doi:10.1101/2025.04.08.647757}.
\item Novelli L, Stoliker D, Barta T, Greaves MD, Chopra S, Jackson J, Kwee J, Williams ML, Razi A. (2025). \textit{PsiConnect: A Multimodal Neuroimaging Study of Psilocybin-Induced Changes in Brain and Behaviour}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.11.643415}{doi:10.1101/2025.04.11.643415}.
\item University Hospital, Basel, Switzerland (2025). \textit{Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects: A Placebo-controlled Cross-over Study (DMT BDR-Study).}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05695495}{source link}.
\item Hu S, Lin C, Wang H, Wang X (2025). \textit{Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00094}{doi:10.1021/acsptsci.5c00094}.
\item Turizo Smith AD, Botero Jsramillo N, Berrio Cuartas DM. (2025). \textit{Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological, and Clinical Approach}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202504.0888.v1}{doi:10.20944/preprints202504.0888.v1}.
\item Eklund Julia, Bremberg Ulf, Larsson Jessica, Torkelsson Edvard, Wennerberg Johan, Zandelin Symantha, Odell Luke R. (2025). \textit{Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties}. Journal of Medicinal Chemistry. [published; Crossref]. \href{https://doi.org/10.1021/acs.jmedchem.4c02612}{doi:10.1021/acs.jmedchem.4c02612}.
\item Ardini M, Angelucci F, Rea F, Paluzzi L, Gabriele F, Palerma M, Di Leandro L, Ippoliti R, Pitari G (2025). \textit{Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.}. Biology direct. [published; PubMed]. \href{https://doi.org/10.1186/s13062-025-00632-z}{doi:10.1186/s13062-025-00632-z}.
\item Mary E. Kittur, L. Martínez, Brett D. M. Jones, Daniel M. Blumberger, Benoit H. Mulsant, Joshua D. Rosenblat, Ishrat Husain (2025). \textit{188. Mapping Psilocybin Therapy: A Systematic Review of Therapeutic Frameworks, Adaptations, and Standardization Across Contemporary Clinical Trials}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.425}{doi:10.1016/j.biopsych.2025.02.425}.
\item Subha Subramanian, Demetrius Perry, Travis Rick Renau, Ravi V. Chacko, Timothy O. Laumann, Karin Flavin, Christine Horan, Julia Schweiger, Nicholas V. Metcalf, Eric J. Lenze, Abraham Z. Snyder, Nico U.F. Dosenbach, Ginger E. Nicol, Joshua S. Siegel (2025). \textit{Precision Functional Mapping of Psilocybin’s Acute and Persistent Brain Effects}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.130}{doi:10.1016/j.biopsych.2025.02.130}.
\item Chuck T. Chen, Aidan D Tyrrell, Darryl Hudson, Ralph Landau, Adam H. Metherel, Richard P. Bazinet (2025). \textit{458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene Expression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.696}{doi:10.1016/j.biopsych.2025.02.696}.
\item Scott Aaronson, Tammy Miller, Audrey Shoultz, Bryce Lund, Jeffrey LaPratt, Margo Lauterbach, Kim Swartz, Andrew van der Vaart (2025). \textit{630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label Study}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.869}{doi:10.1016/j.biopsych.2025.02.869}.
\item Orly Lipsitz, Joshua D. Rosenblat (2025). \textit{194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.431}{doi:10.1016/j.biopsych.2025.02.431}.
\item Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat (2025). \textit{187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.424}{doi:10.1016/j.biopsych.2025.02.424}.
\item Danica E. Johnson, Erica Kaczmarek, Noah Chisamore, Orly Lipitz, Zoe Doyle, Rodrigo B. Mansur, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted Psychotherapy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.423}{doi:10.1016/j.biopsych.2025.02.423}.
\item Ashton Barber, Sydney Gifford, Patrick H. Roseboom, Jonathan A. Oler, Nate Jones, Molly C. Pellitteri-Hahn, Cameron O. Scarlett, Cody J. Wenthur, Paul R. Hutson, Ned H. Kalin (2025). \textit{58. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman Primates}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.295}{doi:10.1016/j.biopsych.2025.02.295}.
\item Xue Zhang, Emily Zhai, Claire Bertrand, Sara Ellis, Isabelle Wydler, Anna J. Donnelly, Trisha Suppes, Leanne M. Williams (2025). \textit{166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.403}{doi:10.1016/j.biopsych.2025.02.403}.
\item Danielle Bukovsky, Aron Amaev, Jianmeng Song, Edgardo Torres Carmona, S. Lauren Kyte, Fumihiko Ueno, Vincenzo De Luca, Christopher R. Bowie, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2025). \textit{13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging Study}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.250}{doi:10.1016/j.biopsych.2025.02.250}.
\item Nathalie M. Rieser, Raoul Bitar, Halm Simon, Christina Rossgoderer, Ladina P Gubser, Maeva Thévenaz, Yara Kreis, Robin von Rotz, Carlos Nordt, Flora Moujaes, Etna Engeli, Andres Ort, Erich Seifritz, Franz X. Vollenweider, Katrin H. Preller (2025). \textit{595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCT}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.834}{doi:10.1016/j.biopsych.2025.02.834}.
\item Noah Chisamore, Erica Kaczmarek, Zoe Doyle, Danica E. Johnson, Rodrigo B. Mansur, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.561}{doi:10.1016/j.biopsych.2025.02.561}.
\item University of Otago (2025). \textit{Psilocybin-assisted Interpersonal Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05581797}{source link}.
\item Omidian H, Omidian A (2025). \textit{The Emergence of Psilocybin in Psychiatry and Neuroscience.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18040555}{doi:10.3390/ph18040555}.
\item Lu OD, White K, Raymond K, Liu C, Klein AS, Green N, Vaillancourt S, Gallagher A, Shindy L, Li A, Wallquist K, Li R, Zou M, Casey AB, Cameron LP, Pomrenze MB, Sohal V, Kheirbek MA, Gomez AM, Lammel S, Heifets BD, Malenka R (2025). \textit{A multi-institutional investigation of psilocybin's effects on mouse behavior.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.04.08.647810}{doi:10.1101/2025.04.08.647810}.
\item Jennifer Jones (2025). \textit{Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1565852}{doi:10.3389/fpsyt.2025.1565852}.
\item Emmanuelle A. D. Schindler, Christopher Gottschalk, Deepak Cyril D’Souza (2025). \textit{Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)}. Neurology. [published; OpenAlex]. \href{https://doi.org/10.1212/wnl.0000000000210945}{doi:10.1212/wnl.0000000000210945}.
\item Ammineni D, Park R (2025). \textit{The compulsive eating paradigm: can psychedelics help in treating obesity?}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01186-7}{doi:10.1186/s40337-024-01186-7}.
\item Ana Cláudia Mesquita Garcia (2025). \textit{Therapeutic Potential of Psilocybin-Assisted Therapy in Hospice and Palliative Care}. Revista Cacto - Ciência Arte Comunicação em Transdisciplinaridade Online. [published; OpenAlex]. \href{https://doi.org/10.31416/cacto.v5i1.1448}{doi:10.31416/cacto.v5i1.1448}.
\item Kurkova V, Winkler O, Greenshaw A, Jetly R, Swainson J, Lodewyk K, Saghafi P, Dennett E, Burback L (2025). \textit{Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111333}{doi:10.1016/j.pnpbp.2025.111333}.
\item Bysiek A, Wojtas A, Szpręgiel I, Wawrzczak-Bargieła A, Maćkowiak M, Gołembiowska K (2025). \textit{The effect of low-dose psilocybin on brain neurotransmission and rat behavior.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111347}{doi:10.1016/j.pnpbp.2025.111347}.
\item Reiche S, Hirschfeld T, Gröticke AL, Traub M, Hafiz NJ, Haas R, Sedlaczek L, Ortlieb L, Leistenschneider G, Basedow LA, Lohse A, Bermpohl F, Riemer TG, Majić T (2025). \textit{Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111353}{doi:10.1016/j.pnpbp.2025.111353}.
\item Seillier L, Čechová B, Seillier A, Šlamberová R (2025). \textit{Psilocybin has a narrow therapeutic window as an antidepressant treatment.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111368}{doi:10.1016/j.pnpbp.2025.111368}.
\item Nathalie M. Rieser, Raoul Bitar, Simon Halm, Christina Rossgoderer, Ladina P Gubser, Maeva Thévenaz, Yara Kreis, Robin von Rotz, Carlos Nordt, Monika Visentini, Flora Moujaes, Etna Engeli, Andres Ort, Erich Seifritz, Franz Xaver Vollenweider, Marcus Herdener, Katrin H. Preller (2025). \textit{Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-284304}{doi:10.5167/uzh-284304}.
\item Ioana A. Cristea, G Tomei, Jazmín Freddi, A. Bonessio (2025). \textit{Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2025.393}{doi:10.1192/j.eurpsy.2025.393}.
\item Niloufar Pouyan, Jacob S. Aday, David G. Williams, Kevin F. Boehnke, Steven E. Harte (2025). \textit{Pictorial Representation of Illness and Self Measure: A Putative Transdiagnostic Tool for Evaluating Therapeutic Effects of Psilocybin-Assisted Therapy in Fibromyalgia}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.105024}{doi:10.1016/j.jpain.2025.105024}.
\item Adriana Judit Batista, Hugo A. Almirón, Gisela Forlín, Natalia A. Ramírez, Orlando F. Popoff, Nicolás Niveiro (2025). \textit{Psilocybe cubensis y Panaeolus cyanescens (Basidiomycota, Agaricales), dos especies de hongos alucinógenos en el NE de Argentina}. Boletín de la Sociedad Argentina de Botánica. [published; OpenAlex]. \href{https://doi.org/10.31055/1851.2372.v60.n1.46185}{doi:10.31055/1851.2372.v60.n1.46185}.
\item Nicholas Gregory, Tyler E. Girard, Akila Ram, Austen B. Casey, Robert C. Malenka, Vivianne L. Tawfik, Boris D. Heifets (2025). \textit{Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.104862}{doi:10.1016/j.jpain.2025.104862}.
\item A. Oliveira-Maia (2025). \textit{Reporting of psychotherapeutic methods in psychedelic treatments: on the road to ethical, professional and regulatory oversight}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2025.64}{doi:10.1192/j.eurpsy.2025.64}.
\item Octavian Brinzei (2025). \textit{Clarifying the legal landscape of psilocybin regulation: A medico-legal perspective}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245251337360}{doi:10.1177/20503245251337360}.
\item Sean M. Viña (2025). \textit{Minorities’ diminished psychedelic returns: Depression, suicide, distress, and serious mental illness}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245251337357}{doi:10.1177/20503245251337357}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE (2025). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association. [published; PubMed]. \href{https://doi.org/10.1097/njh.0000000000001113}{doi:10.1097/njh.0000000000001113}.
\item Filer CN (2025). \textit{The remarkable reimagining of psilocybin.}. Natural product research. [published; PubMed]. \href{https://doi.org/10.1080/14786419.2023.2272285}{doi:10.1080/14786419.2023.2272285}.
\item Stephan JF, Karam S (2025). \textit{Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-Report.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2024.0277}{doi:10.1089/jpm.2024.0277}.
\item Sutherland I, Ho MF, Croarkin PE (2025). \textit{Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.}. Journal of child and adolescent psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1089/cap.2024.0082}{doi:10.1089/cap.2024.0082}.
\item Irrmischer M, Puxty D, Yıldırım BO, Deijen JB, Engelbregt H (2025). \textit{Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06733-3}{doi:10.1007/s00213-024-06733-3}.
\item Correia MS, Gonzaga MJ, Temple C, Gerona RR (2025). \textit{Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2025.2450240}{doi:10.1080/15563650.2025.2450240}.
\item Balabandian Mohammad, Manavi Mohammad Amin, Lesani Ali, Mohammad Jafari Razieh, Shafaroodi Hamed, Heidari Navid, Mirnajafi-Zadeh Javad, Foroumadi Alireza, Afrooghe Arya, Dehpour Ahmad Reza (2025). \textit{Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways}. Pharmacology Research \& Perspectives. [published; Crossref]. \href{https://doi.org/10.1002/prp2.70079}{doi:10.1002/prp2.70079}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE (2025). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association. [published; PubMed]. \href{https://doi.org/10.1097/njh.0000000000001096}{doi:10.1097/njh.0000000000001096}.
\item Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY (2025). \textit{Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.}. Advanced science (Weinheim, Baden-Wurttemberg, Germany). [published; PubMed]. \href{https://doi.org/10.1002/advs.202413786}{doi:10.1002/advs.202413786}.
\item Matsukubo J, Dickson S, Xiao J, Friesen EL, Solmi M, Fiedorowicz JG, Fischer B, Myran DT (2025). \textit{Psilocybin Dispensaries and Online Health Claims in Canada.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2025.2853}{doi:10.1001/jamanetworkopen.2025.2853}.
\item Hutson PR (2025). \textit{Psilocybin Dispensaries and Advertising-Buyer Beware.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2025.2858}{doi:10.1001/jamanetworkopen.2025.2858}.
\item Huang Z, Yao Y, Di R, Zhang J, Pan Y, Liu G (2025). \textit{De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli.}. Microbial biotechnology. [published; PubMed]. \href{https://doi.org/10.1111/1751-7915.70135}{doi:10.1111/1751-7915.70135}.
\item Schenberg EE (2025). \textit{From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence-Based Policy and Practice.}. Pharmacology research \& perspectives. [published; PubMed]. \href{https://doi.org/10.1002/prp2.70097}{doi:10.1002/prp2.70097}.
\item Mimms C, Sotelo K, Khaliq AS (2025). \textit{Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.82532}{doi:10.7759/cureus.82532}.
\item Keenan R, Haque R, Jin X, Mustafa T, Homman-Ludiye J, Elysee K, Wee ZS, Simonds S, Foldi C, Cowley M. (2025). \textit{Effects of a single dose of psilocybin on diet-induced weight loss in obese mice}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6225000/v1}{doi:10.21203/rs.3.rs-6225000/v1}.
\item Thomson S, Thomacos N (2025). \textit{Utilizing Psychedelics to Enhance Well-Being: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2484380}{doi:10.1080/02791072.2025.2484380}.
\item Unity Health Toronto (2025). \textit{Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06731335}{source link}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v2}{doi:10.31234/osf.io/7x8q4\_v2}.
\item Turkia M. (2025). \textit{Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/mzkyv\_v1}{doi:10.31234/osf.io/mzkyv\_v1}.
\item University Hospital, Basel, Switzerland (2025). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899334}{source link}.
\item Mika Turkia (2025). \textit{Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/mzkyv\_v1}{source link}.
\item Silverstein BH, Kolbman N, Nelson A, Liu T, Guzzo P, Gilligan J, Lee U, Mashour GA, Vanini G, Pal D (2025). \textit{Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-025-03308-4}{doi:10.1038/s41398-025-03308-4}.
\item Meshkat S, Al-Shamali H, Perivolaris A, Tullu T, Zeifman RJ, Zhang Y, Burback L, Winkler O, Greenshaw A, Husain MI, C Reichelt A, Vermetten E, Jha MK, Jetly R, Loebenberg R, Bhat V (2025). \textit{Pharmacokinetics of Psilocybin: A Systematic Review.}. Pharmaceutics. [published; PubMed]. \href{https://doi.org/10.3390/pharmaceutics17040411}{doi:10.3390/pharmaceutics17040411}.
\item Robinson GI, Gerasymchuk M, Zanikov T, Gojani EG, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cruz C, Cameron M, Zahoruiko Y, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I (2025). \textit{LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18040451}{doi:10.3390/ph18040451}.
\item Meng C, Guo W, Xiao C, Wen Y, Zhu X, Zhang Q, Liang Y, Li H, Xu S, Qiu Y, Chen H, Lin WJ, Wu B (2025). \textit{Structural basis for psilocybin biosynthesis.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-025-58239-x}{doi:10.1038/s41467-025-58239-x}.
\item M. Cirillo (2025). \textit{Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678251321040}{doi:10.1177/00221678251321040}.
\item Henry J, Giribaldi B, Nutt DJ, Erritzoe D, Carhart-Harris R, Lyons T. (2025). \textit{The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.03.17.25324123}{doi:10.1101/2025.03.17.25324123}.
\item Portes MAM, Werle I, Bertoglio LJ (2025). \textit{Is there a place for psychedelics in sports practice?}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2025.13}{doi:10.1017/neu.2025.13}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A (2025). \textit{Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111300}{doi:10.1016/j.pnpbp.2025.111300}.
\item McMaster University (2025). \textit{An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06225232}{source link}.
\item Insel Gruppe AG, University Hospital Bern (2025). \textit{Molecular Imaging Study of Harmine/DMT: a Basic Research Approach}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06252506}{source link}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Psilocybin in Alcohol Use Disorder With Comorbid Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06235411}{source link}.
\item University of Washington (2025). \textit{A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05163496}{source link}.
\item Harari R, Getselter D, Elliott E (2025). \textit{The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex.}. Molecular brain. [published; PubMed]. \href{https://doi.org/10.1186/s13041-025-01191-0}{doi:10.1186/s13041-025-01191-0}.
\item Meyer TD, Ibrahim M, Vale LN, Soares JC (2025). \textit{Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.12.044}{doi:10.1016/j.jad.2024.12.044}.
\item Farinha-Ferreira M, Miranda-Lourenço C, Galipeau C, Lenkei Z, Sebastião AM (2025). \textit{Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2024.110280}{doi:10.1016/j.neuropharm.2024.110280}.
\item Gattuso JJ, Wilson C, Li S, Hannan AJ, Renoir T (2025). \textit{Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin.}. European journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.ejphar.2025.177304}{doi:10.1016/j.ejphar.2025.177304}.
\item Valentin Yurievich Skryabin (2025). \textit{The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?}. Neurology Bulletin. [published; OpenAlex]. \href{https://doi.org/10.17816/nb639991}{doi:10.17816/nb639991}.
\item Bobak L, Dorney I, Kovacevich A, Barnett BS (2025). \textit{Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2478097}{doi:10.1080/02791072.2025.2478097}.
\item Wang X, Lin C, Wang X (2025). \textit{Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00034}{doi:10.1021/acsptsci.5c00034}.
\item Shimal Yonuis Abdulhadi, Noor Alaubidi, Walla H. Shuker, Sanabel A. Abd Almajeed (2025). \textit{BIOLOGICAL ACTIVITY OF PSILOCYBIN EXTRACTS FROM THE FRUITING BODIES OF PSILOCYBE CUBENSIS ANTIOXIDANT AND ANTIMICROBIAL POTENTIAL}. Journal of Microbiology Biotechnology and Food Sciences. [published; OpenAlex]. \href{https://doi.org/10.55251/jmbfs.12097}{doi:10.55251/jmbfs.12097}.
\item Thomas Hesslow (2025). \textit{Interview with Allen Kalpin and Reiko Ikemoto-Joseph: psychedelics and ISTDP}. Journal of Contemporary ISTDP. [published; OpenAlex]. \href{https://doi.org/10.70839/jejtzv59}{doi:10.70839/jejtzv59}.
\item Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (2025). \textit{Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00302744}{source link}.
\item Dr Hafiz Shafique Ahmad, Muhammad Waqar Ali, Usman Ul Haq (2025). \textit{PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS}. Journal of medical \& health sciences review.. [published; OpenAlex]. \href{https://doi.org/10.62019/r713mw08}{doi:10.62019/r713mw08}.
\item Kangaslampi S, Lietz MP. (2025). \textit{Psychedelics and autobiographical memory - Six open questions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/su7ch\_v2}{doi:10.31234/osf.io/su7ch\_v2}.
\item Stoliker D, Novelli L, Khajehnejad M, Biabani M, Greaves MD, Barta T, Williams M, Chopra S, Bazin O, Simonsson O, Chambers R, Barrett F, Deco G, Preller KH, Carhart-Harris R, Seth A, Sundram S, Egan GF, Razi A. (2025). \textit{Psychedelics Align Brain Activity with Context}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.09.642197}{doi:10.1101/2025.03.09.642197}.
\item Samuli Kangaslampi, Morten P. Lietz (2025). \textit{Psychedelics and autobiographical memory - Six open questions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/su7ch\_v2}{source link}.
\item Quah S, Glick C, Roseman L, Pasquini L, Carhart-Harris R, Saggar M. (2025). \textit{Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.05.641592}{doi:10.1101/2025.03.05.641592}.
\item Song C, Chang T, Buchborn T, Knöpfel T (2025). \textit{Lasting effect of psilocybin on sociability can be blocked by DNA methyltransferase inhibition.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.03.10.642385}{doi:10.1101/2025.03.10.642385}.
\item Biba B, O'Shea B. (2025). \textit{Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6xgu8\_v2}{doi:10.31234/osf.io/6xgu8\_v2}.
\item Galdino Taynah P., Oliveira Lucas C., Luz Mateus A., Jesus Raquel A., Lima Eunice P. N., Torres Maria C. M., Sivieri Katia, Afonso Victor I., Delgado João M. P. Q., Lima Antonio G. B., Silva Suédina M. L., Fook Marcus V. L. (2025). \textit{Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications}. Pharmaceuticals. [published; Crossref]. \href{https://doi.org/10.3390/ph18030380}{doi:10.3390/ph18030380}.
\item Brandon-Joe Biba, Brian O'Shea (2025). \textit{Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6xgu8\_v1}{doi:10.31234/osf.io/6xgu8\_v1}.
\item Lauren Wilseck, Preet Chatha, Lawrence Canale, Dhvanit Raval, Jeremy Weleff (2025). \textit{Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2025.200301}{doi:10.1176/appi.ajp-rj.2025.200301}.
\item Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Katarzyna Kalinowska (2025). \textit{Risks of using psilocybin in treatment of treatment-resistant depression}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2025.79.58319}{doi:10.12775/jehs.2025.79.58319}.
\item University Hospital, Basel, Switzerland (2025). \textit{Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05523401}{source link}.
\item Rosales CA, Lepinsky NA, Gebeyehu W, Wasslen KV, Colquhoun F, Warnes BB, Chihabi J, Manthorpe JM, Smith JC (2025). \textit{Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi.}. Journal of the American Society for Mass Spectrometry. [published; PubMed]. \href{https://doi.org/10.1021/jasms.4c00382}{doi:10.1021/jasms.4c00382}.
\item Aicher HD, Müller F, Gasser P (2025). \textit{Further education in psychedelic-assisted therapy - experiences from Switzerland.}. BMC medical education. [published; PubMed]. \href{https://doi.org/10.1186/s12909-025-06871-y}{doi:10.1186/s12909-025-06871-y}.
\item Yalovitser J, Levine J, Zweber C, Tien L, Stultz M, Mitchell H, Cote E, MacLean CD (2025). \textit{Vermont Primary Care Provider Perspectives on Psychedelics - A Cross-Sectional Study.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2474246}{doi:10.1080/02791072.2025.2474246}.
\item Craig, Danny R, Blalock, Eric M. (2025). \textit{Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?}. UKnowledge (University of Kentucky). [published; OpenAlex]. \href{https://uknowledge.uky.edu/jpns/vol2/iss1/1}{source link}.
\item Barnett BS, Mauney EE, King F (2025). \textit{Psychedelic-assisted therapy: An overview for the internist.}. Cleveland Clinic journal of medicine. [published; PubMed]. \href{https://doi.org/10.3949/ccjm.92a.24032}{doi:10.3949/ccjm.92a.24032}.
\item Kepner W, Yang KH, Dionicio P, Bailey K, Satybaldiyeva N, Moore A, Han BH, Palamar JJ (2025). \textit{Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2474243}{doi:10.1080/02791072.2025.2474243}.
\item Goodwin GM, Nowakowska A, Atli M, Dunlop BW, Feifel D, Hellerstein DJ, Marwood L, Shabir Z, Mistry S, Stansfield SC, Teoh E, Tsai J, Young MB, Malievskaia E (2025). \textit{Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp.24m15449}{doi:10.4088/jcp.24m15449}.
\item Elmira Zolali, Mahfuz Sakib, Jenny L. Wilkerson, Lance Richard McMahon, Samuel Obeng (2025). \textit{Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2024.100843}{doi:10.1016/j.jpet.2024.100843}.
\item Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M (2025). \textit{Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02800-5}{doi:10.1038/s41380-024-02800-5}.
\item Høgsted ES, Beliveau V, Ozenne B, Madsen MK, Svarer C, Dam VH, Johansen A, Fisher P, Knudsen GM, Frokjaer VG, Sankar A (2025). \textit{Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.}. The British journal of psychiatry: the journal of mental science. [published; PubMed]. \href{https://doi.org/10.1192/bjp.2024.143}{doi:10.1192/bjp.2024.143}.
\item Dutcher EG, Krystal AD (2025). \textit{Treatment Expectancies and Psilocybin vs Escitalopram for Depression.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2024.4387}{doi:10.1001/jamapsychiatry.2024.4387}.
\item Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E (2025). \textit{The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.12.061}{doi:10.1016/j.jad.2024.12.061}.
\item Chen Junqi, Wang Ziteng, Yong Ching Yee, Goh Evelyn Mei Ling, Moy Hooi Yan, Chan Eric Chun Yong (2025). \textit{Elucidating the Phase I metabolism of psilocin in vitro}. Archives of Toxicology. [published; Crossref]. \href{https://doi.org/10.1007/s00204-024-03952-7}{doi:10.1007/s00204-024-03952-7}.
\item Haft SL, Downey AE, Raymond-Flesch M, Fernandes-Osterhold G, Bradley ER, O'Donovan A, Woolley J (2025). \textit{A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116359}{doi:10.1016/j.psychres.2025.116359}.
\item Viohl Niklas, Hakami Zanjani Ali Asghar, Khandelia Himanshu (2025). \textit{Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit Gqα}. FEBS Letters. [published; Crossref]. \href{https://doi.org/10.1002/1873-3468.15099}{doi:10.1002/1873-3468.15099}.
\item Müller F, Sauer T, Hänny C, Mühlhauser M, Lang UE (2025). \textit{Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116381}{doi:10.1016/j.psychres.2025.116381}.
\item Calder AE, Qualls C, Hasler G, Elmiger D, Strassman R (2025). \textit{The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample.}. Biological psychiatry global open science. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsgos.2024.100436}{doi:10.1016/j.bpsgos.2024.100436}.
\item Fleury V, Tomkova E, Catalano Chiuvé S, Penzenstadler L (2025). \textit{Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report.}. Journal of Parkinson's disease. [published; PubMed]. \href{https://doi.org/10.1177/1877718x241312604}{doi:10.1177/1877718x241312604}.
\item Otto Marije E., van der Heijden Katelijne V., Schoones Jan W., van Esdonk Michiel J., Borghans Laura G. J. M., Jacobs Gabriel E., van Hasselt J. G. Coen (2025). \textit{Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis}. Clinical Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1007/s40262-025-01487-3}{doi:10.1007/s40262-025-01487-3}.
\item Petrušková A, Guhathakurta D, Akdaş EY, Perelló-Amorós B, Frischknecht R, Weiss EM, Páleníček T, Fejtová A (2025). \textit{Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.70020}{doi:10.1111/jnc.70020}.
\item Kovacevich A, Dorney I, Bobak L, Kaelber DC, Barnett BS (2025). \textit{Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2474239}{doi:10.1080/02791072.2025.2474239}.
\item Somers M, Scheepers FE (2025). \textit{Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20240121}{doi:10.1176/appi.ajp.20240121}.
\item Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB (2025). \textit{Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.}. Cancer medicine. [published; PubMed]. \href{https://doi.org/10.1002/cam4.70586}{doi:10.1002/cam4.70586}.
\item Gold ND, Pagni BA, Petridis PD, Bogenschutz MP (2025). \textit{Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2024.0030}{doi:10.1089/psymed.2024.0030}.
\item Modlin NL, McPhee T, Zazon N, Sarang M, Hignett R, Pick S, Cleare A, Williamson V, Rucker J (2025). \textit{Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2024.0027}{doi:10.1089/psymed.2024.0027}.
\item Meshkat S, Kaczmarek E, Doyle Z, Brudner RM, Gomes FA, Blainey MG, Weiglein G, McIntyre RS, Mansur RB, Rosenblat JD (2025). \textit{Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2024.0032}{doi:10.1089/psymed.2024.0032}.
\item Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME (2025). \textit{A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2024.0019}{doi:10.1089/psymed.2024.0019}.
\item Dino F (2025). \textit{A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.80707}{doi:10.7759/cureus.80707}.
\item Serretti A (2025). \textit{Anhedonia: Current and future treatments.}. PCN reports: psychiatry and clinical neurosciences. [published; PubMed]. \href{https://doi.org/10.1002/pcn5.70088}{doi:10.1002/pcn5.70088}.
\item Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H. (2025). \textit{Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/26tz7\_v1}{doi:10.31234/osf.io/26tz7\_v1}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v3}{doi:10.31234/osf.io/93x5h\_v3}.
\item Dan Petrovitch, Samuel Hosford, Andrew K. Littlefield, Heather Austin-Robillard (2025). \textit{Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/26tz7\_v1}{source link}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v2}{doi:10.31234/osf.io/93x5h\_v2}.
\item Anna-Leigh Hodge, Anna Forsyth, Tehseen Noorani, Suresh Muthukumaraswamy, Anna Rolleston, Patrick McHugh (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/93x5h\_v3}{source link}.
\item Perna J, Trop J, Palitsky R, Bosshardt Z, Vantine H, Dunlop BW, Zarrabi AJ (2025). \textit{Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report.}. BMC psychiatry. [published; PubMed]. \href{https://doi.org/10.1186/s12888-024-06303-z}{doi:10.1186/s12888-024-06303-z}.
\item Michel Bourin (2025). \textit{Psychedelics are Bringing a new wind to the Pharmacopoeia}. Neuroscience and Neurological Surgery. [published; OpenAlex]. \href{https://doi.org/10.31579/2578-8868/360}{doi:10.31579/2578-8868/360}.
\item Hitchins K, Reynolds J. (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/48yg7\_v2}{doi:10.31234/osf.io/48yg7\_v2}.
\item Karla Hitchins, James Reynolds (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/48yg7\_v2}{source link}.
\item Hitchins K, Reynolds J. (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/48yg7\_v1}{doi:10.31234/osf.io/48yg7\_v1}.
\item Julia Wójcik, Kacper Wojciech Pamuła, Marcin Cholewa, Karolina Kinga Kantor, Julia Plewniok, Maria Partyka, Maciej Kuca, Karolina Jaglarz, Wiktoria Maria Szymańska, Maksymilian Janeczek (2025). \textit{BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW}. Health Problems of Civilization. [published; OpenAlex]. \href{https://doi.org/10.5114/hpc.2025.147763}{doi:10.5114/hpc.2025.147763}.
\item Meshkat S, Malik T, Zeifman R, Swainson J, Zhang Y, Burback L, Winkler O, Greenshaw AJ, Claire Reichelt A, Vermetten E, Erritzoe D, Jha MK, Dunn W, Jetly R, Husain MI, Bhat V (2025). \textit{Psychedelics and Suicide-Related Outcomes: A Systematic Review.}. Journal of clinical medicine. [published; PubMed]. \href{https://doi.org/10.3390/jcm14051416}{doi:10.3390/jcm14051416}.
\item Fábio Nogueira Pereira, Ana Carina Rothechedl Cavalieri, João Paulo Crespo Ferreira, Kelly De Souza Ventura (2025). \textit{Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted Psychotherapy}. Polymatheia.. [published; OpenAlex]. \href{https://doi.org/10.52521/poly.v18i1.14945}{doi:10.52521/poly.v18i1.14945}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v1}{doi:10.31234/osf.io/7x8q4\_v1}.
\item Adamczyk S, Paczyńska M, Ruban A, Szczypiński J, Bola M, Orłowski P (2025). \textit{Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Psychedelic-Induced Ego Dissolution.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2464797}{doi:10.1080/02791072.2025.2464797}.
\item Kargbo RB (2025). \textit{Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.5c00031}{doi:10.1021/acsmedchemlett.5c00031}.
\item Hartter, Nina, Däumichen, Marvin, Schmidt, Christopher, Wolff, Max, Gründer, Gerhard, Jungaberle, Henrik (2025). \textit{Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländern}. edoc Publication server (Humboldt University of Berlin). [published; OpenAlex]. \href{https://doi.org/10.18452/35395}{doi:10.18452/35395}.
\item Bollinger IM, Singer H, Jacobs J, Tyler M, Scott K, Pauli CS, Miller DR, Barlow C, Rockefeller A, Slot JC, Angel-Mosti V (2025). \textit{High-quality draft genomes of ecologically and geographically diverse species.}. Microbiology resource announcements. [published; PubMed]. \href{https://doi.org/10.1128/mra.00250-24}{doi:10.1128/mra.00250-24}.
\item Brengel EK, Axe B, Maheswari A, Abeer MI, Ortiz RJ, Woodward TJ, Walhof R, Utama R, Sawada C, Balaji S, Kulkarni PP, Bradshaw HB, Gitcho MA, Ferris CF (2025). \textit{Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.02.03.636248}{doi:10.1101/2025.02.03.636248}.
\item Aqil M, de Hollander G, Vreugdenhil N, Knapen T, Dumoulin SO. (2025). \textit{Psilocybin alters visual contextual computations}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.06.636848}{doi:10.1101/2025.02.06.636848}.
\item Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL (2025). \textit{A qualitative analysis of the psychedelic mushroom come-up and come-down.}. Npj mental health research. [published; PubMed]. \href{https://doi.org/10.1038/s44184-024-00095-6}{doi:10.1038/s44184-024-00095-6}.
\item Bor Luen Tang (2025). \textit{Psychedelics for Moral Bioenhancement in Healthy Individuals-A Violation of the Non-Maleficence Principle?}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4010005}{doi:10.3390/psychoactives4010005}.
\item Jenna Hartel, James L. Kent Cydelic, Tim Gorichanaz, Keith Munro (2025). \textit{Psychedelic Information Theory}. Proceedings of the Annual Conference of CAIS / Actes du congrès annuel de l ACSI. [published; OpenAlex]. \href{https://doi.org/10.29173/cais1980}{doi:10.29173/cais1980}.
\item Fuini E, Chang A, Ortiz RJ, Nasseef T, Edwards J, Latta M, Gonzalez E, Woodward TJ, Bradshaw HB, Axe B, Maheswari A, Cavallaro N, Kulkarni PP, Ferris CF. (2025). \textit{Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.01.636078}{doi:10.1101/2025.02.01.636078}.
\item Lucido MJ, Dunlop BW (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Hogea L, Tabugan DC, Costea I, Albai O, Nussbaum L, Cojocaru A, Corsaro L, Anghel T (2025). \textit{The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.}. Medicina (Kaunas, Lithuania). [published; PubMed]. \href{https://doi.org/10.3390/medicina61020278}{doi:10.3390/medicina61020278}.
\item Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard (2025). \textit{Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00375}{doi:10.1556/2054.2025.00375}.
\item Brian S. Barnett (2025). \textit{Funding Success of United States Federal Grant Applications Proposing to Study Therapeutic Applications of Psychedelics: A Survey Study}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4010004}{doi:10.3390/psychoactives4010004}.
\item Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ (2025). \textit{Psychological Support Approaches in Psychedelic Therapy: Results From a Survey of Psychedelic Practitioners.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp.24m15521}{doi:10.4088/jcp.24m15521}.
\item de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL (2025). \textit{Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.}. Expert opinion on drug discovery. [published; PubMed]. \href{https://doi.org/10.1080/17460441.2025.2460674}{doi:10.1080/17460441.2025.2460674}.
\item Mori-Kreiner A, Aggarwal A, Bordoloi M (2025). \textit{Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.}. Psychopharmacology bulletin. [published; PubMed]. \href{https://doi.org/10.64719/pb.4525}{doi:10.64719/pb.4525}.
\item Martina Colognesi, Daniela Gabbia, A. Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Franco Folli, Lucia Centofanti, S. La Rosa, G Finzi, M. Pappagallo, Paolo Manfredi, Sara De Martin (2025). \textit{Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver Disease}. Digestive and Liver Disease. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dld.2025.01.135}{doi:10.1016/j.dld.2025.01.135}.
\item A. Signor, Martina Colognesi, Daniela Gabbia, Ilaria Zanotto, Y. Frion-Herrera, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Franco Folli, M. Pappagallo, Paolo Manfredi, S. De Martin (2025). \textit{Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytes}. Digestive and Liver Disease. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dld.2025.01.134}{doi:10.1016/j.dld.2025.01.134}.
\item Daisuke Ibi, Rika Takaba, Keisuke Yoshida, Takayoshi Mamiya, Shinji Kitagaki, Masayuki Hiramatsu (2025). \textit{BEHAVIORAL ANALYSES OF ANTIDEPRESSANT-LIKE EFFECT OF SEROTONERGIC PSYCHEDELICS IN MICE}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyae059.584}{doi:10.1093/ijnp/pyae059.584}.
\item Matthew Weirick Johnson (2025). \textit{Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco Addiction}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112187}{doi:10.1016/j.drugalcdep.2024.112187}.
\item Myfanwy Graham, Wayne Hall, Rosalie Liccardo Pacula, David Hammond (2025). \textit{International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMA}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112089}{doi:10.1016/j.drugalcdep.2024.112089}.
\item Jérémie Richard, Sandeep M. Nayak, Nathan D. Sepeda, Albert Garcia-Romeu (2025). \textit{Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112184}{doi:10.1016/j.drugalcdep.2024.112184}.
\item Destiny Carbello, Tomáš Páleníček (2025). \textit{Source Localized Auditory Erp Sensory and Preattentive Correlates of Psilocybin-Induced Ego-Dissolution Related Effects}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112090}{doi:10.1016/j.drugalcdep.2024.112090}.
\item Tamara A. Millay, Nae Won, Anna Wang, Joseph J. Palamar, Linda B. Cottler (2025). \textit{Prevalence of Use of Psilocybin and MDMA in Multiple US Cities}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112186}{doi:10.1016/j.drugalcdep.2024.112186}.
\item Kellie Pertl, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Sarann Bielavitz, Dennis McCarty, Christopher S. Stauffer, Cameron Wolf, P. Todd Korthuis (2025). \textit{Oregon’s Emerging Psilocybin Services Workforce: An Environmental Scan}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.111569}{doi:10.1016/j.drugalcdep.2024.111569}.
\item Amanda L. Elmore, Marina Bolser, Matt Richey (2025). \textit{Lifetime Psilocybin Use and Opioid Use Disorder in Pregnant and Non-Pregnant Women of Reproductive Age}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.111723}{doi:10.1016/j.drugalcdep.2024.111723}.
\item *Zitong Wang, Yanbo Zhang, Xin-Min Li (2025). \textit{PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY THE ENDOCANNABINOID SYSTEM (ECS)}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814968}{source link}.
\item Sofia Nasini, Sara Tidei, Benedetta Barzon, Sara De Martin, Marco Banzato, Andrea Mattarei, Franco Folli, Marco Pappagallo, Paolo L Manfredi, *Stefano Comai (2025). \textit{ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11815219}{source link}.
\item *Leonard Lerer, Katherine Spear, Jeet Varia, Cecily Keim, Alex Buko, Karin Blakolmer, Bernard Lerer (2025). \textit{BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11815225}{source link}.
\item Rebecca Harding, Natalie Ertl, Rayyan Zafar (2025). \textit{ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814992}{source link}.
\item Martha Lopez Canul, Vivienne Nguyen, Antonio Inserra, Ella Nield, Hannah Billings, Gabriella Gobbi (2025). \textit{EFFECT OF ACUTE PSILOCYBIN ON THERMAL AND NEUROPATHIC PAIN IN RODENTS}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814656}{source link}.
\item Dong L, Li L, Wu Y, Zhao X, Zhong H, Cheng X, Liu L, Cheng C, Ouyang M, Tao L (2025). \textit{A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.}. International journal of behavioral medicine. [published; PubMed]. \href{https://doi.org/10.1007/s12529-024-10262-w}{doi:10.1007/s12529-024-10262-w}.
\item Andrews CM, Hall W, Humphreys K, Marsden J (2025). \textit{Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16575}{doi:10.1111/add.16575}.
\item Bogenschutz MP (2025). \textit{A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16647}{doi:10.1111/add.16647}.
\item Kilmer B (2025). \textit{How psychedelics legalization debates could differ from cannabis.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16644}{doi:10.1111/add.16644}.
\item Jones G, Lowe MX, Nayak S, Sepeda N, Kettner H, Carhart-Harris R, Jackson H, Garcia-Romeu A (2025). \textit{Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.10.058}{doi:10.1016/j.jad.2024.10.058}.
\item Rogge K, Wagner TJ, Hoffmeister D, Rupp B, Werten S (2025). \textit{Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis.}. FEBS letters. [published; PubMed]. \href{https://doi.org/10.1002/1873-3468.15042}{doi:10.1002/1873-3468.15042}.
\item Calder AE, Hase A, Hasler G (2025). \textit{Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02830-z}{doi:10.1038/s41380-024-02830-z}.
\item Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB (2025). \textit{The safety of psilocybin-assisted psychotherapy: A systematic review.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674241289024}{doi:10.1177/00048674241289024}.
\item Marazziti D, Weiss F, Gurrieri R, Russomanno G, Gambini M, Magnesa A, Coccoglioniti A, Perugi G (2025). \textit{Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2024.2445016}{doi:10.1080/14737175.2024.2445016}.
\item Geller J, Whitney E (2025). \textit{Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-024-01577-2}{doi:10.1007/s11920-024-01577-2}.
\item Ferreira AE, Reis-Pina P (2025). \textit{Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.}. Journal of psychosomatic research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychores.2024.112020}{doi:10.1016/j.jpsychores.2024.112020}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ (2025). \textit{Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.116337}{doi:10.1016/j.psychres.2024.116337}.
\item Louie E, Towers E, Morse AR, Watt J, Bryant Z, Haber P, Morley K (2025). \textit{The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour.}. International journal of mental health nursing. [published; PubMed]. \href{https://doi.org/10.1111/inm.70010}{doi:10.1111/inm.70010}.
\item Shaughnessy AF (2025). \textit{Among Psychedelics, Only Psilocybin Has Demonstrated Benefit to Treat Depression.}. American family physician. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/39964936/}{source link}.
\item Martin Kuchař, Klara Gotwaldova, Jan Borovička, Radek Jurok, Petra Cihlářová, Kateřina Hájková (2025). \textit{DETERMINATION OF TRYPTAMINE ALKALOIDS AND THEIR STABILITY IN PSYCHOTROPIC MUSHROOMS}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyae059.260}{doi:10.1093/ijnp/pyae059.260}.
\item Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J (2025). \textit{Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16762}{doi:10.1111/add.16762}.
\item Zeifman RJ, Spriggs MJ, Kettner H, Lyons T, Rosas FE, Mediano PAM, Erritzoe D, Carhart-Harris RL (2025). \textit{From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-023-28111-3}{doi:10.1038/s41598-023-28111-3}.
\item Kurzbaum E, Páleníček T, Shrchaton A, Azerrad S, Dekel Y (2025). \textit{Exploring Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof11020099}{doi:10.3390/jof11020099}.
\item Louis Plourde, Sue-Ling Chang, Houman Farzin, Jean-François Stephan, Jean-Sébastien Fallu, Michel Dorval (2025). \textit{Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00431}{doi:10.1556/2054.2024.00431}.
\item Ganguly A, James M, Alici Y (2025). \textit{When death is desired: A case of MAiD \& the CL psychiatrist.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s1478951524002037}{doi:10.1017/s1478951524002037}.
\item Central Institute of Mental Health, Mannheim (2025). \textit{A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04670081}{source link}.
\item Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M (2025). \textit{Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph18010130}{doi:10.3390/ph18010130}.
\item Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S, Grunstein M, Vadhan NP, Duarte RA (2025). \textit{Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-024-01321-8}{doi:10.1007/s11916-024-01321-8}.
\item Krawczyk N, Miller M, Gu EY, Irvine N, Ramirez E, Santaella-Tenorio J, Lippincott T, Bogenschutz M, Bunting AM, Meacham MC (2025). \textit{Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16767}{doi:10.1111/add.16767}.
\item Ellis S, Bostian C, Feng W, Fischer E, Schwartz G, Eisen K, Lean M, Conlan E, Ostacher M, Aaronson S, Suppes T (2025). \textit{Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.09.133}{doi:10.1016/j.jad.2024.09.133}.
\item Li JR, Chiang KT, Kao YC, Yu CL, Yang FC, Liang CS, Hsu TW (2025). \textit{The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.10.016}{doi:10.1016/j.jad.2024.10.016}.
\item Zylko A, Rakoczy R, Roberts B, Wilson M, Powell A, Page A, Heitkamp M, Fiest D, Jones J, McMurray M. (2025). \textit{Age- and estrous-dependent effects of psilocybin in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.10.632408}{doi:10.1101/2025.01.10.632408}.
\item Amin Sharifan (2025). \textit{What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?}. Cochrane Clinical Answers. [published; OpenAlex]. \href{https://doi.org/10.1002/cca.4512}{doi:10.1002/cca.4512}.
\item Valerie A. Canady (2025). \textit{Study finds encouraging results in psilocybin treatment for TRD patients}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.34292}{doi:10.1002/mhw.34292}.
\item Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y (2025). \textit{The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111139}{doi:10.1016/j.pnpbp.2024.111139}.
\item Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C (2025). \textit{Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111155}{doi:10.1016/j.pnpbp.2024.111155}.
\item Kopra EI, Penttinen J, Rucker JJ, Copeland CS (2025). \textit{Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111177}{doi:10.1016/j.pnpbp.2024.111177}.
\item Wang Z, Robbins B, Zhuang R, Sandini T, van Bruggen R, Li XM, Zhang Y (2025). \textit{Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111243}{doi:10.1016/j.pnpbp.2024.111243}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Destoop M, Mohr P, Butlen F, Kéri P, Samochowiec J, De Picker L, Fiorillo A, Kuypers KPC, Dom G (2025). \textit{Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.}. European psychiatry: the journal of the Association of European Psychiatrists. [published; PubMed]. \href{https://doi.org/10.1192/j.eurpsy.2024.1806}{doi:10.1192/j.eurpsy.2024.1806}.
\item Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo (2025). \textit{PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS}. Health and Society. [published; OpenAlex]. \href{https://doi.org/10.51249/hs.v5i01.2377}{doi:10.51249/hs.v5i01.2377}.
\item Schuler H, Zhou D, Savignac C, Cvetkovska V, Tse Y, Meccia J, Lopez J, Harutyunyan AS, Ragoussis J, Bzdok D, Bagot RC. (2025). \textit{Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.08.631940}{doi:10.1101/2025.01.08.631940}.
\item Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, Misra L, Gomez D, Viswanath O, Emami E, Leathem J (2025). \textit{Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-024-01353-0}{doi:10.1007/s11916-024-01353-0}.
\item Han XX, Phurbu D, Cao B, Li JX, Zhu XY, Liu LH, Thongklang N, Hyde KD, Zhao RL (2025). \textit{Molecular Phylogeny and Morphology Reveal Four New Species of (Bolbitiaceae, Agaricales) from the Qinghai-Xizang Plateau, China.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof11010045}{doi:10.3390/jof11010045}.
\item Cook SG, Lee S, Ference E, Shi Y, Rojas-Carvajal M, Hen R, Bains JS, Füzesi T, Turi GF. (2025). \textit{Psilocybin induces sex- and context-specific recruitment of the stress axis}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.06.631556}{doi:10.1101/2025.01.06.631556}.
\item Zhang M, Yang Y, Yang Z, Wen X, Zhang C, Xiao P, Wang Y, Sun J, Wang H, Wang X (2025). \textit{Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT receptor activation and psychedelic-like activity.}. European journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1016/j.ejmech.2024.117049}{doi:10.1016/j.ejmech.2024.117049}.
\item Liao C, O'Farrell E, Qalieh Y, Savalia NK, Girgenti MJ, Kwan KY, Kwan AC (2025). \textit{Single-nucleus transcriptomics reveals time-dependent and cell-type-specific effects of psilocybin on gene expression.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2025.01.04.631335}{doi:10.1101/2025.01.04.631335}.
\item Socoró Garrigosa M, Sanz Perl Y, Kringelbach ML, Carhart-Harris R, Vohryzek J, Deco G. (2025). \textit{Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.01.631011}{doi:10.1101/2025.01.01.631011}.
\item Kelly TJ, Liu QS (2025). \textit{Exploring the therapeutic potential of psychedelics: Fear extinction mechanisms and amygdala modulation.}. Psychedelics. [published; PubMed]. \href{https://doi.org/10.61373/pp024b.0019}{doi:10.61373/pp024b.0019}.
\item Molly Mifsud, Jill Robinson (2025). \textit{Exploring the relationship between personality traits, attitudes toward psilocybin use, and motivations for using psilocybin}. UVic's Research and Learning Repository. [published; OpenAlex]. \href{https://hdl.handle.net/1828/21985}{source link}.
\item Milojičić, Jelica, Ramljak, Marta, Zulić, Mario (2025). \textit{Beyond the veil of perception: investigating the relationship between predictors of psychedelic experiences}. Ramiro and Zoran Bujas Days 2024. [published; OpenAlex]. \href{https://hdl.handle.net/21.15107/rcub\_reff\_7590}{source link}.
\item Papp N, Gonda X (2025). \textit{[Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?].}. Psychiatria Hungarica: A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/42412648/}{source link}.
\item Caitlyn S. Greenspun (2025). \textit{The Right to 'Trip:' Navigating Psilocybin-Assisted Psychotherapy Under the Right to Try Pathway}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://lawecommons.luc.edu/luclj/vol56/iss3/6}{source link}.
\item Jimmy Nicolas Hernandez Herrera, Marian Daniela Guio Sierra (2025). \textit{Clinical use of psilocybin in mental disorders:: a bibliometric analysis in Scopus and Web of Science}. Dialnet (Universidad de la Rioja). [published; OpenAlex]. \href{https://dialnet.unirioja.es/servlet/oaiart?codigo=10631403}{source link}.
\item Patricia A. Cioe, Garrett S Stang, Danish Azam, Sarah Dugal (2025). \textit{Additional file 1 of “I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.29615217}{doi:10.6084/m9.figshare.29615217}.
\item Hyder, Cameron (2025). \textit{Hallucinogen Usage, Experiencing Mystical Phenomena, and Transformational Identity Change}. Journal of International Crisis and Risk Communication Research. [published; OpenAlex]. \href{https://stars.library.ucf.edu/etd2024/156}{source link}.
\item Siddhant Pusdekar (2025). \textit{Psilocybin rewires specific mouse cortical networks in lasting ways}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/pkim3530}{doi:10.53053/pkim3530}.
\item Koschützke, Leif (2025). \textit{Psychedelics induced modulation of motor recovery after stroke}. Bundesinstitut für Risikobewertung Fachgruppe ZEBET - Datenbank und Informationsbeschaffung Abteilung Experimentelle Toxikologie und ZEBET. [published; OpenAlex]. \href{https://doi.org/10.17590/asr.0000411}{doi:10.17590/asr.0000411}.
\item Machado Henrique Tofoli Vieira, Seixas Geovana Mendes de, Silva Luis Gustavo Alves, Brito Mariana Duarte Garcia, Castro Giovanna Miziara (2025). \textit{Alternative therapy for neurological and psychiatric disorders using psilocybin}. São Paulo Medical Journal. [published; Crossref]. \href{https://doi.org/10.5327/1516-3180.cpn.1123}{doi:10.5327/1516-3180.cpn.1123}.
\item Kostić Marina D., Nedić Jana, Dragojević Jovana S., Divac Vera M. (2025). \textit{In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor}. Book of Proceedings. [published; Crossref]. \href{https://doi.org/10.46793/iccbikg25.477k}{doi:10.46793/iccbikg25.477k}.
\item Madison M. H. Simounet, Joy Drinnon (2025). \textit{Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies}. Psi Chi Journal of Psychological Research. [published; OpenAlex]. \href{https://doi.org/10.24839/2325-7342.jn30.4.345}{doi:10.24839/2325-7342.jn30.4.345}.
\item Andreia Machado Brito da Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias-da-Silva (2025). \textit{Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; OpenAlex]. \href{https://doi.org/10.51126/revsalus.v7isup.1031}{doi:10.51126/revsalus.v7isup.1031}.
\item Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris (2025). \textit{Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105421}{doi:10.1016/j.nsa.2025.105421}.
\item Michal Brownstien (2025). \textit{Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105450}{doi:10.1016/j.nsa.2025.105450}.
\item Tess L. Veuthey, Prasad Shirvalkar (2025). \textit{Uncovering the dynamics of psilocybin in human neural pain circuits with intracranial neural recordings}. Brain stimulation. [published; OpenAlex]. \href{https://doi.org/10.1016/j.brs.2024.12.653}{doi:10.1016/j.brs.2024.12.653}.
\item Friederike Klein (2025). \textit{Therapieresistente Depression: Studie zur Psilocybin-augmentierten Psychotherapie nicht erfolgreich}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-024-4209-z}{doi:10.1007/s15005-024-4209-z}.
\item RM Moosa-Battey (2025). \textit{Psilocybin: revealing the enigmas of a revolutionary fungi}. SA pharmaceutical journal.. [published; OpenAlex]. \href{https://doi.org/10.36303/sapj.0982}{doi:10.36303/sapj.0982}.
\item Mile Jevtić (2025). \textit{The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry}. Engrami. [published; OpenAlex]. \href{https://doi.org/10.5937/engrami47-57385}{doi:10.5937/engrami47-57385}.
\item Charles S. Brennan, Yanyi Huang, Margaret A. Brennan (2025). \textit{Mushroom bioactives-polysaccharides to psilocybin: a viewpoint on the therapeutic use of mushrooms for consumers and patients for health and neuroplasticity}. Translational Food Sciences. [published; OpenAlex]. \href{https://doi.org/10.1093/trfood/vxaf001}{doi:10.1093/trfood/vxaf001}.
\item Azimjon Karimov, Dilshodbek Rasulov (2025). \textit{Moral Considerations and the Experience of Ego Dissolution: Insights from Psilocybin}. Asian Journal of Ethics in Health and Medicine. [published; OpenAlex]. \href{https://doi.org/10.51847/ml10ckoxsw}{doi:10.51847/ml10ckoxsw}.
\item Y. Tony Yang (2025). \textit{From Safe Touch to Sexual Abuse: Walking the Tightrope of Patient Safety in Psychedelic Therapy}. The American Journal of Bioethics. [published; OpenAlex]. \href{https://doi.org/10.1080/15265161.2024.2433418}{doi:10.1080/15265161.2024.2433418}.
\item Juuso Kähönen (2025). \textit{Subjective Effects of Psychedelics Are the Plausible Mechanism of Psychedelic Moral Enhancement Rather than a Risk. Comment on Tang, B.L. Psychedelics for Moral Bioenhancement in Healthy Individuals-A Violation of the Non-Maleficence Principle? Psychoactives 2025, 4, 5}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040043}{doi:10.3390/psychoactives4040043}.
\item Joshua Woolley, MD, PhD (2025). \textit{Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04932434}{source link}.
\item Bahji A, Lunsky I, Gutierrez G, Vazquez G (2025). \textit{Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2278586}{doi:10.1080/02791072.2023.2278586}.
\item Hadley M, Halliday A, Stone JM (2025). \textit{Association of Hallucinogen Persisting Perception Disorder with Trait Neuroticism and Mental Health Symptoms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2287081}{doi:10.1080/02791072.2023.2287081}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S (2025). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Molecular biotechnology. [published; PubMed]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Hovmand OR, Ebbesen Jensen M, Søgaard Juul T, Korsbak Madsen M, MacDonald Fisher P, Siggaard Stenbæk D (2025). \textit{Validation of the Danish Translation of the Revised Mystical Experience Questionnaire (MEQ30) and Possible Impact of Setting, Dose and Intention.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2302186}{doi:10.1080/02791072.2024.2302186}.
\item Humphreys K, Todd Korthuis P, Stjepanović D, Hall W (2025). \textit{Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.}. Annual review of psychology. [published; PubMed]. \href{https://doi.org/10.1146/annurev-psych-020124-023532}{doi:10.1146/annurev-psych-020124-023532}.
\item Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D (2025). \textit{Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.3459}{doi:10.1002/cpt.3459}.
\item Negrine JJ, Puljević C, Ferris J, Liknaitzky P, Perlman C, Piatkowski T (2025). \textit{Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling.}. Drug and alcohol review. [published; PubMed]. \href{https://doi.org/10.1111/dar.13973}{doi:10.1111/dar.13973}.
\item Richardson E, Patterson R, Meltzer-Brody S, McClure R, Tow A (2025). \textit{Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.}. Annual review of medicine. [published; PubMed]. \href{https://doi.org/10.1146/annurev-med-050423-095712}{doi:10.1146/annurev-med-050423-095712}.
\item Zech JM, Yaden DB, Jones GM (2025). \textit{Associations between psychedelic use and cannabis use disorder in a nationally representative sample.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112502}{doi:10.1016/j.drugalcdep.2024.112502}.
\item Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS (2025). \textit{Practical considerations in the establishment of psychedelic research programs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06722-6}{doi:10.1007/s00213-024-06722-6}.
\item Seybert C, Schimmers N, Silva L, Breeksema JJ, Veraart J, Bessa BS, d'Orsi D, Schoevers RA, Oliveira-Maia AJ (2025). \textit{Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(24)00333-x}{doi:10.1016/s2215-0366(24)00333-x}.
\item Katragunta K, Avula B, Chittiboyina AG, Lata H, Khan IA (2025). \textit{Quantitative LC-QToF-MS Analysis of Mycochemicals in Amanita muscaria, Psilocybe spp. (Agaricomycetes), and Consumer Products.}. International journal of medicinal mushrooms. [published; PubMed]. \href{https://doi.org/10.1615/intjmedmushrooms.2024056373}{doi:10.1615/intjmedmushrooms.2024056373}.
\item Kirlić N, Lennard-Jones M, Atli M, Malievskaia E, Modlin NL, Peck SK, Gaillard A, Goodwin GM, Koelpin D (2025). \textit{Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230884}{doi:10.1176/appi.ajp.20230884}.
\item O'Donnell KC, Grigsby J, Grob CS (2025). \textit{Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230785}{doi:10.1176/appi.ajp.20230785}.
\item Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB (2025). \textit{Psilocybin: From Psychiatric Pariah to Perceived Panacea.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230682}{doi:10.1176/appi.ajp.20230682}.
\item Ramaekers JG, Reckweg JT, Mason NL (2025). \textit{Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230890}{doi:10.1176/appi.ajp.20230890}.
\item Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Suppes T, Sackeim HA (2025). \textit{Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20231063}{doi:10.1176/appi.ajp.20231063}.
\item Wolfgang AS, McClair VL, Schnurr PP, Holtzheimer PE, Woolley JD, Stauffer CS, Wolf RC, States LJ, Benedek DM, Capaldi VF, Bradley J, Fuller MA, Smyth MJ, Hermes EDA, Tenhula W, Wiechers IR (2025). \textit{Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20240751}{doi:10.1176/appi.ajp.20240751}.
\item Pagni BA, Zeifman RJ, Mennenga SE, Carrithers BM, Goldway N, Bhatt S, O'Donnell KC, Ross S, Bogenschutz MP (2025). \textit{Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230887}{doi:10.1176/appi.ajp.20230887}.
\item Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM (2025). \textit{Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.}. Clinical neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1097/wnf.0000000000000617}{doi:10.1097/wnf.0000000000000617}.
\item Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL (2025). \textit{Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial.}. medRxiv: the preprint server for health sciences. [published; PubMed]. \href{https://doi.org/10.1101/2024.12.31.24319806}{doi:10.1101/2024.12.31.24319806}.
\item Cohen IG, Marks M (2025). \textit{Psychedelic Medicine Exceptionalism.}. The American journal of bioethics: AJOB. [published; PubMed]. \href{https://doi.org/10.1080/15265161.2025.2434398}{doi:10.1080/15265161.2025.2434398}.
\item Otto Marije E., van der Heijden Katelijne V., Schoones Jan W., van Esdonk Michiel J., Borghans Laura G. J. M., Jacobs Gabriel E., van Hasselt J. G. Coen (2025). \textit{Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis}. Clinical Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1007/s40262-024-01454-4}{doi:10.1007/s40262-024-01454-4}.
\item Miller CE, Zoladz PR (2025). \textit{Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1124/jpet.124.002237}{doi:10.1124/jpet.124.002237}.
\item Wijesekara T, Xu B (2025). \textit{Insights into therapeutic potential and practical applications of natural toxins from poisonous mushrooms.}. Human \& experimental toxicology. [published; PubMed]. \href{https://doi.org/10.1177/09603271251323134}{doi:10.1177/09603271251323134}.
\item Nogueira M, García-Hernández S, Roberto GS, Marques LZ (2025). \textit{Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions.}. International journal of medicinal mushrooms. [published; PubMed]. \href{https://doi.org/10.1615/intjmedmushrooms.2024057053}{doi:10.1615/intjmedmushrooms.2024057053}.
\item Bires J (2025). \textit{Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.}. Journal of psychosocial oncology. [published; PubMed]. \href{https://doi.org/10.1080/07347332.2025.2482917}{doi:10.1080/07347332.2025.2482917}.
\item Zhu X, Zhang C, Hellerstein D, Feusner JD, Wheaton MG, Gomez GJ, Schneier F (2025). \textit{Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder.}. Psychedelics. [published; PubMed]. \href{https://doi.org/10.61373/pp024r.0028}{doi:10.61373/pp024r.0028}.
\item Won NY, Wang A, Athay R, Striley CW, Cottler LB (2025). \textit{Geographical Differences in Self-Reported Past 12-Month Drug Use: Results from the NDEWS Rapid Street Reporting, 2021-2023.}. Substance use \& misuse. [published; PubMed]. \href{https://doi.org/10.1080/10826084.2025.2511242}{doi:10.1080/10826084.2025.2511242}.
\item Wall MB, Carhart-Harris RL (2025). \textit{Human neuroimaging: fMRI.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.04.013}{doi:10.1016/bs.irn.2025.04.013}.
\item Godfrey K, Luan LX, Timmermann C (2025). \textit{Effects of psychedelics on human oscillatory brain activity.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.04.012}{doi:10.1016/bs.irn.2025.04.012}.
\item Cumming P, Egger K, Knudsen GM (2025). \textit{Molecular brain imaging of psychedelic action.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.005}{doi:10.1016/bs.irn.2025.02.005}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC (2025). \textit{Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.03.002}{doi:10.1016/bs.irn.2025.03.002}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item DuPont CM, Johnson MW (2025). \textit{Psychedelics and substance use disorder treatment.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.03.005}{doi:10.1016/bs.irn.2025.03.005}.
\item Bostoen T, Tap S, Breeksema J, Schoevers R (2025). \textit{Post-traumatic stress disorder in psychedelic research.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.004}{doi:10.1016/bs.irn.2025.02.004}.
\item Tap S, Bostoen T, Breeksema J, Schoevers R (2025). \textit{Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.03.001}{doi:10.1016/bs.irn.2025.03.001}.
\item Vogt SB, Liechti ME (2025). \textit{Clinical pharmacology.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.003}{doi:10.1016/bs.irn.2025.02.003}.
\item Savickaitė E, Laubner-Sakalauskienė G (2025). \textit{Emerging Risks of Amanita Muscaria: Case Reports on Increasing Consumption and Health Risks.}. Acta medica Lituanica. [published; PubMed]. \href{https://doi.org/10.15388/amed.2025.32.1.23}{doi:10.15388/amed.2025.32.1.23}.
\item Sommer WH, Spanagel R (2025). \textit{Behavioral Neurobiology of Alcohol Addiction: A Decade of Great Challenges, New Hopes, and Hypes.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2025\_586}{doi:10.1007/7854\_2025\_586}.
\item Godfrey K, Weiss B, Zhang X, Spriggs M, Peill J, Lyons T, Carhart-Harris R, Erritzoe D (2025). \textit{An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2024.104092}{doi:10.1016/j.nsa.2024.104092}.
\item Perez GM, Rosenberg BM, Xu W, Oathes DJ (2025). \textit{Brain changes associated with depression treatment: a meta-analysis.}. NeuroImage. Clinical. [published; PubMed]. \href{https://doi.org/10.1016/j.nicl.2025.103874}{doi:10.1016/j.nicl.2025.103874}.
\item Garcia ACM, Maia LO (2025). \textit{Psychedelic-assisted therapies for existential and spiritual suffering in palliative care.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2025.07.002}{doi:10.1016/bs.pbr.2025.07.002}.
\item D M Schuman H, Barkova S, Mina R, Deleemans JM, Nguyen T, Carlson LE (2025). \textit{"" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.}. Integrative cancer therapies. [published; PubMed]. \href{https://doi.org/10.1177/15347354251370982}{doi:10.1177/15347354251370982}.
\item Norouzkhani F, Gojani E, Wang B, Li D, Shujat S, Shrestha A, Rodriguez-Juarez R, Kovalchuk O, Kovalchuk I (2025). \textit{Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts.}. Biochemistry and cell biology = Biochimie et biologie cellulaire. [published; PubMed]. \href{https://doi.org/10.1139/bcb-2025-0250}{doi:10.1139/bcb-2025-0250}.
\item Tuğcan MO, Akpınar AA (2025). \textit{Mushroom poisoning: An updated review.}. Turkish journal of emergency medicine. [published; PubMed]. \href{https://doi.org/10.4103/tjem.tjem\_129\_24}{doi:10.4103/tjem.tjem\_129\_24}.
\item Brooks BM, Cordero FJ, Alchermes SL, Brooks BM (2025). \textit{Social pain: A systematic review on interventions.}. F1000Research. [published; PubMed]. \href{https://doi.org/10.12688/f1000research.159561.1}{doi:10.12688/f1000research.159561.1}.
\item Meshkat S, J Zeifman R, Stewart K, Janssen-Aguilar R, Lou W, Jetly R, Monson CM, Bhat V (2025). \textit{Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0313741}{doi:10.1371/journal.pone.0313741}.
\item O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D (2025). \textit{Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.78171}{doi:10.7759/cureus.78171}.
\item Kinderlehrer DA (2025). \textit{Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s500337}{doi:10.2147/ndt.s500337}.
\item O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D (2025). \textit{Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.c209}{doi:10.7759/cureus.c209}.
\item Zamaria JA, Fernandes-Osterhold G, Shedler J, Yehuda R (2025). \textit{Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2025.1505894}{doi:10.3389/fpsyg.2025.1505894}.
\item Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P (2025). \textit{A review of psychedelics trials completed in depression, informed by European regulatory perspectives.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2025.105516}{doi:10.1016/j.nsa.2025.105516}.
\item Junges LH, Müller-Santos M (2025). \textit{Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.}. Biotechnology progress. [published; PubMed]. \href{https://doi.org/10.1002/btpr.3513}{doi:10.1002/btpr.3513}.
\item Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L (2025). \textit{Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1508811}{doi:10.3389/fpsyt.2025.1508811}.
\item Jerotic S (2025). \textit{Is there room for ethics of authenticity in psilocybin research?}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2025.105519}{doi:10.1016/j.nsa.2025.105519}.
\item Harlow AF, Hendricks PS, Leventhal AM, Barrington-Trimis JL (2025). \textit{Psychedelic Microdosing among Young Adults from Southern California.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2313684}{doi:10.1080/02791072.2024.2313684}.
\item Tunstad PA, Kvam TM, Uthaug MV, Stewart LH, Andersen KAA, Grønnerød C (2025). \textit{Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2025.1556299}{doi:10.3389/fphar.2025.1556299}.
\item Dorval M, Chang SL, Farzin H, Nguyen O, Stephan JF, Tapp D, Deschamps P, Joly Y, Moureaux F, Foxman R, Masse-Grenier M, Fallu JS, P3A Research Group (2025). \textit{Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care.}. Palliative medicine reports. [published; PubMed]. \href{https://doi.org/10.1089/pmr.2024.0108}{doi:10.1089/pmr.2024.0108}.
\item Williams ML, Rudin D, Schmid Y, von Salm J (2025). \textit{Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1600812}{doi:10.3389/fpsyt.2025.1600812}.
\item Metastasio A, Prevete E, Venturini S, Garofalo A, Cecconello B, De Pisapia N, Corazza O (2025). \textit{The phenomenology of psilocybin: transformative insights for research and clinical practice.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2025.1455902}{doi:10.3389/fpsyg.2025.1455902}.
\item Dwyer J, Johnston RB, O'Callaghan C, Kallianis V, Ross ML (2025). \textit{Music as a collaborating actor: new insights into the nature and role of music in psychedelic-assisted psychotherapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1541528}{doi:10.3389/fpsyt.2025.1541528}.
\item Mauney E, King F, Burton-Murray H, Kuo B (2025). \textit{Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.}. Journal of clinical gastroenterology. [published; PubMed]. \href{https://doi.org/10.1097/mcg.0000000000002149}{doi:10.1097/mcg.0000000000002149}.
\item Neitzke-Spruill L, Beit CS, Robinson JO, Singh N, Kambala S, Ramesh R, McGuire AL (2025). \textit{A landscape analysis of psychedelic retreat organizations advertising online.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0321648}{doi:10.1371/journal.pone.0321648}.
\item Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B (2025). \textit{A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0318343}{doi:10.1371/journal.pone.0318343}.
\item Jones G (2025). \textit{Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorder.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0321461}{doi:10.1371/journal.pone.0321461}.
\item Hooper JF, Gyongyosi EL, Hutchison KE, Mueller RL (2025). \textit{Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2025.1533055}{doi:10.3389/fpsyg.2025.1533055}.
\item Gao JL, Wu XP, Zhou YL, Yu WJ, Fan YG (2025). \textit{Additions to the sect. (Agaricales) in China: new species from tropical rainforests, new geographical distributions, and toxin detection.}. Frontiers in microbiology. [published; PubMed]. \href{https://doi.org/10.3389/fmicb.2025.1540570}{doi:10.3389/fmicb.2025.1540570}.
\item Ross BM (2025). \textit{Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence.}. Frontiers in artificial intelligence. [published; PubMed]. \href{https://doi.org/10.3389/frai.2025.1589086}{doi:10.3389/frai.2025.1589086}.
\item Roseby W, Kettner H, Roseman L, Spriggs MJ, Lyons T, Peill J, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris RL (2025). \textit{Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2025.1580663}{doi:10.3389/fpsyg.2025.1580663}.
\item Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J (2025). \textit{Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251342319}{doi:10.1177/20451253251342319}.
\item De Gasperi R, Perez Garcia G, Gama Sosa MA, Perez GM, Abutarboush R, Kawoos U, Hof PR, Zhu CW, Ahlers ST, Elder GA (2025). \textit{Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure.}. Frontiers in neurology. [published; PubMed]. \href{https://doi.org/10.3389/fneur.2025.1594335}{doi:10.3389/fneur.2025.1594335}.
\item Marek J, Domek-Gumprecht M, Macionga A, Szafoni S, Więckiewicz G (2025). \textit{PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1591658}{doi:10.3389/fpsyt.2025.1591658}.
\item Nayak SM, White SH, Hilbert SN, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB (2025). \textit{Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2346130}{doi:10.1080/02791072.2024.2346130}.
\item Barnett BS, Koons CJ, Van den Eynde V, Gillman PK, Bodkin JA (2025). \textit{Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2368617}{doi:10.1080/02791072.2024.2368617}.
\item Beneš M, Páleníček T, Horáček J (2025). \textit{What fMRI studies say about the nature of the psychedelic effect: a scoping review.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2025.1606798}{doi:10.3389/fnins.2025.1606798}.
\item Liechti ME, Gasser P, Aicher HD, Mueller F, Hawrot T, Schmid Y (2025). \textit{Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2025.105525}{doi:10.1016/j.nsa.2025.105525}.
\item Małgorzata W, Kopczyk R, Gerlach A, Rymaszewska J (2025). \textit{Therapeutic and legal aspects of psilocybin in cancer-related depression.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1591864}{doi:10.3389/fpsyt.2025.1591864}.
\item Adeyinka D, Forsyth D, Currie S, Faraone N (2025). \textit{Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models.}. Frontiers in systems neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnsys.2025.1585367}{doi:10.3389/fnsys.2025.1585367}.
\item Blest-Hopley G, Pasculli G, Ruffell SGD, Tsang W, Emmanuel O, Pate KM, Kettner H, Roseman L, Erritzoe D, Carhart-Harris R (2025). \textit{Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1594307}{doi:10.3389/fpsyt.2025.1594307}.
\item Bhave A (2025). \textit{Magic of the Mushrooms: Effects of Psilocybin Decriminalization.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2376755}{doi:10.1080/02791072.2024.2376755}.
\item Thaoboonruang N, Lohitnavy M, Lohitnavy O (2025). \textit{Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (): A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2399128}{doi:10.1080/02791072.2024.2399128}.
\item Ludbrook G, Bryson N, Taylor B, Hocevar-Trnka J, Johnson MW, Hirman J, Morrish G, Alexander R, Pollack M (2025). \textit{Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000002047}{doi:10.1097/jcp.0000000000002047}.
\item Hultgren J, Hafsteinsson MH, Brulin JG (2025). \textit{A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy.}. General hospital psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.genhosppsych.2025.07.020}{doi:10.1016/j.genhosppsych.2025.07.020}.
\item Ross ML, Iyer R, Williams ML, Boughey M, O'Callaghan C, Hiscock R, Dwyer J (2025). \textit{Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial.}. General hospital psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.genhosppsych.2025.08.001}{doi:10.1016/j.genhosppsych.2025.08.001}.
\item Moreno-Chaparro J, Castañeda-Millán G, Eslava Schmalbach J (2025). \textit{Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review.}. Clinical neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1097/wnf.0000000000000653}{doi:10.1097/wnf.0000000000000653}.
\item Mikellides G, Kyriazis M (2025). \textit{Psychedelics and mental health: reimagining care through science, insight, and compassion.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2025.1649929}{doi:10.3389/fphar.2025.1649929}.
\item Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI (2025). \textit{Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251372449}{doi:10.1177/20451253251372449}.
\item Wierzbicka M, Kopczyk R, Gerlach A, Rymaszewska J (2025). \textit{Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1698185}{doi:10.3389/fpsyt.2025.1698185}.
\item Hooper JF, Ellingson JM, Hutchison KE (2025). \textit{Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2025.1648968}{doi:10.3389/fpsyg.2025.1648968}.
\item Alhaj HA, Samara J, Alnamous A, Karima R, Saber-Ayad M (2025). \textit{Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2025.1651898}{doi:10.3389/fphar.2025.1651898}.
\item Cheung K, Propes C, Graziosi M, Patch K, Yaden DB (2025). \textit{Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.}. AJOB empirical bioethics. [published; PubMed]. \href{https://doi.org/10.1080/23294515.2025.2526339}{doi:10.1080/23294515.2025.2526339}.
\item Meikle S, Carter O, Liknaitzky P, Johansen L, Iyer R, Strauss N, Williams M, Castle D, Rossell SL (2025). \textit{Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251377187}{doi:10.1177/20451253251377187}.
\item Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI (2025). \textit{Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251384513}{doi:10.1177/20451253251384513}.
\item Burmeister JR, Jung JK (2025). \textit{High Risk, Low Key: The New Face of Drug Use.}. Substance use: research and treatment. [published; PubMed]. \href{https://doi.org/10.1177/29768357251389682}{doi:10.1177/29768357251389682}.
\item Glynos NG, Baker A, Aday JS, Pouyan N, Barron J, Herberholz M, Kruger D, Boehnke KF (2025). \textit{Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2024.2405685}{doi:10.1080/02791072.2024.2405685}.
\item Havlik JL, Isaac S, Raman P, Tran N, Hidalgo K, Suppes T (2025). \textit{Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000002095}{doi:10.1097/jcp.0000000000002095}.
\item Ostuni S, Voto P, Birkebak J, Meyer MGE, Geurin Z, Slot JC (2025). \textit{: A new species from central Florida, with notes on and.}. Mycologia. [published; PubMed]. \href{https://doi.org/10.1080/00275514.2025.2552612}{doi:10.1080/00275514.2025.2552612}.
\item Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders J, Ljuslin M, Guérin B, Sholevar R, Roddy K, Tulsky JA, Agrawal M (2025). \textit{Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.}. General hospital psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.genhosppsych.2025.10.010}{doi:10.1016/j.genhosppsych.2025.10.010}.
\item McHerron D, Barber M, Ham R, Liknaitzky P, Carter A, Gardner J (2025). \textit{The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251377191}{doi:10.1177/20451253251377191}.
\item Machado T, Rodrigues ASL, Costa J (2025). \textit{Comment on: Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251397590}{doi:10.1177/20451253251397590}.
\item Dodds C, Dawson R, Lim A, Tye S, Nasrallah F (2025). \textit{Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251396255}{doi:10.1177/20451253251396255}.
\item Ching THW, Stahnke B, Shnayder S, Agin-Liebes G, Adams TG, Amoroso L, Baiz O, Belser A, Bohner C, Burke M, D'Amico E, DePalmer G, Eilbott J, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Purohit P, Schaer H, Sierra YP, Witherow C, Pittenger C, Kelmendi B (2025). \textit{Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1726818}{doi:10.3389/fpsyt.2025.1726818}.
\item Afsharnia S, Liang V, Lunsky Y, Orsini AP, Tint A, Lin HY (2025). \textit{Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey.}. PLOS mental health. [published; PubMed]. \href{https://doi.org/10.1371/journal.pmen.0000514}{doi:10.1371/journal.pmen.0000514}.
\item Sobieraj J, Sleziak J, Szyszka M, Błażejewska M, Łukańko K, Soczomska P, Bodziony K, Piotrowski P (2025). \textit{Self-administered complementary and alternative methods of treating mental disorders among students in Wrocław: a cross-sectional study.}. Frontiers in public health. [published; PubMed]. \href{https://doi.org/10.3389/fpubh.2025.1734137}{doi:10.3389/fpubh.2025.1734137}.
\item Zafar RR, Kleine P, Kurtin D, Wall M, Erritzoe D (2025). \textit{High hopes? Precision psychedelic addiction medicine.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1681795}{doi:10.3389/fpsyt.2025.1681795}.
\item Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly (2024). \textit{Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse}. Saudi Journal of Medicine and Public Health. [published; OpenAlex]. \href{https://doi.org/10.64483/20251153}{doi:10.64483/20251153}.
\item Mohammad Ali, Urbah Viqar (2024). \textit{Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy}. Annals of Punjab Medical College. [published; OpenAlex]. \href{https://doi.org/10.29054/apmc/2024.1658}{doi:10.29054/apmc/2024.1658}.
\item Godinho de Oliveira, Elisabete (2024). \textit{Psilocybin-containing mushrooms as a prospective therapeutic for Parkinson’s disease. Pre-clinical study}. Southern Cross Research Portal (Southern Cross University). [published; OpenAlex]. \href{https://doi.org/10.25918/thesis.558}{doi:10.25918/thesis.558}.
\item Muniz, John Marco D.F. (2024). \textit{Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration}. Journal of International Crisis and Risk Communication Research. [published; OpenAlex]. \href{https://stars.library.ucf.edu/hut2024/268}{source link}.
\item Maud, Kaitlin (2024). \textit{Use Cases for Art Therapy Intervention in Clinical Psychedelic Praxis}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.25768866.v2}{doi:10.6084/m9.figshare.25768866.v2}.
\item Emma Cinotti (2024). \textit{Political Attitudes towards the Legalization of Cannabis and Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.5258746}{doi:10.2139/ssrn.5258746}.
\item Leistenschneider G, Majić T, Reiche S, Riemer TG (2024). \textit{Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-82216-x}{doi:10.1038/s41598-024-82216-x}.
\item Volodymyr V. Tkach, Tetiana V. Morozova, Marta V. Kushnir, Sílvio C. de Oliveira, Viktor V. Kryvetskyi, Inna I. Kryvetska, Igor V. Kryvetskyi, Igor G. Biryuk, Tetiana B. Sykyrytska, Yana G. Ivanushko, Alla V. Velyka, Petro I. Yagodynets, Adriano O. da Silva, Jarem R. Garcia, José Inácio Ferrão da Paiva Martins, Gennadii F. Tkach, Oleg P. Melnyk, Oleksii O. Melnyk, Maria V. Melnyk, Maria João Monteiro, Lilia O. Nikitchenko, Iryna G. Patseva, Vitalina Lukyanova, Liudmyla Mohelnytska (2024). \textit{Theoretical Description for Psilocin and Coprine Electrochemical Determination in Mushroom Pulp and Biological Liquids over Cobalt (II) Oxyhydroxide-Modified Electrode}. Letters in Applied NanoBioScience. [published; Crossref]. \href{https://doi.org/10.33263/lianbs134.173}{doi:10.33263/lianbs134.173}.
\item Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G (2024). \textit{Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.}. Deutsches Arzteblatt international. [published; PubMed]. \href{https://doi.org/10.3238/arztebl.m2024.0224}{doi:10.3238/arztebl.m2024.0224}.
\item Koning E, Chaves C, Kirkpatrick RH, Brietzke E (2024). \textit{Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01185-8}{doi:10.1186/s40337-024-01185-8}.
\item Vohryzek J, Garcia Guzman E, Kringelbach ML, Lopez-Sola E, Timmermann C, Roseman L, Tagliazucchi E, Ruffini G, Carhart-Harris R, Deco G, Sanz Perl Y. (2024). \textit{Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.21.629922}{doi:10.1101/2024.12.21.629922}.
\item García-Cabrerizo R, Beruete-Fresnillo I, García-Fuster MJ. (2024). \textit{Characterizing psilocybin as an antidepressant for adolescence in male and female rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.20.629571}{doi:10.1101/2024.12.20.629571}.
\item Lodetti G, de Bitencourt RM, Rico EP (2024). \textit{Classic psychedelics and the treatment for alcoholism.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2024.111129}{doi:10.1016/j.pnpbp.2024.111129}.
\item Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD. (2024). \textit{Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.16.628764}{doi:10.1101/2024.12.16.628764}.
\item Gitte Moos Knudsen (2024). \textit{The Neurobiological Effect of 5-HT2AR Modulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03289949}{source link}.
\item Christina M. Andrews, Wayne Hall, Keith Humphreys, John Marsden (2024). \textit{Disentangling debate about therapeutic and recreational use of psychedelics}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16744}{doi:10.1111/add.16744}.
\item Purple RJ, Gupta R, Thomas CW, Golden CT, Froudist-Walsh S, Jones MW. (2024). \textit{Short- and long-term reconfiguration of rat prefrontal cortical networks following single doses of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.10.627734}{doi:10.1101/2024.12.10.627734}.
\item Schonholz SM, Appel JM, Bursztajn HJ, Nair M, MacIntyre MR (2024). \textit{Legal and Ethics Concerns of Psilocybin as Medicine.}. The journal of the American Academy of Psychiatry and the Law. [published; PubMed]. \href{https://doi.org/10.29158/jaapl.240089-24}{doi:10.29158/jaapl.240089-24}.
\item Kargbo RB (2024). \textit{Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.4c00519}{doi:10.1021/acsmedchemlett.4c00519}.
\item Kargbo Robert B. (2024). \textit{Advanced Delivery Systems and Novel Psilocin Derivatives for Enhanced Therapeutic Applications}. ACS Medicinal Chemistry Letters. [published; Crossref]. \href{https://doi.org/10.1021/acsmedchemlett.4c00521}{doi:10.1021/acsmedchemlett.4c00521}.
\item Wahba M, Hayes C, Kletter M, McAllister-Williams RH (2024). \textit{Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2024.768}{doi:10.1192/bjo.2024.768}.
\item Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick (2024). \textit{Chronic pain education: past, present, and future of psychedelics for the management of chronic pain}. Pain Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/pm/pnae124}{doi:10.1093/pm/pnae124}.
\item Yumin Kim, Rachel Bigley, Aubrey DeVinney, Paul S. Nestadt (2024). \textit{The many faces of psilocybin-related psychosis: A case series}. Psychiatry Research Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psycr.2024.100243}{doi:10.1016/j.psycr.2024.100243}.
\item COMPASS Pathways (2024). \textit{Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05481736}{source link}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML (2024). \textit{Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-024-03187-1}{doi:10.1038/s41398-024-03187-1}.
\item Hudspeth J, Rogge K, Wagner T, Müll M, Hoffmeister D, Rupp B, Werten S (2024). \textit{The Second Methylation in Psilocybin Biosynthesis Is Enabled by a Hydrogen Bonding Network Extending into the Secondary Sphere Surrounding the Methyltransferase Active Site.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202400497}{doi:10.1002/cbic.202400497}.
\item Enriquez-Geppert S, Krc J, O'Higgins FJ, Lietz M (2024). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study.}. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. [published; PubMed]. \href{https://doi.org/10.1098/rstb.2023.0095}{doi:10.1098/rstb.2023.0095}.
\item Back AL, Freeman-Young TK, Morgan L, Sethi T, Baker KK, Myers S, McGregor BA, Harvey K, Tai M, Kollefrath A, Thomas BJ, Sorta D, Kaelen M, Kelmendi B, Gooley TA (2024). \textit{Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2024.49026}{doi:10.1001/jamanetworkopen.2024.49026}.
\item Shabir Kanwal (2024). \textit{Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence}. Premier Journal of Science. [published; Crossref]. \href{https://doi.org/10.70389/pjs.100036}{doi:10.70389/pjs.100036}.
\item Eline Pottie, G.C. Glatfelter, M.H. Baumann, Christophe P. Stove (2024). \textit{Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2023.100109}{doi:10.1016/j.etdah.2023.100109}.
\item Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M. P. Singh, Manchala Raghunath (2024). \textit{Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related Dementia}. Alzheimer s \& Dementia. [published; OpenAlex]. \href{https://doi.org/10.1002/alz.084413}{doi:10.1002/alz.084413}.
\item Juan Scuro (2024). \textit{God hasn’t died, it has merely been encapsulated - Psilocybin and ayahuasca in the psychedelic renaissance: Intersections between religion, indigenous cosmologies, spirituality, and science}. Social Compass. [published; OpenAlex]. \href{https://doi.org/10.1177/00377686241301923}{doi:10.1177/00377686241301923}.
\item Jeffrey JK, Weintraub MJ, Grob CS (2024). \textit{Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.}. Journal of the American Academy of Child and Adolescent Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.jaac.2024.03.021}{doi:10.1016/j.jaac.2024.03.021}.
\item Hinkle JT, Graziosi M, Nayak SM, Yaden DB (2024). \textit{Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2024.2546}{doi:10.1001/jamapsychiatry.2024.2546}.
\item Li G, Facchini PJ (2024). \textit{New frontiers in the biosynthesis of psychoactive specialized metabolites.}. Current opinion in plant biology. [published; PubMed]. \href{https://doi.org/10.1016/j.pbi.2024.102626}{doi:10.1016/j.pbi.2024.102626}.
\item Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S (2024). \textit{Exploring the regulatory framework of psychedelics in the US \& Europe.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2024.104242}{doi:10.1016/j.ajp.2024.104242}.
\item Werle I, Bertoglio LJ (2024). \textit{Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2024.105899}{doi:10.1016/j.neubiorev.2024.105899}.
\item Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V (2024). \textit{Impact of psilocybin on cognitive function: A systematic review.}. Psychiatry and clinical neurosciences. [published; PubMed]. \href{https://doi.org/10.1111/pcn.13741}{doi:10.1111/pcn.13741}.
\item Szpręgiel I, Bysiek A (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item Marwood L, Croal M, Mistry S, Simmons H, Tsai J, Young MB, Goodwin GM (2024). \textit{The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2024.10.009}{doi:10.1016/j.jpsychires.2024.10.009}.
\item Collins HM (2024). \textit{Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyae057}{doi:10.1093/ijnp/pyae057}.
\item de Jonge D, van der Meer PB, Kramers C, Schellekens A (2024). \textit{Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-024-01567-4}{doi:10.1007/s11920-024-01567-4}.
\item Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A (2024). \textit{The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852924002268}{doi:10.1017/s1092852924002268}.
\item Fradet M, Kelly CM, Donnelly AJ, Suppes T (2024). \textit{Psilocybin and hallucinogenic mushrooms.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852924002487}{doi:10.1017/s1092852924002487}.
\item Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB (2024). \textit{Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2024.2357668}{doi:10.1080/09540261.2024.2357668}.
\item Back A, Myers S, Guy J, Perez J, Lazar Thorn L, McGregor B (2024). \textit{Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0069}{doi:10.1089/psymed.2023.0069}.
\item Piercey CJ, Gray B, Sung A, Henry D, Karoly HC (2024). \textit{Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0052}{doi:10.1089/psymed.2023.0052}.
\item Terao I, Kodama W (2024). \textit{Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.}. PCN reports: psychiatry and clinical neurosciences. [published; PubMed]. \href{https://doi.org/10.1002/pcn5.70042}{doi:10.1002/pcn5.70042}.
\item Arman Fard, Allison Cohen (2024). \textit{Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings}. Journal of Student Research. [published; OpenAlex]. \href{https://doi.org/10.47611/jsrhs.v13i4.7602}{doi:10.47611/jsrhs.v13i4.7602}.
\item George Tewfik, Adejuyigbe Adaralegbe, Sangel Gomez, Rania Aziz, Faraz Chaudhry, Daniel Rodriguez-Correa, Dorisanne O. Adaralegbe (2024). \textit{Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implications}. Trends in Anaesthesia and Critical Care. [published; OpenAlex]. \href{https://doi.org/10.1016/j.tacc.2024.101514}{doi:10.1016/j.tacc.2024.101514}.
\item Morris SL (2024). \textit{A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient.}. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.9758/cpn.24.1180}{doi:10.9758/cpn.24.1180}.
\item Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B. (2024). \textit{Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.28.625811}{doi:10.1101/2024.11.28.625811}.
\item Ande Bagdasarian, Kristian Larsen, Patrick M. Fisher, Hanne D. Hansen, Hsiao-Ying Wey (2024). \textit{Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human Primates}. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition. [published; OpenAlex]. \href{https://doi.org/10.58530/2024/1133}{doi:10.58530/2024/1133}.
\item Adams DR, Allen H, Nicol GE, Cabassa LJ (2024). \textit{Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.}. Translational behavioral medicine. [published; PubMed]. \href{https://doi.org/10.1093/tbm/ibae053}{doi:10.1093/tbm/ibae053}.
\item Aboharb F, Davoudian PA, Shao LX, Liao C, Rzepka GN, Wojtasiewicz C, Indajang J, Dibbs M, Rondeau J, Sherwood AM, Kaye AP, Kwan AC (2024). \textit{Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.05.23.590306}{doi:10.1101/2024.05.23.590306}.
\item Jaime Rojas-Hernández, Lucas F. Borkel, Domingo Jesús Quintana Hernández, Ángelo Santana del Pino, Luis Alberto Henríquez-Hernández (2024). \textit{Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)}. Current Psychology. [published; OpenAlex]. \href{https://doi.org/10.1007/s12144-024-07017-x}{doi:10.1007/s12144-024-07017-x}.
\item Wood MJ, McAlpine RG, Kamboj SK (2024). \textit{Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-79931-w}{doi:10.1038/s41598-024-79931-w}.
\item Yale University (2024). \textit{Psilocybin Treatment in Obsessive-Compulsive Disorder: a Preliminary Efficacy Study and Exploratory Investigation of Neural Correlates.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03356483}{source link}.
\item TRYP Therapeutics (2024). \textit{A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05035927}{source link}.
\item Raj Nashikkar, Kavita Mane, Rajendra Patil (2024). \textit{Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials}. International Journal for Research in Applied Science and Engineering Technology. [published; OpenAlex]. \href{https://doi.org/10.22214/ijraset.2024.65160}{doi:10.22214/ijraset.2024.65160}.
\item Wang E, Mathai DS, Gukasyan N, Nayak S, Garcia-Romeu A (2024). \textit{Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-78736-1}{doi:10.1038/s41598-024-78736-1}.
\item Kargbo RB (2024). \textit{Expanding the Therapeutic Horizons of Psilocybin in Mental Health.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.4c00488}{doi:10.1021/acsmedchemlett.4c00488}.
\item Padawer-Curry JA, Krentzman OJ, Kuo CC, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ (2024). \textit{Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.09.23.559145}{doi:10.1101/2023.09.23.559145}.
\item University of Utah (2024). \textit{PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05557643}{source link}.
\item Stéphanie Knatz Peck, Hannah M. Fisher, Jessie Kim, Samantha Shao, Julie Trim, Walter H. Kaye (2024). \textit{Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024e.0034}{doi:10.61373/pp024e.0034}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h}{doi:10.31234/osf.io/93x5h}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v1}{doi:10.31234/osf.io/93x5h\_v1}.
\item Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2024). \textit{Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.06.622302}{doi:10.1101/2024.11.06.622302}.
\item Gribben A, Burke T, Harrington C, Husein A, Murnane KS, Hendricks PS, Tobin K, Ivers JH, Thuery G, Harkin A, Kelly JR (2024). \textit{Amid magic and menace: psychiatrists' attitudes to psilocybin therapy.}. Irish journal of psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/ipm.2024.49}{doi:10.1017/ipm.2024.49}.
\item Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak (2024). \textit{Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1485337}{doi:10.3389/fpsyt.2024.1485337}.
\item Imperial College London (2024). \textit{PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06258031}{source link}.
\item Valdez T, Patel V, Senesombath N, Hatahet-Donovan Z, Hornick M (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph17111484}{doi:10.3390/ph17111484}.
\item Aday JS, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Harte SE, Pouyan N, Glynos NG, Baker AK, Guss J, Davis AK, Burgess HJ, Mashour GA, Clauw DJ, Boehnke KF. (2024). \textit{Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/j8zb5}{doi:10.31234/osf.io/j8zb5}.
\item Jeanblanc J, Bordy R, Fouquet G, Jeanblanc V, Naassila M (2024). \textit{Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats.}. Brain: a journal of neurology. [published; PubMed]. \href{https://doi.org/10.1093/brain/awae136}{doi:10.1093/brain/awae136}.
\item Swanson LR, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson JL, Schallmo MP (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial.}. Journal of vision. [published; PubMed]. \href{https://doi.org/10.1167/jov.24.12.5}{doi:10.1167/jov.24.12.5}.
\item Jacob S. Aday, Jenna McAfee, Deirdre A. Conroy, Avinash Hosanagar, Vijay Tarnal, Cody Weston, Katharine Scott, Dana Horowitz, Steven E. Harte, Niloufar Pouyan (2024). \textit{Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/j8zb5\_v1}{source link}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC (2024). \textit{Pyramidal cell types and 5-HT receptors are essential for psilocybin's lasting drug action.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.11.02.621692}{doi:10.1101/2024.11.02.621692}.
\item Emese Prandovszky O’Donnell, Zachary A. Cordner, Hua Liu, Shuojia Yang, Lindsey Macias, Kellie L. Tamashiro, Frederick S. Barrett, Robert H. Yolken (2024). \textit{Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical models}. Brain Behavior and Immunity. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbi.2024.12.146}{doi:10.1016/j.bbi.2024.12.146}.
\item Lamia Özgör (2024). \textit{Psilocybin-unterstützte Psychotherapie reduziert Ängste und Depressionen}. InFo Hämatologie + Onkologie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15004-024-0785-9}{doi:10.1007/s15004-024-0785-9}.
\item Jonathan Westover (2024). \textit{Will Psychedelics Propel Your Career? Exploring the Potential Impact of Psychedelics on Work, Productivity and Well-Being}. Human capital leadership.. [published; OpenAlex]. \href{https://doi.org/10.70175/hclreview.2020.14.4.14}{doi:10.70175/hclreview.2020.14.4.14}.
\item D Silva, Antônio Carlos Pereira de Menezes Filho, Aurélio Ferreira Melo, Porshia Sharma, Tullyo Henrique Lima Machado, Vanêcia Oliveira Cunha Machado, Matheus Vinícius Abadia Ventura (2024). \textit{Phytochemical screening, phenolic and flavonoid contents, psilocybin, antioxidant, and acetylcholinesterase inhibition activities of the aqueous extract from the fungi Cyathus striatus, Laternea dringii, and Marasmius haematocephalus}. Brazilian Journal of Science. [published; OpenAlex]. \href{https://doi.org/10.14295/bjs.v3i11.694}{doi:10.14295/bjs.v3i11.694}.
\item Keeler JL, Kan C, Treasure J, Himmerich H (2024). \textit{Novel treatments for anorexia nervosa: Insights from neuroplasticity research.}. European eating disorders review: the journal of the Eating Disorders Association. [published; PubMed]. \href{https://doi.org/10.1002/erv.3039}{doi:10.1002/erv.3039}.
\item Kim A, Halton B, Shah A, Seecof OM, Ross S (2024). \textit{Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.}. Annals of palliative medicine. [published; PubMed]. \href{https://doi.org/10.21037/apm-24-35}{doi:10.21037/apm-24-35}.
\item Pohořalá V, Kuchař M, Spanagel R, Bernardi RE (2024). \textit{Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice.}. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroscience.2024.09.006}{doi:10.1016/j.neuroscience.2024.09.006}.
\item Anderson K, Elf P, Isham A (2024). \textit{Psychedelics as a tool for a more connected and sustainable world? Considering the importance of rituals, boundaries, and commitment.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2024.104571}{doi:10.1016/j.drugpo.2024.104571}.
\item Zhen Z, Sun X, Yuan S, Zhang J (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Gartner HT, Wan HZ, Simmons RE, Sollee DR, Sheikh S (2024). \textit{Psychedelic mushroom-containing chocolate exposures: Case series.}. The American journal of emergency medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.ajem.2024.09.038}{doi:10.1016/j.ajem.2024.09.038}.
\item Ivan VE, Tomàs-Cuesta DP, Esteves IM, Luczak A, Mohajerani M, McNaughton BL, Gruber AJ (2024). \textit{Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex.}. The European journal of neuroscience. [published; PubMed]. \href{https://doi.org/10.1111/ejn.16558}{doi:10.1111/ejn.16558}.
\item Imperio CG, Levin FR, Martinez D (2024). \textit{The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20231023}{doi:10.1176/appi.ajp.20231023}.
\item Janevska S, Weiser S, Huang Y, Lin J, Hoefgen S, Jojić K, Barber AE, Schäfer T, Fricke J, Hoffmeister D, Regestein L, Valiante V, Kufs JE (2024). \textit{Optimized psilocybin production in tryptophan catabolism-repressed fungi.}. Microbial biotechnology. [published; PubMed]. \href{https://doi.org/10.1111/1751-7915.70039}{doi:10.1111/1751-7915.70039}.
\item Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R (2024). \textit{Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-024-01539-8}{doi:10.1007/s11920-024-01539-8}.
\item Forte V, Shaughnessy AF, Kurotschka PK (2024). \textit{[Depression and effectiveness of psychedelics: high-dose psilocybin has shown benefits in improving symptoms.].}. Recenti progressi in medicina. [published; PubMed]. \href{https://doi.org/10.1701/4365.43590}{doi:10.1701/4365.43590}.
\item Petridis PD, Grinband J, Agin-Liebes G, Kinslow CJ, Zeifman RJ, Bogenschutz MP, Griffiths RR, Ross S (2024). \textit{Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.}. Nature. Mental health. [published; PubMed]. \href{https://doi.org/10.1038/s44220-024-00331-0}{doi:10.1038/s44220-024-00331-0}.
\item Holikulov Utkirjon, Kazachenko Aleksandr S., Issaoui Noureddine, Kazachenko Anna S., Raja Murugesan, Al-Dossary Omar M., Xiang Zhouyang (2024). \textit{The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocin}. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. [published; Crossref]. \href{https://doi.org/10.1016/j.saa.2024.124600}{doi:10.1016/j.saa.2024.124600}.
\item Luoma JB, Wilson-Poe A, Pertl K, Hoffman K, Bazinet A, Stauffer C, McCarty D, Korthuis P. (2024). \textit{Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dwhcu\_v1}{doi:10.31234/osf.io/dwhcu\_v1}.
\item Wahba M, Hayes C, Kletter M, McAllister-Williams RH (2024). \textit{Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: Case report and thematic analysis of one participant's experience}. BJPsych Open. [published; OpenAlex]. \href{https://openalex.org/W7139416359}{source link}.
\item Jason Luoma, Adie Wilson-Poe, Kellie Pertl, Kim Hoffman, Alissa Bazinet, Christopher Stauffer, Dennis McCarty, Philip Korthuis (2024). \textit{Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dwhcu\_v1}{source link}.
\item Filament Health Corp. (2024). \textit{A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06666010}{source link}.
\item Pamela Kryskow, Paul Stamets, Joseph La Torre, Kathy Sattler, Vivian W. L. Tsang, Monnica T. Williams (2024). \textit{“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00379}{doi:10.1556/2054.2024.00379}.
\item Wiens Kennedy R., Brooks Noah A. H., Riar Ishvin, Greuel Bridget K., Lindhout Ivan A., Klegeris Andis (2024). \textit{Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner}. Molecules. [published; Crossref]. \href{https://doi.org/10.3390/molecules29215084}{doi:10.3390/molecules29215084}.
\item Imperial College London (2024). \textit{Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03429075}{source link}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2024). \textit{Psilocybin Reduces Grooming in the SAPAP3 Knockout Mouse Model of Compulsive Behaviour}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.23.619763}{doi:10.1101/2024.10.23.619763}.
\item Perez Rosal SR, La Torre JT, Birnkammer S, Chernoloz O, Williams MT, Faber SC (2024). \textit{Expert recommendations for Germany's integration of psychedelic-assisted therapy.}. BMC medical education. [published; PubMed]. \href{https://doi.org/10.1186/s12909-024-06141-3}{doi:10.1186/s12909-024-06141-3}.
\item Mott, Sarah E., Clyde W. Hodge, Jessica L. Hoffman, Maria Echeveste Sanchez, Christian S. Rollison, Margaret W. High, Devin P. Effinger, Melissa A. Herman, Sarah N. Magee, Daniel Toedt, Sema G. Quadir (2024). \textit{Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/kg31-1v38}{doi:10.17615/kg31-1v38}.
\item Majic T, Schmidt TT, Gröticke A, Gasser P, Richards WA, Riemer TG, Evens R. (2024). \textit{The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/s6bzc}{doi:10.31234/osf.io/s6bzc}.
\item Mallaroni P, Singleton P, Mason NL, Satterthwaite TD, Ramaekers JG. (2024). \textit{The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.22.619393}{doi:10.1101/2024.10.22.619393}.
\item Tomislav Majic, Timo Torsten Schmidt, Anna Gröticke, Peter Gasser, William A Richards, Thomas Günther Riemer, Ricarda Evens (2024). \textit{The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/s6bzc\_v1}{source link}.
\item Fleury S, Nautiyal KM. (2024). \textit{The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.18.618582}{doi:10.1101/2024.10.18.618582}.
\item Hooper J, Gyongyosi E, Hutchison K, Mueller R. (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u9yeg\_v1}{doi:10.31234/osf.io/u9yeg\_v1}.
\item Hooper J, Gyongyosi E, Hutchison K, Mueller R. (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u9yeg}{doi:10.31234/osf.io/u9yeg}.
\item Jake Hooper, Emily Gyongyosi, Kent Hutchison, Raeghan Mueller (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/u9yeg\_v1}{source link}.
\item Olami A, Peled-Avron L (2024). \textit{Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-74810-w}{doi:10.1038/s41598-024-74810-w}.
\item Valdez T, Patel V, Senesombath D, Hatahet-Donovan Z, Hornick MG. (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202410.1406.v1}{doi:10.20944/preprints202410.1406.v1}.
\item Ivy Fitzsimons, Andrew J. Moore, Sara Jo Nixon (2024). \textit{An Early Exploration into Individuals in Treatment Who Co-Use Alcohol and Hallucinogens}. UF Journal of Undergraduate Research. [published; OpenAlex]. \href{https://doi.org/10.32473/ufjur.26.135357}{doi:10.32473/ufjur.26.135357}.
\item Danica E. Johnson, Joshua D. Rosenblat (2024). \textit{Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional properties}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-024-00332-z}{doi:10.1038/s44220-024-00332-z}.
\item Lyons T, Spriggs M, Kerkelä L, Rosas F, Roseman L, Mediano P, Timmermann C, Oestreich L, Pagni B, Zeifman R, Hampshire A, Trender W, Douglass H, Girn M, Godfrey K, Kettner H, Sharif F, Espasiano L, Gazzaley A, Wall M, Erritzoe D, Nutt D, Carhart-Harris R. (2024). \textit{Human brain changes after first psilocybin use}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.11.617955}{doi:10.1101/2024.10.11.617955}.
\item Lee J, Tantillo DJ, Wang LP, Fiehn O (2024). \textit{Impact of Protonation Sites on Collision-Induced Dissociation-MS/MS Using CIDMD Quantum Chemistry Modeling.}. Journal of chemical information and modeling. [published; PubMed]. \href{https://doi.org/10.1021/acs.jcim.4c00761}{doi:10.1021/acs.jcim.4c00761}.
\item Barnett BS. (2024). \textit{A survey investigating United States federal grant submissions proposing to investigate therapeutic applications of psychedelics}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.10.12.24315367}{doi:10.1101/2024.10.12.24315367}.
\item de la Fuente Revenga M, González-Maeso J (2024). \textit{Snapshot of 5-HT receptor activation in the mouse brain via IP detection.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.10.11.617861}{doi:10.1101/2024.10.11.617861}.
\item Hannah Douglass (2024). \textit{The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.25560/118978}{doi:10.25560/118978}.
\item Morgan Justin, Kerry Watrin (2024). \textit{Does psilocybin reduce symptoms of depression in adults with major depressive disorder or life-threatening cancer?}. Evidence-Based Practice. [published; OpenAlex]. \href{https://doi.org/10.1097/ebp.0000000000002281}{doi:10.1097/ebp.0000000000002281}.
\item James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu (2024). \textit{Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study}. Headache The Journal of Head and Face Pain. [published; OpenAlex]. \href{https://doi.org/10.1111/head.14846}{doi:10.1111/head.14846}.
\item Jesper Dunell (2024). \textit{A psilocybin haven: the use of comparison to legitimate transgression at a psychedelic retreat}. Drugs Education Prevention and Policy. [published; OpenAlex]. \href{https://doi.org/10.1080/09687637.2024.2412636}{doi:10.1080/09687637.2024.2412636}.
\item Jarrett Robert Rose (2024). \textit{Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00363}{doi:10.1556/2054.2024.00363}.
\item MycoMedica Life Sciences PBC (2024). \textit{A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06326606}{source link}.
\item Yu SJ, Wu KJ, Wang YS, Bae E, Chianelli F, Bambakidis N, Wang Y (2024). \textit{Neuroprotective effects of psilocybin in a rat model of stroke.}. BMC neuroscience. [published; PubMed]. \href{https://doi.org/10.1186/s12868-024-00903-x}{doi:10.1186/s12868-024-00903-x}.
\item Pincombe J, Williams M, Carruthers S, Rossell S. (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ga9p2}{doi:10.31234/osf.io/ga9p2}.
\item Jennifer Pincombe, Martin Williams, Sean Carruthers, Susan Rossell (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ga9p2\_v1}{source link}.
\item Dahan JDC, Dadiomov D, Bostoen T, Dahan A (2024). \textit{Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome.}. Npj mental health research. [published; PubMed]. \href{https://doi.org/10.1038/s44184-024-00091-w}{doi:10.1038/s44184-024-00091-w}.
\item Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar (2024). \textit{Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3040029}{doi:10.3390/psychoactives3040029}.
\item Daniel Spinosa, Stacy M. Fischer, Richard J. Zeifman, Carolyn Lefkowits, Petros Petridis, Stephen Ross (2024). \textit{PR012/\#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial}. International Journal of Gynecological Cancer. [published; OpenAlex]. \href{https://doi.org/10.1136/ijgc-2024-igcs.54}{doi:10.1136/ijgc-2024-igcs.54}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7}{doi:10.31234/osf.io/uxhv7}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7\_v1}{doi:10.31234/osf.io/uxhv7\_v1}.
\item Conn K, Milton LK, Huang K, Munguba H, Ruuska J, Lemus MB, Greaves E, Homman-Ludiye J, Oldfield BJ, Foldi CJ (2024). \textit{Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02575-9}{doi:10.1038/s41380-024-02575-9}.
\item Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Wells HG, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Jones JA, McMurray MS (2024). \textit{Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.16466}{doi:10.1111/bph.16466}.
\item Nadeem Z, Parker S, McGovern H, Oestreich LK (2024). \textit{Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674241261779}{doi:10.1177/00048674241261779}.
\item Doss MK, Mallaroni P, Mason NL, Ramaekers JG (2024). \textit{Psilocybin and 2C-B at Encoding Distort Episodic Familiarity.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.06.008}{doi:10.1016/j.bpsc.2024.06.008}.
\item Shakir J, Pedicini M, Bullock BC, Hoen PW, Macias LK, Freiman J, Pletnikov MV, Tamashiro KLK, Cordner ZA (2024). \textit{Effects of psilocybin on body weight, body composition, and metabolites in male and female mice.}. Physiology \& behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.physbeh.2024.114627}{doi:10.1016/j.physbeh.2024.114627}.
\item Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A (2024). \textit{Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-024-01101-3}{doi:10.1007/s40263-024-01101-3}.
\item Owe-Larsson M, Kamińska K, Buchalska B, Mirowska-Guzel D, Cudnoch-Jędrzejewska A (2024). \textit{Psilocybin in pharmacotherapy of obsessive-compulsive disorder.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-024-00633-1}{doi:10.1007/s43440-024-00633-1}.
\item Madden K, Flood B, Young Shing D, Ade-Conde M, Kashir I, Mark M, MacKillop J, Bhandari M, Adili A (2024). \textit{Psilocybin for clinical indications: A scoping review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241269751}{doi:10.1177/02698811241269751}.
\item Hovmand OR, Madsen MK, Fisher PM, Stenbæk DS (2024). \textit{Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaire.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241269669}{doi:10.1177/02698811241269669}.
\item Yang X, Kuang W (2024). \textit{Letter to editor regarding "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis".}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.116136}{doi:10.1016/j.psychres.2024.116136}.
\item Najib J (2024). \textit{The role of psilocybin in depressive disorders.}. Current medical research and opinion. [published; PubMed]. \href{https://doi.org/10.1080/03007995.2024.2396536}{doi:10.1080/03007995.2024.2396536}.
\item Savides IA, Outhoff K (2024). \textit{Less is more? A review of psilocybin microdosing.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241278769}{doi:10.1177/02698811241278769}.
\item Calder AE, Rausch B, Liechti ME, Holze F, Hasler G (2024). \textit{Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241278873}{doi:10.1177/02698811241278873}.
\item Sarris J, Halman A, Urokohara A, Lehrner M, Perkins D (2024). \textit{Artificial intelligence and psychedelic medicine.}. Annals of the New York Academy of Sciences. [published; PubMed]. \href{https://doi.org/10.1111/nyas.15229}{doi:10.1111/nyas.15229}.
\item Meling D, Egger K, Aicher HD, Jareño Redondo J, Mueller J, Dornbierer J, Temperli E, Vasella EA, Caflisch L, Pfeiffer DJ, Schlomberg JT, Smallridge JW, Dornbierer DA, Scheidegger M (2024). \textit{Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241282637}{doi:10.1177/02698811241282637}.
\item Masse-Grenier M, Chang SL, Bélanger A, Stephan JF, Hébert J, Deschamps P, Plourde L, Provost F, Farzin H, Fallu JS, Dorval M, P3A Research Group (2024). \textit{What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s1478951524001494}{doi:10.1017/s1478951524001494}.
\item Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R (2024). \textit{Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.}. EClinicalMedicine. [published; PubMed]. \href{https://doi.org/10.1016/j.eclinm.2024.102799}{doi:10.1016/j.eclinm.2024.102799}.
\item Colloca L, Fava M (2024). \textit{What should constitute a control condition in psychedelic drug trials?}. Nature. Mental health. [published; PubMed]. \href{https://doi.org/10.1038/s44220-024-00321-2}{doi:10.1038/s44220-024-00321-2}.
\item Lane CP, Tarka VM, Valentin O, Lehmann A, Hamel E, de Villers-Sidani E. (2024). \textit{Psilocybin prevents habituation to familiar stimuli and preserves sensitivity to sound following repeated stimulation in mouse primary auditory cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.27.614985}{doi:10.1101/2024.09.27.614985}.
\item Fisher EL, Smith R, Conn K, Corcoran AW, Milton LK, Hohwy J, Foldi CJ (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-024-03103-7}{doi:10.1038/s41398-024-03103-7}.
\item Lafrance A, Spriggs MJ, Gukasyan N, Peck SK (2024). \textit{Beyond the numbers: reimagining healing with psychedelics for eating disorders.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01111-y}{doi:10.1186/s40337-024-01111-y}.
\item Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros (2024). \textit{The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement}. Middle East Research Journal of Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.36348/merjbs.2024.v04i05.001}{doi:10.36348/merjbs.2024.v04i05.001}.
\item Western University, Canada (2024). \textit{The Effects of Psilocybin on Shared Experience in Film Processing}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06529939}{source link}.
\item Aleš Oblak, Liam Korošec Hudnik, Anja Levačić, Kristian Elersič, Peter Pregelj, Jurij Bon (2024). \textit{Salience, sensemaking, and setting in psilocybin microdosing: Methodological lessons and preliminary findings of a mixed method qualitative study}. Philosophical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/09515089.2024.2393690}{doi:10.1080/09515089.2024.2393690}.
\item Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P, Vollenweider F, Diaconescu A. (2024). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4492873/v1}{doi:10.21203/rs.3.rs-4492873/v1}.
\item University of California, San Francisco (2024). \textit{An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05065294}{source link}.
\item Bushra Yasin, Shivani Mehta, George Tewfik, Alex Bekker (2024). \textit{Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2024.00058}{doi:10.37349/en.2024.00058}.
\item Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF. (2024). \textit{Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.23.614626}{doi:10.1101/2024.09.23.614626}.
\item Brian L. Quick, Ethan Morrow, Sam R. Wilson, Minhey Chung, Daniel E. Hartman, Brenda Koester (2024). \textit{Psilocybin legalization in the United States and psychological reactance: A test of evidence uncertainty, controlling language, and an ambiguous call to action.}. Motivation Science. [published; OpenAlex]. \href{https://doi.org/10.1037/mot0000361}{doi:10.1037/mot0000361}.
\item Lazar M, Brownstien M, Botvinnik A, Shevakh C, Shahar O, Lifschytz T, Lerer B. (2024). \textit{Premorbid Characteristics of the SAPAP3-Mouse Model of Obsessive-Compulsive Disorder: Behavior, Neuroplasticity, and Psilocybin Treatment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.22.614317}{doi:10.1101/2024.09.22.614317}.
\item Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK, Johansen A, Stenbæk DS, Knudsen GM, Fisher PM. (2024). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.19.24313958}{doi:10.1101/2024.09.19.24313958}.
\item Askey T, Allen-Ross D, Lasrado R, Gilmour G, Hunt S, Tamagnini F, Ahmed M, Stephens G, Maiarú M. (2024). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates the gabapentin-mediated analgesia}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5026806/v1}{doi:10.21203/rs.3.rs-5026806/v1}.
\item Armstrong SB, Davis AK (2024). \textit{Psychedelic research at a crossroads.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.adt1024}{doi:10.1126/science.adt1024}.
\item University Hospital, Ghent (2024). \textit{Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06378229}{source link}.
\item Mageean S, Daniel A, Tai S. (2024). \textit{Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distress}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4862438/v1}{doi:10.21203/rs.3.rs-4862438/v1}.
\item Spoelstra SK, Schoevers RA, Venema SD, Knegtering H (2024). \textit{Psychedelics as a potential treatment for tobacco use disorder: a systematic review.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-024-00095-0}{doi:10.1007/s44192-024-00095-0}.
\item Danielle B Rodrigues (2024). \textit{Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials}. Journal of Complementary Medicine \& Alternative Healthcare. [published; OpenAlex]. \href{https://doi.org/10.19080/jcmah.2024.13.555852}{doi:10.19080/jcmah.2024.13.555852}.
\item Thomas Carroll (2024). \textit{The Psychedelic Renaissance: A Catholic Perspective}. The Linacre Quarterly. [published; OpenAlex]. \href{https://doi.org/10.1177/00243639241274818}{doi:10.1177/00243639241274818}.
\item Syed F. Rab, Charles L. Raison, Elliot Marseille (2024). \textit{An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024r.0025}{doi:10.61373/pp024r.0025}.
\item James Perry, Cara C. Young, Julie Williams (2024). \textit{B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult Populations}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acae067.222}{doi:10.1093/arclin/acae067.222}.
\item Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C (2024). \textit{Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.}. The Cochrane database of systematic reviews. [published; PubMed]. \href{https://doi.org/10.1002/14651858.cd015383.pub2}{doi:10.1002/14651858.cd015383.pub2}.
\item Kargbo RB (2024). \textit{Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.4c00412}{doi:10.1021/acsmedchemlett.4c00412}.
\item Kargbo RB (2024). \textit{Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.4c00414}{doi:10.1021/acsmedchemlett.4c00414}.
\item Alan K. Davis, Mark J. Bates, Erik M. Lund, Nathan D. Sepeda, Adam W. Levin, Stacey B. Armstrong, Robert L. Koffman, Katinka Hooyer, Rachel Yehuda (2024). \textit{The Epidemiology of Psychedelic Use Among United States Military Veterans}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2024.2401977}{doi:10.1080/02791072.2024.2401977}.
\item Nikolic M, Mediano P, Froese T, Reydellet D, Palenicek T. (2024). \textit{Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent manner}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.09.24313316}{doi:10.1101/2024.09.09.24313316}.
\item Ana Ferreira, Sharon Martindale, David Luke (2024). \textit{Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00368}{doi:10.1556/2054.2024.00368}.
\item Cynthia Duan, Navid Farkhondehpay, Viana Safa, Emma Yuan (2024). \textit{Usage of Psilocybin to Treat Huntington's Disease: A Research Protocol}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.644}{doi:10.26685/urncst.644}.
\item Megha Kodancha (2024). \textit{Psychedelic-assisted therapy: Magical thinking or a meaningful treatment for mental illness}. UCC Student Medical Journal. [published; OpenAlex]. \href{https://doi.org/10.33178/smj.2024.1.13}{doi:10.33178/smj.2024.1.13}.
\item Anna Graue, Sören Kuitunen-Paul, Henry G. Harder, Lisa Emily Richter (2024). \textit{Psilocybin-induzierte mystische Erfahrungen in subjektiven Berichten: Ein Scoping Review mit qualitativer Inhaltsanalyse.}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0044-1790396}{doi:10.1055/s-0044-1790396}.
\item Arnim Quante (2024). \textit{Einmalig Psilocybin: antidepressive Effekte}. PSYCH up2date. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2185-5208}{doi:10.1055/a-2185-5208}.
\item Albert Garcia-Romeu (2024). \textit{Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Psychedelic Medicine}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2024.65789.rfs2023}{doi:10.1089/psymed.2024.65789.rfs2023}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T (2024). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item Köhne S, Hillemacher T, Glahn A, Bach P (2024). \textit{Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.}. Expert opinion on emerging drugs. [published; PubMed]. \href{https://doi.org/10.1080/14728214.2024.2342951}{doi:10.1080/14728214.2024.2342951}.
\item Darke S, Duflou J, Peacock A, Farrell M, Hall W, Lappin J (2024). \textit{A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16518}{doi:10.1111/add.16518}.
\item Jackson ES, Goldway N, Gerlach-Houck H, Gold ND (2024). \textit{Stutterers' experiences on classic psychedelics: A preliminary self-report study.}. Journal of fluency disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jfludis.2024.106062}{doi:10.1016/j.jfludis.2024.106062}.
\item Korthuis PT, Wilson-Poe AR, Black JC, Monte A (2024). \textit{Commentary on Darke et al.: Expanded psychedelic access requires new safety monitoring systems.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16589}{doi:10.1111/add.16589}.
\item Jacobs DS, Bogachuk AP, Le Moing CL, Moghaddam B (2024). \textit{Effects of psilocybin on uncertain punishment learning.}. Neurobiology of learning and memory. [published; PubMed]. \href{https://doi.org/10.1016/j.nlm.2024.107954}{doi:10.1016/j.nlm.2024.107954}.
\item Clark MP (2024). \textit{Psilocybin: Medicine for My Soul. Relief from Emotional and Spiritual Pain as a Hospice Nurse Diagnosed with Cancer.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2024.0066}{doi:10.1089/jpm.2024.0066}.
\item Guo Q, Guo L, Wang Y, Shang S (2024). \textit{Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.116018}{doi:10.1016/j.psychres.2024.116018}.
\item Rogers J (2024). \textit{Psilocybin desynchronization persists in the human brain.}. Nature reviews. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41583-024-00854-6}{doi:10.1038/s41583-024-00854-6}.
\item Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA (2024). \textit{Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2024.107338}{doi:10.1016/j.phrs.2024.107338}.
\item Jungwirth J, Bavato F, Quednow BB (2024). \textit{[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].}. Der Nervenarzt. [published; PubMed]. \href{https://doi.org/10.1007/s00115-024-01727-0}{doi:10.1007/s00115-024-01727-0}.
\item Federico S, Geo M, Entela M, Bachmann S, Elisa R, Silvio C, Zoë D, Louise P, Gabriel T, Joël B, Daniele Z (2024). \textit{Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.}. Clinical case reports. [published; PubMed]. \href{https://doi.org/10.1002/ccr3.9305}{doi:10.1002/ccr3.9305}.
\item Treviranus GRS (2024). \textit{Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?}. Psychiatria Danubina. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/39378462/}{source link}.
\item Loizaga-Velder A, Loizaga Pazzi A (2024). \textit{Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.}. Journal of studies on alcohol and drugs. [published; PubMed]. \href{https://doi.org/10.15288/jsad.23-00011}{doi:10.15288/jsad.23-00011}.
\item Smith CL, Sackett N, Stark BC, Dinh V, Romesburg EW, Roll J (2024). \textit{Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative Analysis.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0074}{doi:10.1089/psymed.2023.0074}.
\item Jevotovsky DS, Chopra H, Wing C, Spotswood CJ, Castellanos J (2024). \textit{Refractory CRPS pain treated with psilocybin: A case report.}. Clinical case reports. [published; PubMed]. \href{https://doi.org/10.1002/ccr3.9421}{doi:10.1002/ccr3.9421}.
\item Amany E. Ayad (2024). \textit{G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?}. Ask the expert - Psychedelic substances. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2024-esra.582}{doi:10.1136/rapm-2024-esra.582}.
\item University of Arizona (2024). \textit{Psilocybin for Treatment of Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03300947}{source link}.
\item Jerry B. Brown *, Julie M. Brown (2024). \textit{Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided Imagery}. Clinical Endocrinology and Metabolism. [published; OpenAlex]. \href{https://doi.org/10.31579/2834-8761/056}{doi:10.31579/2834-8761/056}.
\item Yoo M, Sakopoulos S. (2024). \textit{The Birth of the Psychedelic Industry: Capitalizing on the Psychedelic Renaissance}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.172496618.87990987/v1}{doi:10.22541/au.172496618.87990987/v1}.
\item Charlotte Smith (2024). \textit{Psychedelics, Psychedelic-Assisted Therapy and Employees’ Wellbeing}. Journal of Management Inquiry. [published; OpenAlex]. \href{https://doi.org/10.1177/10564926241267208}{doi:10.1177/10564926241267208}.
\item Yao Y, Zhang YZ, Liang JQ, Liu F, Li ZF, Li HJ, Xu F (2024). \textit{Mushroom poisoning of Panaeolus subbalteatus from Ningxia, northwest China, with species identification and tryptamine detection.}. Toxicon: official journal of the International Society on Toxinology. [published; PubMed]. \href{https://doi.org/10.1016/j.toxicon.2024.107849}{doi:10.1016/j.toxicon.2024.107849}.
\item Tsang V. (2024). \textit{A Cohort Based Case Series: Learnings from an Iterative Group Therapy Model to Support Psilocybin-Assisted Therapy for Patients with a Terminal Diagnosis}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11860442}{source link}.
\item Tsang V, Roney C. (2024). \textit{Improving Access to Psilocybin-Assisted Therapy: Barriers, Challenges, and Recommendations}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11861878}{source link}.
\item Klučková T, Nikolič M, Tylš F, Viktorin V, Vejmola Č, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Zach P, Hájková K, Kuchař M, Balíková M, Brunovský M, Horáček J, Páleníček T. (2024). \textit{The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.08.26.24311611}{doi:10.1101/2024.08.26.24311611}.
\item Frye MA, Singh B, Breitinger SA, Oesterle TS (2024). \textit{Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse: A Cautionary Tale.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp.24cr15378}{doi:10.4088/jcp.24cr15378}.
\item Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A. (2024). \textit{­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4947184/v1}{doi:10.21203/rs.3.rs-4947184/v1}.
\item Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS (2024). \textit{Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj-2023-078607}{doi:10.1136/bmj-2023-078607}.
\item Emiliano Loria, Elisabetta Lalumera, Ambra D’Imperio (2024). \textit{Psilocybin, moralization and psychotherapy: a scoping review and a case report}. Philosophical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/09515089.2024.2389962}{doi:10.1080/09515089.2024.2389962}.
\item Doğancan Sönmez, Aslı Enzel Koç (2024). \textit{Psilocybin in the Treatment of Mental Disorders}. DergiPark (Istanbul University). [published; OpenAlex]. \href{https://doi.org/10.30708/mantar.1535344}{doi:10.30708/mantar.1535344}.
\item Jim Weil (2024). \textit{Tripping on Utopia: Margaret Mead, the Cold War, and the troubled birth of psychedelic science By BenjaminBreen. New York: Grand Central Publishing, 2024. 384 pp.}. American Anthropologist. [published; OpenAlex]. \href{https://doi.org/10.1111/aman.28009}{doi:10.1111/aman.28009}.
\item Alnagger NL, Cardone P, Martial C, Sanz Perl Y, Mindlin I, Sitt JD, Roseman L, Carhart-Harris R, Nutt D, Mallaroni P, Mason NL, Ramaekers JG, Bonhomme V, Laureys S, Deco G, Gosseries O, Nunez P, Annen J. (2024). \textit{A virtual clinical trial of psychedelics to treat patients with disorders of consciousness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.08.16.608251}{doi:10.1101/2024.08.16.608251}.
\item Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M (2024). \textit{Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci14080829}{doi:10.3390/brainsci14080829}.
\item William M. Campo, Ann Marie Yali (2024). \textit{Psychedelic use and psychological flexibility: The role of meaningful intention and decentering}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00350}{doi:10.1556/2054.2024.00350}.
\item Clairvoyant Therapeutics (2024). \textit{A 24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05646303}{source link}.
\item Holas P, Kaminska J. (2024). \textit{Prevalence and Correlates of Psychedelic Use in Poland: A Study on a Representative Sample of Polish Adults}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4860906/v1}{doi:10.21203/rs.3.rs-4860906/v1}.
\item Frederick A. Bagdasarian, Hanne D. Hansen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey (2024). \textit{Acute Effects of Psilocybin and Salvinorin-A on Functional Connectivity}. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition. [published; OpenAlex]. \href{https://doi.org/10.58530/2023/3494}{doi:10.58530/2023/3494}.
\item Rodolfo Myronn de Melo Rodrigues (2024). \textit{Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024c.0022}{doi:10.61373/pp024c.0022}.
\item Ashley Glowiak (2024). \textit{Resurrecting Ancestral Familial Health: A Role for Psilocybin?}. The Family Journal. [published; OpenAlex]. \href{https://doi.org/10.1177/10664807241269505}{doi:10.1177/10664807241269505}.
\item Sheppard Pratt Health System (2024). \textit{An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04433858}{source link}.
\item Vella Y, Syrova K, Petruskova A, Koutrouli I, Kutna V, Pala J, Nikolic M, Sichova K, Mazoch V, Jurok R, Kuchar M, Bendova Z, Palenicek T. (2024). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.08.07.606965}{doi:10.1101/2024.08.07.606965}.
\item Brugmann University Hospital (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy \& (Neuro)Cognitive Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06160232}{source link}.
\item Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach (2024). \textit{Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-024-00298-y}{doi:10.1038/s44220-024-00298-y}.
\item Mehtani NJ, Johnson MO, Hendricks PS, Mitchell J, Anderson BT (2024). \textit{Psilocybin-assisted therapy and HIV-related shame.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-68908-4}{doi:10.1038/s41598-024-68908-4}.
\item Sarah Jane Palmer (2024). \textit{Insights into the efficacy of psilocybin in treating depression and other disorders}. British Journal of Neuroscience Nursing. [published; OpenAlex]. \href{https://doi.org/10.12968/bjnn.2024.0046}{doi:10.12968/bjnn.2024.0046}.
\item Véliz-García O, Domic M. (2024). \textit{Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4706910/v1}{doi:10.21203/rs.3.rs-4706910/v1}.
\item Kaminski D, Reinert JP (2024). \textit{The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.}. The Annals of pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1177/10600280231205645}{doi:10.1177/10600280231205645}.
\item Tipado Z, Kuypers KPC, Sorger B, Ramaekers JG (2024). \textit{Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2024.04.011}{doi:10.1016/j.euroneuro.2024.04.011}.
\item Sakai K, Bradley ER, Zamaria JA, Agin-Liebes G, Kelley DP, Fish A, Martini V, Ferris MC, Morton E, Michalak EE, O'Donovan A, Woolley JD (2024). \textit{Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06585-x}{doi:10.1007/s00213-024-06585-x}.
\item Nutt D, Crome I, Young AH (2024). \textit{Is it now time to prepare psychiatry for a psychedelic future?}. The British journal of psychiatry: the journal of mental science. [published; PubMed]. \href{https://doi.org/10.1192/bjp.2024.76}{doi:10.1192/bjp.2024.76}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD (2024). \textit{Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2024.05.051}{doi:10.1016/j.jpsychires.2024.05.051}.
\item Polito V, Liknaitzky P (2024). \textit{Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241254831}{doi:10.1177/02698811241254831}.
\item Appiani FJ, Caroff SN (2024). \textit{The cyclical revival of psychedelics in psychiatric treatment.}. Current medical research and opinion. [published; PubMed]. \href{https://doi.org/10.1080/03007995.2024.2368725}{doi:10.1080/03007995.2024.2368725}.
\item Korthuis PT, Hoffman K, Wilson-Poe AR, Luoma JB, Bazinet A, Pertl K, Morgan DL, Cook RR, Bielavitz S, Myers R, Wolf RC, McCarty D, Stauffer CS (2024). \textit{Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241257839}{doi:10.1177/02698811241257839}.
\item Lake S, Lucas P (2024). \textit{The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2024.104507}{doi:10.1016/j.drugpo.2024.104507}.
\item Mograbi DC, Rodrigues R, Bienemann B, Huntley J (2024). \textit{Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-024-01353-y}{doi:10.1007/s11910-024-01353-y}.
\item Siegel JS, Subramanian S, Perry D, Kay BP, Gordon EM, Laumann TO, Reneau TR, Metcalf NV, Chacko RV, Gratton C, Horan C, Krimmel SR, Shimony JS, Schweiger JA, Wong DF, Bender DA, Scheidter KM, Whiting FI, Padawer-Curry JA, Shinohara RT, Chen Y, Moser J, Yacoub E, Nelson SM, Vizioli L, Fair DA, Lenze EJ, Carhart-Harris R, Raison CL, Raichle ME, Snyder AZ, Nicol GE, Dosenbach NUF (2024). \textit{Psilocybin desynchronizes the human brain.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-024-07624-5}{doi:10.1038/s41586-024-07624-5}.
\item Kaiserman A, Vanderjist L, Kornreich C (2024). \textit{CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.}. Psychiatria Danubina. [published; PubMed]. \href{https://doi.org/10.24869/psyd.2024.174}{doi:10.24869/psyd.2024.174}.
\item Khajavinia Amir, Michel Deborah, Ezeaka Udoka C., Purves Randy W., Laprairie Robert B., El-Aneed Anas (2024). \textit{Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method}. Journal of Chromatography A. [published; Crossref]. \href{https://doi.org/10.1016/j.chroma.2024.465123}{doi:10.1016/j.chroma.2024.465123}.
\item V Suresh, Jitendra Lakhani, R Balaraman (2024). \textit{Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients}. Journal of Natural Remedies. [published; OpenAlex]. \href{https://doi.org/10.18311/jnr/2024/35676}{doi:10.18311/jnr/2024/35676}.
\item O'Leary K (2024). \textit{How psilocybin affects the brain.}. Nature medicine. [published; PubMed]. \href{https://doi.org/10.1038/d41591-024-00055-9}{doi:10.1038/d41591-024-00055-9}.
\item Peder Clark (2024). \textit{Expanding Mindscapes: A Global History of Psychedelics. By ErikaDyck, ChrisElcock (Eds.), Cambridge, MA: The MIT Press. 2023. ISBN: 9780262546935}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16634}{doi:10.1111/add.16634}.
\item Claire Walker, Timothy Piatkowski, Jason Ferris, Emma Davies, Monica J. Barratt, Adam Winstock, Cheneal Puljević (2024). \textit{From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241265762}{doi:10.1177/02698811241265762}.
\item david J, Berkovich-Ohana A, Dor-Ziderman Y. (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/tmeb3}{doi:10.31234/osf.io/tmeb3}.
\item Jonathan David, Aviva Berkovich-Ohana, ‪Yair Dor-Ziderman‬‏ (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/tmeb3\_v1}{source link}.
\item Washington University School of Medicine (2024). \textit{Psilocybin for the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05675800}{source link}.
\item Ibrahim Lanre Folorunsho, Nkechinyere Mary Harry, Chukwubueze Obiajunwa, Oluwatosin Arubuolawe, Adeniyi Kayode Busari, Chidalu Ibeneme, Gibson Anugwom (2024). \textit{PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin}. Journal of Advances in Medicine and Medical Research. [published; OpenAlex]. \href{https://doi.org/10.9734/jammr/2024/v36i85525}{doi:10.9734/jammr/2024/v36i85525}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR. (2024). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.22543.1}{doi:10.12688/wellcomeopenres.22543.1}.
\item Viohl N, Zanjani AAH, Khandelia H. (2024). \textit{Molecular insights into the modulation of the 5HT 2A receptor by serotonin, psilocin, and the G protein subunit Gqα}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.07.23.604750}{doi:10.1101/2024.07.23.604750}.
\item Bader H, Farraj H, Maghnam J, Abu Omar Y (2024). \textit{Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis.}. World journal of clinical oncology. [published; PubMed]. \href{https://doi.org/10.5306/wjco.v15.i7.908}{doi:10.5306/wjco.v15.i7.908}.
\item Liam Engel, Sascha Thal, Stephen Bright, Mitchell Low (2024). \textit{Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00377}{doi:10.1556/2054.2024.00377}.
\item Bagdasarian FA, Hansen HD, Chen J, Yoo CH, Placzek MS, Hooker JM, Wey HY (2024). \textit{Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.4c00245}{doi:10.1021/acschemneuro.4c00245}.
\item de la Salle S, Kettner H, Thibault Lévesque J, Garel N, Dames S, Patchett-Marble R, Rej S, Gloeckler S, Erritzoe D, Carhart-Harris R, Greenway KT (2024). \textit{Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-66817-0}{doi:10.1038/s41598-024-66817-0}.
\item Kristoffer Andreas Aamodt Andersen, Bjørn Holmøy, Lowan H. Stewart (2024). \textit{Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00346}{doi:10.1556/2054.2024.00346}.
\item Anders Fink-Jensen, MD, DMSci (2024). \textit{Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04718792}{source link}.
\item Nogueira M, García-Hernández S, Roberto GS, Marques LZ. (2024). \textit{Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussions}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.07.11.24310147}{doi:10.1101/2024.07.11.24310147}.
\item Ari Brouwer, Charles L. Raison, F. LeRon Shults (2024). \textit{The trajectory of psychedelic, spiritual, and psychotic experiences: implications for cognitive scientific perspectives on religion}. Religion Brain \& Behavior. [published; OpenAlex]. \href{https://doi.org/10.1080/2153599x.2024.2349151}{doi:10.1080/2153599x.2024.2349151}.
\item Ahuja S, Zaher F, Palaniyappan L. (2024). \textit{Quantitative Natural Language Processing Markers of Psychoactive Drug Effects: A Pre-Registered Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4534997/v1}{doi:10.21203/rs.3.rs-4534997/v1}.
\item Zarankin M, Pellegrini MS, Zenteno F (2024). \textit{[Psilocybin fungi microdose treatment in major depressive disorder: a case report].}. Vertex (Buenos Aires, Argentina). [published; PubMed]. \href{https://doi.org/10.53680/vertex.v35i164.544}{doi:10.53680/vertex.v35i164.544}.
\item DeBattista C, Schatzberg AF (2024). \textit{The Black Book of Psychotropic Dosing and Monitoring.}. Psychopharmacology bulletin. [published; PubMed]. \href{https://doi.org/10.64719/pb.4493}{doi:10.64719/pb.4493}.
\item Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek (2024). \textit{Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence}. Current Psychopharmacologye. [published; OpenAlex]. \href{https://doi.org/10.2174/0122115560288779240628043307}{doi:10.2174/0122115560288779240628043307}.
\item Poulin JM, Bigford GE, Lanctôt KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, Husain MI, Rosenblat JD, Cao X, MacIntosh BJ, Nestor SM (2024). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.}. Trials. [published; PubMed]. \href{https://doi.org/10.1186/s13063-024-08268-6}{doi:10.1186/s13063-024-08268-6}.
\item Nae Won, Anna Wang, Joseph J. Palamar, Nicole D. Fitzgerald, MeLisa R. Creamer, Catherine W. Striley, Linda B. Cottler (2024). \textit{Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110222}{doi:10.1016/j.drugalcdep.2023.110222}.
\item Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Sitara M. Weerakoon, Moudou Baquai, Ramessu Iyi, Michelle Weiner, Sarah Messiah (2024). \textit{Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110578}{doi:10.1016/j.drugalcdep.2023.110578}.
\item Broc A. Pagni, Noah D. Gold, Michael P. Bogenschutz (2024). \textit{SPONTANEOUS CHANGES IN CIGARETTE SMOKING FOLLOWING PSILOCYBIN-ASSISTED TREATMENT FOR ALCOHOL USE DISORDER}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110063}{doi:10.1016/j.drugalcdep.2023.110063}.
\item Denise C. Vidot, Bria-Necole Diggs, Amrit Baral, Michaela E. Larson, Sitara M. Weerakoon, Moudou Baquai, Ramessu Iyi, Michelle Weiner, Marlene Camacho-Rivera, Sarah Messiah (2024). \textit{High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110575}{doi:10.1016/j.drugalcdep.2023.110575}.
\item Alan K. Davis, Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Frederick S. Barrett, Roland R. Griffiths (2024). \textit{Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin Therapy}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110609}{doi:10.1016/j.drugalcdep.2023.110609}.
\item Shelby A. McGriff, Grant C. Glatfelter, David R. Manke, A.R. Chadeayne, Charles W. Schindler, Michaël Baumann (2024). \textit{Physiological Effects of Psilocybin, Psilacetin, and DOI in Rats}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110445}{doi:10.1016/j.drugalcdep.2023.110445}.
\item Lauren Gorfinkel, Julia M. Bujno, Claire Walsh, Dvora Shmulewitz, Deborah S. Hasin (2024). \textit{Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008-2019}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110267}{doi:10.1016/j.drugalcdep.2023.110267}.
\item Ryan K. Lanier, Michael P. Bogenschutz, Emmanuelle A. D. Schindler, Benjamin Kelmendi, Caitlyn Durgin, Judy Ashworth (2024). \textit{Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110862}{doi:10.1016/j.drugalcdep.2023.110862}.
\item Rafael Lancelotta, Christopher Timmerman, Ana María Ortiz Bernal, Sandeep M. Nayak, Nathan D. Sepeda, Aki Nikolaidis, Roland R. Griffiths, Alan K. Davis (2024). \textit{Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110861}{doi:10.1016/j.drugalcdep.2023.110861}.
\item P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, David Morgan, Sarann Bielavitz, Dennis McCarty, Christopher S. Stauffer (2024). \textit{Developing Core Consensus Measures for Assessment of Psilocybin Services}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110268}{doi:10.1016/j.drugalcdep.2023.110268}.
\item Peck SK, Shao S, Gruen T, Yang K, Babakanian A, Trim J, Finn DM, Kaye WH (2024). \textit{Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study.}. Focus (American Psychiatric Publishing). [published; PubMed]. \href{https://doi.org/10.1176/appi.focus.24022013}{doi:10.1176/appi.focus.24022013}.
\item Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A (2024). \textit{Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2024.01.002}{doi:10.1016/j.biopsych.2024.01.002}.
\item Shahar O, Botvinnik A, Shwartz A, Lerer E, Golding P, Buko A, Hamid E, Kahn D, Guralnick M, Blakolmer K, Wolf G, Lotan A, Lerer L, Lerer B, Lifschytz T (2024). \textit{Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-024-02477-w}{doi:10.1038/s41380-024-02477-w}.
\item Hatfield SP, Thornton NL, Greenstien K, Glozier N (2024). \textit{A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674241240597}{doi:10.1177/00048674241240597}.
\item Xenakis SN, Shannon SM (2024). \textit{What is needed for the roll-out of psychedelic treatments?}. Current opinion in psychiatry. [published; PubMed]. \href{https://doi.org/10.1097/yco.0000000000000946}{doi:10.1097/yco.0000000000000946}.
\item Korkmaz ND, Cikrikcili U, Akan M, Yucesan E (2024). \textit{Psychedelic therapy in depression and substance use disorders.}. The European journal of neuroscience. [published; PubMed]. \href{https://doi.org/10.1111/ejn.16421}{doi:10.1111/ejn.16421}.
\item Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X (2024). \textit{Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115960}{doi:10.1016/j.psychres.2024.115960}.
\item Brockett AT, Francis NA (2024). \textit{Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex.}. Journal of neurophysiology. [published; PubMed]. \href{https://doi.org/10.1152/jn.00124.2024}{doi:10.1152/jn.00124.2024}.
\item Ramos L, Vicente SG (2024). \textit{The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.}. Journal of clinical and experimental neuropsychology. [published; PubMed]. \href{https://doi.org/10.1080/13803395.2024.2363343}{doi:10.1080/13803395.2024.2363343}.
\item Neumann Joachim, Dimov Kiril, Azatsian Karyna, Hofmann Britt, Gergs Ulrich (2024). \textit{Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans}. Toxicology Letters. [published; Crossref]. \href{https://doi.org/10.1016/j.toxlet.2024.06.006}{doi:10.1016/j.toxlet.2024.06.006}.
\item Singleton SP, Kuceyeski A (2024). \textit{Bridging Psilocybin-Induced Changes in the Brain's Dynamic Functional Connectome With an Individual's Subjective Experience.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.05.003}{doi:10.1016/j.bpsc.2024.05.003}.
\item Shadani S, Conn K, Andrews ZB, Foldi CJ (2024). \textit{Potential Differences in Psychedelic Actions Based on Biological Sex.}. Endocrinology. [published; PubMed]. \href{https://doi.org/10.1210/endocr/bqae083}{doi:10.1210/endocr/bqae083}.
\item Downey AE, Gorrell S (2024). \textit{Innovative and Emerging Treatments for Anorexia Nervosa.}. Focus (American Psychiatric Publishing). [published; PubMed]. \href{https://doi.org/10.1176/appi.focus.20230041}{doi:10.1176/appi.focus.20230041}.
\item Kozlov M (2024). \textit{Your brain on shrooms - how psilocybin resets neural networks.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/d41586-024-02275-y}{doi:10.1038/d41586-024-02275-y}.
\item Hanstein AP, Felchlin C (2024). \textit{Treating Anxiety and Depression With Psilocybin Therapy.}. Radiologic technology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/39079732/}{source link}.
\item Nauman Ashraf (2024). \textit{IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?}. Journal of Pakistan Psychiatric Society. [published; OpenAlex]. \href{https://doi.org/10.63050/jpps.21.02.935}{doi:10.63050/jpps.21.02.935}.
\item Brownstien M, Lazar M, Botvinnik A, Shevakh C, Blakolmer K, Lerer L, Lifschytz T, Lerer B (2024). \textit{Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.06.25.600634}{doi:10.1101/2024.06.25.600634}.
\item Bennett Lange, Luke Morgan, Christopher Mattox, Suhrud Pathak, Keyi Liu, Rishi Nadar, Jun Ren, Jeyaram Bharathi Jeyabalan, Timothy Moore, Muralikrishnan Dhanasekaran (2024). \textit{Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare}. Trends in Medical Research. [published; OpenAlex]. \href{https://doi.org/10.3923/tmr.2024.245.273}{doi:10.3923/tmr.2024.245.273}.
\item Van Maldegem M, Vohryzek J, Atasoy S, Alnagger N, Cardone P, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Kringelbach ML, Stamatakis EA, Luppi AI. (2024). \textit{Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional Organisation}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.20.599885}{doi:10.1101/2024.06.20.599885}.
\item Empower Research Inc (2024). \textit{Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First Responders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06471959}{source link}.
\item Parker C, Wood BM (2024). \textit{At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.}. Social work. [published; PubMed]. \href{https://doi.org/10.1093/sw/swae019}{doi:10.1093/sw/swae019}.
\item Casanova AF, Ort A, Smallridge JW, Preller KH, Seifritz E, Vollenweider FX (2024). \textit{The influence of psilocybin on subconscious and conscious emotional learning.}. iScience. [published; PubMed]. \href{https://doi.org/10.1016/j.isci.2024.110034}{doi:10.1016/j.isci.2024.110034}.
\item Fluyau D, Kailasam VK, Revadigar N. (2024). \textit{Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.06.17.24308787}{doi:10.1101/2024.06.17.24308787}.
\item Bryson N, Alexander R, Asnis-Alibozek A, Ehlers MD (2024). \textit{RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-,-diisopropyltryptamine.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.4c00058}{doi:10.1021/acschemneuro.4c00058}.
\item Johns Hopkins University (2024). \textit{Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02243813}{source link}.
\item Imperial College London (2024). \textit{Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04505189}{source link}.
\item Torrado Pacheco A, Moghaddam B (2024). \textit{Licit use of illicit drugs for treating depression: the pill and the process.}. The Journal of clinical investigation. [published; PubMed]. \href{https://doi.org/10.1172/jci180217}{doi:10.1172/jci180217}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T. (2024). \textit{Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.594677}{doi:10.1101/2024.06.13.594677}.
\item Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS (2024). \textit{Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.03.165}{doi:10.1016/j.jad.2024.03.165}.
\item Nicholas CR, Banks MI, Lennertz RL, Wenthur CJ, Krause BM, Riedner BA, Smith RF, Hutson PR, Sauder CJ, Dunne JD, Roseman L, Raison CL. (2024). \textit{Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.598878}{doi:10.1101/2024.06.13.598878}.
\item Kargbo RB (2024). \textit{Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.4c00181}{doi:10.1021/acsmedchemlett.4c00181}.
\item Linda M. Richmond (2024). \textit{Psychedelics’ Use as Medicine Hits Significant Roadblock}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.07.7.54}{doi:10.1176/appi.pn.2024.07.7.54}.
\item Linda Nguyen, Sona Regonda, Adam Gaisinsky (2024). \textit{Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research Protocol}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.588}{doi:10.26685/urncst.588}.
\item Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK. (2024). \textit{Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/adnpg}{doi:10.31234/osf.io/adnpg}.
\item University of Sydney (2024). \textit{A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06444243}{source link}.
\item Dan Petrovitch, Sean M. Mitchell, Jason Van Allen, Andrew K. Littlefield (2024). \textit{Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/adnpg\_v1}{source link}.
\item Ouliana Panova, Nichols D.E, Shoichet B.K, Lyu J, Georgios Skiniotis, Che T, Roth B.L, DiBerto J.F, Daniel Wacker, Robertson M.J, Kami Kim, Krumm B.E, Seven A.B (2024). \textit{Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/yb2v-ca64}{doi:10.17615/yb2v-ca64}.
\item Turkia M. (2024). \textit{5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/bvk2f}{doi:10.31234/osf.io/bvk2f}.
\item Calder A, Hasler G. (2024). \textit{Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/um2cy}{doi:10.31234/osf.io/um2cy}.
\item Mika Turkia (2024). \textit{5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/bvk2f\_v1}{source link}.
\item Abigail Calder, Gregor Hasler (2024). \textit{Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/um2cy\_v1}{source link}.
\item Sean M. Viña (2024). \textit{Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and Distress}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3020019}{doi:10.3390/psychoactives3020019}.
\item Nikola Lash, George Tadros, Eman Tadros (2024). \textit{Therapeutic Implications of Psilocybin in the Wake of Decriminalization}. Integrative and Complementary Therapies. [published; OpenAlex]. \href{https://doi.org/10.1089/ict.2024.27206.nl}{doi:10.1089/ict.2024.27206.nl}.
\item Zeller Matthias, Parent Stephan, Schultheiss Nate (2024). \textit{Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hydroxy-N,N-dimethyltryptamine)}. Acta Crystallographica Section E Crystallographic Communications. [published; Crossref]. \href{https://doi.org/10.1107/s2056989024004201}{doi:10.1107/s2056989024004201}.
\item Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2024.108641}{doi:10.1016/j.pharmthera.2024.108641}.
\item Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A (2024). \textit{[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].}. Fortschritte der Neurologie-Psychiatrie. [published; PubMed]. \href{https://doi.org/10.1055/a-2046-5202}{doi:10.1055/a-2046-5202}.
\item Iorgu AM, Vasilescu AN, Pfeiffer N, Spanagel R, Mallien AS, Inta D, Gass P (2024). \textit{Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney's lesions.}. European archives of psychiatry and clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.1007/s00406-023-01699-3}{doi:10.1007/s00406-023-01699-3}.
\item Yaden DB, Gukasyan N, Nayak SM (2024). \textit{Psilocybin in Bipolar II Study Provides Preliminary Data on Safety.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2023.4680}{doi:10.1001/jamapsychiatry.2023.4680}.
\item Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Sackeim HA, Suppes T (2024). \textit{Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2023.4685}{doi:10.1001/jamapsychiatry.2023.4685}.
\item Szigeti B, Weiss B, Rosas FE, Erritzoe D, Nutt D, Carhart-Harris R (2024). \textit{Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s0033291723003653}{doi:10.1017/s0033291723003653}.
\item Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D, Young A, Aarsland D, Vernon A, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases}. Pharmacology \& therapeutics. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11847495}{source link}.
\item Fried EI, Cristea IA, Naudet F (2024). \textit{Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2024.0420}{doi:10.1001/jamapsychiatry.2024.0420}.
\item Aaronson ST, van der Vaart A, Sackeim HA (2024). \textit{Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2024.0423}{doi:10.1001/jamapsychiatry.2024.0423}.
\item Maloney G, Ching T, Kichuk SA, Pittenger C, Kelmendi B (2024). \textit{Mechanisms of therapeutic change after psychedelic treatment in OCD.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115907}{doi:10.1016/j.psychres.2024.115907}.
\item Agor D, Knettel BA, Daici K, Meanley S (2024). \textit{The Intersection of Mental Health and Sexual and Gender Minority Identities for Older Adults Living with Human Immunodeficiency Virus: A Narrative Review.}. The Nursing clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.cnur.2024.01.005}{doi:10.1016/j.cnur.2024.01.005}.
\item Soliman PS, Curley DE, Capone C, Eaton E, Haass-Koffler CL (2024). \textit{In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06598-6}{doi:10.1007/s00213-024-06598-6}.
\item Warren AL, Lankri D, Cunningham MJ, Serrano IC, Parise LF, Kruegel AC, Duggan P, Zilberg G, Capper MJ, Havel V, Russo SJ, Sames D, Wacker D (2024). \textit{Structural pharmacology and therapeutic potential of 5-methoxytryptamines.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-024-07403-2}{doi:10.1038/s41586-024-07403-2}.
\item Chopra H, Furnish T, Verduzco-Gutierrez M, Jevotovsky DS, Castellanos J (2024). \textit{Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report.}. Clinical case reports. [published; PubMed]. \href{https://doi.org/10.1002/ccr3.8791}{doi:10.1002/ccr3.8791}.
\item Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J (2024). \textit{A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0051}{doi:10.1089/psymed.2023.0051}.
\item DiRenzo D, Barrett FS, Perin J, Darrah E, Christopher-Stine L, Griffiths RR (2024). \textit{Impact of Psilocybin on Peripheral Cytokine Production.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0039}{doi:10.1089/psymed.2023.0039}.
\item Floris G, Dabrowski KR, Zanda MT, Daws SE (2024). \textit{Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.05.28.596205}{doi:10.1101/2024.05.28.596205}.
\item Martina Colognesi, Daniela Gabbia, Andrea Rinaldi, Luciano Cascione, Ilaria Zanotto, Stefano Comai, Katia Sayaf, Andrea Mattarei, Marco Banzato, Gianfranco Pasut, Franco Folli, Lucia Centofanti, Sergio Traversa, M. Pappagallo, Paolo L. Manfredi, Sara De Martin (2024). \textit{THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLD}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(24)01739-2}{doi:10.1016/s0168-8278(24)01739-2}.
\item Jessica L. Maltman, Derrick Zhao, Alaina M. Jaster, Yunling Tai, Jing Zeng, Javier Maeso-Gonzalez, Huiping Zhou, Jasmohan S. Bajaj (2024). \textit{WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male mice}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(24)00826-2}{doi:10.1016/s0168-8278(24)00826-2}.
\item Amrit Baral, Yue Pan, Alberto J. Caban Martinez, Paulo S. Pinheiro, WayWay M. Hlaing, Denise C. Vidot (2024). \textit{Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2024.42.16\_suppl.e22518}{doi:10.1200/jco.2024.42.16\_suppl.e22518}.
\item Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM (2024). \textit{Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.}. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.9758/cpn.23.1134}{doi:10.9758/cpn.23.1134}.
\item Vohryzek J, Luppi AI, Atasoy S, Deco G, Carhart-Harris RL, Timmermann C, Kringelbach ML (2024). \textit{Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.05.30.596410}{doi:10.1101/2024.05.30.596410}.
\item Harris E (2024). \textit{Therapeutic Psilocybin's Adverse Effects Mostly Resolved Within 2 Days.}. JAMA. [published; PubMed]. \href{https://doi.org/10.1001/jama.2024.6733}{doi:10.1001/jama.2024.6733}.
\item Ghaznavi S, Bernardez LM, Stern TA (2024). \textit{Medical Uses and Adverse Effects of Psilocybin.}. The primary care companion for CNS disorders. [published; PubMed]. \href{https://doi.org/10.4088/pcc.23f03652}{doi:10.4088/pcc.23f03652}.
\item McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M. (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/y8sb7}{doi:10.31234/osf.io/y8sb7}.
\item Hugh McGovern, Nick Wellman, Brendan Hutchinson, Lena Oestreich, Samuel E Cooper, Gregory Fonzo, Manoj Doss (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/y8sb7\_v1}{source link}.
\item Hoyer D. (2024). \textit{On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171648613.31141136/v1}{doi:10.22541/au.171648613.31141136/v1}.
\item Bhagavan C, Glue P, Evans W, Reynolds L, Turner T, King C, Russell BR, Morunga E, Mills JL, Layton G, Menkes DB (2024). \textit{Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.}. Trials. [published; PubMed]. \href{https://doi.org/10.1186/s13063-024-08174-x}{doi:10.1186/s13063-024-08174-x}.
\item Marinis J, Clarke ST, Bedi G. (2024). \textit{Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4bk2p}{doi:10.31234/osf.io/4bk2p}.
\item Jonathon Marinis, Sarah Tomoyo Clarke, Gillinder Bedi (2024). \textit{Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4bk2p\_v1}{source link}.
\item Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ. (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.16.594614}{doi:10.1101/2024.05.16.594614}.
\item Harari R, Chatterjee I, Getselter D, Elliott E (2024). \textit{Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor.}. iScience. [published; PubMed]. \href{https://doi.org/10.1016/j.isci.2024.109686}{doi:10.1016/j.isci.2024.109686}.
\item Shunichiro Ikeda, Toshihiko Kinoshita (2024). \textit{Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens}. Psychiatry and Clinical Neurosciences Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/pcn5.196}{doi:10.1002/pcn5.196}.
\item Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Mazurek, Wiktoria Wilanowska (2024). \textit{Psilocybin as a new way for depression treatment}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2024.68.50168}{doi:10.12775/jehs.2024.68.50168}.
\item Copa D, Erritzoe D, Giribaldi B, Nutt D, Carhart-Harris R, Tagliazucchi E (2024). \textit{Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.02.089}{doi:10.1016/j.jad.2024.02.089}.
\item Schindler EAD, Sewell RA, Gottschalk CH, Flynn LT, Zhu Y, Pittman BP, Cozzi NV, D'Souza DC (2024). \textit{Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.}. Journal of the neurological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jns.2024.122993}{doi:10.1016/j.jns.2024.122993}.
\item Rogers SA, Heller EA, Corder G (2024). \textit{Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.02.04.578811}{doi:10.1101/2024.02.04.578811}.
\item Zhang R, Anguiano M, Aarrestad IK, Lin S, Chandra J, Vadde SS, Olson DE, Kim CK (2024). \textit{Rapid, biochemical tagging of cellular activity history in vivo.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.09.06.556431}{doi:10.1101/2023.09.06.556431}.
\item M. Imad Damaj, Javier González-Maeso, Belle Buzzi (2024). \textit{The Classical Psychedelic Psilocybin Mitigates Oxycodone Withdrawal}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.320.935210}{doi:10.1124/jpet.320.935210}.
\item N. Jones, John A. Razidlo, Zarmeen Zahid, Cody J. Wenthur (2024). \textit{Psilocybin-induced anxiolytic effects supported by transient elevation of corticosterone}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.337.128335}{doi:10.1124/jpet.337.128335}.
\item Viña S. (2024). \textit{Psychedelics Use and the Risk of Reduced Formal Mental Health Care}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4378944/v1}{doi:10.21203/rs.3.rs-4378944/v1}.
\item Terri D’Arrigo (2024). \textit{Calls to Poison Centers Involving Psilocybin Rising in Youth}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.06.6.2}{doi:10.1176/appi.pn.2024.06.6.2}.
\item M Ro Rsted E, Jensen AA, Smits G, Frydenvang K, Kristensen JL (2024). \textit{Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT Receptor Agonists.}. Journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1021/acs.jmedchem.4c00082}{doi:10.1021/acs.jmedchem.4c00082}.
\item Nova Mentis Life Science Corp (2024). \textit{An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05832255}{source link}.
\item Barri Babow (2024). \textit{The Psilocybin Connection: Psychedelics, the Transformation of Consciousness, and Evolution on the Planet}. World Futures. [published; OpenAlex]. \href{https://doi.org/10.1080/02604027.2024.2340772}{doi:10.1080/02604027.2024.2340772}.
\item University of Calgary (2024). \textit{Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05995769}{source link}.
\item Woodburn SC, Levitt CM, Koester AM, Kwan AC. (2024). \textit{Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.04.592469}{doi:10.1101/2024.05.04.592469}.
\item Olami A, Peled-Avron L. (2024). \textit{Effects of Classical Psychedelics on Implicit and Explicit Emotional Empathy and Cognitive Empathy: A Meta-analysis of MET task}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.02.592231}{doi:10.1101/2024.05.02.592231}.
\item British Medical Journal Publishing Group (2024). \textit{EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj.q1025}{doi:10.1136/bmj.q1025}.
\item Brancaccio Hanna (2024). \textit{Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders}. Research Posters. [published; Crossref]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}.
\item Patel Prince, Gollapudi Samrat, Mathew Brian Joseph, Patel Bhaumik (2024). \textit{Brain Connectivity Pattern Changes Associated With Psychedelic-Assisted Psychotherapy}. Research Poster. [published; Crossref]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}.
\item Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie (2024). \textit{From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine}. European Journal of Arts Humanities and Social Sciences. [published; OpenAlex]. \href{https://doi.org/10.59324/ejahss.2024.1(3).10}{doi:10.59324/ejahss.2024.1(3).10}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maeda K, González-Maeso J, Kitagaki S, Hiramatsu M (2024). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.}. Naunyn-Schmiedeberg's archives of pharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00210-023-02778-x}{doi:10.1007/s00210-023-02778-x}.
\item Moujaes F, Rieser NM, Phillips C, de Matos NMP, Brügger M, Dürler P, Smigielski L, Stämpfli P, Seifritz E, Vollenweider FX, Anticevic A, Preller KH (2024). \textit{Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2023.07.003}{doi:10.1016/j.bpsc.2023.07.003}.
\item Geyer MA (2024). \textit{A Brief Historical Overview of Psychedelic Research.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2023.11.003}{doi:10.1016/j.bpsc.2023.11.003}.
\item Holze F, Singh N, Liechti ME, D'Souza DC (2024). \textit{Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.01.007}{doi:10.1016/j.bpsc.2024.01.007}.
\item Palamar JJ, Fitzgerald ND, Carr TH, Rutherford C, Keyes KM, Cottler LB (2024). \textit{National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2024.111086}{doi:10.1016/j.drugalcdep.2024.111086}.
\item Schmid Y, Bershad AK (2024). \textit{Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.02.001}{doi:10.1016/j.bpsc.2024.02.001}.
\item Shafiee A, Arabzadeh Bahri R, Rafiei MA, Esmaeilpur Abianeh F, Razmara P, Jafarabady K, Amini MJ (2024). \textit{The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241234247}{doi:10.1177/02698811241234247}.
\item Szigeti B, Heifets BD (2024). \textit{Expectancy Effects in Psychedelic Trials.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.02.004}{doi:10.1016/j.bpsc.2024.02.004}.
\item Farah R, Kerns AF, Murray AC, Holstege CP (2024). \textit{Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade.}. The Journal of adolescent health: official publication of the Society for Adolescent Medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.jadohealth.2024.01.027}{doi:10.1016/j.jadohealth.2024.01.027}.
\item Erritzoe D, Barba T, Spriggs MJ, Rosas FE, Nutt DJ, Carhart-Harris R (2024). \textit{Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241237870}{doi:10.1177/02698811241237870}.
\item Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y (2024). \textit{Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115886}{doi:10.1016/j.psychres.2024.115886}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A (2024). \textit{Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115880}{doi:10.1016/j.psychres.2024.115880}.
\item Peill J, Marguilho M, Erritzoe D, Barba T, Greenway KT, Rosas F, Timmermann C, Carhart-Harris R (2024). \textit{Psychedelics and the 'inner healer': Myth or mechanism?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241239206}{doi:10.1177/02698811241239206}.
\item Zhao X, Du Y, Yao Y, Dai W, Yin Y, Wang G, Li Y, Zhang L (2024). \textit{Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241249436}{doi:10.1177/02698811241249436}.
\item De Giorgi R, Ede R (2024). \textit{Psilocybin for depression.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj.q798}{doi:10.1136/bmj.q798}.
\item Metaxa AM, Clarke M (2024). \textit{Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj-2023-078084}{doi:10.1136/bmj-2023-078084}.
\item Ruan Y, Yuan R, He J, Jiang Y, Chu S, Chen N (2024). \textit{New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.}. Cell death discovery. [published; PubMed]. \href{https://doi.org/10.1038/s41420-024-01974-9}{doi:10.1038/s41420-024-01974-9}.
\item Zeller M, Parent S, Schultheiss N. (2024). \textit{Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hy­droxy-N,N-di­methyl­tryptamine)}. Acta Crystallographica Section E: Crystallographic Communications. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11151301}{source link}.
\item Manoj K. Doss, Pablo Mallaroni, Natasha L. Mason, Jan Ramaekers (2024). \textit{1. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity and Positively Bias Emotional Metamemory}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2024.02.179}{doi:10.1016/j.biopsych.2024.02.179}.
\item Thomann Jan, Kolaczynska Karolina E., Stoeckmann Oliver V., Rudin Deborah, Vizeli Patrick, Hoener Marius C., Pryce Christopher R., Vollenweider Franz X., Liechti Matthias E., Duthaler Urs (2024). \textit{In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin}. Frontiers in Pharmacology. [published; Crossref]. \href{https://doi.org/10.3389/fphar.2024.1391689}{doi:10.3389/fphar.2024.1391689}.
\item Chandana P Vibin, Jahangir Majeed (2024). \textit{Measuring Insight Level After Psychedelic Experience Among The Indian Population}. Educational Administration Theory and Practices. [published; OpenAlex]. \href{https://doi.org/10.53555/kuey.v30i4.2800}{doi:10.53555/kuey.v30i4.2800}.
\item Bellman V (2024). \textit{Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon.}. Cancers. [published; PubMed]. \href{https://doi.org/10.3390/cancers16091702}{doi:10.3390/cancers16091702}.
\item Ron Cole-Turner (2024). \textit{Psychedelic Mysticism and Christian Spirituality: From Science to Love}. Religions. [published; OpenAlex]. \href{https://doi.org/10.3390/rel15050537}{doi:10.3390/rel15050537}.
\item University Hospital, Basel, Switzerland (2024). \textit{Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05384678}{source link}.
\item Whelan TP, Daly E, Puts NA, Smith P, Allison C, Baron-Cohen S, Malievskaia E, Murphy DGM, McAlonan GM (2024). \textit{The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.}. BMC psychiatry. [published; PubMed]. \href{https://doi.org/10.1186/s12888-024-05768-2}{doi:10.1186/s12888-024-05768-2}.
\item Seibold PS, Dörner S, Fricke J, Schäfer T, Beemelmanns C, Hoffmeister D (2024). \textit{Genetic regulation of L-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis.}. Fungal biology and biotechnology. [published; PubMed]. \href{https://doi.org/10.1186/s40694-024-00173-6}{doi:10.1186/s40694-024-00173-6}.
\item Petrovitch D, Van Allen J, Mitchell SM, Littlefield AK. (2024). \textit{Do undergraduates’ views of psychedelics relate to the context for psychedelic use?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xnu5c}{doi:10.31234/osf.io/xnu5c}.
\item Pagni B, Petridis P, Podrebarac S, Grinband J, Claus E, Bogenschutz M. (2024). \textit{300 Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot study}. Journal of clinical and translational science. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11033768}{source link}.
\item Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M (2024). \textit{Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01005-z}{doi:10.1186/s40337-024-01005-z}.
\item Dan Petrovitch, Jason Van Allen, Sean M. Mitchell, Andrew K. Littlefield (2024). \textit{Do undergraduates’ views of psychedelics relate to the context for psychedelic use?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xnu5c\_v1}{source link}.
\item Terri D’Arrigo (2024). \textit{MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.05.5.1}{doi:10.1176/appi.pn.2024.05.5.1}.
\item Singer B, Meling D, Hirsch-Hoffmann M, Michels L, Kometer M, Smigielski L, Dornbierer D, Seifritz E, Vollenweider FX, Scheidegger M (2024). \textit{Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-59897-5}{doi:10.1038/s41598-024-59897-5}.
\item Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL. (2024). \textit{The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.19.590212}{doi:10.1101/2024.04.19.590212}.
\item Ivan V, Tomas-Cuesta D, Esteves I, Luczak A, Mohajerani M, McNaughton B, Gruber A. (2024). \textit{Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortex}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171378690.00112411/v1}{doi:10.22541/au.171378690.00112411/v1}.
\item Section for Affective Disorders; Northern Stockholm Psychiatry (2024). \textit{The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04630964}{source link}.
\item Sarosh Nawaz, Abdulaziz Mohammed Althwanay, Esraa M. AlEdani MB Ch B, Harleen Kaur, Malik Kasapoglu, Rajesh Yadavalli, Ann Kashmer Yu (2024). \textit{Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review}. Journal For International Medical Graduates. [published; OpenAlex]. \href{https://doi.org/10.56570/jimgs.v1i1.155}{doi:10.56570/jimgs.v1i1.155}.
\item Sloshower J, Zeifman RJ, Guss J, Krause R, Safi-Aghdam H, Pathania S, Pittman B, D'Souza DC (2024). \textit{Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-58318-x}{doi:10.1038/s41598-024-58318-x}.
\item Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden (2024). \textit{Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3020014}{doi:10.3390/psychoactives3020014}.
\item Juliani A, Chelu V, Graesser L, Safron A. (2024). \textit{A dual-receptor model of serotonergic psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.12.589282}{doi:10.1101/2024.04.12.589282}.
\item Valerie A. Canady (2024). \textit{Psychedelic therapists, pharma collaborate on clinical trial}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.34009}{doi:10.1002/mhw.34009}.
\item Erika Dyck (2024). \textit{Who will staff the psychedelic resurgence?}. Open Access Government. [published; OpenAlex]. \href{https://doi.org/10.56367/oag-042-10690}{doi:10.56367/oag-042-10690}.
\item Tina Singh, Dipa Patel, Kasey Bishop, Rhea Shishodia, Sadeepa Bulathsinhala (2024). \textit{Mushroom Therapy: Psilocybin’s Role in Treating Substance Use Disorders (P3-9.018)}. Neurology. [published; OpenAlex]. \href{https://doi.org/10.1212/wnl.0000000000206718}{doi:10.1212/wnl.0000000000206718}.
\item Brian Pilecki, Jason B. Luoma, Kati M. Lear (2024). \textit{A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00295}{doi:10.1556/2054.2024.00295}.
\item López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J (2024). \textit{[Psychedelic psychiatry].}. Lakartidningen. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/38572715/}{source link}.
\item M. Nordin, Jón Ingi Hlynsson, Jakob Håkansson Eklund, Per Carlbring (2024). \textit{A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00337}{doi:10.1556/2054.2024.00337}.
\item J. S. Seo (2024). \textit{Current situation regarding psychedelics and magic mushroom in Korea}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2024.1695}{doi:10.1192/j.eurpsy.2024.1695}.
\item Eva Maria Schindowski, Franz X. Vollenweider (2024). \textit{Fallbeispiele zur Therapie der rezidivierenden Depression mit Psilocybin}. Nervenheilkunde. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2283-0221}{doi:10.1055/a-2283-0221}.
\item Kim P. C. Kuypers (2024). \textit{Microdosing psychedelics in the treatment of ADHD and comorbid disorders}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2024.44}{doi:10.1192/j.eurpsy.2024.44}.
\item Wilson Lavonne, Babumon Muthiramalil T., Irvine William, Morrison Isaac, Foster Kimberly, Delgoda Rupika (2024). \textit{Inhibition of cytochrome P450 3A4 enzyme activity by alkaloid psilocin from magic mushrooms: potential for drug interactions}. Drug Metabolism and Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1016/j.dmpk.2023.100829}{doi:10.1016/j.dmpk.2023.100829}.
\item Rucker JJ (2024). \textit{Evidence versus expectancy: the development of psilocybin therapy.}. BJPsych bulletin. [published; PubMed]. \href{https://doi.org/10.1192/bjb.2023.28}{doi:10.1192/bjb.2023.28}.
\item Kelly TJ, Bonniwell EM, Mu L, Liu X, Hu Y, Friedman V, Yu H, Su W, McCorvy JD, Liu QS (2024). \textit{Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-023-01744-8}{doi:10.1038/s41386-023-01744-8}.
\item Simonsson O, Osika W, Stenfors CUD, Goldberg SB, Honk L, Hendricks PS (2024). \textit{Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s0033291723003082}{doi:10.1017/s0033291723003082}.
\item Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders JJ, Ljuslin M, Guérin B, Thambi P, Tulsky JA, Agrawal M (2024). \textit{Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.}. Cancer. [published; PubMed]. \href{https://doi.org/10.1002/cncr.35024}{doi:10.1002/cncr.35024}.
\item Thrul J, Kozak Z, Carducci MA, Garcia-Romeu A, Yaden DB (2024). \textit{Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.}. Cancer. [published; PubMed]. \href{https://doi.org/10.1002/cncr.35127}{doi:10.1002/cncr.35127}.
\item Agrawal M, Richards W, Beaussant Y, Shnayder S, Ameli R, Roddy K, Stevens N, Richards B, Schor N, Honstein H, Jenkins B, Bates M, Thambi P (2024). \textit{Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.}. Cancer. [published; PubMed]. \href{https://doi.org/10.1002/cncr.35010}{doi:10.1002/cncr.35010}.
\item Steward T (2024). \textit{Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin.}. Trends in molecular medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.molmed.2023.12.001}{doi:10.1016/j.molmed.2023.12.001}.
\item Ghofrani-Jahromi Z, Nouri-Darehno S, Rahimi-Danesh M, Talaee N, Jasemi E, Razmi A, Vaseghi S (2024). \textit{Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder.}. Behavioral neuroscience. [published; PubMed]. \href{https://doi.org/10.1037/bne0000579}{doi:10.1037/bne0000579}.
\item Wong S, Kwan ATH, Teopiz KM, Le GH, Meshkat S, Ho R, d'Andrea G, Cao B, Di Vincenzo JD, Rosenblat JD, McIntyre RS (2024). \textit{A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2024.01.142}{doi:10.1016/j.jad.2024.01.142}.
\item Sinha JK, Trisal A, Ghosh S, Gupta S, Singh KK, Han SS, Mahapatra M, Abomughaid MM, Abomughayedh AM, Almutary AG, Iqbal D, Bhaskar R, Mishra PC, Jha SK, Jha NK, Singh AK (2024). \textit{Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.}. Ageing research reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.arr.2024.102211}{doi:10.1016/j.arr.2024.102211}.
\item Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J (2024). \textit{Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.}. JAMA network open. [published; PubMed]. \href{https://doi.org/10.1001/jamanetworkopen.2024.5960}{doi:10.1001/jamanetworkopen.2024.5960}.
\item Tap SC (2024). \textit{The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.13386}{doi:10.1111/adb.13386}.
\item Wilkes R, Roberts DM, Liknaitzky P, Brett J (2024). \textit{The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2024.2346612}{doi:10.1080/15563650.2024.2346612}.
\item Blake Beaton, Jurg Gerber (2024). \textit{From Outsider to Insider: A Look at the Subculture of Microdosing}. Deviant Behavior. [published; OpenAlex]. \href{https://doi.org/10.1080/01639625.2024.2336198}{doi:10.1080/01639625.2024.2336198}.
\item M. Imad Damaj, Eda Köşeli, Belle Buzzi, Yogesh Rakholia, Melissa J. Lewis, Javier González-Maeso (2024). \textit{Pharmacology of Classical Psychedelic in Mouse Models of Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2024.01.093}{doi:10.1016/j.jpain.2024.01.093}.
\item Smedfors G, Jennysdotter Olofsgård F, Steinberg A, Waldenlind E, Ran C, Belin AC (2024). \textit{Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci14040348}{doi:10.3390/brainsci14040348}.
\item Laabi S, LeMmon C, Vogel C, Chacon M, Jimenez VM (2024). \textit{Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights.}. International immunopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.intimp.2024.111753}{doi:10.1016/j.intimp.2024.111753}.
\item Hudspeth J, Rogge K, Dörner S, Müll M, Hoffmeister D, Rupp B, Werten S (2024). \textit{Methyl transfer in psilocybin biosynthesis.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-024-46997-z}{doi:10.1038/s41467-024-46997-z}.
\item Shenvi RA (2024). \textit{Natural Product Synthesis in the 21st Century: Beyond the Mountain Top.}. ACS central science. [published; PubMed]. \href{https://doi.org/10.1021/acscentsci.3c01518}{doi:10.1021/acscentsci.3c01518}.
\item Terri D’Arrigo (2024). \textit{MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.04.4.1}{doi:10.1176/appi.pn.2024.04.4.1}.
\item Singer B, Meling D, Hirsch-Hoffmann M, Michels L, Kometer M, Smigielski L, Dornbierer D, Seifritz E, Vollenweider FX, Scheidegger M (2024). \textit{Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-55726-x}{doi:10.1038/s41598-024-55726-x}.
\item David Nutt (2024). \textit{Psychedelics: reconnecting the brain to heal the mind}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_156}{doi:10.1042/bio\_2023\_156}.
\item Shreyasee Das, Rahul Shil (2024). \textit{Psychedelic Drugs: A Mind-expanding Hallucinogens}. Indian Journal of Behavioural Sciences. [published; OpenAlex]. \href{https://doi.org/10.55229/ijbs.v27i1.13}{doi:10.55229/ijbs.v27i1.13}.
\item Adrian Preda (2024). \textit{Psychedelic Renaissance: Evidence and Culture}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.04.4.39}{doi:10.1176/appi.pn.2024.04.4.39}.
\item University of Utah (2024). \textit{A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04522804}{source link}.
\item Hoener S, Wolfgang A, Nissan D, Howe E (2024). \textit{Ethical considerations for psychedelic-assisted therapy in military clinical settings.}. Journal of medical ethics. [published; PubMed]. \href{https://doi.org/10.1136/jme-2023-108943}{doi:10.1136/jme-2023-108943}.
\item Vandevelde M, Simoens A, Vandekerckhove B, Stevens C (2024). \textit{Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond.}. RSC medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1039/d4md00043a}{doi:10.1039/d4md00043a}.
\item Yang WQ, Li JX, He MQ, Wang SH, Zhu XY, Phurbu D, Yun JM, Zhao RL (2024). \textit{Five New Species of from Xizang Autonomous Region of China and Surrounding Areas.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof10030220}{doi:10.3390/jof10030220}.
\item Natalie Ertl, Matthew B. Wall (2024). \textit{Scanning the new frontier of mental health: psychedelic brain imaging}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_171}{doi:10.1042/bio\_2023\_171}.
\item Ben Seal (2024). \textit{Psychedelic drugs and the law: What’s next?}. Knowable Magazine. [published; OpenAlex]. \href{https://doi.org/10.1146/knowable-031424-2}{doi:10.1146/knowable-031424-2}.
\item Kulikov Aleksandr V., Zheleznyak Ilya Yu. (2024). \textit{Problems of Qualification of Trafficking in Plants and Plant Parts Containing Psychoactive Substances and Mushrooms Containing Psilocybin and (or) Psilocin}. Drug control. [published; Crossref]. \href{https://doi.org/10.18572/2072-4160-2024-1-23-26}{doi:10.18572/2072-4160-2024-1-23-26}.
\item Song-Smith C, Jacobs E, Rucker J, Saint M, Cooke J, Schlosser M (2024). \textit{UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2023-083595}{doi:10.1136/bmjopen-2023-083595}.
\item Kargbo RB (2024). \textit{Pioneering Methods in Brain Optimization and Mental Health Treatment.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.4c00058}{doi:10.1021/acsmedchemlett.4c00058}.
\item Hiroshi Ito, Minori Fujita, Daiki Kobayashi (2024). \textit{Psilocybin poisoning from Psilocybe argentipes ingestion}. Visual Journal of Emergency Medicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.visj.2024.101939}{doi:10.1016/j.visj.2024.101939}.
\item Robert Gerlai (2024). \textit{Magic mushroom and zebrafish: A new recipe?}. Lab Animal. [published; OpenAlex]. \href{https://doi.org/10.1038/s41684-024-01350-1}{doi:10.1038/s41684-024-01350-1}.
\item Aaronson ST, Kozak Z (2024). \textit{New evidence for flexible psilocybin dosing in patients with treatment-resistant depression.}. Med (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1016/j.medj.2024.01.014}{doi:10.1016/j.medj.2024.01.014}.
\item Rosenblat JD, Meshkat S, Doyle Z, Kaczmarek E, Brudner RM, Kratiuk K, Mansur RB, Schulz-Quach C, Sethi R, Abate A, Ali S, Bawks J, Blainey MG, Brietzke E, Cronin V, Danilewitz J, Dhawan S, Di Fonzo A, Di Fonzo M, Drzadzewski P, Dunlop W, Fiszter H, Gomes FA, Grewal S, Leon-Carlyle M, McCallum M, Mofidi N, Offman H, Riva-Cambrin J, Schmidt J, Smolkin M, Quinn JM, Zumrova A, Marlborough M, McIntyre RS (2024). \textit{Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.}. Med (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1016/j.medj.2024.01.005}{doi:10.1016/j.medj.2024.01.005}.
\item Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe (2024). \textit{Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-024-01253-9}{doi:10.1007/s11469-024-01253-9}.
\item Ho C, Crawford JR (2024). \textit{Neuroimaging features of psilocybin-induced toxic-metabolic encephalopathy in an adolescent.}. BMJ case reports. [published; PubMed]. \href{https://doi.org/10.1136/bcr-2024-259721}{doi:10.1136/bcr-2024-259721}.
\item Velit-Salazar MR, Shiroma PR, Cherian E (2024). \textit{A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci14030248}{doi:10.3390/brainsci14030248}.
\item Henning Hintzsche (2024). \textit{Psilocybin zur Behandlung depressiver Erkrankungen}. BIOspektrum. [published; OpenAlex]. \href{https://doi.org/10.1007/s12268-024-2157-2}{doi:10.1007/s12268-024-2157-2}.
\item Capaldi JM, Shabanian J, Finster LB, Asher A, Wertheimer JC, Zebrack BJ, Shirazipour CH (2024). \textit{Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: a systematic scoping review of interventions.}. Health psychology review. [published; PubMed]. \href{https://doi.org/10.1080/17437199.2022.2162947}{doi:10.1080/17437199.2022.2162947}.
\item Gomonit Munchelou M., Skillman Britni, Swortwood Madeleine J. (2024). \textit{Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS)}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1111/1556-4029.15454}{doi:10.1111/1556-4029.15454}.
\item Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F (2024). \textit{Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2023.12.006}{doi:10.1016/j.euroneuro.2023.12.006}.
\item Sekssaoui M, Bockaert J, Marin P, Bécamel C (2024). \textit{Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT receptor the unique player?}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-024-01794-6}{doi:10.1038/s41386-024-01794-6}.
\item Rouaud A, Calder AE, Hasler G (2024). \textit{Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231225609}{doi:10.1177/02698811231225609}.
\item Wood Madeleine E, Brown Glenna J, Karschner Erin L, Seither Joshua Z, Brown Jordan T, Knittel Jessica L, Walterscheid Jeffrey P (2024). \textit{Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry}. Journal of Analytical Toxicology. [published; Crossref]. \href{https://doi.org/10.1093/jat/bkae002}{doi:10.1093/jat/bkae002}.
\item Strickland JC, Garcia-Romeu A, Johnson MW (2024). \textit{The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0046}{doi:10.1089/psymed.2023.0046}.
\item Barnett BS, Arakelian M, Beebe D, Ontko J, Riegal C, Siu WO, Weleff J, Pope HG (2024). \textit{American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0036}{doi:10.1089/psymed.2023.0036}.
\item Hibicke M, Billac G, Nichols CD (2024). \textit{Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0037}{doi:10.1089/psymed.2023.0037}.
\item Watford T, Masood N (2024). \textit{Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.}. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.9758/cpn.23.1120}{doi:10.9758/cpn.23.1120}.
\item Amarnani AD, Free MF, Baweja R (2024). \textit{Psilocybin and the Development of Serotonin Toxicity.}. The primary care companion for CNS disorders. [published; PubMed]. \href{https://doi.org/10.4088/pcc.23cr03648}{doi:10.4088/pcc.23cr03648}.
\item Aicher H. D., Schmid Y., Gasser P. (2024). \textit{Psychedelika-assistierte Psychotherapie}. Die Psychotherapie. [published; Crossref]. \href{https://doi.org/10.1007/s00278-024-00711-y}{doi:10.1007/s00278-024-00711-y}.
\item Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL. (2024). \textit{The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s Journey}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3941205/v1}{doi:10.21203/rs.3.rs-3941205/v1}.
\item Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt MW, Bernhardt N. (2024). \textit{Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3905152/v1}{doi:10.21203/rs.3.rs-3905152/v1}.
\item Bhatt KV, Weissman CR (2024). \textit{The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects.}. Npj mental health research. [published; PubMed]. \href{https://doi.org/10.1038/s44184-023-00053-8}{doi:10.1038/s44184-023-00053-8}.
\item Nicholas Spiers, Beatriz Caiuby Labate, Anna O. Ermakova, Patrick Farrell, Osiris Sinuhé González Romero, Ibrahim Gabriell, Nidia Olvera (2024). \textit{Indigenous psilocybin mushroom practices: An annotated bibliography}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00297}{doi:10.1556/2054.2023.00297}.
\item McAlpine RG, Sacchet MD, Simonsson O, Khan M, Krajnovic K, Morometescu L, Kamboj SK (2024). \textit{Development of a digital intervention for psychedelic preparation (DIPP).}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-54642-4}{doi:10.1038/s41598-024-54642-4}.
\item Alison Knopf (2024). \textit{NIDA: Psilocybin mushroom seizures rose significantly}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.34037}{doi:10.1002/adaw.34037}.
\item Funk D, Araujo J, Slassi M, Lanthier J, Atkinson J, Feng D, Lau W, Lê A, Higgins GA (2024). \textit{Effect of a single psilocybin treatment on Fos protein expression in male rat brain.}. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroscience.2024.01.001}{doi:10.1016/j.neuroscience.2024.01.001}.
\item Frautschi PC, Singh AP, Stowe NA, Yu JJ (2024). \textit{Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.}. AJNR. American journal of neuroradiology. [published; PubMed]. \href{https://doi.org/10.3174/ajnr.a8118}{doi:10.3174/ajnr.a8118}.
\item Silverstein BH, Kolbman N, Nelson A, Liu T, Guzzo P, Gilligan J, Lee U, Mashour GA, Vanini G, Pal D (2024). \textit{Psilocybin induces dose-dependent changes in functional network organization in rat cortex.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2024.02.09.579718}{doi:10.1101/2024.02.09.579718}.
\item Dirk Trauner, Kenny Calderon-Godinez (2024). \textit{Tryptamine Derivatives of Norpsilocin Induce Psychedelic-Like Responses in Mice}. Synfacts. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0043-1773080}{doi:10.1055/s-0043-1773080}.
\item Hatzipantelis CJ, Olson DE (2024). \textit{The Effects of Psychedelics on Neuronal Physiology.}. Annual review of physiology. [published; PubMed]. \href{https://doi.org/10.1146/annurev-physiol-042022-020923}{doi:10.1146/annurev-physiol-042022-020923}.
\item Hernandez-Leon A, Escamilla-Orozco RI, Tabal-Robles AR, Martínez-Vargas D, Romero-Bautista L, Escamilla-Soto G, González-Romero OS, Torres-Valencia M, González-Trujano ME (2024). \textit{Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.}. Journal of ethnopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.jep.2023.117415}{doi:10.1016/j.jep.2023.117415}.
\item Yale University (2024). \textit{Repeat Dosing of Psilocybin in Headache Disorders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04218539}{source link}.
\item Timmermann C, Zeifman RJ, Erritzoe D, Nutt DJ, Carhart-Harris RL (2024). \textit{Effects of DMT on mental health outcomes in healthy volunteers.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-53363-y}{doi:10.1038/s41598-024-53363-y}.
\item Pagni BA, Petridis PD, Podrebarac SK, Grinband J, Claus ED, Bogenschutz MP (2024). \textit{Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-52967-8}{doi:10.1038/s41598-024-52967-8}.
\item Barba T, Kettner H, Radu C, Peill JM, Roseman L, Nutt DJ, Erritzoe D, Carhart-Harris R, Giribaldi B (2024). \textit{Psychedelics and sexual functioning: a mixed-methods study.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-023-49817-4}{doi:10.1038/s41598-023-49817-4}.
\item Breeksema JJ, Niemeijer A, Krediet E, Karsten T, Kamphuis J, Vermetten E, van den Brink W, Schoevers R (2024). \textit{Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-024-53188-9}{doi:10.1038/s41598-024-53188-9}.
\item Johns Hopkins University (2024). \textit{A Randomized, Double-Blind Study of Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05242029}{source link}.
\item Thomas Müller (2024). \textit{Psilocybin gegen Depressionen}. CME. [published; OpenAlex]. \href{https://doi.org/10.1007/s11298-023-3754-y}{doi:10.1007/s11298-023-3754-y}.
\item Sara De Martin, Daniela Gabbia, Martina Colognesi, Andrea Rinaldi, Luciano Cascione, Ilaria Zanotto, Katia Sayaf, Stefano Comai, Andrea Mattarei, Marco Banzato, Gianfranco Pasut, Franco Folli, Lucia Centofanti, Sergio Traversa, M. Pappagallo, Paolo L. Manfredi (2024). \textit{Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLD}. Digestive and Liver Disease. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dld.2024.01.104}{doi:10.1016/j.dld.2024.01.104}.
\item Alexandra Le Bras (2024). \textit{Effect of psilocybin on pain}. Lab Animal. [published; OpenAlex]. \href{https://doi.org/10.1038/s41684-024-01323-4}{doi:10.1038/s41684-024-01323-4}.
\item Agin-Liebes G, Nielson EM, Zingman M, Kim K, Haas A, Owens LT, Rogers U, Bogenschutz M (2024). \textit{Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.}. Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors. [published; PubMed]. \href{https://doi.org/10.1037/adb0000935}{doi:10.1037/adb0000935}.
\item Borissova A, Rucker JJ (2024). \textit{The development of psilocybin therapy for treatment-resistant depression: an update.}. BJPsych bulletin. [published; PubMed]. \href{https://doi.org/10.1192/bjb.2023.25}{doi:10.1192/bjb.2023.25}.
\item Videira NB, Nair V, Paquet V, Calhoun D (2024). \textit{The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.}. Journal of applied toxicology: JAT. [published; PubMed]. \href{https://doi.org/10.1002/jat.4533}{doi:10.1002/jat.4533}.
\item Sicignano D, Hernandez AV, Schiff B, Elmahy N, White CM (2024). \textit{The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis.}. Current medical research and opinion. [published; PubMed]. \href{https://doi.org/10.1080/03007995.2023.2296968}{doi:10.1080/03007995.2023.2296968}.
\item Fletcher PJ, Li Z, Ji XD, Lê AD (2024). \textit{Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT receptor agonist TCB-2 in male DBA/2J mice.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2023.173703}{doi:10.1016/j.pbb.2023.173703}.
\item Reed F, Foldi CJ (2024). \textit{Do the therapeutic effects of psilocybin involve actions in the gut?}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2023.12.007}{doi:10.1016/j.tips.2023.12.007}.
\item De Filippo R, Schmitz D (2024). \textit{Synthetic surprise as the foundation of the psychedelic experience.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2024.105538}{doi:10.1016/j.neubiorev.2024.105538}.
\item Goff Roman, Smith Morgan, Islam Sabrina, Sisley Sue, Ferguson Jonathan, Kuzdzal Scott, Badal Sunil, Kumar Arun Babu, Sreenivasan Uma, Schug Kevin A. (2024). \textit{Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry}. Analytica Chimica Acta. [published; Crossref]. \href{https://doi.org/10.1016/j.aca.2023.342161}{doi:10.1016/j.aca.2023.342161}.
\item Plourde L, Chang SL, Farzin H, Gagnon P, Hébert J, Foxman R, Deschamps P, Provost F, Masse-Grenier M, Stephan JF, Cheung K, Joly Y, Fallu JS, Dorval M, P3A Study Group (2024). \textit{Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.}. Palliative medicine. [published; PubMed]. \href{https://doi.org/10.1177/02692163231222430}{doi:10.1177/02692163231222430}.
\item Cho M, Rosenbaum D, Schneider E, Hales S (2024). \textit{Will Psilocybin-Assisted Therapy Reduce the Incidence of Medical Assistance in Dying?}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2023.0668}{doi:10.1089/jpm.2023.0668}.
\item Foster K, Morrison I, Tyler M, Delgoda R (2024). \textit{The effect of casing and gypsum on the yield and psychoactive tryptamine content of Psilocybe cubensis (Earle) Singer.}. Fungal biology. [published; PubMed]. \href{https://doi.org/10.1016/j.funbio.2023.12.001}{doi:10.1016/j.funbio.2023.12.001}.
\item Norred MA, Zuschlag ZD, Hamner MB (2024). \textit{A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-023-01983-5}{doi:10.1007/s40265-023-01983-5}.
\item Phil Wolfson, Gita Vaid (2024). \textit{Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1209419}{doi:10.3389/fpsyt.2024.1209419}.
\item Houman Farzin (2024). \textit{Psilocybin-assisted psychotherapy for cancer patients}. International Journal of Whole Person Care. [published; OpenAlex]. \href{https://doi.org/10.26443/ijwpc.v11i1.390}{doi:10.26443/ijwpc.v11i1.390}.
\item Gojani EG, Wang B, Li DP, Kovalchuk O, Kovalchuk I (2024). \textit{The Impact of Psilocybin on High Glucose/Lipid-Induced Changes in INS-1 Cell Viability and Dedifferentiation.}. Genes. [published; PubMed]. \href{https://doi.org/10.3390/genes15020183}{doi:10.3390/genes15020183}.
\item Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3010004}{doi:10.3390/psychoactives3010004}.
\item Timur Zanikov, Marta Gerasymchuk, Gregory Ian Robinson, Esmaeel Ghasemi Gojani, Shima Asghari, Alyssa Groves, Mackenzie Cameron, Rocio Rodriguez-Juarez, Alexandra Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{Psilocybin and eugenol prevent DSS-induced neuroinflammation in mice}. Biocatalysis and Agricultural Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bcab.2024.103033}{doi:10.1016/j.bcab.2024.103033}.
\item University Hospital, Basel, Switzerland (2024). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04227756}{source link}.
\item Massachusetts General Hospital (2024). \textit{The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05381974}{source link}.
\item Payal Ghosh, Debjeet Sur (2024). \textit{Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/0126660822258502231120074036}{doi:10.2174/0126660822258502231120074036}.
\item Brockett AT, Francis NA. (2024). \textit{Psilocybin biphasically modulates cortical and behavioral activity in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.18.576229}{doi:10.1101/2024.01.18.576229}.
\item Javier González-Maeso (2024). \textit{Psychedelics for mental health: a biochemical perspective}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_161}{doi:10.1042/bio\_2023\_161}.
\item Imperial College London (2024). \textit{Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05548075}{source link}.
\item Sherwood AM, Burkhartzmeyer EK, Williamson SE, Baumann MH, Glatfelter GC (2024). \textit{Psychedelic-like Activity of Norpsilocin Analogues.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.3c00610}{doi:10.1021/acschemneuro.3c00610}.
\item Lo DF, Zia H, Rajkumar P, Thakur A, O'Donnell H (2024). \textit{Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.}. The primary care companion for CNS disorders. [published; PubMed]. \href{https://doi.org/10.4088/pcc.23r03581}{doi:10.4088/pcc.23r03581}.
\item Kelsey Klute, Lou Lukas, Soonjo Hwang, Yeongjin Gwon, Mridula Krishnan, Jean L. Grem, Sunil R. Hingorani, Jody Koenig Kellas (2024). \textit{Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma}. Cancer Research. [published; OpenAlex]. \href{https://doi.org/10.1158/1538-7445.panca2023-c001}{doi:10.1158/1538-7445.panca2023-c001}.
\item Marc J. Weintraub, David J. Miklowitz (2024). \textit{How should psychotherapy proceed when adjoined with psychedelics?}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21170}{doi:10.1002/wps.21170}.
\item Kaadt E, Søkilde R, Hansen H, Raval N, Lundgaard L, Just J, Knudsen G, Elfving B. (2024). \textit{MicroRNAs underlying the antidepressant effect of psilocybin - Establishing an nCounter pipeline for microRNA-quantification in the pig brain}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3787179/v1}{doi:10.21203/rs.3.rs-3787179/v1}.
\item Jørgen Østensjø (2024). \textit{Psilocybin virker godt mot depresjon}. Tidsskrift for Den norske legeforening. [published; OpenAlex]. \href{https://doi.org/10.4045/tidsskr.23.0712}{doi:10.4045/tidsskr.23.0712}.
\item Swanson L, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson J, Schallmo M. (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5rm62}{doi:10.31234/osf.io/5rm62}.
\item Link Swanson, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D Evans, Jessica L. Nielson, Michael-Paul Schallmo (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5rm62\_v1}{source link}.
\item Duan W, Cao D, Wang S, Cheng J (2024). \textit{Serotonin 2A Receptor (5-HTR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.}. Chemical reviews. [published; PubMed]. \href{https://doi.org/10.1021/acs.chemrev.3c00375}{doi:10.1021/acs.chemrev.3c00375}.
\item Hinchcliffe JK, Stuart SA, Wood CM, Bartlett J, Kamenish K, Arban R, Thomas CW, Selimbeyoglu A, Hurley S, Hengerer B, Gilmour G, Robinson ESJ (2024). \textit{Rapid-acting antidepressant drugs modulate affective bias in rats.}. Science translational medicine. [published; PubMed]. \href{https://doi.org/10.1126/scitranslmed.adi2403}{doi:10.1126/scitranslmed.adi2403}.
\item Jones Nathan T., Wagner Laura, Hahn Molly C. Pellitteri, Scarlett Cameron O., Wenthur Cody J. (2024). \textit{In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin}. Frontiers in Psychiatry. [published; Crossref]. \href{https://doi.org/10.3389/fpsyt.2023.1303365}{doi:10.3389/fpsyt.2023.1303365}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W. (2024). \textit{Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.07.573163}{doi:10.1101/2024.01.07.573163}.
\item L. Richter, Jozef Al-Gousous, Gabriel Lima Barros de Araújo, Neal M. Davies, Raimar Löbenberg (2024). \textit{Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin}. Journal of Drug Delivery Science and Technology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jddst.2023.105305}{doi:10.1016/j.jddst.2023.105305}.
\item Haakon B. Benestad (2024). \textit{Usikker effekt av psilocybin ved anoreksi}. Tidsskrift for Den norske legeforening. [published; OpenAlex]. \href{https://doi.org/10.4045/tidsskr.23.0734}{doi:10.4045/tidsskr.23.0734}.
\item Johns Hopkins University (2024). \textit{Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05562973}{source link}.
\item Shore R, Dobson K, Thomson N, Barnim N, Bergman H, Rideout K, McKeown S, Olmstead MC, Goldie C, Dumont E. (2024). \textit{Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.04.574146}{doi:10.1101/2024.01.04.574146}.
\item Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X. (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3829237/v1}{doi:10.21203/rs.3.rs-3829237/v1}.
\item Verneri Pellinen (2024). \textit{Psilocybin as a treatment for psychiatric disorders: a review of the literature}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/575808}{source link}.
\item Paula Pastor Muñoz (2024). \textit{Differential effects of psychedelics and classical antidepressants on TrkB dimerization and neurotrophic signalling}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/577777}{source link}.
\item Shayla Frinton (2024). \textit{Perceptions of Psychedelics: University Students' Attitudes and Motives for Psilocybin Use}. UVic's Research and Learning Repository. [published; OpenAlex]. \href{https://hdl.handle.net/1828/16134}{source link}.
\item Michael D. Alpert, Kelley C. O’Donnell, Casey A. Paleos, Evan Sola, Christopher S. Stauffer, Anne Catherine Wagner, Christopher R. Nicholas, Michael C. Mithoefer (2024). \textit{Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20230665}{doi:10.1176/appi.ajp.20230665}.
\item Barajas, Carlos (2024). \textit{Psilocybin’s Role in Major Depressive Disorder: A Scoping Review}. Digital Commons - George Fox University (George Fox University). [published; OpenAlex]. \href{https://digitalcommons.georgefox.edu/dmsc/31}{source link}.
\item R.S. Treviranus, Gottfried (2024). \textit{RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?}. University of Zagreb University Computing Centre (SRCE). [published; OpenAlex]. \href{https://doi.org/10.24869/psyd.2024.134}{doi:10.24869/psyd.2024.134}.
\item Sebastiaan Werten (2024). \textit{Referee report. For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 2; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.80786.r276698}{doi:10.5256/f1000research.80786.r276698}.
\item Manoj K. Doss (2024). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 2 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r96124}{doi:10.21956/wellcomeopenres.24838.r96124}.
\item Rayyan Zafar (2024). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved, 3 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r96127}{doi:10.21956/wellcomeopenres.24838.r96127}.
\item Manesh Girn (2024). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r93854}{doi:10.21956/wellcomeopenres.24838.r93854}.
\item Lorenzo Pasquini (2024). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 3 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r95501}{doi:10.21956/wellcomeopenres.24838.r95501}.
\item Bridget Verhaaren (2024). \textit{Panini and Psilocybin}. Dialogue A Journal of Mormon Thought. [published; OpenAlex]. \href{https://doi.org/10.5406/15549399.57.4.08}{doi:10.5406/15549399.57.4.08}.
\item Matthew B. Young, J. Chai-Rees, Anna Nowakowska, Jeng-Yu Tsai, Guy M. Goodwin (2024). \textit{Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatment}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104163}{doi:10.1016/j.nsa.2024.104163}.
\item Thomas Barba, David Erritzøe, Kyle T. Greenway, Rinki Murphy, John Martell, Christopher Timmermann, Ashleigh Murphy-Beiner, Bruna Giribaldi, Michelle Baker Jones, Brandon Weiss, Robin Carhart-Harris (2024). \textit{Psilocybin vs Escitalopram for depression: 6-month follow-up}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104377}{doi:10.1016/j.nsa.2024.104377}.
\item Kristoffer Brendstrup-Brix, Patrick M. Fisher, Dea Siggaard Stenbæk, Anja Sofie Petersen, Stéphane Armand, Drummond E-Wen McCulloch, Maja Rou Marstrand-Joergensen, Sara Marie Ulv Larsen, Annette Johansen, Rigmor Jensen, Gitte M. Knudsen, M. Madsen (2024). \textit{Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patients}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.105131}{doi:10.1016/j.nsa.2024.105131}.
\item C. Schmitz, Hana Adolphi, Michael Frank, E. Seeger, Maciej Musiał, Moritz Spangemacher, Michael Koslowski, Lea J. Mertens, Florian Schlagenhauf, Gerhard Gründer (2024). \textit{Neural effects of psilocybin-treatment in patients with treatment-resistant depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.105028}{doi:10.1016/j.nsa.2024.105028}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Jaana Ruuska, Mónica Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2024). \textit{Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104774}{doi:10.1016/j.nsa.2024.104774}.
\item L. Belinger, Flora Moujaes, Robin von Rotz, Nathalie M. Rieser, Marcus Herdener, Franz X. Vollenweider, Katrin H. Preller (2024). \textit{Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patients}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104768}{doi:10.1016/j.nsa.2024.104768}.
\item Nerea Martínez-Álvarez, Ines Erkizia-Santamaría, Elena Hernández-Hernández, Amaia M. Erdozain, J. Javier Meana, J.E. Ortega (2024). \textit{Evaluation of the long-term cognitive effects of psilocybin in a chronic stress mouse model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104783}{doi:10.1016/j.nsa.2024.104783}.
\item Watford Tessa (2024). \textit{The Therapeutic Potential of Psilocybin for Depression}. Scientia. [published; Crossref]. \href{https://doi.org/10.33548/scientia1082}{doi:10.33548/scientia1082}.
\item Elena Markos (2024). \textit{Cannabis and Psilocybin: Insurance Reimbursement, Legalization, and Rescheduling}. Health Law Outlook. [published; OpenAlex]. \href{https://doi.org/10.60095/gatb5689}{doi:10.60095/gatb5689}.
\item Prosenjit Ghosh, Avinash Desousa (2024). \textit{Psychedelics: The New Kid on the Block}. Annals of Indian Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4103/aip.aip\_195\_23}{doi:10.4103/aip.aip\_195\_23}.
\item Agata Korlatowicz, Katarzyna Latocha, Paulina Pabian, Ryszard Bugno, Adam S. Hogendorf, Tamás Kovács, Andrzej J. Bojarski, Zoltán V. Varga, Agata Faron-Górecka (2024). \textit{Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104020}{doi:10.1016/j.nsa.2024.104020}.
\item Dominic Sisti (2024). \textit{Introduction to the Special Section on Psychedelics Research and Treatment}. Perspectives in biology and medicine. [published; OpenAlex]. \href{https://doi.org/10.1353/pbm.2024.a919714}{doi:10.1353/pbm.2024.a919714}.
\item Correa RMS (2024). \textit{Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders}. Annals of Bioethics \& Clinical Applications. [published; OpenAlex]. \href{https://doi.org/10.23880/abca-16000266}{doi:10.23880/abca-16000266}.
\item N. Hewitt, J. Chai-Rees, Megan Croal, S. Mistry, Jeng-Yu Tsai, Matthew B. Young, Guy M. Goodwin (2024). \textit{Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousness}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104391}{doi:10.1016/j.nsa.2024.104391}.
\item Rakesh Khanna (2024). \textit{Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions?}. Journal of Indira Gandhi Institute Of Medical Sciences. [published; OpenAlex]. \href{https://doi.org/10.4103/jigims.jigims\_60\_23}{doi:10.4103/jigims.jigims\_60\_23}.
\item Dráulio Barros de Araújo, Tiago Arruda Sanchez, Sidarta Ribeiro (2024). \textit{Brazilian Psychedelic Science and the Frontiers of Psychiatry}. Jornal Brasileiro de Psiquiatria. [published; OpenAlex]. \href{https://doi.org/10.1590/0047-2085-2023-0087}{doi:10.1590/0047-2085-2023-0087}.
\item Kolesnik E., Navarro M. López, Raval N.R., Ozenne B., Hansen H.D. (2024). \textit{Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigs}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2024.105133}{doi:10.1016/j.nsa.2024.105133}.
\item Low F, Earleywine M (2024). \textit{Educational Materials and Image Induction Increase Treatment Credibility.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2154722}{doi:10.1080/02791072.2022.2154722}.
\item Gukasyan N, Narayan SK (2024). \textit{Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2157350}{doi:10.1080/02791072.2022.2157350}.
\item Koning E, Brietzke E (2024). \textit{Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.}. Trends in psychiatry and psychotherapy. [published; PubMed]. \href{https://doi.org/10.47626/2237-6089-2022-0597}{doi:10.47626/2237-6089-2022-0597}.
\item Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D (2024). \textit{Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s0033291723001514}{doi:10.1017/s0033291723001514}.
\item Goodwin GM, Malievskaia E, Fonzo GA, Nemeroff CB (2024). \textit{Must Psilocybin Always "Assist Psychotherapy"?}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20221043}{doi:10.1176/appi.ajp.20221043}.
\item Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D (2024). \textit{Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s0033291723002039}{doi:10.1017/s0033291723002039}.
\item Cavarra M, Mason NL, Kuypers KPC, Bonnelle V, Smith WJ, Feilding A, Kryskow P, Ramaekers JG (2024). \textit{Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.}. European journal of pain (London, England). [published; PubMed]. \href{https://doi.org/10.1002/ejp.2171}{doi:10.1002/ejp.2171}.
\item Gonzales SAB, Alexopoulos C, Arkfeld DG (2024). \textit{Potential Benefits of Psilocybin for Lupus Pain: A Case Report.}. Current rheumatology reviews. [published; PubMed]. \href{https://doi.org/10.2174/1573397119666230904150750}{doi:10.2174/1573397119666230904150750}.
\item Stocker K, Hartmann M, Ley L, Becker AM, Holze F, Liechti ME (2024). \textit{The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231199112}{doi:10.1177/02698811231199112}.
\item Jacobs E, Murphy-Beiner A, Rouiller I, Nutt D, Spriggs MJ (2024). \textit{When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.}. Neuroethics. [published; PubMed]. \href{https://doi.org/10.1007/s12152-023-09536-z}{doi:10.1007/s12152-023-09536-z}.
\item Heresco-Levy U, Lerer B (2024). \textit{Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-023-02312-8}{doi:10.1038/s41380-023-02312-8}.
\item Wolinsky D, Barrett FS, Vandrey R (2024). \textit{The psychedelic effects of cannabis: A review of the literature.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231209194}{doi:10.1177/02698811231209194}.
\item Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D (2024). \textit{Psilocybin and Other Classic Psychedelics in Depression.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2023\_451}{doi:10.1007/7854\_2023\_451}.
\item Hovmand OR, Poulsen ED, Arnfred S (2024). \textit{Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231200019}{doi:10.1177/02698811231200019}.
\item Halman A, Kong G, Sarris J, Perkins D (2024). \textit{Drug-drug interactions involving classic psychedelics: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231211219}{doi:10.1177/02698811231211219}.
\item Jerotic K, Vuust P, Kringelbach ML (2024). \textit{Psychedelia: The interplay of music and psychedelics.}. Annals of the New York Academy of Sciences. [published; PubMed]. \href{https://doi.org/10.1111/nyas.15082}{doi:10.1111/nyas.15082}.
\item Yaden DB, Berghella AP, Hendricks PS, Yaden ME, Levine M, Rohde JS, Nayak S, Johnson MW, Garcia-Romeu A (2024). \textit{IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2023.106998}{doi:10.1016/j.phrs.2023.106998}.
\item Borkel LF, Rojas-Hernández J, Henríquez-Hernández LA, Santana Del Pino Á, Quintana-Hernández DJ (2024). \textit{Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2023.2295997}{doi:10.1080/17512433.2023.2295997}.
\item Nogueira GN, Vasconcelos MMA, Souza FGM, Bisol LW (2024). \textit{Is there credible evidence to assert psilocybin-assisted therapy for depression?}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2023.11.003}{doi:10.1016/j.euroneuro.2023.11.003}.
\item Simonsson O, Hendricks PS, Stenfors CU, Goldberg SB, Honk L, Osika W (2024). \textit{Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231218931}{doi:10.1177/02698811231218931}.
\item O'Donnell KC, Anderson BT, Barrett FS, Bogenschutz MP, Grob CS, Hendricks PS, Kelmendi B, Nayak SM, Nicholas CR, Paleos CA, Stauffer CS, Gukasyan N (2024). \textit{Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230661}{doi:10.1176/appi.ajp.20230661}.
\item Schenberg EE, King F, da Fonseca JE, Roseman L (2024). \textit{Is Poorly Assisted Psilocybin Treatment an Increasing Risk?}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230664}{doi:10.1176/appi.ajp.20230664}.
\item Earleywine M, De Leo J, Bhayana D, Rajanna B, Scott K (2024). \textit{Psilocybin Without Psychotherapy: A Cart Without a Horse?}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230572}{doi:10.1176/appi.ajp.20230572}.
\item Goodwin GM, Malievskaia E, Fonzo GA, Nemeroff CB (2024). \textit{Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230905}{doi:10.1176/appi.ajp.20230905}.
\item Smith WR, Sisti DA, Appelbaum PS (2024). \textit{The safety of supported psilocybin use in Oregon.}. Nature medicine. [published; PubMed]. \href{https://doi.org/10.1038/s41591-023-02727-4}{doi:10.1038/s41591-023-02727-4}.
\item Madsen MK, Petersen AS, Stenbaek DS, Sørensen IM, Schiønning H, Fjeld T, Nykjaer CH, Larsen SMU, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM (2024). \textit{CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.}. Headache. [published; PubMed]. \href{https://doi.org/10.1111/head.14656}{doi:10.1111/head.14656}.
\item Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y (2024). \textit{Older adults in psychedelic-assisted therapy trials: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231215420}{doi:10.1177/02698811231215420}.
\item Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R (2024). \textit{The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1570159x22666231027111147}{doi:10.2174/1570159x22666231027111147}.
\item Cheung K, Earp BD, Yaden DB (2024). \textit{Valuing the Acute Subjective Experience.}. Perspectives in biology and medicine. [published; PubMed]. \href{https://doi.org/10.1353/pbm.2024.a919717}{doi:10.1353/pbm.2024.a919717}.
\item Ibi D (2024). \textit{[Up-to-Date on clinical and preclinical studies of psilocybin therapy].}. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. [published; PubMed]. \href{https://doi.org/10.1254/fpj.24007}{doi:10.1254/fpj.24007}.
\item Olivier B, Olivier JDA (2024). \textit{Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-97-4402-2\_3}{doi:10.1007/978-981-97-4402-2\_3}.
\item Vamvakopoulou IA, Nutt DJ (2024). \textit{Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.}. European addiction research. [published; PubMed]. \href{https://doi.org/10.1159/000540062}{doi:10.1159/000540062}.
\item Marinho EAV, Serra YA, Oliveira-Lima AJ, Marcourakis T, Berro LF (2024). \textit{Ayahuasca for the treatment of alcohol use disorder.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2024.07.007}{doi:10.1016/bs.irn.2024.07.007}.
\item Martire G, Sipple D, Baron D, Gold MS, Lewandowski KU, Dennen CA, Sharafshah A, Elman I, Thanos PK, Modestino EJ, Badgaiyan RD, Pinhasov A, Bowirrat A, Makale M, Roy AK, Sunder K, Murphy KT, Mahajan S, Mahajan Y, Levin C, Blum K (2024). \textit{Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.}. Journal of addiction psychiatry. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/39634920/}{source link}.
\item Armand S, Larsen K, Madsen MK, Ozenne B, Preller KH, Knudsen GM, Stenbæk DS, Fisher PM (2024). \textit{Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2023.103934}{doi:10.1016/j.nsa.2023.103934}.
\item McCulloch DE, Lopez JP, Dalla C, Castrén E, Erritzoe D, Frokjaer VG, Lundberg J, Preller KH, Fisher PM, Knudsen GM (2024). \textit{Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2023.103929}{doi:10.1016/j.nsa.2023.103929}.
\item E-Wen McCulloch D, Liechti ME, Kuypers KP, Nutt D, Lundberg J, Stenbæk DS, Goodwin GM, Gründer G, Butlen-Ducuing F, Haberkamp M, Thirstrup S, Knudsen GM (2024). \textit{Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2024.103938}{doi:10.1016/j.nsa.2024.103938}.
\item Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V (2024). \textit{Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s432537}{doi:10.2147/ndt.s432537}.
\item Neumann J, Dhein S, Kirchhefer U, Hofmann B, Gergs U (2024). \textit{Effects of hallucinogenic drugs on the human heart.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2024.1334218}{doi:10.3389/fphar.2024.1334218}.
\item Petranker R, Anderson T, Fewster EC, Aberman Y, Hazan M, Gaffrey M, Seli P (2024). \textit{Keeping the promise: a critique of the current state of microdosing research.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1217102}{doi:10.3389/fpsyt.2024.1217102}.
\item Fang S, Yang X, Zhang W (2024). \textit{Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1359088}{doi:10.3389/fpsyt.2024.1359088}.
\item Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B (2024). \textit{Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1372373}{doi:10.3389/fpsyt.2024.1372373}.
\item Glynos NG, Aday JS, Kruger D, Boehnke KF, Lake S, Lucas P (2024). \textit{Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1349565}{doi:10.3389/fpsyt.2024.1349565}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.}. American journal of therapeutics. [published; PubMed]. \href{https://doi.org/10.1097/mjt.0000000000001727}{doi:10.1097/mjt.0000000000001727}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.}. American journal of therapeutics. [published; PubMed]. \href{https://doi.org/10.1097/mjt.0000000000001724}{doi:10.1097/mjt.0000000000001724}.
\item Çatal Y, Northoff G (2024). \textit{Where do the symptoms come from in depression? Topography and dynamics matter.}. Brain communications. [published; PubMed]. \href{https://doi.org/10.1093/braincomms/fcae067}{doi:10.1093/braincomms/fcae067}.
\item Robinson CL, Fonseca ACG, Diejomaoh EM, D'Souza RS, Schatman ME, Orhurhu V, Emerick T (2024). \textit{Scoping Review: The Role of Psychedelics in the Management of Chronic Pain.}. Journal of pain research. [published; PubMed]. \href{https://doi.org/10.2147/jpr.s439348}{doi:10.2147/jpr.s439348}.
\item Levin AW, Lancelotta R, Sepeda ND, Gukasyan N, Nayak S, Wagener TL, Barrett FS, Griffiths RR, Davis AK (2024). \textit{The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0300501}{doi:10.1371/journal.pone.0300501}.
\item Straumann I, Holze F, Becker AM, Ley L, Halter N, Liechti ME (2024). \textit{Safety pharmacology of acute psilocybin administration in healthy participants.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2024.104060}{doi:10.1016/j.nsa.2024.104060}.
\item Thomas KL, Jesse R, Mehtani NJ, Mitchell JM, Anderson BT (2024). \textit{Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2201244}{doi:10.1080/02791072.2023.2201244}.
\item Sandbrink JD, Johnson K, Gill M, Yaden DB, Savulescu J, Hannikainen IR, Earp BD (2024). \textit{Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists.}. AJOB neuroscience. [published; PubMed]. \href{https://doi.org/10.1080/21507740.2024.2303154}{doi:10.1080/21507740.2024.2303154}.
\item Norring SA, Spigarelli MG (2024). \textit{The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov.}. Drug design, development and therapy. [published; PubMed]. \href{https://doi.org/10.2147/dddt.s443177}{doi:10.2147/dddt.s443177}.
\item Lerer E, Botvinnik A, Shahar O, Grad M, Blakolmer K, Shomron N, Lotan A, Lerer B, Lifschytz T (2024). \textit{Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2024.1391412}{doi:10.3389/fphar.2024.1391412}.
\item Wang JR, Mendez Araque SJ, Micciche G, McMillan A, Coughlin E, Mattiola R, English D, Kaliebe K (2024). \textit{Palliative care patients' attitudes and openness towards psilocybin-assisted psychotherapy for existential distress.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1301960}{doi:10.3389/fpsyt.2024.1301960}.
\item Yu Z, Burback L, Winkler O, Xu L, Dennett L, Vermetten E, Greenshaw A, Li XM, Milne M, Wang F, Cao B, Winship IR, Zhang Y, Chan AW (2024). \textit{Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1386321}{doi:10.3389/fpsyt.2024.1386321}.
\item Žuljević MF, Breški N, Kaliterna M, Hren D (2024). \textit{Attitudes of European psychiatrists on psychedelics: a qualitative study.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1411234}{doi:10.3389/fpsyt.2024.1411234}.
\item Xu M, Kiss AJ, Jones JA, McMurray MS, Shi H (2024). \textit{Effect of oral tryptamines on the gut microbiome of rats-a preliminary study.}. PeerJ. [published; PubMed]. \href{https://doi.org/10.7717/peerj.17517}{doi:10.7717/peerj.17517}.
\item Wang CK, Kim G, Aleksandrova LR, Panenka WJ, Barr AM (2024). \textit{A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2024.1387158}{doi:10.3389/fphar.2024.1387158}.
\item Bornemann J, Close JB, Ahmad K, Barba T, Godfrey K, Macdonald L, Erritzoe D, Nutt D, Carhart-Harris R (2024). \textit{Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1320780}{doi:10.3389/fpsyt.2024.1320780}.
\item Szafoni S, Gręblowski P, Grabowska K, Więckiewicz G (2024). \textit{Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1406888}{doi:10.3389/fpsyt.2024.1406888}.
\item Jones GM, Ricard JA, Nock MK (2024). \textit{Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1169686}{doi:10.3389/fpsyt.2024.1169686}.
\item Bienemann B, Barbosa AR, Cruz LVMD, Multedo M, Mograbi D (2024). \textit{Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2226414}{doi:10.1080/02791072.2023.2226414}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO (2024). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Zheng S, Ma R, Yang Y, Li G (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Do A, Michaud V, Stephan JF, Moreau M, Benoît É, Bérubé FA, Bibaud-De Serres A, Taillefer A, Vincent P (2024). \textit{Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1394962}{doi:10.3389/fpsyt.2024.1394962}.
\item DeBonis K (2024). \textit{Revisiting psychiatry's relationship with spirituality.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1441922}{doi:10.3389/fpsyt.2024.1441922}.
\item Bhagavan C, Kanaan R, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, McKernon D, Roebuck G, Rucker J, Butler M, Bryson A (2024). \textit{Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.}. Psychiatric research and clinical practice. [published; PubMed]. \href{https://doi.org/10.1176/appi.prcp.20240047}{doi:10.1176/appi.prcp.20240047}.
\item Amberger C, Szczesniak L (2024). \textit{[The nursing role in psychedelic-assisted psychotherapy].}. Revue de l'infirmiere. [published; PubMed]. \href{https://doi.org/10.1016/j.revinf.2024.07.014}{doi:10.1016/j.revinf.2024.07.014}.
\item VanderZwaag B, Garcia-Romeu A, Garcia-Barrera MA (2024). \textit{Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253241264812}{doi:10.1177/20451253241264812}.
\item Chen MH, Cheng SL, Kao YC, Tseng PT, Hsu CW, Yu CL, Yang FC, Thompson T, Hsu TW, Liang CS (2024). \textit{The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1439347}{doi:10.3389/fpsyt.2024.1439347}.
\item Martial C, Carhart-Harris R, Timmermann C (2024). \textit{Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niae033}{doi:10.1093/nc/niae033}.
\item Davis AK, Timmermann C, Ortiz Bernal AM, Lancelotta R, Nayak S, Sepeda ND, Nikolaidis A, Griffiths RR (2024). \textit{Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2232379}{doi:10.1080/02791072.2023.2232379}.
\item Korman BA (2024). \textit{On the mushrooming reports of "quiet quitting": Employees' lifetime psilocybin use predicts their overtime hours worked.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2242358}{doi:10.1080/02791072.2023.2242358}.
\item Palamar JJ, Rutherford C, Le A, Keyes KM (2024). \textit{Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2240322}{doi:10.1080/02791072.2023.2240322}.
\item Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM, Rosenblat JD, Blumberger DM, Mulsant BH, Husain MI (2024). \textit{Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2251133}{doi:10.1080/02791072.2023.2251133}.
\item Gobbi G (2024). \textit{CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.}. Journal of psychiatry \& neuroscience: JPN. [published; PubMed]. \href{https://doi.org/10.1503/jpn.240037}{doi:10.1503/jpn.240037}.
\item Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W (2024). \textit{Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1416420}{doi:10.3389/fpsyt.2024.1416420}.
\item Mamat R, Rashid RA, Shin SM, Ibrahim B, Wahab S, Ahmad A (2024). \textit{Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia.}. Journal of addictive diseases. [published; PubMed]. \href{https://doi.org/10.1080/10550887.2023.2240932}{doi:10.1080/10550887.2023.2240932}.
\item Kim K, Yusuf A, Sud A, Persaud N, Kirubarajan A, Moller M, Lloyd T, O'Neill B (2024). \textit{Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0309911}{doi:10.1371/journal.pone.0309911}.
\item Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT (2024). \textit{A narrative exploration of psilocybin's potential in mental health.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1429373}{doi:10.3389/fpsyt.2024.1429373}.
\item Card KG, Grewal A, Closson K, Martin G, Baracaldo L, Allison S, Kruger DJ, Walsh Z (2024). \textit{Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2268640}{doi:10.1080/02791072.2023.2268640}.
\item Žuljević MF, Mijatović A, Marušić SL, Kudrjavets G, Buljan I, Hren D (2024). \textit{Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2274382}{doi:10.1080/02791072.2023.2274382}.
\item Rahman SM, Salem Y, Hussain A (2024). \textit{Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.}. Dermatitis: contact, atopic, occupational, drug. [published; PubMed]. \href{https://doi.org/10.1089/derm.2023.0292}{doi:10.1089/derm.2023.0292}.
\item Kanis FC, Broude CN, Hellwarth EB, Gibbons WJ, Sen AK, Adams AM, Wang X, Jones JA (2024). \textit{Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities.}. Biotechnology progress. [published; PubMed]. \href{https://doi.org/10.1002/btpr.3492}{doi:10.1002/btpr.3492}.
\item Woollacott M, Riddle J, Hermansson N, Sacchet MD, Ingram DM (2024). \textit{Fire Kasina advanced meditation produces experiences comparable to psychedelic and near-death experiences: A pilot study.}. Explore (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1016/j.explore.2024.103056}{doi:10.1016/j.explore.2024.103056}.
\item Rucker J, Butler M, Hambleton S, Bird C, Seynaeve M, Cheema S, Campbell-Coker K, Maggio C, Dunbar F, Lambru G, Matharu M (2024). \textit{Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.}. Headache. [published; PubMed]. \href{https://doi.org/10.1111/head.14837}{doi:10.1111/head.14837}.
\item Lee J, Philip K, Wijeysundera DN, Clarke H, Pritlove C, Katz J, Ritvo P, Goel A, Husain MI, Ladha KS (2024). \textit{Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial.}. Canadian journal of pain = Revue canadienne de la douleur. [published; PubMed]. \href{https://doi.org/10.1080/24740527.2024.2406285}{doi:10.1080/24740527.2024.2406285}.
\item Noah S, Shen M, Erowid E, Erowid F, Silver M (2024). \textit{A novel method for quantitative analysis of subjective experience reports: application to psychedelic visual experiences.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2024.1397064}{doi:10.3389/fpsyg.2024.1397064}.
\item Brett J, Knock E, Watson K, Albert S, Siefried KJ, Guss J (2024). \textit{Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1490907}{doi:10.3389/fpsyt.2024.1490907}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LSM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR (2024). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.}. Wellcome open research. [published; PubMed]. \href{https://doi.org/10.12688/wellcomeopenres.22543.2}{doi:10.12688/wellcomeopenres.22543.2}.
\item Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG, Pozo OJ (2023). \textit{Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.}. Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie. [published; PubMed]. \href{https://doi.org/10.1016/j.biopha.2023.115775}{doi:10.1016/j.biopha.2023.115775}.
\item Verheijen Marcha C.T. (2023). \textit{Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge}. Journal of the Netherlands Society of Toxicology. [published; Crossref]. \href{https://doi.org/10.61833/jnst.2024.0002}{doi:10.61833/jnst.2024.0002}.
\item Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś (2023). \textit{Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.50.01.005}{doi:10.12775/jehs.2023.50.01.005}.
\item Tianran Liu (2023). \textit{The Therapeutic Effect and Potential Application of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/3cfwjn09}{doi:10.54097/3cfwjn09}.
\item Danias G, Appel J (2023). \textit{Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis.}. JMIR formative research. [published; PubMed]. \href{https://doi.org/10.2196/43850}{doi:10.2196/43850}.
\item Poulin JM, Bigford GE, Lanctot KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, MacIntosh BJ, Nestor SM. (2023). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3474764/v1}{doi:10.21203/rs.3.rs-3474764/v1}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/byms6}{doi:10.31234/osf.io/byms6}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a8xwk}{doi:10.31234/osf.io/a8xwk}.
\item Multidisciplinary Association for Psychedelic Studies (2023). \textit{Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00979693}{source link}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/byms6\_v1}{source link}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a8xwk\_v1}{source link}.
\item Wojtas A, Gołembiowska K (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Jingxuan Chen (2023). \textit{Application of psilocybin in mental health disorders}. Theoretical and Natural Science. [published; OpenAlex]. \href{https://doi.org/10.54254/2753-8818/21/20230859}{doi:10.54254/2753-8818/21/20230859}.
\item Du Y, Li Y, Zhao X, Yao Y, Wang B, Zhang L, Wang G (2023). \textit{Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity.}. Chinese medical journal. [published; PubMed]. \href{https://doi.org/10.1097/cm9.0000000000002647}{doi:10.1097/cm9.0000000000002647}.
\item Kolbman N, Liu T, Guzzo P, Gilligan J, Mashour GA, Vanini G, Pal D (2023). \textit{Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain.}. Current biology: CB. [published; PubMed]. \href{https://doi.org/10.1016/j.cub.2023.10.016}{doi:10.1016/j.cub.2023.10.016}.
\item Yale University (2023). \textit{Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02981173}{source link}.
\item Robinson GI, Li D, Wang B, Rahman T, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I (2023). \textit{Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.}. Life (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/life13122345}{doi:10.3390/life13122345}.
\item Reinwald JR, Schmitz CN, Skorodumov I, Kuchar M, Weber-Fahr W, Spanagel R, Meinhardt MW (2023). \textit{Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-023-02690-1}{doi:10.1038/s41398-023-02690-1}.
\item Caíque Gois Cardoso, Milena de Barros Viana (2023). \textit{Psychedelics and cognitive function: A systematic review}. Research Society and Development. [published; OpenAlex]. \href{https://doi.org/10.33448/rsd-v12i14.44436}{doi:10.33448/rsd-v12i14.44436}.
\item Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C. (2023). \textit{Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.12.571374}{doi:10.1101/2023.12.12.571374}.
\item Cardoso Marilia Santoro, da Cunha Kelly Francisco, Silva Izabelly Geraldes, Fiorentin Taís Regina, de Campos Eduardo G, Costa Jose Luiz (2023). \textit{Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samples}. Journal of Analytical Toxicology. [published; Crossref]. \href{https://doi.org/10.1093/jat/bkad064}{doi:10.1093/jat/bkad064}.
\item Ivana Turek (2023). \textit{Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin}. Medical Writing. [published; OpenAlex]. \href{https://doi.org/10.56012/tsen2260}{doi:10.56012/tsen2260}.
\item Trần Nguyên Hà, Đặng Đức Khanh, Phạm Đức Trọng, Nguyễn Xuân Trường (2023). \textit{CHIẾT XUẤT PSILOCIN TỪ NẤM THỨC THẦN LÀM NGUYÊN LIỆU THIẾT LẬP CHUẨN}. Tạp chí Y học Quân sự. [published; Crossref]. \href{https://doi.org/10.59459/1859-1655/jmm.282}{doi:10.59459/1859-1655/jmm.282}.
\item Starkey J, Carhart-Harris RL, Pigorini A, Nobili L, Barrett AB. (2023). \textit{Statistical diversity distinguishes global states of consciousness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.05.570101}{doi:10.1101/2023.12.05.570101}.
\item McTaggart AR, McLaughlin S, Slot JC, McKernan K, Appleyard C, Bartlett TL, Weinert M, Barlow C, Warne LN, Shuey LS, Drenth A, James TY (2023). \textit{Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.}. Current biology: CB. [published; PubMed]. \href{https://doi.org/10.1016/j.cub.2023.10.059}{doi:10.1016/j.cub.2023.10.059}.
\item Skiles Z, Dixon JR, Friedrich D, Reed D, Stauffer CS (2023). \textit{Peer support and psychedelics.}. Journal of military, veteran and family health. [published; PubMed]. \href{https://doi.org/10.3138/jmvfh-2023-0008}{doi:10.3138/jmvfh-2023-0008}.
\item Dyck E, Marchildon GP (2023). \textit{A history and future of psychedelics: The case of the Canadian military.}. Journal of military, veteran and family health. [published; PubMed]. \href{https://doi.org/10.3138/jmvfh-2023-0010}{doi:10.3138/jmvfh-2023-0010}.
\item Schindler EAD, Sico JJ (2023). \textit{Studying classic psychedelics for the management of headache disorders: Considerations for Veterans.}. Journal of military, veteran and family health. [published; PubMed]. \href{https://doi.org/10.3138/jmvfh-2023-0006}{doi:10.3138/jmvfh-2023-0006}.
\item Nicoletta Faraone (2023). \textit{Flies on ’Shrooms: Studying the Psychotherapeutic Potential of Psilocybin using Drosophila}. American Entomologist. [published; OpenAlex]. \href{https://doi.org/10.1093/ae/tmad063}{doi:10.1093/ae/tmad063}.
\item McCrone P, Fisher H, Knight C, Harding R, Schlag AK, Nutt DJ, Neill JC (2023). \textit{Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s0033291723001411}{doi:10.1017/s0033291723001411}.
\item Keyes KM, Patrick ME (2023). \textit{Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16259}{doi:10.1111/add.16259}.
\item Crowe M, Manuel J, Carlyle D, Lacey C (2023). \textit{Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?}. International journal of mental health nursing. [published; PubMed]. \href{https://doi.org/10.1111/inm.13214}{doi:10.1111/inm.13214}.
\item Gramling R, Bennett E, Curtis K, Richards W, Rizzo DM, Arnoldy F, Hegg L, Porter J, Honstein H, Pratt S, Tarbi E, Reblin M, Thambi P, Agrawal M (2023). \textit{Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2023.0189}{doi:10.1089/jpm.2023.0189}.
\item Jones G, Herrmann F, Wang E (2023). \textit{Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use.}. Addictive behaviors reports. [published; PubMed]. \href{https://doi.org/10.1016/j.abrep.2023.100513}{doi:10.1016/j.abrep.2023.100513}.
\item Pepe M, Hesami M, de la Cerda KA, Perreault ML, Hsiang T, Jones AMP (2023). \textit{A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.}. Biotechnology advances. [published; PubMed]. \href{https://doi.org/10.1016/j.biotechadv.2023.108247}{doi:10.1016/j.biotechadv.2023.108247}.
\item Śladowska K, Kawalec P, Brzostek T, Pilc A (2023). \textit{Potential use of psilocybin drugs in the treatment of depression.}. Expert opinion on emerging drugs. [published; PubMed]. \href{https://doi.org/10.1080/14728214.2023.2264180}{doi:10.1080/14728214.2023.2264180}.
\item Wsół A (2023). \textit{Cardiovascular safety of psychedelic medicine: current status and future directions.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00539-4}{doi:10.1007/s43440-023-00539-4}.
\item Kolasa M, Faron-Górecka A (2023). \textit{Preclinical models of treatment-resistant depression: challenges and perspectives.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00542-9}{doi:10.1007/s43440-023-00542-9}.
\item Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST (2023). \textit{Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.}. Drug discovery today. [published; PubMed]. \href{https://doi.org/10.1016/j.drudis.2023.103818}{doi:10.1016/j.drudis.2023.103818}.
\item Holas P, Kamińska J (2023). \textit{Mindfulness meditation and psychedelics: potential synergies and commonalities.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00551-8}{doi:10.1007/s43440-023-00551-8}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Wojtas A (2023). \textit{The possible place for psychedelics in pharmacotherapy of mental disorders.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00550-9}{doi:10.1007/s43440-023-00550-9}.
\item Boudreau E, Orlowski K (2023). \textit{Psilocybin therapy to reduce depression following a terminal diagnosis.}. JAAPA: official journal of the American Academy of Physician Assistants. [published; PubMed]. \href{https://doi.org/10.1097/01.jaa.0000994952.07847.2d}{doi:10.1097/01.jaa.0000994952.07847.2d}.
\item Ahlskog G (2023). \textit{Psilocybin's Erasure of EGO.}. Psychoanalytic review. [published; PubMed]. \href{https://doi.org/10.1521/prev.2023.110.4.457}{doi:10.1521/prev.2023.110.4.457}.
\item Mathai DS, Hilbert S, Sepeda ND, Strickland JC, Griffiths RR, Garcia-Romeu A (2023). \textit{Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0035}{doi:10.1089/psymed.2023.0035}.
\item Carter S, Packard G, Coghlan C, George JR, Brown AJ, Ching THW, Julian J, Maples-Keller JL (2023). \textit{Perceptions of psychedelic-assisted therapy among Black Americans.}. Journal of mood and anxiety disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.xjmad.2023.100023}{doi:10.1016/j.xjmad.2023.100023}.
\item Weintraub MJ, Jeffrey JK, Grob CS, Ichinose MC, Bergman RL, Cooper ZD, Miklowitz DJ (2023). \textit{Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0018}{doi:10.1089/psymed.2023.0018}.
\item Brennan W, Kelman AR, Belser AB (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0007}{doi:10.1089/psymed.2023.0007}.
\item Nicholas CR, Horton DM, Malicki J, Baltes A, Hutson PR, Brown RT (2023). \textit{Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0012}{doi:10.1089/psymed.2023.0012}.
\item Lennart Wiepking, Eduard J. de Bruin, Alexandra Ghiţă (2023). \textit{The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00244}{doi:10.1556/2054.2023.00244}.
\item Apex Labs Ltd. (2023). \textit{A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD).}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06141876}{source link}.
\item van der Schuur-Saleem R, Visser E, Robben H, Zwols M, den Besten-Berthololee D (2023). \textit{[Feeling unwell after eating a piece of chocolate].}. Nederlands tijdschrift voor geneeskunde. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/38175555/}{source link}.
\item McAlpine R, Krajnović K, Khan M, Morometescu L, Simonsson O, Sacchet M, Kamboj S. (2023). \textit{Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9ev27}{doi:10.31234/osf.io/9ev27}.
\item Rosalind McAlpine, Katarina Krajnović, Maisha Khan, Larisa Morometescu, Otto Simonsson, Matthew Sacchet, Sunjeev Kamboj (2023). \textit{Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9ev27\_v1}{source link}.
\item Tahlia R. Harrison (2023). \textit{Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00267}{doi:10.1556/2054.2023.00267}.
\item McTaggart A, Scarlett K, Slot J, Barlow C, Appleyard C, Gardiner D, Fechner N, Tilden J, Hass D, Voogelbreinder S, Lording W, Lloyd R, Shuey L, Drenth A, James T. (2023). \textit{Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphere}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.170019739.91075425/v1}{doi:10.22541/au.170019739.91075425/v1}.
\item Danelle Jones (2023). \textit{Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00306}{doi:10.1556/2054.2023.00306}.
\item Kamilė Žalkauskaitė, Justina Kirdeikytė, Vilius Ogenskas (2023). \textit{The potential use of psilocybin in psychiatry}. Lithuanian University of Health Sciences. [published; OpenAlex]. \href{https://hdl.handle.net/20.500.12512/239546}{source link}.
\item Schoeller F, Jain A, Adrien V, Maes P, Reggente N. (2023). \textit{Aesthetic Chills Mitigate Maladaptive Cognition In Depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3582420/v1}{doi:10.21203/rs.3.rs-3582420/v1}.
\item COMPASS Pathways (2023). \textit{The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04739865}{source link}.
\item Rosas FE, Mediano PA, Timmermann C, Luppi AI, Candia-Rivera D, Abbasi-Asl R, Gazzaley A, Kringelbach ML, Muthukumaraswamy S, Bor D, Garfinkel S, Carhart-Harris RL. (2023). \textit{The entropic heart: Tracking the psychedelic state via heart rate dynamics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.11.07.566008}{doi:10.1101/2023.11.07.566008}.
\item Omer A. Syed, Benjamin Tsang (2023). \textit{Managing expectations with psychedelic microdosing}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-023-00044-9}{doi:10.1038/s44184-023-00044-9}.
\item Elizabeth Sugiarto, Rebecca Leung, Jamie Yuen (2023). \textit{Pharmacists’ perspectives on psilocybin in Canada}. JAPhA Practice Innovations. [published; OpenAlex]. \href{https://doi.org/10.1016/j.japhpi.2023.100003}{doi:10.1016/j.japhpi.2023.100003}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A (2023). \textit{Beyond the 5-HT Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item Lucas A. Paul, Cyril T. Namba-Nzanguim, Aidani Telesphory, Jehoshaphat Oppong Mensah, Denis Mteremko, Rene Costa, Saidi Mohamedi Katundu, Lucas P. Kwiyukwa, Naserian Daniel Kambaine, Julius Juvenary, Sixberth Mlowe, Geradius Deogratias, Daniel M. Shadrack, Andrew S. Paluch (2023). \textit{Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation study}. Journal of Molecular Liquids. [published; OpenAlex]. \href{https://doi.org/10.1016/j.molliq.2023.123479}{doi:10.1016/j.molliq.2023.123479}.
\item 7450 Summit Cir, Davison, MI48423, Sarah Naher (2023). \textit{The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review}. Journal of Sociology Psychology \& Religious Studies. [published; OpenAlex]. \href{https://doi.org/10.53819/81018102t4217}{doi:10.53819/81018102t4217}.
\item Van Der Walt J, Parker R (2023). \textit{LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.}. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. [published; PubMed]. \href{https://doi.org/10.7196/samj.2023.v113i11.814}{doi:10.7196/samj.2023.v113i11.814}.
\item Gray JC, Murphy M, Carter SE, Johnson MW, Wolfgang AS, Roy MJ, Maples-Keller JL (2023). \textit{Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury.}. Military medicine. [published; PubMed]. \href{https://doi.org/10.1093/milmed/usac400}{doi:10.1093/milmed/usac400}.
\item Schäfer E, Seibold PS, Bartram S, Trottmann F, Haensch VG, Gressler M, Chadeayne AR, Hertweck C, O'Connor SE, Hoffmeister D (2023). \textit{A "Magic Mushroom" Multi-Product Sesquiterpene Synthase.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202300511}{doi:10.1002/cbic.202300511}.
\item Miller DR, Jacobs JT, Rockefeller A, Singer H, Bollinger IM, Conway J, Slot JC, Cliffel DE (2023). \textit{Cultivation, chemistry, and genome of.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.11.01.564784}{doi:10.1101/2023.11.01.564784}.
\item Emese Prandovszky, Zachary A. Cordner, Hua Liu, Megan Pedicini, Lindsey Macias, Kellie L. Tamashiro, Robert H. Yolken (2023). \textit{Anxiolytic behavior accompanied by the alteration of the intestinal bacteriome during psilocybin treatment}. Brain Behavior and Immunity. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbi.2024.01.164}{doi:10.1016/j.bbi.2024.01.164}.
\item Roxanne Sholevar (2023). \textit{Peak Experiences: Lessons Learned from a Feasibility Study of Psilocybin-assisted Therapy for Demoralization in Patients Receiving Hospice Care}. Journal of the Academy of Consultation-Liaison Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaclp.2023.11.229}{doi:10.1016/j.jaclp.2023.11.229}.
\item Muller S, Cavanna F, de la Fuente L, Bruno N, D’Amelio TA, Pallavicini C, Tagliazucchi E. (2023). \textit{Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.27.564413}{doi:10.1101/2023.10.27.564413}.
\item Baker KM, Ulrich CM, Meghani SH (2023). \textit{An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations.}. The American journal of hospice \& palliative care. [published; PubMed]. \href{https://doi.org/10.1177/10499091221147700}{doi:10.1177/10499091221147700}.
\item Downey AE, Boyd M, Chaphekar AV, Woolley J, Raymond-Flesch M (2023). \textit{"But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.}. The International journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1002/eat.24041}{doi:10.1002/eat.24041}.
\item Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2023.07.011}{doi:10.1016/j.euroneuro.2023.07.011}.
\item Mason NL, Szabo A, Kuypers KPC, Mallaroni PA, de la Torre Fornell R, Reckweg JT, Tse DHY, Hutten NRPW, Feilding A, Ramaekers JG (2023). \textit{Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study.}. Brain, behavior, and immunity. [published; PubMed]. \href{https://doi.org/10.1016/j.bbi.2023.09.004}{doi:10.1016/j.bbi.2023.09.004}.
\item Linguiti S, Vogel JW, Sydnor VJ, Pines A, Wellman N, Basbaum A, Eickhoff CR, Eickhoff SB, Edwards RR, Larsen B, McKinstry-Wu A, Scott JC, Roalf DR, Sharma V, Strain EC, Corder G, Dworkin RH, Satterthwaite TD (2023). \textit{Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2023.105421}{doi:10.1016/j.neubiorev.2023.105421}.
\item Malikowska-Racia N, Koniewski M, Golebiowska J, Popik P (2023). \textit{Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231205692}{doi:10.1177/02698811231205692}.
\item Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2023.115531}{doi:10.1016/j.psychres.2023.115531}.
\item Olafsson RP, Kvaran K, Ketilsdottir K, Hallgrimsdottir K, Sigurdsson EL, Sigurdsson E (2023). \textit{[Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].}. Laeknabladid. [published; PubMed]. \href{https://doi.org/10.17992/lbl.2023.11.766}{doi:10.17992/lbl.2023.11.766}.
\item Liu LQ, Chen JZ, Fu WS, Tang CY (2023). \textit{[Determination of amanita peptide and tryptamine toxins in wild mushrooms by high performance liquid chromatography-tandem mass spectrometry].}. Se pu = Chinese journal of chromatography. [published; PubMed]. \href{https://doi.org/10.3724/sp.j.1123.2023.07013}{doi:10.3724/sp.j.1123.2023.07013}.
\item Raj P, Rauniyar S, Sapkale B (2023). \textit{Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.48719}{doi:10.7759/cureus.48719}.
\item Henry Harder, Fabian P. Steinmetz, Maja Kohek (2023). \textit{The Psychedelic Social Club: a regulatory concept for people who use psychedelics?}. Drugs Education Prevention and Policy. [published; OpenAlex]. \href{https://doi.org/10.1080/09687637.2023.2276067}{doi:10.1080/09687637.2023.2276067}.
\item Banushi B, Polito V (2023). \textit{A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.}. Biology. [published; PubMed]. \href{https://doi.org/10.3390/biology12111380}{doi:10.3390/biology12111380}.
\item Patricia Kubala (2023). \textit{Songs of Life: Psychedelic-Assisted Psychotherapy and Deleuze and Guattari’s ‘Desiring-Production’}. Deleuze and Guattari Studies. [published; OpenAlex]. \href{https://doi.org/10.3366/dlgs.2023.0531}{doi:10.3366/dlgs.2023.0531}.
\item Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B. (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4gfyd}{doi:10.31234/osf.io/4gfyd}.
\item Sarah Kratina, Chris Lo, Robert Schwartz, Carol Strike, Sydney Jopling, Ayah Nayfeh, Brian Rush (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4gfyd\_v1}{source link}.
\item Natasha Biscoe, Amanda Bonson, Max Slavin, Walter Busuttil, Deirdre MacManus, Andrew T. Cox, Dominic Murphy (2023). \textit{Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol}. European Journal of Trauma \& Dissociation. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ejtd.2023.100359}{doi:10.1016/j.ejtd.2023.100359}.
\item Jules Evans, Oliver Robinson, Eirini K. Argyri, Shayam Suseelan, Ashleigh Murphy-Beiner, Rosalind McAlpine, David Luke, Katrina Michelle, Ed Prideaux (2023). \textit{Extended difficulties following the use of psychedelic drugs: A mixed methods study}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0293349}{doi:10.1371/journal.pone.0293349}.
\item Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Andrew Jones J, McMurray MS. (2023). \textit{Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.19.563138}{doi:10.1101/2023.10.19.563138}.
\item Lucia Carbajal, Tessa E. Moore, R. H. Barry Sample, Joseph Nelson (2023). \textit{Is psilocybin effective for treatment of depression?}. Evidence-Based Practice. [published; OpenAlex]. \href{https://doi.org/10.1097/ebp.0000000000002021}{doi:10.1097/ebp.0000000000002021}.
\item Brian Macallan (2023). \textit{Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences}. Religions. [published; OpenAlex]. \href{https://doi.org/10.3390/rel14101312}{doi:10.3390/rel14101312}.
\item Mathai DS, Roberts DE, Nayak SM, Sepeda ND, Lehrner A, Johnson M, Lowe MX, Jackson H, Garcia-Romeu A. (2023). \textit{Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/hm6jn}{doi:10.31234/osf.io/hm6jn}.
\item Mathai DS, Roberts DE, Nayak SM, Sepeda ND, Lehrner A, Johnson M, Lowe MX, Jackson H, Garcia-Romeu A. (2023). \textit{Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/hm6jn\_v1}{doi:10.31234/osf.io/hm6jn\_v1}.
\item Rieser NM, Gubser LP, Moujaes F, Duerler P, Lewis CR, Michels L, Vollenweider FX, Preller KH (2023). \textit{Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-023-44153-z}{doi:10.1038/s41598-023-44153-z}.
\item David S Mathai, Daniel E Roberts, Sandeep M Nayak, Nathan D Sepeda, Amy Lehrner, Matthew Johnson, Matthew X Lowe, Heather Jackson, Albert Garcia-Romeu (2023). \textit{Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/hm6jn\_v1}{source link}.
\item Ian B. Hickie, Allan H. Young, F. Markus Leweke (2023). \textit{Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?}. Research Directions Depression. [published; OpenAlex]. \href{https://doi.org/10.1017/dep.2023.21}{doi:10.1017/dep.2023.21}.
\item Tyagi R, Saraf TS, Canal CE (2023). \textit{The Psychedelic,-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.3c00137}{doi:10.1021/acsptsci.3c00137}.
\item Payman Baharmand, Amardeep Kambo (2023). \textit{Assessing Metro Vancouver Residents’ Knowledge and Opinions of Psilocybin}. BCIT Environmental Public Health Journal. [published; OpenAlex]. \href{https://doi.org/10.47339/ephj.2023.229}{doi:10.47339/ephj.2023.229}.
\item Yale University (2023). \textit{Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03806985}{source link}.
\item Yale University (2023). \textit{Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03341689}{source link}.
\item Kargbo RB (2023). \textit{Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.3c00390}{doi:10.1021/acsmedchemlett.3c00390}.
\item Enriquez-Geppert S, Krc J, O'Higgins F, Lietz MP. (2023). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/jqasf}{doi:10.31234/osf.io/jqasf}.
\item Stefanie Enriquez-Geppert, Jaroslav Krc, Fiachra O'Higgins, Morten P. Lietz (2023). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/jqasf\_v1}{source link}.
\item Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter (2023). \textit{Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future}. Georgetown Scientific Research Journal. [published; OpenAlex]. \href{https://doi.org/10.48091/gsr.v3i2.62}{doi:10.48091/gsr.v3i2.62}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2023). \textit{Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.06.561183}{doi:10.1101/2023.10.06.561183}.
\item Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain (2023). \textit{Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?}. Clinical Pharmacology \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1002/cpt.3050}{doi:10.1002/cpt.3050}.
\item Donegan CJ, Daldegan-Bueno D, Sumner R, Menkes D, Evans W, Hoeh N, Sundram F, Reynolds L, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Forsyth A, Bansal M, Muthukumaraswamy S (2023). \textit{An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).}. Pilot and feasibility studies. [published; PubMed]. \href{https://doi.org/10.1186/s40814-023-01399-8}{doi:10.1186/s40814-023-01399-8}.
\item Chloé Galipeau, Miguel Farinha-Ferreira, Jean-Charles Mariani, Samuel Diebolt, Louis Barthe, Renata Santos, Zsolt Lenkei, Ana M. Sebastião (2023). \textit{UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBIN}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1116}{doi:10.1016/j.ibneur.2023.08.1116}.
\item Aneta Petrušková, Eva-Maria Weiss, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló, Renato Frischknecht, Tomáš Páleníček, Anna Fejtová (2023). \textit{MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.608}{doi:10.1016/j.ibneur.2023.08.608}.
\item Ines Erkizia-Santamaría, J. Javier Meana, Igor Horrillo, Jorge E. Ortega (2023). \textit{PSILOCYBIN EXERTS ANTIDEPRESSANT EFFECTS IN A CHRONIC UNPREDICTABLE MILD STRESS (CUMS) ANIMAL MODEL}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1097}{doi:10.1016/j.ibneur.2023.08.1097}.
\item Tomáš Páleníček, Tereza Klučková, M. Nikolič, Čestmír Vejmola, Filip Tylš, Vojtěch Viktorin, Jiřı́ Horáček, Martin Brunovský (2023). \textit{DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1240}{doi:10.1016/j.ibneur.2023.08.1240}.
\item Amanda E. Downey (2023). \textit{6.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the Research}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2023.07.666}{doi:10.1016/j.jaac.2023.07.666}.
\item Müller T. (2023). \textit{Psilocybin kann offenbar Depressionen lindern.}. MMW Fortschritte der Medizin. [published; Europe PMC]. \href{https://doi.org/10.1007/s15006-023-3025-6}{doi:10.1007/s15006-023-3025-6}.
\item Vejmola Cestmir, Syrová Kateřina, Šíchová Klára, Koudelka Vlastimil, Hubený Jan, Kluckova Tereza, Nikolic Marek, Kelemen Eduard, Páleníček Tomáš (2023). \textit{CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANS}. IBRO Neuroscience Reports. [published; Crossref]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1471}{doi:10.1016/j.ibneur.2023.08.1471}.
\item Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S (2023). \textit{Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0604}{doi:10.1089/jpm.2022.0604}.
\item Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, Coviello F, Dierbach S, Thomann J, Duthaler U, Luethi D, Varghese N, Eckert A, Liechti ME (2023). \textit{Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-023-01607-2}{doi:10.1038/s41386-023-01607-2}.
\item Brown O (2023). \textit{Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression".}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.05.088}{doi:10.1016/j.jad.2023.05.088}.
\item Calder A, Mock S, Friedli N, Pasi P, Hasler G (2023). \textit{Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2023.05.008}{doi:10.1016/j.euroneuro.2023.05.008}.
\item Wolfgang AS, Hoge CW (2023). \textit{Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-023-01446-4}{doi:10.1007/s11920-023-01446-4}.
\item Syed OA, Tsang B, Gerlai R (2023). \textit{The zebrafish for preclinical psilocybin research.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2023.105381}{doi:10.1016/j.neubiorev.2023.105381}.
\item Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS (2023). \textit{Use of Psychedelics for Pain: A Scoping Review.}. Anesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/aln.0000000000004673}{doi:10.1097/aln.0000000000004673}.
\item Kevin M. Gray, Paul E. Croarkin (2023). \textit{Psychedelics as Therapeutics: Research Advances and Implications for Practice}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2023.07.1001}{doi:10.1016/j.jaac.2023.07.1001}.
\item University of New Mexico (2023). \textit{Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01534494}{source link}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Maćkowiak M, Gołembiowska K. (2023). \textit{Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202309.1649.v1}{doi:10.20944/preprints202309.1649.v1}.
\item Schuitmaker Nicole (2023). \textit{Psilocybin-Assisted Therapy: A scoping review of participants’ and facilitators’ experiences in qualitative studies}. Research, Society and Development. [published; Crossref]. \href{https://doi.org/10.33448/rsd-v12i9.43308}{doi:10.33448/rsd-v12i9.43308}.
\item Mitch Earleywine, Maha N. Mian, Joseph A. De Leo (2023). \textit{Expectancies for Subjective and Antidepressant Effects in Psilocybin Users}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678231194798}{doi:10.1177/00221678231194798}.
\item Milan Scheidegger (2023). \textit{Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05780216}{source link}.
\item University of Zurich (2023). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04141501}{source link}.
\item Sam Elias, Stephanie Spivak, Alexa Alverez, Alejandro Gili Olivares, Maria Ferrol, Julian Paul Keenan (2023). \textit{Self-perception and self-recognition while looking in the mirror on psilocybin}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00251}{doi:10.1556/2054.2023.00251}.
\item Mortaheb S, Fort LD, Mason NL, Mallaroni P, Ramaekers JG, Demertzi A. (2023). \textit{Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.18.558309}{doi:10.1101/2023.09.18.558309}.
\item Guy M. Goodwin (2023). \textit{The psychedelic experience and treatment-resistant depression}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21140}{doi:10.1002/wps.21140}.
\item Heal DJ, Smith SL, Belouin SJ, Henningfield JE (2023). \textit{Psychedelics: Threshold of a Therapeutic Revolution.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109610}{doi:10.1016/j.neuropharm.2023.109610}.
\item Lobe Sciences Ltd. (2023). \textit{Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06035900}{source link}.
\item Julien Chupin, Jorge López-Castromán, Caroline Brière, Fabrício Pereira, Coraline Hingray, Ismaël Conejero (2023). \textit{Can a single dose of psilocybin improve cognitive control in functional dissociative seizures?}. Medical Hypotheses. [published; OpenAlex]. \href{https://doi.org/10.1016/j.mehy.2023.111163}{doi:10.1016/j.mehy.2023.111163}.
\item Chen Xue, Jing Li, Lisa Yu, Francesca Maule, Li-Mei Chang, Jonathan Gallant, David J. Press, Sheetal A. Raithatha, Jillian M. Hagel, Peter J. Facchini (2023). \textit{A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines}. Journal of Biological Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jbc.2023.105231}{doi:10.1016/j.jbc.2023.105231}.
\item Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout, Jeremy Weleff (2023). \textit{Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2023.190103}{doi:10.1176/appi.ajp-rj.2023.190103}.
\item Attia E, Steinglass JE (2023). \textit{Psilocybin for anorexia nervosa: If it helps, let's learn how.}. Med (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1016/j.medj.2023.08.003}{doi:10.1016/j.medj.2023.08.003}.
\item Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR (2023). \textit{Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.}. JAMA. [published; PubMed]. \href{https://doi.org/10.1001/jama.2023.14530}{doi:10.1001/jama.2023.14530}.
\item Shannon L. Thomas, Colton Myers, Kevin A. Schug (2023). \textit{Comparison of fragrance and flavor components in non-psilocybin and psilocybin mushrooms using vacuum-assisted headspace high-capacity solid-phase microextraction and gas chromatography-mass spectrometry}. Advances in Sample Preparation. [published; OpenAlex]. \href{https://doi.org/10.1016/j.sampre.2023.100090}{doi:10.1016/j.sampre.2023.100090}.
\item Mark D. Sims, John Hendrick (2023). \textit{Psilocybin Use in Palliative Care \#464}. Journal of Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/jpm.2023.0180}{doi:10.1089/jpm.2023.0180}.
\item Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D (2023). \textit{Neuroimaging in psychedelic drug development: past, present, and future.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-023-02271-0}{doi:10.1038/s41380-023-02271-0}.
\item Costa A.M., Silva-Carvalho M., Madureira-Carvalho A., Dinis-Oliveira R.J., Dias-da-Silva D. (2023). \textit{P05-02: Assessment of the CYP450 inhibitory activity of psilocybin, psilocin, LSD, 5-MeO-DMT and mescaline: An in vitro study}. Toxicology Letters. [published; Crossref]. \href{https://doi.org/10.1016/s0378-4274(23)00499-x}{doi:10.1016/s0378-4274(23)00499-x}.
\item Ezeaka Udoka C., Kim Hye Ji J., Laprairie Robert B. (2023). \textit{Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models}. Current Topics in Medicinal Chemistry. [published; Crossref]. \href{https://doi.org/10.2174/1568026623666230705151922}{doi:10.2174/1568026623666230705151922}.
\item White CM, Weisman N, Dalo J (2023). \textit{Psychedelics for Patients With Cancer: A Comprehensive Literature Review.}. The Annals of pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1177/10600280221144055}{doi:10.1177/10600280221144055}.
\item Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking P (2023). \textit{HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.}. Journal of pain and symptom management. [published; PubMed]. \href{https://doi.org/10.1016/j.jpainsymman.2023.06.006}{doi:10.1016/j.jpainsymman.2023.06.006}.
\item Nikolič M, Viktorin V, Zach P, Tylš F, Dudysová D, Janků K, Kopřivová J, Kuchař M, Brunovský M, Horáček J, Páleníček T (2023). \textit{Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2023.04.019}{doi:10.1016/j.euroneuro.2023.04.019}.
\item Rakić V (2023). \textit{Psilocybin: The most effective moral bio-enhancer?}. Bioethics. [published; PubMed]. \href{https://doi.org/10.1111/bioe.13196}{doi:10.1111/bioe.13196}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. International clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Goodwin GM, Croal M, Feifel D, Kelly JR, Marwood L, Mistry S, O'Keane V, Peck SK, Simmons H, Sisa C, Stansfield SC, Tsai J, Williams S, Malievskaia E (2023). \textit{Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-023-01648-7}{doi:10.1038/s41386-023-01648-7}.
\item Szigeti B, Phillips LD, Nutt D (2023). \textit{Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins.}. British journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bcp.15841}{doi:10.1111/bcp.15841}.
\item Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A (2023). \textit{Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.}. Fitoterapia. [published; PubMed]. \href{https://doi.org/10.1016/j.fitote.2023.105620}{doi:10.1016/j.fitote.2023.105620}.
\item Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB (2023). \textit{Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2023.115349}{doi:10.1016/j.psychres.2023.115349}.
\item Schindler EAD (2023). \textit{The Potential of Psychedelics for the Treatment of Episodic Migraine.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-023-01145-y}{doi:10.1007/s11916-023-01145-y}.
\item Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R (2023). \textit{The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231190865}{doi:10.1177/02698811231190865}.
\item Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ (2023). \textit{Psilocybin history, action and reaction: A narrative clinical review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231190858}{doi:10.1177/02698811231190858}.
\item Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA (2023). \textit{Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.}. Journal of psychiatric practice. [published; PubMed]. \href{https://doi.org/10.1097/pra.0000000000000729}{doi:10.1097/pra.0000000000000729}.
\item Miller M, Rosa WE, Doerner Rinaldi A, Addicott K, Spence D, Beaussant Y (2023). \textit{Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0009}{doi:10.1089/psymed.2022.0009}.
\item Kiilerich KF, Lorenz J, Scharff MB, Speth N, Brandt TG, Czurylo J, Xiong M, Jessen NS, Casado-Sainz A, Shalgunov V, Kjaerby C, Satała G, Bojarski AJ, Jensen AA, Herth MM, Cumming P, Overgaard A, Palner M (2023). \textit{Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.}. Molecular psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41380-023-02280-z}{doi:10.1038/s41380-023-02280-z}.
\item Bhuiya NMA, Jacobs RJ, Wang K, Sun Y, Nava B, Sampiere L, Yerubandi A, Caballero J (2023). \textit{Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.45169}{doi:10.7759/cureus.45169}.
\item Pagán AF, Lex C, Soares JC, Meyer TD (2023). \textit{Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0022}{doi:10.1089/psymed.2023.0022}.
\item Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S (2023). \textit{Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0030}{doi:10.1089/psymed.2023.0030}.
\item Xuehan Du (2023). \textit{Pharmacology and Therapeutic Effects of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/hset.v65i.11331}{doi:10.54097/hset.v65i.11331}.
\item Kolbman N, Liu T, Guzzo P, Gilligan JP, Mashour GA, Vanini G, Pal D. (2023). \textit{Intravenous psilocybin administration attenuates mechanical hypersensitivity in a rat model of chronic pain}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.08.26.554802}{doi:10.1101/2023.08.26.554802}.
\item Siegel JS, Subramanian S, Perry D, Kay B, Gordon E, Laumann T, Reneau R, Gratton C, Horan C, Metcalf N, Chacko R, Schweiger J, Wong D, Bender D, Padawer-Curry J, Raison C, Raichle M, Lenze EJ, Snyder AZ, Dosenbach NUF, Nicol G (2023). \textit{Psilocybin desynchronizes brain networks.}. medRxiv: the preprint server for health sciences. [published; PubMed]. \href{https://doi.org/10.1101/2023.08.22.23294131}{doi:10.1101/2023.08.22.23294131}.
\item Zeifman RJ, Kettner H, Pagni BA, Mallard A, Roberts DE, Erritzoe D, Ross S, Carhart-Harris RL (2023). \textit{Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-023-40856-5}{doi:10.1038/s41598-023-40856-5}.
\item Benjamin M. Ross, James T. Neill (2023). \textit{Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00264}{doi:10.1556/2054.2023.00264}.
\item Rebecchi K. (2023). \textit{“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/c9fpj}{doi:10.31234/osf.io/c9fpj}.
\item Kevin Rebecchi (2023). \textit{“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/c9fpj\_v1}{source link}.
\item Justyna Woźniak, Rafał BOGACZ, Magdalena Gaik, Ewa URAM, Inga MAGDA, Karol Womperski, Magdalena OSUCH (2023). \textit{use of psilocybin in the treatment of psychiatric disorders - review}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.43.01.009}{doi:10.12775/jehs.2023.43.01.009}.
\item Nick Zagorski (2023). \textit{Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.09.9.20}{doi:10.1176/appi.pn.2023.09.9.20}.
\item Usona Institute (2023). \textit{A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05478278}{source link}.
\item Robinson GI, Li D, Wang B, Zahoruiko Y, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I (2023). \textit{Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells.}. Current issues in molecular biology. [published; PubMed]. \href{https://doi.org/10.3390/cimb45080427}{doi:10.3390/cimb45080427}.
\item Thase ME (2023). \textit{Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp.mulmdd3048sho}{doi:10.4088/jcp.mulmdd3048sho}.
\item Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Razidlo J, Banks MI, Wenthur CJ (2023). \textit{Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.3c00123}{doi:10.1021/acsptsci.3c00123}.
\item Jordan A (2023). \textit{Emerging Perspectives in Addiction Psychiatry.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp. muladx3048sho}{doi:10.4088/jcp. muladx3048sho}.
\item Bonny-Noach H, Shapira B, Baumol P, Tadmor N, Rosca P, Shoshan S, Harel-Fisch Y, Caduri A (2023). \textit{Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-023-00845-3}{doi:10.1186/s12954-023-00845-3}.
\item Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek (2023). \textit{Psilocybin's Emerging Role in Combating Depressive Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.40.01.011}{doi:10.12775/jehs.2023.40.01.011}.
\item Yaniv D, Ramondetta LM, Cohen L, Amit M (2023). \textit{Psilocybin-assisted psychotherapy for cancer-related anxiety and depression.}. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society. [published; PubMed]. \href{https://doi.org/10.1136/ijgc-2023-004659}{doi:10.1136/ijgc-2023-004659}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item Ibrahim IB, Videbech P, Straszek SPV (2023). \textit{[Not Available].}. Ugeskrift for laeger. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/37615227/}{source link}.
\item Moritz Spangemacher (2023). \textit{Psilocybin und Funktionalität bei Depression}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-023-3336-2}{doi:10.1007/s15005-023-3336-2}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M (2023). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Crowe M, Manuel J, Carlyle D, Lacey C (2023). \textit{Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis.}. International journal of mental health nursing. [published; PubMed]. \href{https://doi.org/10.1111/inm.13127}{doi:10.1111/inm.13127}.
\item Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A (2023). \textit{Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109528}{doi:10.1016/j.neuropharm.2023.109528}.
\item Zeifman RJ, Wagner AC, Monson CM, Carhart-Harris RL (2023). \textit{How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.04.105}{doi:10.1016/j.jad.2023.04.105}.
\item Jing X, Hoeh NR, Menkes DB (2023). \textit{Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s147895152300069x}{doi:10.1017/s147895152300069x}.
\item Flower JE, Gibbons WJ, Adams AM, Wang X, Broude CN, Jones JA (2023). \textit{"Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli".}. Biotechnology and bioengineering. [published; PubMed]. \href{https://doi.org/10.1002/bit.28480}{doi:10.1002/bit.28480}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Majić T, Ehrlich S (2023). \textit{Psilocybin for the treatment of anorexia nervosa.}. Nature medicine. [published; PubMed]. \href{https://doi.org/10.1038/s41591-023-02458-6}{doi:10.1038/s41591-023-02458-6}.
\item Tetiana Kudrina, Kozlovska Anna (2023). \textit{THE CONNECTION BETWEEN THE INDIVIDUAL SUBJECTIVE WELL-BEING AND THE MYSTICAL EXPERIENCE PRODUCED BY THE USE OF PSYCHEDELICS}. PSYCHOLOGICAL JOURNAL. [published; OpenAlex]. \href{https://doi.org/10.31108/1.2023.9.7.5}{doi:10.31108/1.2023.9.7.5}.
\item Terri D’Arrigo (2023). \textit{Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.08.8.3}{doi:10.1176/appi.pn.2023.08.8.3}.
\item Brain and Cognition Discovery Foundation (2023). \textit{The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05029466}{source link}.
\item Finkelstein C, Soha O, Roy A, Phillipou A, Rossell S. (2023). \textit{“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3189970/v1}{doi:10.21203/rs.3.rs-3189970/v1}.
\item The Roots to Thrive Society for Psychedelic Therapy (2023). \textit{An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05958758}{source link}.
\item Husain MI, Blumberger DM, Castle DJ, Ledwos N, Fellows E, Jones BDM, Ortiz A, Kloiber S, Wang W, Rosenblat JD, Mulsant BH (2023). \textit{Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2023.535}{doi:10.1192/bjo.2023.535}.
\item Rudzki S (2023). \textit{Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?}. Military medicine. [published; PubMed]. \href{https://doi.org/10.1093/milmed/usac095}{doi:10.1093/milmed/usac095}.
\item Shahar O, Botvinnik A, Shwartz A, Lerer E, Buko A, Hamid E, Kahn D, Guralnick M, Blakolmer K, Wolf G, Lerer L, Lerer B, Lifschytz T. (2023). \textit{Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3146433/v1}{doi:10.21203/rs.3.rs-3146433/v1}.
\item Goodwin G, Marwood L, Mistry S, Nowakowska A, Simmons H, Tsai J, Williams S, Young M, Malievskaia E. (2023). \textit{Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10595939}{source link}.
\item Husain M, Blumberger D, Castle D, Kloiber S, Ortiz A, Rosenblat J, Mulsant B. (2023). \textit{A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10660879}{source link}.
\item Kuypers K. (2023). \textit{Psychedelics for depression: from neurobiology to treatment}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10417770}{source link}.
\item Sousa R, Costa L, Brás J, Vaz R, Martins J, Abreu J, Almeida E, Castro N, Andrade R, Cunha N. (2023). \textit{Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10596667}{source link}.
\item Ramírez González J, Fernández Márquez I, Ferreiro González S, Ruíz E. (2023). \textit{The therapeutic potential of psilocybin in depression resistant to psychotropic drugs}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10479004}{source link}.
\item Bhanot S, Lin M, Bains S, Monroe A, Tsang V. (2023). \textit{A systematic review to assess the use of psilocybin in the treatment of headaches}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10660046}{source link}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Zeiss R. (2023). \textit{Psilocybin as an antidepressant strategy - a review of safety aspects}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://doi.org/10.1192/j.eurpsy.2023.679}{doi:10.1192/j.eurpsy.2023.679}.
\item Вікторія Шаповалова, Alina Osyntseva, Валерій Шаповалов, Serhii Nehretskii (2023). \textit{Pharmacognostic, Forensic and Pharmaceutical, Organizational and Legal, Clinical and Pharmacological Multidisciplinary Study with an Assessment of Peculiarities of Circulation (Use) of Smoking Mixtures of Spices and Entheogens of Amanita Muscaria Mushroom}. SSP Modern Pharmacy and Medicine. [published; OpenAlex]. \href{https://doi.org/10.53933/sspmpm.v3i3.105}{doi:10.53933/sspmpm.v3i3.105}.
\item William Brennan, Alex Kelman, Alexander B. Belser (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1089/psymed.2023.00071}{doi:10.1089/psymed.2023.00071}.
\item Brennan B, Kelman A, Belser AB. (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2ab59}{doi:10.31234/osf.io/2ab59}.
\item Nkadimeng SM, Hay L, Steinmann CM, Eloff JN. (2023). \textit{Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3088850/v1}{doi:10.21203/rs.3.rs-3088850/v1}.
\item Venugopal Kaden L. (2023). \textit{Psilocybin Therapy for Major Depressive Disorder: A Systematic Review}. Undergraduate Research in Natural and Clinical Science and Technology Journal. [published; Crossref]. \href{https://doi.org/10.26685/urncst.489}{doi:10.26685/urncst.489}.
\item Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway (2023). \textit{Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings}. Frontiers in Human Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnhum.2023.1200393}{doi:10.3389/fnhum.2023.1200393}.
\item Jorge Valdiviezo-Oña, Lizbeth Toscano-Molina, Juan Fernando Chávez, Jonathan Elias Herrera Criollo, Clara Paz (2023). \textit{Outcomes of usage of psychedelics by people reporting an eating disorder in clinical and non-clinical settings: a scoping review}. Advances in Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1080/18387357.2023.2235030}{doi:10.1080/18387357.2023.2235030}.
\item A. Jones (2023). \textit{Confronting the figure of the “mad scientist” in psychedelic history: LSD’s use as a correctional tool in the postwar period}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2023.1129428}{doi:10.3389/fpsyg.2023.1129428}.
\item Nogrady B (2023). \textit{Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj.p1599}{doi:10.1136/bmj.p1599}.
\item Jim Gilligan (2023). \textit{Leveraging psychedelic therapies for binge eating disorder}. Open Access Government. [published; OpenAlex]. \href{https://doi.org/10.56367/oag-039-10936}{doi:10.56367/oag-039-10936}.
\item Chernoff T, Kliger B, Venturini DH (2023). \textit{[Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models].}. Vertex (Buenos Aires, Argentina). [published; PubMed]. \href{https://doi.org/10.53680/vertex.v34i160.463}{doi:10.53680/vertex.v34i160.463}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maede K, González-Maeso J, Kitagaki S, Hiramatsu M (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.}. Research square. [published; PubMed]. \href{https://doi.org/10.21203/rs.3.rs-3138705/v1}{doi:10.21203/rs.3.rs-3138705/v1}.
\item Tetem J, Fischmann T, Möller TJ. (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ztyxh}{doi:10.31234/osf.io/ztyxh}.
\item Cybin Therapeutics Inc. (2023). \textit{Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05594667}{source link}.
\item Jenny Tetem, Tamara Fischmann, Tim Julian Möller (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ztyxh\_v1}{source link}.
\item Scott R. Walker, Glenn A. Pullella, Matthew Piggott, Peter J. Duggan (2023). \textit{Introduction to the chemistry and pharmacology of psychedelic drugs}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch23050}{doi:10.1071/ch23050}.
\item McCulloch DE, Olsen AS, Ozenne B, Stenbaek DS, Armand S, Madsen MK, Knudsen GM, Fisher PM. (2023). \textit{Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effects}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.07.03.23292164}{doi:10.1101/2023.07.03.23292164}.
\item Grace Wade (2023). \textit{Psychedelic drug psilocybin shows promise treating anorexia in early trials}. The New Scientist. [published; OpenAlex]. \href{https://doi.org/10.1016/s0262-4079(23)01394-5}{doi:10.1016/s0262-4079(23)01394-5}.
\item Kiara Mohamed Amin, Priya Sharma (2023). \textit{Trip Where you Stand: Towards Psychedelic Liberation}. Feminist Review. [published; OpenAlex]. \href{https://doi.org/10.1177/01417789231157308}{doi:10.1177/01417789231157308}.
\item Kopra EI, Ferris JA, Winstock AR, Kuypers KP, Young AH, Rucker JJ (2023). \textit{Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231158245}{doi:10.1177/02698811231158245}.
\item Sloshower J, Skosnik PD, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D'Souza DC (2023). \textit{Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231154852}{doi:10.1177/02698811231154852}.
\item Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM (2023). \textit{The need for establishing best practices and gold standards in psychedelic medicine.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.03.083}{doi:10.1016/j.jad.2023.03.083}.
\item Hakami Zanjani Ali Asghar, Nguyen Teresa Quynh Tram, Jacobsen Luise, Khandelia Himanshu (2023). \textit{The molecular basis of the antidepressant action of the magic mushroom extract, psilocin}. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. [published; Crossref]. \href{https://doi.org/10.1016/j.bbapap.2023.140914}{doi:10.1016/j.bbapap.2023.140914}.
\item Weiss B, Erritzoe D, Giribaldi B, Nutt DJ, Carhart-Harris RL (2023). \textit{A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231167848}{doi:10.1177/02698811231167848}.
\item Rossell SL, Meikle SE, Williams ML, Castle DJ (2023). \textit{Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674231172691}{doi:10.1177/00048674231172691}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS (2023). \textit{Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2023.120130}{doi:10.1016/j.neuroimage.2023.120130}.
\item Kisely S (2023). \textit{The down-scheduling of MDMA and psilocybin(e): Too fast and too soon.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674231174171}{doi:10.1177/00048674231174171}.
\item Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN (2023). \textit{New Pharmacologic Approaches to the Treatment of Bipolar Depression.}. Drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40265-023-01872-x}{doi:10.1007/s40265-023-01872-x}.
\item Benvenuti F, Colombo D, Soverchia L, Cannella N, Domi E, Ciccocioppo R (2023). \textit{Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-023-06384-w}{doi:10.1007/s00213-023-06384-w}.
\item Gukasyan N, Griffiths RR, Yaden DB, Antoine DG, Nayak SM (2023). \textit{Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231179910}{doi:10.1177/02698811231179910}.
\item Haridy R (2023). \textit{Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/d41586-023-02093-8}{doi:10.1038/d41586-023-02093-8}.
\item Skosnik PD, Sloshower J, Safi-Aghdam H, Pathania S, Syed S, Pittman B, D'Souza DC (2023). \textit{Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231179800}{doi:10.1177/02698811231179800}.
\item Bonnieux JN, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera MA (2023). \textit{Psilocybin's effects on cognition and creativity: A scoping review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231179801}{doi:10.1177/02698811231179801}.
\item Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ (2023). \textit{Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231180276}{doi:10.1177/02698811231180276}.
\item Valerie A. Canady (2023). \textit{FDA issues first draft guidance on psychedelic research}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.33697}{doi:10.1002/mhw.33697}.
\item Gwyther M, Aspell JE. (2023). \textit{Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8ncj6}{doi:10.31234/osf.io/8ncj6}.
\item Matt Gwyther, Jane E Aspell (2023). \textit{Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8ncj6\_v1}{source link}.
\item Jachimowski A, Kucia K (2023). \textit{Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives.}. Psychiatria polska. [published; PubMed]. \href{https://doi.org/10.12740/pp/150053}{doi:10.12740/pp/150053}.
\item Flora Graham (2023). \textit{Daily briefing: Australia will be first to prescribe these psychedelics as medicines}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-023-02211-6}{doi:10.1038/d41586-023-02211-6}.
\item Halucenex Life Sciences Inc. (2023). \textit{Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05243329}{source link}.
\item Terri D’Arrigo (2023). \textit{Experts Offer Tips on Talking With Patients About Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.07.7.51}{doi:10.1176/appi.pn.2023.07.7.51}.
\item Nick Zagorski (2023). \textit{Psychedelic Therapy Requires Enhanced Consent Discussions}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.07.7.46}{doi:10.1176/appi.pn.2023.07.7.46}.
\item Hecker L, kato k, Kleinhenz JMK, Shin Y, Papageorgiou J, Zarrabi A. (2023). \textit{Psilocybin decelerates cellular senescence}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2921423/v1}{doi:10.21203/rs.3.rs-2921423/v1}.
\item Cheung K, Patch K, Earp BD, Yaden DB (2023). \textit{Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation.}. Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees. [published; PubMed]. \href{https://doi.org/10.1017/s0963180123000270}{doi:10.1017/s0963180123000270}.
\item Tylš Filip, Vejmola Čestmír, Koudelka Vlastimil, Piorecká Václava, Kadeřábek Lukáš, Bochin Marcel, Novák Tomáš, Kuchař Martin, Bendová Zdeňka, Brunovský Martin, Horáček Jiří, Pálení ček Tomáš (2023). \textit{Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats}. Frontiers in Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnins.2023.1152578}{doi:10.3389/fnins.2023.1152578}.
\item Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NLN, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA (2023). \textit{In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.}. Science advances. [published; PubMed]. \href{https://doi.org/10.1126/sciadv.adf8332}{doi:10.1126/sciadv.adf8332}.
\item Wulff AB, Nichols CD, Thompson SM (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Romain Nardou, Edward J. Sawyer, Young Jun Song, M. F. Wilkinson, Yasmin Padovan-Hernandez, Júnia L. de Deus, Noelle Wright, Carine Lama, Sehr Faltin, Loyal A. Goff, Genevieve Stein-O’Brien, Gül Dölen (2023). \textit{Psychedelics reopen the social reward learning critical period}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/s41586-023-06204-3}{doi:10.1038/s41586-023-06204-3}.
\item Kevin Herkenham (2023). \textit{A regulatory framework review of Schedule I psychedelics in the United States}. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. [published; OpenAlex]. \href{https://doi.org/10.1002/jac5.1841}{doi:10.1002/jac5.1841}.
\item Turkia M. (2023). \textit{The treatment of abandonment anxiety with MDMA and LSD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/pw2tf}{doi:10.31234/osf.io/pw2tf}.
\item Nayak SM, White S, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB. (2023). \textit{Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/auycp}{doi:10.31234/osf.io/auycp}.
\item Turkia M. (2023). \textit{Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/qyce5}{doi:10.31234/osf.io/qyce5}.
\item Mika Turkia (2023). \textit{The treatment of abandonment anxiety with MDMA and LSD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/pw2tf\_v1}{source link}.
\item Nayak SM, White SH, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB. (2023). \textit{Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/auycp\_v1}{doi:10.31234/osf.io/auycp\_v1}.
\item Sandeep M Nayak, Sydney White, Samantha Hilbert, Matthew X Lowe, Heather Jackson, Roland R. Griffiths, Albert Garcia-Romeu, David Bryce Yaden (2023). \textit{Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/auycp\_v1}{source link}.
\item Mika Turkia (2023). \textit{Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/qyce5\_v1}{source link}.
\item O'Grady C (2023). \textit{No trip needed for psychedelics to lift mood?}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.adj1031}{doi:10.1126/science.adj1031}.
\item Kargbo RB (2023). \textit{Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.3c00168}{doi:10.1021/acsmedchemlett.3c00168}.
\item Nkadimeng SM, Steinmann CM, Eloff JN. (2023). \textit{Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202306.0362.v1}{doi:10.20944/preprints202306.0362.v1}.
\item Schmidt TT, Costines C, Tagliazucchi E, Millière R, Garrido JM, Cuiule JI. (2023). \textit{The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/45z7w}{doi:10.31234/osf.io/45z7w}.
\item Polito V, Liknaitzky P. (2023). \textit{Is Microdosing a Placebo?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/3ykst\_v1}{doi:10.31234/osf.io/3ykst\_v1}.
\item Timo Torsten Schmidt, Cyril Costines, Enzo Tagliazucchi, Raphaël Millière, Juan Manuel Garrido, Juan Ignacio Cuiule (2023). \textit{The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/45z7w\_v1}{source link}.
\item Polito V, Liknaitzky P. (2023). \textit{Is Microdosing a Placebo?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/3ykst}{doi:10.31234/osf.io/3ykst}.
\item Vince Polito, Paul Liknaitzky (2023). \textit{Is Microdosing a Placebo?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/3ykst\_v1}{source link}.
\item Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2023). \textit{Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.29.23290667}{doi:10.1101/2023.05.29.23290667}.
\item Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala (2023). \textit{Psilocybin therapy: A novel approach to treating depression}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000175}{doi:10.1097/gh9.0000000000000175}.
\item N. Jiten Singh (2023). \textit{Psilocybin (Magic Mushrooms)}. GFNPSS-International Journal of Multidisciplinary Research. [published; OpenAlex]. \href{https://doi.org/10.46376/ijmr/4.5.2023.2260-2265}{doi:10.46376/ijmr/4.5.2023.2260-2265}.
\item Basant Pradhan, Ankit Rana, Edward Goldschmidt, Anthony L. Rostain (2023). \textit{ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study Design}. Neuromodulation Technology at the Neural Interface. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neurom.2023.04.144}{doi:10.1016/j.neurom.2023.04.144}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.06.01.23290811}{doi:10.1101/2023.06.01.23290811}.
\item Xi D, Berger A, Shurtleff D, Zia FZ, Belouin S (2023). \textit{National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109467}{doi:10.1016/j.neuropharm.2023.109467}.
\item Irvine W, Tyler M, Delgoda R (2023). \textit{In silico characterization of the psilocybin biosynthesis pathway.}. Computational biology and chemistry. [published; PubMed]. \href{https://doi.org/10.1016/j.compbiolchem.2023.107854}{doi:10.1016/j.compbiolchem.2023.107854}.
\item Agrawal M, Emanuel E, Richards B, Richards W, Roddy K, Thambi P (2023). \textit{Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.}. JAMA oncology. [published; PubMed]. \href{https://doi.org/10.1001/jamaoncol.2023.0351}{doi:10.1001/jamaoncol.2023.0351}.
\item Kamal S, Jha MK, Radhakrishnan R (2023). \textit{Role of Psychedelics in Treatment-Resistant Depression.}. The Psychiatric clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.psc.2023.02.004}{doi:10.1016/j.psc.2023.02.004}.
\item Meyer M, Slot J (2023). \textit{The evolution and ecology of psilocybin in nature.}. Fungal genetics and biology: FG \& B. [published; PubMed]. \href{https://doi.org/10.1016/j.fgb.2023.103812}{doi:10.1016/j.fgb.2023.103812}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M (2023). \textit{Global species diversity and distribution of the psychedelic fungal genus.}. Heliyon. [published; PubMed]. \href{https://doi.org/10.1016/j.heliyon.2023.e16338}{doi:10.1016/j.heliyon.2023.e16338}.
\item Moliner R, Girych M, Brunello CA, Kovaleva V, Biojone C, Enkavi G, Antenucci L, Kot EF, Goncharuk SA, Kaurinkoski K, Kuutti M, Fred SM, Elsilä LV, Sakson S, Cannarozzo C, Diniz CRAF, Seiffert N, Rubiolo A, Haapaniemi H, Meshi E, Nagaeva E, Öhman T, Róg T, Kankuri E, Vilar M, Varjosalo M, Korpi ER, Permi P, Mineev KS, Saarma M, Vattulainen I, Casarotto PC, Castrén E (2023). \textit{Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.}. Nature neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/s41593-023-01316-5}{doi:10.1038/s41593-023-01316-5}.
\item Holoyda B (2023). \textit{The Perilous Policy of Oregon's Psilocybin Services.}. The journal of the American Academy of Psychiatry and the Law. [published; PubMed]. \href{https://doi.org/10.29158/jaapl.230023-23}{doi:10.29158/jaapl.230023-23}.
\item Lake S, Lucas P (2023). \textit{The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0002}{doi:10.1089/psymed.2023.0002}.
\item Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD (2023). \textit{Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0011}{doi:10.1089/psymed.2022.0011}.
\item Manish Agrawal, Sarah Shnayder, Heather Honstein, Ezekiel Emanuel, Paul Thambi (2023). \textit{Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2023.41.16\_suppl.12021}{doi:10.1200/jco.2023.41.16\_suppl.12021}.
\item Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM. (2023). \textit{Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.25.23290521}{doi:10.1101/2023.05.25.23290521}.
\item Combat Stress (2023). \textit{Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05876481}{source link}.
\item Qasim S, Zaheer Z, Jawad MY, Shad MU (2023). \textit{Neurobiological Correlates of Psilocybin Response in Depression.}. The primary care companion for CNS disorders. [published; PubMed]. \href{https://doi.org/10.4088/pcc.22r03419}{doi:10.4088/pcc.22r03419}.
\item University of Wisconsin, Madison (2023). \textit{Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04842045}{source link}.
\item Ort A, Smallridge JW, Sarasso S, Casarotto S, von Rotz R, Casanova A, Seifritz E, Preller KH, Tononi G, Vollenweider FX (2023). \textit{TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology.}. iScience. [published; PubMed]. \href{https://doi.org/10.1016/j.isci.2023.106589}{doi:10.1016/j.isci.2023.106589}.
\item Fonseka LN, Woo BK (2023). \textit{Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.}. World journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.5498/wjp.v13.i5.182}{doi:10.5498/wjp.v13.i5.182}.
\item Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ. (2023). \textit{Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.05.16.540994}{doi:10.1101/2023.05.16.540994}.
\item Catharine Carfagno, M Vest, Kevin S. Murnane, Kariann Lamon, Bo Jarrett Wood (2023). \textit{Characterization of Novel Tryptamines’ Anxiolytic and Anti-Inflammatory Effects in Relation to their Psychoactive Effects}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.122.192360}{doi:10.1124/jpet.122.192360}.
\item Eliza Milliken, Peter Galettis, Jenny Martin (2023). \textit{A review of psilocybin: chemistry, clinical uses and future research directions}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch23010}{doi:10.1071/ch23010}.
\item Chirag Ambaliya, Dimple Gupta, Ashok Vala, Krupa Mukeshbhai Unadkat (2023). \textit{THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE}. PARIPEX-INDIAN JOURNAL OF RESEARCH. [published; OpenAlex]. \href{https://doi.org/10.36106/paripex/6712845}{doi:10.36106/paripex/6712845}.
\item University of Wisconsin, Madison (2023). \textit{A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05467761}{source link}.
\item THORENS G, PENZENSTADLER l, FURTADO LCDC, SERAGNOLI F, ROTHEN S, MABILAIS C, ZULLINO D. (2023). \textit{Exposure therapy under psilocybin for general anxiety disorder and claustrophobia}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2859973/v1}{doi:10.21203/rs.3.rs-2859973/v1}.
\item Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL, Kuceyeski A (2023). \textit{Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.05.11.540409}{doi:10.1101/2023.05.11.540409}.
\item Więckiewicz G, Marek J, Stokłosa I, Szafoni S, Pluta S, Smukowska K, Żebrowska G, Stokłosa M, Gorczyca P, Pudlo R (2023). \textit{The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey.}. Medicina (Kaunas, Lithuania). [published; PubMed]. \href{https://doi.org/10.3390/medicina59050908}{doi:10.3390/medicina59050908}.
\item Johns Hopkins University (2023). \textit{Effects of Psilocybin in Anorexia Nervosa}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04052568}{source link}.
\item Davis AK, Levin AW, Nagib PB, Armstrong SB, Lancelotta RL (2023). \textit{Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2022-068884}{doi:10.1136/bmjopen-2022-068884}.
\item Margaret Ross, Justin Dwyer (2023). \textit{Using Psilocybin Therapy for treating end of life distress trial}. The Ballarat naturalist.. [published; OpenAlex]. \href{https://doi.org/10.5962/p.388212}{doi:10.5962/p.388212}.
\item Søgaard Juul T, Ebbesen Jensen M, Fink-Jensen A (2023). \textit{The use of classic psychedelics among adults: a Danish online survey study.}. Nordic journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1080/08039488.2022.2125069}{doi:10.1080/08039488.2022.2125069}.
\item Goodwin GM, Croal M, Marwood L, Malievskaia E (2023). \textit{Unblinding and demand characteristics in the treatment of depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.02.030}{doi:10.1016/j.jad.2023.02.030}.
\item Palamar JJ, Le A, Cleland CM, Keyes KM (2023). \textit{Trends in drug use among nightclub and festival attendees in New York City, 2017-2022.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2023.104001}{doi:10.1016/j.drugpo.2023.104001}.
\item Rosenblat JD, Leon-Carlyle M, Ali S, Husain MI, McIntyre RS (2023). \textit{Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20220835}{doi:10.1176/appi.ajp.20220835}.
\item Ibi D (2023). \textit{[Contribution of serotonin 5-HT receptor to antidepressant effect of serotonergic psychedelics].}. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. [published; PubMed]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item Schneier FR, Feusner J, Wheaton MG, Gomez GJ, Cornejo G, Naraindas AM, Hellerstein DJ (2023). \textit{Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2023.03.031}{doi:10.1016/j.jpsychires.2023.03.031}.
\item Uchida H (2023). \textit{[Drugs in the Developmental Stage (Psychotropics)].}. Brain and nerve = Shinkei kenkyu no shinpo. [published; PubMed]. \href{https://doi.org/10.11477/mf.1416202356}{doi:10.11477/mf.1416202356}.
\item Bae S, Vaysblat M, Bae E, Dejanovic I, Pierce M (2023). \textit{Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.38669}{doi:10.7759/cureus.38669}.
\item Dunn Harmony, Freeman Judy, Michael John Dochniak (2023). \textit{Psilocybin-Based Breakthroughs in Natural Medicine}. Case Reports and Reviews. [published; OpenAlex]. \href{https://doi.org/10.33425/2693-1516.1021}{doi:10.33425/2693-1516.1021}.
\item Dunn Harmony, Freeman Judy, D Michael (2023). \textit{Psilocybin-based mushrooms and usage}. Case Reports and Reviews. [published; OpenAlex]. \href{https://doi.org/10.33425/2693-1516.1022}{doi:10.33425/2693-1516.1022}.
\item McAlpine R, Blackburne G, Kamboj S. (2023). \textit{Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/gw9jp}{doi:10.31234/osf.io/gw9jp}.
\item Rosalind McAlpine, George Blackburne, Sunjeev Kamboj (2023). \textit{Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gw9jp\_v1}{source link}.
\item Eric N. Kramer, Kalyn Reddy, Bryan Shapiro (2023). \textit{A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history}. Psychiatry Research Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psycr.2023.100118}{doi:10.1016/j.psycr.2023.100118}.
\item Elisabeth Jean Wood (2023). \textit{Psychedelic Sensationalism: An Analysis of the Schedule Classification of Psilocybin}. Vanderbilt Undergraduate Research Journal. [published; OpenAlex]. \href{https://doi.org/10.15695/vurj.v13i1.5403}{doi:10.15695/vurj.v13i1.5403}.
\item COMPASS Pathways (2023). \textit{The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03775200}{source link}.
\item Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R. (2023). \textit{A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.04.12.23288325}{doi:10.1101/2023.04.12.23288325}.
\item Braun D, Rosenberg A, Haruvi R, Malamud D, Barbara R, Kawashima T. (2023). \textit{High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.04.13.536830}{doi:10.1101/2023.04.13.536830}.
\item Goodwin GM, Aaronson ST, Alvarez O, Atli M, Bennett JC, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Lennard-Jones MR, Licht RW, Marwood L, Mistry S, Páleníček T, Redjep O, Repantis D, Schoevers RA, Septimus B, Simmons HJ, Soares JC, Somers M, Stansfield SC, Stuart JR, Tadley HH, Thiara NK, Tsai J, Wahba M, Williams S, Winzer RI, Young AH, Young MB, Zisook S, Malievskaia E (2023). \textit{Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.01.108}{doi:10.1016/j.jad.2023.01.108}.
\item Glatfelter GC, Naeem M, Pham DNK, Golen JA, Chadeayne AR, Manke DR, Baumann MH (2023). \textit{Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy--dimethyltryptamine in Mice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.2c00222}{doi:10.1021/acsptsci.2c00222}.
\item Aron Amaev, Jianmeng Song, Yasaman Kambari, Fumihiko Ueno, Edgardo Torres-Carmona, Ali Abdolizadeh, Teruki Koizumi, Vincenzo De Luca, Bruce G. Pollock, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2023). \textit{118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.358}{doi:10.1016/j.biopsych.2023.02.358}.
\item Xi Zhu, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria Gómez, Franklin R. Schneier (2023). \textit{347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.587}{doi:10.1016/j.biopsych.2023.02.587}.
\item Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Audrey Shoultz, Trisha Suppes (2023). \textit{96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.336}{doi:10.1016/j.biopsych.2023.02.336}.
\item David Nutt (2023). \textit{Psychedelic Medicine: From Brain Science to Clinical Trials}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.022}{doi:10.1016/j.biopsych.2023.02.022}.
\item Jonah H. Shepherd, Caitlin Baten, Amanda M. Klassen, Gladys Zamora, Sarah Saravia, Elizabeth Pritchard, Zulaikha Ali, Saneh K. Kahlon, Kyla Whitelock, Fabiola A. Reyes, Dawson H. Hedges, J. Paul Hamilton, Matthew D. Sacchet, Chris H. Miller (2023). \textit{509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural Activity}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.749}{doi:10.1016/j.biopsych.2023.02.749}.
\item Volodymyr Tkach, Kucher Mykhailo, Kushnir Marta, Ivanushko Yana, Akınay Yüksel, Karakoyun Necdet, Yagodynets Petro, Kormosh Zholt (2023). \textit{The Theoretical Description for Psilocin Electrochemical Determination over Cobalt Oxyhydroxide}. Orbital: The Electronic Journal of Chemistry. [published; Crossref]. \href{https://doi.org/10.17807/orbital.v15i1.18012}{doi:10.17807/orbital.v15i1.18012}.
\item Jianmeng Song, Yasaman Kambari, Aron Amaev, Fumihiko Ueno, Edgardo Torres Carmona, Vincenzo De Luca, Bruce G. Pollock, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2023). \textit{Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment}. Medical Hypotheses. [published; OpenAlex]. \href{https://doi.org/10.1016/j.mehy.2023.111068}{doi:10.1016/j.mehy.2023.111068}.
\item Julia Mertens L. (2023). \textit{Psilocybin zeigt Wirkung bei Depression.}. MMW Fortschritte der Medizin. [published; Europe PMC]. \href{https://doi.org/10.1007/s15006-023-2540-9}{doi:10.1007/s15006-023-2540-9}.
\item Christensen JA, Fipps DC, Bostwick JM (2023). \textit{To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.}. Experimental and clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1037/pha0000597}{doi:10.1037/pha0000597}.
\item Lyes M, Yang KH, Castellanos J, Furnish T (2023). \textit{Microdosing psilocybin for chronic pain: a case series.}. Pain. [published; PubMed]. \href{https://doi.org/10.1097/j.pain.0000000000002778}{doi:10.1097/j.pain.0000000000002778}.
\item VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ (2023). \textit{The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.}. Neurochemical research. [published; PubMed]. \href{https://doi.org/10.1007/s11064-022-03772-0}{doi:10.1007/s11064-022-03772-0}.
\item Holze F, Becker AM, Kolaczynska KE, Duthaler U, Liechti ME (2023). \textit{Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.2821}{doi:10.1002/cpt.2821}.
\item Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ (2023). \textit{Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.}. Neurosurgery. [published; PubMed]. \href{https://doi.org/10.1227/neu.0000000000002275}{doi:10.1227/neu.0000000000002275}.
\item Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP, van der Wal SEI (2023). \textit{Are psychedelics the answer to chronic pain: A review of current literature.}. Pain practice: the official journal of World Institute of Pain. [published; PubMed]. \href{https://doi.org/10.1111/papr.13203}{doi:10.1111/papr.13203}.
\item Sellers EM, Romach MK (2023). \textit{Psychedelics: Science sabotaged by Social Media.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2023.109426}{doi:10.1016/j.neuropharm.2023.109426}.
\item Modlin NL, Miller TM, Rucker JJ, Kirlic N, Lennard-Jones M, Schlosser D, Aaronson ST (2023). \textit{Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.01.077}{doi:10.1016/j.jad.2023.01.077}.
\item Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB (2023). \textit{Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.01.073}{doi:10.1016/j.jad.2023.01.073}.
\item Simpson GHR, Chatwin C, van Hellemont E (2023). \textit{Liminal spaces, seasonal faces: Challenging drug market assumptions via an exploration of naturally occurring magic mushroom markets in rural Kent.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2023.103973}{doi:10.1016/j.drugpo.2023.103973}.
\item Wang Y, Sun H, Ji Q, Wei J, Zhu P (2023). \textit{Systematic Review of Interventions for Demoralization in Patients With Cancer.}. The Journal of nervous and mental disease. [published; PubMed]. \href{https://doi.org/10.1097/nmd.0000000000001615}{doi:10.1097/nmd.0000000000001615}.
\item Simonsson C, Chambers R, Hendricks PS, Goldberg SB, Osika W, Schlosser M, Ryde A, Christersson E, Simonsson O (2023). \textit{Classic psychedelic use and current meditation practice.}. Mindfulness. [published; PubMed]. \href{https://doi.org/10.1007/s12671-023-02103-w}{doi:10.1007/s12671-023-02103-w}.
\item Wang K, Sun Y, Nava B, Sampiere L, Jacobs RJ (2023). \textit{Predictors of Medical Students' Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.37450}{doi:10.7759/cureus.37450}.
\item Dawood Hristova JJ, Pérez-Jover V (2023). \textit{Psychotherapy with Psilocybin for Depression: Systematic Review.}. Behavioral sciences (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/bs13040297}{doi:10.3390/bs13040297}.
\item University Hospital, Basel, Switzerland (2023). \textit{Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04849013}{source link}.
\item Colin H. Simonds (2023). \textit{View, meditation, action: A Tibetan framework to inform psychedelic-assisted therapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00255}{doi:10.1556/2054.2023.00255}.
\item Terri D’Arrigo (2023). \textit{Experts to Discuss the Ethics of Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.04.3.10}{doi:10.1176/appi.pn.2023.04.3.10}.
\item Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J (2023). \textit{Default Mode Network Modulation by Psychedelics: A Systematic Review.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyac074}{doi:10.1093/ijnp/pyac074}.
\item Domanegg K, Sommer WH, Meinhardt MW (2023). \textit{Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.}. Cells. [published; PubMed]. \href{https://doi.org/10.3390/cells12060963}{doi:10.3390/cells12060963}.
\item Tolle HM, Farah JC, Mallaroni P, Mason NL, Ramaekers JG, Amico E. (2023). \textit{The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.03.20.532894}{doi:10.1101/2023.03.20.532894}.
\item Optimi Health Corporation (2023). \textit{Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05252598}{source link}.
\item Ching THW, Grazioplene R, Pittenger C, Kelmendi B. (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ba42z}{doi:10.31234/osf.io/ba42z}.
\item Terence Ching, Rachael Grazioplene, Christopher Pittenger, Benjamin Kelmendi (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ba42z\_v1}{source link}.
\item Marks M (2023). \textit{The varieties of psychedelic law.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109399}{doi:10.1016/j.neuropharm.2022.109399}.
\item Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ (2023). \textit{Canalization and plasticity in psychopathology.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109398}{doi:10.1016/j.neuropharm.2022.109398}.
\item Ryan RS, Copello A, Fox AP (2023). \textit{Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health.}. BMC psychiatry. [published; PubMed]. \href{https://doi.org/10.1186/s12888-023-04628-9}{doi:10.1186/s12888-023-04628-9}.
\item Zanikov T, Gerasymchuk M, Ghasemi Gojani E, Robinson GI, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cameron M, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I (2023). \textit{The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules28062624}{doi:10.3390/molecules28062624}.
\item New York State Psychiatric Institute (2023). \textit{Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04656301}{source link}.
\item Parker Emmerson (2023). \textit{Patternizing Psilocybin in Logic Space}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.7720548}{doi:10.5281/zenodo.7720548}.
\item Turkia M. (2023). \textit{Understanding psychedelic 'mystical experience'-A case example}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dh92g}{doi:10.31234/osf.io/dh92g}.
\item Turkia M. (2023). \textit{Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/wupvy}{doi:10.31234/osf.io/wupvy}.
\item Turkia M. (2023). \textit{Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/t6k9b}{doi:10.31234/osf.io/t6k9b}.
\item Mika Turkia (2023). \textit{Understanding psychedelic 'mystical experience'-A case example}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dh92g\_v1}{source link}.
\item Mika Turkia (2023). \textit{Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/wupvy\_v1}{source link}.
\item Mika Turkia (2023). \textit{Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/t6k9b\_v1}{source link}.
\item Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand (2023). \textit{Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?}. Clinical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1093/clinchem/hvad016}{doi:10.1093/clinchem/hvad016}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Shi En Kim (2023). \textit{How psychedelics spark neuronal growth}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10108-scicon1}{doi:10.1021/cen-10108-scicon1}.
\item Emmerich N, Humphries B (2023). \textit{Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training?}. Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees. [published; PubMed]. \href{https://doi.org/10.1017/s0963180123000099}{doi:10.1017/s0963180123000099}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Antioxidants (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R (2023). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0002}{doi:10.1089/psymed.2022.0002}.
\item Kisely S, Connor M, Somogyi AA, Siskind D (2023). \textit{A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/00048674221083868}{doi:10.1177/00048674221083868}.
\item Schmidt C, Wolff M, Gründer G, Jungaberle H (2023). \textit{[Attitudes of Mental Health Experts Towards Psilocybin].}. Fortschritte der Neurologie-Psychiatrie. [published; PubMed]. \href{https://doi.org/10.1055/a-1846-1161}{doi:10.1055/a-1846-1161}.
\item Lee HJ, Stein MB (2023). \textit{Update on treatments for anxiety-related disorders.}. Current opinion in psychiatry. [published; PubMed]. \href{https://doi.org/10.1097/yco.0000000000000841}{doi:10.1097/yco.0000000000000841}.
\item Heal DJ, Gosden J, Smith SL, Atterwill CK (2023). \textit{Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109375}{doi:10.1016/j.neuropharm.2022.109375}.
\item Otterman LS (2023). \textit{Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.}. Journal of bioethical inquiry. [published; PubMed]. \href{https://doi.org/10.1007/s11673-022-10220-9}{doi:10.1007/s11673-022-10220-9}.
\item McTaggart AR, James TY, Slot JC, Barlow C, Fechner N, Shuey LS, Drenth A (2023). \textit{Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.}. Fungal genetics and biology: FG \& B. [published; PubMed]. \href{https://doi.org/10.1016/j.fgb.2022.103769}{doi:10.1016/j.fgb.2022.103769}.
\item Zohairi F, Khandelia H, Hakami Zanjani AA (2023). \textit{Interaction of psychedelic tryptamine derivatives with a lipid bilayer.}. Chemistry and physics of lipids. [published; PubMed]. \href{https://doi.org/10.1016/j.chemphyslip.2023.105279}{doi:10.1016/j.chemphyslip.2023.105279}.
\item Wang Jing, Liang Min, Shang Qing, Qian Hongyan, An Ran, Liu Hua, Shao Gaojie, Li Tao, Liu Xinshe (2023). \textit{Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling}. CNS Neuroscience \& Therapeutics. [published; Crossref]. \href{https://doi.org/10.1111/cns.14054}{doi:10.1111/cns.14054}.
\item Pedicini M, Cordner ZA (2023). \textit{Utility of preclinical models in the study of psilocybin - A comprehensive review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2023.105046}{doi:10.1016/j.neubiorev.2023.105046}.
\item Oster E, Čudina N, Pavasović H, Prevendar Crnić A, Božić F, Fadel C, Giorgi M (2023). \textit{Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs.}. Veterinary and animal science. [published; PubMed]. \href{https://doi.org/10.1016/j.vas.2023.100288}{doi:10.1016/j.vas.2023.100288}.
\item Jha MK, Mathew SJ (2023). \textit{Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230025}{doi:10.1176/appi.ajp.20230025}.
\item Karow A (2023). \textit{[Psychedelic Therapy with Psilocybin and Psychotherapy - Where do we Stand?].}. Psychotherapie, Psychosomatik, medizinische Psychologie. [published; PubMed]. \href{https://doi.org/10.1055/a-2010-7640}{doi:10.1055/a-2010-7640}.
\item Hibicke M, Kramer HM, Nichols CD (2023). \textit{A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0012}{doi:10.1089/psymed.2022.0012}.
\item Aday JS, Skiles Z, Eaton N, Fredenburg L, Pleet M, Mantia J, Bradley ER, Fernandes-Osterhold G, Woolley JD (2023). \textit{Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0004}{doi:10.1089/psymed.2022.0004}.
\item J. H. Shepherd, C.T.M. Baten, A. C. Klassen, G. Zamora, Sarah Saravia, Elizabeth Pritchard, Ziad A. Ali, S. K. Kahlon, Kyla Whitelock, F. A. Reyes, D. W. Hedges, J. Paul Hamilton, Matthew D. Sacchet, Chris H. Miller (2023). \textit{The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2023.1948}{doi:10.1192/j.eurpsy.2023.1948}.
\item Roberts BF, Zylko AL, Waters CE, Crowder JD, Gibbons WJ, Sen AK, Jones JA, McMurray MS (2023). \textit{Effect of psilocybin on decision-making and motivation in the healthy rat.}. Behavioural brain research. [published; PubMed]. \href{https://doi.org/10.1016/j.bbr.2022.114262}{doi:10.1016/j.bbr.2022.114262}.
\item Østergaard SD, Hieronymus F (2023). \textit{Psilocybin for Treatment-Resistant Depression.}. The New England journal of medicine. [published; PubMed]. \href{https://doi.org/10.1056/nejmc2215459}{doi:10.1056/nejmc2215459}.
\item Rijsketic DR, Casey AB, Barbosa DAN, Zhang X, Hietamies TM, Ramirez-Ovalle G, Pomrenze M, Halpern CH, Williams LM, Malenka RC, Heifets BD (2023). \textit{UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.02.19.528997}{doi:10.1101/2023.02.19.528997}.
\item Jacques Ambrose, J.S. Zabinski (2023). \textit{Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.43}{doi:10.1176/appi.pn.2023.03.3.43}.
\item Terri D’Arrigo (2023). \textit{Psychedelics Legislation Gains Momentum}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.4}{doi:10.1176/appi.pn.2023.03.3.4}.
\item Mallaroni P, Mason NL, Reckweg JT, Paci R, Ritscher S, Toennes SW, Theunissen EL, Kuypers KP, Ramaekers JG. (2023). \textit{Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.02.16.528808}{doi:10.1101/2023.02.16.528808}.
\item Ashish Sarangi, Omotola Akinkunmi (2023). \textit{Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease}. American Journal of Geriatric Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jagp.2022.12.201}{doi:10.1016/j.jagp.2022.12.201}.
\item Calderon SN, Bonson KR, Reissig CJ, Lloyd JM, Galati S, Chiapperino D (2023). \textit{Considerations in assessing the abuse potential of psychedelics during drug development.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109352}{doi:10.1016/j.neuropharm.2022.109352}.
\item Shnayder S, Ameli R, Sinaii N, Berger A, Agrawal M (2023). \textit{Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2022.11.046}{doi:10.1016/j.jad.2022.11.046}.
\item Meir P, Taylor L, Soares JC, Meyer TD (2023). \textit{Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2022.12.050}{doi:10.1016/j.jad.2022.12.050}.
\item Jeffery Heilman (2023). \textit{The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy}. Journal of Scientific Exploration. [published; OpenAlex]. \href{https://doi.org/10.31275/20222633}{doi:10.31275/20222633}.
\item Jones G, Lipson J, Wang E (2023). \textit{Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-023-29763-x}{doi:10.1038/s41598-023-29763-x}.
\item Florence Butlen-Ducuing, Drummond E-Wen McCulloch, Marion Haberkamp, Taina Mattila, Ewa Bałkowiec-Iskra, Georgios Aislaitner, П. В. Балабанов, Johan Lundberg, Dea Siggaard Stenbæk, André Elferink, Gitte M. Knudsen, Steffen Thirstrup (2023). \textit{The therapeutic potential of psychedelics: the European regulatory perspective}. The Lancet. [published; OpenAlex]. \href{https://doi.org/10.1016/s0140-6736(23)00264-7}{doi:10.1016/s0140-6736(23)00264-7}.
\item Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF (2023). \textit{Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.}. Toxics. [published; PubMed]. \href{https://doi.org/10.3390/toxics11020148}{doi:10.3390/toxics11020148}.
\item Lea J. Mertens (2023). \textit{Wirkt Psilocybin nachhaltig antidepressiv?}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-023-3166-2}{doi:10.1007/s15005-023-3166-2}.
\item Aryan Sarparast (2023). \textit{More on psilocybin}. Current Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.12788/cp.0333}{doi:10.12788/cp.0333}.
\item Gonda X, Dome P, Neill JC, Tarazi FI (2023). \textit{Novel antidepressant drugs: Beyond monoamine targets.}. CNS spectrums. [published; PubMed]. \href{https://doi.org/10.1017/s1092852921000791}{doi:10.1017/s1092852921000791}.
\item Ko K, Kopra EI, Cleare AJ, Rucker JJ (2023). \textit{Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2022.09.168}{doi:10.1016/j.jad.2022.09.168}.
\item Wang H, Wang Y (2023). \textit{Matrix-assisted laser-desorption/ionization-mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated target plate.}. Analytical and bioanalytical chemistry. [published; PubMed]. \href{https://doi.org/10.1007/s00216-022-04467-9}{doi:10.1007/s00216-022-04467-9}.
\item Burmester DR, Madsen MK, Szabo A, Aripaka SS, Stenbæk DS, Frokjaer VG, Elfving B, Mikkelsen JD, Knudsen GM, Fisher PM (2023). \textit{Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation.}. Comprehensive psychoneuroendocrinology. [published; PubMed]. \href{https://doi.org/10.1016/j.cpnec.2022.100163}{doi:10.1016/j.cpnec.2022.100163}.
\item Cameron LP, Patel SD, Vargas MV, Barragan EV, Saeger HN, Warren HT, Chow WL, Gray JA, Olson DE (2023). \textit{5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.2c00718}{doi:10.1021/acschemneuro.2c00718}.
\item von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX (2023). \textit{Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.}. EClinicalMedicine. [published; PubMed]. \href{https://doi.org/10.1016/j.eclinm.2022.101809}{doi:10.1016/j.eclinm.2022.101809}.
\item von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX (2023). \textit{Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.}. EClinicalMedicine. [published; PubMed]. \href{https://doi.org/10.1016/j.eclinm.2023.101841}{doi:10.1016/j.eclinm.2023.101841}.
\item Rucker JJ (2023). \textit{Psilocybin therapy for depression. A good trip?}. Journal of mental health (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09638237.2023.2183492}{doi:10.1080/09638237.2023.2183492}.
\item Jennings Hernandez (2023). \textit{Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health}. Advances in Research. [published; OpenAlex]. \href{https://doi.org/10.9734/air/2023/v24i1931}{doi:10.9734/air/2023/v24i1931}.
\item Washington University School of Medicine (2023). \textit{SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05601648}{source link}.
\item Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P (2023). \textit{Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph20031870}{doi:10.3390/ijerph20031870}.
\item Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck (2023). \textit{Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00222}{doi:10.1556/2054.2022.00222}.
\item Dragana Marković, Eleonora Čapelja (2023). \textit{Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder}. AIDASCO Reviews. [published; OpenAlex]. \href{https://doi.org/10.59783/aire.2023.15}{doi:10.59783/aire.2023.15}.
\item Keith Heinzerling (2023). \textit{Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04410913}{source link}.
\item Mann JJ (2023). \textit{Is psilocybin an effective antidepressant and what is its Mechanism of action?}. Cell reports. Medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.xcrm.2022.100906}{doi:10.1016/j.xcrm.2022.100906}.
\item Benjamin A. Korman (2023). \textit{Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeism}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00240}{doi:10.1556/2054.2022.00240}.
\item Anna Lutkajtis, Jules Evans (2023). \textit{Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00232}{doi:10.1556/2054.2022.00232}.
\item Gukasyan N (2023). \textit{On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression.}. Med (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1016/j.medj.2022.12.003}{doi:10.1016/j.medj.2022.12.003}.
\item Berlowitz I, García Torres E, Maake C, Wolf U, Martin-Soelch C (2023). \textit{Indigenous-Amazonian Traditional Medicine's Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study.}. Plants (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/plants12020346}{doi:10.3390/plants12020346}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Bhadoria Poonam, Ramanathan Venkatnarayan (2023). \textit{Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights}. ChemistrySelect. [published; Crossref]. \href{https://doi.org/10.1002/slct.202203994}{doi:10.1002/slct.202203994}.
\item Torrado Pacheco A, Olson RJ, Garza G, Moghaddam B (2023). \textit{Acute psilocybin enhances cognitive flexibility in rats.}. bioRxiv: the preprint server for biology. [published; PubMed]. \href{https://doi.org/10.1101/2023.01.09.523291}{doi:10.1101/2023.01.09.523291}.
\item Houman Farzin (2023). \textit{Healing at death’s door: one patient’s mystical experience with psilocybin}. International Journal of Whole Person Care. [published; OpenAlex]. \href{https://doi.org/10.26443/ijwpc.v10i1.373}{doi:10.26443/ijwpc.v10i1.373}.
\item Kaden Venugopal, Nefissa Bedri (2023). \textit{The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.420}{doi:10.26685/urncst.420}.
\item Andersen S. (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f26ce}{doi:10.31234/osf.io/f26ce}.
\item Sidsel Andersen (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/f26ce\_v1}{source link}.
\item Sebastian William Foster (2023). \textit{Cognitive liberty and the constitutionality of criminalising psilocybin mushrooms in South Africa}. South African Journal on Human Rights. [published; OpenAlex]. \href{https://doi.org/10.1080/02587203.2023.2202875}{doi:10.1080/02587203.2023.2202875}.
\item Fabiano F. da Silva, Thaysa Adriane Costa Bernardo, Johny Ricarte das Silva Rodrigues, Pierre Teodósio Félix (2023). \textit{Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature review}. IJS - International Journal of Sciences. [published; OpenAlex]. \href{https://doi.org/10.29327/229003.5.3-1}{doi:10.29327/229003.5.3-1}.
\item Eklund, Julia (2023). \textit{Psilocin esters - An investigation of synthetic feasibility, chemical, and metabolic stability}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.16912635}{doi:10.5281/zenodo.16912635}.
\item Tucker, Kathryn L., Martinez, Holly, Morris, Ebony (2023). \textit{In Search of: A Federal Safe Harbor for State Legalization of Psilocybin}. Lewis \& Clark Law Review. [published; OpenAlex]. \href{https://lawcommons.lclark.edu/lclr/vol26/iss4/6}{source link}.
\item Klaus Richter Larsen, Ulrich Lindberg, Brice Ozenne, Drummond E-Wen McCulloch, Sophia Armand, M. Madsen, Annette Johansen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher (2023). \textit{Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102665}{doi:10.1016/j.nsa.2023.102665}.
\item Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2023). \textit{Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102452}{doi:10.1016/j.nsa.2023.102452}.
\item Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons, E.K. Teoh, Jeng-Yu Tsai, E. Malievskaia (2023). \textit{The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102906}{doi:10.1016/j.nsa.2023.102906}.
\item Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk, Andrzej Pilc (2023). \textit{Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102939}{doi:10.1016/j.nsa.2023.102939}.
\item Sofia Nasini, Martina Colognesi, Sara Tidei, Sara De Martin, Marco Banzato, Andrea Mattarei, Franco Folli, P. Marco, Paolo L. Manfredi, Stefano Comai (2023). \textit{Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103378}{doi:10.1016/j.nsa.2023.103378}.
\item Guy M. Goodwin, Megan Croal, J. Chai-Rees, Lindsey Marwood, S. Mistry, Anna Nowakowska, H. Clifton Simmons, Jeng-Yu Tsai (2023). \textit{Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103487}{doi:10.1016/j.nsa.2023.103487}.
\item Miriam L. Navarro, Alberte Wollesen Breum, Annette Johansen, Brice Ozenne, Vibe G. Frøkjær, Gitte M. Knudsen (2023). \textit{Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103646}{doi:10.1016/j.nsa.2023.103646}.
\item Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M. Madsen, Gitte M. Knudsen, Patrick M. Fisher (2023). \textit{A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteers}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103723}{doi:10.1016/j.nsa.2023.103723}.
\item M. Nikolič, P. Mediano, Tom Froese, Tomáš Páleníček (2023). \textit{Investigating changes in EEG entropy rate in response to psilocybin - a comparison of lempel ziv and state-space entropy rate measures}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103667}{doi:10.1016/j.nsa.2023.103667}.
\item Shao Ling-Xiao, Liao Clara, Gregg Ian, Davoudian Pasha A, Savalia Neil K, Delagarza Kristina, Kwan Alex C. (2023). \textit{Visualizing drug actions on dendrites: psilocybin and other classic psychedelics}. Biophotonics Congress: Optics in the Life Sciences 2023 (OMA, NTM, BODA, OMP, BRAIN). [published; Crossref]. \href{https://doi.org/10.1364/brain.2023.btu2b.2}{doi:10.1364/brain.2023.btu2b.2}.
\item Adriana D’Arienzo, Giorgio Samorini (2023). \textit{Italian psychedelic therapies of the past century: An historical overview}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231179687}{doi:10.1177/20503245231179687}.
\item Peter Hess (2023). \textit{Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/etcr6498}{doi:10.53053/etcr6498}.
\item Peter Hess (2023). \textit{Company on brink takes psilocybin to trial for fragile X syndrome}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/mkkk7368}{doi:10.53053/mkkk7368}.
\item O. Shahar, A. Botvinik, T. Lifschytz, B. Lerer (2023). \textit{Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders.}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.101067}{doi:10.1016/j.nsa.2023.101067}.
\item Peter Hess (2023). \textit{Going on Trial: Arbaclofen reboot; cell implants; psilocybin microdoses}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/nbdr8957}{doi:10.53053/nbdr8957}.
\item Nadiia Omelchenko, Anton Kurapov (2023). \textit{Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change}. Bulletin of Taras Shevchenko National University of Kyiv Psychology. [published; OpenAlex]. \href{https://doi.org/10.17721/bpsy.2023.1(17).8}{doi:10.17721/bpsy.2023.1(17).8}.
\item John R. Rossiter (2023). \textit{Psychedelic Drug Therapy for Mental Disorders?}. Open Journal of Medical Psychology. [published; OpenAlex]. \href{https://doi.org/10.4236/ojmp.2023.123010}{doi:10.4236/ojmp.2023.123010}.
\item Sebastian William Foster (2023). \textit{The right to privacy in the decriminalisation of psilocybin mushrooms in South Africa}. Law Democracy \& Development. [published; OpenAlex]. \href{https://doi.org/10.17159/2077-4907/2023/ldd.v27.1}{doi:10.17159/2077-4907/2023/ldd.v27.1}.
\item Hannah Douglass, Merle Spriggs, Kate Godfrey, Jennifer L. Danby, Francisco Magalhães, Kirsty L. Alderton, Liane Macdonald, Stephanie Archer, Tim Read, Adèle Lafrance, Dasha Nicholls, David Erritzøe, R. Park, David Nutt, Robin Carhart-Harris (2023). \textit{Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102878}{doi:10.1016/j.nsa.2023.102878}.
\item Jaden Brandt (2023). \textit{A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231170340}{doi:10.1177/20503245231170340}.
\item Brian S. Barnett, Noah Wiles Sweat, Peter S. Hendricks (2023). \textit{Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231172536}{doi:10.1177/20503245231172536}.
\item McCartney AM, McGovern HT, De Foe A (2023). \textit{Predictors of Psychedelic Experience: A Thematic Analysis.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2129885}{doi:10.1080/02791072.2022.2129885}.
\item Vejmola Č., Hubený J., Koudelka V., Griškova-Bulanova I., Páleníček T. (2023). \textit{Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2023.103662}{doi:10.1016/j.nsa.2023.103662}.
\item Simonsson O, Goldberg SB (2023). \textit{Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.2022816}{doi:10.1080/02791072.2021.2022816}.
\item Hadar A, David J, Shalit N, Roseman L, Gross R, Sessa B, Lev-Ran S (2023). \textit{The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.2022254}{doi:10.1080/02791072.2021.2022254}.
\item Glynos NG, Pierce J, Davis AK, McAfee J, Boehnke KF (2023). \textit{Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.2022817}{doi:10.1080/02791072.2021.2022817}.
\item Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC (2023). \textit{The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2044096}{doi:10.1080/02791072.2022.2044096}.
\item Earleywine M, Low F, Altman BR, De Leo J (2023). \textit{How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2047842}{doi:10.1080/02791072.2022.2047842}.
\item Knudsen GM (2023). \textit{Sustained effects of single doses of classical psychedelics in humans.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-022-01361-x}{doi:10.1038/s41386-022-01361-x}.
\item Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V (2023). \textit{The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437221111371}{doi:10.1177/07067437221111371}.
\item Calder AE, Hasler G (2023). \textit{Towards an understanding of psychedelic-induced neuroplasticity.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-022-01389-z}{doi:10.1038/s41386-022-01389-z}.
\item Johnston CB, Mangini M, Grob C, Anderson B (2023). \textit{The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.}. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.jagp.2022.08.007}{doi:10.1016/j.jagp.2022.08.007}.
\item Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ (2023). \textit{Mescaline: The forgotten psychedelic.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109294}{doi:10.1016/j.neuropharm.2022.109294}.
\item Jones GM (2023). \textit{Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221127304}{doi:10.1177/02698811221127304}.
\item Gutman Ori, Tenne Dana, Bretler Uriel (2023). \textit{Psilocin - The “real deal” or an extraction byproduct}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1111/1556-4029.15167}{doi:10.1111/1556-4029.15167}.
\item Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T, Douglass HM, Roseman L, Timmermann C, Erritzoe D, Nutt DJ, Carhart-Harris RL (2023). \textit{Body mass index (BMI) does not predict responses to psilocybin.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221131994}{doi:10.1177/02698811221131994}.
\item Kious B, Schwartz Z, Lewis B (2023). \textit{Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221133461}{doi:10.1177/02698811221133461}.
\item Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R (2023). \textit{Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221125354}{doi:10.1177/02698811221125354}.
\item Buzzelli V, Carbone E, Manduca A, Schiavi S, Feo A, Perederiy JV, Ambert KH, Hausman M, Trezza V (2023). \textit{Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06286-3}{doi:10.1007/s00213-022-06286-3}.
\item Siegel JS, Daily JE, Perry DA, Nicol GE (2023). \textit{Psychedelic Drug Legislative Reform and Legalization in the US.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2022.4101}{doi:10.1001/jamapsychiatry.2022.4101}.
\item Morton E, Sakai K, Ashtari A, Pleet M, Michalak EE, Woolley J (2023). \textit{Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221131997}{doi:10.1177/02698811221131997}.
\item Meccia J, Lopez J, Bagot RC (2023). \textit{Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06297-0}{doi:10.1007/s00213-022-06297-0}.
\item Henningfield JE, Ashworth J, Heal DJ, Smith SL (2023). \textit{Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221140004}{doi:10.1177/02698811221140004}.
\item Forstmann M, Kettner HS, Sagioglou C, Irvine A, Gandy S, Carhart-Harris RL, Luke D (2023). \textit{Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221146356}{doi:10.1177/02698811221146356}.
\item Whinkin E, Opalka M, Watters C, Jaffe A, Aggarwal S (2023). \textit{Psilocybin in Palliative Care: An Update.}. Current geriatrics reports. [published; PubMed]. \href{https://doi.org/10.1007/s13670-023-00383-7}{doi:10.1007/s13670-023-00383-7}.
\item Kotoula V, Evans JW, Punturieri C, Johnson SC, Zarate CA (2023). \textit{Functional MRI markers for treatment-resistant depression: Insights and challenges.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2023.04.001}{doi:10.1016/bs.pbr.2023.04.001}.
\item Chen MH, Tu PC, Su TP (2023). \textit{Next generation antidepressants with novel mechanisms for treatment resistant depression.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2023.02.005}{doi:10.1016/bs.pbr.2023.02.005}.
\item Rivera-García MT, Cruz SL (2023). \textit{The Resurgence of Hallucinogen Drugs in Clinical Research.}. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. [published; PubMed]. \href{https://doi.org/10.24875/ric.23000108}{doi:10.24875/ric.23000108}.
\item Unzueta-Larrinaga P, Urigüen L (2023). \textit{Evaluation of Sensorimotor Gating Deficits in Mice Through Prepulse Inhibition (PPI) of the Startle Response.}. Methods in molecular biology (Clifton, N.J.). [published; PubMed]. \href{https://doi.org/10.1007/978-1-0716-3307-6\_5}{doi:10.1007/978-1-0716-3307-6\_5}.
\item Tamman AJF, Jiang L, Averill CL, Mason GF, Averill LA, Abdallah CG (2023). \textit{Biological embedding of early trauma: the role of higher prefrontal synaptic strength.}. European journal of psychotraumatology. [published; PubMed]. \href{https://doi.org/10.1080/20008066.2023.2246338}{doi:10.1080/20008066.2023.2246338}.
\item Ahmed H, Mushahid H, Arshad T (2023). \textit{UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.}. Psychiatria Danubina. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/37992112/}{source link}.
\item Feulner L, Sermchaiwong T, Rodland N, Galarneau D (2023). \textit{Efficacy and Safety of Psychedelics in Treating Anxiety Disorders.}. Ochsner journal. [published; PubMed]. \href{https://doi.org/10.31486/toj.23.0076}{doi:10.31486/toj.23.0076}.
\item Edelsohn GA, Sisti D (2023). \textit{Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment.}. Perspectives in biology and medicine. [published; PubMed]. \href{https://doi.org/10.1353/pbm.2023.0007}{doi:10.1353/pbm.2023.0007}.
\item Martinovic J (2023). \textit{When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s.}. Historia, ciencias, saude--Manguinhos. [published; PubMed]. \href{https://doi.org/10.1590/s0104-59702022000500007}{doi:10.1590/s0104-59702022000500007}.
\item Rudin D, Areesanan A, Liechti ME, Gründemann C (2023). \textit{Classic psychedelics do not affect T cell and monocyte immune responses.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1042440}{doi:10.3389/fpsyt.2023.1042440}.
\item van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE, Kramers K, Schellekens A, Somers M, Bossong MG, Batalla A (2023). \textit{Therapeutic effect of psilocybin in addiction: A systematic review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1134454}{doi:10.3389/fpsyt.2023.1134454}.
\item Ragnhildstveit A, Kaiyo M, Snyder MB, Jackson LK, Lopez A, Mayo C, Miranda AC, August RJ, Seli P, Robison R, Averill LA (2023). \textit{Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1051542}{doi:10.3389/fpsyt.2023.1051542}.
\item Chen Y, Liu J, Yao Y, Yan H, Su R (2023). \textit{Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1021729}{doi:10.3389/fphar.2023.1021729}.
\item Kinderlehrer DA (2023). \textit{The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study.}. International medical case reports journal. [published; PubMed]. \href{https://doi.org/10.2147/imcrj.s395342}{doi:10.2147/imcrj.s395342}.
\item Lewis CR, McMurray M, Mennenga SE, Helms Tillery S (2023). \textit{Editorial: What is up with psychedelics anyway?}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1161868}{doi:10.3389/fnins.2023.1161868}.
\item Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR, Patterson JC, Stauffer CS (2023). \textit{Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1123424}{doi:10.3389/fpsyt.2023.1123424}.
\item Vorobyeva N, Kozlova AA (2023). \textit{Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1184726}{doi:10.3389/fphar.2023.1184726}.
\item Shaw L, Rea K, Lachowsky NJ, Roth EA (2023). \textit{Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2054746}{doi:10.1080/02791072.2022.2054746}.
\item Fauvel B, Kangaslampi S, Strika-Bruneau L, Roméo B, Piolino P (2023). \textit{Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2059796}{doi:10.1080/02791072.2022.2059796}.
\item Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG (2023). \textit{Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.}. International journal of clinical and health psychology: IJCHP. [published; PubMed]. \href{https://doi.org/10.1016/j.ijchp.2022.100349}{doi:10.1016/j.ijchp.2022.100349}.
\item IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I (2023). \textit{The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.}. Innovations in clinical neuroscience. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/37387703/}{source link}.
\item Rankaduwa S, Owen AM (2023). \textit{Psychedelics, entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niad001}{doi:10.1093/nc/niad001}.
\item Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A (2023). \textit{Use of Selective Alternative Therapies for Treatment of OCD.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s403997}{doi:10.2147/ndt.s403997}.
\item Mosurinjohn S, Roseman L, Girn M (2023). \textit{Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1077311}{doi:10.3389/fpsyt.2023.1077311}.
\item Urban MM, Stingl MR, Meinhardt MW (2023). \textit{Mini-review: The neurobiology of treating substance use disorders with classical psychedelics.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1156319}{doi:10.3389/fnins.2023.1156319}.
\item Ching THW, Grazioplene R, Bohner C, Kichuk SA, DePalmer G, D'Amico E, Eilbott J, Jankovsky A, Burke M, Hokanson J, Martins B, Witherow C, Patel P, Amoroso L, Schaer H, Pittenger C, Kelmendi B (2023). \textit{Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1178529}{doi:10.3389/fpsyt.2023.1178529}.
\item Purohit P, Dutta P, Roy PK (2023). \textit{Empirically validated theoretical analysis of visual-spatial perception under change of nervous system arousal.}. Frontiers in computational neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fncom.2023.1136985}{doi:10.3389/fncom.2023.1136985}.
\item Blest-Hopley G, Amit BH, O'Neill A, Ruffell SGD (2023). \textit{Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1191970}{doi:10.3389/fpsyt.2023.1191970}.
\item Davis O (2023). \textit{Henri Michaux's program for the psychedelic humanities.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2023.1152896}{doi:10.3389/fpsyg.2023.1152896}.
\item Liu J, Wang Y, Xia K, Wu J, Zheng D, Cai A, Yan H, Su R (2023). \textit{Acute psilocybin increased cortical activities in rats.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1168911}{doi:10.3389/fnins.2023.1168911}.
\item Evens R, Schmidt ME, Majić T, Schmidt TT (2023). \textit{The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253231172254}{doi:10.1177/20451253231172254}.
\item Ratkovic G, Sosteric M, Sosteric T (2023). \textit{A case-study evaluation of the "Copenhagen Music Program" for psilocybin-assisted therapy.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2023.1156852}{doi:10.3389/fpsyg.2023.1156852}.
\item Phan AN, Terry GE (2023). \textit{Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1144276}{doi:10.3389/fpsyt.2023.1144276}.
\item Zhornitsky S, Oliva HNP, Jayne LA, Allsop ASA, Kaye AP, Potenza MN, Angarita GA (2023). \textit{Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1197890}{doi:10.3389/fpsyt.2023.1197890}.
\item Li I, Fong R, Hagen M, Tabaac B (2023). \textit{Medical student attitudes and perceptions of psychedelic-assisted therapies.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1190507}{doi:10.3389/fpsyt.2023.1190507}.
\item Blond BN, Schindler EAD (2023). \textit{Case report: Psychedelic-induced seizures captured by intracranial electrocorticography.}. Frontiers in neurology. [published; PubMed]. \href{https://doi.org/10.3389/fneur.2023.1214969}{doi:10.3389/fneur.2023.1214969}.
\item De La Haye W, Walcott G, Eaton J, Beckford J, Greene J (2023). \textit{Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1136990}{doi:10.3389/fpsyt.2023.1136990}.
\item Hartong V, van Emmerik A (2023). \textit{Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2080616}{doi:10.1080/02791072.2022.2080616}.
\item Lawson K (2023). \textit{What is the progress of experimental drug development for fibromyalgia?}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2023.2230118}{doi:10.1080/13543784.2023.2230118}.
\item McIntyre RS (2023). \textit{Serotonin 5-HT receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents.}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2023.2248883}{doi:10.1080/14740338.2023.2248883}.
\item McIntyre RS (2023). \textit{Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents.}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2023.2253144}{doi:10.1080/14740338.2023.2253144}.
\item Schindler EAD, Hendricks PS (2023). \textit{Adapting psychedelic medicine for headache and chronic pain disorders.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2023.2246655}{doi:10.1080/14737175.2023.2246655}.
\item Kozak Z, Johnson MW, Aaronson ST (2023). \textit{Assessing potential of psilocybin for depressive disorders.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2023.2273493}{doi:10.1080/13543784.2023.2273493}.
\item Simonsson O, Stenfors CUD, Goldberg SB, Hendricks PS, Osika W (2023). \textit{Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2023.1151626}{doi:10.3389/fpsyg.2023.1151626}.
\item Więckiewicz G, Stokłosa I, Stokłosa M, Więckiewicz W, Gorczyca P, Gondek TM (2023). \textit{Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1184023}{doi:10.3389/fpsyt.2023.1184023}.
\item Boehnke KF, Cox K, Weston C, Herberholz M, Glynos N, Kolbman N, Fields CW, Barron J, Kruger DJ (2023). \textit{Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1224551}{doi:10.3389/fpsyt.2023.1224551}.
\item Abrams SK, Rabinovitch BS, Zafar R, Aziz AS, Cherup NP, McMillan DW, Nielson JL, Lewis EC (2023). \textit{Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics.}. Neurotrauma reports. [published; PubMed]. \href{https://doi.org/10.1089/neur.2023.0022}{doi:10.1089/neur.2023.0022}.
\item Jones G, Al-Suwaidi M, Castro-Ramirez F, McGuire TC, Mair P, Nock MK (2023). \textit{Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1169692}{doi:10.3389/fpsyt.2023.1169692}.
\item Longo MSC, Bienemann B, Multedo M, Negreiros MA, Schenberg E, Mograbi DC (2023). \textit{The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2112788}{doi:10.1080/02791072.2022.2112788}.
\item Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ (2023). \textit{Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2125467}{doi:10.1080/02791072.2022.2125467}.
\item Weleff J, Akiki TJ, Barnett BS (2023). \textit{Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2133757}{doi:10.1080/02791072.2022.2133757}.
\item Kruger DJ, Glynos NG, Fields CW, Herberholz M, Boehnke KF (2023). \textit{An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2142709}{doi:10.1080/02791072.2022.2142709}.
\item Dubus Z, Grandgeorge E, Verroust V (2023). \textit{History of the administration of psychedelics in France.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2023.1131565}{doi:10.3389/fpsyg.2023.1131565}.
\item Lawrence DW (2023). \textit{Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.}. Innovations in clinical neuroscience. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/37817818/}{source link}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Expert opinion on pharmacotherapy. [published; PubMed]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Heinzerling KG, Sergi K, Linton M, Rich R, Youssef B, Bentancourt I, Bramen J, Siddarth P, Schwartzberg L, Kelly DF (2023). \textit{Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1215972}{doi:10.3389/fpsyt.2023.1215972}.
\item Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, Garcia-Romeu A (2023). \textit{Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1199642}{doi:10.3389/fpsyt.2023.1199642}.
\item Black T (2023). \textit{Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the "high-risk" addiction patient.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1159843}{doi:10.3389/fpsyt.2023.1159843}.
\item Halim HJ, Burk BG, Fargason RE, Birur B (2023). \textit{Manic episode following psilocybin use in a man with bipolar II disorder: a case report.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1221131}{doi:10.3389/fpsyt.2023.1221131}.
\item Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK (2023). \textit{Bedside to bench: the outlook for psychedelic research.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1240295}{doi:10.3389/fphar.2023.1240295}.
\item Ko K, Carter B, Cleare AJ, Rucker JJ (2023). \textit{Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s426193}{doi:10.2147/ndt.s426193}.
\item Barnett BS, Bassir Nia A, Sackett NB, Weleff J (2023). \textit{Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1305478}{doi:10.3389/fpsyt.2023.1305478}.
\item Sharma R, Batchelor R, Sin J (2023). \textit{Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2190319}{doi:10.1080/02791072.2023.2190319}.
\item Kruger DJ, Enghoff O, Herberholz M, Barron J, Boehnke KF (2023). \textit{"How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2201263}{doi:10.1080/02791072.2023.2201263}.
\item Escamilla R, González-Trujano ME, González Mariscal JM, Torres-Valencia JM, Guzmán-González H, Vega JL, Loizaga-Velder A (2023). \textit{A Proposal to Study the Safety and Efficacy of in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2246459}{doi:10.1080/02791072.2023.2246459}.
\item Kovacevich A, Weleff J, Claytor B, Barnett BS (2023). \textit{Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2253538}{doi:10.1080/02791072.2023.2253538}.
\item Kvam TM, Uthaug MV, Andersen KAA, Refsum BB, Tunstad PA, Stewart LH, Jacobsen HB, Grønnerød C (2023). \textit{Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1287196}{doi:10.3389/fpsyt.2023.1287196}.
\item Tasker NR, Pazur EJ, Wipf P (2023). \textit{Biological studies of clavine alkaloids targeting CNS receptors.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1286941}{doi:10.3389/fpsyt.2023.1286941}.
\item Waldbillig A, Baranova M, Neumann S, Andrade J, Sidhu S (2023). \textit{Exploring spp. mycelium and fruiting body chemistry for potential therapeutic compounds.}. Frontiers in fungal biology. [published; PubMed]. \href{https://doi.org/10.3389/ffunb.2023.1295223}{doi:10.3389/ffunb.2023.1295223}.
\item Marseille E, Stauffer CS, Agrawal M, Thambi P, Roddy K, Mithoefer M, Bertozzi SM, Kahn JG (2023). \textit{Group psychedelic therapy: empirical estimates of cost-savings and improved access.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1293243}{doi:10.3389/fpsyt.2023.1293243}.
\item Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B (2023). \textit{Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1278823}{doi:10.3389/fpsyt.2023.1278823}.
\item Freidel N, Kreuder L, Rabinovitch BS, Chen FY, Huang RST, Lewis EC (2023). \textit{Psychedelics, epilepsy, and seizures: a review.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1326815}{doi:10.3389/fphar.2023.1326815}.
\item Andrew M. Robie (2022). \textit{Ego Birth: Measure 109, The NMHA, and Forward Movement in the Nascent Psilocybin Industry}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.4459584}{doi:10.2139/ssrn.4459584}.
\item Octavian Dixon Ritchie, Cameron N Donley, Gabrielle Dixon Ritchie (2022). \textit{From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231198472}{doi:10.1177/20503245231198472}.
\item Munafò A, Arillotta D, Mannaioni G, Schifano F, Bernardini R, Cantarella G (2022). \textit{Psilocybin for Depression: From Credibility to Feasibility, What's Missing?}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph16010068}{doi:10.3390/ph16010068}.
\item Vanessa Eveline VLAIC, Andreea ONA (2022). \textit{The Potential of Psilocybe Genus Fungi to Treat Depression and Some Addictions}. Hop and Medicinal Plants. [published; OpenAlex]. \href{https://doi.org/10.15835/hpm.v30i1-2.14453}{doi:10.15835/hpm.v30i1-2.14453}.
\item Serreau R, Amirouche A, Benyamina A, Berteina-Raboin S (2022). \textit{A Review of Synthetic Access to Therapeutic Compounds Extracted from.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph16010040}{doi:10.3390/ph16010040}.
\item Nick Zagorski (2022). \textit{Depression Improves Following Single Dose of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.01.1.50}{doi:10.1176/appi.pn.2023.01.1.50}.
\item Bradshaw AJ, Backman TA, Ramírez-Cruz V, Forrister DL, Winter JM, Guzmán-Dávalos L, Furci G, Stamets P, Dentinger BTM (2022). \textit{DNA Authentication and Chemical Analysis of Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites.}. Applied and environmental microbiology. [published; PubMed]. \href{https://doi.org/10.1128/aem.01498-22}{doi:10.1128/aem.01498-22}.
\item Jones G, Arias D, Nock M (2022). \textit{Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-25658-5}{doi:10.1038/s41598-022-25658-5}.
\item Kevin Zannese (2022). \textit{High time? Psychedelics on cannabis-like fast track to legalization}. Canadian Medical Association Journal. [published; OpenAlex]. \href{https://doi.org/10.1503/cmaj.1096029}{doi:10.1503/cmaj.1096029}.
\item Schäfer T, Kramer K, Werten S, Rupp B, Hoffmeister D (2022). \textit{Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202200551}{doi:10.1002/cbic.202200551}.
\item Bradshaw AJ, Ramírez-Cruz V, Awan AR, Furci G, Guzmán-Dávalos L, Stamets P, Dentinger BT. (2022). \textit{Phylogenomics of the psychoactive mushroom genus Psilocybe and evolution of the psilocybin biosynthetic gene cluster}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.12.13.520147}{doi:10.1101/2022.12.13.520147}.
\item Geoffrey M. Bove, David J. Mokler (2022). \textit{Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00230}{doi:10.1556/2054.2022.00230}.
\item Pędzich BD, Medrano M, Buckinx A, Smolders I, De Bundel D (2022). \textit{Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms232315284}{doi:10.3390/ijms232315284}.
\item Magiatis P, Dadiotis E, Antonopoulos R K, Ioannidis K, Mitsis V, Melliou E, Gonou-Zagou Z (2022). \textit{Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens}. Planta Medica. [published; Crossref]. \href{https://doi.org/10.1055/s-0042-1759062}{doi:10.1055/s-0042-1759062}.
\item Kelly JR, Baker A, Babiker M, Burke L, Brennan C, O'Keane V (2022). \textit{The psychedelic renaissance: the next trip for psychiatry?}. Irish journal of psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/ipm.2019.39}{doi:10.1017/ipm.2019.39}.
\item Walsh CA, Livne O, Shmulewitz D, Stohl M, Hasin DS (2022). \textit{Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002-2019.}. Addictive behaviors reports. [published; PubMed]. \href{https://doi.org/10.1016/j.abrep.2022.100454}{doi:10.1016/j.abrep.2022.100454}.
\item Hartogsohn I, Petranker R (2022). \textit{Set and setting in microdosing: an oft-overlooked principle.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06249-8}{doi:10.1007/s00213-022-06249-8}.
\item O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J, Ross S, Forcehimes AA, Bogenschutz MP (2022). \textit{Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.}. Contemporary clinical trials. [published; PubMed]. \href{https://doi.org/10.1016/j.cct.2022.106976}{doi:10.1016/j.cct.2022.106976}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M (2022). \textit{Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.}. 3 Biotech. [published; PubMed]. \href{https://doi.org/10.1007/s13205-022-03355-4}{doi:10.1007/s13205-022-03355-4}.
\item Olsen Anders S., Lykkebo-Valløe Anders, Ozenne Brice, Madsen Martin K., Stenbæk Dea S., Armand Sophia, Mørup Morten, Ganz Melanie, Knudsen Gitte M., Fisher Patrick M. (2022). \textit{Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects}. NeuroImage. [published; Crossref]. \href{https://doi.org/10.1016/j.neuroimage.2022.119716}{doi:10.1016/j.neuroimage.2022.119716}.
\item Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS (2022). \textit{Psychedelic-Assisted Therapy for People with Eating Disorders.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01394-5}{doi:10.1007/s11920-022-01394-5}.
\item Barber G, Nemeroff CB, Siegel S (2022). \textit{A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.22010073}{doi:10.1176/appi.ajp.22010073}.
\item Kelmendi B, Kichuk SA, DePalmer G, Maloney G, Ching THW, Belser A, Pittenger C (2022). \textit{Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.}. Heliyon. [published; PubMed]. \href{https://doi.org/10.1016/j.heliyon.2022.e12135}{doi:10.1016/j.heliyon.2022.e12135}.
\item Dooper Marten (2022). \textit{Antidepressant properties of psilocybin might be related to changes in sleep}. Medicom Conference Report ECNP 2022. [published; Crossref]. \href{https://doi.org/10.55788/c6e5fc91}{doi:10.55788/c6e5fc91}.
\item Dooper Marten (2022). \textit{Fast and sustained effect of 2 administrations of psilocybin on depression}. Medicom Conference Report ECNP 2022. [published; Crossref]. \href{https://doi.org/10.55788/0629715f}{doi:10.55788/0629715f}.
\item Dooper Marten (2022). \textit{Mode of action of psilocybin}. Medicom Conference Report ECNP 2022. [published; Crossref]. \href{https://doi.org/10.55788/9af70cfc}{doi:10.55788/9af70cfc}.
\item NWTraumatherapies (2022). \textit{NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05042466}{source link}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A, Wolf G, Lerer B, Lifschytz T (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms232214148}{doi:10.3390/ijms232214148}.
\item Guss J, Krause R, Sloshower J. (2022). \textit{Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/r96tc}{doi:10.31234/osf.io/r96tc}.
\item Jeffrey Guss, Robert Krause, Jordan Sloshower (2022). \textit{Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/r96tc\_v1}{source link}.
\item Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA. (2022). \textit{Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.15.516655}{doi:10.1101/2022.11.15.516655}.
\item Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT (2022). \textit{Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109214}{doi:10.1016/j.neuropharm.2022.109214}.
\item Gotvaldová K, Borovička J, Hájková K, Cihlářová P, Rockefeller A, Kuchař M (2022). \textit{Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms232214068}{doi:10.3390/ijms232214068}.
\item Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, Kaylo K, Pham DNK, Naeem M, Sammeta VR, DeBoer S, Golen JA, Hulley EB, Stove CP, Chadeayne AR, Manke DR, Baumann MH (2022). \textit{Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.2c00177}{doi:10.1021/acsptsci.2c00177}.
\item NYU Langone Health (2022). \textit{A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02061293}{source link}.
\item Valerie A. Canady (2022). \textit{Experts assess role of therapists in psychedelic-assisted therapy}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.33435}{doi:10.1002/mhw.33435}.
\item Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC. (2022). \textit{5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.03.515044}{doi:10.1101/2022.11.03.515044}.
\item Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E (2022). \textit{Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.}. The New England journal of medicine. [published; PubMed]. \href{https://doi.org/10.1056/nejmoa2206443}{doi:10.1056/nejmoa2206443}.
\item Madras BK (2022). \textit{Psilocybin in Treatment-Resistant Depression.}. The New England journal of medicine. [published; PubMed]. \href{https://doi.org/10.1056/nejme2210975}{doi:10.1056/nejme2210975}.
\item Iacobucci G (2022). \textit{Psilocybin reduces symptoms in treatment resistant depression, trial results show.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj.o2623}{doi:10.1136/bmj.o2623}.
\item Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh (2022). \textit{The psychedelic renaissance: can psilocybin possibly combat depression?}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000089}{doi:10.1097/gh9.0000000000000089}.
\item Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J, Tse D, Hutten N, Feilding A, Ramaekers J. (2022). \textit{Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.10.31.22281688}{doi:10.1101/2022.10.31.22281688}.
\item Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR (2022). \textit{Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2022.108195}{doi:10.1016/j.pharmthera.2022.108195}.
\item Berens N, Kim SY (2022). \textit{Rapid-Response Treatments for Depression and Requests for Physician-Assisted Death: An Ethical Analysis.}. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.jagp.2022.07.003}{doi:10.1016/j.jagp.2022.07.003}.
\item Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L (2022). \textit{The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06187-5}{doi:10.1007/s00213-022-06187-5}.
\item Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ (2022). \textit{Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109220}{doi:10.1016/j.neuropharm.2022.109220}.
\item Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA (2022). \textit{Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1111/adb.13229}{doi:10.1111/adb.13229}.
\item Patchett-Marble R, O'Sullivan S, Tadwalkar S, Hapke E (2022). \textit{Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer.}. Canadian family physician Medecin de famille canadien. [published; PubMed]. \href{https://doi.org/10.46747/cfp.6811823}{doi:10.46747/cfp.6811823}.
\item Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Zhu Y, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC (2022). \textit{Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.}. Headache. [published; PubMed]. \href{https://doi.org/10.1111/head.14420}{doi:10.1111/head.14420}.
\item Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J (2022). \textit{Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.31796}{doi:10.7759/cureus.31796}.
\item Syed Rizwan A. Bokhari, Ahmad Makmom Abdullah, Zamir A. Zamir, Raquel M. Rosen (2022). \textit{A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive Emergency}. Journal of the American Society of Nephrology. [published; OpenAlex]. \href{https://doi.org/10.1681/asn.20223311s1895a}{doi:10.1681/asn.20223311s1895a}.
\item Victor Lange, Marie, Sidsel (2022). \textit{Kan psilocybin forbedre vores moral?}. Research at the University of Copenhagen (University of Copenhagen). [published; OpenAlex]. \href{https://paradoks.nu/2022/09/29/kan-psilocybin-forbedre-vores-moral/}{source link}.
\item b2xvysw192 (2022). \textit{What Are Magic Mushrooms? Why They Are Popular In British Columbia}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.7262470}{doi:10.5281/zenodo.7262470}.
\item Winston De La Haye (2022). \textit{Psychedelics for Use and Wellbeing Cultural Context and Recent Developments: A Jamaican Perspective}. Online Journal of Complementary \& Alternative Medicine. [published; OpenAlex]. \href{https://doi.org/10.33552/ojcam.2022.08.000676}{doi:10.33552/ojcam.2022.08.000676}.
\item Gukasyan N, Griffiths RR, Yaden DB, Antoine D, Nayak SM. (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2zys9}{doi:10.31234/osf.io/2zys9}.
\item Natalie Gukasyan, Roland R. Griffiths, David Bryce Yaden, Denis Antoine, Sandeep M Nayak (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2zys9\_v1}{source link}.
\item Sheppard Pratt Health System (2022). \textit{The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04433845}{source link}.
\item Stefan Baumann, Robin Carhart-Harris, David Nutt, David Erritzoe (2022). \textit{Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/s4qhf\_v1}{source link}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2022.119434}{doi:10.1016/j.neuroimage.2022.119434}.
\item Alison Knopf (2022). \textit{Psilocybin treatment for AUD: Promise in new study}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.33584}{doi:10.1002/adaw.33584}.
\item Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A (2022). \textit{Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2022-066019}{doi:10.1136/bmjopen-2022-066019}.
\item Beckley Psytech Limited (2022). \textit{An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04905121}{source link}.
\item Merlin Kirubakarababu, Arputharaj Samson Nesaraj (2022). \textit{Fungal Hallucinogens: Chemistry, Synthesis, Behavior, Toxicity and Detection Methods in Forensic Perspective}. Indian Journal of Forensic Medicine \& Toxicology. [published; OpenAlex]. \href{https://doi.org/10.37506/ijfmt.v16i4.18608}{doi:10.37506/ijfmt.v16i4.18608}.
\item Jones GM, Nock MK (2022). \textit{Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-18645-3}{doi:10.1038/s41598-022-18645-3}.
\item Silberner J (2022). \textit{Psilocybin: a revolution in psychedelic medicines in the US?}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj.o2178}{doi:10.1136/bmj.o2178}.
\item Ching THW, Kichuk S, DePalmer G, Pittenger C, Kelmendi B. (2022). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/85s9p}{doi:10.31234/osf.io/85s9p}.
\item Terence Ching, Stephen Kichuk, Giuliana DePalmer, Christopher Pittenger, Benjamin Kelmendi (2022). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/85s9p\_v1}{source link}.
\item Poonam Bhadoria, V. Ramanathan (2022). \textit{Conformational Landscape and Properties of Psilocybin: A Computational Approach}. ChemistrySelect. [published; OpenAlex]. \href{https://doi.org/10.1002/slct.202203026}{doi:10.1002/slct.202203026}.
\item Slomski A (2022). \textit{Psilocybin for Treatment of Alcohol Use Disorder.}. JAMA. [published; PubMed]. \href{https://doi.org/10.1001/jama.2022.15436}{doi:10.1001/jama.2022.15436}.
\item Benjamin R. Lewis, Kevin Byrne, Anna C. Beck (2022). \textit{Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)}. Journal of Anesthesiology and Pain Therapy. [published; OpenAlex]. \href{https://doi.org/10.29245/2768-5365/2023/3.1145}{doi:10.29245/2768-5365/2023/3.1145}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A (2022). \textit{Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.}. Nature communications. [published; PubMed]. \href{https://doi.org/10.1038/s41467-022-33578-1}{doi:10.1038/s41467-022-33578-1}.
\item Liu Y, Guo ZJ, Zhou XW (2022). \textit{Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules27196576}{doi:10.3390/molecules27196576}.
\item Natalie Gukasyan (2022). \textit{19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2022.07.664}{doi:10.1016/j.jaac.2022.07.664}.
\item Timmermann C, Watts R, Dupuis D (2022). \textit{Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221082796}{doi:10.1177/13634615221082796}.
\item Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC (2022). \textit{If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.}. The journal of pain. [published; PubMed]. \href{https://doi.org/10.1016/j.jpain.2022.05.003}{doi:10.1016/j.jpain.2022.05.003}.
\item Meyer TD, Meir P, Lex C, Soares JC (2022). \textit{Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2022.114727}{doi:10.1016/j.psychres.2022.114727}.
\item Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM (2022). \textit{Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.}. Expert opinion on drug discovery. [published; PubMed]. \href{https://doi.org/10.1080/17460441.2022.2111415}{doi:10.1080/17460441.2022.2111415}.
\item Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J (2022). \textit{Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01361-0}{doi:10.1007/s11920-022-01361-0}.
\item Levin A, Nagib PB, Deiparine S, Gao T, Mitchell J, Davis AK (2022). \textit{Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2022.103816}{doi:10.1016/j.drugpo.2022.103816}.
\item Barnett BS, Ziegler K, Doblin R, Carlo AD (2022). \textit{Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221117536}{doi:10.1177/02698811221117536}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, Hendricks PS (2022). \textit{Prevalence and associations of classic psychedelic-related seizures in a population-based sample.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2022.109586}{doi:10.1016/j.drugalcdep.2022.109586}.
\item Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L (2022). \textit{Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2022.2096}{doi:10.1001/jamapsychiatry.2022.2096}.
\item Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA (2022). \textit{Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221116926}{doi:10.1177/02698811221116926}.
\item Kaypak AC, Raz A (2022). \textit{Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221119386}{doi:10.1177/13634615221119386}.
\item Erkizia-Santamaría I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE (2022). \textit{Serotonin 5-HT, 5-HT and 5-HT receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.}. Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie. [published; PubMed]. \href{https://doi.org/10.1016/j.biopha.2022.113612}{doi:10.1016/j.biopha.2022.113612}.
\item Butler M, Jelen L, Rucker J (2022). \textit{Expectancy in placebo-controlled trials of psychedelics: if so, so what?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06221-6}{doi:10.1007/s00213-022-06221-6}.
\item Asher BF (2022). \textit{Why Otolaryngologists Should Be Interested in Psychedelic Medicine.}. Otolaryngologic clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.otc.2022.06.002}{doi:10.1016/j.otc.2022.06.002}.
\item Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, Castle D, McIntyre RS (2022). \textit{A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-022-00944-y}{doi:10.1007/s40263-022-00944-y}.
\item Barber GS, Aaronson ST (2022). \textit{The Emerging Field of Psychedelic Psychotherapy.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01363-y}{doi:10.1007/s11920-022-01363-y}.
\item Odland AU, Kristensen JL, Andreasen JT (2022). \textit{Animal Behavior in Psychedelic Research.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pharmrev.122.000590}{doi:10.1124/pharmrev.122.000590}.
\item Dupuis D, Veissière S (2022). \textit{Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221131465}{doi:10.1177/13634615221131465}.
\item Gobbi G, Inserra A, Greenway KT, Lifshitz M, Kirmayer LJ (2022). \textit{Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221119388}{doi:10.1177/13634615221119388}.
\item Wong A, Raz A (2022). \textit{Microdosing with classical psychedelics: Research trajectories and practical considerations.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221129115}{doi:10.1177/13634615221129115}.
\item Goel DB, Zilate S (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item Mohamed A, Touheed S, Ahmed M, Hor M, Fatima S (2022). \textit{The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.30919}{doi:10.7759/cureus.30919}.
\item Carol Vidal, Kevin M. Gray (2022). \textit{THE RENAISSANCE OF PSYCHEDELICS IN PSYCHIATRY: EVIDENCE, ETHICS, AND POTENTIAL IN MENTAL HEALTH TREATMENT FOR ADOLESCENTS}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2022.07.661}{doi:10.1016/j.jaac.2022.07.661}.
\item Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA. (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kh3cx}{doi:10.31234/osf.io/kh3cx}.
\item Robert F. Dougherty, Patrick Clarke, Merve Alti, Joanna Kuc, Danielle Schlosser, Boadie W. Dunlop, David J. Hellerstein, Scott T. Aaronson, Sidney Zisook, Allan H Young (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kh3cx\_v1}{source link}.
\item Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M (2022). \textit{Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms231911450}{doi:10.3390/ijms231911450}.
\item Elie Dolgin (2022). \textit{Taking the tripping out of psychedelic medicine}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-022-02869-4}{doi:10.1038/d41586-022-02869-4}.
\item Clare Watson (2022). \textit{The psychedelic remedy for chronic pain}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-022-02878-3}{doi:10.1038/d41586-022-02878-3}.
\item Michael Eisenstein (2022). \textit{The psychedelic escape from depression}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-022-02872-9}{doi:10.1038/d41586-022-02872-9}.
\item Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J (2022). \textit{Differences across sexes on head-twitch behavior and 5-HT receptor signaling in C57BL/6J mice.}. Neuroscience letters. [published; PubMed]. \href{https://doi.org/10.1016/j.neulet.2022.136836}{doi:10.1016/j.neulet.2022.136836}.
\item COMPASS Pathways (2022). \textit{Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04519957}{source link}.
\item Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2060381/v1}{doi:10.21203/rs.3.rs-2060381/v1}.
\item Gomathi Saminathan, Kavitha Kandasamy, Savitha Navaneethakrishnan, Mohana Ashokkumar, Brindha Veerappan, Krishnamoorthy Bellie Sundaram, G Aghajanian, G Marek, J.-C Bque, M Imad, L Mladenovic, J Gingrich, R Andrade, R Glennon, J Rosecrans, R Young, C Krumhansl, E Kessler, D Nichols, Psychedelics, Hallucinogens, P Delgado, F Moreno, C Nichols, B Liester, R Strassman, L Roseman, L Demetriou, M Wall, D Nutt, R Carhart-Harris, B Krishnamoorthy, S Kahlal, S Ghosh, J.-F Halet, Electronic, A Thakur, K Chakrahari, S Bose, P Hamon, T Roisnel, B Le Guennic, J.-Y Saillard, K Geetharani, S Mobin, F Neese, A Sherwood, R Kargbo, K Kaylo, N Cozzi, P Meisenheimer, J Kaduk, J Daniel, M Haberman, T Prisinzano, P Cumming, M Scheidegger, D Dornbierer, M Palner, B Quednow, C Martin-Soelch, A Rickli, O Moning, M Hoener, M Liechti, M Madsen, D Stenbaek, A Arvidsson, S Armand, M Marstrand-Joergensen, S Johansen, K Linnet, B Ozenne, G Knudsen, P Fisher, E Pottie, O Kupriyanova, A Brandt (2022). \textit{Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational Study}. Letters in Applied NanoBioScience. [published; OpenAlex]. \href{https://doi.org/10.33263/lianbs124.105}{doi:10.33263/lianbs124.105}.
\item da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M (2022). \textit{Psychedelic drugs for psychiatric disorders.}. Journal of the neurological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jns.2022.120332}{doi:10.1016/j.jns.2022.120332}.
\item Kavita Golia (2022). \textit{Psilocybin as a healer}. Consciousness Spirituality \& Transpersonal Psychology. [published; OpenAlex]. \href{https://doi.org/10.53074/cstp.2022.37}{doi:10.53074/cstp.2022.37}.
\item Victor Jivanescu (2022). \textit{Long-term transformative effects and integration challenges of psychedelic experiences}. Consciousness Spirituality \& Transpersonal Psychology. [published; OpenAlex]. \href{https://doi.org/10.53074/cstp.2022.29}{doi:10.53074/cstp.2022.29}.
\item Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A. (2022). \textit{Neural mechanisms of psychedelic visual imagery}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.07.22279700}{doi:10.1101/2022.09.07.22279700}.
\item Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A. (2022). \textit{Effective connectivity of emotion and cognition under psilocybin}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.06.22279626}{doi:10.1101/2022.09.06.22279626}.
\item Mellner C, Dahlen M, Simonsson O (2022). \textit{Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph191811353}{doi:10.3390/ijerph191811353}.
\item Lerer B, Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2001983/v1}{doi:10.21203/rs.3.rs-2001983/v1}.
\item O'Leary K (2022). \textit{Psilocybin therapy reduces heavy drinking.}. Nature medicine. [published; PubMed]. \href{https://doi.org/10.1038/d41591-022-00093-1}{doi:10.1038/d41591-022-00093-1}.
\item Doss MK, Barrett FS, Corlett PR (2022). \textit{Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.2c00461}{doi:10.1021/acschemneuro.2c00461}.
\item Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R (2022). \textit{Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.}. BJPsych open. [published; PubMed]. \href{https://doi.org/10.1192/bjo.2022.565}{doi:10.1192/bjo.2022.565}.
\item special to C EN Attabey Rodríguez Benítez (2022). \textit{Psychedelics’ binding depends on receptor mutations}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10031-scicon6}{doi:10.1021/cen-10031-scicon6}.
\item Diana Dias da Silva, Andreia Machado Brito-da-Costa, Silveira Martins, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho (2022). \textit{P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications}. Toxicology Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/j.toxlet.2022.07.283}{doi:10.1016/j.toxlet.2022.07.283}.
\item Henry A. Nasrallah (2022). \textit{From neuroplasticity to psychoplasticity: Psilocybin may reverse personality disorders and political fanaticism}. Current Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.12788/cp.0283}{doi:10.12788/cp.0283}.
\item Mitch Earleywine, Zachary Herrmann (2022). \textit{Psychedelics for Psychiatric Disorders: Promise, Not Panacea}. Psychiatric Annals. [published; OpenAlex]. \href{https://doi.org/10.3928/00485713-20220810-01}{doi:10.3928/00485713-20220810-01}.
\item Brian S. Barnett, Jeremy Weleff (2022). \textit{Psychedelics in the Treatment of Substance Use Disorders}. Psychiatric Annals. [published; OpenAlex]. \href{https://doi.org/10.3928/00485713-20220804-01}{doi:10.3928/00485713-20220804-01}.
\item Rodrigues J, Nombora O, Ribeiro L. (2022). \textit{Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567436}{source link}.
\item Girala N. (2022). \textit{Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567945}{source link}.
\item National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders. (2022). \textit{Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop}. National Academies Press (US), Washington (DC). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36049038}{source link}.
\item Chue P, Andreiev A, Bucuci E, Els C, Chue J. (2022). \textit{A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://doi.org/10.1192/j.eurpsy.2022.2297}{doi:10.1192/j.eurpsy.2022.2297}.
\item Bhadoria P, Venkatnarayan R. (2022). \textit{Interplay of hydrogen bonding in deciding the conformers of psilocin: Computational insights}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.166200851.10677416/v1}{doi:10.22541/au.166200851.10677416/v1}.
\item Shah K, Trivedi C, Kamrai D, Akbar M, Tankersley W. (2022). \textit{Association of Psilocybin Use in Adolescents with Major Depressive Episode}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9563652}{source link}.
\item Brito-da-Costa A.M., Madureira-Carvalho A., Dinis-Oliveira R.J., Silva D. Dias da (2022). \textit{P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)}. Toxicology Letters. [published; Crossref]. \href{https://doi.org/10.1016/j.toxlet.2022.07.280}{doi:10.1016/j.toxlet.2022.07.280}.
\item Lehto RH, Miller M, Sender J (2022). \textit{The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.}. Journal of holistic nursing: official journal of the American Holistic Nurses' Association. [published; PubMed]. \href{https://doi.org/10.1177/08980101211039086}{doi:10.1177/08980101211039086}.
\item Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H (2022). \textit{Magic mushroom extracts in lipid membranes.}. Biochimica et biophysica acta. Biomembranes. [published; PubMed]. \href{https://doi.org/10.1016/j.bbamem.2022.183957}{doi:10.1016/j.bbamem.2022.183957}.
\item Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E (2022). \textit{Natural language signatures of psilocybin microdosing.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06170-0}{doi:10.1007/s00213-022-06170-0}.
\item Schindler EAD (2022). \textit{Psychedelics as preventive treatment in headache and chronic pain disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109166}{doi:10.1016/j.neuropharm.2022.109166}.
\item Johannesdottir A, Sigurdsson E (2022). \textit{[The use of psilocybin for treatment-resistant depression].}. Laeknabladid. [published; PubMed]. \href{https://doi.org/10.17992/lbl.2022.09.706}{doi:10.17992/lbl.2022.09.706}.
\item Chomynová P, Kočárová R, Kňažek F, Plevková M, Bláhová B, Valeš K, Mravčík V (2022). \textit{Use of psychedelics in the Czech Republic: results of recent population surveys.}. Central European journal of public health. [published; PubMed]. \href{https://doi.org/10.21101/cejph.a7079}{doi:10.21101/cejph.a7079}.
\item Clifton JM, Belcher AM, Greenblatt AD, Welsh CM, Cole TO, Davis AK (2022). \textit{Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.}. Journal of psychedelic studies. [published; PubMed]. \href{https://doi.org/10.1556/2054.2022.00214}{doi:10.1556/2054.2022.00214}.
\item McManus KR, Patrick R, Striepe MI, Drury MJ, Ozonsi R, Forester BP, Weinberg MS (2022). \textit{Psychedelics for Alzheimer's Disease Palliative Care.}. Advances in psychiatry and behavioral health. [published; PubMed]. \href{https://doi.org/10.1016/j.ypsc.2022.06.001}{doi:10.1016/j.ypsc.2022.06.001}.
\item Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME (2022). \textit{The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.29167}{doi:10.7759/cureus.29167}.
\item Nutt D. (2022). \textit{Psychedelic Psychiatry}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9565852}{source link}.
\item Graham Zoe (2022). \textit{‘Shrooms for the Blues: Psilocybin to alleviate difficult-to-treat depression}. Journal of High School Science. [published; Crossref]. \href{https://doi.org/10.64336/001c.37945}{doi:10.64336/001c.37945}.
\item Charles D. Nichols (2022). \textit{Psychedelics as potent anti-inflammatory therapeutics}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2022.109232}{doi:10.1016/j.neuropharm.2022.109232}.
\item Neşe Devenot, Trey Conner, Richard Doyle (2022). \textit{Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12154}{doi:10.1111/anoc.12154}.
\item Mark Molumby, Keith Gaynor, Suzanne Guérin, Róisín McNamara (2022). \textit{Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678221110331}{doi:10.1177/00221678221110331}.
\item Ken Garber (2022). \textit{Delix Therapeutics: psychedelics without the trip}. Nature Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1038/d41587-022-00006-0}{doi:10.1038/d41587-022-00006-0}.
\item Yao S, Wei C, Lin H, Zhang P, Liu Y, Deng Y, Huang Q, Xie B (2022). \textit{Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Mushroom via Amino Acid Metabolism Pathways.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof8080870}{doi:10.3390/jof8080870}.
\item Brian Peacock (2022). \textit{A-118 Psychedelic Interventions for Neuropsychological Conditions}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acac060.118}{doi:10.1093/arclin/acac060.118}.
\item Gumpper RH, Fay JF, Roth BL (2022). \textit{Molecular insights into the regulation of constitutive activity by RNA editing of 5HT serotonin receptors.}. Cell reports. [published; PubMed]. \href{https://doi.org/10.1016/j.celrep.2022.111211}{doi:10.1016/j.celrep.2022.111211}.
\item Ortiz CE, Dourron HM, Sweat NW, Garcia-Romeu A, MacCarthy S, Anderson BT, Hendricks PS (2022). \textit{Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2022.109127}{doi:10.1016/j.neuropharm.2022.109127}.
\item Henner RL, Keshavan MS, Hill KP (2022). \textit{Review of potential psychedelic treatments for PTSD.}. Journal of the neurological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jns.2022.120302}{doi:10.1016/j.jns.2022.120302}.
\item Jesús M. González Mariscal, Paulina E. Sosa-Cortés (2022). \textit{Insights for Modern Applications of Psilocybin Therapy from a Case Study of Traditional Mazatec Medicine}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12168}{doi:10.1111/anoc.12168}.
\item María de Ángeles Equihua Orozco, Shana Harris (2022). \textit{Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12162}{doi:10.1111/anoc.12162}.
\item Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Larsen IB, Knudsen GM, Klein AB, Clemmensen C (2022). \textit{Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-022-02103-9}{doi:10.1038/s41398-022-02103-9}.
\item Gitte Moos Knudsen (2022). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04280055}{source link}.
\item Antonella Fagetti, Roberto E. Mercadillo (2022). \textit{Experiences With Sacred Mushrooms and Psilocybin In Dialogue: Transdisciplinary Interpretations Of The “Velada”}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12163}{doi:10.1111/anoc.12163}.
\item George Winter (2022). \textit{Psilocybin administration}. Journal of Prescribing Practice. [published; OpenAlex]. \href{https://doi.org/10.12968/jprp.2022.4.8.340}{doi:10.12968/jprp.2022.4.8.340}.
\item Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E (2022). \textit{Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-022-02039-0}{doi:10.1038/s41398-022-02039-0}.
\item Terri D’Arrigo (2022). \textit{Med Check: Psilocybin for OCD, Nuplazid Vote, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.08.8.2}{doi:10.1176/appi.pn.2022.08.8.2}.
\item Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y (2022). \textit{Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0036}{doi:10.1089/jpm.2022.0036}.
\item Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ (2022). \textit{Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221084063}{doi:10.1177/02698811221084063}.
\item Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R (2022). \textit{Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2022.119220}{doi:10.1016/j.neuroimage.2022.119220}.
\item Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Whitelock K, Stratford A, Auwärter V, Halberstadt AL (2022). \textit{Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.}. Drug testing and analysis. [published; PubMed]. \href{https://doi.org/10.1002/dta.3281}{doi:10.1002/dta.3281}.
\item Polito V, Liknaitzky P (2022). \textit{The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104706}{doi:10.1016/j.neubiorev.2022.104706}.
\item Jairaj C, Rucker JJ (2022). \textit{Postpartum depression: A role for psychedelics?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221093793}{doi:10.1177/02698811221093793}.
\item Fulmali A, Bharate SS (2022). \textit{Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.}. Drug development research. [published; PubMed]. \href{https://doi.org/10.1002/ddr.21953}{doi:10.1002/ddr.21953}.
\item Felsch CL, Kuypers KPC (2022). \textit{Don't be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104724}{doi:10.1016/j.neubiorev.2022.104724}.
\item Rusanen SS, De S, Schindler EAD, Artto VA, Storvik M (2022). \textit{Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.}. Current pain and headache reports. [published; PubMed]. \href{https://doi.org/10.1007/s11916-022-01063-5}{doi:10.1007/s11916-022-01063-5}.
\item Suleiman M, Basu A, Belal S, Jacob T (2022). \textit{From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.}. The Journal of nervous and mental disease. [published; PubMed]. \href{https://doi.org/10.1097/nmd.0000000000001489}{doi:10.1097/nmd.0000000000001489}.
\item Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D (2022). \textit{Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221101061}{doi:10.1177/02698811221101061}.
\item Makin S (2022). \textit{Mushrooms' Legal Trip: As psilocybin research ramps up, the drug's status under the law is shifting.}. Scientific American. [published; PubMed]. \href{https://doi.org/10.1038/scientificamerican0822-12}{doi:10.1038/scientificamerican0822-12}.
\item James A. Kaduk, Alexander M. Sherwood, Robert B. Kargbo, Kristi W. Kaylo, Poncho Meisenheimer, Nicholas V. Cozzi (2022). \textit{Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples}. Acta Crystallographica Section A Foundations and Advances. [published; OpenAlex]. \href{https://doi.org/10.1107/s2053273322097261}{doi:10.1107/s2053273322097261}.
\item Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z (2022). \textit{Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-17428-0}{doi:10.1038/s41598-022-17428-0}.
\item Golden CT, Chadderton P (2022). \textit{Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-16325-w}{doi:10.1038/s41598-022-16325-w}.
\item University of California, San Diego (2022). \textit{Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04661514}{source link}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Wolf G, Lerer B, Lifschytz T. (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implications}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.22.501026}{doi:10.1101/2022.07.22.501026}.
\item Dörner S, Rogge K, Fricke J, Schäfer T, Wurlitzer JM, Gressler M, Pham DNK, Manke DR, Chadeayne AR, Hoffmeister D (2022). \textit{Genetic Survey of Psilocybe Natural Products.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202200249}{doi:10.1002/cbic.202200249}.
\item Glatfelter GC, Pham DNK, Walther D, Golen JA, Chadeayne AR, Baumann MH, Manke DR (2022). \textit{Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.}. ACS omega. [published; PubMed]. \href{https://doi.org/10.1021/acsomega.2c03476}{doi:10.1021/acsomega.2c03476}.
\item y7fceaj128 (2022). \textit{9 Signs You Need Help With Magic Mushrooms uk}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.6847342}{doi:10.5281/zenodo.6847342}.
\item Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lerer B, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.13.498401}{doi:10.1101/2022.07.13.498401}.
\item Farley M, Tran H, Towler S, Gevorkyan J, Pearring S, Rodda LN (2022). \textit{A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.}. Journal of analytical toxicology. [published; PubMed]. \href{https://doi.org/10.1093/jat/bkab075}{doi:10.1093/jat/bkab075}.
\item Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NL, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA. (2022). \textit{Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.12.499688}{doi:10.1101/2022.07.12.499688}.
\item Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM. (2022). \textit{Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.07.10.22277414}{doi:10.1101/2022.07.10.22277414}.
\item Zeifman R, Spriggs MJ, Kettner H, Lyons T, Rosas F, Mediano P, Erritzoe D, Carhart-Harris R. (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/w8j6t}{doi:10.31234/osf.io/w8j6t}.
\item Richard J. Zeifman, Meg J Spriggs, Hannes Kettner, Taylor Lyons, Fernando Rosas, Pedro Mediano, David Erritzoe, Robin Carhart-Harris (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/w8j6t\_v1}{source link}.
\item Rajkumar RP. (2022). \textit{Pharmacotherapy for the Secondary Prevention of Suicide: Leads from the Social Pain Hypothesis}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202207.0064.v1}{doi:10.20944/preprints202207.0064.v1}.
\item Lenz Claudius, Dörner Sebastian, Trottmann Felix, Hertweck Christian, Sherwood Alexander, Hoffmeister Dirk (2022). \textit{Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines}. ChemBioChem. [published; Crossref]. \href{https://doi.org/10.1002/cbic.202200183}{doi:10.1002/cbic.202200183}.
\item Bosch OG, Halm S, Seifritz E (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. International journal of bipolar disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.30.497950}{doi:10.1101/2022.06.30.497950}.
\item Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL. (2022). \textit{Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.29.498015}{doi:10.1101/2022.06.29.498015}.
\item Gandia A, Adamatzky A. (2022). \textit{Electrical spiking of psilocybin fungi}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.02.498545}{doi:10.1101/2022.07.02.498545}.
\item Gokul Raj (2022). \textit{Psychedelic use in India, its pattern and personal significance - findings from an online survey}. Indian Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry\_447\_21}{doi:10.4103/indianjpsychiatry.indianjpsychiatry\_447\_21}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM (2022). \textit{Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104689}{doi:10.1016/j.neubiorev.2022.104689}.
\item Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas F, Peill JM, Giribaldi B, Erritzoe D, Nutt D, Carhart-Harris R. (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/sb5ur}{doi:10.31234/osf.io/sb5ur}.
\item Fradkin D (2022). \textit{Psilocybin: A brief overview for psychiatric mental health nurse practitioners.}. Perspectives in psychiatric care. [published; PubMed]. \href{https://doi.org/10.1111/ppc.12888}{doi:10.1111/ppc.12888}.
\item Kozlowska U, Nichols C, Wiatr K, Figiel M (2022). \textit{From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15509}{doi:10.1111/jnc.15509}.
\item Slocum ST, DiBerto JF, Roth BL (2022). \textit{Molecular insights into psychedelic drug action.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15540}{doi:10.1111/jnc.15540}.
\item Saeger HN, Olson DE (2022). \textit{Psychedelic-inspired approaches for treating neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15544}{doi:10.1111/jnc.15544}.
\item Köck P, Froelich K, Walter M, Lang U, Dürsteler KM (2022). \textit{A systematic literature review of clinical trials and therapeutic applications of ibogaine.}. Journal of substance abuse treatment. [published; PubMed]. \href{https://doi.org/10.1016/j.jsat.2021.108717}{doi:10.1016/j.jsat.2021.108717}.
\item Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H (2022). \textit{Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-1714-9097}{doi:10.1055/a-1714-9097}.
\item Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y, Dang Y (2022). \textit{Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS.}. Drug testing and analysis. [published; PubMed]. \href{https://doi.org/10.1002/dta.3255}{doi:10.1002/dta.3255}.
\item Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS (2022). \textit{The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2022.114577}{doi:10.1016/j.psychres.2022.114577}.
\item Smausz R, Neill J, Gigg J (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Pöllänen E, Osika W, Stenfors CUD, Simonsson O (2022). \textit{Classic Psychedelics and Human-Animal Relations.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph19138114}{doi:10.3390/ijerph19138114}.
\item Sandeep M Nayak, Bilal A Bari, David Bryce Yaden, Meg J Spriggs, Fernando Rosas, Joseph M Peill, Bruna Giribaldi, David Erritzoe, David Nutt, Robin Carhart-Harris (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/sb5ur\_v1}{source link}.
\item Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P.C. Kuypers, Zach Walsh (2022). \textit{Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls}. VIUspace. [published; OpenAlex]. \href{https://doi.org/10.25316/ir-20556}{doi:10.25316/ir-20556}.
\item Wake Network, Inc. (2022). \textit{Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04989972}{source link}.
\item Wall M, Harding R, Zafar R, Rabiner EA, Nutt D, Erritzoe D. (2022). \textit{Neuroimaging in psychedelic drug development: Past, present, and future}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xwu4j}{doi:10.31234/osf.io/xwu4j}.
\item Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z (2022). \textit{Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-14512-3}{doi:10.1038/s41598-022-14512-3}.
\item Matthew B. Wall, Rebecca Harding, Rayyan Zafar, Eugenii A. Rabiner, David Nutt, David Erritzoe (2022). \textit{Neuroimaging in psychedelic drug development: Past, present, and future}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xwu4j\_v1}{source link}.
\item J Schneider, JP Cooper, S Davies, K Beltran (2022). \textit{MSR20 Challenges in the Development of Economic Evaluations for Psychedelics in Treatment of Depression}. Value in Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jval.2022.04.1227}{doi:10.1016/j.jval.2022.04.1227}.
\item Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, Gabriela Morales-Lima, João Ariel Bonar Fernandes, Renato Filev (2022). \textit{Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current research}. Addiction Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.addicn.2022.100025}{doi:10.1016/j.addicn.2022.100025}.
\item Jones G, Lipson J, Nock MK (2022). \textit{Associations between classic psychedelics and nicotine dependence in a nationally representative sample.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-14809-3}{doi:10.1038/s41598-022-14809-3}.
\item Wahab Alahmari Abdul (2022). \textit{The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini Review}. Brain and Neurological Disorders. [published; Crossref]. \href{https://doi.org/10.31579/2692-9422/027}{doi:10.31579/2692-9422/027}.
\item Viktorin V, Griškova-Bulanova I, Voicikas A, Dojčánová D, Zach P, Bravermanová A, Andrashko V, Tylš F, Korčák J, Viktorinová M, Koudelka V, Hájková K, Kuchař M, Horáček J, Brunovský M, Páleníček T (2022). \textit{Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.}. Journal of personalized medicine. [published; PubMed]. \href{https://doi.org/10.3390/jpm12061004}{doi:10.3390/jpm12061004}.
\item Kevin F. Boehnke, Alan K. Davis, Jenna McAfee (2022). \textit{Applying Lessons From Cannabis to the Psychedelic Highway}. JAMA Health Forum. [published; OpenAlex]. \href{https://doi.org/10.1001/jamahealthforum.2022.1618}{doi:10.1001/jamahealthforum.2022.1618}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K (2022). \textit{Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms23126713}{doi:10.3390/ijms23126713}.
\item Hibicke M, Nichols CD (2022). \textit{Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-14165-2}{doi:10.1038/s41598-022-14165-2}.
\item Annie M. McCartney, H. T. McGovern, Alexander De Foe (2022). \textit{Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00211}{doi:10.1556/2054.2022.00211}.
\item Polo-Castellano C, Álvarez JÁ, Palma M, Barbero GF, Ayuso J, Ferreiro-González M (2022). \textit{Optimization through a Box-Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi ().}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof8060598}{doi:10.3390/jof8060598}.
\item Anthony Principe (2022). \textit{Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin}. SURG Journal. [published; OpenAlex]. \href{https://doi.org/10.21083/surg.v14i1.6870}{doi:10.21083/surg.v14i1.6870}.
\item Kaushal Shah, C. Trivedi, D. Kamrai, M. Akbar, W. Tankersley (2022). \textit{Association of Psilocybin Use in Adolescents with Major Depressive Episode}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2022.837}{doi:10.1192/j.eurpsy.2022.837}.
\item van Elk M, Fejer G, Lempe P, Prochazckova L, Kuchar M, Hajkova K, Marschall J (2022). \textit{Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05857-0}{doi:10.1007/s00213-021-05857-0}.
\item Corrigan K, Haran M, McCandliss C, McManus R, Cleary S, Trant R, Kelly Y, Ledden K, Rush G, O'Keane V, Kelly JR (2022). \textit{Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.}. Irish journal of medical science. [published; PubMed]. \href{https://doi.org/10.1007/s11845-021-02668-2}{doi:10.1007/s11845-021-02668-2}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J (2022). \textit{Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05913-9}{doi:10.1007/s00213-021-05913-9}.
\item Murray CH, Tare I, Perry CM, Malina M, Lee R, de Wit H (2022). \textit{Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05991-9}{doi:10.1007/s00213-021-05991-9}.
\item Bender D, Hellerstein DJ (2022). \textit{Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-06049-6}{doi:10.1007/s00213-021-06049-6}.
\item Miceli McMillan R, Jordens C (2022). \textit{Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.}. Medicine, health care, and philosophy. [published; PubMed]. \href{https://doi.org/10.1007/s11019-022-10070-7}{doi:10.1007/s11019-022-10070-7}.
\item Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S (2022). \textit{Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06066-z}{doi:10.1007/s00213-022-06066-z}.
\item Maia LO, Beaussant Y, Garcia ACM (2022). \textit{The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.}. Journal of pain and symptom management. [published; PubMed]. \href{https://doi.org/10.1016/j.jpainsymman.2022.01.024}{doi:10.1016/j.jpainsymman.2022.01.024}.
\item van Amsterdam J, van den Brink W (2022). \textit{The therapeutic potential of psilocybin: a systematic review.}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2022.2047929}{doi:10.1080/14740338.2022.2047929}.
\item Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J (2022). \textit{Effects of the 5-HT receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06092-x}{doi:10.1007/s00213-022-06092-x}.
\item Popik Piotr, Hogendorf Adam, Bugno Ryszard, Khoo Shaun Yon-Seng, Zajdel Pawel, Malikowska-Racia Natalia, Nikiforuk Agnieszka, Golebiowska Joanna (2022). \textit{Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats}. Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1007/s00213-021-06020-5}{doi:10.1007/s00213-021-06020-5}.
\item Sarparast A, Thomas K, Malcolm B, Stauffer CS (2022). \textit{Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06083-y}{doi:10.1007/s00213-022-06083-y}.
\item McClure-Begley TD, Roth BL (2022). \textit{The promises and perils of psychedelic pharmacology for psychiatry.}. Nature reviews. Drug discovery. [published; PubMed]. \href{https://doi.org/10.1038/s41573-022-00421-7}{doi:10.1038/s41573-022-00421-7}.
\item Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA (2022). \textit{Development of an -based norbaeocystin production platform and evaluation of behavioral effects in rats.}. Metabolic engineering communications. [published; PubMed]. \href{https://doi.org/10.1016/j.mec.2022.e00196}{doi:10.1016/j.mec.2022.e00196}.
\item van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH (2022). \textit{How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06106-8}{doi:10.1007/s00213-022-06106-8}.
\item Husain MI, Umer M, Mulsant BH (2022). \textit{Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2022.2063274}{doi:10.1080/14740338.2022.2063274}.
\item Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG (2022). \textit{Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2022.2066650}{doi:10.1080/14740338.2022.2066650}.
\item Inouye A, Wolfgang A (2022). \textit{3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.26402}{doi:10.7759/cureus.26402}.
\item M Rekatsina, E Moka, A Vadalouca, G Varrassi (2022). \textit{SP56 Psychedelic drugs and pain}. Invited speakers. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2022-esra.62}{doi:10.1136/rapm-2022-esra.62}.
\item Manish Agrawal, Paul Thambi, Sarah Shnayder (2022). \textit{The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2022.40.16\_suppl.12097}{doi:10.1200/jco.2022.40.16\_suppl.12097}.
\item Al-Imam A, Motyka MA, Witulska Z, Younus M, Michalak M (2022). \textit{Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph19116619}{doi:10.3390/ijerph19116619}.
\item Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD. (2022). \textit{Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.05.20.492842}{doi:10.1101/2022.05.20.492842}.
\item Richard Karel (2022). \textit{Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.06.6.30}{doi:10.1176/appi.pn.2022.06.6.30}.
\item Dominique Strauss, Soumya Ghosh, Zurika Murray, Marieka Gryzenhout (2022). \textit{An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus}. Frontiers in Forests and Global Change. [published; OpenAlex]. \href{https://doi.org/10.3389/ffgc.2022.813998}{doi:10.3389/ffgc.2022.813998}.
\item Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M (2022). \textit{New Paradigms of Old Psychedelics in Schizophrenia.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph15050640}{doi:10.3390/ph15050640}.
\item National Institute of Mental Health, Czech Republic (2022). \textit{Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05383313}{source link}.
\item Edinoff AN, Fort JM, Singh C, Wagner SE, Rodriguez JR, Johnson CA, Cornett EM, Murnane KS, Kaye AM, Kaye AD (2022). \textit{Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.}. Neurology international. [published; PubMed]. \href{https://doi.org/10.3390/neurolint14020035}{doi:10.3390/neurolint14020035}.
\item Kotts WJ, Gamble DT, Dawson DK, Connor D (2022). \textit{Psilocybin-induced takotsubo cardiomyopathy.}. BMJ case reports. [published; PubMed]. \href{https://doi.org/10.1136/bcr-2021-245863}{doi:10.1136/bcr-2021-245863}.
\item Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan (2022). \textit{The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/2666082218666220513142002}{doi:10.2174/2666082218666220513142002}.
\item Mocanu V, Mackay L, Christie D, Argento E (2022). \textit{Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.}. Substance abuse treatment, prevention, and policy. [published; PubMed]. \href{https://doi.org/10.1186/s13011-022-00468-0}{doi:10.1186/s13011-022-00468-0}.
\item Stephan Schleim (2022). \textit{Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2022.906487}{doi:10.3389/fpsyt.2022.906487}.
\item Carhart-Harris R, Daws RE, Nutt D. (2022). \textit{A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/pdbf5}{doi:10.31234/osf.io/pdbf5}.
\item Robin Carhart-Harris, Richard E Daws, David Nutt (2022). \textit{A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/pdbf5\_v1}{source link}.
\item Johansen L, Liknaitzky P, Nedeljkovic M, Mastin-Purcell L, Murray G (2022). \textit{The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.}. Systematic reviews. [published; PubMed]. \href{https://doi.org/10.1186/s13643-022-01930-7}{doi:10.1186/s13643-022-01930-7}.
\item Grant C. Glatfelter, David R. Manke, Andrew R. Chadayne, Michael H. Baumann (2022). \textit{Receptor binding profiles and behavioral effects of psilocybin analogs}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2022.36.s1.r3639}{doi:10.1096/fasebj.2022.36.s1.r3639}.
\item Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P, Kuehne SS, Roder MA, Duthaler U, Kolaczynska KE, Varghese N, Eckert A, Liechti ME (2022). \textit{Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-022-01297-2}{doi:10.1038/s41386-022-01297-2}.
\item Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M (2022). \textit{The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.}. Journal of midwifery \& women's health. [published; PubMed]. \href{https://doi.org/10.1111/jmwh.13371}{doi:10.1111/jmwh.13371}.
\item Elsouri KN, Kalhori S, Colunge D, Grabarczyk G, Hanna G, Carrasco C, Aleman Espino A, Francisco A, Borosky B, Bekheit B, Ighanifard M, Astudillo AA, Demory Beckler M (2022). \textit{Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.25235}{doi:10.7759/cureus.25235}.
\item Sotille R, Singh H, Weisman A, Vida T (2022). \textit{Unraveling the Mysteries of Mental Illness With Psilocybin.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.25414}{doi:10.7759/cureus.25414}.
\item Claudia Schwarz-Plaschg (2022). \textit{Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States}. European Journal of Futures Research. [published; OpenAlex]. \href{https://doi.org/10.1186/s40309-022-00199-2}{doi:10.1186/s40309-022-00199-2}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Effinger D, Quadir S, Ramage M, Cone M, Herman M. (2022). \textit{Sex-Specific Effects of Psychedelic Drug Exposure on Central Amygdala Reactivity and Behavioral Responding}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.04.28.489882}{doi:10.1101/2022.04.28.489882}.
\item Doss M, Barrett FS, Corlett PR. (2022). \textit{Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a25wb}{doi:10.31234/osf.io/a25wb}.
\item Manoj Doss, Frederick Streeter Barrett, Philip R. Corlett (2022). \textit{Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a25wb\_v1}{source link}.
\item Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes (2022). \textit{P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2022.02.624}{doi:10.1016/j.biopsych.2022.02.624}.
\item Stéphanie Knatz Peck, Samatha Shao, Susan Murray, Walter H. Kaye (2022). \textit{P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary Efficacy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2022.02.686}{doi:10.1016/j.biopsych.2022.02.686}.
\item Hackl B, Todt H, Kubista H, Hilber K, Koenig X (2022). \textit{Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyab085}{doi:10.1093/ijnp/pyab085}.
\item Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS (2022). \textit{Models of psychedelic drug action: modulation of cortical-subcortical circuits.}. Brain: a journal of neurology. [published; PubMed]. \href{https://doi.org/10.1093/brain/awab406}{doi:10.1093/brain/awab406}.
\item Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W (2022). \textit{Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules27082520}{doi:10.3390/molecules27082520}.
\item Cátia Esteves, Elena M. M. de Redrojo, José Luis Manjón, Gabriel Moreno, Filipe E. Antunes, Gemma Montalvo, Fernando E. Ortega-Ojeda (2022). \textit{Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discrimination}. Forensic Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.forc.2022.100421}{doi:10.1016/j.forc.2022.100421}.
\item Brian Macallan (2022). \textit{Charismatic, Synchronous and Psychedelic Religious Experiences: A Personal Account}. Religions. [published; OpenAlex]. \href{https://doi.org/10.3390/rel13040331}{doi:10.3390/rel13040331}.
\item Jones G, Ricard JA, Lipson J, Nock MK (2022). \textit{Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-08085-4}{doi:10.1038/s41598-022-08085-4}.
\item Costa Fernandes Joana Margarida, Filho Cesar, Machado Brito-da-Costa Andreia, Marin-Bruzos Marieta, Saayman Jean, Sanders Daniel, Dinis-Oliveira Ricardo Jorge (2022). \textit{Production and extraction of psilocybin and psilocin from Psilocybe spp. mushrooms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.456}{doi:10.51126/revsalus.v4isup.456}.
\item Filho Cesar, Costa Fernandes Joana Margarida, Machado Brito-da-Costa Andreia, Marin-Bruzos Marieta, Saayman Jean, Sanders Daniel, Dinis-Oliveira Ricardo Jorge (2022). \textit{Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DAD}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.455}{doi:10.51126/revsalus.v4isup.455}.
\item Lemos Martins Sofia, Machado Brito-da-Costa Andreia, Madureira-Carvalho Áurea, Dinis-Oliveira Ricardo Jorge, Dias da Silva Diana (2022). \textit{Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.271}{doi:10.51126/revsalus.v4isup.271}.
\item Antonia Kuhn, Matthias F. Melzig (2022). \textit{Psilocybe mexicana R. Heim - Mexikanischer Kahlkopf}. Zeitschrift für Phytotherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-1540-9907}{doi:10.1055/a-1540-9907}.
\item Cox DJ, Johnson MW (2022). \textit{Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.}. Experimental and clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1037/pha0000404}{doi:10.1037/pha0000404}.
\item Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Grünblatt E, Liechti ME (2022). \textit{Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.2487}{doi:10.1002/cpt.2487}.
\item Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK (2022). \textit{Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.}. Fungal biology. [published; PubMed]. \href{https://doi.org/10.1016/j.funbio.2022.01.003}{doi:10.1016/j.funbio.2022.01.003}.
\item Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R (2022). \textit{Increased global integration in the brain after psilocybin therapy for depression.}. Nature medicine. [published; PubMed]. \href{https://doi.org/10.1038/s41591-022-01744-z}{doi:10.1038/s41591-022-01744-z}.
\item Abdulwahab F. Alahmari (2022). \textit{Neuroimaging Documentation of Psychedelic Drugs Effect on the Brain: DMT, LSD, Psilocybin, and Ibogaine as Examples: A Mini Review}. International Journal of Neurobiology. [published; Crossref]. \href{https://doi.org/10.36266/ijn/144f}{doi:10.36266/ijn/144f}.
\item Michael Avissar, Adrian Jacques H. Ambrose (2022). \textit{Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.04.4.35}{doi:10.1176/appi.pn.2022.04.4.35}.
\item Davoudian PA, Shao L, Kwan AC. (2022). \textit{Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.03.18.484437}{doi:10.1101/2022.03.18.484437}.
\item Benjamin Hearn, Michael D. Brubaker, George B. Richardson (2022). \textit{Counselors’ attitudes toward psychedelics and their use in therapy}. Journal of Counseling \& Development. [published; OpenAlex]. \href{https://doi.org/10.1002/jcad.12429}{doi:10.1002/jcad.12429}.
\item Lahood G. (2022). \textit{The mushroom, the frog, and the rainbow of desire: A participatory-psychedelic spiritual emergence.}. The International Journal of Transpersonal Studies. [published; Crossref]. \href{https://doi.org/10.24972/ijts.2019.38.2.182}{doi:10.24972/ijts.2019.38.2.182}.
\item Pearson C, Siegel J, Gold JA (2022). \textit{Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.}. Journal of the neurological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jns.2021.120096}{doi:10.1016/j.jns.2021.120096}.
\item Meade E, Hehir S, Rowan N, Garvey M (2022). \textit{Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof8030290}{doi:10.3390/jof8030290}.
\item Amrutha Garimella, Bradley Kerr, Reese H. Hyzer, Megan A. Moreno (2022). \textit{184. Hallucinogens on TikTok}. Journal of Adolescent Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jadohealth.2022.01.101}{doi:10.1016/j.jadohealth.2022.01.101}.
\item Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K, Brodin A, von Kieseritzky F, Olson L, Karlsson T. (2022). \textit{Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-1321542/v1}{doi:10.21203/rs.3.rs-1321542/v1}.
\item Bethany Halford﻿ (2022). \textit{Rediscovering psychedelics}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10009-cover}{doi:10.1021/cen-10009-cover}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths R, Mostofsky SH, Mejia A, Barrett F. (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.28.482395}{doi:10.1101/2022.02.28.482395}.
\item Kiraga M, Kuypers KPC, Uthaug MV, Ramaekers J, Mason NL. (2022). \textit{Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.03.02.22271743}{doi:10.1101/2022.03.02.22271743}.
\item Gass P, Vasilescu AN, Inta D (2022). \textit{[Rapid-acting antidepressants-neurobiological mechanisms of action].}. Der Nervenarzt. [published; PubMed]. \href{https://doi.org/10.1007/s00115-021-01225-7}{doi:10.1007/s00115-021-01225-7}.
\item Elman I, Pustilnik A, Borsook D (2022). \textit{Beating pain with psychedelics: Matter over mind?}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2021.12.005}{doi:10.1016/j.neubiorev.2021.12.005}.
\item Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M, Mertens LJ (2022). \textit{[Are psychedelics fast acting antidepressant agents?].}. Der Nervenarzt. [published; PubMed]. \href{https://doi.org/10.1007/s00115-021-01255-1}{doi:10.1007/s00115-021-01255-1}.
\item Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ (2022). \textit{Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211069100}{doi:10.1177/02698811211069100}.
\item Wolff M, Mertens LJ, Walter M, Enge S, Evens R (2022). \textit{The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211073758}{doi:10.1177/02698811211073758}.
\item Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF (2022). \textit{Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.}. Current treatment options in oncology. [published; PubMed]. \href{https://doi.org/10.1007/s11864-022-00954-4}{doi:10.1007/s11864-022-00954-4}.
\item Thomas Christopher W., Blanco-Duque Cristina, Bréant Benjamin J., Goodwin Guy M., Sharp Trevor, Bannerman David M., Vyazovskiy Vladyslav V. (2022). \textit{Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice}. Translational Psychiatry. [published; Crossref]. \href{https://doi.org/10.1038/s41398-022-01846-9}{doi:10.1038/s41398-022-01846-9}.
\item Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E. (2022). \textit{Natural language signatures of psilocybin microdosing}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.20.481177}{doi:10.1101/2022.02.20.481177}.
\item Jones GM, Nock MK (2022). \textit{Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-022-06580-2}{doi:10.1038/s41598-022-06580-2}.
\item Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL. (2022). \textit{Increased low-frequency brain responses to music after psilocybin therapy for depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.13.480302}{doi:10.1101/2022.02.13.480302}.
\item Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S (2022). \textit{Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).}. ACS omega. [published; PubMed]. \href{https://doi.org/10.1021/acsomega.1c06708}{doi:10.1021/acsomega.1c06708}.
\item NYU Langone Health (2022). \textit{A Randomized Controlled Trial of the Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02421263}{source link}.
\item Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP (2022). \textit{Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.}. Journal of clinical medicine. [published; PubMed]. \href{https://doi.org/10.3390/jcm11040938}{doi:10.3390/jcm11040938}.
\item Coppola M, Bevione F, Mondola R (2022). \textit{Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?}. Journal of xenobiotics. [published; PubMed]. \href{https://doi.org/10.3390/jox12010004}{doi:10.3390/jox12010004}.
\item Bethany Halford﻿ (2022). \textit{Hallucinogen chemistry guides antidepressant drug discovery}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10005-leadcon}{doi:10.1021/cen-10005-leadcon}.
\item Yang Y, Meng G, Ni S, Zhang H, Dong C (2022). \textit{Genomic Analysis of Reveals Its Nutritional Strategy and Application Potential in Bioremediation.}. Journal of fungi (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/jof8020162}{doi:10.3390/jof8020162}.
\item Redden WM, Paracha SU, Sheheryar Q (2022). \textit{Hallucinogen Use and Misuse in Older Adults.}. Clinics in geriatric medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.cger.2021.07.007}{doi:10.1016/j.cger.2021.07.007}.
\item Hase A, Erdmann M, Limbach V, Hasler G (2022). \textit{Analysis of recreational psychedelic substance use experiences classified by substance.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06062-3}{doi:10.1007/s00213-022-06062-3}.
\item Toby BH (2022). \textit{Crystallographic hallucinations.}. Acta crystallographica. Section C, Structural chemistry. [published; PubMed]. \href{https://doi.org/10.1107/s2053229622000511}{doi:10.1107/s2053229622000511}.
\item Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR (2022). \textit{Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211073759}{doi:10.1177/02698811211073759}.
\item Averill LA, Abdallah CG (2022). \textit{Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2035358}{doi:10.1080/13543784.2022.2035358}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S (2022). \textit{Structure-based discovery of nonhallucinogenic psychedelic analogs.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.abl8615}{doi:10.1126/science.abl8615}.
\item James Bailey Sanford (2022). \textit{Psychedelics hold promise for primary care research}. Family Practice. [published; OpenAlex]. \href{https://doi.org/10.1093/fampra/cmac009}{doi:10.1093/fampra/cmac009}.
\item Jurriaan F. M. Strous (2022). \textit{Psilocybine vergeleken met escitalopram bij depressie}. Pure Amsterdam UMC. [published; OpenAlex]. \href{https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae}{source link}.
\item Strous JFM (2022). \textit{[Psilocybin compared with escitalopram for depression].}. Nederlands tijdschrift voor geneeskunde. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/35138714/}{source link}.
\item Valerie A. Canady (2022). \textit{Pennsylvania bill seeks clinical research on psychedelics}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.33077}{doi:10.1002/mhw.33077}.
\item Ellen Saikku (2022). \textit{Classic psychedelics in the treatment of depression: mechanisms of action and the role of therapy}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/606412}{source link}.
\item Klaus Richter Larsen, Drummond E-Wen McCulloch, Brice Ozenne, Ulrich Lindberg, Sophia Armand, M. Madsen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher (2022). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100335}{doi:10.1016/j.nsa.2022.100335}.
\item A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska (2022). \textit{Neurochemical properties of psilocybin in comparison to ketamine in vivo}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100408}{doi:10.1016/j.nsa.2022.100408}.
\item E. Stojek, Jack Prenderville, F. Dunphy-Doherty (2022). \textit{Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviour}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100764}{doi:10.1016/j.nsa.2022.100764}.
\item Nathalie M. Rieser, Ladina P Gubser, Franz X. Vollenweider, Meyer Lars, Katrin H. Preller (2022). \textit{Effects of psilocybin in relative and global cerebral blood flow and behavioural correlates}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100702}{doi:10.1016/j.nsa.2022.100702}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, Albert Adell, J. Javier Meana, J.E. Ortega (2022). \textit{Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100407}{doi:10.1016/j.nsa.2022.100407}.
\item Lucie Olejníková, Klára Šíchová, K. Chona, Hynek Danda, Tomáš Páleníček (2022). \textit{The effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100948}{doi:10.1016/j.nsa.2022.100948}.
\item K. Šíchová, K. Chona, Lucie Olejníková Ladislavová, T. Páleníček (2022). \textit{The role of psilocybin in memory consolidation in the animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100953}{doi:10.1016/j.nsa.2022.100953}.
\item Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M.K. Madsen, Gitte M. Knudsen, Patrick M. Fisher (2022). \textit{Acute change in functional brain entropy following psilocybin administration in healthy volunteers}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100701}{doi:10.1016/j.nsa.2022.100701}.
\item Daisuke Ibi (2022). \textit{Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.96.0\_4-b-s43-2}{doi:10.1254/jpssuppl.96.0\_4-b-s43-2}.
\item Jeff Tarrant (2022). \textit{SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?}. Biofeedback. [published; OpenAlex]. \href{https://doi.org/10.5298/1081-5937-50.03.03}{doi:10.5298/1081-5937-50.03.03}.
\item Russell J. Zwanka (2022). \textit{Exploratory review of psilocybin usage and awareness amongst college students and potential consumer goods tradeoffs resulting from increased usage}. International Journal of Research in Marketing Management and Sales. [published; OpenAlex]. \href{https://doi.org/10.33545/26633329.2022.v4.i1a.88}{doi:10.33545/26633329.2022.v4.i1a.88}.
\item Daisuke Ibi (2022). \textit{Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.95.0\_3-s35-1}{doi:10.1254/jpssuppl.95.0\_3-s35-1}.
\item Friederike Holze, Laura Ley, F. Müller, V. Nimmy, Anne Eckert, Matthias E. Liechti (2022). \textit{Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjects}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100075}{doi:10.1016/j.nsa.2022.100075}.
\item Nathalie M. Rieser, Ladina P Gubser, C. Rossgoderer Da Silva, Franz X. Vollenweider, Marcus Herdener, Katrin H. Preller (2022). \textit{Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100102}{doi:10.1016/j.nsa.2022.100102}.
\item G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia (2022). \textit{The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100213}{doi:10.1016/j.nsa.2022.100213}.
\item Josh Nagra (2022). \textit{Psychedelic Agents as Potential Therapeutics for Obsessive Compulsive Disorder}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03}{source link}.
\item Rayyan Zafar, Dustin Sulak, Jaime Brambila, David Nutt, Anne Katrin Schlag (2022). \textit{Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245221114323}{doi:10.1177/20503245221114323}.
\item G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia (2022). \textit{The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100511}{doi:10.1016/j.nsa.2022.100511}.
\item Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti (2022). \textit{Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100410}{doi:10.1016/j.nsa.2022.100410}.
\item Marcos Garcia de Teresa (2022). \textit{Selling the Priceless Mushroom: A History of Psilocybin Mushroom Trade in the Sierra Mazateca (Oaxaca)}. Journal of Illicit Economies and Development. [published; OpenAlex]. \href{https://doi.org/10.31389/jied.101}{doi:10.31389/jied.101}.
\item John Bailey, Joanna Kempner (2022). \textit{Standards Without Labs: Drug Development in the Psychedelic Underground}. Citizen Science Theory and Practice. [published; OpenAlex]. \href{https://doi.org/10.5334/cstp.527}{doi:10.5334/cstp.527}.
\item F. N. Smith, Joanna C. Neill, Verity Wainwright (2022). \textit{An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245221124117}{doi:10.1177/20503245221124117}.
\item Khaleel Rajwani (2022). \textit{Should Adolescents be Included in Emerging Psychedelic Research?}. Canadian Journal of Bioethics. [published; OpenAlex]. \href{https://doi.org/10.7202/1089784ar}{doi:10.7202/1089784ar}.
\item Christina Sagioglou, Matthias Forstmann (2022). \textit{Psychedelic use predicts objective knowledge about climate change via increases in nature relatedness}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245221129803}{doi:10.1177/20503245221129803}.
\item Vejmola Č., Syrová K., Šíchová K., Vlastimil K., Klučková T., Kelemen E., Páleníček T. (2022). \textit{Rats hallucinate in a similar manner to humans after psilocin}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2022.100950}{doi:10.1016/j.nsa.2022.100950}.
\item Bhadoria Poonam, Venkatnarayan Ramanathan (2022). \textit{Unravelling a New Conformer of Psilocin Through Computational Methods}. SSRN Electronic Journal. [published; Crossref]. \href{https://doi.org/10.2139/ssrn.4162669}{doi:10.2139/ssrn.4162669}.
\item Elcock C (2022). \textit{Psychedelic philanthropy: The nonprofit sector and Timothy Leary's 1960s psychedelic movement.}. Journal of the history of the behavioral sciences. [published; PubMed]. \href{https://doi.org/10.1002/jhbs.22083}{doi:10.1002/jhbs.22083}.
\item Petranker R, Anderson T, Maier LJ, Barratt MJ, Ferris JA, Winstock AR (2022). \textit{Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120953994}{doi:10.1177/0269881120953994}.
\item Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL (2022). \textit{Psychedelics and health behaviour change.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211008554}{doi:10.1177/02698811211008554}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM (2022). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211026454}{doi:10.1177/02698811211026454}.
\item Mayer CE, LeBaron VT, Acquaviva KD (2022). \textit{Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.1916659}{doi:10.1080/02791072.2021.1916659}.
\item Leger RF, Unterwald EM (2022). \textit{Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211044688}{doi:10.1177/02698811211044688}.
\item Li NX, Hu YR, Chen WN, Zhang B (2022). \textit{Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2021.09.041}{doi:10.1016/j.jad.2021.09.041}.
\item Barnett BS, Parker SE, Weleff J (2022). \textit{United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2021.103473}{doi:10.1016/j.drugpo.2021.103473}.
\item Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P (2022). \textit{Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_267}{doi:10.1007/7854\_2021\_267}.
\item Liechti ME, Holze F (2022). \textit{Dosing Psychedelics and MDMA.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_270}{doi:10.1007/7854\_2021\_270}.
\item Ehrmann K, Allen JJB, Moreno FA (2022). \textit{Psilocybin for the Treatment of Obsessive-Compulsive Disorders.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_279}{doi:10.1007/7854\_2021\_279}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS (2022). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Agin-Liebes G, Davis AK (2022). \textit{Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_282}{doi:10.1007/7854\_2021\_282}.
\item Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA (2022). \textit{Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-06027-y}{doi:10.1007/s00213-021-06027-y}.
\item Sousa TR, Rema J, Machado S, Novais F (2022). \textit{Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.}. Current topics in medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/1568026621666211201145800}{doi:10.2174/1568026621666211201145800}.
\item Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D (2022). \textit{Psychedelic medicines for mood disorders: current evidence and clinical considerations.}. Current opinion in psychiatry. [published; PubMed]. \href{https://doi.org/10.1097/yco.0000000000000759}{doi:10.1097/yco.0000000000000759}.
\item Rieser NM, Herdener M, Preller KH (2022). \textit{Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_284}{doi:10.1007/7854\_2021\_284}.
\item Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M (2022). \textit{Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211050556}{doi:10.1177/02698811211050556}.
\item Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR (2022). \textit{The Potential of Psychedelics for End of Life and Palliative Care.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_278}{doi:10.1007/7854\_2021\_278}.
\item Sherwood AM, Kargbo RB, Kaylo KW, Cozzi NV, Meisenheimer P, Kaduk JA (2022). \textit{Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.}. Acta crystallographica. Section C, Structural chemistry. [published; PubMed]. \href{https://doi.org/10.1107/s2053229621013164}{doi:10.1107/s2053229621013164}.
\item Jones GM, Nock MK (2022). \textit{MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211058923}{doi:10.1177/02698811211058923}.
\item Jones GM, Nock MK (2022). \textit{Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211066714}{doi:10.1177/02698811211066714}.
\item Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH (2022). \textit{The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211064720}{doi:10.1177/02698811211064720}.
\item Jones GM, Nock MK (2022). \textit{Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211058933}{doi:10.1177/02698811211058933}.
\item Strickland JC, Johnson MW (2022). \textit{Human behavioral pharmacology of psychedelics.}. Advances in pharmacology (San Diego, Calif.). [published; PubMed]. \href{https://doi.org/10.1016/bs.apha.2021.10.003}{doi:10.1016/bs.apha.2021.10.003}.
\item Plotnik L, Gibbs G, Graham T (2022). \textit{Psilocybin Conspectus: Status, Production Methods, and Considerations.}. International journal of medicinal mushrooms. [published; PubMed]. \href{https://doi.org/10.1615/intjmedmushrooms.2021041921}{doi:10.1615/intjmedmushrooms.2021041921}.
\item Schindler EAD (2022). \textit{Psychedelics in the Treatment of Headache and Chronic Pain Disorders.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_365}{doi:10.1007/7854\_2022\_365}.
\item Flanagan TW, Nichols CD (2022). \textit{Psychedelics and Anti-inflammatory Activity in Animal Models.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_367}{doi:10.1007/7854\_2022\_367}.
\item Johnson MW (2022). \textit{Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_327}{doi:10.1007/7854\_2022\_327}.
\item Khan AJ, Bradley E, O'Donovan A, Woolley J (2022). \textit{Psilocybin for Trauma-Related Disorders.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_366}{doi:10.1007/7854\_2022\_366}.
\item Kiguchi Y (2022). \textit{[A Novel System for Discovering High-affinity Antibody Mutants That Enables Immunoassays with Higher Sensitivities -Development and Application of Clonal Array Profiling (CAP)].}. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan. [published; PubMed]. \href{https://doi.org/10.1248/yakushi.22-00141}{doi:10.1248/yakushi.22-00141}.
\item Zhang X, Yu H, Wang Z, Yang Q, Xia R, Qu Y, Tao R, Shi Y, Xiang P, Zhang S, Li C (2022). \textit{Multi-locus identification of by high-resolution melting (HRM).}. Forensic sciences research. [published; PubMed]. \href{https://doi.org/10.1080/20961790.2021.1875580}{doi:10.1080/20961790.2021.1875580}.
\item Devenot N, Seale-Feldman A, Smith E, Noorani T, Garcia-Romeu A, Johnson MW (2022). \textit{Psychedelic Identity Shift: A Critical Approach to Set And Setting.}. Kennedy Institute of Ethics journal. [published; PubMed]. \href{https://doi.org/10.1353/ken.2022.0022}{doi:10.1353/ken.2022.0022}.
\item Sekula AD, Downey L, Puspanathan P (2022). \textit{Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.813746}{doi:10.3389/fpsyg.2022.813746}.
\item Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G (2022). \textit{Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.}. Neuroscience applied. [published; PubMed]. \href{https://doi.org/10.1016/j.nsa.2022.100104}{doi:10.1016/j.nsa.2022.100104}.
\item McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS (2022). \textit{Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.841648}{doi:10.3389/fphar.2022.841648}.
\item Raison CL, Jain R, Penn AD, Cole SP, Jain S (2022). \textit{Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.831092}{doi:10.3389/fpsyt.2022.831092}.
\item Dworatzyk K, Jansen T, Schmidt TT (2022). \textit{Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0264927}{doi:10.1371/journal.pone.0264927}.
\item Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L (2022). \textit{Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.877390}{doi:10.3389/fpsyt.2022.877390}.
\item Davis AK, Arterberry BJ, Xin Y, Agin-Liebes G, Schwarting C, Williams MT (2022). \textit{Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.}. Frontiers in epidemiology. [published; PubMed]. \href{https://doi.org/10.3389/fepid.2022.876706}{doi:10.3389/fepid.2022.876706}.
\item Pots W, Chakhssi F (2022). \textit{Psilocybin-Assisted Compassion Focused Therapy for Depression.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.812930}{doi:10.3389/fpsyg.2022.812930}.
\item Hayes C, Wahba M, Watson S (2022). \textit{Will psilocybin lose its magic in the clinical setting?}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253221090822}{doi:10.1177/20451253221090822}.
\item Huang J, Pham M, Panenka WJ, Honer WG, Barr AM (2022). \textit{Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.891512}{doi:10.3389/fpsyt.2022.891512}.
\item Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW (2022). \textit{Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.873279}{doi:10.3389/fpsyg.2022.873279}.
\item Frymann T, Whitney S, Yaden DB, Lipson J (2022). \textit{The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.863247}{doi:10.3389/fpsyg.2022.863247}.
\item Wang Q, Ren Y, Cui Y, Gao B, Zhang H, Jiang Q, Loor JJ, Deng Z, Xu C (2022). \textit{Produces Amino Acids to Stimulate Protein Synthesis in Ruminal Tissue Explants the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta-Serine/Threonine Kinase-Mammalian Target of Rapamycin Complex 1 Pathway.}. Frontiers in veterinary science. [published; PubMed]. \href{https://doi.org/10.3389/fvets.2022.852321}{doi:10.3389/fvets.2022.852321}.
\item Vorobyeva N, Kozlova AA (2022). \textit{Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.927984}{doi:10.3389/fphar.2022.927984}.
\item Lyons A (2022). \textit{Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.}. Innovations in clinical neuroscience. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/36204170/}{source link}.
\item Kiraga MK, Kuypers KPC, Uthaug MV, Ramaekers JG, Mason NL (2022). \textit{Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.883869}{doi:10.3389/fpsyt.2022.883869}.
\item Ko K, Knight G, Rucker JJ, Cleare AJ (2022). \textit{Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.917199}{doi:10.3389/fpsyt.2022.917199}.
\item Roseman L, Preller KH, Fotiou E, Winkelman MJ (2022). \textit{Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.979764}{doi:10.3389/fphar.2022.979764}.
\item Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V (2022). \textit{Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.}. Chronic stress (Thousand Oaks, Calif.). [published; PubMed]. \href{https://doi.org/10.1177/24705470221115342}{doi:10.1177/24705470221115342}.
\item Sweeney MM, Nayak S, Hurwitz ES, Mitchell LN, Swift TC, Griffiths RR (2022). \textit{Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0271926}{doi:10.1371/journal.pone.0271926}.
\item Yan YY, Zhang YZ, Vauras J, Zhao LN, Fan YG, Li HJ, Xu F (2022). \textit{﻿ (Inocybaceae), a new poisonous species from Eurasia, based on morphological, ecological, molecular and biochemical evidence.}. MycoKeys. [published; PubMed]. \href{https://doi.org/10.3897/mycokeys.92.86277}{doi:10.3897/mycokeys.92.86277}.
\item Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J (2022). \textit{Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.1971343}{doi:10.1080/02791072.2021.1971343}.
\item Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J (2022). \textit{Comment and Response: (Lugo-Radillo \& Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.1983673}{doi:10.1080/02791072.2021.1983673}.
\item Cruzat J, Perl YS, Escrichs A, Vohryzek J, Timmermann C, Roseman L, Luppi AI, Ibañez A, Nutt D, Carhart-Harris R, Tagliazucchi E, Deco G, Kringelbach ML (2022). \textit{Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.}. Network neuroscience (Cambridge, Mass.). [published; PubMed]. \href{https://doi.org/10.1162/netn\_a\_00250}{doi:10.1162/netn\_a\_00250}.
\item López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D (2022). \textit{3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.990405}{doi:10.3389/fpsyt.2022.990405}.
\item Søndergaard A, Madsen MK, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS (2022). \textit{Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.948729}{doi:10.3389/fpsyg.2022.948729}.
\item Sottile RJ, Vida T (2022). \textit{A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.991753}{doi:10.3389/fpsyt.2022.991753}.
\item Gandia A, Adamatzky A (2022). \textit{Electrical spiking of psilocybin fungi.}. Communicative \& integrative biology. [published; PubMed]. \href{https://doi.org/10.1080/19420889.2022.2136118}{doi:10.1080/19420889.2022.2136118}.
\item Li SN, Xu F, Long P, Liu F, Zhang P, Fan YG, Chen ZH (2022). \textit{Five new species of from China: Morphological characteristics, phylogenetic analyses, and toxin detection.}. Frontiers in microbiology. [published; PubMed]. \href{https://doi.org/10.3389/fmicb.2022.1021583}{doi:10.3389/fmicb.2022.1021583}.
\item Altman BR, Earleywine M, De Leo J (2022). \textit{Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.2020382}{doi:10.1080/02791072.2021.2020382}.
\item Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI (2022). \textit{A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000001608}{doi:10.1097/jcp.0000000000001608}.
\item Balon R (2022). \textit{Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000001610}{doi:10.1097/jcp.0000000000001610}.
\item Paganin W, Signorini S, Leccese V, Sciarretta A (2022). \textit{[Treatment-resistant depression. From classification to new therapies.].}. Rivista di psichiatria. [published; PubMed]. \href{https://doi.org/10.1708/3922.39072}{doi:10.1708/3922.39072}.
\item Messell C, Summer L, Bonde LO, Beck BD, Stenbæk DS (2022). \textit{Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.873455}{doi:10.3389/fpsyg.2022.873455}.
\item Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB (2022). \textit{Classic psychedelics, health behavior, and physical health.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253221135363}{doi:10.1177/20451253221135363}.
\item MacCallum CA, Lo LA, Pistawka CA, Deol JK (2022). \textit{Therapeutic use of psilocybin: Practical considerations for dosing and administration.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1040217}{doi:10.3389/fpsyt.2022.1040217}.
\item Passie T, Guss J, Krähenmann R (2022). \textit{Lower-dose psycholytic therapy - A neglected approach.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1020505}{doi:10.3389/fpsyt.2022.1020505}.
\item Marseille E, Bertozzi S, Kahn JG (2022). \textit{The economics of psychedelic-assisted therapies: A research agenda.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1025726}{doi:10.3389/fpsyt.2022.1025726}.
\item DellaCrosse M, Pleet M, Morton E, Ashtari A, Sakai K, Woolley J, Michalak E (2022). \textit{"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0279073}{doi:10.1371/journal.pone.0279073}.
\item Mayer FP, Luethi D, Areal LB, Sitte HH (2022). \textit{Editorial: Old and new psychoactive substances: Pharmacology and potential applications.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1087005}{doi:10.3389/fpsyt.2022.1087005}.
\item Alper K, Cange J, Sah R, Schreiber-Gregory D, Sershen H, Vinod KY (2022). \textit{Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.1074633}{doi:10.3389/fphar.2022.1074633}.
\item Rabinowitz J, Lev-Ran S, Gross R (2022). \textit{The association between naturalistic use of psychedelics and co-occurring substance use disorders.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1066369}{doi:10.3389/fpsyt.2022.1066369}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2022). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item Victor Chiruta, Paulina K Zemla, Pixie Miller, Nicola Santarossa, John A Hannan (2021). \textit{Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020}. Journal of Medical and Health Studies. [published; OpenAlex]. \href{https://doi.org/10.32996/jmhs.2021.2.2.18}{doi:10.32996/jmhs.2021.2.2.18}.
\item Poonam Bhadoria, Manish K. Tripathi, V. Ramanathan (2021). \textit{Conformational Analysis of Psilocybin: A Computational Approach}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.4098712}{doi:10.2139/ssrn.4098712}.
\item University Hospital, Basel, Switzerland (2021). \textit{LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03153579}{source link}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5d7fc}{doi:10.31234/osf.io/5d7fc}.
\item Annie McCartney, Hugh McGovern, Alexander De Foe (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5d7fc\_v1}{source link}.
\item Niles H, Fogg C, Kelmendi B, Lazenby M (2021). \textit{Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.}. BMC palliative care. [published; PubMed]. \href{https://doi.org/10.1186/s12904-021-00889-x}{doi:10.1186/s12904-021-00889-x}.
\item McKernan K, Kane L, Helbert Y, Zhang L, Houde N, McLaughlin S. (2021). \textit{A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.55301.2}{doi:10.12688/f1000research.55301.2}.
\item Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S, Mørup M, Ganz M, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin modulation of dynamic functional connectivity is associated with plasma psilocin and subjective effects}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.12.17.21267992}{doi:10.1101/2021.12.17.21267992}.
\item National Council of Scientific and Technical Research, Argentina (2021). \textit{Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05160220}{source link}.
\item Johns Hopkins University (2021). \textit{Effects of Psilocybin in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03181529}{source link}.
\item McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS. (2021). \textit{A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xqzu2}{doi:10.31234/osf.io/xqzu2}.
\item Drummond E-Wen McCulloch, Maria Zofia Grzywacz, Martin Korsbak Madsen, Peter Steen Jensen, Brice Ozenne, Sophia Armand, Gitte Moos Knudsen, Patrick MacDonald Fisher, Dea Siggard Stenbæk (2021). \textit{A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xqzu2\_v1}{source link}.
\item Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek (2021). \textit{Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000662}{doi:10.1097/fbp.0000000000000662}.
\item Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E. (2021). \textit{Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.11.30.470657}{doi:10.1101/2021.11.30.470657}.
\item Drummond E-Wen McCulloch, M. Madsen, Dea Siggaard Stenbæk, Søren Kristiansen, Brice Ozenne, P.S. Jensen, Gitte M. Knudsen, Patrick M. Fisher (2021). \textit{P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.557}{doi:10.1016/j.euroneuro.2021.10.557}.
\item Hannah Douglass, Meg J. Spriggs, R.J. Park, Tim Read, Jennifer L. Danby, Frederico José Coelho de Magalhães, Kirsty L. Alderton, Adèle Lafrance, Dasha Nicholls, David Erritzøe, David Nutt, Robin Carhart-Harris (2021). \textit{P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.335}{doi:10.1016/j.euroneuro.2021.10.335}.
\item Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Max Wolff, Andreas Ströhle, Stefan Wellek, Gerhard Gründer (2021). \textit{P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.394}{doi:10.1016/j.euroneuro.2021.10.394}.
\item Dea Siggaard Stenbæk, M. Madsen, Sophia Armand, Catharina Messel, Maria Zofia Grzywacz, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2021). \textit{P.0828 Psilocybin enhances emotional response to music in healthy individuals}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.687}{doi:10.1016/j.euroneuro.2021.10.687}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2021). \textit{P.0298 Evaluation of the acute mechanism of action of psilocybin in mice}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.282}{doi:10.1016/j.euroneuro.2021.10.282}.
\item A. Andreiev, E. Bucuci, James Chue, Charl Els, Pierre Chue (2021). \textit{P.0623 The clinical relevance of the pharmacokinetics of psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.588}{doi:10.1016/j.euroneuro.2021.10.588}.
\item Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris (2021). \textit{P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.741}{doi:10.1016/j.euroneuro.2021.10.741}.
\item Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo, M. Magalhães, L. Moreno, N. Ribeiro, Inês Fonseca, Ana Margarida Romão Franco, Luís Madruga, A. Gamito (2021). \textit{P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.797}{doi:10.1016/j.euroneuro.2021.10.797}.
\item Olejníková L., Danda H., Lhotková E., Kútná V., Šíchová K., Syrová K., Mazochová K., Páleníček T. (2021). \textit{P.0553 Effect of chronic microdosing of psilocin on cell proliferation and behavior in rats}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.523}{doi:10.1016/j.euroneuro.2021.10.523}.
\item Vejmola Č., Syrová K., Koudelka V., Šíchová K., Tesař M., Dodoková A., Kelemen E., Páleníček T. (2021). \textit{P.0858 Psilocin induces perceptual alterations in rats: visual discrimination study}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.715}{doi:10.1016/j.euroneuro.2021.10.715}.
\item Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D (2021). \textit{Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/0004867421998785}{doi:10.1177/0004867421998785}.
\item Horton DM, Morrison B, Schmidt J (2021). \textit{Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.}. American journal of psychotherapy. [published; PubMed]. \href{https://doi.org/10.1176/appi.psychotherapy.20200055}{doi:10.1176/appi.psychotherapy.20200055}.
\item Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS (2021). \textit{Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2021.103380}{doi:10.1016/j.drugpo.2021.103380}.
\item Lukačovič M, Masaryk R (2021). \textit{Use of hallucinogens in Slovakia: Does it differ from global trends?}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2021.103385}{doi:10.1016/j.drugpo.2021.103385}.
\item Gibbons WJ, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA (2021). \textit{Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?}. Bioengineered. [published; PubMed]. \href{https://doi.org/10.1080/21655979.2021.1987090}{doi:10.1080/21655979.2021.1987090}.
\item Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A (2021). \textit{Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.}. BMJ open. [published; PubMed]. \href{https://doi.org/10.1136/bmjopen-2021-056091}{doi:10.1136/bmjopen-2021-056091}.
\item Linda M. Richmond (2021). \textit{Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.11.29}{doi:10.1176/appi.pn.2021.11.29}.
\item Angenoorth TJF, Stankovic S, Niello M, Holy M, Brandt SD, Sitte HH, Maier J (2021). \textit{Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms222312995}{doi:10.3390/ijms222312995}.
\item Alfafar M., Farinha R., Pontes F. (2021). \textit{P.0620 Psilocybin as a treatment of addictions: a review of the literature}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.585}{doi:10.1016/j.euroneuro.2021.10.585}.
\item David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman (2021). \textit{Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.12.14}{doi:10.1176/appi.pn.2021.12.14}.
\item Ron Cole-Turner (2021). \textit{Psychedelic Epistemology: William James and the “Noetic Quality” of Mystical Experience}. Religions. [published; OpenAlex]. \href{https://doi.org/10.3390/rel12121058}{doi:10.3390/rel12121058}.
\item Enzo Tagliazucchi (2021). \textit{Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.5745892}{doi:10.5281/zenodo.5745892}.
\item Weleff J, Akiki TJ, Barnett BS. (2021). \textit{Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.11.22.21266718}{doi:10.1101/2021.11.22.21266718}.
\item Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P (2021). \textit{Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph14121213}{doi:10.3390/ph14121213}.
\item Cadena Botero (2021). \textit{Mestizo Visionary Art of the Americas in the Late Twentieth Century: Hallucinogens, Politics, Aesthetics and Mass Consumer Culture in the United States, Mexico, and Colombia}. Columbia University Academic Commons. [published; OpenAlex]. \href{https://doi.org/10.7916/d8-efa5-7m74}{doi:10.7916/d8-efa5-7m74}.
\item Molumby M, Gaynor K, Guerin S. (2021). \textit{Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability test}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6f9qp}{doi:10.31234/osf.io/6f9qp}.
\item Mark Molumby, Keith Gaynor, Suzanne Guerin, Roisin McNamara (2021). \textit{Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability test}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6f9qp\_v1}{source link}.
\item Duerler P, Brem S, Fraga-González G, Neef T, Allen M, Zeidman P, Stämpfli P, Vollenweider FX, Preller KH (2021). \textit{Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.}. Cerebral cortex (New York, N.Y.: 1991). [published; PubMed]. \href{https://doi.org/10.1093/cercor/bhab202}{doi:10.1093/cercor/bhab202}.
\item Gary Enos (2021). \textit{Researchers hope psilocybin could improve quit rates for smokers}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.33270}{doi:10.1002/adaw.33270}.
\item Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen Und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH (2021). \textit{Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.}. Science advances. [published; PubMed]. \href{https://doi.org/10.1126/sciadv.abh2399}{doi:10.1126/sciadv.abh2399}.
\item Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Polito V, Bourzat F, Walsh Z (2021). \textit{Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-021-01811-4}{doi:10.1038/s41598-021-01811-4}.
\item Basky G (2021). \textit{Policy in focus: Is psilocybin the next cannabis?}. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. [published; PubMed]. \href{https://doi.org/10.1503/cmaj.1095974}{doi:10.1503/cmaj.1095974}.
\item Graham F (2021). \textit{Daily briefing: Largest trial shows psilocybin is effective to treat depression.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/d41586-021-03413-6}{doi:10.1038/d41586-021-03413-6}.
\item Karim Ashraf ElAgamy (2021). \textit{Psychedelics and their therapeutic effects}. University of Debrecen Electronic Archive. [published; OpenAlex]. \href{http://hdl.handle.net/2437/336821}{source link}.
\item Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS (2021). \textit{Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-021-01706-y}{doi:10.1038/s41398-021-01706-y}.
\item Joanna Kuc, Hannes Kettner, Fernando E. Rosas, David Erritzøe, Eline Haijen, Mendel Kaelen, David Nutt, Robin Carhart-Harris (2021). \textit{Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-021-05999-1}{doi:10.1007/s00213-021-05999-1}.
\item Sam Wong (2021). \textit{Psilocybin steps closer to credibility}. The New Scientist. [published; OpenAlex]. \href{https://doi.org/10.1016/s0262-4079(21)02061-3}{doi:10.1016/s0262-4079(21)02061-3}.
\item Hendin HM, Penn AD (2021). \textit{An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.}. Bipolar disorders. [published; PubMed]. \href{https://doi.org/10.1111/bdi.13095}{doi:10.1111/bdi.13095}.
\item Aleksandrova LR, Phillips AG (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Bogadi M, Kaštelan S (2021). \textit{A potential effect of psilocybin on anxiety in neurotic personality structures in adolescents.}. Croatian medical journal. [published; PubMed]. \href{https://doi.org/10.3325/cmj.2021.62.528}{doi:10.3325/cmj.2021.62.528}.
\item Liu WQ, Shi Y, Xiang P, Yu F, Xie B, Dong M, Ha J, Ma CL, Wen D (2021). \textit{Analysis of Five Mushroom Toxins in Blood by UPLC-HRMS.}. Fa yi xue za zhi. [published; PubMed]. \href{https://doi.org/10.12116/j.issn.1004-5619.2020.301001}{doi:10.12116/j.issn.1004-5619.2020.301001}.
\item Dee Dee Goldpaugh (2021). \textit{Finding the divine within: exploring the role of the sacred in psychedelic integration therapy for sexual trauma and dysfunction}. Sexual \& Relationship Therapy. [published; OpenAlex]. \href{https://doi.org/10.1080/14681994.2021.1994138}{doi:10.1080/14681994.2021.1994138}.
\item Maryland Oncology Hematology, PA (2021). \textit{The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04593563}{source link}.
\item Kargbo Robert B. (2021). \textit{Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders}. ACS Medicinal Chemistry Letters. [published; Crossref]. \href{https://doi.org/10.1021/acsmedchemlett.1c00467}{doi:10.1021/acsmedchemlett.1c00467}.
\item Andrian Fajar Kusumadewi (2021). \textit{Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication}. Archives of The Medicine and Case Reports. [published; OpenAlex]. \href{https://doi.org/10.37275/amcr.v1i2.7}{doi:10.37275/amcr.v1i2.7}.
\item Radakovic C, Radakovic R, Peryer G, Geere J. (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yu7jf}{doi:10.31234/osf.io/yu7jf}.
\item Chelsea Radakovic, Ratko Radakovic, Guy Peryer, Jo-Anne Geere (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yu7jf\_v1}{source link}.
\item Ryan Cross﻿ (2021). \textit{Delix to synthesize psychedelic drugs}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09936-buscon3}{doi:10.1021/cen-09936-buscon3}.
\item Vejmola Čestmír, Tylš Filip, Piorecká Václava, Koudelka Vlastimil, Kadeřábek Lukáš, Novák Tomáš, Páleníček Tomáš (2021). \textit{Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity}. Translational Psychiatry. [published; Crossref]. \href{https://doi.org/10.1038/s41398-021-01603-4}{doi:10.1038/s41398-021-01603-4}.
\item Fitzgerald PJ (2021). \textit{Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms221910706}{doi:10.3390/ijms221910706}.
\item Charles S. Grob (2021). \textit{6.3 CURRENT RESEARCH ON PSILOCYBIN TREATMENT ON END-OF-LIFE ANXIETY AND MDMA TREATMENT OF SOCIAL ANXIETY IN AUTISM SPECTRUM DISORDER}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2021.07.053}{doi:10.1016/j.jaac.2021.07.053}.
\item Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT (2021). \textit{Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.}. Experimental and clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1037/pha0000490}{doi:10.1037/pha0000490}.
\item Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS (2021). \textit{Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.}. Psychiatry investigation. [published; PubMed]. \href{https://doi.org/10.30773/pi.2021.0209}{doi:10.30773/pi.2021.0209}.
\item Matt T. Keener (2021). \textit{6.2 OVERVIEW OF PSYCHEDELIC COMPOUNDS AND THEIR USE IN TREATMENT}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2021.07.052}{doi:10.1016/j.jaac.2021.07.052}.
\item Castro BN, Prata Saraiva R, Afonso João D, Dantas Costa S (2021). \textit{Magic mushroom: all is not as it seems.}. Acta chirurgica Belgica. [published; PubMed]. \href{https://doi.org/10.1080/00015458.2021.1972590}{doi:10.1080/00015458.2021.1972590}.
\item Vincent Verroust, Rayyan Zafar, Meg J. Spriggs (2021). \textit{Psilocybin in the treatment of anorexia nervosa: The English transition of a French 1959 case study}. Annales Médico-psychologiques revue psychiatrique. [published; OpenAlex]. \href{https://doi.org/10.1016/j.amp.2021.08.004}{doi:10.1016/j.amp.2021.08.004}.
\item Zeiss R, Gahr M, Graf H (2021). \textit{Rediscovering Psilocybin as an Antidepressive Treatment Strategy.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph14100985}{doi:10.3390/ph14100985}.
\item Alison Knopf (2021). \textit{Psilocybin: Next to treat depression, OCD and nicotine addiction}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.33204}{doi:10.1002/adaw.33204}.
\item Hagsäter SM, Pettersson R, Pettersson C, Atanasovski D, Näslund J, Eriksson E (2021). \textit{A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyab040}{doi:10.1093/ijnp/pyab040}.
\item Pascal Kintz, Jean-Sébastien Raul, Alice Ameline (2021). \textit{Testing human hair after magic mushrooms abuse by LC-MS/MS: Pitfalls and limitations}. Forensic Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.forc.2021.100364}{doi:10.1016/j.forc.2021.100364}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances}. European Psychologist. [published; OpenAlex]. \href{https://doi.org/10.1027/1016-9040/a000447}{doi:10.1027/1016-9040/a000447}.
\item Bill Brennan, Margo A. Jackson, Katherine A. MacLean, Joseph G. Ponterotto (2021). \textit{A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678211045265}{doi:10.1177/00221678211045265}.
\item Morita I, Kiguchi Y, Oyama H, Takeuchi A, Tode C, Tanaka R, Ogata J, Kikura-Hanajiri R, Kobayashi N (2021). \textit{Derivatization-assisted enzyme-linked immunosorbent assay for identifying hallucinogenic mushrooms with enhanced sensitivity.}. Analytical methods: advancing methods and applications. [published; PubMed]. \href{https://doi.org/10.1039/d1ay01157j}{doi:10.1039/d1ay01157j}.
\item Dan Cătălin Oprea, Loretta Epure, Vasile Chiriță, Adrian Cantemir (2021). \textit{The therapeutical role of psychedelic drugs in treatment of mental disorders}. Bulletin of Integrative Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.36219/bpi.2021.3.09}{doi:10.36219/bpi.2021.3.09}.
\item Benjamin R. Lewis, Kevin Byrne (2021). \textit{Is MDD the right target for early-stage psychedelic-assisted therapy trials?}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2021.00180}{doi:10.1556/2054.2021.00180}.
\item Tehseen Noorani, Jonny Martell (2021). \textit{New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2021.727050}{doi:10.3389/fpsyt.2021.727050}.
\item Gonçalo Cotovio, Ana Maia, Ana Velosa, Carolina Seybert, Albino J. Oliveira-Maia (2021). \textit{Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?}. Revista Portuguesa de Psiquiatria e Saúde Mental. [published; OpenAlex]. \href{https://doi.org/10.51338/rppsm.2021.v7.i3.241}{doi:10.51338/rppsm.2021.v7.i3.241}.
\item Samantha K. Podrebarac, Kelley C. O’Donnell, Sarah E. Mennenga, Lindsey T. Owens, Tara C. Malone, Jessie H. Duane, Michael P. Bogenschutz (2021). \textit{Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.}. Spirituality in Clinical Practice. [published; OpenAlex]. \href{https://doi.org/10.1037/scp0000242}{doi:10.1037/scp0000242}.
\item Askew R, Williams L (2021). \textit{Rethinking enhancement substance use: A critical discourse studies approach.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2020.102994}{doi:10.1016/j.drugpo.2020.102994}.
\item Liokaftos D (2021). \textit{Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2020.103099}{doi:10.1016/j.drugpo.2020.103099}.
\item Muthukumaraswamy SD, Forsyth A, Lumley T (2021). \textit{Blinding and expectancy confounds in psychedelic randomized controlled trials.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2021.1933434}{doi:10.1080/17512433.2021.1933434}.
\item Magaraggia I, Kuiperes Z, Schreiber R (2021). \textit{Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.}. Neurobiology of learning and memory. [published; PubMed]. \href{https://doi.org/10.1016/j.nlm.2021.107467}{doi:10.1016/j.nlm.2021.107467}.
\item Bambauer TP, Wagmann L, Weber AA, Meyer MR (2021). \textit{Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions.}. Drug testing and analysis. [published; PubMed]. \href{https://doi.org/10.1002/dta.3106}{doi:10.1002/dta.3106}.
\item Madsen Martin K., Stenbæk Dea S., Arvidsson Albin, Armand Sophia, Marstrand-Joergensen Maja R., Johansen Sys S., Linnet Kristian, Ozenne Brice, Knudsen Gitte M., Fisher Patrick M. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.06.001}{doi:10.1016/j.euroneuro.2021.06.001}.
\item Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR (2021). \textit{Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-1524-2794}{doi:10.1055/a-1524-2794}.
\item Kverno KS, Mangano E (2021). \textit{Treatment-Resistant Depression: Approaches to Treatment.}. Journal of psychosocial nursing and mental health services. [published; PubMed]. \href{https://doi.org/10.3928/02793695-20210816-01}{doi:10.3928/02793695-20210816-01}.
\item Wiley JF, Bei B (2021). \textit{Psilocybin for Depression.}. The New England journal of medicine. [published; PubMed]. \href{https://doi.org/10.1056/nejmc2108082}{doi:10.1056/nejmc2108082}.
\item Ryan Cross﻿ (2021). \textit{Beckley raises funds for psychedelic drugs}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09930-buscon17}{doi:10.1021/cen-09930-buscon17}.
\item Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, Gukasyan N, Mathur BN, Barrett FS (2021). \textit{Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyab026}{doi:10.1093/ijnp/pyab026}.
\item Frederico Marques Silveira, Amanda Pereira Mendes, Mayara Rodrigues dos Santos, Júlia Ramos Cerchi, IRIS TIYONO TAVARES UMEDA, Breno Basílio de Melo, Luiza Elena Casaburi, Mateus Nóbrega Oliveira, Douglas Reis Abdalla (2021). \textit{Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review}. Research Society and Development. [published; OpenAlex]. \href{https://doi.org/10.33448/rsd-v10i10.19297}{doi:10.33448/rsd-v10i10.19297}.
\item Lenz Claudius, Dörner Sebastian, Sherwood Alexander, Hoffmeister Dirk (2021). \textit{Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin Dimerization}. Chemistry - A European Journal. [published; Crossref]. \href{https://doi.org/10.1002/chem.202101382}{doi:10.1002/chem.202101382}.
\item Shao LX, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC (2021). \textit{Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.}. Neuron. [published; PubMed]. \href{https://doi.org/10.1016/j.neuron.2021.06.008}{doi:10.1016/j.neuron.2021.06.008}.
\item DiBerto JF, Roth BL (2021). \textit{The cranial windows of perception.}. Neuron. [published; PubMed]. \href{https://doi.org/10.1016/j.neuron.2021.07.017}{doi:10.1016/j.neuron.2021.07.017}.
\item Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J. (2021). \textit{Therapeutic interventions for PTSD - current evidence on the the role of psychedelics}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475922}{source link}.
\item Peixoto C, Santos F, Rego D, Medeiros H. (2021). \textit{Psychedelics and psychiatric disorders: A emerging role}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9470409}{source link}.
\item Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A. (2021). \textit{Treating addiction with psychedelics - are we waking up?}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480123}{source link}.
\item Torres S. (2021). \textit{Psychedelics: A new era of treatment?}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475866}{source link}.
\item Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A. (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480034}{source link}.
\item Descalço N, Medeiros A, Santos C, Borges G. (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European psychiatry: the journal of the Association of European Psychiatrists. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9476072}{source link}.
\item Wayne Hall, Michael Farrell (2021). \textit{What can we learn from the history of research on psychedelic drugs in the addictions?}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.15560}{doi:10.1111/add.15560}.
\item Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R (2021). \textit{Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph14080793}{doi:10.3390/ph14080793}.
\item Nkadimeng SM, Steinmann CML, Eloff JN. (2021). \textit{Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells.}. DOAJ (DOAJ: Directory of Open Access Journals). [published; Europe PMC]. \href{https://doi.org/10.2147/jir.s317182}{source link}.
\item Markus Weih (2021). \textit{Mit Psilocybin gegen Depression}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-021-2012-7}{doi:10.1007/s15005-021-2012-7}.
\item Berkovitch L, Roméo B, Karila L, Gaillard R, Benyamina A (2021). \textit{[Efficacy of psychedelics in psychiatry, a systematic review of the literature].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2020.12.002}{doi:10.1016/j.encep.2020.12.002}.
\item Waters K (2021). \textit{Pharmacologic Similarities and Differences Among Hallucinogens.}. Journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1002/jcph.1917}{doi:10.1002/jcph.1917}.
\item van Dongen RM, Alderliefste GJ, Onderwater GLJ, Ferrari MD, Terwindt GM (2021). \textit{Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.}. European journal of neurology. [published; PubMed]. \href{https://doi.org/10.1111/ene.14914}{doi:10.1111/ene.14914}.
\item Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M (2021). \textit{The Potential Role of Serotonergic Hallucinogens in Depression Treatment.}. Life (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/life11080765}{doi:10.3390/life11080765}.
\item Chong Siew Koon, Tuan Sharipah binti Tuan Hadi, Izatt Syafieq bin Abd Rashad, Ruzila binti Ali (2021). \textit{A Case Series Describing the Tale of ‘The Magic Mushroom’; An Increasing Trend of Psychedelic Misuse Among Substance Abusers in Terengganu}. Malaysian Journal of Psychiatry. [published; OpenAlex]. \href{https://openalex.org/W3186346443}{source link}.
\item Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K (2021). \textit{Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.}. Cells. [published; PubMed]. \href{https://doi.org/10.3390/cells10081902}{doi:10.3390/cells10081902}.
\item Tim Hirschfeld, Laura Smit-Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić (2021). \textit{Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-021-00385-5}{doi:10.1007/s40429-021-00385-5}.
\item Nick Zagorski (2021). \textit{Psychedelic Therapy Hits Another Milestone, But Caution Urged}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.7.14}{doi:10.1176/appi.pn.2021.7.14}.
\item King's College London (2021). \textit{A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04959253}{source link}.
\item Siegel V, Emmert-Aronson B. (2021). \textit{Both partners practicing orgasmic meditation report having a mystical-type experience: results using the Mystical Experience Questionnaire}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.53496.1}{doi:10.12688/f1000research.53496.1}.
\item Bao SH, Jiang H, Zhu LY, Yao G, Han PG, Wan XK, Wang K, Song TY, Liu CJ, Wang S, Zhang ZY, Zhang DY, Meng E (2021). \textit{A dynamic and multilocus metabolic regulation strategy using quorum-sensing-controlled bacterial small RNA.}. Cell reports. [published; PubMed]. \href{https://doi.org/10.1016/j.celrep.2021.109413}{doi:10.1016/j.celrep.2021.109413}.
\item Letheby C. (2021). \textit{Naturalistic Entheogenics: Précis of Philosophy of Psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ztewb}{doi:10.31234/osf.io/ztewb}.
\item Chris Letheby (2021). \textit{Naturalistic Entheogenics: Précis of Philosophy of Psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ztewb\_v1}{source link}.
\item Watts R. (2021). \textit{Psilocybin for Depression: The ACE Model Manual}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5x2bu}{doi:10.31234/osf.io/5x2bu}.
\item Marta Kaczmarczyk, Rosalind Watts (2021). \textit{Psilocybin for Depression: The ACE Model Manual}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5x2bu\_v1}{source link}.
\item Cox DJ, Garcia-Romeu A, Johnson MW (2021). \textit{Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.}. The American journal of drug and alcohol abuse. [published; PubMed]. \href{https://doi.org/10.1080/00952990.2021.1910830}{doi:10.1080/00952990.2021.1910830}.
\item Philipp Matteo Härter (2021). \textit{The Influence of Psychedelic Drugs on the 'Sense of Self'}. Maastricht Student Journal of Psychology and Neuroscience. [published; OpenAlex]. \href{https://openjournals.maastrichtuniversity.nl/MSJPN/article/view/661}{source link}.
\item Kevin McKernan, Liam T. Kane, Yvonne Helbert, Lei Zhang, Nathan Houde, Stephen McLaughlin (2021). \textit{A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.5062843}{doi:10.5281/zenodo.5062843}.
\item Z C (2021). \textit{Psilocybin Therapy May Work as Well as Common Antidepressant}. Scientific American. [published; OpenAlex]. \href{https://doi.org/10.1038/scientificamericanmind0821-9}{doi:10.1038/scientificamericanmind0821-9}.
\item Mertens LJ, Preller KH (2021). \textit{Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-1341-1907}{doi:10.1055/a-1341-1907}.
\item Earleywine M, Ueno LF, Mian MN, Altman BR (2021). \textit{Cannabis-induced oceanic boundlessness.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121997099}{doi:10.1177/0269881121997099}.
\item Gründer G, Jungaberle H (2021). \textit{The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/a-1486-7386}{doi:10.1055/a-1486-7386}.
\item Siegel AN, Meshkat S, Benitah K, Lipsitz O, Gill H, Lui LMW, Teopiz KM, McIntyre RS, Rosenblat JD (2021). \textit{Registered clinical studies investigating psychedelic drugs for psychiatric disorders.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2021.05.019}{doi:10.1016/j.jpsychires.2021.05.019}.
\item Zhou Liying, Xiang Ping, Wen Di, Shen Baohua, Wang Xin, Li Le, Deng Hongxiao, Chen Hang, Yan Hui, Shen Min, Shi Yan, Liu Wanhui (2021). \textit{Sensitive quantitative analysis of psilocin and psilocybin in hair samples from suspected users and their distribution in seized hallucinogenic mushrooms}. Forensic Toxicology. [published; Crossref]. \href{https://doi.org/10.1007/s11419-020-00566-3}{doi:10.1007/s11419-020-00566-3}.
\item Coppola M, Bevione F, Mondola R. (2021). \textit{Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202106.0682.v1}{doi:10.20944/preprints202106.0682.v1}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9kuhs}{doi:10.31234/osf.io/9kuhs}.
\item Annie McCartney, Hugh McGovern, Alexander De Foe (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9kuhs\_v1}{source link}.
\item Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire (2021). \textit{Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa}. OBM Neurobiology. [published; OpenAlex]. \href{https://doi.org/10.21926/obm.neurobiol.2102102}{doi:10.21926/obm.neurobiol.2102102}.
\item Elizabeth M. Nielson (2021). \textit{Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current Practice}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678211021204}{doi:10.1177/00221678211021204}.
\item Andrea Ens (2021). \textit{Silencing indigenous pasts: critical Indigenous theory and the history of psychedelics}. International Journal of Qualitative Studies in Education. [published; OpenAlex]. \href{https://doi.org/10.1080/09518398.2021.1942297}{doi:10.1080/09518398.2021.1942297}.
\item Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L. (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych open. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC8770735}{source link}.
\item Prochazkova L, van Elk M, Marschall JC, Rifkin BD, Fejer G, Schoen N, Fiacchino D, Kuchar M, Hommel B. (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/emcxw}{doi:10.31234/osf.io/emcxw}.
\item Luisa Prochazkova, Michiel van Elk, Josephine Marschall, Ben David Rifkin, George Fejer, Neil Schoen, Donatella Fiacchino, Martin Kuchar, Bernhard Hommel (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/emcxw\_v1}{source link}.
\item Gabrielle Agin-Liebes, Eve Ekman, B. Anderson, Maxx Malloy, Alexandra Haas, Josh Woolley (2021). \textit{Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678211022949}{doi:10.1177/00221678211022949}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM. (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/64kyg}{doi:10.31234/osf.io/64kyg}.
\item Drummond E-Wen McCulloch, Gitte Moos Knudsen, Frederick Streeter Barrett, Manoj Doss, Gustavo Deco, Robin Carhart-Harris, Fernando Rosas, Katrin Preller, Johannes Ramaekers, Natasha Mason (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/64kyg\_v1}{source link}.
\item Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2021.456}{doi:10.1192/bjo.2021.456}.
\item Chao YS, Horton J. (2021). \textit{Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders}. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36170470}{source link}.
\item Kelly JR, Crockett MT, Alexander L, Haran M, Baker A, Burke L, Brennan C, O'Keane V (2021). \textit{Psychedelic science in post-COVID-19 psychiatry.}. Irish journal of psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/ipm.2020.94}{doi:10.1017/ipm.2020.94}.
\item Corneille JS, Luke D. (2021). \textit{Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8aeyf}{doi:10.31234/osf.io/8aeyf}.
\item Jessica Sophie Corneille, David Luke (2021). \textit{Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8aeyf\_v1}{source link}.
\item Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R. (2021). \textit{Decreased brain modularity after psilocybin therapy for depression.}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-513323/v1}{doi:10.21203/rs.3.rs-513323/v1}.
\item Evan Lewis-Healey, Ruben Eero Laukkonen, Michiel van Elk (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1037/pne0000290}{doi:10.1037/pne0000290}.
\item Lewis-Healey E, Laukkonen RE, van Elk M. (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q3ymd}{doi:10.31234/osf.io/q3ymd}.
\item Wayne Hall (2021). \textit{The need for publicly funded research on therapeutic use of psychedelic drugs}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20847}{doi:10.1002/wps.20847}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A. (2021). \textit{LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.05.14.444193}{doi:10.1101/2021.05.14.444193}.
\item Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L (2021). \textit{The Therapeutic Potential of Psilocybin.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules26102948}{doi:10.3390/molecules26102948}.
\item Forstmann M, Sagioglou C. (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2489x}{doi:10.31234/osf.io/2489x}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2489x\_v1}{source link}.
\item Simonsson O, Hendricks PS, Carhart-Harris R, Kettner H, Osika W (2021). \textit{Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year.}. Hypertension (Dallas, Tex.: 1979). [published; PubMed]. \href{https://doi.org/10.1161/hypertensionaha.120.16715}{doi:10.1161/hypertensionaha.120.16715}.
\item Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa, Maria Carolaine Souza da Silva, Rafaela da Conceição de Lemos, Elisângela Marcionilo Da Conceição, Joyce Kelly Soares da Silva, Carlos Alberto Tiburcio Valeriano, David Filipe de Santana (2021). \textit{A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n3-012}{doi:10.34119/bjhrv4n3-012}.
\item Madison Hagood (2021). \textit{Non-Traditional Psychotherapy Techniques: An Assessment of the Value of MDMA, Psilocybin and LSD.}. Arizona State University Repository. [published; OpenAlex]. \href{https://repository.asu.edu/items/63943}{source link}.
\item Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR (2021). \textit{Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2020.3285}{doi:10.1001/jamapsychiatry.2020.3285}.
\item Reynolds CF (2021). \textit{Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression-Quo Vadis?}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2020.2901}{doi:10.1001/jamapsychiatry.2020.2901}.
\item Davis AK, Griffiths RR (2021). \textit{Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.}. JAMA psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/jamapsychiatry.2020.4638}{doi:10.1001/jamapsychiatry.2020.4638}.
\item Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A (2021). \textit{Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2021.03.002}{doi:10.1016/j.jpsychires.2021.03.002}.
\item Bird CIV, Modlin NL, Rucker JJH (2021). \textit{Psilocybin and MDMA for the treatment of trauma-related psychopathology.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2021.1919062}{doi:10.1080/09540261.2021.1919062}.
\item Senese Nicolas, Nguyen Thu, Cologna Stephanie, Rasenick Mark (2021). \textit{Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signaling}. The FASEB Journal. [published; Crossref]. \href{https://doi.org/10.1096/fasebj.2021.35.s1.03168}{doi:10.1096/fasebj.2021.35.s1.03168}.
\item Despina Stratidakis (2021). \textit{Addressing the Implicit Impacts of Sexual Trauma: An Exploration of Somatic Experiencing as an Adjunct to Psilocybin-Assisted Therapy}. National University System Repository (National University System). [published; OpenAlex]. \href{http://hdl.handle.net/20.500.11803/1295}{source link}.
\item Johannes Thrul, Albert Garcia-Romeu (2021). \textit{Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment}. Drugs Education Prevention and Policy. [published; OpenAlex]. \href{https://doi.org/10.1080/09687637.2021.1897331}{doi:10.1080/09687637.2021.1897331}.
\item University of Zurich (2021). \textit{Characterization of Altered Waking States of Consciousness in Healthy Humans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03853577}{source link}.
\item Katrin H. Preller (2021). \textit{Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2021.02.036}{doi:10.1016/j.biopsych.2021.02.036}.
\item Julia Benville, Gabrielle Agin-Liebes, Daniel E. Roberts, Sharon L. Lo, Leila Ghazal, Silvia J. Franco-Corso, Stephen Ross (2021). \textit{Effects of Psilocybin on Suicidal Ideation in Patients With Life-Threatening Cancer}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2021.02.591}{doi:10.1016/j.biopsych.2021.02.591}.
\item Hisham Alshaikhli, Redhwan Ahmed Al-Naggar, Gwen Erlam (2021). \textit{Effectiveness of Psilocybin on Depression: A Qualitative Study}. Electronic Journal of General Medicine. [published; OpenAlex]. \href{https://doi.org/10.29333/ejgm/10862}{doi:10.29333/ejgm/10862}.
\item University Hospital, Basel, Switzerland (2021). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin in a Random-order Placebo-controlled Cross-over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03604744}{source link}.
\item Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM (2021). \textit{Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.2022489118}{doi:10.1073/pnas.2022489118}.
\item Andrew Penn, Janis Phelps, William E. Rosa, Jean Watson (2021). \textit{Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of Treatment}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678211011013}{doi:10.1177/00221678211011013}.
\item Fricke J, Sherwood AM, Halberstadt AL, Kargbo RB, Hoffmeister D (2021). \textit{Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.}. Journal of natural products. [published; PubMed]. \href{https://doi.org/10.1021/acs.jnatprod.1c00087}{doi:10.1021/acs.jnatprod.1c00087}.
\item Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C (2021). \textit{Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules26092451}{doi:10.3390/molecules26092451}.
\item Giovanni Pereira Pio, Aline Moreira Vitorino, Naira Braga Aidar, Alissa Amoras Magalhães, Eduardo Cammerer Mombelli, Gabriela Marques Ferraz, Rodrigo Pereira Pio (2021). \textit{O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depression}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n2-395}{doi:10.34119/bjhrv4n2-395}.
\item Anna Lutkajtis (2021). \textit{Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2021.00162}{doi:10.1556/2054.2021.00162}.
\item Henrik Børsting Jacobsen, Audun Stubhaug, Bjørn Holmøy, Tor Morten Kvam, Silje Endresen Rème (2021). \textit{Have Norwegians tried psilocybin, and do they accept it as a medicine?}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2021.00167}{doi:10.1556/2054.2021.00167}.
\item Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ (2021). \textit{Trial of Psilocybin versus Escitalopram for Depression.}. The New England journal of medicine. [published; PubMed]. \href{https://doi.org/10.1056/nejmoa2032994}{doi:10.1056/nejmoa2032994}.
\item Jeffrey A. Lieberman (2021). \textit{Back to the Future - The Therapeutic Potential of Psychedelic Drugs}. New England Journal of Medicine. [published; OpenAlex]. \href{https://doi.org/10.1056/nejme2102835}{doi:10.1056/nejme2102835}.
\item Kevin McKernan, Liam T. Kane, Seth Crawford, Chen-Shan Chin, Aaron Trippe, Stephen McLaughlin (2021). \textit{A draft sequence reference of the Psilocybe cubensis genome}. F1000Research. [published; OpenAlex]. \href{https://doi.org/10.12688/f1000research.51613.1}{doi:10.12688/f1000research.51613.1}.
\item Zeifman RJ, Singhal N, Breslow L, Weissman CR (2021). \textit{On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.1c00024}{doi:10.1021/acsptsci.1c00024}.
\item Gatch MB, Hoch A, Carbonaro TM (2021). \textit{Discriminative Stimulus Effects of Substituted Tryptamines in Rats.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.0c00173}{doi:10.1021/acsptsci.0c00173}.
\item Stauffer CS, Anderson BT, Ortigo KM, Woolley J (2021). \textit{Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.0c00169}{doi:10.1021/acsptsci.0c00169}.
\item Klein AK, Chatha M, Laskowski LJ, Anderson EI, Brandt SD, Chapman SJ, McCorvy JD, Halberstadt AL (2021). \textit{Investigation of the Structure-Activity Relationships of Psilocybin Analogues.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.0c00176}{doi:10.1021/acsptsci.0c00176}.
\item Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE (2021). \textit{Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.1c00020}{doi:10.1021/acsptsci.1c00020}.
\item Gerber K, Flores IG, Ruiz AC, Ali I, Ginsberg NL, Schenberg EE (2021). \textit{Ethical Concerns about Psilocybin Intellectual Property.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.0c00171}{doi:10.1021/acsptsci.0c00171}.
\item Mason NL, Kuypers KPC, Reckweg JT, Müller F, Tse DHY, Da Rios B, Toennes SW, Stiers P, Feilding A, Ramaekers JG (2021). \textit{Spontaneous and deliberate creative cognition during and after psilocybin exposure.}. Translational psychiatry. [published; PubMed]. \href{https://doi.org/10.1038/s41398-021-01335-5}{doi:10.1038/s41398-021-01335-5}.
\item Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD. (2021). \textit{Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.04.02.21254838}{doi:10.1101/2021.04.02.21254838}.
\item Sasha Faichuk (2021). \textit{‘Is There Magic in These Mushrooms?’ Discussing Current Psychiatric Treatment Options, and the Potential of Psilocybin Mushrooms in the Future of Such Treatments}. Voices of Forensic Science. [published; OpenAlex]. \href{https://jps.library.utoronto.ca/index.php/forensic/article/download/36300/27603}{source link}.
\item Dworatzyk K, Jansen T, Schmidt TT. (2021). \textit{Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kxmgq}{doi:10.31234/osf.io/kxmgq}.
\item Katharina Dworatzyk, Tallulah Jansen, Timo Torsten Schmidt (2021). \textit{Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kxmgq\_v1}{source link}.
\item Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1114}{doi:10.1192/j.eurpsy.2021.1114}.
\item A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1836}{doi:10.1192/j.eurpsy.2021.1836}.
\item Jefsen OH, Elfving B, Wegener G, Müller HK (2021). \textit{Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120959614}{doi:10.1177/0269881120959614}.
\item Bottemanne H, Claret A, Fossati P (2021). \textit{[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2020.08.006}{doi:10.1016/j.encep.2020.08.006}.
\item Savalia NK, Shao LX, Kwan AC (2021). \textit{A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.}. Trends in neurosciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tins.2020.11.008}{doi:10.1016/j.tins.2020.11.008}.
\item Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR (2021). \textit{Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120967878}{doi:10.1177/0269881120967878}.
\item Stenbæk DS, Madsen MK, Ozenne B, Kristiansen S, Burmester D, Erritzoe D, Knudsen GM, Fisher PM (2021). \textit{Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120959609}{doi:10.1177/0269881120959609}.
\item Bates MLS, Trujillo KA (2021). \textit{Use and abuse of dissociative and psychedelic drugs in adolescence.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2021.173129}{doi:10.1016/j.pbb.2021.173129}.
\item Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR (2021). \textit{Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121991822}{doi:10.1177/0269881121991822}.
\item Hirschfeld T, Schmidt TT (2021). \textit{Dose-response relationships of psilocybin-induced subjective experiences in humans.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121992676}{doi:10.1177/0269881121992676}.
\item Fedorova EV, Wong CF, Ataiants J, Iverson E, Conn BM, Lankenau SE (2021). \textit{Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2021.108648}{doi:10.1016/j.drugalcdep.2021.108648}.
\item Simonsson O, Sexton JD, Hendricks PS (2021). \textit{Associations between lifetime classic psychedelic use and markers of physical health.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121996863}{doi:10.1177/0269881121996863}.
\item Dos Santos RG, Hallak JE, Baker G, Dursun S (2021). \textit{Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120986422}{doi:10.1177/0269881120986422}.
\item Stanley N. Caroff (2021). \textit{The Return of Psychedelics: Still Time to Prevent Tragedy}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.4.8}{doi:10.1176/appi.pn.2021.4.8}.
\item Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R. (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8vks6}{doi:10.31234/osf.io/8vks6}.
\item Pedro Teixeira, Matthew Johnson, Christopher Timmermann, Rosalind Watts, David Erritzoe, Hannah Douglass, Hannes Kettner, Robin Carhart-Harris (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8vks6\_v1}{source link}.
\item Cho SE, Jo JW, Kwag YN, Lee H, Chung JW, Oh SH, Kim CS (2021). \textit{Complete mitochondrial genome sequence of.}. Mitochondrial DNA. Part B, Resources. [published; PubMed]. \href{https://doi.org/10.1080/23802359.2021.1895692}{doi:10.1080/23802359.2021.1895692}.
\item Khan A, Singh G, Jacob J (2021). \textit{A Rare Presentation of Anticholinergic Toxicity in a Young Patient Due to Over-The-Counter Cold Medicines.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.13919}{doi:10.7759/cureus.13919}.
\item Musikaphongsakul Prinya, Ya Kimheang, Subsoontorn Pakpoom, Lohitnavy Manupat (2021). \textit{Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans}. F1000Research. [published; Crossref]. \href{https://doi.org/10.12688/f1000research.28133.1}{doi:10.12688/f1000research.28133.1}.
\item Muthukumaraswamy S, Forsyth A, Lumley T. (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q2hzm}{doi:10.31234/osf.io/q2hzm}.
\item Suresh Muthukumaraswamy, Anna Forsyth, Thomas Lumley (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/q2hzm\_v1}{source link}.
\item Kozłowska U, Klimczak A, Wiatr K, Figiel M. (2021). \textit{The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.03.07.434103}{doi:10.1101/2021.03.07.434103}.
\item Odland AU, Kristensen JL, Andreasen JT (2021). \textit{Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.}. Behavioural brain research. [published; PubMed]. \href{https://doi.org/10.1016/j.bbr.2020.113093}{doi:10.1016/j.bbr.2020.113093}.
\item Burton M. Altura, Bella T. Altura (2021). \textit{Stroke and Adverse Effects on The Immune and Cardiovascular Systems: The Danger of the Rise and Use of Psychedelic Drugs for Depression and PTSD}. Journal of Clinical \& Experimental Immunology. [published; Crossref]. \href{https://doi.org/10.33140/jcei.06.02.01}{doi:10.33140/jcei.06.02.01}.
\item Nick Zagorski (2021). \textit{Session on Psychedelics Sure to Be Enlightening}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2021.3.14}{doi:10.1176/appi.pn.2021.3.14}.
\item Healy CJ (2021). \textit{The acute effects of classic psychedelics on memory in humans.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05756-w}{doi:10.1007/s00213-020-05756-w}.
\item Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Felix Müller, Johannes G. Ramaekers (2021). \textit{P.214 (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.01.043}{doi:10.1016/j.euroneuro.2021.01.043}.
\item Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. (2021). \textit{Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/r726d}{doi:10.31234/osf.io/r726d}.
\item Avinash Hosanagar, Joseph Cusimano, Rajiv Radhakrishnan (2021). \textit{Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.20ac13787}{doi:10.4088/jcp.20ac13787}.
\item Patocka J, Wu R, Nepovimova E, Valis M, Wu W, Kuca K (2021). \textit{Chemistry and Toxicology of Major Bioactive Substances in Mushrooms.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms22042218}{doi:10.3390/ijms22042218}.
\item Emily Pellicano (2021). \textit{Psychedelic Strategies; Alternative Phenomenologies, Translations, and Representations of the Human Body in Relation to Interior Space}. Journal of Interior Design. [published; OpenAlex]. \href{https://doi.org/10.1111/joid.12186}{doi:10.1111/joid.12186}.
\item Peter G. Brindley (2021). \textit{How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence}. Anesthesia \& Analgesia. [published; OpenAlex]. \href{https://doi.org/10.1213/ane.0000000000005349}{doi:10.1213/ane.0000000000005349}.
\item Shao L, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC. (2021). \textit{Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.17.431629}{doi:10.1101/2021.02.17.431629}.
\item Thomas CW, Blanco-Duque C, Bréant B, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2021). \textit{Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.16.431276}{doi:10.1101/2021.02.16.431276}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.03.429325}{doi:10.1101/2021.02.03.429325}.
\item R. Andrew Yockey, Keith A. King (2021). \textit{Use of psilocybin (“mushrooms”) among US adults: 2015-2018}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00159}{doi:10.1556/2054.2020.00159}.
\item De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G (2021). \textit{Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.1659-20.2020}{doi:10.1523/jneurosci.1659-20.2020}.
\item Zoe Cormier (2021). \textit{Psilocybin Treatment for Mental Health Gets Legal Framework}. Scientific American. [published; OpenAlex]. \href{https://doi.org/10.1038/scientificamerican022021-2ffafdugrrwbrn7c72rys4}{doi:10.1038/scientificamerican022021-2ffafdugrrwbrn7c72rys4}.
\item Gotvaldová K, Hájková K, Borovička J, Jurok R, Cihlářová P, Kuchař M (2021). \textit{Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis.}. Drug testing and analysis. [published; PubMed]. \href{https://doi.org/10.1002/dta.2950}{doi:10.1002/dta.2950}.
\item Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D (2021). \textit{Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.}. Acta psychiatrica Scandinavica. [published; PubMed]. \href{https://doi.org/10.1111/acps.13249}{doi:10.1111/acps.13249}.
\item Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J (2021). \textit{Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05719-1}{doi:10.1007/s00213-020-05719-1}.
\item Pham Duyen N. K., Chadeayne Andrew R., Golen James A., Manke David R. (2021). \textit{Psilacetin derivatives: fumarate salts of the methyl-ethyl, methyl-allyl and diallyl variants of the psilocin prodrug}. Acta Crystallographica Section E Crystallographic Communications. [published; Crossref]. \href{https://doi.org/10.1107/s2056989021000116}{doi:10.1107/s2056989021000116}.
\item Kolaczynska Karolina E., Liechti Matthias E., Duthaler Urs (2021). \textit{Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma}. Journal of Chromatography B. [published; Crossref]. \href{https://doi.org/10.1016/j.jchromb.2020.122486}{doi:10.1016/j.jchromb.2020.122486}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.01.28.428377}{doi:10.1101/2021.01.28.428377}.
\item Joost J. Breeksema, Martijn H B Koolen, Metten Somers, Robert A. Schoevers (2021). \textit{Behandeling met psilocybine}. Data Archiving and Networked Services (DANS). [published; OpenAlex]. \href{https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429}{source link}.
\item Breeksema JJ, Koolen MHB, Somers M, Schoevers RA (2021). \textit{[Treatment with psilocybin: applications for patients with psychiatric disorders].}. Nederlands tijdschrift voor geneeskunde. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/33560605/}{source link}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM (2021). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms22020835}{doi:10.3390/ijms22020835}.
\item Anthony P. Bossis (2021). \textit{Psilocybin, Spirituality, and Palliative Care: Research and Implications}. Alternative and Complementary Therapies. [published; OpenAlex]. \href{https://doi.org/10.1089/act.2020.29309.apb}{doi:10.1089/act.2020.29309.apb}.
\item Willy Pedersen, Heith Copes, Liridona Gashi (2021). \textit{Narratives of the mystical among users of psychedelics}. Acta Sociologica. [published; OpenAlex]. \href{https://doi.org/10.1177/0001699320980050}{doi:10.1177/0001699320980050}.
\item Joshua Woolley (2021). \textit{Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02950467}{source link}.
\item Konkel Z, Scott K, Slot JC (2021). \textit{Draft Genome Sequence of the Termite-Associated "Cuckoo Fungus," () sp. TMB Strain TB5.}. Microbiology resource announcements. [published; PubMed]. \href{https://doi.org/10.1128/mra.01230-20}{doi:10.1128/mra.01230-20}.
\item Vagner Fagnani Linartevichi, Matheus Gonzales Froza, Rafael de Morais Cury, Francisney Pinto do Nascimento (2021). \textit{POTENCIAL USO DA PSILOCIBINA NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO / POTENTIAL USE OF PSILOCYBIN IN THE DEPRESSION TREATMENT: A REVIEW}. Brazilian Journal of Development. [published; OpenAlex]. \href{https://doi.org/10.34117/bjdv7n3-783}{doi:10.34117/bjdv7n3-783}.
\item Nkadimeng SM, Steinmann CML, Eloff JN (2021). \textit{Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells.}. Journal of inflammation research. [published; PubMed]. \href{https://doi.org/10.2147/jir.s317182}{doi:10.2147/jir.s317182}.
\item Michael W. Dzierlenga (2021). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81816}{doi:10.5256/f1000research.31120.r81816}.
\item Quoc Ba Tran (2021). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81474}{doi:10.5256/f1000research.31120.r81474}.
\item Bryn T. M. Dentinger, Alexander J. Bradshaw (2021). \textit{Referee report. For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.58864.r95528}{doi:10.5256/f1000research.58864.r95528}.
\item Victor Lange, Marie, Sidsel (2021). \textit{Exploring moral bio-enhancement through psilocybin facilitated prosocial effects}. Research at the University of Copenhagen (University of Copenhagen). [published; OpenAlex]. \href{https://researchprofiles.ku.dk/da/publications/f4c6737a-15ce-4a92-a7c5-ce5345cc1cff}{source link}.
\item Danielle Nicole Daniel (2021). \textit{"It kind of polishes all your flaws away": long-term experiences with psilocybin mushrooms and the influence of set and setting}. Cal Poly Humboldt Digital Commons. [published; OpenAlex]. \href{https://digitalcommons.humboldt.edu/cgi/viewcontent.cgi?article=1541\&context=etd}{source link}.
\item Yogesh Kumar Chahar (2021). \textit{Unmet need in depression: Psilocybin, a breakthrough treatment option}. International Journal of Advanced Research in Medicine. [published; OpenAlex]. \href{https://doi.org/10.22271/27069567.2021.v3.i1f.159}{doi:10.22271/27069567.2021.v3.i1f.159}.
\item Harmony I. Risca (2021). \textit{Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety}. Western Michigan University ScholarWorks. [published; OpenAlex]. \href{https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777\&context=dissertations}{source link}.
\item Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research (2021). \textit{Psychedelics and Psychedelic-Assisted Psychotherapy.}. Focus (American Psychiatric Publishing). [published; PubMed]. \href{https://doi.org/10.1176/appi.focus.19104}{doi:10.1176/appi.focus.19104}.
\item Kaasik H, Souza RCZ, Zandonadi FS, Tófoli LF, Sussulini A (2021). \textit{Chemical Composition of Traditional and Analog Ayahuasca.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1815911}{doi:10.1080/02791072.2020.1815911}.
\item Varker T, Watson L, Gibson K, Forbes D, O'Donnell ML (2021). \textit{Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1817639}{doi:10.1080/02791072.2020.1817639}.
\item Gashi L, Sandberg S, Pedersen W (2021). \textit{Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2020.102997}{doi:10.1016/j.drugpo.2020.102997}.
\item Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC (2021). \textit{Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.}. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. [published; PubMed]. \href{https://doi.org/10.1007/s13311-020-00962-y}{doi:10.1007/s13311-020-00962-y}.
\item Lenz C, Sherwood A, Kargbo R, Hoffmeister D (2021). \textit{Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products.}. ChemPlusChem. [published; PubMed]. \href{https://doi.org/10.1002/cplu.202000581}{doi:10.1002/cplu.202000581}.
\item Donovan LL, Johansen JV, Ros NF, Jaberi E, Linnet K, Johansen SS, Ozenne B, Issazadeh-Navikas S, Hansen HD, Knudsen GM (2021). \textit{Effects of a single dose of psilocybin on behaviour, brain 5-HT receptor occupancy and gene expression in the pig.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2020.11.013}{doi:10.1016/j.euroneuro.2020.11.013}.
\item Inserra A, De Gregorio D, Gobbi G (2021). \textit{Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pharmrev.120.000056}{doi:10.1124/pharmrev.120.000056}.
\item Tullis P (2021). \textit{How ecstasy and psilocybin are shaking up psychiatry.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/d41586-021-00187-9}{doi:10.1038/d41586-021-00187-9}.
\item Higgins GA, Sellers EM (2021). \textit{5-HT and 5-HT receptors as potential targets for the treatment of nicotine use and dependence.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2021.01.007}{doi:10.1016/bs.pbr.2021.01.007}.
\item Bouso JC, Ona G, Dos Santos RG, Hallak JEC (2021). \textit{Psychedelic Medicines in Major Depression: Progress and Future Challenges.}. Advances in experimental medicine and biology. [published; PubMed]. \href{https://doi.org/10.1007/978-981-33-6044-0\_26}{doi:10.1007/978-981-33-6044-0\_26}.
\item Williams MT, Davis AK, Xin Y, Sepeda ND, Grigas PC, Sinnott S, Haeny AM (2021). \textit{People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.}. Drugs (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09687637.2020.1854688}{doi:10.1080/09687637.2020.1854688}.
\item Sheppard B (2021). \textit{A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.}. Journal of law and health. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/35026878/}{source link}.
\item Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E (2021). \textit{Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.586682}{doi:10.3389/fpsyt.2021.586682}.
\item Castro Santos H, Gama Marques J (2021). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Porto biomedical journal. [published; PubMed]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Winkelman MJ (2021). \textit{The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.619890}{doi:10.3389/fphar.2021.619890}.
\item Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM (2021). \textit{Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.640241}{doi:10.3389/fphar.2021.640241}.
\item Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE (2021). \textit{The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.}. Risk management and healthcare policy. [published; PubMed]. \href{https://doi.org/10.2147/rmhp.s300656}{doi:10.2147/rmhp.s300656}.
\item Gorman I, Nielson EM, Molinar A, Cassidy K, Sabbagh J (2021). \textit{Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2021.645246}{doi:10.3389/fpsyg.2021.645246}.
\item Lugo-Radillo A, Cortes-Lopez JL (2021). \textit{Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1849879}{doi:10.1080/02791072.2020.1849879}.
\item Diab H, Malcolm B (2021). \textit{Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT).}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1847366}{doi:10.1080/02791072.2020.1847366}.
\item McKernan K, Kane LT, Crawford S, Chin CS, Trippe A, McLaughlin S (2021). \textit{A draft reference assembly of the genome.}. F1000Research. [published; PubMed]. \href{https://doi.org/10.12688/f1000research.51613.2}{doi:10.12688/f1000research.51613.2}.
\item Rucker JJ, Young AH (2021). \textit{Psilocybin: From Serendipity to Credibility?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.659044}{doi:10.3389/fpsyt.2021.659044}.
\item Rocha JM, Rossi GN, de Lima Osório F, Bouso JC, de Oliveira Silveira G, Yonamine M, Campos AC, Bertozi G, Cecílio Hallak JE, Dos Santos RG (2021). \textit{Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/jcp.0000000000001396}{doi:10.1097/jcp.0000000000001396}.
\item Giancola NB, Korson CJ, Caplan JP, McKnight CA (2021). \textit{A "Trip" to the Intensive Care Unit: An Intravenous Injection of Psilocybin.}. Journal of the Academy of Consultation-Liaison Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.jaclp.2020.12.012}{doi:10.1016/j.jaclp.2020.12.012}.
\item Révész D, Ona G, Rossi GN, Rocha JM, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC (2021). \textit{Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.687546}{doi:10.3389/fpsyt.2021.687546}.
\item Mans K, Kettner H, Erritzoe D, Haijen ECHM, Kaelen M, Carhart-Harris RL (2021). \textit{Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.647909}{doi:10.3389/fpsyt.2021.647909}.
\item Barnett BS, Greer GR (2021). \textit{Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.}. Journal of the Academy of Consultation-Liaison Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.jaclp.2020.12.011}{doi:10.1016/j.jaclp.2020.12.011}.
\item Kočárová R, Horáček J, Carhart-Harris R (2021). \textit{Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.661233}{doi:10.3389/fpsyt.2021.661233}.
\item Mendes Rocha J, Rossi GN, Osório FL, Bouso Saiz JC, Silveira GO, Yonamine M, Crevelin EJ, Queiroz ME, Cecílio Hallak JE, Dos Santos RG (2021). \textit{Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.688439}{doi:10.3389/fpsyt.2021.688439}.
\item Eleftheriou ME, Thomas E (2021). \textit{Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.707057}{doi:10.3389/fpsyt.2021.707057}.
\item Corneille JS, Luke D (2021). \textit{Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Well-Being.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2021.720579}{doi:10.3389/fpsyg.2021.720579}.
\item Dahmane Elyes, Hutson Paul R., Gobburu Jogarao V. S. (2021). \textit{Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin}. Clinical Pharmacology in Drug Development. [published; Crossref]. \href{https://doi.org/10.1002/cpdd.796}{doi:10.1002/cpdd.796}.
\item Madsen Martin K., Knudsen Gitte M. (2021). \textit{Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-020-00823-4}{doi:10.1038/s41386-020-00823-4}.
\item Lawrence DW, Sharma B, Griffiths RR, Carhart-Harris R (2021). \textit{Trends in the Top-Cited Articles on Classic Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.1874573}{doi:10.1080/02791072.2021.1874573}.
\item Argento E, Christie D, Mackay L, Callon C, Walsh Z (2021). \textit{Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.716593}{doi:10.3389/fpsyt.2021.716593}.
\item de Vos CMH, Mason NL, Kuypers KPC (2021). \textit{Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.724606}{doi:10.3389/fpsyt.2021.724606}.
\item Basedow LA, Riemer TG, Reiche S, Kreutz R, Majić T (2021). \textit{Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.739966}{doi:10.3389/fphar.2021.739966}.
\item Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M (2021). \textit{The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.739053}{doi:10.3389/fphar.2021.739053}.
\item Rodríguez Arce JM, Winkelman MJ (2021). \textit{Psychedelics, Sociality, and Human Evolution.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2021.729425}{doi:10.3389/fpsyg.2021.729425}.
\item Vargas MV, Meyer R, Avanes AA, Rus M, Olson DE (2021). \textit{Psychedelics and Other Psychoplastogens for Treating Mental Illness.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.727117}{doi:10.3389/fpsyt.2021.727117}.
\item Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL (2021). \textit{Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.735523}{doi:10.3389/fpsyt.2021.735523}.
\item Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J (2021). \textit{Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.737738}{doi:10.3389/fpsyt.2021.737738}.
\item Whitfield HJ (2021). \textit{A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.727572}{doi:10.3389/fpsyt.2021.727572}.
\item Vilca-Melendez S, Uthaug MV, Griffin JL (2021). \textit{H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.742856}{doi:10.3389/fpsyt.2021.742856}.
\item Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V (2021). \textit{Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.800072}{doi:10.3389/fpsyt.2021.800072}.
\item Frontiers Production Office (2021). \textit{Erratum: A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.832766}{doi:10.3389/fpsyt.2021.832766}.
\item Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L (2021). \textit{Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.780696}{doi:10.3389/fpsyt.2021.780696}.
\item Khan FI, Hassan F, Lai D (2021). \textit{Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor.}. Frontiers in immunology. [published; PubMed]. \href{https://doi.org/10.3389/fimmu.2021.794780}{doi:10.3389/fimmu.2021.794780}.
\item Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF (2021). \textit{Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.}. Frontiers in neuroergonomics. [published; PubMed]. \href{https://doi.org/10.3389/fnrgo.2021.784576}{doi:10.3389/fnrgo.2021.784576}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G (2021). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R (2021). \textit{Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2021.788155}{doi:10.3389/fphar.2021.788155}.
\item Ravital LaBua (2020). \textit{The Effect of Psilocybin on Personality}. CUNY Academic Works (City University of New York). [published; OpenAlex]. \href{https://academicworks.cuny.edu/gc\_etds/4460}{source link}.
\item Robert A. Mikos (2020). \textit{We Need a Cole Memorandum for Magic Mushrooms}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3839551}{source link}.
\item Jacob Evans (2020). \textit{Waiting for a Miracle: Medical Psilocybin and Mdma under 'Right to Try'}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.3762134}{doi:10.2139/ssrn.3762134}.
\item Mason Marks, I. Glenn Cohen (2020). \textit{Patents on Psychedelics: The Next Legal Battlefront of Drug Development}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.3948757}{doi:10.2139/ssrn.3948757}.
\item Jonas Bååth, Johan Nordgren (2020). \textit{Trip Reports: Exploring the Experience of Psychedelic Intoxication}. Lund University Publications (Lund University). [published; OpenAlex]. \href{https://doi.org/10.4324/9780429058141-26}{doi:10.4324/9780429058141-26}.
\item Strickland JC, Garcia-Romeu A, Johnson M. (2020). \textit{Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f5dmt}{doi:10.31234/osf.io/f5dmt}.
\item Nkadimeng SM, Steinmann CML, Eloff JN (2020). \textit{Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-020-79328-5}{doi:10.1038/s41598-020-79328-5}.
\item Dudysová Daniela, Janku Karolina, Smotek Michal, Saifutdinova Elizaveta, Koprivova Jana, Bušková Jitka, Mander Bryce Anthony, Brunovský Martin, Zach Peter, Korčák Jakub, Andrashko Veronika, Viktorinová Michaela, Tylš Filip, Bravermanová Anna, Froese Tom, Páleníček Tomáš, Horáček Jiří (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action}. Institutional Repositories DataBase (IRDB). [published; OpenAlex]. \href{http://id.nii.ac.jp/1394/00001681/}{source link}.
\item Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL (2020). \textit{DARK Classics in Chemical Neuroscience: NBOMes.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.9b00528}{doi:10.1021/acschemneuro.9b00528}.
\item Benjamin Dueck (2020). \textit{Describing the Unspeakable: Psychedelic Communication Technologies and the Development of a Posthuman Language}. Journal of Posthuman Studies. [published; OpenAlex]. \href{https://doi.org/10.5325/jpoststud.4.2.0166}{doi:10.5325/jpoststud.4.2.0166}.
\item University Hospital, Basel, Switzerland (2020). \textit{Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03912974}{source link}.
\item Weston NM, Gibbs D, Bird CIV, Daniel A, Jelen LA, Knight G, Goldsmith D, Young AH, Rucker JJ (2020). \textit{Historic psychedelic drug trials and the treatment of anxiety disorders.}. Depression and anxiety. [published; PubMed]. \href{https://doi.org/10.1002/da.23065}{doi:10.1002/da.23065}.
\item Smigielski L, Kometer M, Scheidegger M, Stress C, Preller KH, Koenig T, Vollenweider FX (2020). \textit{P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap.}. Human brain mapping. [published; PubMed]. \href{https://doi.org/10.1002/hbm.25174}{doi:10.1002/hbm.25174}.
\item Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS (2020). \textit{The emerging role of psilocybin and MDMA in the treatment of mental illness.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2020.1826931}{doi:10.1080/14737175.2020.1826931}.
\item Ona G, Bouso JC (2020). \textit{Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2020.09.035}{doi:10.1016/j.neubiorev.2020.09.035}.
\item Holoyda B (2020). \textit{Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.}. Psychiatric services (Washington, D.C.). [published; PubMed]. \href{https://doi.org/10.1176/appi.ps.202000213}{doi:10.1176/appi.ps.202000213}.
\item Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, Raison CL (2020). \textit{Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s003329172000389x}{doi:10.1017/s003329172000389x}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2020). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202011.0742.v1}{doi:10.20944/preprints202011.0742.v1}.
\item Shi Y, Wang R, Yuan S, Qiang H, Shen M, Shen B, Drummer OH, Yu Z, Zhao Y, Xiang P (2020). \textit{UHPLC-MS/MS method for simultaneously detecting 16 tryptamines and their metabolites in human hair and applications to real forensics cases.}. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jchromb.2020.122392}{doi:10.1016/j.jchromb.2020.122392}.
\item Felix Müller, Friederike Holze, Patrick C. Dolder, Laura Ley, Patrick Vizeli, Alain Soltermann, Matthias E. Liechti, Stefan Borgwardt (2020). \textit{MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-00906-2}{doi:10.1038/s41386-020-00906-2}.
\item Al-Matrouk A, Al-Hasan M, Naqi HA, Al-Abkal N, Mohammed H, Haider M, Al-Shammeri D, Bojbarah H. (2020). \textit{Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-33143/v2}{doi:10.21203/rs.3.rs-33143/v2}.
\item Courtney C. Walton, Paul Liknaitzky (2020). \textit{Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy}. Journal of Applied Sport Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/10413200.2020.1848941}{doi:10.1080/10413200.2020.1848941}.
\item University of Zurich (2020). \textit{Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03736980}{source link}.
\item Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, Nelson Ros, Brice Ozenne, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.589}{doi:10.1016/j.euroneuro.2020.09.589}.
\item Mason NL, Kuypers KPC, Müller F, Reckweg J, Tse DHY, Toennes SW, Hutten NRPW, Jansen JFA, Stiers P, Feilding A, Ramaekers JG (2020). \textit{Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-020-0718-8}{doi:10.1038/s41386-020-0718-8}.
\item Madsen M.K., Stenbæk D.S., Ozenne B., Armand S., Marstrand-Jørgensen M.R., Arvidsson A., Johansen S.S., Linnet K., Knudsen G.M., Fisher P.M. (2020). \textit{P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experience}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.169}{doi:10.1016/j.euroneuro.2020.09.169}.
\item Luoma JB, Chwyl C, Bathje G, Davis AK, Lancelotta RL. (2020). \textit{A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/nhbjk}{doi:10.31234/osf.io/nhbjk}.
\item Nagy J, Veress T (2020). \textit{Systematic Error for Extraction of Controlled Substances from Plant/Fungal Materials.}. Journal of chromatographic science. [published; PubMed]. \href{https://doi.org/10.1093/chromsci/bmaa067}{doi:10.1093/chromsci/bmaa067}.
\item Ona GS, Dos Santos RG, Hallak JEC, Bouso JC (2020). \textit{Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing?}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.0c00614}{doi:10.1021/acschemneuro.0c00614}.
\item NYU Langone Health (2020). \textit{Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00957359}{source link}.
\item Olivia Gosseries, Charlotte Martial (2020). \textit{The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.}. Open Repository and Bibliography (University of Liège). [published; OpenAlex]. \href{https://doi.org/10.34700/gv0w-y052}{doi:10.34700/gv0w-y052}.
\item Lawrence Silver (2020). \textit{Turn On, Tune In, Drop In: Psychedelics, Creativity and Entrepreneurship}. American Journal of Management. [published; OpenAlex]. \href{https://doi.org/10.33423/ajm.v20i3.3104}{doi:10.33423/ajm.v20i3.3104}.
\item Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch (2020). \textit{The Role of Psychedelics and Counseling in Mental Health Treatment}. Journal of Mental Health Counseling. [published; OpenAlex]. \href{https://doi.org/10.17744/mehc.42.4.03}{doi:10.17744/mehc.42.4.03}.
\item Nichols DE (2020). \textit{Psilocybin: from ancient magic to modern medicine.}. The Journal of antibiotics. [published; PubMed]. \href{https://doi.org/10.1038/s41429-020-0311-8}{doi:10.1038/s41429-020-0311-8}.
\item Romeo B, Karila L, Martelli C, Benyamina A (2020). \textit{Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120919957}{doi:10.1177/0269881120919957}.
\item Cozzi NV, Daley PF (2020). \textit{Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials.}. Drug testing and analysis. [published; PubMed]. \href{https://doi.org/10.1002/dta.2889}{doi:10.1002/dta.2889}.
\item Netzband N, Ruffell S, Linton S, Tsang WF, Wolff T (2020). \textit{Modulatory effects of ayahuasca on personality structure in a traditional framework.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05601-0}{doi:10.1007/s00213-020-05601-0}.
\item Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J (2020). \textit{Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.}. EClinicalMedicine. [published; PubMed]. \href{https://doi.org/10.1016/j.eclinm.2020.100538}{doi:10.1016/j.eclinm.2020.100538}.
\item Hendricks PS (2020). \textit{Psilocybin-assisted group therapy: A new hope for demoralization.}. EClinicalMedicine. [published; PubMed]. \href{https://doi.org/10.1016/j.eclinm.2020.100557}{doi:10.1016/j.eclinm.2020.100557}.
\item Morita Izumi, Oyama Hiroyuki, Kiguchi Yuki, Oguri Akari, Fujimoto Natsumi, Takeuchi Atsuko, Tanaka Rie, Ogata Jun, Kikura-Hanajiri Ruri, Kobayashi Norihiro (2020). \textit{Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms}. Journal of Pharmaceutical and Biomedical Analysis. [published; Crossref]. \href{https://doi.org/10.1016/j.jpba.2020.113485}{doi:10.1016/j.jpba.2020.113485}.
\item Nicole Harrington Cirino (2020). \textit{Wait for the Science Before Widespread Use of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.10a32}{doi:10.1176/appi.pn.2020.10a32}.
\item Agata Tadeja (2020). \textit{Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine.}. Farmacja Polska. [published; OpenAlex]. \href{https://doi.org/10.32383/farmpol/127922}{doi:10.32383/farmpol/127922}.
\item Johnstad PG (2020). \textit{Cannabis as entheogen: survey and interview data on the spiritual use of cannabis.}. Journal of cannabis research. [published; PubMed]. \href{https://doi.org/10.1186/s42238-020-00032-2}{doi:10.1186/s42238-020-00032-2}.
\item Shevaugn Johnson, Quentin Black (2020). \textit{Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder: a Case Report}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-020-00398-7}{doi:10.1007/s11469-020-00398-7}.
\item Mollinedo-Gajate I, Song C, Sintes-Rodriguez M, Whelan T, Soula A, Selimbeyoglu A, Hurley S, Knöpfel T. (2020). \textit{Psilocybin rescues sociability deficits in an animal model of autism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.09.09.289348}{doi:10.1101/2020.09.09.289348}.
\item Vitkauskas M, Mathuru AS (2020). \textit{Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms21186525}{doi:10.3390/ijms21186525}.
\item Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L (2020). \textit{Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines8090331}{doi:10.3390/biomedicines8090331}.
\item Jones TK, Lippmann S (2020). \textit{Psilocybin Can Diminish Depression.}. The primary care companion for CNS disorders. [published; PubMed]. \href{https://doi.org/10.4088/pcc.19br02580}{doi:10.4088/pcc.19br02580}.
\item Barrett FS, Krimmel SR, Griffiths RR, Seminowicz DA, Mathur BN (2020). \textit{Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2020.116980}{doi:10.1016/j.neuroimage.2020.116980}.
\item Greif A, Šurkala M (2020). \textit{Compassionate use of psychedelics.}. Medicine, health care, and philosophy. [published; PubMed]. \href{https://doi.org/10.1007/s11019-020-09958-z}{doi:10.1007/s11019-020-09958-z}.
\item James E, Robertshaw TL, Hoskins M, Sessa B (2020). \textit{Psilocybin occasioned mystical-type experiences.}. Human psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1002/hup.2742}{doi:10.1002/hup.2742}.
\item Roberts CA, Osborne-Miller I, Cole J, Gage SH, Christiansen P (2020). \textit{Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120936508}{doi:10.1177/0269881120936508}.
\item Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA (2020). \textit{Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.}. CNS drugs. [published; PubMed]. \href{https://doi.org/10.1007/s40263-020-00748-y}{doi:10.1007/s40263-020-00748-y}.
\item Mishraki-Berkowitz Tehila, Kochelski Esti, Kavanagh Pierce, O'Brien John, Dunne Clodagh, Talbot Brian, Ennis Patricia, Wolf Udi (Ehud) (2020). \textit{The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1111/1556-4029.14368}{doi:10.1111/1556-4029.14368}.
\item Nkadimeng SM, Nabatanzi A, Steinmann CML, Eloff JN (2020). \textit{Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Magic Mushroom.}. Plants (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/plants9091127}{doi:10.3390/plants9091127}.
\item Lin Denise S (2020). \textit{Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin Mushrooms}. Journal of Healthcare. [published; OpenAlex]. \href{https://doi.org/10.36959/569/456}{doi:10.36959/569/456}.
\item Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Banks MI, Wenthur CJ. (2020). \textit{Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.08.12.248229}{doi:10.1101/2020.08.12.248229}.
\item James D. Tucker (2020). \textit{Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/Delivery.cfm/SSRN\_ID3783484\_code4550530.pdf?abstractid=3783484\&mirid=1}{source link}.
\item Guss J, Krause R, Sloshower J. (2020). \textit{The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u6v9y}{doi:10.31234/osf.io/u6v9y}.
\item Jeffrey Guss, Robert Krause, Jordan Sloshower (2020). \textit{The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/u6v9y\_v1}{source link}.
\item Callie Munson, Elyse Sunshine (2020). \textit{Psilocybin as an Effective Treatment for Patients with Life-Threatening Cancer and Psychological Distress: A Critically Appraised Topic}. Pacific University CommonKnowledge. [published; OpenAlex]. \href{https://commons.pacificu.edu/work/sc/b2be0580-b85b-405c-af50-8414cb3b2419}{source link}.
\item Mitina O, Mirsaidov M, Molchanova N, Tutrin A. (2020). \textit{Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/b7mnz}{doi:10.31234/osf.io/b7mnz}.
\item Olga Mitina, Mir Mirsaidov, Natalia Molchanova, Andy Tutrin (2020). \textit{Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/b7mnz\_v1}{source link}.
\item Carbonaro TM, Johnson MW, Griffiths RR (2020). \textit{Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05533-9}{doi:10.1007/s00213-020-05533-9}.
\item Reinert JP, Colunga K, Etuk A, Richardson V, Dunn RL (2020). \textit{Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2020.1794811}{doi:10.1080/17512433.2020.1794811}.
\item Back AL (2020). \textit{What Psilocybin Taught Me, One Year Later.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2020.0018}{doi:10.1089/jpm.2020.0018}.
\item Robin Carhart-Harris (2020). \textit{4 Psychedelics: therapeutic mechanisms}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2020-bnpa.4}{doi:10.1136/jnnp-2020-bnpa.4}.
\item O'Callaghan C, Hubik DJ, Dwyer J, Williams M, Ross M (2020). \textit{Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.}. Journal of music therapy. [published; PubMed]. \href{https://doi.org/10.1093/jmt/thaa006}{doi:10.1093/jmt/thaa006}.
\item Preller KH, Duerler P, Burt JB, Ji JL, Adkinson B, Stämpfli P, Seifritz E, Repovš G, Krystal JH, Murray JD, Anticevic A, Vollenweider FX (2020). \textit{Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2019.12.027}{doi:10.1016/j.biopsych.2019.12.027}.
\item Kargbo Robert B., Sherwood Alexander, Walker Andrew, Cozzi Nicholas V., Dagger Raymond E., Sable Jessica, O’Hern Kelsey, Kaylo Kristi, Patterson Tura, Tarpley Gary, Meisenheimer Poncho (2020). \textit{Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin}. ACS Omega. [published; Crossref]. \href{https://doi.org/10.1021/acsomega.0c02387}{doi:10.1021/acsomega.0c02387}.
\item Fricke J, Kargbo R, Regestein L, Lenz C, Peschel G, Rosenbaum MA, Sherwood A, Hoffmeister D (2020). \textit{Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin.}. Chemistry (Weinheim an der Bergstrasse, Germany). [published; PubMed]. \href{https://doi.org/10.1002/chem.202000134}{doi:10.1002/chem.202000134}.
\item Milne N, Thomsen P, Mølgaard Knudsen N, Rubaszka P, Kristensen M, Borodina I (2020). \textit{Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives.}. Metabolic engineering. [published; PubMed]. \href{https://doi.org/10.1016/j.ymben.2019.12.007}{doi:10.1016/j.ymben.2019.12.007}.
\item Meinhardt MW, Güngör C, Skorodumov I, Mertens LJ, Spanagel R (2020). \textit{Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-020-0694-z}{doi:10.1038/s41386-020-0694-z}.
\item Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E (2020). \textit{Reviewing the Potential of Psychedelics for the Treatment of PTSD.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyaa018}{doi:10.1093/ijnp/pyaa018}.
\item Hossein Khastar, Kobra Foroughi, Seyed Shahrokh Aghayan, Maryam Yarmohammadi, Moslem Jafarisani (2020). \textit{Molecular docking and binding interaction between psychedelic drugs and human serum albumin}. Biotechnologia. [published; OpenAlex]. \href{https://doi.org/10.5114/bta.2020.94770}{doi:10.5114/bta.2020.94770}.
\item Luoma JB. (2020). \textit{A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/sgujx}{doi:10.31234/osf.io/sgujx}.
\item Hirschfeld T, Schmidt TT. (2020). \textit{How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.06.09.142802}{doi:10.1101/2020.06.09.142802}.
\item Edward Jacobs (2020). \textit{A potential role for psilocybin in the treatment of obsessive-compulsive disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00128}{doi:10.1556/2054.2020.00128}.
\item Rosenbaum D, Weissman C, Anderson T, Petranker R, Dinh-Williams LA, Hui K, Hapke E (2020). \textit{Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120908004}{doi:10.1177/0269881120908004}.
\item Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK (2020). \textit{Long-term effects of psychedelic drugs: A systematic review.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2020.03.017}{doi:10.1016/j.neubiorev.2020.03.017}.
\item Bambauer TP, Wagmann L, Maurer HH, Weber AA, Meyer MR (2020). \textit{Development and application of a strategy for analyzing eight biomarkers in human urine to verify toxic mushroom or ricinus communis ingestions by means of hydrophilic interaction LC coupled to HRMS/MS.}. Talanta. [published; PubMed]. \href{https://doi.org/10.1016/j.talanta.2020.120847}{doi:10.1016/j.talanta.2020.120847}.
\item Greenway KT, Garel N, Jerome L, Feduccia AA (2020). \textit{Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2020.1772054}{doi:10.1080/17512433.2020.1772054}.
\item Rafael G. dos Santos, José Carlos Bouso, Jaime E. C. Hallak (2020). \textit{Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy}. Brazilian Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1590/1516-4446-2020-1035}{doi:10.1590/1516-4446-2020-1035}.
\item Nick Zagorski (2020). \textit{Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.6a34}{doi:10.1176/appi.pn.2020.6a34}.
\item Smith WR, Sisti D (2020). \textit{Ethics and ego dissolution: the case of psilocybin.}. Journal of medical ethics. [published; PubMed]. \href{https://doi.org/10.1136/medethics-2020-106070}{doi:10.1136/medethics-2020-106070}.
\item Ron Shore, Nigel Barnim, Katrina Dobson, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Animal Research}. Queen's University QSpace. [protocol; OpenAlex]. \href{https://qspace.library.queensu.ca/handle/1974/27834}{source link}.
\item Ron Shore, Paul Ioudovski, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Therapy Research}. Queen's University QSpace. [protocol; OpenAlex]. \href{https://qspace.library.queensu.ca/jspui/handle/1974/27833}{source link}.
\item Abbott KL, Gill KS, Flannery PC, Boothe DM, Dhanasekaran M, Pondugula SR (2020). \textit{Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.0c00241}{doi:10.1021/acschemneuro.0c00241}.
\item Ron Shore (2020). \textit{Psychedelics, Safety and Clinical Trial Design}. QSpace (Queen's University Library). [published; OpenAlex]. \href{http://hdl.handle.net/1974/27835}{source link}.
\item Katie R. Barnes, Stephanie N. Lewis (2020). \textit{Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor}. VTechWorks (Virginia Tech). [published; OpenAlex]. \href{http://hdl.handle.net/10919/99299}{source link}.
\item Demmler R, Fricke J, Dörner S, Gressler M, Hoffmeister D (2020). \textit{S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in "Magic" Mushrooms.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.201900649}{doi:10.1002/cbic.201900649}.
\item Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Spreng RN. (2020). \textit{Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.05.01.072314}{doi:10.1101/2020.05.01.072314}.
\item Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD (2020). \textit{Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2019.107933}{doi:10.1016/j.neuropharm.2019.107933}.
\item Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M (2020). \textit{Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05477-0}{doi:10.1007/s00213-020-05477-0}.
\item Olson JA, Suissa-Rocheleau L, Lifshitz M, Raz A, Veissière SPL (2020). \textit{Tripping on nothing: placebo psychedelics and contextual factors.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05464-5}{doi:10.1007/s00213-020-05464-5}.
\item Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research (2020). \textit{Psychedelics and Psychedelic-Assisted Psychotherapy.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.2019.19010035}{doi:10.1176/appi.ajp.2019.19010035}.
\item Kringelbach ML, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris R, Whybrow PC, Logothetis NK, Deco G (2020). \textit{Dynamic coupling of whole-brain neuronal and neurotransmitter systems.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.1921475117}{doi:10.1073/pnas.1921475117}.
\item Morten Hesse (2020). \textit{Klassiske psykedeliske stoffer - inkl. psilocybin og LSD}. Patienthåndbogen. [published; OpenAlex]. \href{https://pure.au.dk/portal/en/publications/45be7e79-66e2-4f51-af03-6c20860526cd}{source link}.
\item David R. Glowacki, Mark D. Wonnacott, Rachel Freire, Becca R. Glowacki, Ella M. Gale, James E. Pike, Tiu de Haan, Mike Chatziapostolou, Oussama Metatla (2020). \textit{Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics}. Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems. [published; OpenAlex]. \href{https://doi.org/10.1145/3313831.3376649}{doi:10.1145/3313831.3376649}.
\item University of Wisconsin, Madison (2020). \textit{Pharmacokinetics of Psilocybin in Normal Adult Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02163707}{source link}.
\item Chi T, Gold JA (2020). \textit{A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.}. Journal of the neurological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jns.2020.116715}{doi:10.1016/j.jns.2020.116715}.
\item Nick Zagorski (2020). \textit{Psychedelics for Psychiatric Disorders: More Research Needed}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.4a14}{doi:10.1176/appi.pn.2020.4a14}.
\item Petranker R, Anderson T, Maier L, Barratt MJ, Ferris J, Winstock A. (2020). \textit{Global Drug Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xb8ve}{doi:10.31234/osf.io/xb8ve}.
\item Rotem Petranker, Thomas Anderson, Larissa Maier, Monica Barratt, Jason Ferris, Adam Winstock (2020). \textit{Global Drug Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xb8ve\_v1}{source link}.
\item Kargbo RB (2020). \textit{Psilocybin Therapeutic Research: The Present and Future Paradigm.}. ACS medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1021/acsmedchemlett.0c00048}{doi:10.1021/acsmedchemlett.0c00048}.
\item Nutt D, Erritzoe D, Carhart-Harris R (2020). \textit{Psychedelic Psychiatry's Brave New World.}. Cell. [published; PubMed]. \href{https://doi.org/10.1016/j.cell.2020.03.020}{doi:10.1016/j.cell.2020.03.020}.
\item Madsen MK, Fisher PM, Stenbæk DS, Kristiansen S, Burmester D, Lehel S, Páleníček T, Kuchař M, Svarer C, Ozenne B, Knudsen GM (2020). \textit{A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2020.02.001}{doi:10.1016/j.euroneuro.2020.02.001}.
\item Meghan Hibicke, Charles D. Nichols (2020). \textit{One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2020.34.s1.02912}{doi:10.1096/fasebj.2020.34.s1.02912}.
\item Poliwoda Anna, Zielińska Katarzyna, Wieczorek Piotr P. (2020). \textit{Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis}. Molecules. [published; Crossref]. \href{https://doi.org/10.3390/molecules25071566}{doi:10.3390/molecules25071566}.
\item Richard Simoneaux (2020). \textit{Long-Term Analysis of Psilocybin in Cancer Patients With Distress}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000660232.19098.7f}{doi:10.1097/01.cot.0000660232.19098.7f}.
\item Katie O’Connor (2020). \textit{Can Psychedelics Radically Change SUD Treatment?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.2a12}{doi:10.1176/appi.pn.2020.2a12}.
\item Hibicke M, Landry AN, Kramer HM, Talman ZK, Nichols CD (2020). \textit{Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.9b00493}{doi:10.1021/acschemneuro.9b00493}.
\item Brent Schnipke (2020). \textit{Trip: Psychedelics, Alienation, and Change}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2020.150310}{doi:10.1176/appi.ajp-rj.2020.150310}.
\item Benko J, Vranková S (2020). \textit{Natural Psychoplastogens As Antidepressant Agents.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules25051172}{doi:10.3390/molecules25051172}.
\item Wendy Kline (2020). \textit{Psychedelic Birth: Bodies, Boundaries and the Perception of Pain in the 1970s}. Gender \& History. [published; OpenAlex]. \href{https://doi.org/10.1111/1468-0424.12471}{doi:10.1111/1468-0424.12471}.
\item Meikle SE, Liknaitzky P, Rossell SL, Ross M, Strauss N, Thomas N, Murray G, Williams M, Castle DJ (2020). \textit{Psilocybin-assisted therapy for depression: How do we advance the field?}. The Australian and New Zealand journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/0004867419888575}{doi:10.1177/0004867419888575}.
\item Mathai DS, Meyer MJ, Storch EA, Kosten TR (2020). \textit{The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2019.12.023}{doi:10.1016/j.jad.2019.12.023}.
\item Sherwood AM, Halberstadt AL, Klein AK, McCorvy JD, Kaylo KW, Kargbo RB, Meisenheimer P (2020). \textit{Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin.}. Journal of natural products. [published; PubMed]. \href{https://doi.org/10.1021/acs.jnatprod.9b01061}{doi:10.1021/acs.jnatprod.9b01061}.
\item Case Medical Research (2020). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04280055}{doi:10.31525/ct1-nct04280055}.
\item Lewis CR, Preller KH, Braden BB, Riecken C, Vollenweider FX (2020). \textit{Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines8020034}{doi:10.3390/biomedicines8020034}.
\item Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR (2020). \textit{Emotions and brain function are altered up to one month after a single high dose of psilocybin.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-020-59282-y}{doi:10.1038/s41598-020-59282-y}.
\item Forstmann M, Yudkin DA, Prosser AMB, Heller SM, Crockett MJ (2020). \textit{Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.1918477117}{doi:10.1073/pnas.1918477117}.
\item Maho Hirasawa (2020). \textit{Effects of psilocin on the striatal monoamine contents in mice and rats}. The Pharmaceutical Society of Japan. [published; OpenAlex]. \href{https://confit.atlas.jp/guide/event/pharm140/subject/4P156-201-13/detail}{source link}.
\item Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Ponté KL, Guss J, Bossis AP, Grigsby J, Fischer S, Ross S (2020). \textit{Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881119897615}{doi:10.1177/0269881119897615}.
\item Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR (2020). \textit{The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2020.112749}{doi:10.1016/j.psychres.2020.112749}.
\item Mertens LJ, Wall MB, Roseman L, Demetriou L, Nutt DJ, Carhart-Harris RL (2020). \textit{Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881119895520}{doi:10.1177/0269881119895520}.
\item Rebecca Wallersteiner (2020). \textit{Richard Alpert (Ram Dass): Harvard psychologist who experimented with psychedelic drugs and became one of America’s most prominent and respected spiritual leaders}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.m407}{doi:10.1136/bmj.m407}.
\item Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Desmond H. Y. Tse, Felix Müller, Stefan W. Toennes, Amanda Feilding, Johannes G. Ramaekers (2020). \textit{P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.12.087}{doi:10.1016/j.euroneuro.2019.12.087}.
\item Heidi Bush (2020). \textit{Psychedelic therapy: Fresh promise for mental health}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.32207}{doi:10.1002/mhw.32207}.
\item Vogel M, Strasser H, Thorens G, Zullino D, Humair JP, Simon O, Broers B, Haettel C, Devaud C, Gothuey I, Favrod-Counej T, Daeppen JB (2020). \textit{[Addictions].}. Revue medicale suisse. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/31961074/}{source link}.
\item Case Medical Research (2020). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04227756}{doi:10.31525/ct1-nct04227756}.
\item Michael Draper (2020). \textit{Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America}. Journal of the History of Medicine and Allied Sciences. [published; OpenAlex]. \href{https://doi.org/10.1093/jhmas/jraa002}{doi:10.1093/jhmas/jraa002}.
\item Blei F, Dörner S, Fricke J, Baldeweg F, Trottmann F, Komor A, Meyer F, Hertweck C, Hoffmeister D (2020). \textit{Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.}. Chemistry (Weinheim an der Bergstrasse, Germany). [published; PubMed]. \href{https://doi.org/10.1002/chem.201904363}{doi:10.1002/chem.201904363}.
\item Robert B. Kargbo, Alexander M. Sherwood, Poncho Meisenheimer, Gary Tarpley (2020). \textit{An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin}. Synthesis. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0039-1691565}{doi:10.1055/s-0039-1691565}.
\item Case Medical Research (2020). \textit{Repeat Dosing of Psilocybin in Migraine Headache}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04218539}{doi:10.31525/ct1-nct04218539}.
\item Courtney Hutchison, Sara Bressi (2020). \textit{Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments}. Clinical Social Work Journal. [published; OpenAlex]. \href{https://doi.org/10.1007/s10615-019-00743-x}{doi:10.1007/s10615-019-00743-x}.
\item Dalton Budhram, Preet Dhaliwal (2020). \textit{Psilocybin Therapy for Depression: A Scoping Review Protocol}. Open MIND. [published; OpenAlex]. \href{https://osf.io/4syt6}{source link}.
\item Dudysová D, Janků K, Šmotek M, Saifutdinova E, Kopřivová J, Bušková J, Mander BA, Brunovský M, Zach P, Korčák J, Andrashko V, Viktorinová M, Tylš F, Bravermanová A, Froese T, Páleníček T, Horáček J (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2020.602590}{doi:10.3389/fphar.2020.602590}.
\item Brooke Reichenbach (2020). \textit{Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/531}{source link}.
\item Courtney Ledford (2020). \textit{Predicting the Efficacy of Psilocybin in Treating Mental Health and Addiction}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/altreu\_projects/5}{source link}.
\item Ammar Jawad (2020). \textit{Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting Abilities}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/uresposters/356}{source link}.
\item Laura Sanders (2020). \textit{Psilocybin may help cancer patients with depression and anxiety for years}. Access Science. [published; OpenAlex]. \href{https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031}{source link}.
\item James Rucker, Jessie Schnall, Daniel D’Hotman, David King, Timmy Davis, Joanna C. Neill (2020). \textit{Medicinal use of psilocybin: Reducing restrictions on research and treatment.}. Conservative Drug Policy Reform Group. [published; OpenAlex]. \href{https://www.drugsandalcohol.ie/32599/}{source link}.
\item JEC Anthony, Adam Winstock, JA Ferris, DJ Nutt (2020). \textit{Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324520942345}{doi:10.1177/2050324520942345}.
\item Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers (2020). \textit{Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324519900068}{doi:10.1177/2050324519900068}.
\item Germann CB (2020). \textit{The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1016/j.mehy.2019.109406}{doi:10.1016/j.mehy.2019.109406}.
\item Lea T, Amada N, Jungaberle H, Schecke H, Klein M (2020). \textit{Microdosing psychedelics: Motivations, subjective effects and harm reduction.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2019.11.008}{doi:10.1016/j.drugpo.2019.11.008}.
\item Moreton SG, Szalla L, Menzies RE, Arena AF (2020). \textit{Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05391-0}{doi:10.1007/s00213-019-05391-0}.
\item Dos Santos RG, Hallak JEC (2020). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item Ho JT, Preller KH, Lenggenhager B (2020). \textit{Neuropharmacological modulation of the aberrant bodily self through psychedelics.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.006}{doi:10.1016/j.neubiorev.2019.12.006}.
\item Palamar JJ, Acosta P (2020). \textit{A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines.}. Human psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1002/hup.2719}{doi:10.1002/hup.2719}.
\item Vermetten E, Krediet E, Bostoen T, Breeksema JJ, Schoevers RA, van den Brink W (2020). \textit{[Psychedelics in the treatment of PTSD].}. Tijdschrift voor psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/32816292/}{source link}.
\item Schimmel N, Breeksema JJ, Veraart JKE, van den Brink W, Schoevers RA (2020). \textit{[Psychedelics for existential distress in terminally ill patients].}. Tijdschrift voor psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/32816294/}{source link}.
\item Kuypers KPC (2020). \textit{[Microdosing with psychedelics: what do we know?].}. Tijdschrift voor psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/32816295/}{source link}.
\item Voineskos D, Daskalakis ZJ, Blumberger DM (2020). \textit{Management of Treatment-Resistant Depression: Challenges and Strategies.}. Neuropsychiatric disease and treatment. [published; PubMed]. \href{https://doi.org/10.2147/ndt.s198774}{doi:10.2147/ndt.s198774}.
\item Bienemann B, Ruschel NS, Campos ML, Negreiros MA, Mograbi DC (2020). \textit{Self-reported negative outcomes of psilocybin users: A quantitative textual analysis.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0229067}{doi:10.1371/journal.pone.0229067}.
\item Wolff M, Evens R, Mertens LJ, Koslowski M, Betzler F, Gründer G, Jungaberle H (2020). \textit{Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00005}{doi:10.3389/fpsyt.2020.00005}.
\item Heuschkel K, Kuypers KPC (2020). \textit{Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00224}{doi:10.3389/fpsyt.2020.00224}.
\item Lea T, Amada N, Jungaberle H (2020). \textit{Psychedelic Microdosing: A Subreddit Analysis.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1683260}{doi:10.1080/02791072.2019.1683260}.
\item Butler M, Seynaeve M, Nicholson TR, Pick S, Kanaan RA, Lees A, Young AH, Rucker J (2020). \textit{Psychedelic treatment of functional neurological disorder: a systematic review.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125320912125}{doi:10.1177/2045125320912125}.
\item Müller F, Johnson MW, Borgwardt S (2020). \textit{Editorial: Hallucinogens and Entactogens: Establishing a New Class of Drugs?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00497}{doi:10.3389/fpsyt.2020.00497}.
\item Petranker R, Anderson T, Farb N (2020). \textit{Psychedelic Research and the Need for Transparency: Polishing Alice's Looking Glass.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2020.01681}{doi:10.3389/fpsyg.2020.01681}.
\item Vann Jones SA, O'Kelly A (2020). \textit{Psychedelics as a Treatment for Alzheimer's Disease Dementia.}. Frontiers in synaptic neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnsyn.2020.00034}{doi:10.3389/fnsyn.2020.00034}.
\item Kuypers KPC (2020). \textit{The therapeutic potential of microdosing psychedelics in depression.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125320950567}{doi:10.1177/2045125320950567}.
\item Kangaslampi S, Hausen A, Rauteenmaa T (2020). \textit{Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1767321}{doi:10.1080/02791072.2020.1767321}.
\item Forrester MB (2020). \textit{Hallucinogenic mushroom misuse reported to Texas poison centers.}. Journal of addictive diseases. [published; PubMed]. \href{https://doi.org/10.1080/10550887.2020.1785817}{doi:10.1080/10550887.2020.1785817}.
\item Nobile B, Olié E, Courtet P (2020). \textit{Commentary: Psychedelic Psychiatry's Brave New World.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.594077}{doi:10.3389/fpsyt.2020.594077}.
\item Heradstveit O, Skogen JC, Edland-Gryt M, Hesse M, Vallentin-Holbech L, Lønning KJ, Sivertsen B (2020). \textit{Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.543507}{doi:10.3389/fpsyt.2020.543507}.
\item Grassi G, Cecchelli C, Vignozzi L, Pacini S (2020). \textit{Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.}. Journal of experimental pharmacology. [published; PubMed]. \href{https://doi.org/10.2147/jep.s255375}{doi:10.2147/jep.s255375}.
\item Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ (2020). \textit{Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2020.00043}{doi:10.3389/fnins.2020.00043}.
\item Dax Oliver (2019). \textit{Analysis of Newspaper Coverage of Psilocybin from January 1, 1989 to December 31, 2019}. CUNY Academic Works (City University of New York). [published; OpenAlex]. \href{https://academicworks.cuny.edu/gc\_etds/4074}{source link}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Sofia Gyllvik (2019). \textit{The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729}{source link}.
\item Katariina Sarajärvi (2019). \textit{Psilocybin's effects on the brain and implications for depression treatment}. Epubl LTU. [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481}{source link}.
\item Reham Shaba (2019). \textit{Development of an improved psilocybin synthesis}. Uppsala University Publications (Uppsala University). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295}{source link}.
\item Johns Hopkins University (2019). \textit{Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02145091}{source link}.
\item Krishna Kumar Varshney (2019). \textit{Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3528349}{source link}.
\item Rosalind Watts, Jason B. Luoma (2019). \textit{The use of the psychological flexibility model to support psychedelic assisted therapy}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.12.004}{doi:10.1016/j.jcbs.2019.12.004}.
\item Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On. (2019). \textit{Mapping Psilocybin-Assisted Therapies: A Scoping Review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2019.12.04.19013896}{doi:10.1101/2019.12.04.19013896}.
\item K. Kiilerich, Nikolaj Speth, J. Lorenz, Agata Casado-Sainz, Vladimir Shalgunov, Denise Lange, Mengfei Xiong, Matthias M. Herth, Agnete Overgaard, Hanne D. Hansen, Mikael Palner (2019). \textit{P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.271}{doi:10.1016/j.euroneuro.2019.09.271}.
\item Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel, Tomáš Páleníček, Claus Svarer, B. Ozenne, Gitte M. Knudsen (2019). \textit{P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.232}{doi:10.1016/j.euroneuro.2019.09.232}.
\item Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris (2019). \textit{P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.593}{doi:10.1016/j.euroneuro.2019.09.593}.
\item Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2019). \textit{P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.702}{doi:10.1016/j.euroneuro.2019.09.702}.
\item Adams AM, Kaplan NA, Wei Z, Brinton JD, Monnier CS, Enacopol AL, Ramelot TA, Jones JA (2019). \textit{In vivo production of psilocybin in E. coli.}. Metabolic engineering. [published; PubMed]. \href{https://doi.org/10.1016/j.ymben.2019.09.009}{doi:10.1016/j.ymben.2019.09.009}.
\item Andersson M, Kjellgren A (2019). \textit{Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-019-0333-3}{doi:10.1186/s12954-019-0333-3}.
\item Fricke J, Sherwood A, Kargbo R, Orry A, Blei F, Naschberger A, Rupp B, Hoffmeister D (2019). \textit{Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.201900358}{doi:10.1002/cbic.201900358}.
\item Claudius Lenz, Jonas Wick, Daniel Braga, María García-Altares, Gerald Lackner, Christian Hertweck, Markus Gressler, Dirk Hoffmeister (2019). \textit{Injury-Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms}. Angewandte Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/ange.201910175}{doi:10.1002/ange.201910175}.
\item Case Medical Research (2019). \textit{Psilocybin-assisted Psychotherapy for Opioid Use Disorder}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04161066}{doi:10.31525/ct1-nct04161066}.
\item Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed, Matthew D. Skinta (2019). \textit{Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.11.002}{doi:10.1016/j.jcbs.2019.11.002}.
\item Russ SL, Carhart-Harris RL, Maruyama G, Elliott MS (2019). \textit{Replication and extension of a model predicting response to psilocybin.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05279-z}{doi:10.1007/s00213-019-05279-z}.
\item Muttoni S, Ardissino M, John C (2019). \textit{Classical psychedelics for the treatment of depression and anxiety: A systematic review.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2019.07.076}{doi:10.1016/j.jad.2019.07.076}.
\item Chris Letheby (2019). \textit{The Varieties of Psychedelic Epistemology}. UWA Profiles and Research Repository (University of Western Australia). [published; OpenAlex]. \href{https://admin.research-repository.uwa.edu.au/en/publications/12436068-2f0c-4c50-8bb8-de189a427289}{source link}.
\item Case Medical Research (2019). \textit{Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04141501}{doi:10.31525/ct1-nct04141501}.
\item Dos Santos RG, Bouso JC, Hallak JEC (2019). \textit{Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.}. BMC psychiatry. [published; PubMed]. \href{https://doi.org/10.1186/s12888-019-2288-z}{doi:10.1186/s12888-019-2288-z}.
\item Nick Zagorski (2019). \textit{Johns Hopkins Opens Research Center on Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.10a16}{doi:10.1176/appi.pn.2019.10a16}.
\item Smigielski L, Kometer M, Scheidegger M, Krähenmann R, Huber T, Vollenweider FX (2019). \textit{Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-019-50612-3}{doi:10.1038/s41598-019-50612-3}.
\item Pallavicini C, Vilas MG, Villarreal M, Zamberlan F, Muthukumaraswamy S, Nutt D, Carhart-Harris R, Tagliazucchi E (2019). \textit{Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2019.06.053}{doi:10.1016/j.neuroimage.2019.06.053}.
\item Kernel Networks Inc. (2019). \textit{Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04123314}{doi:10.31525/ct1-nct04123314}.
\item Megha Satyanarayana (2019). \textit{Modified E. coli pump out psilocybin}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09739-scicon9}{doi:10.1021/cen-09739-scicon9}.
\item Lord LD, Expert P, Atasoy S, Roseman L, Rapuano K, Lambiotte R, Nutt DJ, Deco G, Carhart-Harris RL, Kringelbach ML, Cabral J (2019). \textit{Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2019.05.060}{doi:10.1016/j.neuroimage.2019.05.060}.
\item Johns Hopkins University (2019). \textit{Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02971605}{source link}.
\item Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz (2019). \textit{Psilocybin for depression: Considerations for clinical trial design}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.026}{doi:10.1556/2054.2019.026}.
\item Hannes Kettner, Natasha L. Mason, Kim P. C. Kuypers (2019). \textit{Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users}. Contemporary Drug Problems. [published; OpenAlex]. \href{https://doi.org/10.1177/0091450919863899}{doi:10.1177/0091450919863899}.
\item Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M. (2019). \textit{Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/751255}{doi:10.1101/751255}.
\item Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW (2019). \textit{Cessation and reduction in alcohol consumption and misuse after psychedelic use.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881119845793}{doi:10.1177/0269881119845793}.
\item Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D (2019). \textit{Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881119857204}{doi:10.1177/0269881119857204}.
\item Begola MJ, Schillerstrom JE (2019). \textit{Hallucinogens and Their Therapeutic Use: A Literature Review.}. Journal of psychiatric practice. [published; PubMed]. \href{https://doi.org/10.1097/pra.0000000000000409}{doi:10.1097/pra.0000000000000409}.
\item Chadeayne Andrew R., Pham Duyen N. K., Golen James A., Manke David R. (2019). \textit{The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocin}. Acta Crystallographica Section E Crystallographic Communications. [published; Crossref]. \href{https://doi.org/10.1107/s2056989019011253}{doi:10.1107/s2056989019011253}.
\item Blake Beaton, Heith Copes, Megan Webb, Andy Hochstetler, Peter S. Hendricks (2019). \textit{Accounting for Microdosing Classic Psychedelics}. Journal of Drug Issues. [published; OpenAlex]. \href{https://doi.org/10.1177/0022042619871008}{doi:10.1177/0022042619871008}.
\item Dustin Marlan (2019). \textit{Beyond Cannabis: Psychedelic Decriminalization and Social Justice}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://lawcommons.lclark.edu/lclr/vol23/iss3/4}{source link}.
\item David Luke, Christopher Timmermann, Mendel Kaelen, David Schwartman, Beth Bell-Langford, Aimee Tollan, Viktor Hadzhiyski, Gabriella Bergin-Cartwright (2019). \textit{Non-drug altered states as psychedelic experiences}. Greenwich Academic Literature Archive (University of Greenwich). [published; OpenAlex]. \href{https://www.breakingconvention.co.uk/speaker-DavidLuke.html}{source link}.
\item King's College London (2019). \textit{A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03661125}{source link}.
\item Smigielski L, Scheidegger M, Kometer M, Vollenweider FX (2019). \textit{Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2019.04.009}{doi:10.1016/j.neuroimage.2019.04.009}.
\item Webb M, Copes H, Hendricks PS (2019). \textit{Narrative identity, rationality, and microdosing classic psychedelics.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2019.04.013}{doi:10.1016/j.drugpo.2019.04.013}.
\item Jefsen O, Højgaard K, Christiansen SL, Elfving B, Nutt DJ, Wegener G, Müller HK (2019). \textit{Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.}. Acta neuropsychiatrica. [published; PubMed]. \href{https://doi.org/10.1017/neu.2019.15}{doi:10.1017/neu.2019.15}.
\item Gardner J, Carter A, O'Brien K, Seear K (2019). \textit{Psychedelic-assisted therapies: The past, and the need to move forward responsibly.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2019.05.019}{doi:10.1016/j.drugpo.2019.05.019}.
\item Heifets BD, Malenka RC. (2019). \textit{Disruptive Psychopharmacology.}. JAMA Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2019.1145}{doi:10.1001/jamapsychiatry.2019.1145}.
\item Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK. (2019). \textit{Decreased Directed Functional Connectivity in the Psychedelic State}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/703660}{doi:10.1101/703660}.
\item Anderson T, Petranker R, Christopher A, Rosenbaum D, Weissman C, Dinh-Williams LA, Hui K, Hapke E (2019). \textit{Psychedelic microdosing benefits and challenges: an empirical codebook.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-019-0308-4}{doi:10.1186/s12954-019-0308-4}.
\item Jihun Lyu, Benjamin C. Hambro, Trisha Suppes (2019). \textit{A SYSTEMATIC REVIEW OF PSILOCYBIN IN THE TREATMENT OF DEPRESSION AND ANXIETY}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2018.10.335}{doi:10.1016/j.jad.2018.10.335}.
\item Back AL (2019). \textit{What Psilocybin Taught Me About Dying.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2018.0561}{doi:10.1089/jpm.2018.0561}.
\item Honyiglo E, Franchi A, Cartiser N, Bottinelli C, Advenier AS, Bévalot F, Fanton L (2019). \textit{Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.}. Journal of forensic sciences. [published; PubMed]. \href{https://doi.org/10.1111/1556-4029.13982}{doi:10.1111/1556-4029.13982}.
\item Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC (2019). \textit{Motives and Side-Effects of Microdosing With Psychedelics Among Users.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyz029}{doi:10.1093/ijnp/pyz029}.
\item Carhart-Harris RL, Friston KJ (2019). \textit{REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pr.118.017160}{doi:10.1124/pr.118.017160}.
\item Richard Simoneaux (2019). \textit{The Potential of Psilocybin Administration in Terminal Cancer Patients}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000574916.46844.cf}{doi:10.1097/01.cot.0000574916.46844.cf}.
\item Doreen M. Lewis (2019). \textit{Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments}. Addictive Disorders \& Their Treatment. [published; OpenAlex]. \href{https://doi.org/10.1097/adt.0000000000000178}{doi:10.1097/adt.0000000000000178}.
\item Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS (2019). \textit{Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2019.01.002}{doi:10.1016/j.pnpbp.2019.01.002}.
\item Jerry B. Brown, Julie M. Brown (2019). \textit{Entheogens in Christian art: Wasson, Allegro, and the Psychedelic Gospels}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.019}{doi:10.1556/2054.2019.019}.
\item Michael Winkelman (2019). \textit{Introduction: Evidence for entheogen use in prehistory and world religions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.024}{doi:10.1556/2054.2019.024}.
\item Sakloth F, Leggett E, Moerke MJ, Townsend EA, Banks ML, Negus SS (2019). \textit{Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.}. Experimental and clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1037/pha0000253}{doi:10.1037/pha0000253}.
\item Madsen Martin K., Fisher Patrick M., Burmester Daniel, Dyssegaard Agnete, Stenbæk Dea S., Kristiansen Sara, Johansen Sys S., Lehel Sczabolz, Linnet Kristian, Svarer Claus, Erritzoe David, Ozenne Brice, Knudsen Gitte M. (2019). \textit{Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-019-0324-9}{doi:10.1038/s41386-019-0324-9}.
\item Madsen Martin K., Fisher Patrick M., Burmester Daniel, Dyssegaard Agnete, Stenbæk Dea S., Kristiansen Sara, Johansen Sys S., Lehel Sczabolz, Linnet Kristian, Svarer Claus, Erritzoe David, Ozenne Brice, Knudsen Gitte M. (2019). \textit{Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels}. Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1038/s41386-019-0360-5}{doi:10.1038/s41386-019-0360-5}.
\item Chadeayne Andrew R., Golen James A., Manke David R. (2019). \textit{Bis(4-acetoxy-N,N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrug}. Acta Crystallographica Section E Crystallographic Communications. [published; Crossref]. \href{https://doi.org/10.1107/s2056989019007370}{doi:10.1107/s2056989019007370}.
\item Morita I., Oyama H., Tanaka R., Kikura-Hanajiri R., Kobayashi N. (2019). \textit{Generation of monoclonal antibodies for on-site analysis of psilocin and psilocybin in hallucinogenic mushrooms}. Clinica Chimica Acta. [published; Crossref]. \href{https://doi.org/10.1016/j.cca.2019.03.139}{doi:10.1016/j.cca.2019.03.139}.
\item Webster P (2019). \textit{Denver votes to decriminalise psilocybin mushrooms.}. Lancet (London, England). [published; PubMed]. \href{https://doi.org/10.1016/s0140-6736(19)31082-7}{doi:10.1016/s0140-6736(19)31082-7}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR (2019). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Stenbaek DS, Kristiansen S, Burmester D, Madsen MK, Frokjaer VG, Knudsen GM, Fisher PM (2019). \textit{Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.}. Human brain mapping. [published; PubMed]. \href{https://doi.org/10.1002/hbm.24511}{doi:10.1002/hbm.24511}.
\item Paul Summergrad (2019). \textit{Psychedelic Medicine: Careful Studies, Regulations Are the Answer}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.5a25}{doi:10.1176/appi.pn.2019.5a25}.
\item B. Anderson, Alicia Danforth, Robert B. Daroff, Christopher S. Stauffer, James Dilley, Jennifer Mitchell, Joshua Woolley (2019). \textit{T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2019.03.460}{doi:10.1016/j.biopsych.2019.03.460}.
\item Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, Laura Orsolini, Amira Guirguis, John Corkery, Stefania Bonaccorso, A Ricciardi, Norbert Scherbaum, Alessandro Vento (2019). \textit{New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-019-00249-z}{doi:10.1007/s40429-019-00249-z}.
\item McKenna Silva (2019). \textit{Attitudes Toward Medical Psychedelics}. Dominican Scholar (Dominican University of California). [published; OpenAlex]. \href{https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83}{source link}.
\item Kernel Networks Inc. (2019). \textit{Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct03912974}{doi:10.31525/ct1-nct03912974}.
\item Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols (2019). \textit{Psychedelics Improve the Mental Health of Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2019.33.1\_supplement.666.1}{doi:10.1096/fasebj.2019.33.1\_supplement.666.1}.
\item de Coo IF, Naber WC, Wilbrink LA, Haan J, Ferrari MD, Fronczek R (2019). \textit{Increased use of illicit drugs in a Dutch cluster headache population.}. Cephalalgia: an international journal of headache. [published; PubMed]. \href{https://doi.org/10.1177/0333102418804160}{doi:10.1177/0333102418804160}.
\item Kuypers KPC (2019). \textit{Psychedelic medicine: The biology underlying the persisting psychedelic effects.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1016/j.mehy.2019.02.029}{doi:10.1016/j.mehy.2019.02.029}.
\item Yuri Rahayu, Andi Riyanto, Agung Wibowo (2019). \textit{Relationship Of Magic Mushroom Literation As A Drug With Abuse It's Use As A Hallucination}. International Journal on Advanced Science Education and Religion. [published; OpenAlex]. \href{https://doi.org/10.33648/ijoaser.v2i1.25}{doi:10.33648/ijoaser.v2i1.25}.
\item Kernel Networks Inc. (2019). \textit{A Study of Psilocybin for Major Depressive Disorder (MDD)}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct03866174}{doi:10.31525/ct1-nct03866174}.
\item Rácz N, Nagy J, Jiang W, Veress T (2019). \textit{Modeling Retention Behavior on Analysis of Hallucinogenic Mushrooms Using Hydrophilic Interaction Liquid Chromatography.}. Journal of chromatographic science. [published; PubMed]. \href{https://doi.org/10.1093/chromsci/bmy104}{doi:10.1093/chromsci/bmy104}.
\item Austin E, Myron HS, Summerbell RK, Mackenzie C (2019). \textit{Acute renal injury cause by confirmed mushroom ingestion.}. Medical mycology case reports. [published; PubMed]. \href{https://doi.org/10.1016/j.mmcr.2018.12.007}{doi:10.1016/j.mmcr.2018.12.007}.
\item Nick Zagorski (2019). \textit{Is Psychedelic Medicine on the Horizon?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2019.1b1}{doi:10.1176/appi.pn.2019.1b1}.
\item Jenna Varley (2019). \textit{Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.005}{doi:10.1556/2054.2019.005}.
\item Ahmed Al-Imam, Faris Lami (2019). \textit{One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip}. Modern Applied Science. [published; OpenAlex]. \href{https://doi.org/10.5539/mas.v13n3p13}{doi:10.5539/mas.v13n3p13}.
\item Xue Qin Ng, Asimah Hamzah, Mei Ling Evelyn Goh, Hooi Yan Moy, Yi Ju Yao, Chi Pang Lui (2019). \textit{Qualitative analysis of synthetic opioids, synthetic hallucinogens and LSD in urine using LC-MS/MS}. Australian Journal of Forensic Sciences. [published; OpenAlex]. \href{https://doi.org/10.1080/00450618.2019.1568565}{doi:10.1080/00450618.2019.1568565}.
\item Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS (2019). \textit{Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-018-5106-2}{doi:10.1007/s00213-018-5106-2}.
\item James E, Robertshaw TL, Westwell AD (2019). \textit{Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances.}. Future medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.4155/fmc-2018-0447}{doi:10.4155/fmc-2018-0447}.
\item Michiel van Elk, George Fejer, Josephine Marschall, Pascal Lempe (2019). \textit{The effects of psilocybin microdosing on perception: a double-blind controlled study}. OSF Preprints (OSF Preprints). [published; OpenAlex]. \href{https://osf.io/cn8z4}{source link}.
\item Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D (2019). \textit{Production Options for Psilocybin: Making of the Magic.}. Chemistry (Weinheim an der Bergstrasse, Germany). [published; PubMed]. \href{https://doi.org/10.1002/chem.201802758}{doi:10.1002/chem.201802758}.
\item Varley T, Carhart-Harris R, Roseman L, Menon DK, Stamatakis E. (2019). \textit{Serotonergic Psychedelics LSD \& Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal Domains}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/517847}{doi:10.1101/517847}.
\item Katherine Gruppo (2019). \textit{Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled Trial}. Yale School of Medicine Physician Associate Program Thesis. [published; OpenAlex]. \href{https://elischolar.library.yale.edu/cgi/viewcontent.cgi?article=1050\&context=ysmpa\_theses}{source link}.
\item William G. Crane (2019). \textit{Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality}. Furman University Scholar Exchange (Furman University). [published; OpenAlex]. \href{https://scholarexchange.furman.edu/furmanengaged/2019/all/522}{source link}.
\item Tina Hesman Saey (2019). \textit{These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstop}. Access Science. [published; OpenAlex]. \href{https://www.accessscience.com/content/these-fungi-drug-cicadas-with-psilocybin-or-amphetamine-to-make-them-mate-nonstop/SN1907011}{source link}.
\item P. Dürler (2019). \textit{Psilocybin induces aberrant prediction error processing for tactile mismatch responses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.477}{doi:10.1016/j.euroneuro.2018.11.477}.
\item Felix Scholkmann, Lisa Holper, Katrin H. Preller, Franz X. Vollenweider (2019). \textit{Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot study}. Matters. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-181782}{doi:10.5167/uzh-181782}.
\item Jacob S. Aday, Christopher C. Davoli, Emily K. Bloesch (2019). \textit{2018: A watershed year for psychedelic science}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324519872284}{doi:10.1177/2050324519872284}.
\item Brinsko Kelly M., Golemis Dean, King Meggan B., Laughlin Gary J., Sparenga Sebastian B. (2019). \textit{Microcrystal Tests for the Identification of Illicit Drugs: Phencyclidine, Pseudoephedrine, and Psilocin}. The Microscope. [published; Crossref]. \href{https://doi.org/10.59082/tnwk8166}{doi:10.59082/tnwk8166}.
\item Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL (2019). \textit{Rapid-acting antidepressants.}. Advances in pharmacology (San Diego, Calif.). [published; PubMed]. \href{https://doi.org/10.1016/bs.apha.2019.03.002}{doi:10.1016/bs.apha.2019.03.002}.
\item Dinis-Oliveira RJ, Pereira CL, da Silva DD (2019). \textit{Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.}. Current molecular pharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1874467211666181010154139}{doi:10.2174/1874467211666181010154139}.
\item Solano J, Anabalón L, Figueroa S, Lizama C, Reyes LC, Gangitano D (2019). \textit{Psychedelic fungus (Psilocybe sp.) authentication in a case of illegal drug traffic: sporological, molecular analysis and identification of the psychoactive substance.}. Science \& justice: journal of the Forensic Science Society. [published; PubMed]. \href{https://doi.org/10.1016/j.scijus.2018.08.005}{doi:10.1016/j.scijus.2018.08.005}.
\item Dorsen C, Palamar J, Shedlin MG (2019). \textit{Ceremonial "plant medicine" use and its relationship to recreational drug use: an exploratory study.}. Addiction research \& theory. [published; PubMed]. \href{https://doi.org/10.1080/16066359.2018.1455187}{doi:10.1080/16066359.2018.1455187}.
\item Nutt D (2019). \textit{Psychedelic drugs-a new era in psychiatry?.}. Dialogues in clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.31887/dcns.2019.21.2/dnutt}{doi:10.31887/dcns.2019.21.2/dnutt}.
\item Corne R, Mongeau R (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Biologie aujourd'hui. [published; PubMed]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Mason NL, Mischler E, Uthaug MV, Kuypers KPC (2019). \textit{Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1580804}{doi:10.1080/02791072.2019.1580804}.
\item Fadiman J, Korb S (2019). \textit{Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1593561}{doi:10.1080/02791072.2019.1593561}.
\item Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD (2019). \textit{Psychedelic-Assisted Group Therapy: A Systematic Review.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1593559}{doi:10.1080/02791072.2019.1593559}.
\item Doblin RE, Christiansen M, Jerome L, Burge B (2019). \textit{The Past and Future of Psychedelic Science: An Introduction to This Issue.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1606472}{doi:10.1080/02791072.2019.1606472}.
\item Scott G, Carhart-Harris RL (2019). \textit{Psychedelics as a treatment for disorders of consciousness.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niz003}{doi:10.1093/nc/niz003}.
\item Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R (2019). \textit{Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0214377}{doi:10.1371/journal.pone.0214377}.
\item Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG (2019). \textit{Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125319845774}{doi:10.1177/2045125319845774}.
\item Aday JS, Bloesch EK, Davoli CC (2019). \textit{Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20 Century.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1581961}{doi:10.1080/02791072.2019.1581961}.
\item Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC (2019). \textit{Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2019.00672}{doi:10.3389/fpsyt.2019.00672}.
\item Peterson A, Tagliazucchi E, Weijer C (2019). \textit{The ethics of psychedelic research in disorders of consciousness.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niz013}{doi:10.1093/nc/niz013}.
\item Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW (2019). \textit{Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2019.00955}{doi:10.3389/fpsyt.2019.00955}.
\item Sexton JD, Nichols CD, Hendricks PS (2019). \textit{Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2019.00896}{doi:10.3389/fpsyt.2019.00896}.
\item Madsen M.K., Burmester D., Stenbæk D.S., Kristiansen S., Dyssegaard A., Lehel S., Linnet K., Johansen S.S., Svarer C., Ozenne B., Erritzøe D., Fisher P.M., Knudsen G.M. (2019). \textit{Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.474}{doi:10.1016/j.euroneuro.2018.11.474}.
\item Isabella Stendahl (2018). \textit{THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749}{source link}.
\item Emma Christersson (2018). \textit{The Psychedelic Altered State of Consciousness: An Assessment of the Current Status of Psychedelic Research}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17255}{source link}.
\item Camden Grant-Howard, Joel S. Steele (2018). \textit{Use of MDMA \& Psilocybin in the Treatment of PTSD}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/studentsymposium/2019/Posters/14}{source link}.
\item Vorster A, Gerber AM, van der Merwe LJ, van Zyl S (2018). \textit{Second and third year medical students' self-reported alcohol and substance use, smoking habits and academic performance at a South African medical school.}. Health SA = SA Gesondheid. [published; PubMed]. \href{https://doi.org/10.4102/hsag.v24i0.1041}{doi:10.4102/hsag.v24i0.1041}.
\item Torrens-Spence MP, Liu CT, Pluskal T, Chung YK, Weng JK (2018). \textit{Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom.}. ACS chemical biology. [published; PubMed]. \href{https://doi.org/10.1021/acschembio.8b00821}{doi:10.1021/acschembio.8b00821}.
\item Leonard JB, Anderson B, Klein-Schwartz W (2018). \textit{Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881118793086}{doi:10.1177/0269881118793086}.
\item Kvam TM, Stewart LH, Andreassen OA (2018). \textit{Psychedelic drugs in the treatment of anxiety, depression and addiction.}. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke. [published; PubMed]. \href{https://doi.org/10.4045/tidsskr.17.1110}{doi:10.4045/tidsskr.17.1110}.
\item Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K, Hapke E, Farb NAS. (2018). \textit{Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/gk4jd}{doi:10.31234/osf.io/gk4jd}.
\item Thomas Anderson, Rotem Petranker, Daniel Rosenbaum, Cory Weissman, Le-Anh Dinh-Williams, Katrina Hui, Emma Hapke, Norman Farb (2018). \textit{Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gk4jd\_v1}{source link}.
\item Di Giovanni G, De Deurwaerdère P (2018). \textit{TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT receptor pharmacological tool, or none of the above?}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2017.10.004}{doi:10.1016/j.neuropharm.2017.10.004}.
\item Rucker JJH, Iliff J, Nutt DJ (2018). \textit{Psychiatry \& the psychedelic drugs. Past, present \& future.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2017.12.040}{doi:10.1016/j.neuropharm.2017.12.040}.
\item Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL (2018). \textit{Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2017.12.041}{doi:10.1016/j.neuropharm.2017.12.041}.
\item Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE (2018). \textit{The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2018.05.012}{doi:10.1016/j.neuropharm.2018.05.012}.
\item Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL (2018). \textit{Effects of psilocybin therapy on personality structure.}. Acta psychiatrica Scandinavica. [published; PubMed]. \href{https://doi.org/10.1111/acps.12904}{doi:10.1111/acps.12904}.
\item Puschner B, Wegenast C (2018). \textit{Mushroom Poisoning Cases in Dogs and Cats: Diagnosis and Treatment of Hepatotoxic, Neurotoxic, Gastroenterotoxic, Nephrotoxic, and Muscarinic Mushrooms.}. The Veterinary clinics of North America. Small animal practice. [published; PubMed]. \href{https://doi.org/10.1016/j.cvsm.2018.06.008}{doi:10.1016/j.cvsm.2018.06.008}.
\item Jalal B (2018). \textit{The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-018-5042-1}{doi:10.1007/s00213-018-5042-1}.
\item Blei F, Fricke J, Wick J, Slot JC, Hoffmeister D (2018). \textit{Iterative l-Tryptophan Methylation in Psilocybe Evolved by Subdomain Duplication.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.201800336}{doi:10.1002/cbic.201800336}.
\item Nichols DE (2018). \textit{Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00043}{doi:10.1021/acschemneuro.8b00043}.
\item Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC (2018). \textit{Psychedelics and Personality.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00237}{doi:10.1021/acschemneuro.8b00237}.
\item Geiger HA, Wurst MG, Daniels RN (2018). \textit{DARK Classics in Chemical Neuroscience: Psilocybin.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00186}{doi:10.1021/acschemneuro.8b00186}.
\item Cameron LP, Olson DE (2018). \textit{Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00101}{doi:10.1021/acschemneuro.8b00101}.
\item Wasko MJ, Witt-Enderby PA, Surratt CK (2018). \textit{DARK Classics in Chemical Neuroscience: Ibogaine.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.8b00294}{doi:10.1021/acschemneuro.8b00294}.
\item Elizabeth M. Nielson, Jeffrey Guss (2018). \textit{The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2018.009}{doi:10.1556/2054.2018.009}.
\item Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-018-4981-x}{doi:10.1007/s00213-018-4981-x}.
\item Nicole Fossos-Wong, Ha-Yoon Lee, Kathryn B. Vincent, Devon Alisa Abdallah, Krista S. Dashtestani, M. Dolores Cimini, Karen L. Sokolowski, Geetha Subramaniam, Irene M. Geisner (2018). \textit{1.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and Consequences}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2018.09.029}{doi:10.1016/j.jaac.2018.09.029}.
\item Robin Carhart-Harris (2018). \textit{Serotonin, psychedelics and psychiatry}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20555}{doi:10.1002/wps.20555}.
\item Cowan AF, Elkins KM (2018). \textit{Detection and Identification of Psilocybe cubensis DNA Using a Real-Time Polymerase Chain Reaction High Resolution Melt Assay.}. Journal of forensic sciences. [published; PubMed]. \href{https://doi.org/10.1111/1556-4029.13714}{doi:10.1111/1556-4029.13714}.
\item Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC (2018). \textit{Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2018.1511424}{doi:10.1080/17512433.2018.1511424}.
\item Horsley Rachel R., Páleníček Tomáš, Kolin Jan, Valeš Karel (2018). \textit{Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/fbp.0000000000000394}{doi:10.1097/fbp.0000000000000394}.
\item Sophie-Charlotte Alice Adler (2018). \textit{Entheogene Pilze: Welches Potential bietet die psychoaktive Substanz Psilocybin für die moderne Psychotherapie in Forschung und Praxis? / Sophie-Charlotte Alice Adler}. University of Innsbruck. [published; OpenAlex]. \href{https://diglib.uibk.ac.at/ulbtirolhs/content/titleinfo/2793753}{source link}.
\item Chu Hsien Lim, Brian D. Kangas, Jack Bergman (2018). \textit{The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients}. Biochemistry and Molecular Biology Education. [published; OpenAlex]. \href{https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients}{source link}.
\item Flanagan TW, Nichols CD (2018). \textit{Psychedelics as anti-inflammatory agents.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Ross S (2018). \textit{Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1482261}{doi:10.1080/09540261.2018.1482261}.
\item Barrett FS, Preller KH, Kaelen M (2018). \textit{Psychedelics and music: neuroscience and therapeutic implications.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1484342}{doi:10.1080/09540261.2018.1484342}.
\item Hendricks PS (2018). \textit{Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1474185}{doi:10.1080/09540261.2018.1474185}.
\item Garcia-Romeu A, Richards WA (2018). \textit{Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1486289}{doi:10.1080/09540261.2018.1486289}.
\item Lord L, Expert P, Atasoy S, Roseman L, Rapuano K, Lambiotte R, Nutt DJ, Deco G, Carhart-Harris RL, Kringelbach ML, Cabral J. (2018). \textit{Altered trajectories in the dynamical repertoire of functional network states under psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/376491}{doi:10.1101/376491}.
\item Awan AR, Winter JM, Turner D, Shaw WM, Suz LM, Bradshaw AJ, Ellis T, Dentinger BT. (2018). \textit{Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/374199}{doi:10.1101/374199}.
\item Boyce GR, Gluck-Thaler E, Slot JC, Stajich JE, Davis WJ, James TY, Cooley JR, Panaccione DG, Eilenberg J, Licht HHDF, Macias AM, Berger MC, Wickert KL, Stauder CM, Spahr EJ, Maust MD, Metheny AM, Simon C, Kritsky G, Hodge KT, Humber RA, Gullion T, Short DPG, Kijimoto T, Mozgai D, Arguedas N, Kasson MT. (2018). \textit{Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/375105}{doi:10.1101/375105}.
\item Johns Hopkins University (2018). \textit{Psychopharmacology of Psilocybin in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00465595}{source link}.
\item Blei F, Baldeweg F, Fricke J, Hoffmeister D (2018). \textit{Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.}. Chemistry (Weinheim an der Bergstrasse, Germany). [published; PubMed]. \href{https://doi.org/10.1002/chem.201801047}{doi:10.1002/chem.201801047}.
\item Lyons T, Carhart-Harris RL (2018). \textit{Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881117748902}{doi:10.1177/0269881117748902}.
\item Thiessen MS, Walsh Z, Bird BM, Lafrance A (2018). \textit{Psychedelic use and intimate partner violence: The role of emotion regulation.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881118771782}{doi:10.1177/0269881118771782}.
\item Hoefgen S, Lin J, Fricke J, Stroe MC, Mattern DJ, Kufs JE, Hortschansky P, Brakhage AA, Hoffmeister D, Valiante V (2018). \textit{Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi.}. Metabolic engineering. [published; PubMed]. \href{https://doi.org/10.1016/j.ymben.2018.05.014}{doi:10.1016/j.ymben.2018.05.014}.
\item Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW (2018). \textit{Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881118780612}{doi:10.1177/0269881118780612}.
\item Nicholas CR, Henriquez KM, Gassman MC, Cooper KM, Muller D, Hetzel S, Brown RT, Cozzi NV, Thomas C, Hutson PR (2018). \textit{High dose psilocybin is associated with positive subjective effects in healthy volunteers.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881118780713}{doi:10.1177/0269881118780713}.
\item Pietsch J, Scheffel K, Acquarone D, Koch I, Deters M, Hermanns-Clausen M (2018). \textit{[Trends in Abuse of Biogenic Drugs in Parts of Germany 2007-2013].}. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). [published; PubMed]. \href{https://doi.org/10.1055/s-0042-108644}{doi:10.1055/s-0042-108644}.
\item Kuypers KPC (2018). \textit{Out of the box: A psychedelic model to study the creative mind.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1016/j.mehy.2018.03.010}{doi:10.1016/j.mehy.2018.03.010}.
\item Grimm O, Kraehenmann R, Preller KH, Seifritz E, Vollenweider FX (2018). \textit{Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2018.03.016}{doi:10.1016/j.euroneuro.2018.03.016}.
\item Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA (2018). \textit{Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-018-26656-2}{doi:10.1038/s41598-018-26656-2}.
\item Rocchi R, Simeoni MC, Montesano C, Vannutelli G, Curini R, Sergi M, Compagnone D (2018). \textit{Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography-tandem mass spectrometry.}. Drug testing and analysis. [published; PubMed]. \href{https://doi.org/10.1002/dta.2330}{doi:10.1002/dta.2330}.
\item Whelan A, Johnson MI (2018). \textit{Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?}. Pain management. [published; PubMed]. \href{https://doi.org/10.2217/pmt-2017-0068}{doi:10.2217/pmt-2017-0068}.
\item Michael C. McKenna, John R. Fedota, Albert Garcia-Romeu, Matthew R. Johnson, Roland R. Griffiths, Elliot A. Stein (2018). \textit{T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking Smokers}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2018.02.600}{doi:10.1016/j.biopsych.2018.02.600}.
\item Sellers EM, Leiderman DB (2018). \textit{Psychedelic Drugs as Therapeutics: No Illusions About the Challenges.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.776}{doi:10.1002/cpt.776}.
\item Byock I (2018). \textit{Taking Psychedelics Seriously.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2017.0684}{doi:10.1089/jpm.2017.0684}.
\item Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL (2018). \textit{Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2018.01.006}{doi:10.1016/j.jad.2018.01.006}.
\item Ramachandran V, Chunharas C, Marcus Z, Furnish T, Lin A (2018). \textit{Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF).}. Neurocase. [published; PubMed]. \href{https://doi.org/10.1080/13554794.2018.1468469}{doi:10.1080/13554794.2018.1468469}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC (2018). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity.}. Evolution letters. [published; PubMed]. \href{https://doi.org/10.1002/evl3.42}{doi:10.1002/evl3.42}.
\item Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi (2018). \textit{Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22127/rjp.2018.58486}{doi:10.22127/rjp.2018.58486}.
\item Mascha M.J. Linszen, Hidde Kleijer, Iris E. Sommer (2018). \textit{Visual hallucinations and lifetime use of hallucinogen perception persisting disorder associated recreational drugs: results from a large online survey}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2017.12.114}{doi:10.1016/j.euroneuro.2017.12.114}.
\item Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T (2018). \textit{Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2017.09.012}{doi:10.1016/j.pnpbp.2017.09.012}.
\item Sessa B (2018). \textit{The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4713-7}{doi:10.1007/s00213-017-4713-7}.
\item Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL (2018). \textit{Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4754-y}{doi:10.1007/s00213-017-4754-y}.
\item Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4769-4}{doi:10.1007/s00213-017-4769-4}.
\item Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ (2018). \textit{Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4771-x}{doi:10.1007/s00213-017-4771-x}.
\item Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J, Horáček J, Balíková M, Griškova-Bulanova I, Danielová D, Vlček P, Mohr P, Brunovský M, Koudelka V, Páleníček T (2018). \textit{Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4807-2}{doi:10.1007/s00213-017-4807-2}.
\item Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R (2018). \textit{The hidden therapist: evidence for a central role of music in psychedelic therapy.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-017-4820-5}{doi:10.1007/s00213-017-4820-5}.
\item Jessica Hamzelou (2018). \textit{Can psychedelic drug help with depression?}. The New Scientist. [published; OpenAlex]. \href{https://doi.org/10.1016/s0262-4079(18)30332-4}{doi:10.1016/s0262-4079(18)30332-4}.
\item Ira Byock, Charles S. Grob (2018). \textit{Taking Psychedelics Seriously (TH316)}. Journal of Pain and Symptom Management. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpainsymman.2017.12.019}{doi:10.1016/j.jpainsymman.2017.12.019}.
\item N. M. Uaniti, O. O. Ratnayani, S. A. Sari (2018). \textit{ANALISIS SENYAWA HALUSINOGEN DALAM MINUMAN MAGIC MUSHROOM (Psilocybin baeocystis) YANG BEREDAR DI KAWASAN KUTA-BALI}. Jurnal Kimia. [published; OpenAlex]. \href{https://doi.org/10.24843/jchem.2018.v12.i01.p17}{doi:10.24843/jchem.2018.v12.i01.p17}.
\item Camila Sanz, Federico Zamberlán, Earth Erowid, Fire Erowid, Enzo Tagliazucchi (2018). \textit{The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2018.00007}{doi:10.3389/fnins.2018.00007}.
\item Volodymyr Mykhalevych (2018). \textit{The theory and practice of psilocybin assisted psychotherapy: an intervention design checklist}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/606091}{source link}.
\item Link Swanson (2018). \textit{Unlearning to See: Linking the Perceptual and Clinical Effects of Psychedelic Drugs.}. Cognitive Science. [published; OpenAlex]. \href{https://escholarship.org/uc/item/67x0n7rq}{source link}.
\item Kayla Wilwohl (2018). \textit{Are psychedelics effective in treating anxiety associated with a lifethreatening disease}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/308}{source link}.
\item Thomas Cody Swift (2018). \textit{Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological Distress}. Western CEDAR (Western Washington University). [published; OpenAlex]. \href{https://cedar.wwu.edu/pci/lectures\_events/holistic\_pain\_management/3}{source link}.
\item Phil Wolfson (2018). \textit{Psychedelics, the Spiritual and Consciousness-an Evolving Confluence in the Cultural Stream}. Tikkun. [published; OpenAlex]. \href{https://doi.org/10.1215/08879982-4354390}{doi:10.1215/08879982-4354390}.
\item Lord L. (2018). \textit{Integration and segregation in whole-brain networks: implications for altered states of consciousness}. University of Oxford. [published; Europe PMC]. \href{https://europepmc.org/article/ETH/770691}{source link}.
\item Kometer M, Vollenweider FX (2018). \textit{Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_461}{doi:10.1007/7854\_2016\_461}.
\item Preller KH, Vollenweider FX (2018). \textit{Phenomenology, Structure, and Dynamic of Psychedelic States.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_459}{doi:10.1007/7854\_2016\_459}.
\item Halberstadt AL, Geyer MA (2018). \textit{Effect of Hallucinogens on Unconditioned Behavior.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_466}{doi:10.1007/7854\_2016\_466}.
\item Barrett FS, Griffiths RR (2018). \textit{Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_474}{doi:10.1007/7854\_2017\_474}.
\item Bogenschutz MP, Ross S (2018). \textit{Therapeutic Applications of Classic Hallucinogens.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD (2018). \textit{The Effects of Hallucinogens on Gene Expression.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item López-Giménez JF, González-Maeso J (2018). \textit{Hallucinogens and Serotonin 5-HT Receptor-Mediated Signaling Pathways.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2017\_478}{doi:10.1007/7854\_2017\_478}.
\item Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA (2018). \textit{Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881117731279}{doi:10.1177/0269881117731279}.
\item Hendricks PS, Crawford MS, Cropsey KL, Copes H, Sweat NW, Walsh Z, Pavela G (2018). \textit{The relationships of classic psychedelic use with criminal behavior in the United States adult population.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881117735685}{doi:10.1177/0269881117735685}.
\item Sherwood AM, Prisinzano TE (2018). \textit{Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2018.1415755}{doi:10.1080/17512433.2018.1415755}.
\item Canal CE (2018). \textit{Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.}. Handbook of experimental pharmacology. [published; PubMed]. \href{https://doi.org/10.1007/164\_2018\_107}{doi:10.1007/164\_2018\_107}.
\item Müller F, Liechti ME, Lang UE, Borgwardt S (2018). \textit{Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2018.08.004}{doi:10.1016/bs.pbr.2018.08.004}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Atasoy S, Vohryzek J, Deco G, Carhart-Harris RL, Kringelbach ML (2018). \textit{Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2018.08.009}{doi:10.1016/bs.pbr.2018.08.009}.
\item Bogenschutz MP, Podrebarac SK, Duane JH, Amegadzie SS, Malone TC, Owens LT, Ross S, Mennenga SE (2018). \textit{Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00100}{doi:10.3389/fphar.2018.00100}.
\item Nielson EM, May DG, Forcehimes AA, Bogenschutz MP (2018). \textit{The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00132}{doi:10.3389/fphar.2018.00132}.
\item Barrett FS, Schlienz NJ, Lembeck N, Waqas M, Vandrey R (2018). \textit{"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.}. Cannabis and cannabinoid research. [published; PubMed]. \href{https://doi.org/10.1089/can.2017.0052}{doi:10.1089/can.2017.0052}.
\item Swanson LR (2018). \textit{Unifying Theories of Psychedelic Drug Effects.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00172}{doi:10.3389/fphar.2018.00172}.
\item Malone TC, Mennenga SE, Guss J, Podrebarac SK, Owens LT, Bossis AP, Belser AB, Agin-Liebes G, Bogenschutz MP, Ross S (2018). \textit{Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00256}{doi:10.3389/fphar.2018.00256}.
\item Vigerelli H, Sciani JM, Eula MAC, Sato LA, Antoniazzi MM, Jared C, Pimenta DC (2018). \textit{Biological Effects and Biodistribution of Bufotenine on Mice.}. BioMed research international. [published; PubMed]. \href{https://doi.org/10.1155/2018/1032638}{doi:10.1155/2018/1032638}.
\item Brandenburg WE, Ward KJ (2018). \textit{Mushroom poisoning epidemiology in the United States.}. Mycologia. [published; PubMed]. \href{https://doi.org/10.1080/00275514.2018.1479561}{doi:10.1080/00275514.2018.1479561}.
\item Skryabin VY, Vinnikova M, Nenastieva A, Alekseyuk V (2018). \textit{Hallucinogen persisting perception disorder: A literature review and three case reports.}. Journal of addictive diseases. [published; PubMed]. \href{https://doi.org/10.1080/10550887.2019.1673655}{doi:10.1080/10550887.2019.1673655}.
\item Barnby JM, Mehta MA (2018). \textit{Psilocybin and Mental Health-Don't Lose Control.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2018.00293}{doi:10.3389/fpsyt.2018.00293}.
\item Schenberg EE (2018). \textit{Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00733}{doi:10.3389/fphar.2018.00733}.
\item Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A (2018). \textit{Psychedelics, Meditation, and Self-Consciousness.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2018.01475}{doi:10.3389/fpsyg.2018.01475}.
\item Bayne T, Carter O (2018). \textit{Dimensions of consciousness and the psychedelic state.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niy008}{doi:10.1093/nc/niy008}.
\item Lyons T, Carhart-Harris RL (2018). \textit{More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2018.01721}{doi:10.3389/fpsyg.2018.01721}.
\item Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K, Polanco M, Grant R, Griffiths RR (2018). \textit{Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2018.02459}{doi:10.3389/fpsyg.2018.02459}.
\item Witkin JM, Knutson DE, Rodriguez GJ, Shi S (2018). \textit{Rapid-Acting Antidepressants.}. Current pharmaceutical design. [published; PubMed]. \href{https://doi.org/10.2174/1381612824666180730104707}{doi:10.2174/1381612824666180730104707}.
\item Anisha Lela Larsson (2017). \textit{Mikrodosering av lysergsyradietylamid och psilocybin och dess effekter på psykisk hälsa}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476}{source link}.
\item Landon M. Klein (2017). \textit{If you give a mouse a mushroom: Behavioral effects of hallucinogens in mice}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/3bx3d6pf}{source link}.
\item University of Helsinki (2017). \textit{Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03380442}{source link}.
\item Joanna Stefaniuk (2017). \textit{„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku}. CeON Repository (Centre for Evaluation in Education and Science). [published; OpenAlex]. \href{https://depot.ceon.pl/handle/123456789/13483}{source link}.
\item Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR (2017). \textit{Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.}. Clinical pharmacokinetics. [published; PubMed]. \href{https://doi.org/10.1007/s40262-017-0540-6}{doi:10.1007/s40262-017-0540-6}.
\item Barbara Geller (2017). \textit{Can Psilocybin Treat Severe Depression}. Journal watch. [published; OpenAlex]. \href{https://doi.org/10.1056/nejm-jw.na45292}{doi:10.1056/nejm-jw.na45292}.
\item Mason Marks (2017). \textit{Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal Obstacles}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/Delivery.cfm/SSRN\_ID3181777\_code2827981.pdf?abstractid=3065035\&mirid=1}{source link}.
\item Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV (2017). \textit{Psychedelic Drugs in Biomedicine.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2017.08.003}{doi:10.1016/j.tips.2017.08.003}.
\item Barrett FS, Johnson MW, Griffiths RR (2017). \textit{Neuroticism is associated with challenging experiences with psilocybin mushrooms.}. Personality and individual differences. [published; PubMed]. \href{https://doi.org/10.1016/j.paid.2017.06.004}{doi:10.1016/j.paid.2017.06.004}.
\item Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ (2017). \textit{Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/s41598-017-13282-7}{doi:10.1038/s41598-017-13282-7}.
\item Dolder PC, Schmid Y, Steuer AE, Kraemer T, Rentsch KM, Hammann F, Liechti ME (2017). \textit{Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.}. Clinical pharmacokinetics. [published; PubMed]. \href{https://doi.org/10.1007/s40262-017-0513-9}{doi:10.1007/s40262-017-0513-9}.
\item Carhart-Harris RL, Goodwin GM (2017). \textit{The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/npp.2017.84}{doi:10.1038/npp.2017.84}.
\item Sellers EM (2017). \textit{Psilocybin: Good Trip or Bad Trip.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.697}{doi:10.1002/cpt.697}.
\item Larsen JK (2017). \textit{LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.}. Nordic journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1080/08039488.2017.1336251}{doi:10.1080/08039488.2017.1336251}.
\item Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX (2017). \textit{Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.}. NeuroImage. [published; PubMed]. \href{https://doi.org/10.1016/j.neuroimage.2017.07.020}{doi:10.1016/j.neuroimage.2017.07.020}.
\item Fricke J, Blei F, Hoffmeister D (2017). \textit{Enzymatic Synthesis of Psilocybin.}. Angewandte Chemie (International ed. in English). [published; PubMed]. \href{https://doi.org/10.1002/anie.201705489}{doi:10.1002/anie.201705489}.
\item Ahmed Al-Imam (2017). \textit{Google Trends Analyses and Case Report: A Persistently Dilated Pupil in Psychedelics’ User}. Global Journal of Health Science. [published; OpenAlex]. \href{https://doi.org/10.5539/gjhs.v9n11p168}{doi:10.5539/gjhs.v9n11p168}.
\item Andersson M, Persson M, Kjellgren A (2017). \textit{Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-017-0186-6}{doi:10.1186/s12954-017-0186-6}.
\item Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX (2017). \textit{Effect of Psilocybin on Empathy and Moral Decision-Making.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyx047}{doi:10.1093/ijnp/pyx047}.
\item STEVE RITTER (2017). \textit{‘Magic mushroom’ enzyme mystery solved}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09533-notw1}{doi:10.1021/cen-09533-notw1}.
\item Chris Letheby (2017). \textit{NATURALIZING PSYCHEDELIC SPIRITUALITY}. Zygon®. [published; OpenAlex]. \href{https://doi.org/10.1111/zygo.12353}{doi:10.1111/zygo.12353}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. (2017). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/176347}{doi:10.1101/176347}.
\item Janis Fricke, Felix Blei, Dirk Hoffmeister (2017). \textit{Enzymatische Synthese von Psilocybin}. Angewandte Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/ange.201705489}{doi:10.1002/ange.201705489}.
\item Jeanne G, Purper-Ouakil D, Rigole H, Franc N (2017). \textit{[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/j.encep.2016.05.012}{doi:10.1016/j.encep.2016.05.012}.
\item Forstmann M, Sagioglou C (2017). \textit{Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881117714049}{doi:10.1177/0269881117714049}.
\item Fabregat-Safont D, Barneo-Muñoz M, Martinez-Garcia F, Sancho JV, Hernández F, Ibáñez M (2017). \textit{Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.}. Journal of chromatography. A. [published; PubMed]. \href{https://doi.org/10.1016/j.chroma.2017.06.010}{doi:10.1016/j.chroma.2017.06.010}.
\item Paul May (2017). \textit{Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]}. Bristol Research (University of Bristol). [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.5245549}{doi:10.6084/m9.figshare.5245549}.
\item Jonathan Nash (2017). \textit{Navigating Psychedelic Medicines through (Inter)national Regulation}. Northumbria Research Link (Northumbria University). [published; OpenAlex]. \href{http://nrl.northumbria.ac.uk/id/eprint/31692/1/\_\_Client\_H\%24\_Documents\_Breaking\%20Convention\%202017\%20Final.pptx}{source link}.
\item Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR (2017). \textit{An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116684335}{doi:10.1177/0269881116684335}.
\item Johnson MW, Griffiths RR (2017). \textit{Potential Therapeutic Effects of Psilocybin.}. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. [published; PubMed]. \href{https://doi.org/10.1007/s13311-017-0542-y}{doi:10.1007/s13311-017-0542-y}.
\item Majić T, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J (2017). \textit{[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].}. Fortschritte der Neurologie-Psychiatrie. [published; PubMed]. \href{https://doi.org/10.1055/s-0043-103085}{doi:10.1055/s-0043-103085}.
\item Feng LY, Battulga A, Han E, Chung H, Li JH (2017). \textit{New psychoactive substances of natural origin: A brief review.}. Journal of food and drug analysis. [published; PubMed]. \href{https://doi.org/10.1016/j.jfda.2017.04.001}{doi:10.1016/j.jfda.2017.04.001}.
\item Janis Phelps (2017). \textit{Developing Guidelines and Competencies for the Training of Psychedelic Therapists}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817711304}{doi:10.1177/0022167817711304}.
\item Rosalind Watts, Camilla Day, Jacob Krzanowski, David Nutt, Robin Carhart-Harris (2017). \textit{Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817709585}{doi:10.1177/0022167817709585}.
\item Strauss N (2017). \textit{Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia.}. The Medical journal of Australia. [published; PubMed]. \href{https://doi.org/10.5694/mja17.00081}{doi:10.5694/mja17.00081}.
\item Thomas Cody Swift, Alexander Belser, Gabrielle Agin-Liebes, Neşe Devenot, Sara Terrana, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross (2017). \textit{Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817715966}{doi:10.1177/0022167817715966}.
\item Anne Walley (2017). \textit{The Effects of LSD and Psilocin on Anxiety-Related Behaviours in Zebrafish}. Student Research Proceedings. [published; OpenAlex]. \href{https://journals.macewan.ca/studentresearch/article/view/1171}{source link}.
\item Liechti ME, Dolder PC, Schmid Y (2017). \textit{Alterations of consciousness and mystical-type experiences after acute LSD in humans.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-016-4453-0}{doi:10.1007/s00213-016-4453-0}.
\item Alexander Belser, Gabrielle Agin-Liebes, Thomas Cody Swift, Sara Terrana, Neşe Devenot, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross (2017). \textit{Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817706884}{doi:10.1177/0022167817706884}.
\item Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD (2017). \textit{Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.}. Scientific reports. [published; PubMed]. \href{https://doi.org/10.1038/srep46421}{doi:10.1038/srep46421}.
\item Stephen Bright, M.L. Williams, David Caldicott (2017). \textit{Should addiction researchers be interested in psychedelic science?}. Drug and Alcohol Review. [published; OpenAlex]. \href{https://doi.org/10.1111/dar.12544}{doi:10.1111/dar.12544}.
\item Jonathan Nash (2017). \textit{The Development and Regulation of Psychedelic Medicines}. Northumbria Research Link (Northumbria University). [published; OpenAlex]. \href{http://nrl.northumbria.ac.uk/id/eprint/31696/1/SLSA.pptx}{source link}.
\item Thomas W. Flanagan, Melaine N. Sebastian, Charles D. Nichols (2017). \textit{Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma models}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.31.1\_supplement.820.4}{doi:10.1096/fasebj.31.1\_supplement.820.4}.
\item Dos Santos RG, Bouso JC, Hallak JEC (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item Schenk-Jaeger KM, Hofer-Lentner KE, Plenert B, Eckart D, Haberl B, Schulze G, Borchert-Avalone J, Stedtler U, Pfab R (2017). \textit{No clinically relevant effects in children after accidental ingestion of Panaeolina foenisecii (lawn mower's mushroom).}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2016.1271129}{doi:10.1080/15563650.2016.1271129}.
\item Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S (2017). \textit{The fibrinolytic system: A new target for treatment of depression with psychedelics.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1016/j.mehy.2017.01.013}{doi:10.1016/j.mehy.2017.01.013}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR (2017). \textit{Psilocybin for treating substance use disorders?}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Nichols DE, Johnson MW, Nichols CD (2017). \textit{Psychedelics as Medicines: An Emerging New Paradigm.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.557}{doi:10.1002/cpt.557}.
\item Huestis MA, Tyndale RF (2017). \textit{Designer Drugs 2.0.}. Clinical pharmacology and therapeutics. [published; PubMed]. \href{https://doi.org/10.1002/cpt.575}{doi:10.1002/cpt.575}.
\item Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths (2017). \textit{Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settings}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2016.08.107}{doi:10.1016/j.drugalcdep.2016.08.107}.
\item Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths (2017). \textit{Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2016.08.058}{doi:10.1016/j.drugalcdep.2016.08.058}.
\item Dinis-Oliveira Ricardo Jorge (2017). \textit{Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance}. Drug Metabolism Reviews. [published; Crossref]. \href{https://doi.org/10.1080/03602532.2016.1278228}{doi:10.1080/03602532.2016.1278228}.
\item Paul May (2017). \textit{Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.5245549.v1}{doi:10.6084/m9.figshare.5245549.v1}.
\item Krishna Lavanya, T.R. Baggi (2017). \textit{A New Spectrophotometric Method for the Determination of Psilocin and Psilocybin}. International Journal of Analytical and Applied Chemistry. [published; OpenAlex]. \href{http://chemical.journalspub.info/index.php?journal=JAAC\&page=article\&op=view\&path\%5B\%5D=263}{source link}.
\item Keli A. Herr (2017). \textit{Sex Differences in Serotonergic and Dopaminergic Mediation of LSD Discrimination in Rats}. ScholarWorks - WMU (Western Michigan University). [published; OpenAlex]. \href{https://scholarworks.wmich.edu/dissertations/3170}{source link}.
\item Henry A. Nasrallah (2017). \textit{Maddening Therapies: How Hallucinogens Morphed into Novel Treatments}. Current psychiatry. [published; OpenAlex]. \href{https://www.questia.com/library/journal/1G1-480992660/maddening-therapies-how-hallucinogens-morphed-into}{source link}.
\item Carlyn Delavan (2017). \textit{Narrative therapy-assisted psilocybin use for treatment of depression}. Seattle Pacific University Research Conference. [published; OpenAlex]. \href{https://digitalcommons.spu.edu/spfc\_research\_conference/spfc\_conf\_2017/spfc\_conf\_2017\_events/43/}{source link}.
\item Piret Saar-Reismaa, Merike Vaher, Mihkel Kaljurand, Maria Kulp, Jekaterina Mazina-Šinkar (2017). \textit{Simultaneous determination of γ-hydroxybutyric acid, ibotenic acid and psilocybin in saliva samples by capillary electrophoresis coupled with a contactless conductivity detector}. Analytical Methods. [published; OpenAlex]. \href{https://doi.org/10.1039/c7ay00742f}{doi:10.1039/c7ay00742f}.
\item Golden C. (2017). \textit{Neuronal dynamics of the anterior cingulate cortex during working memory and serotonergic manipulation}. Imperial College London. [published; Europe PMC]. \href{https://doi.org/10.25560/45527}{doi:10.25560/45527}.
\item Johnson MW, Garcia-Romeu A, Griffiths RR (2017). \textit{Long-term follow-up of psilocybin-facilitated smoking cessation.}. The American journal of drug and alcohol abuse. [published; PubMed]. \href{https://doi.org/10.3109/00952990.2016.1170135}{doi:10.3109/00952990.2016.1170135}.
\item Bogenschutz MP (2017). \textit{It's time to take psilocybin seriously as a possible treatment for substance use disorders.}. The American journal of drug and alcohol abuse. [published; PubMed]. \href{https://doi.org/10.1080/00952990.2016.1200060}{doi:10.1080/00952990.2016.1200060}.
\item Bodnar Willard MA, McGuffin VL, Smith RW (2017). \textit{Statistical comparison of mass spectra for identification of amphetamine-type stimulants.}. Forensic science international. [published; PubMed]. \href{https://doi.org/10.1016/j.forsciint.2016.11.013}{doi:10.1016/j.forsciint.2016.11.013}.
\item Dasgupta A (2017). \textit{Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse.}. Advances in clinical chemistry. [published; PubMed]. \href{https://doi.org/10.1016/bs.acc.2016.07.004}{doi:10.1016/bs.acc.2016.07.004}.
\item Mahapatra A, Gupta R (2017). \textit{Role of psilocybin in the treatment of depression.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125316676092}{doi:10.1177/2045125316676092}.
\item Kraehenmann R (2017). \textit{Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1573413713666170619092629}{doi:10.2174/1573413713666170619092629}.
\item Al-Imam A (2017). \textit{Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand.}. Case reports in neurological medicine. [published; PubMed]. \href{https://doi.org/10.1155/2017/2503762}{doi:10.1155/2017/2503762}.
\item Letheby C, Gerrans P (2017). \textit{Self unbound: ego dissolution in psychedelic experience.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/nix016}{doi:10.1093/nc/nix016}.
\item Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR (2017). \textit{Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2017.01238}{doi:10.3389/fpsyg.2017.01238}.
\item Thomas K, Malcolm B, Lastra D (2017). \textit{Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2017.1320734}{doi:10.1080/02791072.2017.1320734}.
\item Kraehenmann R, Pokorny D, Aicher H, Preller KH, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX (2017). \textit{LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2017.00814}{doi:10.3389/fphar.2017.00814}.
\item Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F (2017). \textit{The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2017.00240}{doi:10.3389/fpsyt.2017.00240}.
\item Roseman L, Nutt DJ, Carhart-Harris RL (2017). \textit{Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2017.00974}{doi:10.3389/fphar.2017.00974}.
\item Daniel J, Haberman M (2017). \textit{Clinical potential of psilocybin as a treatment for mental health conditions.}. The mental health clinician. [published; PubMed]. \href{https://doi.org/10.9740/mhc.2017.01.024}{doi:10.9740/mhc.2017.01.024}.
\item Natalie Engström (2016). \textit{Lysergsyradietylamid (LSD) och psilocybin vid depression och ångestsjukdom: En litteraturstudie om effekter och biverkningar av LSD- och psilocybin-assisterad psykoterapi}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681}{source link}.
\item Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR (2016). \textit{Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116662634}{doi:10.1177/0269881116662634}.
\item Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC (2016). \textit{Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2016.10.026}{doi:10.1016/j.neubiorev.2016.10.026}.
\item Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR (2016). \textit{The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116678781}{doi:10.1177/0269881116678781}.
\item Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH (2016). \textit{Psychedelics in the treatment of unipolar mood disorders: a systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116679368}{doi:10.1177/0269881116679368}.
\item Nutt D (2016). \textit{Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675754}{doi:10.1177/0269881116675754}.
\item Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL (2016). \textit{Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675512}{doi:10.1177/0269881116675512}.
\item Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA (2016). \textit{Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675513}{doi:10.1177/0269881116675513}.
\item Goodwin GM (2016). \textit{Psilocybin: Psychotherapy or drug?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675757}{doi:10.1177/0269881116675757}.
\item Summergrad P (2016). \textit{Psilocybin in end of life care: Implications for further research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675758}{doi:10.1177/0269881116675758}.
\item Shelton RC, Hendricks PS (2016). \textit{Psilocybin and palliative end-of-life care.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675764}{doi:10.1177/0269881116675764}.
\item McCorvy JD, Olsen RH, Roth BL (2016). \textit{Psilocybin for depression and anxiety associated with life-threatening illnesses.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675771}{doi:10.1177/0269881116675771}.
\item Kelmendi B, Corlett P, Ranganathan M, D'Souza C, Krystal JH (2016). \textit{The role of psychedelics in palliative care reconsidered: A case for psilocybin.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675781}{doi:10.1177/0269881116675781}.
\item Spiegel D (2016). \textit{Psilocybin-assisted psychotherapy for dying cancer patients - aiding the final trip.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675783}{doi:10.1177/0269881116675783}.
\item Breckenridge A, Grobbee DE (2016). \textit{Psilocybin: promising results in double-blind trials require confirmation by real-world evidence.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881116675784}{doi:10.1177/0269881116675784}.
\item Patra S (2016). \textit{Return of the psychedelics: Psilocybin for treatment resistant depression.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2016.08.010}{doi:10.1016/j.ajp.2016.08.010}.
\item Celia J. A. Morgan, Amy McAndrew, Tobias Stevens, David Nutt, Will Lawn (2016). \textit{Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use}. Current Opinion in Behavioral Sciences. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cobeha.2016.10.009}{doi:10.1016/j.cobeha.2016.10.009}.
\item Michael P. Bogenschutz, Alyssa A. Forcehimes (2016). \textit{Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816673493}{doi:10.1177/0022167816673493}.
\item Filip Tylš, Čestmír Vejmola, Michaela Viktorinová, L. Kadeřábek, Tomáš Páleníček (2016). \textit{Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31133-6}{doi:10.1016/s0924-977x(16)31133-6}.
\item O. Grimm, Rainer Krähenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2016). \textit{Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31070-7}{doi:10.1016/s0924-977x(16)31070-7}.
\item Kyzar EJ, Kalueff AV (2016). \textit{Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models.}. Zebrafish. [published; PubMed]. \href{https://doi.org/10.1089/zeb.2016.1251}{doi:10.1089/zeb.2016.1251}.
\item Karolina Dydak, Mariola Śliwińska-Mossoń, Halina Milnerowicz (2016). \textit{Psilocybin as an alternative medicine for patients suffering from depression}. Psychiatria i Psychologia Kliniczna. [published; OpenAlex]. \href{https://doi.org/10.15557/pipk.2016.0023}{doi:10.15557/pipk.2016.0023}.
\item William A. Richards (2016). \textit{Psychedelic Psychotherapy: Insights From 25 Years of Research}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816670996}{doi:10.1177/0022167816670996}.
\item Hendrie C, Pickles A (2016). \textit{Psilocybin: panacea or placebo?}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(16)30103-1}{doi:10.1016/s2215-0366(16)30103-1}.
\item Dijkstra FM, Jacobs GE, Cohen AF (2016). \textit{Question-based Drug Development for psilocybin.}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(16)30214-0}{doi:10.1016/s2215-0366(16)30214-0}.
\item Carhart-Harris RL, Nutt DJ (2016). \textit{Question-based Drug Development for psilocybin - Authors' reply.}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(16)30217-6}{doi:10.1016/s2215-0366(16)30217-6}.
\item Cornel N. Stanciu, Thomas M. Penders (2016). \textit{Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; A Review with Illustrative Case}. Current Psychiatry Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/1573400512999160803102947}{doi:10.2174/1573400512999160803102947}.
\item Rickli A, Moning OD, Hoener MC, Liechti ME (2016). \textit{Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2016.05.001}{doi:10.1016/j.euroneuro.2016.05.001}.
\item Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ (2016). \textit{Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(16)30065-7}{doi:10.1016/s2215-0366(16)30065-7}.
\item Cowen P (2016). \textit{Altered states: psilocybin for treatment-resistant depression.}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(16)30087-6}{doi:10.1016/s2215-0366(16)30087-6}.
\item Hardaway R, Schweitzer J, Suzuki J (2016). \textit{Hallucinogen Use Disorders.}. Child and adolescent psychiatric clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.chc.2016.03.006}{doi:10.1016/j.chc.2016.03.006}.
\item Howland RH (2016). \textit{Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.}. Journal of psychosocial nursing and mental health services. [published; PubMed]. \href{https://doi.org/10.3928/02793695-20160616-09}{doi:10.3928/02793695-20160616-09}.
\item Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J (2016). \textit{Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyw016}{doi:10.1093/ijnp/pyw016}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{ChemInform Abstract: Observations Concerning the Synthesis of Tryptamine Homologues and Branched Tryptamine Derivatives via the Borrowing Hydrogen Process: Synthesis of Psilocin, Bufotenin, and Serotonin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.201633131}{doi:10.1002/chin.201633131}.
\item Charlotte Walsh (2016). \textit{MAGIC MUSHROOMS: from sacred entheogen to Class A drug}. Entertainment and Sports Law Journal. [published; OpenAlex]. \href{https://doi.org/10.16997/eslj.100}{doi:10.16997/eslj.100}.
\item Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE (2016). \textit{Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125316638008}{doi:10.1177/2045125316638008}.
\item Tylš Filip, Páleníček Tomáš, Kadeřábek Lukáš, Lipski Michaela, Kubešová Anna, Horáček Jiří (2016). \textit{Sex differences and serotonergic mechanisms in the behavioural effects of psilocin}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/fbp.0000000000000198}{doi:10.1097/fbp.0000000000000198}.
\item Gambaro Veniero, Roda Gabriella, Visconti Giacomo Luca, Arnoldi Sebastiano, Casagni Eleonora, Dell’Acqua Lucia, Farè Fiorenza, Paladino Eleonora, Rusconi Chiara, Arioli Stefania, Mora Diego (2016). \textit{DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin}. Journal of Pharmaceutical and Biomedical Analysis. [published; Crossref]. \href{https://doi.org/10.1016/j.jpba.2016.03.043}{doi:10.1016/j.jpba.2016.03.043}.
\item Tyls F, Michaela Viktorinova T, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J. (2016). \textit{PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC5616440}{source link}.
\item Palenicek T, Tyls F, Viktorinova M, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J. (2016). \textit{PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary report}. The international journal of neuropsychopharmacology. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC5616436}{source link}.
\item Tomáš Páleníček, Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský, Jiřı́ Horáček (2016). \textit{PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary report}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyw041.502}{doi:10.1093/ijnp/pyw041.502}.
\item Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský, Jiřı́ Horáček (2016). \textit{PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyw041.506}{doi:10.1093/ijnp/pyw041.506}.
\item Joseph A. Zamaria (2016). \textit{A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects}. NeuroQuantology. [published; OpenAlex]. \href{https://doi.org/10.14704/nq.2016.14.2.943}{doi:10.14704/nq.2016.14.2.943}.
\item Hawkes N (2016). \textit{Sixty seconds on... psilocybin.}. BMJ (Clinical research ed.). [published; PubMed]. \href{https://doi.org/10.1136/bmj.i2775}{doi:10.1136/bmj.i2775}.
\item Tom Froese, Gastón Guzmán, Laura Guzmán-Dávalos (2016). \textit{On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe1}. Economic Botany. [published; OpenAlex]. \href{https://doi.org/10.1007/s12231-016-9342-2}{doi:10.1007/s12231-016-9342-2}.
\item Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E, Scheidegger M, Vollenweider FX (2016). \textit{Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.1524187113}{doi:10.1073/pnas.1524187113}.
\item Mithoefer MC, Grob CS, Brewerton TD (2016). \textit{Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.}. The lancet. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s2215-0366(15)00576-3}{doi:10.1016/s2215-0366(15)00576-3}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotonin}. Tetrahedron. [published; Crossref]. \href{https://doi.org/10.1016/j.tet.2016.03.007}{doi:10.1016/j.tet.2016.03.007}.
\item Nichols DE (2016). \textit{Psychedelics.}. Pharmacological reviews. [published; PubMed]. \href{https://doi.org/10.1124/pr.115.011478}{doi:10.1124/pr.115.011478}.
\item Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX (2016). \textit{Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2016.01.005}{doi:10.1016/j.euroneuro.2016.01.005}.
\item Suzuki K (2016). \textit{[Three cases of acute serotonin syndrome due to psilocybin mushroom poisoning].}. Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/27255023/}{source link}.
\item Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis (2016). \textit{The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eurpsy.2016.01.1060}{doi:10.1016/j.eurpsy.2016.01.1060}.
\item Johns Hopkins University (2016). \textit{Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00802282}{source link}.
\item Davenport WJ (2016). \textit{Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache.}. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. [published; PubMed]. \href{https://doi.org/10.1503/cmaj.1150082}{doi:10.1503/cmaj.1150082}.
\item Di Lorenzo C, Coppola G, Di Lorenzo G, Bracaglia M, Rossi P, Pierelli F (2016). \textit{The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey.}. Cephalalgia: an international journal of headache. [published; PubMed]. \href{https://doi.org/10.1177/0333102415583145}{doi:10.1177/0333102415583145}.
\item Bogenschutz MP, Johnson MW (2016). \textit{Classic hallucinogens in the treatment of addictions.}. Progress in neuro-psychopharmacology \& biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.pnpbp.2015.03.002}{doi:10.1016/j.pnpbp.2015.03.002}.
\item C. Meribha Christy (2016). \textit{MAGIC MUSHROOM AND ITS EFFECTIVENESS}. International Journal of Pharma and Bio Sciences. [published; OpenAlex]. \href{https://ijpbs.net/abstract.php?article=NTMzNw==}{source link}.
\item Joseph Havens (2016). \textit{MEMO ON THE RELIGIOUS IMPLICATIONS OF THE CONSCIOUSNESS-CHANGING DRUGS (LSD, Mescalin, Psilocybin)}. Journal for the Scientific Study of Religion. [published; OpenAlex]. \href{https://www.jstor.org/stable/1384511}{source link}.
\item Dimitria Electra Gatzia, Berit Brogaard (2016). \textit{Psilocybin, LSD, Mescaline and drug-induced synesthesia}. PhilPapers (PhilPapers Foundation). [published; OpenAlex]. \href{https://philarchive.org/rec/BROPLM}{source link}.
\item Letheby C (2016). \textit{The epistemic innocence of psychedelic states.}. Consciousness and cognition. [published; PubMed]. \href{https://doi.org/10.1016/j.concog.2015.11.012}{doi:10.1016/j.concog.2015.11.012}.
\item Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX (2016). \textit{The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.}. NeuroImage. Clinical. [published; PubMed]. \href{https://doi.org/10.1016/j.nicl.2015.08.009}{doi:10.1016/j.nicl.2015.08.009}.
\item Tófoli LF, de Araujo DB (2016). \textit{Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2016.06.005}{doi:10.1016/bs.irn.2016.06.005}.
\item Shebloski KL, Broadway JM (2016). \textit{Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2016.00736}{doi:10.3389/fpsyg.2016.00736}.
\item Sweat NW, Bates LW, Hendricks PS (2016). \textit{The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2016.1234090}{doi:10.1080/02791072.2016.1234090}.
\item Nagy Julia, Veress Tibor (2016). \textit{HPLC Analysis of Hallucinogenic Mushroom Alkaloids (Psilocin and Psilocybin) Applying Hydrophilic Interaction Chromatography (HILIC)}. Journal of Forensic Research. [published; Crossref]. \href{https://doi.org/10.4172/2157-7145.1000356}{doi:10.4172/2157-7145.1000356}.
\item Susanna Prepeliczay (2015). \textit{Motivationen und Morphologie des Freizeitgebrauchs von Psychedelika (LSD, Psilocybin-Pilze): eine qualitative Interviewstudie}. University of Bremen. [published; OpenAlex]. \href{http://elib.suub.uni-bremen.de/peid=D00105749}{source link}.
\item Spain Aisling, Howarth Clare, Khrapitchev Alexandre A., Sharp Trevor, Sibson Nicola R., Martin Chris (2015). \textit{Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain}. Neuropharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.neuropharm.2015.07.018}{doi:10.1016/j.neuropharm.2015.07.018}.
\item Albert Garcia-Romeu, Tehseen Noorani, Roland R. Griffiths, Matthew W. Johnson (2015). \textit{Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2015.07.1130}{doi:10.1016/j.drugalcdep.2015.07.1130}.
\item Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths (2015). \textit{Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybin}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2015.07.961}{doi:10.1016/j.drugalcdep.2015.07.961}.
\item Barrett FS, Johnson MW, Griffiths RR (2015). \textit{Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881115609019}{doi:10.1177/0269881115609019}.
\item Theresa M. Carbonaro, Margaret A. Klinedinst, Matthew W. Johnson, Roland R. Griffiths (2015). \textit{Comparative phenomenology of psilocybin experiences in research and non-research settings}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2015.07.1017}{doi:10.1016/j.drugalcdep.2015.07.1017}.
\item Stephen Mo Hanan (2015). \textit{The Psyche in Psychedelic}. Tikkun. [published; OpenAlex]. \href{https://doi.org/10.1215/08879982-3328661}{doi:10.1215/08879982-3328661}.
\item Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX (2015). \textit{Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2014.04.010}{doi:10.1016/j.biopsych.2014.04.010}.
\item Geyer MA (2015). \textit{Lysergic Acid Diethylamide and Psilocybin Revisited.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2015.08.003}{doi:10.1016/j.biopsych.2015.08.003}.
\item Kometer M, Pokorny T, Seifritz E, Volleinweider FX (2015). \textit{Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-015-4026-7}{doi:10.1007/s00213-015-4026-7}.
\item Lowe LM, Peterson BL, Couper FJ (2015). \textit{A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.}. Journal of analytical toxicology. [published; PubMed]. \href{https://doi.org/10.1093/jat/bkv092}{doi:10.1093/jat/bkv092}.
\item Dydak K, Śliwińska-Mossoń M, Milnerowicz H (2015). \textit{[Psilocybin - public available psychodysleptic].}. Postepy higieny i medycyny doswiadczalnej (Online). [published; PubMed]. \href{https://doi.org/10.5604/01.3001.0009.6569}{doi:10.5604/01.3001.0009.6569}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(15)30364-3}{doi:10.1016/s0924-977x(15)30364-3}.
\item Hendricks PS, Johnson MW, Griffiths RR (2015). \textit{Psilocybin, psychological distress, and suicidality.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881115598338}{doi:10.1177/0269881115598338}.
\item Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M (2015). \textit{The hallucinogenic world of tryptamines: an updated review.}. Archives of toxicology. [published; PubMed]. \href{https://doi.org/10.1007/s00204-015-1513-x}{doi:10.1007/s00204-015-1513-x}.
\item Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL (2015). \textit{Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.}. Human brain mapping. [published; PubMed]. \href{https://doi.org/10.1002/hbm.22833}{doi:10.1002/hbm.22833}.
\item Wiltshire PE, Hawksworth DL, Edwards KJ (2015). \textit{Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death.}. Journal of forensic and legal medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.jflm.2015.05.010}{doi:10.1016/j.jflm.2015.05.010}.
\item Borovička J, Oborník M, Stříbrný J, Noordeloos ME, Parra Sánchez LA, Gryndler M (2015). \textit{Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes.}. Persoonia. [published; PubMed]. \href{https://doi.org/10.3767/003158515x685283}{doi:10.3767/003158515x685283}.
\item Patricia A. Helvenston (2015). \textit{Psilocybin-containing mushrooms, upper palaeolithic rock art and the neuropsychological model}. Rock Art Research. [published; OpenAlex]. \href{https://search.informit.com.au/documentSummary;dn=997302336792843;res=IELIND}{source link}.
\item Baumeister D, Tojo LM, Tracy DK (2015). \textit{Legal highs: staying on top of the flood of novel psychoactive substances.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314559539}{doi:10.1177/2045125314559539}.
\item Jochen Gartz, Georg Wiedemann (2015). \textit{Discovery of a new caerulescent Psilocybe mushroom in Germany: Psilocybe germanica sp.nov.}. Drug Testing and Analysis. [published; OpenAlex]. \href{https://doi.org/10.1002/dta.1795}{doi:10.1002/dta.1795}.
\item Zhuk Olga, Jasicka-Misiak Izabela, Poliwoda Anna, Kazakova Anastasia, Godovan Vladlena, Halama Marek, Wieczorek Piotr (2015). \textit{Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice}. Toxins. [published; Crossref]. \href{https://doi.org/10.3390/toxins7041018}{doi:10.3390/toxins7041018}.
\item D.J. Nutt (2015). \textit{5HT2a Receptors - a New Target for Depression?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(15)30027-4}{doi:10.1016/s0924-9338(15)30027-4}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(15)30017-1}{doi:10.1016/s0924-9338(15)30017-1}.
\item Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ (2015). \textit{Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114565144}{doi:10.1177/0269881114565144}.
\item Hendricks PS, Thorne CB, Clark CB, Coombs DW, Johnson MW (2015). \textit{Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114565653}{doi:10.1177/0269881114565653}.
\item Majić T, Schmidt TT, Gallinat J (2015). \textit{Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568040}{doi:10.1177/0269881114568040}.
\item Johansen PØ, Krebs TS (2015). \textit{Psychedelics not linked to mental health problems or suicidal behavior: a population study.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568039}{doi:10.1177/0269881114568039}.
\item Cirriez JP (2015). \textit{[Ilicit drugs frequently used by drug addicts].}. Journal de pharmacie de Belgique. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/26571792/}{source link}.
\item Martin Rafaela, Schürenkamp Jennifer, Gasse Angela, Pfeiffer Heidi, Köhler Helga (2015). \textit{Analysis of Psilocin, Bufotenine and LSD in Hair}. Journal of Analytical Toxicology. [published; Crossref]. \href{https://doi.org/10.1093/jat/bku141}{doi:10.1093/jat/bku141}.
\item Steeds H, Carhart-Harris RL, Stone JM (2015). \textit{Drug models of schizophrenia.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314557797}{doi:10.1177/2045125314557797}.
\item Halberstadt AL (2015). \textit{Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.}. Behavioural brain research. [published; PubMed]. \href{https://doi.org/10.1016/j.bbr.2014.07.016}{doi:10.1016/j.bbr.2014.07.016}.
\item Kenny Farisan Badri, Sigit Kirana Lintang Bhima, Tuntas Dhanardhono (2015). \textit{PENGARUH PEMBERIAN EKSTRAK JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT TERHADAP RASA INGIN TAHU MENCIT SWISS WEBSTER YANG DIUKUR DENGAN MANUAL HOLE BOARD}. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal). [published; OpenAlex]. \href{https://www.neliti.com/publications/107936/pengaruh-pemberian-ekstrak-jamur-psilocybe-cubensis-dosis-bertingkat-terhadap-ra}{source link}.
\item Carod-Artal FJ (2015). \textit{Hallucinogenic drugs in pre-Columbian Mesoamerican cultures.}. Neurologia (Barcelona, Spain). [published; PubMed]. \href{https://doi.org/10.1016/j.nrl.2011.07.003}{doi:10.1016/j.nrl.2011.07.003}.
\item Sessa B, Johnson MW (2015). \textit{Can psychedelic compounds play a part in drug dependence therapy?}. The British journal of psychiatry: the journal of mental science. [published; PubMed]. \href{https://doi.org/10.1192/bjp.bp.114.148031}{doi:10.1192/bjp.bp.114.148031}.
\item Tittarelli R, Mannocchi G, Pantano F, Romolo FS (2015). \textit{Recreational use, analysis and toxicity of tryptamines.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/1570159x13666141210222409}{doi:10.2174/1570159x13666141210222409}.
\item Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JA, Hallak JE, Ribeiro S, de Araujo DB (2015). \textit{The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0118143}{doi:10.1371/journal.pone.0118143}.
\item Gallimore AR (2015). \textit{Restructuring consciousness -the psychedelic state in light of integrated information theory.}. Frontiers in human neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnhum.2015.00346}{doi:10.3389/fnhum.2015.00346}.
\item Schindler EA, Gottschalk CH, Weil MJ, Shapiro RE, Wright DA, Sewell RA (2015). \textit{Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2015.1107664}{doi:10.1080/02791072.2015.1107664}.
\item Veniero Gambaro, Gabriella Roda, Giacomo Luca Visconti, Sebastiano Arnoldi, Eleonora Casagni, Caterina Ceravolo, Lucia Dell’Acqua, Fiorenza Farè, Chiara Rusconi, Lucia Tamborini, Stefania Arioli, Diego Mora (2015). \textit{Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and Psilocin}. Journal of Analytical \& Bioanalytical Techniques. [published; Crossref]. \href{https://doi.org/10.4172/2155-9872.1000277}{doi:10.4172/2155-9872.1000277}.
\item Sakashita Yuichi, Abe Kenji, Katagiri Nobuyuki, Kambe Toshie, Saitoh Toshiaki, Utsunomiya Iku, Horiguchi Yoshie, Taguchi Kyoji (2015). \textit{Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats}. Biological \textasciicircum{}|\textasciicircum{} Pharmaceutical Bulletin. [published; Crossref]. \href{https://doi.org/10.1248/bpb.b14-00315}{doi:10.1248/bpb.b14-00315}.
\item Ben Sessa (2014). \textit{Turn on and tune in to evidence-based psychedelic research}. The Lancet Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s2215-0366(14)00120-5}{doi:10.1016/s2215-0366(14)00120-5}.
\item Theresa M. Carbonaro, Frederick S. Barrett, Matthew P. Bradstreet, Matthew W. Johnson, Katherine A. MacLean, Robert L. Jesse, Roland R. Griffiths (2014). \textit{Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenology}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.09.118}{doi:10.1016/j.drugalcdep.2014.09.118}.
\item Frederick S. Barrett, Matthew P. Bradstreet, Jeannie-Marie Leoutsakos, Matthew W. Johnson, Katherine A. MacLean, Robert L. Jesse, Roland R. Griffiths (2014). \textit{The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.09.060}{doi:10.1016/j.drugalcdep.2014.09.060}.
\item Petri G, Expert P, Turkheimer F, Carhart-Harris R, Nutt D, Hellyer PJ, Vaccarino F (2014). \textit{Homological scaffolds of brain functional networks.}. Journal of the Royal Society, Interface. [published; PubMed]. \href{https://doi.org/10.1098/rsif.2014.0873}{doi:10.1098/rsif.2014.0873}.
\item Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX (2014). \textit{Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.}. Cerebral cortex (New York, N.Y.: 1991). [published; PubMed]. \href{https://doi.org/10.1093/cercor/bht178}{doi:10.1093/cercor/bht178}.
\item Marek Halama, Anna Poliwoda, Іzabela Jasicka-Misiak, Piotr Wieczorek, Ryszard Rutkowski (2014). \textit{Pholiotina cyanopus, a rare fungus producingpsychoactive tryptamines}. Open Life Sciences. [published; OpenAlex]. \href{https://doi.org/10.1515/biol-2015-0005}{doi:10.1515/biol-2015-0005}.
\item Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR (2014). \textit{Enhanced repertoire of brain dynamical states during the psychedelic experience.}. Human brain mapping. [published; PubMed]. \href{https://doi.org/10.1002/hbm.22562}{doi:10.1002/hbm.22562}.
\item Pichini S, Marchei E, García-Algar O, Gomez A, Di Giovannandrea R, Pacifici R (2014). \textit{Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers.}. Journal of pharmaceutical and biomedical analysis. [published; PubMed]. \href{https://doi.org/10.1016/j.jpba.2014.08.006}{doi:10.1016/j.jpba.2014.08.006}.
\item Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR (2014). \textit{Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114548296}{doi:10.1177/0269881114548296}.
\item Franck Vandermoere, Philippe Marin (2014). \textit{Hallucinogens induce a specific barcode of phosphorylation on the serotonin2A receptor that underlies a weaker receptor desensitization and internalization}. Receptors \& Clinical Investigation. [published; OpenAlex]. \href{https://doi.org/10.14800/rci.230}{doi:10.14800/rci.230}.
\item Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2014). \textit{P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(14)70316-5}{doi:10.1016/s0924-977x(14)70316-5}.
\item Ron Cole-Turner (2014). \textit{ENTHEOGENS, MYSTICISM, AND NEUROSCIENCE}. Zygon®. [published; OpenAlex]. \href{https://doi.org/10.1111/zygo.12110}{doi:10.1111/zygo.12110}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Law Francis, Poon Grace, Chui Y. C., He Shao-Xiong (2014). \textit{14C-Psilocin tissue distribution in pregnant rats after intravenous administration}. Functional Foods in Health and Disease. [published; Crossref]. \href{https://doi.org/10.31989/ffhd.v4i6.9}{doi:10.31989/ffhd.v4i6.9}.
\item Appendino G, Minassi A, Taglialatela-Scafati O (2014). \textit{Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.}. Natural product reports. [published; PubMed]. \href{https://doi.org/10.1039/c4np00010b}{doi:10.1039/c4np00010b}.
\item Matthew P. Bradstreet, Matthew W. Johnson, Katherine A. MacLean, Roland R. Griffiths (2014). \textit{Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybin}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.02.072}{doi:10.1016/j.drugalcdep.2014.02.072}.
\item Albert Garcia-Romeu, Matthew W. Johnson, Roland R. Griffiths (2014). \textit{Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.02.200}{doi:10.1016/j.drugalcdep.2014.02.200}.
\item Rafael G. dos Santos (2014). \textit{Psychedelics, Glutamate, and Neuroimaging Studies}. Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.1097/aln.0000000000000243}{doi:10.1097/aln.0000000000000243}.
\item Johns Hopkins University (2014). \textit{Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01988311}{source link}.
\item Rambousek Lukas, Palenicek Tomas, Vales Karel, Stuchlik Ales (2014). \textit{The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat}. Frontiers in Behavioral Neuroscience. [published; Crossref]. \href{https://doi.org/10.3389/fnbeh.2014.00180}{doi:10.3389/fnbeh.2014.00180}.
\item Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prézeau L, Bockaert J, Marin P, Vandermoere F (2014). \textit{Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.}. Molecular \& cellular proteomics: MCP. [published; PubMed]. \href{https://doi.org/10.1074/mcp.m113.036558}{doi:10.1074/mcp.m113.036558}.
\item Martin Rafaela, Schürenkamp Jennifer, Pfeiffer Heidi, Lehr Matthias, Köhler Helga (2014). \textit{Synthesis, hydrolysis and stability of psilocin glucuronide}. Forensic Science International. [published; Crossref]. \href{https://doi.org/10.1016/j.forsciint.2014.01.006}{doi:10.1016/j.forsciint.2014.01.006}.
\item Damianus Diaz Ferianto (2014). \textit{TINJAUAN PELAKSANAAN KETENTUAN PIDANA UNDANGUNDANG NOMOR 35 TAHUN 2009 TERHADAP PENYALAHGUNAAN MAGIC MUSHROOM}. UAJY Repository (University of Southampton). [published; OpenAlex]. \href{https://openalex.org/W1489109450}{source link}.
\item Tylš F, Páleníček T, Horáček J (2014). \textit{Psilocybin--summary of knowledge and new perspectives.}. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.euroneuro.2013.12.006}{doi:10.1016/j.euroneuro.2013.12.006}.
\item Tyls F., Palenicek T., Novakova P., Kaderabek L., Fujakova M., Kubesova A., Horacek J. (2014). \textit{P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocin}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/s0924-977x(14)70111-7}{doi:10.1016/s0924-977x(14)70111-7}.
\item dos Santos Rafael G. (2014). \textit{Potential Therapeutic Effects of Psilocybin/Psilocin are Minimized While Possible Adverse Reactions are Overrated}. Therapeutic Drug Monitoring. [published; Crossref]. \href{https://doi.org/10.1097/ftd.0000000000000028}{doi:10.1097/ftd.0000000000000028}.
\item Charles S. Grob (2014). \textit{Psychedelic Research Resurrected: The Contributions of Stanislav Grof}. CIIS Digital Commons (California Institute of Integral Studies). [published; OpenAlex]. \href{https://digitalcommons.ciis.edu/stanislavgrof2014/6}{source link}.
\item Rick Doblin (2014). \textit{Stanislav Grof's Contributions to FDA Drug Development Research with Psychedelics}. CIIS Digital Commons (California Institute of Integral Studies). [published; OpenAlex]. \href{https://digitalcommons.ciis.edu/stanislavgrof2014/12}{source link}.
\item Mary P Cosimano (2014). \textit{My Experience as a Guide in the Johns Hopkins Psilocybin Research Project}. MAPS Bulletin. [published; OpenAlex]. \href{http://www.maps.org/news-letters/v24n3/v24n3\_p39-41.pdf}{source link}.
\item Robert L. Jesse, Roland R. Griffiths (2014). \textit{PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A 2014 REPORT}. Council on Spiritual Practices. [published; OpenAlex]. \href{http://csp.org/HopkinsPsilocybin2014.pdf}{source link}.
\item Faruk Aşıcıoğlu, Mustafa Okudan, Nilay Derman, Mahmut Koca (2014). \textit{Magic Mushroom Growing Kits: A new method for infringement of the narcotic laws.}. Turkish Journal of Forensic Medicine. [published; OpenAlex]. \href{https://doi.org/10.5505/adlitip.2014.60566}{doi:10.5505/adlitip.2014.60566}.
\item Winstock AR, Kaar S, Borschmann R (2014). \textit{Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881113513852}{doi:10.1177/0269881113513852}.
\item Hendricks PS, Clark CB, Johnson MW, Fontaine KR, Cropsey KL (2014). \textit{Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881113513851}{doi:10.1177/0269881113513851}.
\item Nichols DE (2014). \textit{The Heffter Research Institute: past and hopeful future.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2014.873688}{doi:10.1080/02791072.2014.873688}.
\item Garcia-Romeu A, Griffiths RR, Johnson MW (2014). \textit{Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.}. Current drug abuse reviews. [published; PubMed]. \href{https://doi.org/10.2174/1874473708666150107121331}{doi:10.2174/1874473708666150107121331}.
\item Turton S, Nutt DJ, Carhart-Harris RL (2014). \textit{A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.}. Current drug abuse reviews. [published; PubMed]. \href{https://doi.org/10.2174/1874473708666150107120930}{doi:10.2174/1874473708666150107120930}.
\item Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D (2014). \textit{The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.}. Frontiers in human neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnhum.2014.00020}{doi:10.3389/fnhum.2014.00020}.
\item Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL (2014). \textit{The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.}. Frontiers in human neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnhum.2014.00204}{doi:10.3389/fnhum.2014.00204}.
\item Wilcox JA (2014). \textit{Psilocybin and Obsessive Compulsive Disorder.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2014.963754}{doi:10.1080/02791072.2014.963754}.
\item Tomáš Páleníček, Filip Tylš, M. Fujáková, Anna Kubešová, Pavlína Nováková, L. Kadeřábek, Martin Brunovský, Jiřı́ Horáček (2013). \textit{EPA-0137 - EEG power spectra and connectivity changes in animal serotonergic and glutamatergic models of psychosis - implications for treatment}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(14)77609-6}{doi:10.1016/s0924-9338(14)77609-6}.
\item Javier González-Maeso (2013). \textit{EPA-1211 - Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic action}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(14)78457-3}{doi:10.1016/s0924-9338(14)78457-3}.
\item Charlesice Hawkins (2013). \textit{Literature review: Considerations for Psychedelic Research}. UC Merced Undergraduate Research Journal. [published; OpenAlex]. \href{https://doi.org/10.5070/m451020759}{doi:10.5070/m451020759}.
\item Icaza EE, Mashour GA (2013). \textit{Altered states: psychedelics and anesthetics.}. Anesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/01.anes.0000435635.42332.ee}{doi:10.1097/01.anes.0000435635.42332.ee}.
\item Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ (2013). \textit{Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.}. Schizophrenia bulletin. [published; PubMed]. \href{https://doi.org/10.1093/schbul/sbs117}{doi:10.1093/schbul/sbs117}.
\item Halberstadt AL, Geyer MA (2013). \textit{Serotonergic hallucinogens as translational models relevant to schizophrenia.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1017/s1461145713000722}{doi:10.1017/s1461145713000722}.
\item Deepak Prabhakar (2013). \textit{Exposure to Potent Hallucinogens in an Adolescent}. The Primary Care Companion For CNS Disorders. [published; OpenAlex]. \href{https://doi.org/10.4088/pcc.13l01552}{doi:10.4088/pcc.13l01552}.
\item Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ (2013). \textit{Broadband cortical desynchronization underlies the human psychedelic state.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.2063-13.2013}{doi:10.1523/jneurosci.2063-13.2013}.
\item Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM (2013). \textit{Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881113494107}{doi:10.1177/0269881113494107}.
\item Burdick BV, Adinoff B (2013). \textit{A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.}. The American journal of drug and alcohol abuse. [published; PubMed]. \href{https://doi.org/10.3109/00952990.2013.811513}{doi:10.3109/00952990.2013.811513}.
\item Robin Carhart-Harris (2013). \textit{PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2013-306103.17}{doi:10.1136/jnnp-2013-306103.17}.
\item Helander A, Beck O, Hägerkvist R, Hultén P (2013). \textit{Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.}. Scandinavian journal of clinical and laboratory investigation. [published; PubMed]. \href{https://doi.org/10.3109/00365513.2013.793817}{doi:10.3109/00365513.2013.793817}.
\item Catlow BJ, Song S, Paredes DA, Kirstein CL, Sanchez-Ramos J (2013). \textit{Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.}. Experimental brain research. [published; PubMed]. \href{https://doi.org/10.1007/s00221-013-3579-0}{doi:10.1007/s00221-013-3579-0}.
\item Stebelska Katarzyna (2013). \textit{Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol}. Therapeutic Drug Monitoring. [published; Crossref]. \href{https://doi.org/10.1097/ftd.0b013e31828741a5}{doi:10.1097/ftd.0b013e31828741a5}.
\item Kometer M, Schmidt A, Jäncke L, Vollenweider FX (2013). \textit{Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.3007-12.2013}{doi:10.1523/jneurosci.3007-12.2013}.
\item Hallock RM, Dean A, Knecht ZA, Spencer J, Taverna EC (2013). \textit{A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2012.11.010}{doi:10.1016/j.drugalcdep.2012.11.010}.
\item Martin Rafaela, Schürenkamp Jennifer, Gasse Angela, Pfeiffer Heidi, Köhler Helga (2013). \textit{Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS}. International Journal of Legal Medicine. [published; Crossref]. \href{https://doi.org/10.1007/s00414-012-0796-1}{doi:10.1007/s00414-012-0796-1}.
\item Nenad Manevski (2013). \textit{Activity and Enzyme Kinetics of Human UDP-Glucuronosyltransferases: Studies of Psilocin Glucuronidation and the Effects of Albumin on the Enzyme Kinetic Mechanism}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/38186}{source link}.
\item Pellegrini M, Rotolo MC, Marchei E, Pacifici R, Saggio F, Pichini S (2013). \textit{Magic truffles or Philosopher's stones: a legal way to sell psilocybin?}. Drug testing and analysis. [published; PubMed]. \href{https://doi.org/10.1002/dta.1400}{doi:10.1002/dta.1400}.
\item Young SN (2013). \textit{Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.}. Journal of psychiatry \& neuroscience: JPN. [published; PubMed]. \href{https://doi.org/10.1503/jpn.120128}{doi:10.1503/jpn.120128}.
\item Moreno JL, Holloway T, Rayannavar V, Sealfon SC, González-Maeso J (2013). \textit{Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.}. Neuroscience letters. [published; PubMed]. \href{https://doi.org/10.1016/j.neulet.2012.12.053}{doi:10.1016/j.neulet.2012.12.053}.
\item Bogenschutz MP (2013). \textit{Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.}. Current drug abuse reviews. [published; PubMed]. \href{https://doi.org/10.2174/15733998113099990002}{doi:10.2174/15733998113099990002}.
\item Hanks JB, González-Maeso J (2013). \textit{Animal models of serotonergic psychedelics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/cn300138m}{doi:10.1021/cn300138m}.
\item lhsan M Salloum (2013). \textit{The Use of Synthetic Cathinones and Tryptamines in a Psychiatric Population}. Journal of Forensic Toxicology and Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.4172/2325-9841.1000109}{doi:10.4172/2325-9841.1000109}.
\item Mochamad Muntaha, Sigit Kirana Lintang Bhima, Tuntas Dhanardhono (2013). \textit{DETEKSI PSILOCIN URIN PADA MENCIT SWISS WEBSTER TERHADAP PEMBERIAN JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT.}. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal). [published; OpenAlex]. \href{http://ejournal-s1.undip.ac.id/index.php/medico/article/download/4951/4777}{source link}.
\item Michael Kometer, André Schmidt, Lutz Jäncke, Franz X. Vollenweider (2013). \textit{Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations}. Open MIND. [published; OpenAlex]. \href{https://openalex.org/W6929930661}{source link}.
\item Olthuis JV, Darredeau C, Barrett SP (2013). \textit{Substance use initiation: the role of simultaneous polysubstance use.}. Drug and alcohol review. [published; PubMed]. \href{https://doi.org/10.1111/j.1465-3362.2012.00470.x}{doi:10.1111/j.1465-3362.2012.00470.x}.
\item Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F (2013). \textit{The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-012-2811-0}{doi:10.1007/s00213-012-2811-0}.
\item Krebs TS, Johansen PØ (2013). \textit{Over 30 million psychedelic users in the United States.}. F1000Research. [published; PubMed]. \href{https://doi.org/10.12688/f1000research.2-98.v1}{doi:10.12688/f1000research.2-98.v1}.
\item Cummins C, Lyke J (2013). \textit{Peak experiences of psilocybin users and non-users.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2013.785855}{doi:10.1080/02791072.2013.785855}.
\item Müller K, Püschel K, Iwersen-Bergmann S (2013). \textit{[Suicide under the influence of "magic mushrooms"].}. Archiv fur Kriminologie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/23878898/}{source link}.
\item Kosentka P, Sprague SL, Ryberg M, Gartz J, May AL, Campagna SR, Matheny PB (2013). \textit{Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0064646}{doi:10.1371/journal.pone.0064646}.
\item Kjellgren A, Jonsson K (2013). \textit{Methoxetamine (MXE)--a phenomenological study of experiences induced by a "legal high" from the internet.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2013.803647}{doi:10.1080/02791072.2013.803647}.
\item Krebs TS, Johansen PØ (2013). \textit{Psychedelics and mental health: a population study.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0063972}{doi:10.1371/journal.pone.0063972}.
\item Carhart-Harris RL, Nutt DJ (2013). \textit{Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2013.825034}{doi:10.1080/02791072.2013.825034}.
\item Brogaard B (2013). \textit{Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia.}. Frontiers in human neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnhum.2013.00657}{doi:10.3389/fnhum.2013.00657}.
\item Jastrzebski M, Bala A (2013). \textit{[The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].}. Psychiatria polska. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/25007546/}{source link}.
\item Weissbart Hugo (2012). \textit{Effects of psilocybin on the human brain functional network}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.798836.v1}{doi:10.6084/m9.figshare.798836.v1}.
\item Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX (2012). \textit{Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2012.04.005}{doi:10.1016/j.biopsych.2012.04.005}.
\item Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR (2012). \textit{Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.}. Journal for the scientific study of religion. [published; PubMed]. \href{https://doi.org/10.1111/j.1468-5906.2012.01685.x}{doi:10.1111/j.1468-5906.2012.01685.x}.
\item Martin Rafaela, Schürenkamp Jennifer, Pfeiffer Heidi, Köhler Helga (2012). \textit{A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability}. International Journal of Legal Medicine. [published; Crossref]. \href{https://doi.org/10.1007/s00414-011-0652-8}{doi:10.1007/s00414-011-0652-8}.
\item Lim TH, Wasywich CA, Ruygrok PN (2012). \textit{A fatal case of 'magic mushroom' ingestion in a heart transplant recipient.}. Internal medicine journal. [published; PubMed]. \href{https://doi.org/10.1111/j.1445-5994.2012.02955.x}{doi:10.1111/j.1445-5994.2012.02955.x}.
\item Norra MacReady (2012). \textit{Opening Doors of Perception: Psychedelic Drugs and End-of-Life Care}. JNCI Journal of the National Cancer Institute. [published; OpenAlex]. \href{https://doi.org/10.1093/jnci/djs468}{doi:10.1093/jnci/djs468}.
\item Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR (2012). \textit{High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-012-2680-6}{doi:10.1007/s00213-012-2680-6}.
\item Tennison MN (2012). \textit{Moral transhumanism: the next step.}. The Journal of medicine and philosophy. [published; PubMed]. \href{https://doi.org/10.1093/jmp/jhs024}{doi:10.1093/jmp/jhs024}.
\item Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM, Erritzoe D (2012). \textit{Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.}. Human psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1002/hup.2234}{doi:10.1002/hup.2234}.
\item Adam Stasko, Satya P. Rao, Amy Pilley (2012). \textit{Spirituality and Hallucinogen Use: Results from a Pilot Study among College Students}. International Journal of Transpersonal Studies. [published; OpenAlex]. \href{https://doi.org/10.24972/ijts.2012.31.2.23}{doi:10.24972/ijts.2012.31.2.23}.
\item Ümit Sayın (2012). \textit{A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens}. NeuroQuantology. [published; OpenAlex]. \href{https://doi.org/10.14704/nq.2012.10.2.528}{doi:10.14704/nq.2012.10.2.528}.
\item Jacomien Aleman, Mirjam Crul, Peter H. J. van der Voort, Eric J. F. Franssen (2012). \textit{Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms'}. Netherlands Journal of Critical Care. [published; OpenAlex]. \href{https://pure.amsterdamumc.nl/en/publications/9641390d-ba9e-4cf0-a1d5-445ec0f4717b}{source link}.
\item Johnson MW, Sewell RA, Griffiths RR (2012). \textit{Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2011.10.029}{doi:10.1016/j.drugalcdep.2011.10.029}.
\item Roiser JP, Rees G (2012). \textit{Neuroimaging: a scanner, colourfully.}. Current biology: CB. [published; PubMed]. \href{https://doi.org/10.1016/j.cub.2012.02.033}{doi:10.1016/j.cub.2012.02.033}.
\item Evan J. Kyzar, Christopher Collins, Jeremy Green, Siddharth Gaikwad, Andrew Roth, Louis Monnig, Mohamed El-Ounsi, Nicholas Capezio, Andrew J. Freeman, Ari Davis, Allan V. Kalueff (2012). \textit{Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.26.1\_supplement.1043.3}{doi:10.1096/fasebj.26.1\_supplement.1043.3}.
\item Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX (2012). \textit{Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/npp.2011.261}{doi:10.1038/npp.2011.261}.
\item Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ (2012). \textit{Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.}. The British journal of psychiatry: the journal of mental science. [published; PubMed]. \href{https://doi.org/10.1192/bjp.bp.111.103309}{doi:10.1192/bjp.bp.111.103309}.
\item Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ (2012). \textit{Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.1119598109}{doi:10.1073/pnas.1119598109}.
\item Quednow BB, Kometer M, Geyer MA, Vollenweider FX (2012). \textit{Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/npp.2011.228}{doi:10.1038/npp.2011.228}.
\item Natasha Amalda Ediwan (2012). \textit{GAMBARAN KARAKTERISTIK SOSIODEMOGRAFIK, TINGKAT PENGETAHUAN DAN POLA PENGGUNAAN JAMUR Psilocybin PADA MAHASISWA S1 UNIVERSITAS PADJAJARAN PERIODE AJAR2010-2011}. Universitas Padjadjaran Repository. [published; OpenAlex]. \href{https://repository.unpad.ac.id/frontdoor/index/index/year/2019/docId/118252}{source link}.
\item LI Yu-bai (2012). \textit{Flavone Glycoside Antagonizes Psilocybin-Induced Toxicity by Reducing Oxidative Stress in Rats Model}. Zhongguo Yike Daxue xuebao. [published; OpenAlex]. \href{https://en.cnki.com.cn/Article\_en/CJFDTOTAL-ZGYK201201019.htm}{source link}.
\item David Luke, Devin B. Terhune, Ross Friday (2012). \textit{Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia}. Seeing and Perceiving. [published; OpenAlex]. \href{https://doi.org/10.1163/187847612x646956}{doi:10.1163/187847612x646956}.
\item Studerus E, Gamma A, Kometer M, Vollenweider FX (2012). \textit{Prediction of psilocybin response in healthy volunteers.}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0030800}{doi:10.1371/journal.pone.0030800}.
\item Lyvers M, Meester M (2012). \textit{Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2012.736842}{doi:10.1080/02791072.2012.736842}.
\item Joan Arehart-Treichel (2011). \textit{Study Suggests Hallucinogen May Be Personality Changer}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/pn.46.24.psychnews\_46\_24\_19-a}{doi:10.1176/pn.46.24.psychnews\_46\_24\_19-a}.
\item Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R (2011). \textit{Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-011-2358-5}{doi:10.1007/s00213-011-2358-5}.
\item Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ (2011). \textit{The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881110367445}{doi:10.1177/0269881110367445}.
\item Studerus E, Kometer M, Hasler F, Vollenweider FX (2011). \textit{Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881110382466}{doi:10.1177/0269881110382466}.
\item Sumnall HR, Measham F, Brandt SD, Cole JC (2011). \textit{Salvia divinorum use and phenomenology: results from an online survey.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881110385596}{doi:10.1177/0269881110385596}.
\item Halberstadt AL, Koedood L, Powell SB, Geyer MA (2011). \textit{Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881110388326}{doi:10.1177/0269881110388326}.
\item MacLean KA, Johnson MW, Griffiths RR (2011). \textit{Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881111420188}{doi:10.1177/0269881111420188}.
\item Halberstadt AL, Geyer MA (2011). \textit{Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2011.01.017}{doi:10.1016/j.neuropharm.2011.01.017}.
\item Pettigrew J (2011). \textit{Iconography in Bradshaw rock art: breaking the circularity.}. Clinical \& experimental optometry. [published; PubMed]. \href{https://doi.org/10.1111/j.1444-0938.2011.00648.x}{doi:10.1111/j.1444-0938.2011.00648.x}.
\item Shoda Takuji, Fukuhara Kiyoshi, Goda Yukihiro, Okuda Haruhiro (2011). \textit{Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms}. Drug Testing and Analysis. [published; Crossref]. \href{https://doi.org/10.1002/dta.244}{doi:10.1002/dta.244}.
\item Chen Jianbo, Li Meijia, Yan Xitao, Wu Enqi, Zhu Hongmei, Lee Kwan Jun, Chu Van Men, Zhan Lifeng, Lee Wonjae, Kang Jong Seong (2011). \textit{Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis}. Journal of Chromatography B. [published; Crossref]. \href{https://doi.org/10.1016/j.jchromb.2011.07.003}{doi:10.1016/j.jchromb.2011.07.003}.
\item Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt (2011). \textit{P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(11)70495-3}{doi:10.1016/s0924-977x(11)70495-3}.
\item Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J (2011). \textit{Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.}. Neuroscience letters. [published; PubMed]. \href{https://doi.org/10.1016/j.neulet.2011.01.046}{doi:10.1016/j.neulet.2011.01.046}.
\item van Amsterdam J, Opperhuizen A, van den Brink W (2011). \textit{Harm potential of magic mushroom use: a review.}. Regulatory toxicology and pharmacology: RTP. [published; PubMed]. \href{https://doi.org/10.1016/j.yrtph.2011.01.006}{doi:10.1016/j.yrtph.2011.01.006}.
\item Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX (2011). \textit{The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.biopsych.2010.10.002}{doi:10.1016/j.biopsych.2010.10.002}.
\item Sun-Edelstein C, Mauskop A (2011). \textit{Alternative headache treatments: nutraceuticals, behavioral and physical treatments.}. Headache. [published; PubMed]. \href{https://doi.org/10.1111/j.1526-4610.2011.01846.x}{doi:10.1111/j.1526-4610.2011.01846.x}.
\item F. Grass (2011). \textit{Biophotons, hallucinogens, and fluorescence}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(11)72907-8}{doi:10.1016/s0924-9338(11)72907-8}.
\item Moreno JL, Kurita M, Holloway T, López J, Cadagan R, Martínez-Sobrido L, García-Sastre A, González-Maeso J (2011). \textit{Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.}. The Journal of neuroscience: the official journal of the Society for Neuroscience. [published; PubMed]. \href{https://doi.org/10.1523/jneurosci.4230-10.2011}{doi:10.1523/jneurosci.4230-10.2011}.
\item Meyer MR, Maurer HH (2011). \textit{Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.}. Pharmacogenomics. [published; PubMed]. \href{https://doi.org/10.2217/pgs.10.171}{doi:10.2217/pgs.10.171}.
\item Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR (2011). \textit{Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.}. Archives of general psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/archgenpsychiatry.2010.116}{doi:10.1001/archgenpsychiatry.2010.116}.
\item Móró L, Simon K, Bárd I, Rácz J (2011). \textit{Voice of the psychonauts: coping, life purpose, and spirituality in psychedelic drug users.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2011.605661}{doi:10.1080/02791072.2011.605661}.
\item Kjellgren A, Soussan C (2011). \textit{Heaven and hell--a phenomenological study of recreational use of 4-HO-MET in Sweden.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2011.605699}{doi:10.1080/02791072.2011.605699}.
\item Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson (2010). \textit{Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0014074}{doi:10.1371/journal.pone.0014074}.
\item Riley S, Thompson J, Griffin C (2010). \textit{Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2010.07.001}{doi:10.1016/j.drugpo.2010.07.001}.
\item Vollenweider FX, Kometer M (2010). \textit{The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.}. Nature reviews. Neuroscience. [published; PubMed]. \href{https://doi.org/10.1038/nrn2884}{doi:10.1038/nrn2884}.
\item Studerus E, Gamma A, Vollenweider FX (2010). \textit{Psychometric evaluation of the altered states of consciousness rating scale (OAV).}. PloS one. [published; PubMed]. \href{https://doi.org/10.1371/journal.pone.0012412}{doi:10.1371/journal.pone.0012412}.
\item Jan RK, Lin JC, Lee H, Sheridan JL, Kydd RR, Kirk IJ, Russell BR (2010). \textit{Determining the subjective effects of TFMPP in human males.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-010-1911-y}{doi:10.1007/s00213-010-1911-y}.
\item Thiago Berti Kirsten, Maria Martha Bernardi (2010). \textit{Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in mice}. Revista Brasileira de Farmacognosia. [published; OpenAlex]. \href{https://doi.org/10.1590/s0102-695x2010000300017}{doi:10.1590/s0102-695x2010000300017}.
\item Butelman ER, Rus S, Prisinzano TE, Kreek MJ (2010). \textit{The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-009-1771-5}{doi:10.1007/s00213-009-1771-5}.
\item Wark C, Galliher JF (2010). \textit{Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2009.08.004}{doi:10.1016/j.drugpo.2009.08.004}.
\item Guy A. Rutter (2010). \textit{Psilocybin Mushrooms of the World: an identification guide. Paul Stamets.}. Edinburgh Journal of Botany. [published; OpenAlex]. \href{https://doi.org/10.1017/s0960428600001426}{doi:10.1017/s0960428600001426}.
\item Matthias Karst, John H. Halpern, Michael Bernateck, Torsten Passie (2010). \textit{The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series}. Cephalalgia. [published; OpenAlex]. \href{https://doi.org/10.1177/0333102410363490}{doi:10.1177/0333102410363490}.
\item O. Carter, John D. Pettigrew, Felix Hasler, Guy Wallis, Franz X. Vollenweider (2010). \textit{Psilocybin slows binocular rivalry switching through serotonin modulation}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/6.6.43}{doi:10.1167/6.6.43}.
\item Olivia Carter, David C. Burr, John D. Pettigrew, Franz X. Vollenweider (2010). \textit{Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/5.8.683}{doi:10.1167/5.8.683}.
\item Hu Chunmei, Qin Hua, Cui Yuxin, Jia Yanxing (2010). \textit{ChemInform Abstract: Palladium-Catalyzed Synthesis of Tryptamines and Tryptamine Homologues: Synthesis of Psilocin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.201009186}{doi:10.1002/chin.201009186}.
\item Manevski Nenad, Kurkela Mika, Höglund Camilla, Mauriala Timo, Court Michael H., Yli-Kauhaluoma Jari, Finel Moshe (2010). \textit{Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases}. Drug Metabolism and Disposition. [published; Crossref]. \href{https://doi.org/10.1124/dmd.109.031138}{doi:10.1124/dmd.109.031138}.
\item Koçak A, De Cotiis LM, Hoffman DB (2010). \textit{Comparative study of ATR and transflection IR spectroscopic techniques for the analysis of hallucinogenic mushrooms.}. Forensic science international. [published; PubMed]. \href{https://doi.org/10.1016/j.forsciint.2009.11.002}{doi:10.1016/j.forsciint.2009.11.002}.
\item Laussmann T, Meier-Giebing S (2010). \textit{Forensic analysis of hallucinogenic mushrooms and khat (Catha edulis Forsk) using cation-exchange liquid chromatography.}. Forensic science international. [published; PubMed]. \href{https://doi.org/10.1016/j.forsciint.2009.12.013}{doi:10.1016/j.forsciint.2009.12.013}.
\item Matthew J. Baggott (2009). \textit{Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/7409s4th}{source link}.
\item Weiwei Wang (2009). \textit{Aspects of secondary metabolism in basidiomycetes: I. biological and biochemical studies on Psilocybe cubensis II. a survey of phenol-o-methyltransferase in species of Lentinus and Lentinellus}. cIRcle (University of British Columbia). [published; OpenAlex]. \href{https://doi.org/10.14288/1.0094541}{doi:10.14288/1.0094541}.
\item Rose Jade (2009). \textit{Current Research on the Human Experience of Spirituality Following the Ingestion of ‘Magic’ Psilocybin Mushrooms: An Annotated Bibliography for Social Workers and Other Health Care Professionals}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.1714051}{doi:10.2139/ssrn.1714051}.
\item Tooru Kamata, Munehiro Katagi, Hitoshi Tsuchihashi (2009). \textit{Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan}. Forensic Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1007/s11419-009-0087-9}{doi:10.1007/s11419-009-0087-9}.
\item Brandon Huskins, Christopher R. Dockery (2009). \textit{Detection of Psilocybin Mushroom Analogs in Chocolate}. The Chemical Educator. [published; OpenAlex]. \href{https://doi.org/10.1333/s00897092230a}{doi:10.1333/s00897092230a}.
\item Morvan Y, Rouvier J, Olié JP, Lôo H, Krebs MO (2009). \textit{[Student's use of illicit drugs: a survey in a preventive health service].}. L'Encephale. [published; PubMed]. \href{https://doi.org/10.1016/s0013-7006(09)73471-2}{doi:10.1016/s0013-7006(09)73471-2}.
\item Hu Chunmei, Qin Hua, Cui Yuxin, Jia Yanxing (2009). \textit{Palladium-catalyzed synthesis of tryptamines and tryptamine homologues: synthesis of psilocin}. Tetrahedron. [published; Crossref]. \href{https://doi.org/10.1016/j.tet.2009.09.050}{doi:10.1016/j.tet.2009.09.050}.
\item Kovacic Peter (2009). \textit{Unifying electron transfer mechanism for psilocybin and psilocin}. Medical Hypotheses. [published; Crossref]. \href{https://doi.org/10.1016/j.mehy.2009.06.022}{doi:10.1016/j.mehy.2009.06.022}.
\item Lott JP, Marlowe DB, Forman RF (2009). \textit{Availability of websites offering to sell psilocybin spores and psilocybin.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2009.10400541}{doi:10.1080/02791072.2009.10400541}.
\item Matsushima Y, Shirota O, Kikura-Hanajiri R, Goda Y, Eguchi F (2009). \textit{Effects of Psilocybe argentipes on marble-burying behavior in mice.}. Bioscience, biotechnology, and biochemistry. [published; PubMed]. \href{https://doi.org/10.1271/bbb.90095}{doi:10.1271/bbb.90095}.
\item Björnstad K, Hultén P, Beck O, Helander A (2009). \textit{Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650903037181}{doi:10.1080/15563650903037181}.
\item Barbee G, Berry-Cabán C, Barry J, Borys D, Ward J, Salyer S (2009). \textit{Analysis of mushroom exposures in Texas requiring hospitalization, 2005-2006.}. Journal of medical toxicology: official journal of the American College of Medical Toxicology. [published; PubMed]. \href{https://doi.org/10.1007/bf03161087}{doi:10.1007/bf03161087}.
\item Kawamura M, Kikura-Hanajiri R, Goda Y (2009). \textit{[Simple and rapid screening for psychotropic natural products using Direct Analysis in Real Time (DART)-TOFMS].}. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan. [published; PubMed]. \href{https://doi.org/10.1248/yakushi.129.719}{doi:10.1248/yakushi.129.719}.
\item Nef HM, Möllmann H, Hilpert P, Krause N, Troidl C, Weber M, Rolf A, Dill T, Hamm C, Elsässer A (2009). \textit{Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.}. International journal of cardiology. [published; PubMed]. \href{https://doi.org/10.1016/j.ijcard.2007.12.064}{doi:10.1016/j.ijcard.2007.12.064}.
\item Flammer R, Schenk-Jäger KM (2009). \textit{[Mushroom poisoning--the dark side of mycetism].}. Therapeutische Umschau. Revue therapeutique. [published; PubMed]. \href{https://doi.org/10.1024/0040-5930.66.5.357}{doi:10.1024/0040-5930.66.5.357}.
\item Björnstad K, Beck O, Helander A (2009). \textit{A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine.}. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.jchromb.2009.03.004}{doi:10.1016/j.jchromb.2009.03.004}.
\item Hasler F, Kuznetsova OF, Krasikova RN, Cservenyak T, Quednow BB, Vollenweider FX, Ametamey SM, Westera G (2009). \textit{GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.}. Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.apradiso.2008.12.007}{doi:10.1016/j.apradiso.2008.12.007}.
\item Gonmori K, Yokoyama K (2009). \textit{[Acute encephalopathy caused by cyanogenic fungi in 2004, and magic mushroom regulation in Japan].}. Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/19344063/}{source link}.
\item Hasan Rafati, Hossein Riahi, Ali Mohammadi (2009). \textit{Enhancement of Indole Alkaloids Produced by Psilocybe cubensis (Earle) Singer (Agaricomycetideae) in Controlled Harvesting Light Conditions}. International journal of medicinal mushrooms. [published; OpenAlex]. \href{https://doi.org/10.1615/intjmedmushr.v11.i4.80}{doi:10.1615/intjmedmushr.v11.i4.80}.
\item David Serrano Hurtado (2009). \textit{Psilocybin: Historical and pharmacological perspective and current authorized research}. Repositorio Universidad de Caldas. [published; OpenAlex]. \href{https://revistasojs.ucaldas.edu.co/index.php/culturaydroga/article/view/5437}{source link}.
\item Brandon Huskins, Christopher R. Dockery (2009). \textit{Detection of Psilocybin Mushroom Analogs in Chocolate: Incorporating Current Events into the Undergraduate Teaching Laboratory}. The Chemical Educator. [published; OpenAlex]. \href{https://digitalcommons.kennesaw.edu/facpubs/997}{source link}.
\item González-Maeso J, Sealfon SC (2009). \textit{Agonist-trafficking and hallucinogens.}. Current medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/092986709787581851}{doi:10.2174/092986709787581851}.
\item Adams JD (2009). \textit{Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.}. Current medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.2174/092986709789057626}{doi:10.2174/092986709789057626}.
\item Kovacic P, Somanathan R (2009). \textit{Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.}. Oxidative medicine and cellular longevity. [published; PubMed]. \href{https://doi.org/10.4161/oxim.2.4.9380}{doi:10.4161/oxim.2.4.9380}.
\item J.C. Winter (2008). \textit{Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-008-1356-8}{doi:10.1007/s00213-008-1356-8}.
\item McClintock RL, Watts DJ, Melanson S (2008). \textit{Unrecognized magic mushroom abuse in a 28-year-old man.}. The American journal of emergency medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.ajem.2008.01.058}{doi:10.1016/j.ajem.2008.01.058}.
\item Geyer MA, Vollenweider FX (2008). \textit{Serotonin research: contributions to understanding psychoses.}. Trends in pharmacological sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tips.2008.06.006}{doi:10.1016/j.tips.2008.06.006}.
\item Bray JK, Goddard WA (2008). \textit{The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.}. Journal of molecular graphics \& modelling. [published; PubMed]. \href{https://doi.org/10.1016/j.jmgm.2008.02.006}{doi:10.1016/j.jmgm.2008.02.006}.
\item Griffiths R, Richards W, Johnson M, McCann U, Jesse R (2008). \textit{Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881108094300}{doi:10.1177/0269881108094300}.
\item F.X. Vollenweider, Daniel Hell, Michael Kometer (2008). \textit{Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humans}. International Journal of Psychophysiology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ijpsycho.2008.05.397}{doi:10.1016/j.ijpsycho.2008.05.397}.
\item Danuta Marona-Lewicka, Benjamin R. Chemel, David E. Nichols (2008). \textit{Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-008-1238-0}{doi:10.1007/s00213-008-1238-0}.
\item Arran Frood (2008). \textit{Benefits of 'magic mushroom' therapy long lasting}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/news.2008.934}{doi:10.1038/news.2008.934}.
\item Heekeren K, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E (2008). \textit{Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-008-1129-4}{doi:10.1007/s00213-008-1129-4}.
\item Hermle L, Kovar KA, Hewer W, Ruchsow M (2008). \textit{[Hallucinogen-induced psychological disorders].}. Fortschritte der Neurologie-Psychiatrie. [published; PubMed]. \href{https://doi.org/10.1055/s-2008-1038191}{doi:10.1055/s-2008-1038191}.
\item Wojciech Kostowski, W Rewerski, T Piechocki (2008). \textit{II. The Effects of Some Hallucinogens on Aggressiveness of Mice and Rats}. Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1159/000136297}{doi:10.1159/000136297}.
\item H. Holfeld (2008). \textit{Psychophysische Korrelationen unter der Einwirkung von Psycholytika (LSD, Psilocybin und ähnl.)}. Medicina Experimentalis. [published; OpenAlex]. \href{https://doi.org/10.1159/000135082}{doi:10.1159/000135082}.
\item H. Heimann (2008). \textit{Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 85-100}. Psychiatria et Neurologia. [published; OpenAlex]. \href{https://doi.org/10.1159/000131192}{doi:10.1159/000131192}.
\item M. Sercl, J Kovarik, O. Jaros (2008). \textit{Klinische Erfahrungen mit Psilocybin (CY39 Sandoz)}. Psychiatria et Neurologia. [published; OpenAlex]. \href{https://doi.org/10.1159/000131157}{doi:10.1159/000131157}.
\item H Heimann (2008). \textit{Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 69-84}. Psychiatria et Neurologia. [published; OpenAlex]. \href{https://doi.org/10.1159/000131191}{doi:10.1159/000131191}.
\item Wackermann J, Wittmann M, Hasler F, Vollenweider FX (2008). \textit{Effects of varied doses of psilocybin on time interval reproduction in human subjects.}. Neuroscience letters. [published; PubMed]. \href{https://doi.org/10.1016/j.neulet.2008.02.006}{doi:10.1016/j.neulet.2008.02.006}.
\item González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC (2008). \textit{Identification of a serotonin/glutamate receptor complex implicated in psychosis.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/nature06612}{doi:10.1038/nature06612}.
\item Antonio Ceraso (2008). \textit{Entheogens and the Public Mystery: The Rhetoric of R. Gordon Wasson}. Configurations. [published; OpenAlex]. \href{https://doi.org/10.1353/con.0.0050}{doi:10.1353/con.0.0050}.
\item Lee IK, Cho SM, Seok SJ, Yun BS (2008). \textit{Chemical Constituents of Gymnopilus spectabilis and Their Antioxidant Activity.}. Mycobiology. [published; PubMed]. \href{https://doi.org/10.4489/myco.2008.36.1.055}{doi:10.4489/myco.2008.36.1.055}.
\item J.C. Ballenger (2008). \textit{Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder}. Yearbook of Psychiatry and Applied Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1016/s0084-3970(08)70820-x}{doi:10.1016/s0084-3970(08)70820-x}.
\item William A. Richards (2008). \textit{The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by Psilocybin}. Archive for the Psychology of Religion. [published; OpenAlex]. \href{https://doi.org/10.1163/157361208x317196}{doi:10.1163/157361208x317196}.
\item Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC (2008). \textit{Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2007.09.007}{doi:10.1016/j.pbb.2007.09.007}.
\item Winter JC (2008). \textit{Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2007.07.007}{doi:10.1016/j.pbb.2007.07.007}.
\item Riley SC, Blackman G (2008). \textit{Between prohibitions: patterns and meanings of magic mushroom use in the UK.}. Substance use \& misuse. [published; PubMed]. \href{https://doi.org/10.1080/10826080701772363}{doi:10.1080/10826080701772363}.
\item Louis Garraway, Rean Maharaj (2007). \textit{The Screening of Mushrooms Found in Trinidad to Determine the Presence of the Psychoactive Substances Psilocin and Psilocybin}. Living World, Journal of the Trinidad and Tobago Field Naturalists' Club. [published; OpenAlex]. \href{https://www.ttfnc.org/livingworld/index.php/lwj/article/view/garraway2007}{source link}.
\item Briony J. Catlow (2007). \textit{Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis}. Digital Commons - University of South Florida (University of South Florida). [published; OpenAlex]. \href{https://digitalcommons.usf.edu/etd/166}{source link}.
\item Attema-de Jonge ME, Portier CB, Franssen EJ (2007). \textit{[Automutilation after consumption of hallucinogenic mushrooms].}. Nederlands tijdschrift voor geneeskunde. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/18257429/}{source link}.
\item Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX (2007). \textit{Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-007-0930-9}{doi:10.1007/s00213-007-0930-9}.
\item Marona-Lewicka D, Nichols DE (2007). \textit{Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2007.06.001}{doi:10.1016/j.pbb.2007.06.001}.
\item Winter JC, Rice KC, Amorosi DJ, Rabin RA (2007). \textit{Psilocybin-induced stimulus control in the rat.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2007.06.003}{doi:10.1016/j.pbb.2007.06.003}.
\item del Mar Ramirez Fernandez M, Laloup M, Wood M, De Boeck G, Lopez-Rivadulla M, Wallemacq P, Samyn N (2007). \textit{Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.}. Journal of analytical toxicology. [published; PubMed]. \href{https://doi.org/10.1093/jat/31.8.497}{doi:10.1093/jat/31.8.497}.
\item Andy Letcher (2007). \textit{Mad Thoughts on Mushrooms: Discourse and Power in the Study of Psychedelic Consciousness}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1525/ac.2007.18.2.74}{doi:10.1525/ac.2007.18.2.74}.
\item Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB (2007). \textit{The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/sj.npp.1301324}{doi:10.1038/sj.npp.1301324}.
\item TIMOTHY F. KIRN (2007). \textit{Psilocybin Results Inspire Researchers}. Clinical Psychiatry News. [published; OpenAlex]. \href{https://doi.org/10.1016/s0270-6644(07)70405-8}{doi:10.1016/s0270-6644(07)70405-8}.
\item Heekeren K, Neukirch A, Daumann J, Stoll M, Obradovic M, Kovar KA, Geyer MA, Gouzoulis-Mayfrank E (2007). \textit{Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881107077734}{doi:10.1177/0269881107077734}.
\item González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007). \textit{Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.}. Neuron. [published; PubMed]. \href{https://doi.org/10.1016/j.neuron.2007.01.008}{doi:10.1016/j.neuron.2007.01.008}.
\item Veniero Gambaro, Lucia Dell’Acqua, P.F. Croci, CM Pecoraro (2007). \textit{HPLC/DAD analysis of psilocin and psilocybin in psilocybe cubensis}. Meeting on Recent Developments in Pharmaceutical Analysis. [published; OpenAlex]. \href{https://air.unimi.it/handle/2434/146135}{source link}.
\item McCambridge J, Winstock A, Hunt N, Mitcheson L (2007). \textit{5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.}. European addiction research. [published; PubMed]. \href{https://doi.org/10.1159/000095816}{doi:10.1159/000095816}.
\item Majdanik S, Borowiak K, Brzezńska M, Machoy-Mokrzyńska A (2007). \textit{[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine].}. Annales Academiae Medicae Stetinensis. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/20143700/}{source link}.
\item Adamczyk A, Sadakierska-Chudy A, Janoszka J, Rymkiewicz A, Dobosz T (2007). \textit{[Hallucinogenic fungi (psilocybe). Part II. Identification of Psilocybe semilanceata by PCR].}. Archiwum medycyny sadowej i kryminologii. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/17907620/}{source link}.
\item Ondra P, Zedníková K, Válka I (2006). \textit{Detection and determination of abused hallucinogens in biological material.}. Neuro endocrinology letters. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/17159796/}{source link}.
\item Frecska E, Luna LE (2006). \textit{The adverse effects of hallucinogens from intramural perspective.}. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/17211054/}{source link}.
\item Maruyama T, Kawahara N, Yokoyama K, Makino Y, Fukiharu T, Goda Y (2006). \textit{Phylogenetic relationship of psychoactive fungi based on rRNA gene for a large subunit and their identification using the TaqMan assay (II).}. Forensic science international. [published; PubMed]. \href{https://doi.org/10.1016/j.forsciint.2004.10.028}{doi:10.1016/j.forsciint.2004.10.028}.
\item Moreno FA, Wiegand CB, Taitano EK, Delgado PL (2006). \textit{Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.}. The Journal of clinical psychiatry. [published; PubMed]. \href{https://doi.org/10.4088/jcp.v67n1110}{doi:10.4088/jcp.v67n1110}.
\item Kelly Morris (2006). \textit{Hallucinogen research inspires “neurotheology”}. The Lancet Neurology. [published; OpenAlex]. \href{https://doi.org/10.1016/s1474-4422(06)70541-5}{doi:10.1016/s1474-4422(06)70541-5}.
\item David L. Eldridge, Karin Hillenbrand (2006). \textit{Hallucinogens}. Pediatrics in Review. [published; OpenAlex]. \href{https://doi.org/10.1542/pir.27.8.314}{doi:10.1542/pir.27.8.314}.
\item Griffiths RR, Richards WA, McCann U, Jesse R (2006). \textit{Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-006-0457-5}{doi:10.1007/s00213-006-0457-5}.
\item Ivan Amato (2006). \textit{PSILOCYBIN STUDIES TURN A NEW LEAF}. Chemical \& Engineering News. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-v084n029.p010a}{doi:10.1021/cen-v084n029.p010a}.
\item Herbert D. Kleber (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0461-9}{doi:10.1007/s00213-006-0461-9}.
\item Charles R. Schuster (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0460-x}{doi:10.1007/s00213-006-0460-x}.
\item David E. Nichols (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0458-4}{doi:10.1007/s00213-006-0458-4}.
\item Solomon H. Snyder (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0459-3}{doi:10.1007/s00213-006-0459-3}.
\item Kamata Tooru, Nishikawa Mayumi, Katagi Munehiro, Tsuchihashi Hitoshi (2006). \textit{Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user}. Forensic Toxicology. [published; Crossref]. \href{https://doi.org/10.1007/s11419-006-0006-2}{doi:10.1007/s11419-006-0006-2}.
\item Sewell RA, Halpern JH, Pope HG (2006). \textit{Response of cluster headache to psilocybin and LSD.}. Neurology. [published; PubMed]. \href{https://doi.org/10.1212/01.wnl.0000219761.05466.43}{doi:10.1212/01.wnl.0000219761.05466.43}.
\item Jensen N, Gartz J, Laatsch H (2006). \textit{Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens.}. Planta medica. [published; PubMed]. \href{https://doi.org/10.1055/s-2006-931576}{doi:10.1055/s-2006-931576}.
\item Barrett SP, Darredeau C, Pihl RO (2006). \textit{Patterns of simultaneous polysubstance use in drug using university students.}. Human psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1002/hup.766}{doi:10.1002/hup.766}.
\item Lerner M, Lyvers M (2006). \textit{Values and beliefs of psychedelic drug users: a cross-cultural study.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2006.10399838}{doi:10.1080/02791072.2006.10399838}.
\item Tiscione N. B., Miller M. I. (2006). \textit{Psilocin Identified in a DUID Investigation}. Journal of Analytical Toxicology. [published; Crossref]. \href{https://doi.org/10.1093/jat/30.5.342}{doi:10.1093/jat/30.5.342}.
\item Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P, Hell D, Flohr H, Vollenweider FX. (2006). \textit{Effects of psilocybin on time perception and temporal control of behaviour in humans.}. Queensland's institutional digital repository (The University of Queensland). [published; Europe PMC]. \href{https://doi.org/10.1177/0269881106065859}{source link}.
\item Anastos N., Barnett N.W., Pfeffer F.M., Lewis S.W. (2006). \textit{Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography}. Science \& Justice. [published; Crossref]. \href{https://doi.org/10.1016/s1355-0306(06)71579-9}{doi:10.1016/s1355-0306(06)71579-9}.
\item M. Braden, James J. Chambers, David E. Nichols (2006). \textit{Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A Receptor}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.20.4.a247-c}{doi:10.1096/fasebj.20.4.a247-c}.
\item Stamets P (2006). \textit{Can mushrooms help save the world? Interview by Bonnie J. Horrigan.}. Explore (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1016/j.explore.2005.12.011}{doi:10.1016/j.explore.2005.12.011}.
\item Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Sławomir Majdanik, Piotr Waloszczyk, Małgorzata Piasecka, Tomasz Janus, E. Jasionowicz-Piatek, Mirosław Parafiniuk (2006). \textit{Psilocin multiple intake resulted and in cardiotoxic effects}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-f39ab4e7-0a77-47a4-b535-5656f3d5df88}{source link}.
\item Sempere AP, Berenguer-Ruiz L, Almazán F (2006). \textit{[Chronic cluster headache: Response to psilocybin].}. Revista de neurologia. [published; PubMed]. \href{https://doi.org/10.33588/rn.4309.2006432}{doi:10.33588/rn.4309.2006432}.
\item Anastos Nicole, Lewis Simon W., Barnett Neil W., Sims D. Noel (2006). \textit{The Determination of Psilocin and Psilocybin in Hallucinogenic Mushrooms by HPLC Utilizing a Dual Reagent Acidic Potassium Permanganate and Tris(2,2′-bipyridyl)ruthenium(II) Chemiluminescence Detection System}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1111/j.1556-4029.2005.00033.x}{doi:10.1111/j.1556-4029.2005.00033.x}.
\item Howard Sard, Govindaraj Kumaran, Cynthia Morency, Bryan L. Roth, Beth Ann Toth, Ping He, Louis Shuster (2005). \textit{SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist.}. ChemInform. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.200602219}{doi:10.1002/chin.200602219}.
\item Glen A. Palmer, Doyle D. Daiss (2005). \textit{Personality Characteristics of Adolescents with Hallucinogen, Methamphetamine, and Cannabis Dependence: A Comparative Study}. Journal of Child \& Adolescent Substance Abuse. [published; OpenAlex]. \href{https://doi.org/10.1300/j029v15n01\_03}{doi:10.1300/j029v15n01\_03}.
\item Bickel M, Ditting T, Watz H, Roesler A, Weidauer S, Jacobi V, Gueller S, Betz C, Fichtlscherer S, Stein J (2005). \textit{Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse.}. European journal of emergency medicine: official journal of the European Society for Emergency Medicine. [published; PubMed]. \href{https://doi.org/10.1097/00063110-200512000-00011}{doi:10.1097/00063110-200512000-00011}.
\item Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar KA (2005). \textit{Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/s-2005-916185}{doi:10.1055/s-2005-916185}.
\item Sard H, Kumaran G, Morency C, Roth BL, Toth BA, He P, Shuster L (2005). \textit{SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist.}. Bioorganic \& medicinal chemistry letters. [published; PubMed]. \href{https://doi.org/10.1016/j.bmcl.2005.06.104}{doi:10.1016/j.bmcl.2005.06.104}.
\item Soyka M, Koch W, Möller HJ, Rüther T, Tatsch K (2005). \textit{Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.}. European archives of psychiatry and clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.1007/s00406-005-0563-0}{doi:10.1007/s00406-005-0563-0}.
\item Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX (2005). \textit{Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.}. Journal of cognitive neuroscience. [published; PubMed]. \href{https://doi.org/10.1162/089892905774597191}{doi:10.1162/089892905774597191}.
\item Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren (2005). \textit{Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-2005-918695}{doi:10.1055/s-2005-918695}.
\item Palenicek T., Bubenikova V., Votava M. (2005). \textit{B31 3,4-METHYLENEDIOXYMETHAPMHETAMINE (MDMA) AND4-OH-DIMETHYLTRYPTAMINE (PSILOCIN) INTERACTION IN RATS: BEHAVIORAL STUDY ON PREPULSE INHIBITION OF ACOUSTIC STARTLE REACTION AND ON LOCOMOTION}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/00008877-200509001-00236}{doi:10.1097/00008877-200509001-00236}.
\item ANASTOS N, BARNETT N, LEWIS S, GATHERGOOD N, SCAMMELLS P, SIMS D (2005). \textit{Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection respectively}. Talanta. [published; Crossref]. \href{https://doi.org/10.1016/j.talanta.2004.11.038}{doi:10.1016/j.talanta.2004.11.038}.
\item Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S (2005). \textit{Hallucinogen persisting perception disorder after psilocybin consumption: a case study.}. European psychiatry: the journal of the Association of European Psychiatrists. [published; PubMed]. \href{https://doi.org/10.1016/j.eurpsy.2005.04.008}{doi:10.1016/j.eurpsy.2005.04.008}.
\item Ben Sessa (2005). \textit{Can psychedelics have a role in psychiatry once again?}. The British Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/bjp.186.6.457}{doi:10.1192/bjp.186.6.457}.
\item Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX (2005). \textit{Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/sj.npp.1300621}{doi:10.1038/sj.npp.1300621}.
\item Saito K, Toyo'oka T, Kato M, Fukushima T, Shirota O, Goda Y (2005). \textit{Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection.}. Talanta. [published; PubMed]. \href{https://doi.org/10.1016/j.talanta.2004.11.031}{doi:10.1016/j.talanta.2004.11.031}.
\item Maruyama T, Kawahara N, Fukiharu T, Yokoyama K, Makino Y, Goda Y (2005). \textit{[DNA and chemical analyses of commercial fly agaric-related products].}. Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan. [published; PubMed]. \href{https://doi.org/10.3358/shokueishi.46.49}{doi:10.3358/shokueishi.46.49}.
\item Kamata T, Nishikawa M, Katagi M, Tsuchihashi H (2005). \textit{Liquid Chromatography-Mass Spectrometric and Liquid Chromatography-Tandem Mass Spectrometric Determination of Hallucinogenic Indoles Psilocin and Psilocybin in “Magic Mushroom” Samples}. Journal of Forensic and Sciences. [published; Crossref]. \href{https://doi.org/10.1520/jfs2004276}{doi:10.1520/jfs2004276}.
\item Kamata T, Nishikawa M, Katagi M, Tsuchihashi H (2005). \textit{Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/15813544/}{source link}.
\item Rimsza ME, Moses KS (2005). \textit{Substance abuse on the college campus.}. Pediatric clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.pcl.2004.10.008}{doi:10.1016/j.pcl.2004.10.008}.
\item Percy A, McAlister S, Higgins K, McCrystal P, Thornton M (2005). \textit{Response consistency in young adolescents' drug use self-reports: a recanting rate analysis.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/j.1360-0443.2004.00943.x}{doi:10.1111/j.1360-0443.2004.00943.x}.
\item He Xinsheng. (2005). \textit{Study on the biological characteristics and cultivation of panaeolus bisporus}. Wei sheng wu xue tong bao. [published; Europe PMC]. \href{https://europepmc.org/article/CBA/602890}{source link}.
\item Diana Slattery (2004). \textit{The noetic connection: synaesthesia, psychedelics, and language}. Digital Creativity. [published; OpenAlex]. \href{https://doi.org/10.1080/14626260500173146}{doi:10.1080/14626260500173146}.
\item Saito Kimie, Toyo’oka Toshimasa, Fukushima Takeshi, Kato Masaru, Shirota Osamu, Goda Yukihiro (2004). \textit{Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry}. Analytica Chimica Acta. [published; Crossref]. \href{https://doi.org/10.1016/j.aca.2004.08.071}{doi:10.1016/j.aca.2004.08.071}.
\item Albers C., K�hler H., Lehr M., Brinkmann B., Beike J. (2004). \textit{Development of a psilocin immunoassay for serum and blood samples}. International Journal of Legal Medicine. [published; Crossref]. \href{https://doi.org/10.1007/s00414-004-0469-9}{doi:10.1007/s00414-004-0469-9}.
\item Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX (2004). \textit{Psilocybin impairs high-level but not low-level motion perception.}. Neuroreport. [published; PubMed]. \href{https://doi.org/10.1097/00001756-200408260-00023}{doi:10.1097/00001756-200408260-00023}.
\item Beuhler Michael, Lee David C., Gerkin Richard (2004). \textit{The Meixner test in the detection of α-amanitin and false-positive reactions caused by psilocin and 5-substituted tryptamines}. Annals of Emergency Medicine. [published; Crossref]. \href{https://doi.org/10.1016/j.annemergmed.2004.03.017}{doi:10.1016/j.annemergmed.2004.03.017}.
\item Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J (2004). \textit{Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.}. Addictive behaviors. [published; PubMed]. \href{https://doi.org/10.1016/j.addbeh.2004.02.022}{doi:10.1016/j.addbeh.2004.02.022}.
\item Halpern JH (2004). \textit{Hallucinogens and dissociative agents naturally growing in the United States.}. Pharmacology \& therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.pharmthera.2004.03.003}{doi:10.1016/j.pharmthera.2004.03.003}.
\item Nugent KG, Saville BJ (2004). \textit{Forensic analysis of hallucinogenic fungi: a DNA-based approach.}. Forensic science international. [published; PubMed]. \href{https://doi.org/10.1016/j.forsciint.2003.11.022}{doi:10.1016/j.forsciint.2003.11.022}.
\item Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004). \textit{Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-003-1640-6}{doi:10.1007/s00213-003-1640-6}.
\item Fantegrossi WE, Woods JH, Winger G (2004). \textit{Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.}. Behavioural pharmacology. [published; PubMed]. \href{https://doi.org/10.1097/00008877-200403000-00007}{doi:10.1097/00008877-200403000-00007}.
\item Nielen RJ, van der Heijden FM, Tuinier S, Verhoeven WM (2004). \textit{Khat and mushrooms associated with psychosis.}. The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry. [published; PubMed]. \href{https://doi.org/10.1080/15622970410029908}{doi:10.1080/15622970410029908}.
\item Yamaguchi Mitsune, Saito Toshiaki, Horiguchi Yoshie, Ogawa Keita, Tsuchiya Yukihiro, Hishinuma Kayoko, Chikuma Toshiyuki, Makino Yukiko, Hojo Hiroshi (2004). \textit{Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, Psilocin}. Journal of Health Science. [published; Crossref]. \href{https://doi.org/10.1248/jhs.50.600}{doi:10.1248/jhs.50.600}.
\item O. Carter, David Alais, David C. Burr, Felix Hasler, G. Liu, Guy Wallis, Franz X. Vollenweider, John D. Pettigrew (2003). \textit{The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection Thresholds}. Queensland's institutional digital repository (The University of Queensland). [published; OpenAlex]. \href{https://openalex.org/W111026355}{source link}.
\item Tsujikawa K, Kanamori T, Iwata Y, Ohmae Y, Sugita R, Inoue H, Kishi T (2003). \textit{Morphological and chemical analysis of magic mushrooms in Japan.}. Forensic science international. [published; PubMed]. \href{https://doi.org/10.1016/j.forsciint.2003.08.009}{doi:10.1016/j.forsciint.2003.08.009}.
\item Leon Gussow (2003). \textit{Designer Hallucinogens}. Emergency Medicine News. [published; OpenAlex]. \href{https://doi.org/10.1097/00132981-200312000-00015}{doi:10.1097/00132981-200312000-00015}.
\item Kamata Tooru, Nishikawa Mayumi, Katagi Munehiro, Tsuchihashi Hitoshi (2003). \textit{Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples}. Journal of Chromatography B. [published; Crossref]. \href{https://doi.org/10.1016/j.jchromb.2003.08.030}{doi:10.1016/j.jchromb.2003.08.030}.
\item Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider (2003). \textit{P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(03)92355-8}{doi:10.1016/s0924-977x(03)92355-8}.
\item Saviuc P, Flesch F (2003). \textit{[Acute higher funghi mushroom poisoning and its treatment].}. Presse medicale (Paris, France: 1983). [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14534493/}{source link}.
\item Ventegodt S, Merrick J (2003). \textit{Psychoactive drugs and quality of life.}. TheScientificWorldJournal. [published; PubMed]. \href{https://doi.org/10.1100/tsw.2003.57}{doi:10.1100/tsw.2003.57}.
\item Stríbrný J, Borovicka J, Sokol M (2003). \textit{[Levels of psilocybin and psilocin in various types of mushrooms].}. Soudni lekarstvi. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14631713/}{source link}.
\item Vollenweider FX, Vollenweider-Scherpenhuyzen MF (2003). \textit{[Hallucinogens, amphetamines and entactogens].}. Therapeutische Umschau. Revue therapeutique. [published; PubMed]. \href{https://doi.org/10.1024/0040-5930.60.6.323}{doi:10.1024/0040-5930.60.6.323}.
\item Shirota Osamu, Hakamata Wataru, Goda Yukihiro (2003). \textit{Concise Large-Scale Synthesis of Psilocin and Psilocybin, Principal Hallucinogenic Constituents of “Magic Mushroom”}. Journal of Natural Products. [published; Crossref]. \href{https://doi.org/10.1021/np030059u}{doi:10.1021/np030059u}.
\item Gonmori K, Yoshioka N (2003). \textit{The examination of mushroom poisonings at Akita University.}. Legal medicine (Tokyo, Japan). [published; PubMed]. \href{https://doi.org/10.1016/s1344-6223(02)00127-x}{doi:10.1016/s1344-6223(02)00127-x}.
\item Gathergood Nicholas, Scammells Peter J. (2003). \textit{Preparation of the 4-Hydroxytryptamine Scaffold via Palladium-Catalyzed Cyclization: A Practical and Versatile Synthesis of Psilocin}. Organic Letters. [published; Crossref]. \href{https://doi.org/10.1021/ol0341039}{doi:10.1021/ol0341039}.
\item Maruyama T, Shirota O, Kawahara N, Yokoyama K, Makino Y, Goda Y (2003). \textit{[Discrimination of psychoactive fungi (commonly called "magic mushrooms") based on the DNA sequence of the internal transcribed spacer region].}. Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan. [published; PubMed]. \href{https://doi.org/10.3358/shokueishi.44.44}{doi:10.3358/shokueishi.44.44}.
\item Anna Machoy-Mokrzyńska, Krzysztof Safranow, Krzysztof Borowiak, Sławomir Majdanik, Violetta Dziedziejko, Monika Białecka, Dariusz Chlubek (2003). \textit{The influence of psilocin and phenylethylamine on the energy metabolism in the rat heart}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-8e3dbd92-615e-497e-af12-c98c681b8b63}{source link}.
\item Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Leszek Domański, Sławomir Majdanik, Edward Dutkiewicz, K Safranow, Tomasz Janus, V Mikolajek (2003). \textit{Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushrooms}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30}{source link}.
\item O. Carter, Shaun P. Collin, Felix Hasler, George Liu, Franz X. Vollenweider, John D. Pettigrew (2003). \textit{A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A\&2A agonist psilocybin on binocular rivalry rate and rhythmicity}. Social Neuroscience. [published; OpenAlex]. \href{https://espace.library.uq.edu.au/view/UQ:161618}{source link}.
\item Umbricht D, Vollenweider FX, Schmid L, Grübel C, Skrabo A, Huber T, Koller R (2003). \textit{Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/sj.npp.1300005}{doi:10.1038/sj.npp.1300005}.
\item Carod Artal FJ (2003). \textit{[Neurological syndromes associated with the ingestion of plants and fungi with a toxic component (II). Hallucinogenic fungi and plants, mycotoxins and medicinal herbs].}. Revista de neurologia. [published; PubMed]. \href{https://doi.org/10.33588/rn.3610.2003019}{doi:10.33588/rn.3610.2003019}.
\item Riba J, Rodríguez-Fornells A, Barbanoj MJ (2002). \textit{Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-002-1237-5}{doi:10.1007/s00213-002-1237-5}.
\item Gross ST (2002). \textit{Psychotropic drugs in developmental mushrooms: a case study review.}. Journal of forensic sciences. [published; PubMed]. \href{https://doi.org/10.1520/jfs15564j}{doi:10.1520/jfs15564j}.
\item Passie T, Seifert J, Schneider U, Emrich HM (2002). \textit{The pharmacology of psilocybin.}. Addiction biology. [published; PubMed]. \href{https://doi.org/10.1080/1355621021000005937}{doi:10.1080/1355621021000005937}.
\item Hasler Felix, Bourquin Daniel, Brenneisen Rudolf, Vollenweider Franz X (2002). \textit{Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man}. Journal of Pharmaceutical and Biomedical Analysis. [published; Crossref]. \href{https://doi.org/10.1016/s0731-7085(02)00278-9}{doi:10.1016/s0731-7085(02)00278-9}.
\item Albers Christian, Lehr Matthias, Beike Justus, Köhler Helga, Brinkmann Bernd (2002). \textit{Synthesis of a psilocin hapten and a protein-hapten conjugate}. Journal of Pharmacy and Pharmacology. [published; Crossref]. \href{https://doi.org/10.1211/002235702320402116}{doi:10.1211/002235702320402116}.
\item Gross SR, Barrett SP, Shestowsky JS, Pihl RO (2002). \textit{Ecstasy and drug consumption patterns: a Canadian rave population study.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/070674370204700606}{doi:10.1177/070674370204700606}.
\item Yamada Fumio, Tamura Mayumi, Hasegawa Atsuko, Somei Masanori (2002). \textit{ChemInform Abstract: The Chemistry of Indoles. Part 109. Synthetic Studies of Psilocin Analogues Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.200229147}{doi:10.1002/chin.200229147}.
\item Rabin RA, Regina M, Doat M, Winter JC (2002). \textit{5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/s0091-3057(01)00720-1}{doi:10.1016/s0091-3057(01)00720-1}.
\item Moeller MR, Kraemer T (2002). \textit{Drugs of abuse monitoring in blood for control of driving under the influence of drugs.}. Therapeutic drug monitoring. [published; PubMed]. \href{https://doi.org/10.1097/00007691-200204000-00003}{doi:10.1097/00007691-200204000-00003}.
\item Bressloff PC, Cowan JD, Golubitsky M, Thomas PJ, Wiener MC (2002). \textit{What geometric visual hallucinations tell us about the visual cortex.}. Neural computation. [published; PubMed]. \href{https://doi.org/10.1162/089976602317250861}{doi:10.1162/089976602317250861}.
\item Umbricht D, Koller R, Vollenweider FX, Schmid L (2002). \textit{Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s0006-3223(01)01242-2}{doi:10.1016/s0006-3223(01)01242-2}.
\item Fukuda K (2002). \textit{Possible mechanisms of panic attack and schizophrenia via APUD system.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1054/mehy.2001.1473}{doi:10.1054/mehy.2001.1473}.
\item Adrian Linacre, Michael D. Cole, Lee Jc (2002). \textit{Identifying the presence of ‘magic mushrooms’ by DNA profiling}. Science \& Justice. [published; OpenAlex]. \href{https://doi.org/10.1016/s1355-0306(02)71797-8}{doi:10.1016/s1355-0306(02)71797-8}.
\item Kenneth W. Tupper (2002). \textit{Entheogens and Existential Intelligence: The Use of Plant Teachers as Cognitive Tools}. Canadian Journal of Education / Revue canadienne de l éducation. [published; OpenAlex]. \href{https://doi.org/10.2307/1602247}{doi:10.2307/1602247}.
\item Gouzoulis-Mayfrank E, Thelen B, Maier S, Heekeren K, Kovar KA, Sass H, Spitzer M (2002). \textit{Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.}. Neuropsychobiology. [published; PubMed]. \href{https://doi.org/10.1159/000063672}{doi:10.1159/000063672}.
\item ten Berge J (2002). \textit{Jekyll and Hyde revisited: paradoxes in the appreciation of drug experiences and their effects on creativity.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2002.10399961}{doi:10.1080/02791072.2002.10399961}.
\item Yamada Fumio, Tamura Mayumi, Hasegawa Atsuko, Somei Masanori (2002). \textit{Synthetic Studies of Psilocin Analogs Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.}. Chemical and Pharmaceutical Bulletin. [published; Crossref]. \href{https://doi.org/10.1248/cpb.50.92}{doi:10.1248/cpb.50.92}.
\item Vollenweider FX (2001). \textit{Brain mechanisms of hallucinogens and entactogens.}. Dialogues in clinical neuroscience. [published; PubMed]. \href{https://doi.org/10.31887/dcns.2001.3.4/fxvollenweider}{doi:10.31887/dcns.2001.3.4/fxvollenweider}.
\item Vollenweider FX, Geyer MA (2001). \textit{A systems model of altered consciousness: integrating natural and drug-induced psychoses.}. Brain research bulletin. [published; PubMed]. \href{https://doi.org/10.1016/s0361-9230(01)00646-3}{doi:10.1016/s0361-9230(01)00646-3}.
\item Riley SC, James C, Gregory D, Dingle H, Cadger M (2001). \textit{Patterns of recreational drug use at dance events in Edinburgh, Scotland.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1046/j.1360-0443.2001.967103513.x}{doi:10.1046/j.1360-0443.2001.967103513.x}.
\item Grieshaber AF, Moore KA, Levine B (2001). \textit{The Detection of Psilocin in Human Urine}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1520/jfs15014j}{doi:10.1520/jfs15014j}.
\item Grieshaber AF, Moore KA, Levine B (2001). \textit{The detection of psilocin in human urine.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/11373000/}{source link}.
\item Lee JC. (2001). \textit{Towards a molecular approach for the identification of fungal taxa that contain psilocybin}. University of Strathclyde. [published; Europe PMC]. \href{https://doi.org/10.48730/zty1-g223}{doi:10.48730/zty1-g223}.
\item Moldavan MG, Grodzinskaya AA, Solomko EF, Lomberh ML, Wasser SP, Storozhuk VM (2001). \textit{The effect of Psilocybe cubensis extract on hippocampal neurons in vitro.}. Fiziolohichnyi zhurnal (Kiev, Ukraine: 1994). [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/11962085/}{source link}.
\item Vetulani J (2001). \textit{Drug addiction. Part I. Psychoactive substances in the past and presence.}. Polish journal of pharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/11785921/}{source link}.
\item Ho E, Karimi-Tabesh L, Koren G (2000). \textit{Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).}. Neurotoxicology and teratology. [published; PubMed]. \href{https://doi.org/10.1016/s0892-0362(01)00178-7}{doi:10.1016/s0892-0362(01)00178-7}.
\item Salomé F, Boyer P, Fayol M (2000). \textit{The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review.}. European psychiatry: the journal of the Association of European Psychiatrists. [published; PubMed]. \href{https://doi.org/10.1016/s0924-9338(00)00520-4}{doi:10.1016/s0924-9338(00)00520-4}.
\item Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE (2000). \textit{Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.}. Journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1021/jm000339w}{doi:10.1021/jm000339w}.
\item Bogusz MJ (2000). \textit{Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity.}. Journal of chromatography. B, Biomedical sciences and applications. [published; PubMed]. \href{https://doi.org/10.1016/s0378-4347(00)00461-8}{doi:10.1016/s0378-4347(00)00461-8}.
\item Pierrot M, Josse P, Raspiller MF, Goulmy M, Rambourg MO, Manel J, Lambert H (2000). \textit{[Intoxications by hallucinogenic mushrooms].}. Annales de medecine interne. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/11104939/}{source link}.
\item Barrett SP, Archambault J, Engelberg MJ, Pihl RO (2000). \textit{Hallucinogenic drugs attenuate the subjective response to alcohol in humans.}. Human psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}{doi:10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}.
\item Musshoff F, Madea B, Beike J (2000). \textit{Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.}. Forensic science international. [published; PubMed]. \href{https://doi.org/10.1016/s0379-0738(00)00211-5}{doi:10.1016/s0379-0738(00)00211-5}.
\item Sticht G, Käferstein H (2000). \textit{Detection of psilocin in body fluids}. Forensic Science International. [published; Crossref]. \href{https://doi.org/10.1016/s0379-0738(00)00213-9}{doi:10.1016/s0379-0738(00)00213-9}.
\item Adlaf EM, Paglia A, Ivis FJ, Ialomiteanu A (2000). \textit{Nonmedical drug use among adolescent students: highlights from the 1999 Ontario Student Drug Use Survey.}. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/10870495/}{source link}.
\item Gross ST (2000). \textit{Detecting psychoactive drugs in the developmental stages of mushrooms.}. Journal of forensic sciences. [published; PubMed]. \href{https://doi.org/10.1520/jfs14725j}{doi:10.1520/jfs14725j}.
\item Yamada F (2000). \textit{[Development of synthetic methods for 4-substituted indoles and their applications for the syntheses of natural products].}. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan. [published; PubMed]. \href{https://doi.org/10.1248/yakushi1947.120.4\_363}{doi:10.1248/yakushi1947.120.4\_363}.
\item Daniel Umbricht, F.X. Vollenweider, L. Schmid, R. Koller (2000). \textit{177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0006-3223(00)00439-x}{doi:10.1016/s0006-3223(00)00439-x}.
\item Spengos K, Schwartz A, Hennerici M (2000). \textit{Multifocal cerebral demyelination after magic mushroom abuse.}. Journal of neurology. [published; PubMed]. \href{https://doi.org/10.1007/s004150050570}{doi:10.1007/s004150050570}.
\item M. G. Moldavan, Elvira F. Solomko, Anna A. Grodzínskaya, V. М. Storozhuk, Margarita Lomberg (2000). \textit{Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro Studies}. International journal of medicinal mushrooms. [published; OpenAlex]. \href{https://doi.org/10.1615/intjmedmushr.v2.i4.130}{doi:10.1615/intjmedmushr.v2.i4.130}.
\item Gilbert Asselborn, Robert Wennig, Michel Yegles (2000). \textit{TRAGIC FLYING ATTEMPT UNDER THE INFLUENCE OF "MAGIC MUSHROOMS"}. Problems of Forensic Sciences. [published; OpenAlex]. \href{http://www.forensicscience.pl/pfs/42\_asselborn.pdf}{source link}.
\item Schäfer AT (2000). \textit{[Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].}. Archiv fur Kriminologie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/10726173/}{source link}.
\item McBride MC (2000). \textit{Bufotenine: toward an understanding of possible psychoactive mechanisms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2000.10400456}{doi:10.1080/02791072.2000.10400456}.
\item Senn-Irlet Beatrice, Nyffenegger Adolf, Brenneisen Rudolf (1999). \textit{Panaeolus bisporus - an adventitious fungus in central Europe, rich in psilocin}. Mycologist. [published; Crossref]. \href{https://doi.org/10.1016/s0269-915x(99)80107-4}{doi:10.1016/s0269-915x(99)80107-4}.
\item Drummer OH (1999). \textit{Chromatographic screening techniques in systematic toxicological analysis.}. Journal of chromatography. B, Biomedical sciences and applications. [published; PubMed]. \href{https://doi.org/10.1016/s0378-4347(99)00265-0}{doi:10.1016/s0378-4347(99)00265-0}.
\item Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE (1999). \textit{Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.}. Journal of medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.1021/jm990325u}{doi:10.1021/jm990325u}.
\item Keller T, Schneider A, Regenscheit P, Dirnhofer R, Rucker T, Jaspers J, Kisser W (1999). \textit{Analysis of psilocybin and psilocin in psilocybe subcubensis Guzman by ion mobility spectrometry and gas chromatography-mass spectrometry}. Journal of Clinical Forensic Medicine. [published; Crossref]. \href{https://doi.org/10.1016/s1353-1131(99)90073-1}{doi:10.1016/s1353-1131(99)90073-1}.
\item Krämer E, Kovar KA (1999). \textit{On-line coupling of automated solid-phase extraction with high-performance liquid chromatography and electrochemical detection. Quantitation of oxidizable drugs of abuse and their metabolites in plasma and urine.}. Journal of chromatography. B, Biomedical sciences and applications. [published; PubMed]. \href{https://doi.org/10.1016/s0378-4347(99)00212-1}{doi:10.1016/s0378-4347(99)00212-1}.
\item Nichols David E., Frescas Steward (1999). \textit{ChemInform Abstract: Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.199933137}{doi:10.1002/chin.199933137}.
\item Sakagami Hideki, Ogasawara Kunio (1999). \textit{ChemInform Abstract: A New Synthesis of Psilocin}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.199932235}{doi:10.1002/chin.199932235}.
\item Löhrer F, Albers M (1999). \textit{[Biological addictive drugs--is there a change in drug taking behavior of young drug addicts?].}. Psychiatrische Praxis. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/10457973/}{source link}.
\item Yamada Fumio, Tamura Mayumi, Somei Masanori (1999). \textit{ChemInform Abstract: Chemistry of Indoles. Part 88. A Five-Step Synthesis of Psilocin from Indole-3-carbaldehyde.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.199923257}{doi:10.1002/chin.199923257}.
\item Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Büll U, Sass H (1999). \textit{Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/s0893-133x(98)00089-x}{doi:10.1016/s0893-133x(98)00089-x}.
\item Nichols David E. (1999). \textit{Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin}. Synthesis. [published; Crossref]. \href{https://doi.org/10.1055/s-1999-3490}{doi:10.1055/s-1999-3490}.
\item Vollenweider FX, Vontobel P, Hell D, Leenders KL (1999). \textit{5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/s0893-133x(98)00108-0}{doi:10.1016/s0893-133x(98)00108-0}.
\item Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA, Lindenblatt H, Hermle L, Spitzer M, Sass H (1999). \textit{Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s002130050860}{doi:10.1007/s002130050860}.
\item D A Reid, A. Eicker (1999). \textit{South African fungi 9: Psilocybe natalensis - a blueing hallucinogenic species from South Africa}. Mycotaxon. [published; OpenAlex]. \href{https://doi.org/10.5962/p.415161}{doi:10.5962/p.415161}.
\item Shirahama Haruhisa, Sogawa Kazuyo, Hashimoto Kimiko (1999). \textit{H-D Exchange of Psilocin and Its Analogs}. HETEROCYCLES. [published; Crossref]. \href{https://doi.org/10.3987/com-98-s(h)87}{doi:10.3987/com-98-s(h)87}.
\item Keller Thomas, Schneider Andrea, Regenscheit Priska, Richard Dirnhofer, Rücker Thomas, Jaspers Jürgen, Kisser Wolfgang (1999). \textit{Analysis of psilocybin and psilocin in Psilocybe subcubensis GUZMÁN by ion mobility spectrometry and gas chromatography-mass spectrometry}. Forensic Science International. [published; Crossref]. \href{https://doi.org/10.1016/s0379-0738(98)00168-6}{doi:10.1016/s0379-0738(98)00168-6}.
\item Babakhanian RV, Ivanova GV, Kostyrko TA, Safraĭ AE, Iagmurov OD (1999). \textit{[The morphofunctional changes in the internal organs in the modelling of poisonings by psilocybine-containing mushrooms].}. Sudebno-meditsinskaia ekspertiza. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/10396957/}{source link}.
\item Ogasawara Kunio, Sakagami Hideki (1999). \textit{A New Synthesis of Psilocin}. HETEROCYCLES. [published; Crossref]. \href{https://doi.org/10.3987/com-99-8492}{doi:10.3987/com-99-8492}.
\item Stig Pedersen-Bjergaard, Knut Einar Rasmussen (1998). \textit{Capillary electrophoresis of psilocybin in hallucinogenic mushrooms}. Research at the University of Copenhagen (University of Copenhagen). [published; OpenAlex]. \href{https://researchprofiles.ku.dk/da/publications/55ac5ed7-ff92-4676-a56e-cd075fdb7b65}{source link}.
\item Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D (1998). \textit{Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.}. Neuroreport. [published; PubMed]. \href{https://doi.org/10.1097/00001756-199812010-00024}{doi:10.1097/00001756-199812010-00024}.
\item Gouzoulis-Mayfrank E, Heekeren K, Thelen B, Lindenblatt H, Kovar KA, Sass H, Geyer MA (1998). \textit{Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.}. Behavioural pharmacology. [published; PubMed]. \href{https://doi.org/10.1097/00008877-199811000-00011}{doi:10.1097/00008877-199811000-00011}.
\item Adlaf EM, Ivis FJ (1998). \textit{Recent findings from the Ontario Student Drug Use Survey.}. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/9757168/}{source link}.
\item Euphrosyne Gouzoulis-Mayfrank, Karsten Heekeren, B. Thelen, Hiltrud Lindenblatt, K.-A. Kovar, H. Sass, M.A. Geyer (1998). \textit{529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humans}. International Journal of Psychophysiology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0167-8760(98)90528-1}{doi:10.1016/s0167-8760(98)90528-1}.
\item Vollenweider FX (1998). \textit{Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/s-2007-979353}{doi:10.1055/s-2007-979353}.
\item Gouzoulis-Mayfrank E, Schneider F, Friedrich J, Spitzer M, Thelen B, Sass H (1998). \textit{Methodological issues of human experimental research with hallucinogens.}. Pharmacopsychiatry. [published; PubMed]. \href{https://doi.org/10.1055/s-2007-979356}{doi:10.1055/s-2007-979356}.
\item Ametamey S., Vollenweider F. X., Patt J., Bourquin D., Hasler F., Beer H.-F., Schubiger P. A. (1998). \textit{11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formation}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; Crossref]. \href{https://doi.org/10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}{doi:10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}.
\item Lindenblatt Hiltrud, Krämer Edda, Holzmann-Erens Petra, Gouzoulis-Mayfrank Euphrosyne, Kovar Karl-Artur (1998). \textit{Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction}. Journal of Chromatography B: Biomedical Sciences and Applications. [published; Crossref]. \href{https://doi.org/10.1016/s0378-4347(98)00067-x}{doi:10.1016/s0378-4347(98)00067-x}.
\item Mansi Kala, Wojciech Lechowicz, Roman Stanaszek (1998). \textit{Analysis of psilocin in Polish hallucinogenic mushrooms}. Acta Poloniae Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-64d5aaec-f7ca-4434-ad46-5e05030850c8}{source link}.
\item Beck O, Helander A, Karlson-Stiber C, Stephansson N (1998). \textit{Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.}. Journal of analytical toxicology. [published; PubMed]. \href{https://doi.org/10.1093/jat/22.1.45}{doi:10.1093/jat/22.1.45}.
\item Pedersen-Bjergaard S, Rasmussen KE, Sannes E (1998). \textit{Strategies for the capillary electrophoretic separation of indole alkaloids in Psilocybe semilanceata.}. Electrophoresis. [published; PubMed]. \href{https://doi.org/10.1002/elps.1150190107}{doi:10.1002/elps.1150190107}.
\item Borowiak KS, Ciechanowski K, Waloszczyk P (1998). \textit{Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction.}. Journal of toxicology. Clinical toxicology. [published; PubMed]. \href{https://doi.org/10.3109/15563659809162584}{doi:10.3109/15563659809162584}.
\item Doblin R (1998). \textit{Dr. Leary's Concord Prison Experiment: a 34-year follow-up study.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.1998.10399715}{doi:10.1080/02791072.1998.10399715}.
\item Babakhanian RV, Bushuev ES, Zenkevich IG, Kazankov SP, Kostyrko TA, Kuz'minykh KS (1998). \textit{[The forensic chemical study of psilocybine-containing fungi].}. Sudebno-meditsinskaia ekspertiza. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/9989170/}{source link}.
\item Somei Masanori, Yamada Fumio, Tamura Mayumi (1997). \textit{A Five-Step Synthesis of Psilocin from Indole-3-carbaldehyde}. HETEROCYCLES. [published; Crossref]. \href{https://doi.org/10.3987/com-98-s18}{source link}.
\item Pedersen-Bjergaard S, Sannes E, Rasmussen KE, Tønnesen F (1997). \textit{Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis.}. Journal of chromatography. B, Biomedical sciences and applications. [published; PubMed]. \href{https://doi.org/10.1016/s0378-4347(97)00127-8}{doi:10.1016/s0378-4347(97)00127-8}.
\item Hasler F., Bourquin D., Brenneisen R., Bär T., Vollenweider F.X. (1997). \textit{Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man}. Pharmaceutica Acta Helvetiae. [published; Crossref]. \href{https://doi.org/10.1016/s0031-6865(97)00014-9}{doi:10.1016/s0031-6865(97)00014-9}.
\item Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J (1997). \textit{Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/s0893-133x(96)00246-1}{doi:10.1016/s0893-133x(96)00246-1}.
\item Almaula N, Ebersole BJ, Ballesteros JA, Weinstein H, Sealfon SC (1996). \textit{Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.}. Molecular pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/s0026-895x(25)09149-7}{doi:10.1016/s0026-895x(25)09149-7}.
\item Spitzer M, Thimm M, Hermle L, Holzmann P, Kovar KA, Heimann H, Gouzoulis-Mayfrank E, Kischka U, Schneider F (1996). \textit{Increased activation of indirect semantic associations under psilocybin.}. Biological psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/0006-3223(95)00418-1}{doi:10.1016/0006-3223(95)00418-1}.
\item Hanes KR (1996). \textit{Serotonin, psilocybin, and body dysmorphic disorder: a case report.}. Journal of clinical psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1097/00004714-199604000-00011}{doi:10.1097/00004714-199604000-00011}.
\item Horace J. Beach (1996). \textit{Listening for the logos: a study of reports of audible voices at high doses of psilocybin}. Medical Entomology and Zoology. [published; OpenAlex]. \href{http://ci.nii.ac.jp/ncid/BB19813140}{source link}.
\item Hughes JR (1996). \textit{A review of the usefulness of the standard EEG in psychiatry.}. Clinical EEG (electroencephalography). [published; PubMed]. \href{https://doi.org/10.1177/155005949602700106}{doi:10.1177/155005949602700106}.
\item Bergman B, Karlsson AC (1995). \textit{[A caution for psilocybine in wild mushrooms. A young addict acquired acute delirium].}. Lakartidningen. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/7564628/}{source link}.
\item Gartz J, Allen JW, Merlin MD (1994). \textit{Ethnomycology, biochemistry, and cultivation of Psilocybe samuiensis Guzmán, Bandala and Allen, a new psychoactive fungus from Koh Samui, Thailand.}. Journal of ethnopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0378-8741(94)90006-x}{doi:10.1016/0378-8741(94)90006-x}.
\item Marcano V., Méndez A.Morales, Castellano F., Salazar F.J., Martinez L. (1994). \textit{Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes}. Journal of Ethnopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/0378-8741(94)90013-2}{doi:10.1016/0378-8741(94)90013-2}.
\item Chamakura RP (1994). \textit{Bufotenine - A Hallucinogen in Ancient Snuff Powders of South America and a Drug of Abuse on the Streets of New York City.}. Forensic science review. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/26270149/}{source link}.
\item Cuomo MJ, Dyment PG, Gammino VM (1994). \textit{Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.}. Journal of American college health: J of ACH. [published; PubMed]. \href{https://doi.org/10.1080/07448481.1994.9936359}{doi:10.1080/07448481.1994.9936359}.
\item Gouzoulis E, Hermle L, Sass H (1994). \textit{[Psychedelic experiences at the onset of productive episodes of endogenous psychoses].}. Der Nervenarzt. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/8177361/}{source link}.
\item Gartz J (1994). \textit{Extraction and analysis of indole derivatives from fungal biomass.}. Journal of basic microbiology. [published; PubMed]. \href{https://doi.org/10.1002/jobm.3620340104}{doi:10.1002/jobm.3620340104}.
\item Köppel C (1993). \textit{Clinical symptomatology and management of mushroom poisoning.}. Toxicon: official journal of the International Society on Toxinology. [published; PubMed]. \href{https://doi.org/10.1016/0041-0101(93)90337-i}{doi:10.1016/0041-0101(93)90337-i}.
\item Merlin MD, Allen JW (1993). \textit{Species identification and chemical analysis of psychoactive fungi in the Hawaiian islands.}. Journal of ethnopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0378-8741(93)90086-k}{doi:10.1016/0378-8741(93)90086-k}.
\item Robert S. Gable (1993). \textit{Skinner, Maslow, and Psilocybin}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678930333005}{doi:10.1177/00221678930333005}.
\item Gable RS (1993). \textit{Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically.}. The American journal of drug and alcohol abuse. [published; PubMed]. \href{https://doi.org/10.3109/00952999309001618}{doi:10.3109/00952999309001618}.
\item Riedlinger TJ (1993). \textit{Wasson's alternative candidates for soma.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.1993.10472245}{doi:10.1080/02791072.1993.10472245}.
\item Hery F, Hamon M (1993). \textit{[Neuroleptics and serotonin].}. L'Encephale. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/7905821/}{source link}.
\item Strassman RJ (1992). \textit{Human hallucinogen interactions with drugs affecting serotonergic neurotransmission.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1388647/}{source link}.
\item Lassen JF, Lassen NF, Skov J (1992). \textit{[Consumption of psilocybin-containing hallucinogenic mushrooms by young people].}. Ugeskrift for laeger. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1413197/}{source link}.
\item Smith C, Nutbeam D (1992). \textit{Adolescent drug use in Wales.}. British journal of addiction. [published; PubMed]. \href{https://doi.org/10.1111/j.1360-0443.1992.tb02696.x}{doi:10.1111/j.1360-0443.1992.tb02696.x}.
\item Allen JW, Merlin MD (1992). \textit{Psychoactive mushroom use in Koh Samui and Koh Pha-Ngan, Thailand.}. Journal of ethnopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0378-8741(92)90020-r}{doi:10.1016/0378-8741(92)90020-r}.
\item T. Stijve (1991). \textit{Psilocin, psilocybin, serotonin and urea in Panaeolus cyanescens from various origin}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/532101}{source link}.
\item Jones J (1990). \textit{'Magic mushroom' poisoning in a colt.}. The Veterinary record. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2075691/}{source link}.
\item Kysilka Roman, Wurst Milan (1990). \textit{A Novel Extraction Procedure for Psilocybin and Psilocin Determination in Mushroom Samples}. Planta Medica. [published; Crossref]. \href{https://doi.org/10.1055/s-2006-960970}{doi:10.1055/s-2006-960970}.
\item Buckholtz NS, Zhou DF, Freedman DX, Potter WZ (1990). \textit{Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1969270/}{source link}.
\item Kirwan AP (1990). \textit{'Magic mushroom' poisoning in a dog.}. The Veterinary record. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2316139/}{source link}.
\item Lassen JF, Ravn HB, Lassen SF (1990). \textit{[Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].}. Ugeskrift for laeger. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2301080/}{source link}.
\item L. S. Gurevich, E. L. Nezdoĭminogo (1990). \textit{Possible uses of psilocybin and muscarin alkaloids in the chemotaxonomy of Inocybe (Fr.)Fr.}. Mikologiya i Fitopatologiya. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19921250159.html}{source link}.
\item Kysilka Roman (1990). \textit{Determination of psilocin in rat urine by high-performance liquid chromatography with electrochemical detection}. Journal of Chromatography B: Biomedical Sciences and Applications. [published; Crossref]. \href{https://doi.org/10.1016/s0378-4347(00)82176-3}{doi:10.1016/s0378-4347(00)82176-3}.
\item Gartz J (1989). \textit{Biotransformation of Tryptamine in Fruiting Mycelia of Psilocybe cubensis.}. Planta medica. [published; PubMed]. \href{https://doi.org/10.1055/s-2006-961995}{doi:10.1055/s-2006-961995}.
\item Appel JB, Callahan PM (1989). \textit{Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.}. European journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0014-2999(89)90041-1}{doi:10.1016/0014-2999(89)90041-1}.
\item Jochen Gartz, Gregory Möller (1989). \textit{Analysis and Cultivation of Fruit Bodies and Mycelia of Psilocybe bohemica}. Biochemie und Physiologie der Pflanzen. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-3796(89)80023-x}{doi:10.1016/s0015-3796(89)80023-x}.
\item Eivindvik K, Rasmussen KE, Sund RB (1989). \textit{Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.}. Acta pharmaceutica Nordica. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2610906/}{source link}.
\item Gartz J (1989). \textit{Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe.}. Journal of basic microbiology. [published; PubMed]. \href{https://doi.org/10.1002/jobm.3620290608}{doi:10.1002/jobm.3620290608}.
\item Leikin JB, Krantz AJ, Zell-Kanter M, Barkin RL, Hryhorczuk DO (1989). \textit{Clinical features and management of intoxication due to hallucinogenic drugs.}. Medical toxicology and adverse drug experience. [published; PubMed]. \href{https://doi.org/10.1007/bf03259916}{doi:10.1007/bf03259916}.
\item Jochen Gartz (1988). \textit{Occurrence of psilocybin, psilocin and baeocystin in Gymnopilus purpuratus}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/532047}{source link}.
\item Callahan PM, Appel JB (1988). \textit{Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/s0022-3565(25)22199-1}{doi:10.1016/s0022-3565(25)22199-1}.
\item Rudolf Brenneisen, Stefan Borner (1988). \textit{The Occurrence of Tryptamine Derivatives in Psilocybe semilanceata}. Zeitschrift für Naturforschung C. [published; OpenAlex]. \href{https://doi.org/10.1515/znc-1988-7-806}{doi:10.1515/znc-1988-7-806}.
\item Schwartz RH, Smith DE (1988). \textit{Hallucinogenic mushrooms.}. Clinical pediatrics. [published; PubMed]. \href{https://doi.org/10.1177/000992288802700202}{doi:10.1177/000992288802700202}.
\item Rudolf Brenneisen, Stefan Borner, Nelly Peter-Oesch, U. P. Schlunegger (1988). \textit{Synthesis of Baeocystin, a natural Psilocybin Analogue}. Archiv der Pharmazie. [published; OpenAlex]. \href{https://doi.org/10.1002/ardp.19883210812}{doi:10.1002/ardp.19883210812}.
\item Musha M, Kusano G, Tanaka F, Gotoh Y, Ishii A (1988). \textit{[Poisoning by the hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes)--with special reference to subjective experiences during psilocybin poisoning].}. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/3413259/}{source link}.
\item T. Stijve, Th.W. Kuyper (1987). \textit{Absence of psilocybin in species of fungi previously reported to contain psilocybin and related tryptamine derivatives}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/531853}{source link}.
\item Gartz J (1987). \textit{Variation of the Amount of Alkaloids in Fruit Bodies of Inocybe aeruginascens.}. Planta medica. [published; PubMed]. \href{https://doi.org/10.1055/s-2006-962805}{doi:10.1055/s-2006-962805}.
\item Leonard HL, Rapoport JL (1987). \textit{Relief of obsessive-compulsive symptoms by LSD and psilocin}. American Journal of Psychiatry. [published; Crossref]. \href{https://doi.org/10.1176/ajp.144.9.1239b}{doi:10.1176/ajp.144.9.1239b}.
\item Ohenoja E., Jokiranta J., Mäkinen T., Kaikkonen A., Airaksinen M. M. (1987). \textit{The Occurrence of Psilocybin and Psilocin in Finnish Fungi}. Journal of Natural Products. [published; Crossref]. \href{https://doi.org/10.1021/np50052a030}{doi:10.1021/np50052a030}.
\item Gartz J (1987). \textit{Occurrence of Psilocybin and Baeocystin in Fruit Bodies of Pluteus salicinus.}. Planta medica. [published; PubMed]. \href{https://doi.org/10.1055/s-2006-962710}{doi:10.1055/s-2006-962710}.
\item Zilker T (1987). \textit{[Diagnosis and therapy of mushroom poisoning (1)].}. Leber, Magen, Darm. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/3586830/}{source link}.
\item Stefan Borner, Rudolf Brenneisen (1986). \textit{Determination of tryptamine derivatives in hallucinogenic mushrooms using high-performance liquid chromatography with photodiode array detection}. Journal of Chromatography A. [published; OpenAlex]. \href{https://doi.org/10.1016/s0021-9673(01)81831-8}{doi:10.1016/s0021-9673(01)81831-8}.
\item Marta Semerdžieva, M. Wurst, T. Koza, Jochen Gartz (1986). \textit{Psilocybin in Fruchtkörpern vonInocybe aeruginascens}. Planta Medica. [published; OpenAlex]. \href{https://doi.org/10.1055/s-2007-969085}{doi:10.1055/s-2007-969085}.
\item Martin WR, Sloan JW (1986). \textit{Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(86)90369-2}{doi:10.1016/0091-3057(86)90369-2}.
\item Nichols DE (1986). \textit{Studies of the relationship between molecular structure and hallucinogenic activity.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(86)90362-x}{doi:10.1016/0091-3057(86)90362-x}.
\item Poon Grace, Chui Yun-Cheung, Law Francis C. P. (1986). \textit{Synthesis of psilocin labelled with 14C and 3H}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; Crossref]. \href{https://doi.org/10.1002/jlcr.2580230207}{doi:10.1002/jlcr.2580230207}.
\item Jochen Gartz (1986). \textit{Psilocybin in Mycelkulturen von Inocybe aeruginascens}. Biochemie und Physiologie der Pflanzen. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-3796(86)80042-7}{doi:10.1016/s0015-3796(86)80042-7}.
\item Jochen Gartz (1986). \textit{Quantitative Bestimmung der Indolderivate von Psilocybe semilanceata (Fr.) Kumm.}. Biochemie und Physiologie der Pflanzen. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-3796(86)80079-8}{doi:10.1016/s0015-3796(86)80079-8}.
\item Musha M, Ishii A, Tanaka F, Kusano G (1986). \textit{Poisoning by hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes K. Yokoyama) indigenous to Japan.}. The Tohoku journal of experimental medicine. [published; PubMed]. \href{https://doi.org/10.1620/tjem.148.73}{doi:10.1620/tjem.148.73}.
\item Stijve T, Kuyper TW (1985). \textit{Occurrence of psilocybin in various higher fungi from several European countries.}. Planta medica. [published; PubMed]. \href{https://doi.org/10.1055/s-2007-969526}{doi:10.1055/s-2007-969526}.
\item Lee RE (1985). \textit{A Technique for the Rapid Isolation and Identification of Psilocin from Psilocin/Psilocybin-Containing Mushrooms}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1520/jfs11028j}{doi:10.1520/jfs11028j}.
\item Lee RE (1985). \textit{A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4040953/}{source link}.
\item Casale JF (1985). \textit{An Aqueous-Organic Extraction Method for the Isolation and Identification of Psilocin from Hallucinogenic Mushrooms}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1520/jfs10989j}{doi:10.1520/jfs10989j}.
\item Siegel RK (1985). \textit{New trends in drug use among youth in California.}. Bulletin on narcotics. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/3878176/}{source link}.
\item Casale JF (1985). \textit{An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4038992/}{source link}.
\item T. Stijve, Jaroslav Klán, Th.W. Kuyper (1984). \textit{Occurrence of Psilocybin and Baeocystin in the genus Inocybe (Fr.) Fr}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/532375}{source link}.
\item Christiansen A., Rasmussen K., Høiland K. (1984). \textit{Detection of Psilocybin and Psilocin in Norwegian Species ofPluteusandConocybe}. Planta Medica. [published; Crossref]. \href{https://doi.org/10.1055/s-2007-969726}{doi:10.1055/s-2007-969726}.
\item Gonzalez-Lima F, Stiehl WL, Medina R (1984). \textit{Long-lasting behavioral effects of bromocriptine in cats.}. European journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0014-2999(84)90259-0}{doi:10.1016/0014-2999(84)90259-0}.
\item Jokiranta J, Mustola S, Ohenoja E, Airaksinen MM (1984). \textit{Psilocybin in Finnish Psilocybe semilanceata.}. Planta medica. [published; PubMed]. \href{https://doi.org/10.1055/s-2007-969703}{doi:10.1055/s-2007-969703}.
\item Richard Evans Schultes (1984). \textit{The genus psilocybe}. Journal of Ethnopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0378-8741(84)90031-x}{doi:10.1016/0378-8741(84)90031-x}.
\item Badham ER (1984). \textit{Ethnobotany of psilocybin mushrooms, especially Psilocybe cubensis.}. Journal of ethnopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0378-8741(84)90007-2}{doi:10.1016/0378-8741(84)90007-2}.
\item Trulson ME, Preussler DW, Trulson VM (1984). \textit{Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/s0022-3565(25)21616-0}{doi:10.1016/s0022-3565(25)21616-0}.
\item Mack RB (1983). \textit{Phenomenally phunny phungi--psilocybin toxicity.}. North Carolina medical journal. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/6580536/}{source link}.
\item Sottolano SM, Lurie IS (1983). \textit{The quantitation of psilocybin in hallucinogenic mushrooms using high performance liquid chromatography.}. Journal of forensic sciences. [published; PubMed]. \href{https://doi.org/10.1520/jfs11601j}{doi:10.1520/jfs11601j}.
\item Valdés LJ, Díaz JL, Paul AG (1983). \textit{Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.).}. Journal of ethnopharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0378-8741(83)90004-1}{doi:10.1016/0378-8741(83)90004-1}.
\item J. Francis, Virginia Murray (1983). \textit{Review of Enquiries made to the NPIS Concerning Psilocybe Mushroom Ingestion, 1978-1981}. Human Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1177/096032718300200229}{doi:10.1177/096032718300200229}.
\item Peden NR, Pringle SD, Crooks J (1982). \textit{The problem of psilocybin mushroom abuse.}. Human toxicology. [published; PubMed]. \href{https://doi.org/10.1177/096032718200100408}{doi:10.1177/096032718200100408}.
\item A.L. Christiansen, Knut Rasmussen (1982). \textit{Analysis of indole alkaloids in Norwegian Psilocybe semilanceata using high-performance liquid chromatography and mass spectrometry}. Journal of Chromatography A. [published; OpenAlex]. \href{https://doi.org/10.1016/s0021-9673(00)85700-3}{doi:10.1016/s0021-9673(00)85700-3}.
\item Repke David B., Ferguson Wilfred J. (1982). \textit{Psilocin analogs. III. Synthesis of 5-methoxy- and 5-hydroxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570190428}{doi:10.1002/jhet.5570190428}.
\item Beug Michael W., Bigwood Jeremy (1982). \textit{Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.}. Journal of Ethnopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/0378-8741(82)90013-7}{doi:10.1016/0378-8741(82)90013-7}.
\item Bigwood Jeremy, Beug Michael W. (1982). \textit{Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (earle) singer}. Journal of Ethnopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/0378-8741(82)90014-9}{doi:10.1016/0378-8741(82)90014-9}.
\item van Poorten JF, Stienstra R, Dworacek B, Moleman P, Rupreht J (1982). \textit{Physostigmine reversal of psilocybin intoxication.}. Anesthesiology. [published; PubMed]. \href{https://doi.org/10.1097/00000542-198204000-00017}{doi:10.1097/00000542-198204000-00017}.
\item Koerner J, Appel JB (1982). \textit{Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00435266}{doi:10.1007/bf00435266}.
\item McCall RB (1982). \textit{Neurophysiological effects of hallucinogens on serotonergic neuronal systems.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/0149-7634(82)90033-1}{doi:10.1016/0149-7634(82)90033-1}.
\item Mohan D, Mohandas E, Rajat R (1981). \textit{Chloroquine psychosis: a chemical psychosis?}. Journal of the National Medical Association. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/7310924/}{source link}.
\item Peden NR, Bissett AF, Macaulay KE, Crooks J, Pelosi AJ (1981). \textit{Clinical toxicology of "magic mushroom" ingestion.}. Postgraduate medical journal. [published; PubMed]. \href{https://doi.org/10.1136/pgmj.57.671.543}{doi:10.1136/pgmj.57.671.543}.
\item Harries AD, Evans V (1981). \textit{Sequelae of a 'magic mushroom banquet'.}. Postgraduate medical journal. [published; PubMed]. \href{https://doi.org/10.1136/pgmj.57.671.571}{doi:10.1136/pgmj.57.671.571}.
\item REPKE D. B., FERGUSON W. J., BATES D. K. (1981). \textit{ChemInform Abstract: PSILOCIN ANALOGS. PART2. SYNTHESIS OF3-(2-(DIALKYLAMINO)ETHYL)-, 3-(2-(N-METHYL-N-ALKYLAMINO)ETHYL)-, AND3-(2-(CYCLOALKYLAMINO)ETHYL)INDOL-4-OLS}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.198131198}{doi:10.1002/chin.198131198}.
\item MIGLIACCIO G. P., SHIEH T.-L. N., BYRN S. R., HATHAWAY A., NICHOLS D. E. (1981). \textit{ChemInform Abstract: COMPARISON OF SOLUTION CONFORMATIONAL PREFERENCES FOR THE HALLUCINOGENS BUFOTENIN AND PSILOCIN USING 360-MHZ PROTON NMR SPECTROSCOPY}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.198128356}{doi:10.1002/chin.198128356}.
\item Stephen G. Saupe (1981). \textit{Occurrence of Psilocybin/Psilocin in Pluteus salicinus (Pluteaceae)}. Mycologia. [published; OpenAlex]. \href{https://doi.org/10.2307/3759505}{doi:10.2307/3759505}.
\item Christiansen AL, Rasmussen KE, Høiland K (1981). \textit{The content of Psilocybin in Norwegian Psilocybe semilanceata.}. Planta medica. [published; PubMed]. \href{https://doi.org/10.1055/s-2007-971632}{doi:10.1055/s-2007-971632}.
\item Saupe Stephen G. (1981). \textit{Occurrence of Psilocybin/Psilocin in Pluteus Salicinus (Pluteaceae)}. Mycologia. [published; Crossref]. \href{https://doi.org/10.1080/00275514.1981.12021406}{doi:10.1080/00275514.1981.12021406}.
\item Trulson ME, Heym J, Jacobs BL (1981). \textit{Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.}. Brain research. [published; PubMed]. \href{https://doi.org/10.1016/0006-8993(81)90507-2}{doi:10.1016/0006-8993(81)90507-2}.
\item A.L. Christiansen, Knut Rasmussen, Finn Tønnesen (1981). \textit{Determination of psilocybin in Psilocybe semilanceata using high-performance liquid chromatography on a silica column}. Journal of Chromatography A. [published; OpenAlex]. \href{https://doi.org/10.1016/s0021-9673(00)91195-6}{doi:10.1016/s0021-9673(00)91195-6}.
\item Yutaka Koike, Kohko Wada, Genjiro Kusano, Shigeo Nozoe, Kazumasa Yokoyama (1981). \textit{Isolation of Psilocybin From Psilocybe argentipes and Its Determination in Specimens of Some Mushrooms}. Journal of Natural Products. [published; OpenAlex]. \href{https://doi.org/10.1021/np50015a023}{doi:10.1021/np50015a023}.
\item Beug Michael W., Bigwood Jeremy (1981). \textit{Quantitative analysis of psilocybin and psilocin and psilocybe baecystis (singer and smith) by high-performance liquid chromatography and by thin-layer chromatography}. Journal of Chromatography A. [published; Crossref]. \href{https://doi.org/10.1016/s0021-9673(00)88741-5}{doi:10.1016/s0021-9673(00)88741-5}.
\item Laubscher A, Pletscher A, Noll H (1981). \textit{Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/s0022-3565(25)32431-6}{doi:10.1016/s0022-3565(25)32431-6}.
\item Migliaccio Gerald P., Shieh Tiee-Leou N., Byrn Stephen R., Hathaway Bruce A., Nichols David E. (1981). \textit{Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy}. Journal of Medicinal Chemistry. [published; Crossref]. \href{https://doi.org/10.1021/jm00134a016}{doi:10.1021/jm00134a016}.
\item Gelpke R (1981). \textit{On travels in the universe of the soul: reports on self-experiments with delysid (LSD) and psilocybin (CY).}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.1981.10471454}{doi:10.1080/02791072.1981.10471454}.
\item Repke David B., Ferguson Wilfred J., Bates Dallas K. (1981). \textit{Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-ols}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570180131}{doi:10.1002/jhet.5570180131}.
\item McDonald A (1980). \textit{Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/070674378002500709}{doi:10.1177/070674378002500709}.
\item Thomson BM (1980). \textit{Analysis of Psilocybin and Psilocin in Mushroom Extracts by Reversed-Phase High Performance Liquid Chromatography}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1520/jfs11292j}{doi:10.1520/jfs11292j}.
\item Järbe TU (1980). \textit{LDS-25 as a discriminative stimulus for response selection by pigeons.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(80)90279-8}{doi:10.1016/0091-3057(80)90279-8}.
\item Thomson BM (1980). \textit{Analysis of psilocybin and psilocin in mushroom extracts by reversed-phase high performance liquid chromatography.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/7191888/}{source link}.
\item Dewhurst K (1980). \textit{Psilocybin intoxication.}. The British journal of psychiatry: the journal of mental science. [published; PubMed]. \href{https://doi.org/10.1192/bjp.137.3.303a}{doi:10.1192/bjp.137.3.303a}.
\item McCall RB, Aghajanian GK. (1980). \textit{Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.}. Life sciences. [published; Europe PMC]. \href{https://doi.org/10.1016/0024-3205(80)90654-2}{doi:10.1016/0024-3205(80)90654-2}.
\item Fairchild MD, Jenden DJ, Mickey MR, Yale C (1980). \textit{EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(80)90422-0}{doi:10.1016/0091-3057(80)90422-0}.
\item Shulgin AT (1980). \textit{Profiles of psychedelic drugs. Psilocybin.}. Journal of psychedelic drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.1980.10471557}{doi:10.1080/02791072.1980.10471557}.
\item Kaul B, Davidow B (1980). \textit{Application of a radioimmunoassay screening test for detection and management of phencyclidine intoxication.}. Journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1002/j.1552-4604.1980.tb02542.x}{doi:10.1002/j.1552-4604.1980.tb02542.x}.
\item Mills PR, Lesinskas D, Watkinson G (1979). \textit{The danger of hallucinogenic mushrooms.}. Scottish medical journal. [published; PubMed]. \href{https://doi.org/10.1177/003693307902400413}{doi:10.1177/003693307902400413}.
\item Geyer MA, Light RK, Rose GJ, Petersen LR, Horwitt DD, Adams LM, Hawkins RL (1979). \textit{A characteristic effect of hallucinogens on investigatory responding in rats.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00491975}{doi:10.1007/bf00491975}.
\item Vaupel D.B., Nozaki M., Martin W.R., Bright L.D., Morton E.C. (1979). \textit{The inhibition of food intake in the dog by LSD, mescaline, psilocin, -amphetamine and phenylisopropylamine derivatives}. Life Sciences. [published; Crossref]. \href{https://doi.org/10.1016/0024-3205(79)90451-x}{doi:10.1016/0024-3205(79)90451-x}.
\item Benjamin C (1979). \textit{Persistent psychiatric symptoms after eating psilocybin mushrooms.}. British medical journal. [published; PubMed]. \href{https://doi.org/10.1136/bmj.1.6174.1319}{doi:10.1136/bmj.1.6174.1319}.
\item S. E. Unger, R. Graham Cooks (1979). \textit{Application of Mass Spectrometry/Mass Spectrometry (MS/MS) to the Identification of Natural Products in Psilocybe Cyanescens}. Analytical Letters. [published; OpenAlex]. \href{https://doi.org/10.1080/00032717908067906}{doi:10.1080/00032717908067906}.
\item Sbordone RJ, Wingard JA, Gorelick DA, Elliott ML (1979). \textit{Severe aggression in rats induced by mescaline but not other hallucinogens.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00428319}{doi:10.1007/bf00428319}.
\item Chilton W. Scott, Bigwood Jeremy, Jensen Robert E. (1979). \textit{Psilocin, Bufotenine and Serotonin: Historical and Biosynthetic Observations}. Journal of Psychedelic Drugs. [published; Crossref]. \href{https://doi.org/10.1080/02791072.1979.10472093}{doi:10.1080/02791072.1979.10472093}.
\item Geyer MA, Petersen LR, Rose GJ, Horwitt DD, Light RK, Adams LM, Zook JA, Hawkins RL, Mandell AJ (1978). \textit{The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/s0022-3565(25)31486-2}{doi:10.1016/s0022-3565(25)31486-2}.
\item Whitaker PM, Seeman P (1978). \textit{High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00428022}{doi:10.1007/bf00428022}.
\item Bourn WM, Keller WJ, Bonfiglio JF. (1978). \textit{Psychoactivity of normacromerine in animals.}. Life sciences. [published; Europe PMC]. \href{https://doi.org/10.1016/0024-3205(78)90352-1}{doi:10.1016/0024-3205(78)90352-1}.
\item Hyde C, Glancy G, Omerod P, Hall D, Taylor GS (1978). \textit{Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications.}. The British journal of psychiatry: the journal of mental science. [published; PubMed]. \href{https://doi.org/10.1192/bjp.132.6.602}{doi:10.1192/bjp.132.6.602}.
\item Meltzer HY, Fessler RG, Simonovic M, Fang VS (1978). \textit{Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/bf00432847}{doi:10.1007/bf00432847}.
\item Van Went GF (1978). \textit{Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and delta 9-THC, using the micronucleus test.}. Experientia. [published; PubMed]. \href{https://doi.org/10.1007/bf01923013}{doi:10.1007/bf01923013}.
\item Martin WR, Vaupel DB, Nozaki M, Bright LD (1978). \textit{The identification of LSD-like hallucinogens using the chronic spinal dog.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/0376-8716(78)90024-8}{doi:10.1016/0376-8716(78)90024-8}.
\item Green JP, Weinstein H, Maayani S (1978). \textit{Defining the histamine H2-receptor in brain: the interaction with LSD.}. NIDA research monograph. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/30911/}{source link}.
\item Hatfield GM, Valdes LJ (1978). \textit{The occurrence of psilocybin in Gymnopilus species.}. Lloydia. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/565861/}{source link}.
\item Castellano Claudio (1978). \textit{Effects of mescaline and psilocin on acquisition, consolidation, and performance of light-dark discrimination in two inbred strains of mice}. Psychopharmacology. [published; Crossref]. \href{https://doi.org/10.1007/bf00427746}{doi:10.1007/bf00427746}.
\item Jacobs BL, Trulson ME, Stern WC (1977). \textit{Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.}. Brain research. [published; PubMed]. \href{https://doi.org/10.1016/0006-8993(77)90423-1}{doi:10.1016/0006-8993(77)90423-1}.
\item Trulson ME, Stark AD, Jacobs BL (1977). \textit{Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.}. European journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0014-2999(77)90097-8}{doi:10.1016/0014-2999(77)90097-8}.
\item REPKE D. B., FERGUSON W. J., BATES D. K. (1977). \textit{ChemInform Abstract: PSILOCIN ANALOGS. 1. SYNTHESIS OF3-(2-(DIALKYLAMINO)ETHYL)- AND3-(2-(CYCLOALKYLAMINO)ETHYL)INDOL-4-OLS}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197728193}{doi:10.1002/chin.197728193}.
\item Repke David B., Leslie Dale Thomas, Mandell Daniel M., Kish Nicholas G. (1977). \textit{GLC-Mass Spectral Analysis of Psilocin and Psilocybin}. Journal of Pharmaceutical Sciences. [published; Crossref]. \href{https://doi.org/10.1002/jps.2600660539}{doi:10.1002/jps.2600660539}.
\item Davis M, Walters JK (1977). \textit{Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(77)90180-0}{doi:10.1016/0091-3057(77)90180-0}.
\item Repke David B., Ferguson Wilfred J., Bates Dallas K. (1977). \textit{Psilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl] -and 3-[2-(cycloalkylamino)ethyl] indol-4-ols}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570140113}{doi:10.1002/jhet.5570140113}.
\item Repke DB, Leslie DT (1977). \textit{Baeocystin in Psilocybe semilanceata.}. Journal of pharmaceutical sciences. [published; PubMed]. \href{https://doi.org/10.1002/jps.2600660130}{doi:10.1002/jps.2600660130}.
\item Martindale C, Fischer R (1977). \textit{The effects of psilocybin on primary process content in language.}. Confinia psychiatrica. Borderland of psychiatry. Grenzgebiete der Psychiatrie. Les Confins de la psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/608346/}{source link}.
\item Repke DB, Leslie DT, Guzmán G (1977). \textit{Baeocystin in psilocybe, conocybe and panaeolus.}. Lloydia. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/600026/}{source link}.
\item James Edward Guest (1976). \textit{Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbit}. UA Campus Repository (The University of Arizona). [published; OpenAlex]. \href{http://hdl.handle.net/10150/348103}{source link}.
\item J.E. Kleinman, J. Christian Gillin, Richard Jed Wyatt (1976). \textit{A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*}. Schizophrenia Bulletin. [published; OpenAlex]. \href{https://doi.org/10.1093/schbul/3.4.560}{doi:10.1093/schbul/3.4.560}.
\item Holt-Hansen K (1976). \textit{Extraordinary experiences during cross-modal perception.}. Perceptual and motor skills. [published; PubMed]. \href{https://doi.org/10.2466/pms.1976.43.3f.1023}{doi:10.2466/pms.1976.43.3f.1023}.
\item Cameron OG, Appel JB (1976). \textit{Drug-induced conditioned suppression: specificity due to drug employed as UCS.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(76)90020-4}{doi:10.1016/0091-3057(76)90020-4}.
\item Kuhnert-Brandstätter Maria, Heindl Wolfgang (1976). \textit{Polymorphe Modifikationen und Solvate von Psilocin und Psilocybin}. Archiv der Pharmazie. [published; Crossref]. \href{https://doi.org/10.1002/ardp.19763090804}{doi:10.1002/ardp.19763090804}.
\item Parashos AJ (1976). \textit{The psilocybin-induced "state of drunkenness" in normal volunteers and schizophrenics.}. Behavioral neuropsychiatry. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1052267/}{source link}.
\item Ott J, Guzmán G (1976). \textit{Detection of psilocybin in species of Psilocybe, Panaeolus and Psathyrella.}. Lloydia. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/957919/}{source link}.
\item Sybil H. Bullock (1975). \textit{Hallucinogenic Mushrooms Including Chemical Hallucinogens: Bufotenin and Psilocybin; a Select Bibliography.}. Defense Technical Information Center (DTIC). [published; OpenAlex]. \href{http://oai.dtic.mil/oai/oai?\&amp;verb=getRecord\&amp;metadataPrefix=html\&amp;identifier=ADA028792}{source link}.
\item Hungen KV, Roberts S, Hill DF (1975). \textit{Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.}. Brain research. [published; PubMed]. \href{https://doi.org/10.1016/0006-8993(75)90876-8}{doi:10.1016/0006-8993(75)90876-8}.
\item Fischer R, Goldman H (1975). \textit{Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.}. Pharmakopsychiatrie, Neuro-Psychopharmakologie. [published; PubMed]. \href{https://doi.org/10.1055/s-0028-1094457}{doi:10.1055/s-0028-1094457}.
\item S Huković, Elvedina Zvizdić (1975). \textit{The Effect of Psycholitics-Hallucinogens on Tonus and Concentrations of Vegetative Organs}. Acta Medica Academica. [published; OpenAlex]. \href{https://doi.org/10.5644/radovi.191}{doi:10.5644/radovi.191}.
\item Rao KR, Fingerman M. (1975). \textit{Color changes induced by certain indole alkaloids in the fiddler crab, Uca.}. Comparative biochemistry and physiology. C: Comparative pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/0306-4492(75)90037-4}{doi:10.1016/0306-4492(75)90037-4}.
\item Steven H. Pollock (1975). \textit{The Psilocybin Mushroom Pandemic}. Journal of Psychedelic Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.1975.10472640}{doi:10.1080/02791072.1975.10472640}.
\item Aghajanian GK, Hailgler HJ (1975). \textit{Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.}. Psychopharmacology communications. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1063421/}{source link}.
\item Rech RH, Tilson HA, Marquis WJ (1975). \textit{Adaptive changes in behavior after repeated administration of various psychoactive drugs.}. Advances in biochemical psychopharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/1163377/}{source link}.
\item Greenberg I, Kuhn D, Appel JB (1975). \textit{Comparison of the discriminative stimulus properties of delta9-THC and psilocybin in rats.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/0091-3057(75)90131-8}{doi:10.1016/0091-3057(75)90131-8}.
\item Fanciullacci M, Franchi G, Sicuteri F (1974). \textit{Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.}. Experientia. [published; PubMed]. \href{https://doi.org/10.1007/bf01919685}{doi:10.1007/bf01919685}.
\item GERMAIN CLAUDE, BOURDAIS JACQUES (1974). \textit{ChemInform Abstract: NEUER ZUGANG ZU PSILOCIN-DERIVATEN}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197449273}{doi:10.1002/chin.197449273}.
\item 昌子 大野 (1974). \textit{幻覚剤に関する研究-5-Psilocybinの合成(ノ-ト)}. Medical Entomology and Zoology. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/40000202990}{source link}.
\item Hans Peter Weber, Trevor J. Petcher (1974). \textit{ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART1, PSILOCYBIN C12H17N2O4O}. ChemInform. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197435062}{doi:10.1002/chin.197435062}.
\item PETCHER TREVOR J., WEBER HANS PETER (1974). \textit{ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART2, PSILOCIN C12H15N2O}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197435063}{doi:10.1002/chin.197435063}.
\item CAMPAIGNE E., ROGERS R. B. (1974). \textit{ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART21, ON THE PROOF OF STRUCTURE OF THE SULFUR ISOSTERE OF PSILOCIN}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197428268}{doi:10.1002/chin.197428268}.
\item Jan Kolařı́k (1974). \textit{Underlying mechanism of psilocybin induced psychosis}. Acta Universitatis Palackianae Olomucensis Facultatis Medicae. [published; OpenAlex]. \href{https://eurekamag.com/research/027/815/027815362.php}{source link}.
\item Ladefoged O (1974). \textit{The effect of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rabbits.}. Archives internationales de pharmacodynamie et de therapie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4277695/}{source link}.
\item Stolk JM, Barchas JD, Goldstein M, Boggan W, Freedman DX. (1974). \textit{A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.}. The Journal of pharmacology and experimental therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)29806-8}{doi:10.1016/s0022-3565(25)29806-8}.
\item Horibe M (1974). \textit{The effects of psilocybin on EEG and behaviour in monkeys.}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4454934/}{source link}.
\item Hopf A, Eckert H (1974). \textit{Distribution patterns of 14-C-psilocin in the brains of various animals.}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4454947/}{source link}.
\item Hans Peter Weber, Trevor J. Petcher (1974). \textit{Crystal structures of the Teonanácatl hallucinogens. Part I. Psilocybin C12 H17 N2 O4 P}. Journal of the Chemical Society Perkin Transactions 2. [published; OpenAlex]. \href{https://doi.org/10.1039/p29740000942}{doi:10.1039/p29740000942}.
\item Petcher Trevor J., Weber Hans Peter (1974). \textit{Crystal structures of the Teonanácatl hallucinogens. Part II. Psilocin, C12 H15 N2 O}. J. Chem. Soc., Perkin Trans. 2. [published; Crossref]. \href{https://doi.org/10.1039/p29740000946}{doi:10.1039/p29740000946}.
\item Ono M, Shimamine M, Takahashi K, Inoue T (1974). \textit{[Studies on hallucinogens. V. Synthesis of psilocybin].}. Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4477493/}{source link}.
\item Aboul-Enein HY (1974). \textit{Psilocybin: a pharmacological profile.}. American journal of pharmacy and the sciences supporting public health. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4853936/}{source link}.
\item Haefely W. (1973). \textit{The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ.}. Naunyn-Schmiedeberg's archives of pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00503495}{doi:10.1007/bf00503495}.
\item Kuhn DM, Appel JB, Greenberg I. (1973). \textit{An analysis of some discriminative properties of d-amphetamine.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00421458}{doi:10.1007/bf00421458}.
\item Campaigne E., Rogers R. B. (1973). \textit{Benzo[b]thiophene derivatives. XXI. On the proof of structure of the sulfur isostere of psilocin}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570100614}{doi:10.1002/jhet.5570100614}.
\item CAMPAIGNE E., ROGERS R. B. (1973). \textit{ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART19, THE SULFUR ISOSTERES OF PSILOCIN AND RELATED ISOMERS}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197345337}{doi:10.1002/chin.197345337}.
\item Fabrick DM, Winefordner JD (1973). \textit{Quantitative measurement of mixtures of hallucinogens by fluorometry and phosphorimetry.}. Talanta. [published; PubMed]. \href{https://doi.org/10.1016/0039-9140(73)80087-6}{doi:10.1016/0039-9140(73)80087-6}.
\item Kang S, Johnson CL, Green JP. (1973). \textit{Theoretical studies on the conformations of psilocin and mescaline.}. Molecular pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/s0026-895x(25)13989-8}{doi:10.1016/s0026-895x(25)13989-8}.
\item Hill RM, Fischer R (1973). \textit{Induction and extinction of psilocybin induced transformations of visual space.}. Pharmakopsychiatrie, Neuro-Psychopharmakologie. [published; PubMed]. \href{https://doi.org/10.1055/s-0028-1094389}{doi:10.1055/s-0028-1094389}.
\item Kang S, Johnson CL, Green JP (1973). \textit{Theoretical studies on the conformations of psilocin and mescaline.}. Molecular pharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4788158/}{source link}.
\item Ladefoged O (1973). \textit{The effects of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rats.}. Archives internationales de pharmacodynamie et de therapie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4270656/}{source link}.
\item Shaffer JH, Hill RM (1973). \textit{Psychophysics of psilocybin and 9 -tetrahydrocannabinol.}. Agents and actions. [published; PubMed]. \href{https://doi.org/10.1007/bf02023852}{doi:10.1007/bf02023852}.
\item Panton Y, Fischer R (1973). \textit{Hallucinogenic drug-induced behavior under sensory attenuation. Prediction of response to psilocybin.}. Archives of general psychiatry. [published; PubMed]. \href{https://doi.org/10.1001/archpsyc.1973.01750330106017}{doi:10.1001/archpsyc.1973.01750330106017}.
\item CHAPMAN N. B., SCROWSTON R. M., SUTTON T. M. (1973). \textit{ChemInform Abstract: SYNTH. DES SCHWEFELANALOGEN VON PSILOCIN UND EINIGEN VERWANDTEN VERBINDUNGEN}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197308246}{doi:10.1002/chin.197308246}.
\item Dyer DC, Gant DW. (1973). \textit{Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature.}. The Journal of pharmacology and experimental therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)29420-4}{doi:10.1016/s0022-3565(25)29420-4}.
\item Baker RW, Chothia C, Pauling P, Weber HP (1973). \textit{Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.}. Molecular pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/s0026-895x(25)13703-6}{doi:10.1016/s0026-895x(25)13703-6}.
\item Ono M, Shimamine M, Takahashi K (1973). \textit{[Studies on hallucinogens. 3. Synthesis of psilocin (author's transl)].}. Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4800137/}{source link}.
\item 襄 三隅 (1972). \textit{精神分裂病者の病像とPsilocybin,LSD-25反応に関する精神病理学的研究}. Medical Entomology and Zoology. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/40018016189}{source link}.
\item D F Duncan (1972). \textit{Psychedelic Drugs in Correctional Treatment}. Crime \& Delinquency. [published; OpenAlex]. \href{https://doi.org/10.1177/001112877201800307}{doi:10.1177/001112877201800307}.
\item Mulkey D (1972). \textit{Psilocybin.}. Texas medicine. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5039020/}{source link}.
\item Robert Walker, G.N. Woodruff (1972). \textit{The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neurons}. Comparative and General Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0010-4035(72)90039-0}{doi:10.1016/0010-4035(72)90039-0}.
\item Chapman N. B., Scrowston R. M., Sutton T. M. (1971). \textit{Synthesis of the sulphur analogue of psilocin and some related compounds}. Journal of the Chemical Society, Perkin Transactions 1. [published; Crossref]. \href{https://doi.org/10.1039/p19720003011}{doi:10.1039/p19720003011}.
\item Brown JK, Shapazian L, Griffin GD. (1971). \textit{A rapid screening procedure for some "street drugs" by thin-layer chromatography.}. Journal of chromatography. [published; Europe PMC]. \href{https://doi.org/10.1016/s0021-9673(00)92956-x}{doi:10.1016/s0021-9673(00)92956-x}.
\item Schechter MD, Rosecrans JA. (1971). \textit{Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00422707}{doi:10.1007/bf00422707}.
\item Meldrum BS, Naquet R (1971). \textit{Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio).}. Electroencephalography and clinical neurophysiology. [published; PubMed]. \href{https://doi.org/10.1016/0013-4694(71)90072-1}{doi:10.1016/0013-4694(71)90072-1}.
\item Andén NE, Corrodi H, Fuxe K. (1971). \textit{Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons.}. The Journal of pharmacology and experimental therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)29027-9}{doi:10.1016/s0022-3565(25)29027-9}.
\item Thatcher K, Wiederholt WC, Fischer R (1971). \textit{An electroencephalographic analysis of personality-dependent performance under psilocybin.}. Agents and actions. [published; PubMed]. \href{https://doi.org/10.1007/bf01965376}{doi:10.1007/bf01965376}.
\item Marc Julià, JOEL DE ROSNAY (1971). \textit{ChemInform Abstract: CHLORIERTE 2-HYDROXY- UND2-METHOXY-PHENOXYAETHYLAMINE, ANALOGA VON PSILOCYBIN}. Chemischer Informationsdienst Organische Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197110243}{doi:10.1002/chin.197110243}.
\item Kolarík J (1971). \textit{Different reaction of focal and diffuse epileptic EEG activity to psilocybin.}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5000337/}{source link}.
\item Kolarĩk J (1971). \textit{EEG changes after psilocybin in organic brain lesions.}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5122145/}{source link}.
\item JULIA MARC, PASCAL YVES ROBERT (1970). \textit{ChemInform Abstract: INDOLE 22. MITT. INDOLSYNTH., ANWENDUNG AUF PSILOCIN}. Chemischer Informationsdienst. Organische Chemie. [published; Crossref]. \href{https://doi.org/10.1002/chin.197051318}{doi:10.1002/chin.197051318}.
\item K. Genest, Lorna J. Lowry (1970). \textit{Microcrystalloptic tests for lysergic acid diethylamide and other hallucinogens}. Journal of Pharmacy and Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1111/j.2042-7158.1970.tb08449.x}{doi:10.1111/j.2042-7158.1970.tb08449.x}.
\item Meldrum BS, Naquet R (1970). \textit{Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio).}. British journal of pharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4992165/}{source link}.
\item 五郎 中村 (1970). \textit{PsilocybinおよびLSDの精神身体症状におよぼす影響-1-LSDに就て}. 新潟医学会雑誌. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/40018192360}{source link}.
\item Fischer R, Hill R, Thatcher K, Scheib J (1970). \textit{Psilocybin-induced contraction of nearby visual space.}. Agents and actions. [published; PubMed]. \href{https://doi.org/10.1007/bf01965761}{doi:10.1007/bf01965761}.
\item J. PICKER, R. W. RICKARDS (1970). \textit{ChemInform Abstract: AUFTRETEN DES PSYCHOTOMIMETISCHEN AGENS PSILOCYBIN IN DEM AUSTRALISCHEN BLAETTERPILZ PSILOCYBE SUBAERUGINOSA}. Chemischer Informationsdienst Organische Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197029316}{doi:10.1002/chin.197029316}.
\item Richard Hill, Roland A. Fischer (1970). \textit{Psilocybin-Induced Transformations of Visual Space}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094281}{doi:10.1055/s-0028-1094281}.
\item J. PICKER, R. W. RICKARDS (1970). \textit{The occurrence of the psychotomimetic agent psilocybin in an Australian agaric, Psilocybe subaeruginosa}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch9700853}{doi:10.1071/ch9700853}.
\item Thatcher K, Kappeler T, Wisecup P, Fischer R (1970). \textit{Personality trait dependent performance under psilocybin. II.}. Diseases of the nervous system. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4392526/}{source link}.
\item Fischer R, Kappeler T, Wisecup P, Thatcher K (1970). \textit{Personality trait dependent performance under psilocybin.}. Diseases of the nervous system. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5438334/}{source link}.
\item Eberle P, Leuner H. (1970). \textit{[Chromosome defects in patients treated with Psilocybine].}. Humangenetik. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00286993}{doi:10.1007/bf00286993}.
\item Landon M, Fischer R (1970). \textit{On similar linguistic structures in creative performance and psilocybin-induced experience.}. Confinia psychiatrica. Borderland of psychiatry. Grenzgebiete der Psychiatrie. Les Confins de la psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5478353/}{source link}.
\item Martin WR, Eades CG. (1969). \textit{The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00402084}{doi:10.1007/bf00402084}.
\item Peter Gwynne, Roland Fischer, Richard Hill (1969). \textit{Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial Distortion}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094250}{doi:10.1055/s-0028-1094250}.
\item Peter G. Mantle, E. S. Waight (1969). \textit{Occurrence of psilocybin in the sporophores of Psilocybe semilanceata}. Transactions of the British Mycological Society. [published; OpenAlex]. \href{https://doi.org/10.1016/s0007-1536(69)80066-5}{doi:10.1016/s0007-1536(69)80066-5}.
\item Robbers JE, Tyler VE, Ola'h GM (1969). \textit{Additional evidence supporting the occurrence of psilocybin in Panaeolus foenisecii.}. Lloydia. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5390043/}{source link}.
\item Bermond F, Bert J (1969). \textit{[Electrophysiological effects of psilocybin in a cercopithecinae, Papio papio].}. Electroencephalography and clinical neurophysiology. [published; PubMed]. \href{https://doi.org/10.1016/0013-4694(69)90108-4}{doi:10.1016/0013-4694(69)90108-4}.
\item Fischer R, Kappeler T, Wisecup P, Thatcher K (1969). \textit{Measurement of handwriting area to pressure ratios during psilocybin-induced hallucinations.}. Agents and actions. [published; PubMed]. \href{https://doi.org/10.1007/bf01990020}{doi:10.1007/bf01990020}.
\item Edward T. Uyeno (1969). \textit{Alteration of a learned response of the squirrel monkey by hallucinogens}. International Journal of Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0028-3908(69)90045-8}{doi:10.1016/0028-3908(69)90045-8}.
\item Leung AY, Paul AG (1969). \textit{The relationship of carbon and nitrogen nutrition of Psilocybe baeocystis to the production of psilocybin and its analogs.}. Lloydia. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5788770/}{source link}.
\item Fischer R, Hill RM, Warshay D (1969). \textit{Effects of psychodysleptic drug psilocybin on visual perception. Changes in brightness preference.}. Experientia. [published; PubMed]. \href{https://doi.org/10.1007/bf01899102}{doi:10.1007/bf01899102}.
\item Sugrue MF (1969). \textit{A study of the role of noradrenaline in behavioral changes produced in the rat by psychotomimetic drugs.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/j.1476-5381.1969.tb07983.x}{doi:10.1111/j.1476-5381.1969.tb07983.x}.
\item Hill RM, Fischer R, Warshay D. (1969). \textit{Effects of excitatory and tranquilizing drugs on visual perception. Spatial distortion thresholds.}. Experientia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01899105}{doi:10.1007/bf01899105}.
\item Francesca Bermond, Julien Bert (1969). \textit{Action de la psilocybine sur le comportement d'un cercopithecinae papio-papio}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/bf00407043}{doi:10.1007/bf00407043}.
\item Hopf A, Eckert H (1969). \textit{Autoradiographic studies on the distribution of psychoactive drugs in the rat brain. 3. 14C-psilocin.}. Psychopharmacologia. [published; PubMed]. \href{https://doi.org/10.1007/bf02456045}{doi:10.1007/bf02456045}.
\item R Fischer, Diana Warshay (1968). \textit{Psilocybin-induced Autonomic, Perceptual, and Behavioral Change}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094227}{doi:10.1055/s-0028-1094227}.
\item C Schneider (1968). \textit{Behavioural Effects of some Morphine Antagonists and Hallucinogens in the Rat}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/220586a0}{doi:10.1038/220586a0}.
\item Leung AY, Paul AG (1968). \textit{Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis.}. Journal of pharmaceutical sciences. [published; PubMed]. \href{https://doi.org/10.1002/jps.2600571007}{doi:10.1002/jps.2600571007}.
\item Neal JM, Benedict RG, Brady LR. (1968). \textit{Interrelationship of phosphate nutrition, nitrogen metabolism, and accumulation of key secondary metabolites in saprophytic cultures of Psilocybe cubensis, Psilocybe cyanescens, and Panaeolus campanulatus.}. Journal of pharmaceutical sciences. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600571006}{doi:10.1002/jps.2600571006}.
\item Appel JB, Freedman DX. (1968). \textit{Tolerance and cross-tolerance among psychotomimetic drugs.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00401404}{doi:10.1007/bf00401404}.
\item Duke RB, Keeler MH (1968). \textit{The effects of psilocybin, dextro-amphetamine and placebo on performance of the trail making test.}. Journal of clinical psychology. [published; PubMed]. \href{https://doi.org/10.1002/1097-4679(196807)24:3<316::aid-jclp2270240310>3.0.co;2-g}{doi:10.1002/1097-4679(196807)24:3<316::aid-jclp2270240310>3.0.co;2-g}.
\item Tosi O, Rockey MA, Fischer R (1968). \textit{Quantitative measurement of time contraction induced by psilocybin.}. Arzneimittel-Forschung. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5755879/}{source link}.
\item Robert R. Rynearson, M. Robert Wilson, Reginald G. Bickford (1968). \textit{PSILOCYBIN-INDUCED CHANGES IN PSYCHOLOGIC FUNCTION, ELECTROENCEPHALOGRAM, AND LIGHT-EVOKED POTENTIALS IN HUMAN SUBJECTS}. Mayo Clinic Proceedings. [published; OpenAlex]. \href{https://doi.org/10.1016/s0025-6196(26)01583-1}{doi:10.1016/s0025-6196(26)01583-1}.
\item Rynearson RR, Wilson MR, Bickford RG (1968). \textit{Psilocybin-induced changes in psychologic function, electroencephalogram, and light-evoked potentials in human subjects.}. Mayo Clinic proceedings. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4384806/}{source link}.
\item Horibe M (1968). \textit{[Pharmacological studies of hallucinogens. Report 3. I. Bibliographical considerations of psilocybin, with special reference to its actions on the central nervous system].}. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4881757/}{source link}.
\item Horibe M (1968). \textit{[Pharmacological studies of hallucinogens. Report 3. II. Pharmacological studies of influence of psilocybin on the central nervous system].}. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4972692/}{source link}.
\item Gessner PK, Godse DD, Krull AH, McMullan JM (1968). \textit{Structure-activity relationships among 5-methoxy-n:n-dimethyltryptamine, 4-hydroxy-n:n-dimethyltryptamine (psilocin) and other substituted tryptamines.}. Life sciences. [published; PubMed]. \href{https://doi.org/10.1016/0024-3205(68)90200-2}{doi:10.1016/0024-3205(68)90200-2}.
\item Agurell S, Nilsson JL (1968). \textit{A biosynthetic sequence from tryptophan to psilocybin.}. Tetrahedron letters. [published; PubMed]. \href{https://doi.org/10.1016/s0040-4039(01)98891-4}{doi:10.1016/s0040-4039(01)98891-4}.
\item 真広 堀部 (1968). \textit{催幻覚薬に関する薬理学的研究(第3報):第1篇 Psilocybinの文献的考察ことに中枢作用について}. Medical Entomology and Zoology. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/130000757038}{source link}.
\item Agurell S, Nilsson JL (1968). \textit{Biosynthesis of psilocybin. II. Incorporation of labelled tryptamine derivatives.}. Acta chemica Scandinavica. [published; PubMed]. \href{https://doi.org/10.3891/acta.chem.scand.22-1210}{doi:10.3891/acta.chem.scand.22-1210}.
\item 望 諏訪, 晃資 山崎, 裕二 斉藤, 博明 加藤, 勇夫 小野寺, 歩 坂下, 雅之 遠藤, 隆嗣 諸治, 耗三 伊藤 (1967). \textit{34)Psilocybin投与による情動の変化と血中17-CHCSの動態(精神生理)(第8回日本精神身体医学会総会)}. 精神身体医学. [published; OpenAlex]. \href{https://ci.nii.ac.jp/naid/110001112648}{source link}.
\item Snyder SH, Faillace L, Hollister L (1967). \textit{2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.158.3801.669}{doi:10.1126/science.158.3801.669}.
\item Dubanský B, Vyhmánková M (1967). \textit{[Psilocybine in brain injured subjects and its different effects in relation to the localization of the lesion].}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5612963/}{source link}.
\item Dubanský B, Vyhnánková M, Setlík L (1967). \textit{[The association of proprioceptive sensations and neurologic symptoms after psilocybine].}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5612947/}{source link}.
\item Dubanský B, Vyhnánsková M, Setlík L (1967). \textit{[Psilocybine induced changes in extraoptical perception].}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5612948/}{source link}.
\item Levine WG (1967). \textit{Formation of blue oxidation product from psilocybin.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/2151292a0}{doi:10.1038/2151292a0}.
\item Malcolm B. Bowers (1967). \textit{Dynamics of Psychedelic Drug Abuse}. Archives of General Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/archpsyc.1967.01730230044006}{doi:10.1001/archpsyc.1967.01730230044006}.
\item Uyeno ET (1967). \textit{Effects of mescaline and psilocybin on dominance behavior of the rat.}. Archives internationales de pharmacodynamie et de therapie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/6034329/}{source link}.
\item Gilmour LP, O'Brien RD (1967). \textit{Psilocybin: reaction with a fraction of rat brain.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.155.3759.207}{doi:10.1126/science.155.3759.207}.
\item C. Rolsten (1967). \textit{Effects of chlorpromazine and psilocin on pregnancy of c57bl/10 mice and their offspring at birth. Abstr.}. The Mouseion at the JAXlibrary (Jackson Laboratory). [published; OpenAlex]. \href{https://mouseion.jax.org/ssbb1967/193}{source link}.
\item Weber K (1967). \textit{[Alteration of music perception in experimental psychosis (psilocybin)].}. Confinia psychiatrica. Borderland of psychiatry. Grenzgebiete der Psychiatrie. Les Confins de la psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5585740/}{source link}.
\item Leung AY, Paul AG (1967). \textit{Baeocystin, a mono-methyl analog of psilocybin from Psilocybe baeocystis saprophytic culture.}. Journal of pharmaceutical sciences. [published; PubMed]. \href{https://doi.org/10.1002/jps.2600560132}{doi:10.1002/jps.2600560132}.
\item Albert Leung (1966). \textit{Investigations On Psilocybin And Its Analogs In Certain Fungi.}. Deep Blue (University of Michigan). [published; OpenAlex]. \href{https://doi.org/10.7302/15497}{doi:10.7302/15497}.
\item Corne SJ, Pickering RW. (1966). \textit{A possible correlation between drug-induced hallucinations in man and a behavioural response in mice.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00401509}{doi:10.1007/bf00401509}.
\item Richard R. Heim, K. Genest, Donald W. Hughes, G. Belec (1966). \textit{Botanical and Chemical Characterisation of a Forensic Mushroom Specimen of the Genus Psilocybe}. Journal of the Forensic Science Society. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-7368(66)70336-3}{doi:10.1016/s0015-7368(66)70336-3}.
\item Collins RL, Ordy JM, Samorajski T (1966). \textit{Psilocin: effects on behaviour and brain serotonin in mice.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/209785a0}{doi:10.1038/209785a0}.
\item Agurell S, Blomkvist S, Catalfomo P (1966). \textit{Biosynthesis of psilocybin in submerged culture of Psilocybe cubensis. 1. Incorporation of labelled tryptophan and tryptamine.}. Acta pharmaceutica Suecica. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5948634/}{source link}.
\item Fischer R, England SM, Archer RC, Dean RK (1966). \textit{Psilocybin reactivity and time contraction as measured by psychomotor performance.}. Arzneimittel-Forschung. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/6014013/}{source link}.
\item Uyeno ET. (1966). \textit{Inhibition of isolation-induced attack behavior of mice by drugs.}. Journal of pharmaceutical sciences. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600550221}{doi:10.1002/jps.2600550221}.
\item Fischer R, Mead EL (1966). \textit{Time contraction and psychomotor performance produced by "Psilocybin".}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/209433a0}{doi:10.1038/209433a0}.
\item Hebbard FW, Fischer R (1966). \textit{Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements.}. Psychopharmacologia. [published; PubMed]. \href{https://doi.org/10.1007/bf00404719}{doi:10.1007/bf00404719}.
\item Keeler MH (1965). \textit{Similarity of schizophrenia and the psilocybin syndrome as determined by objective methods.}. International journal of neuropsychiatry. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4380179/}{source link}.
\item Albert Leung, Alexander H. Smith, A.G. Paul (1965). \textit{Production of Psilocybin in Psilocybe baeocystis Saprophytic Culture}. Journal of Pharmaceutical Sciences. [published; OpenAlex]. \href{https://doi.org/10.1002/jps.2600541104}{doi:10.1002/jps.2600541104}.
\item Sjoberg BM, Hollister LE. (1965). \textit{The effects of psychotomimetic drugs on primary suggestibility.}. Psychopharmacologia. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00407857}{doi:10.1007/bf00407857}.
\item Abramson HA, Rolo A (1965). \textit{Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.}. The Journal of asthma research. [published; PubMed]. \href{https://doi.org/10.3109/02770906509106904}{doi:10.3109/02770906509106904}.
\item Dubanský B, Vyhnánková M (1965). \textit{Pathologic laughter as manifestation of the psychotomimetic action of psilocybin.}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/5882137/}{source link}.
\item Keeler MH (1965). \textit{The effects of psilocybin on a test of after-image perception.}. Psychopharmacologia. [published; PubMed]. \href{https://doi.org/10.1007/bf00404173}{doi:10.1007/bf00404173}.
\item KEELER MH, DOEHNE EF (1965). \textit{CONSISTENCY OF PSILOCYBIN INDUCED CHANGES IN THE MINNESOTA MULTIPHASIC PERSONALITY INVENTORY.}. Journal of clinical psychology. [published; PubMed]. \href{https://doi.org/10.1002/1097-4679(196507)21:3<284::aid-jclp2270210319>3.0.co;2-c}{doi:10.1002/1097-4679(196507)21:3<284::aid-jclp2270210319>3.0.co;2-c}.
\item Timothy Leary, Ralph Metzner, Presnell Madison, Gunther Weil, Schwitzgebel Ralph, Kinne Sara (1965). \textit{A new behavior change program using psilocybin.}. Psychotherapy. [published; OpenAlex]. \href{https://doi.org/10.1037/h0088612}{doi:10.1037/h0088612}.
\item John C. Pollard, Leonard Uhr, Elizabeth Stein (1965). \textit{Drugs and phantasy: the effects of LSD, psilocybin, and sernyl on college students}. Medical Entomology and Zoology. [published; OpenAlex]. \href{https://doi.org/10.1001/jama.1966.03100150141056}{doi:10.1001/jama.1966.03100150141056}.
\item FERNANDEZ-CERDENO A, LEUNER H (1965). \textit{[THE EXPERIENCE OF ORAL REGRESSION DUE TO THE EFFECT OF HALLUCINOGENS (LSD-25 AND PSILOCYBIN)].}. Zeitschrift fur Psycho-somatische Medizin. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14301325/}{source link}.
\item LUDWIG AM, LEVINE J. (1964). \textit{PATTERNS OF HALLUCINOGENIC DRUG ABUSE.}. JAMA. [published; Europe PMC]. \href{https://doi.org/10.1001/jama.1965.03080020020006}{doi:10.1001/jama.1965.03080020020006}.
\item MIYOSHI A (1964). \textit{[A PSYCHOPATHOLOGICAL STUDY OF THE PSILOCYBIN PSYCHOSIS; COMPARISON WITH THE LSD-25 PSYCHOSIS].}. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14286595/}{source link}.
\item DUBANSKY B (1964). \textit{[USE OF PSILOCYBIN AS A DIAGNOSTIC TEST IN NEUROLOGY].}. Casopis lekaru ceskych. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14178690/}{source link}.
\item HOLLISTER LE, SJOBERG BM (1964). \textit{CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.}. Comprehensive psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s0010-440x(64)80030-4}{doi:10.1016/s0010-440x(64)80030-4}.
\item REDA GC, VELLA G, CANCRINI L, D AGOSTINO E (1964). \textit{[CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].}. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14144273/}{source link}.
\item TOLAN EJ, LINGL FA. (1964). \textit{"MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES.}. American Journal of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1176/ajp.120.8.757}{doi:10.1176/ajp.120.8.757}.
\item Joseph Havens (1964). \textit{A Working Paper: Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin)}. Journal for the Scientific Study of Religion. [published; OpenAlex]. \href{https://doi.org/10.2307/1384511}{doi:10.2307/1384511}.
\item P. Catalfomo, Varro E. Tyler (1964). \textit{The production of psilocybin in submerged culture by Psilocybe cubensis.}. Lloydia. [published; OpenAlex]. \href{https://www.cabdirect.org/cabdirect/abstract/19661300859}{source link}.
\item GODET R, DUPE M, BERT J (1964). \textit{[ACTION OF CHLORPROMAZINE AND PSILOCYBIN ON THE TELENCEPHALIC AROUSAL REACTION OF A DIPNOAN].}. Comptes rendus des seances de la Societe de biologie et de ses filiales. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14210583/}{source link}.
\item Alnaes R (1964). \textit{THERAPEUTIC APPLICATION OF THE CHANGE IN CONSCIOUSNESS PRODUCED BY PSYCHOLYTICA (LSD, PSILOCYBIN, ETC.). THE PSYCHEDELIC EXPERIENCE IN THE TREATEMENT OF NEUROSIS.}. Acta psychiatrica Scandinavica. [published; PubMed]. \href{https://doi.org/10.1111/j.1600-0447.1964.tb04952.x}{doi:10.1111/j.1600-0447.1964.tb04952.x}.
\item LEARY T, LITWIN GH, METZNER R (1963). \textit{REACTIONS TO PSILOCYBIN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT.}. The Journal of nervous and mental disease. [published; PubMed]. \href{https://doi.org/10.1097/00005053-196312000-00007}{doi:10.1097/00005053-196312000-00007}.
\item ABRAMSON HA, GETTNER HH, ROLO A, DEAN G (1963). \textit{LYSERGIC ACID DIETHYLAMIDE (LSD-25). 34. COMPARISON WITH EFFECT OF PSILOCYBIN ON THE SIAMESE FIGHTING FISH.}. The Journal of psychology. [published; PubMed]. \href{https://doi.org/10.1080/00223980.1963.9916652}{doi:10.1080/00223980.1963.9916652}.
\item STEINER JE, SULMAN FG (1963). \textit{SIMULTANEOUS STUDIES OF BLOOD SUGAR, BEHAVIOURAL CHANGES AND EEG ON THE WAKE RABBIT AFTER ADMINISTRATION OF PSILOCYBIN.}. Archives internationales de pharmacodynamie et de therapie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14067558/}{source link}.
\item SOGLIANI G, RABASSINI A, BUOSO GM (1963). \textit{[PSYCHOMIMETIC SUBSTANCES. (CONTRIBUTION TO THE CLINICAL PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN)].}. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14093369/}{source link}.
\item McKay J. B., Parkhurst R. M., Silverstein R. M., Skinner W. A. (1963). \textit{ANALOGUES OF PSILOCIN AND LYSERGIC ACID DIETHYLAMIDE I. CHLORO, NITRO, AND AMINO DERIVATIVES OF3-SUBSTITUTED INDOLES}. Canadian Journal of Chemistry. [published; Crossref]. \href{https://doi.org/10.1139/v63-378}{doi:10.1139/v63-378}.
\item HARTMAN AM, HOLLISTER LE (1963). \textit{EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION.}. Psychopharmacologia. [published; PubMed]. \href{https://doi.org/10.1007/bf00403349}{doi:10.1007/bf00403349}.
\item ZSIGMOND EK, FOLDES VM, FOLDES FF (1963). \textit{THE IN VITRO INHIBITORY EFFECT OF PSILOCYBIN AND RELATED COMPOUNDS OF HUMAN CHOLINESTERASES.}. Psychopharmacologia. [published; PubMed]. \href{https://doi.org/10.1007/bf02584093}{doi:10.1007/bf02584093}.
\item UNGER SM (1963). \textit{Mescaline, LSD, psilocybin, and personality change.}. Psychiatry. [published; PubMed]. \href{https://doi.org/10.1080/00332747.1963.11023344}{doi:10.1080/00332747.1963.11023344}.
\item KANDIC B, DORDEVIC D (1963). \textit{[COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].}. Vojnosanitetski pregled. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14067329/}{source link}.
\item DUBANSKY B, KOLARIK R, SEVCIK M, VYHNANKOVA M (1963). \textit{[EFFECT OF PSILOCYBIN ON THE CLINICAL AND ELECTROENCEPHALOGRAPHIC PICTURE IN ORGANIC CNS LESIONS].}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14070660/}{source link}.
\item HORITA A (1963). \textit{Some biochemical studies on psilocybin and psilogin.}. Journal of neuropsychiatry. [published; PubMed]. \href{https://doi.org/10.21236/ad0291057}{doi:10.21236/ad0291057}.
\item BRODEY JF, STEINER WG, HIMWICH HE (1963). \textit{An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809).}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14015664/}{source link}.
\item Brodey James F., Steiner William G., Himwich Harold E. (1963). \textit{AN ELECTROGRAPHIC STUDY OF PSILOCIN AND4-METHYL-α-METHYL TRYPTAMINE (MP-809)}. The Journal of Pharmacology and Experimental Therapeutics. [published; Crossref]. \href{https://doi.org/10.1016/s0022-3565(25)26511-9}{doi:10.1016/s0022-3565(25)26511-9}.
\item TOSCANO AGUILAR M (1963). \textit{[Psilocybin: prospects of its use in clinical psychiatry].}. Acta neurologica et psychiatrica Belgica. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13993760/}{source link}.
\item KEELER MH (1963). \textit{Inter-relations of the effects of psilocybin on subjective sensation, photopic critical frequency of fusion, and circulating non-esterified fatty acids.}. Experientia. [published; PubMed]. \href{https://doi.org/10.1007/bf02135348}{doi:10.1007/bf02135348}.
\item ALDAHEFF BW (1963). \textit{[The psychomimetic effects of LSD and psilocybin in the clinical exploration of the personality].}. Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14011802/}{source link}.
\item CALANCA A (1963). \textit{[Auto-experimentation with LSD-25 and psilocybin].}. Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14017795/}{source link}.
\item KRISTENSEN KK (1963). \textit{[CLINICAL EXPERIENCES WITH PSILOCYBIN].}. Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.3109/08039486309132763}{doi:10.3109/08039486309132763}.
\item WIART C (1963). \textit{[AUTO-OBSERVATION OF2 EXPERIMENTAL INTOXICATIONS WITH PSILOCYBIN].}. Confinia psychiatrica. Borderland of psychiatry. Grenzgebiete der Psychiatrie. Les Confins de la psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14070405/}{source link}.
\item DORDEVIC D (1963). \textit{[OUR CLINICAL EXPERIENCE WITH A NEW PHARMACOLOGICAL PREPARATION PSILOCYBIN].}. Neuropsihijatrija. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14181869/}{source link}.
\item GREGORETTI L, SINISI C (1962). \textit{[Pharmacopsychiatric observations with psilocybin].}. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13950258/}{source link}.
\item HORITA A, WEBER LJ (1962). \textit{Dephosphorylation of psilocybin in the intact mouse.}. Toxicology and applied pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0041-008x(62)90102-3}{doi:10.1016/0041-008x(62)90102-3}.
\item R. Gordon Wasson (1962). \textit{The Hallucinogenic Mushrooms of Mexico and Psilocybin: a Bibliography}. Botanical Museum leaflets Harvard University. [published; OpenAlex]. \href{https://doi.org/10.5962/p.168536}{doi:10.5962/p.168536}.
\item ADEY WR, BELL FR, DENNIS BJ (1962). \textit{Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.}. Neurology. [published; PubMed]. \href{https://doi.org/10.1212/wnl.12.9.591}{doi:10.1212/wnl.12.9.591}.
\item HOLLISTER LE, HARTMAN AM (1962). \textit{Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.}. Comprehensive psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s0010-440x(62)80024-8}{doi:10.1016/s0010-440x(62)80024-8}.
\item WOOLLEY DW, CAMPBELL NK (1962). \textit{Serotonin-like and antiserotonin properties of psilocybin and psilocin.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.136.3518.777}{doi:10.1126/science.136.3518.777}.
\item MAXWELL GM, KNEEBONE GM, ELLIOTT RB (1962). \textit{The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.}. Archives internationales de pharmacodynamie et de therapie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14471633/}{source link}.
\item BENEDICT RG, BRADY LR, TYLER VE (1962). \textit{Occurrence of psilocin in Psilocybe baeocystis.}. Journal of pharmaceutical sciences. [published; PubMed]. \href{https://doi.org/10.1002/jps.2600510428}{doi:10.1002/jps.2600510428}.
\item CHRISTIANSEN A, BAUM R, WITT PN (1962). \textit{Changes in spider webs brought about by mescaline, psilocybin and an increase in body weight.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/s0022-3565(25)26256-5}{doi:10.1016/s0022-3565(25)26256-5}.
\item Bernard Wilkens, Sidney Malitz, Harold Esecover (1962). \textit{CLINICAL OBSERVATIONS OF SIMULTANEOUS HALLUCINOGEN ADMINISTRATION IN IDENTICAL TWINS}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/ajp.118.9.815}{doi:10.1176/ajp.118.9.815}.
\item R. G. Benedict, L.R. Brady, Alexander H. Smith, Varro E. Tyler (1962). \textit{Occurrence of psilocybin and psilocin in certain Gonocybe and Psilocybe species.}. Lloydia. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19631301636.html}{source link}.
\item HEIMANN H (1962). \textit{[On the treatment of therapy-resistant neuroses with model psychoses (psilocybin)].}. Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13906023/}{source link}.
\item WOLBACH AB, MINER EJ, ISBELL H (1962). \textit{Comparison of psilocin with psilocybin, mescaline and LSD-25.}. Psychopharmacologia. [published; PubMed]. \href{https://doi.org/10.1007/bf00412109}{doi:10.1007/bf00412109}.
\item KALBERER F, KREIS W, RUTSCHMANN J (1962). \textit{The fate of psilocin in the rat.}. Biochemical pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0006-2952(62)90050-3}{doi:10.1016/0006-2952(62)90050-3}.
\item REDA GC, VELLA G, CASINI-NENCINI MG, D'AGOSTINO N, CANCRINI L (1962). \textit{[Initial results of the action of psilocybin in a group of psychiatric patients].}. Rivista di neurologia. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13973488/}{source link}.
\item DUCHE DJ (1961). \textit{[The effects of psilocybin in a case of hysteria].}. La semaine des hopitaux: organe fonde par l'Association d'enseignement medical des hopitaux de Paris. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13888139/}{source link}.
\item HORITA A, WEBER LJ (1961). \textit{The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates.}. Biochemical pharmacology. [published; PubMed]. \href{https://doi.org/10.1016/0006-2952(61)90124-1}{doi:10.1016/0006-2952(61)90124-1}.
\item VITEK V, VOJTECHOVSKY M, GROF S (1961). \textit{[Serotonin metabolism in experimental psilocybin psychosis].}. Activitas nervosa superior. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13926289/}{source link}.
\item Elemér K. Zsigmond, F. F. Foldes, V. M. Foldes (1961). \textit{The inhibitory effect of psilocybin and related compounds on human cholinesterases}. Federation Proceedings. [published; OpenAlex]. \href{https://eurekamag.com/research/025/833/025833520.php}{source link}.
\item HOLLISTER LE (1961). \textit{Clinical, biochemical and psychologic effects of psilocybin.}. Archives internationales de pharmacodynamie et de therapie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13715376/}{source link}.
\item Richard R. Heim (1961). \textit{Psilocybin in psychiatry, and beyond.}. Revue de Mycologie. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19631301013.html}{source link}.
\item Jacoby, John Eric (1961). \textit{The effects of psilocybin and lycergic acid on the extinction of avoidance behavior in rats.}. The Mouseion at the JAXlibrary (Jackson Laboratory). [published; OpenAlex]. \href{https://mouseion.jax.org/strp/1105}{source link}.
\item HEIMANN H (1961). \textit{[Expressive phenomenology of model psychoses (psilocybin). Comparison with self-description and psychic deficiency of performance].}. Psychiatria et neurologia. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13712866/}{source link}.
\item HORITA A, WEBER LJ (1961). \textit{Dephosphorylation of psilocybin to psilocin by alkaline phosphatase.}. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.3181/00379727-106-26228}{doi:10.3181/00379727-106-26228}.
\item ISBELL H, WOLBACH AB, WIKLER A, MINER EJ (1961). \textit{Cross tolerance between LSD and psilocybin.}. Psychopharmacologia. [published; PubMed]. \href{https://doi.org/10.1007/bf00407974}{doi:10.1007/bf00407974}.
\item HOLFELD H (1961). \textit{[Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].}. Medicina experimentalis: International journal of experimental medicine. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13908338/}{source link}.
\item SERCL M, KOVARIK J, JAROS O (1961). \textit{[Clinical experiences with psilocybin (CY39 Sandoz)].}. Psychiatria et neurologia. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13910754/}{source link}.
\item SERCL M, KOVARIK J, JAROS O (1961). \textit{[Clinical experiences with psilocybin Sandoz (CY39 Sandoz)].}. Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13910755/}{source link}.
\item CHAUCHARD P, MAZOUE H (1961). \textit{[Action of psilocybin on the excitability of the nerve centers].}. Comptes rendus des seances de la Societe de biologie et de ses filiales. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/24545494/}{source link}.
\item F. Silva, R.G. Heath, Thomas Rafferty, Robert A. Johnson, William R. Robinson (1960). \textit{Comparative effects of the administration of taraxein, d-LSD, mescaline, and psilocybin to human volunteers}. Comprehensive Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0010-440x(60)80060-0}{doi:10.1016/s0010-440x(60)80060-0}.
\item POLLARD JC, BAKKER C, UHR L, FEUERFILE DF (1960). \textit{Controlled sensory input: a note on the technic of drug evaluation with a preliminary report on a comparative study of sernyl, psilocybin, and LSD-25.}. Comprehensive psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s0010-440x(60)80061-2}{doi:10.1016/s0010-440x(60)80061-2}.
\item HOLLISTER LE, PRUSMACK JJ, PAULSEN A, ROSENQUIST N (1960). \textit{Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects.}. The Journal of nervous and mental disease. [published; PubMed]. \href{https://doi.org/10.1097/00005053-196011000-00007}{doi:10.1097/00005053-196011000-00007}.
\item GESSNER PK, KHAIRALLAH PA, McISAAC WM, PAGE IH (1960). \textit{The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin.}. The Journal of pharmacology and experimental therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/s0022-3565(25)25873-6}{doi:10.1016/s0022-3565(25)25873-6}.
\item S MALITZ, H ESECOVER, B WILKENS, P HOCH (1960). \textit{Some observations on psilocybin, a new hallucinogen, in volunteer subjects}. Corrosion Science. [published; OpenAlex]. \href{https://doi.org/10.1016/s0010-938x(60)80004-2}{doi:10.1016/s0010-938x(60)80004-2}.
\item MALITZ S, ESECOVER H, WILKENS B, HOCH PH (1960). \textit{Some observations on psilocybin, a new hallucinogen, in volunteer subjects.}. Comprehensive psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/s0010-440x(60)80045-4}{doi:10.1016/s0010-440x(60)80045-4}.
\item ROUBICEK J, DRVOTA S (1960). \textit{[Psilocybin, a new hallucinogen].}. Ceskoslovenska psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14439519/}{source link}.
\item K. S�llner (1960). \textit{Zur Identifizierung von Psilocin, einem psychotropen Inhaltstoff mexikanischer Rauschpilze der Gattungen Psilocybe und Stropharia}. Analytical and Bioanalytical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1007/bf00449214}{doi:10.1007/bf00449214}.
\item Henri Michaux (1960). \textit{Psilocybin (experiments and subjective criticism).}. Revue de Mycologie. [published; OpenAlex]. \href{https://www.cabdirect.org/cabdirect/abstract/19631300232}{source link}.
\item Harold A. Abramson, Anabela P. Rolo, B. Sklarofsky, J. Stache (1960). \textit{Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and Psilocybin}. The Journal of Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/00223980.1960.9916396}{doi:10.1080/00223980.1960.9916396}.
\item WEIDMANN H, CERLETTI A (1960). \textit{Studies on psilocybin and related compounds. I. Communication. Structure/activity relationship of oxyindole-derivatives with regard to their effect on the knee jerk of spinal cats.}. Helvetica physiologica et pharmacologica acta. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13843476/}{source link}.
\item CERLETTI A (1959). \textit{[Teonanacatl and psilocybin].}. Deutsche medizinische Wochenschrift (1946). [published; PubMed]. \href{https://doi.org/10.1055/s-0028-1114618}{doi:10.1055/s-0028-1114618}.
\item DELAY J, PICHOT P, LEMPERIERE T, QUETIN AM (1959). \textit{[Therapeutic effect of psilocybin on convulsive neurosis].}. Annales medico-psychologiques. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13815609/}{source link}.
\item MONNIER M (1959). \textit{[The action of psilocybin on the rabbit brain].}. Experientia. [published; PubMed]. \href{https://doi.org/10.1007/bf02158550}{doi:10.1007/bf02158550}.
\item W. de Borr (1959). \textit{Psilocybin - eine neue psychotrope Substanz}. DMW - Deutsche Medizinische Wochenschrift. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1114457}{doi:10.1055/s-0028-1114457}.
\item HOFMANN A, TROXLER F (1959). \textit{[Identification of psilocin].}. Experientia. [published; PubMed]. \href{https://doi.org/10.1007/bf02166696}{doi:10.1007/bf02166696}.
\item F. Troxler, Frauke Seemann, A. Hofmann (1959). \textit{Abwandlungsprodukte von Psilocybin und Psilocin. 2. Mitteilung über synthetische Indolverbindungen}. Helvetica Chimica Acta. [published; OpenAlex]. \href{https://doi.org/10.1002/hlca.19590420638}{doi:10.1002/hlca.19590420638}.
\item A. Hofmann, Richard R. Heim, A. Brack, H. Kobel, A. Frey, H. Ott, Th. Petrzilka, F. Troxler (1959). \textit{Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen}. Helvetica Chimica Acta. [published; OpenAlex]. \href{https://doi.org/10.1002/hlca.19590420518}{doi:10.1002/hlca.19590420518}.
\item DELAY J, THUILLIER J, NAKAJIMA H, DURANDIN MC (1959). \textit{[Effect of psilocybin on the behavior of normal mice \& waltzing mice; comparison with lysergic acid monoethylamide \& diethylamide].}. Comptes rendus des seances de la Societe de biologie et de ses filiales. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13663414/}{source link}.
\item GNIRSS F (1959). \textit{[Studies on psilocybin, a hallucinogenic drug from the Mexican mushroom Psilocybe mexicana].}. Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/13850311/}{source link}.
\item ISBELL H (1959). \textit{Comparison of the reactions induced by psilocybin and LSD-25 in man.}. Psychopharmacologia. [published; PubMed]. \href{https://doi.org/10.1007/bf00408109}{doi:10.1007/bf00408109}.
\item RUEMMELE W (1959). \textit{[The place of psilocybin among other psychotropic substances].}. Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/14440055/}{source link}.
\item HOFMANN A, FREY A, OTT H, PETR ZILKA T, TROXLER F (1958). \textit{[Elucidation of the structure and the synthesis of psilocybin].}. Experientia. [published; PubMed]. \href{https://doi.org/10.1007/bf02160424}{doi:10.1007/bf02160424}.
\item WEIDMANN H, TAESCHLER M, KONZETT H (1958). \textit{[The pharmacology of psilocybin, an ac' principle from Psilocybe mexicana Heim].}. Experientia. [published; PubMed]. \href{https://doi.org/10.1007/bf02159166}{doi:10.1007/bf02159166}.
\item HOFMANN A, HEIM R, BRACK A, KOBEL H (1958). \textit{[Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim].}. Experientia. [published; PubMed]. \href{https://doi.org/10.1007/bf02159243}{doi:10.1007/bf02159243}.
\item A. Hofmann, Richard R. Heim, A. Brack, H. Kobel (1958). \textit{Psilocybin, an active psychotropic material from the Mexican hallucinogenic fungus.}. Revue de Mycologie. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19601300599.html}{source link}.
\item Richard R. Heim, A. Brack, H. Kobel, A. Hofmann, R Cailleux (1958). \textit{The determination of the formation of the carpophores and sclerotia in culture of Psilocybe mexicana Heim, a Mexican, hallucinogenic agaric, and the demonstration of the presence of psilocybin and psilocin.}. Revue de Mycologie. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19601300598.html}{source link}.
\end{enumerate}
\end{document}
